CURB,ASCTY,AST,DI,ASSTT,ASSCAT,SRI,VAI,ASSSUBCEFRAC,RELATY,CI,ASSI,BAFO,ASSST,CONSCO,SRASSI,ASSTAI,TII,Ti,Des,ASSORG,CHEI,ASTI
Intermediate,,A,9866,In vivo,,1,,,N,,7524,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Rattus norvegicus,CHEMBL618647,Kidney
Intermediate,,A,9866,In vivo,,1,,,N,,7525,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,Rattus norvegicus,CHEMBL618648,Kidney
Intermediate,,A,9866,In vivo,,1,,,N,,7526,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,Rattus norvegicus,CHEMBL618649,Kidney
Intermediate,,A,9866,In vivo,,1,,,N,,7527,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Rattus norvegicus,CHEMBL618650,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,7528,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,Rattus norvegicus,CHEMBL618651,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,7529,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,Rattus norvegicus,CHEMBL876497,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,7530,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Rattus norvegicus,CHEMBL618652,Lung
Intermediate,,A,9866,In vivo,,1,,,N,,7531,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,Rattus norvegicus,CHEMBL618653,Lung
Intermediate,,A,9866,In vivo,,1,,,N,,7532,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,Rattus norvegicus,CHEMBL618654,Lung
Intermediate,,A,6351,,,1,,,N,,7533,BAO_0000218,,1,,10116.0,,50597,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,Rattus norvegicus,CHEMBL618655,
Intermediate,,A,1465,,,1,,,N,,7534,BAO_0000218,,1,,10116.0,,50597,Compound was tested for solubility in water,Rattus norvegicus,CHEMBL618656,
Intermediate,,P,5182,,,1,,,U,,7535,BAO_0000100,,0,,,,22229,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),,CHEMBL618657,
Intermediate,,A,17847,,,1,,,N,,7536,BAO_0000218,,1,,10116.0,,50597,Solubility was determined,Rattus norvegicus,CHEMBL618658,
Intermediate,,A,15339,,,1,,,N,,7537,BAO_0000218,,1,,10116.0,,50597,solubility in water (ug/mL) at 37 degree C.,Rattus norvegicus,CHEMBL618659,
Intermediate,,A,5202,,,1,,,N,,7538,BAO_0000218,,1,,10116.0,,50597,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,Rattus norvegicus,CHEMBL618660,
Intermediate,,A,1088,,,1,,,N,,7539,BAO_0000218,,1,,10116.0,,50597,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,Rattus norvegicus,CHEMBL618661,
Intermediate,,A,3169,,,1,,,N,,7540,BAO_0000218,,1,,10116.0,,50597,Half life in rats,Rattus norvegicus,CHEMBL873807,
Intermediate,,A,5353,,,1,,,N,,7541,BAO_0000218,,1,,10116.0,,50597,Half life in Dawley rat,Rattus norvegicus,CHEMBL618662,
Intermediate,,A,2864,In vivo,,1,,,N,,7542,BAO_0000218,,1,,10116.0,,50597,Half life period after 3 mg/kg iv administration,Rattus norvegicus,CHEMBL618663,
Intermediate,,A,2864,In vivo,,1,,,N,,7543,BAO_0000218,,1,,10116.0,,50597,Half life period after 3 mg/kg iv administration in rat,Rattus norvegicus,CHEMBL618664,
Intermediate,,A,2864,In vivo,,1,,,N,,7544,BAO_0000218,,1,,10116.0,,50597,Half life period after 3 mg/kg iv administration in the rat,Rattus norvegicus,CHEMBL618665,
Intermediate,,A,6362,,,1,,,N,,7545,BAO_0000218,,1,,10116.0,,50597,Half life period in female Sprague-Dawley rats,Rattus norvegicus,CHEMBL876498,
Intermediate,,A,6249,,,1,,,N,,7546,BAO_0000218,,1,,10116.0,,50597,Half life period in rat,Rattus norvegicus,CHEMBL618666,
Intermediate,,A,3169,,,1,,,N,,7547,BAO_0000218,,1,,10116.0,,50597,Half-life in rats was determined,Rattus norvegicus,CHEMBL620440,
Intermediate,,A,3169,,,1,,,N,,7548,BAO_0000218,,1,,10116.0,,50597,Half-life in rats with metabolic oxidation,Rattus norvegicus,CHEMBL620441,
Intermediate,,A,3169,,,1,,,N,,7549,BAO_0000218,,1,,10116.0,,50597,Half-life in rats,Rattus norvegicus,CHEMBL620442,
Intermediate,,A,17260,In vivo,,1,,,N,,7550,BAO_0000218,,1,,10116.0,,50597,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Rattus norvegicus,CHEMBL620443,
Intermediate,,A,17260,In vivo,,1,,,N,,7551,BAO_0000218,,1,,10116.0,,50597,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Rattus norvegicus,CHEMBL620444,
Intermediate,,A,17260,In vivo,,1,,,N,,7552,BAO_0000218,,1,,10116.0,,50597,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Rattus norvegicus,CHEMBL620445,
Intermediate,,A,17260,In vivo,,1,,,N,,7553,BAO_0000218,,1,,10116.0,,50597,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Rattus norvegicus,CHEMBL620446,
Intermediate,,A,2879,,,1,,,N,,7554,BAO_0000218,,1,,10116.0,1969.0,50597,Biological half-life measured in plasma of rat,Rattus norvegicus,CHEMBL620447,Plasma
Intermediate,,A,2879,,,1,,,N,,7555,BAO_0000218,,1,,10116.0,1969.0,50597,Biological half-life measured in plasma of rat; 22-25,Rattus norvegicus,CHEMBL621129,Plasma
Intermediate,,A,2879,,,1,,,N,,7556,BAO_0000218,,1,,10116.0,1969.0,50597,Biological half-life measured in plasma of rat; 9-16,Rattus norvegicus,CHEMBL621130,Plasma
Intermediate,,A,3184,In vivo,,1,,,N,,7557,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for its half life when administered intravenously in rat,Rattus norvegicus,CHEMBL873808,
Intermediate,,A,4891,In vivo,,1,,,N,,7558,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,Rattus norvegicus,CHEMBL876598,
Intermediate,,A,429,In vivo,,1,,,N,,7559,BAO_0000218,,1,,10116.0,,50597,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,Rattus norvegicus,CHEMBL621131,
Intermediate,,A,5656,In vivo,,1,,,N,,7560,BAO_0000218,,1,,10116.0,,50597,Half life (T1/2) after oral administration in rat,Rattus norvegicus,CHEMBL621132,
Intermediate,,A,4413,In vivo,,1,,,N,,7561,BAO_0000218,,1,,10116.0,,50597,Half life of compound after iv administration of 20 mg/kg dose in rat,Rattus norvegicus,CHEMBL621133,
Expert,,A,3598,In vivo,,1,,,N,,7562,BAO_0000218,,1,,10116.0,,50597,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,CHEMBL621312,
Intermediate,,A,17267,,,1,,,N,,7563,BAO_0000218,,1,,10116.0,,50597,Half life of compound was determined in rat,Rattus norvegicus,CHEMBL621313,
Intermediate,,A,4727,,,1,,,N,,7564,BAO_0000218,,1,,10116.0,178.0,50597,Half life of compound was determined in rat blood,Rattus norvegicus,CHEMBL621314,Blood
Intermediate,,A,17651,In vivo,,1,,,N,,7565,BAO_0000218,,1,,10116.0,,50597,Half life at 1 mg/kg was determined in rat,Rattus norvegicus,CHEMBL621315,
Intermediate,,A,17651,In vivo,,1,,,N,,7566,BAO_0000218,,1,,10116.0,,50597,Half life at 10 mg/kg was determined in rat,Rattus norvegicus,CHEMBL621316,
Intermediate,,A,401,,,1,,,N,,7567,BAO_0000218,,1,,10116.0,,50597,Half life in rats,Rattus norvegicus,CHEMBL621317,
Intermediate,,A,4942,,,1,,,N,,7568,BAO_0000218,,1,,10116.0,,50597,Half life in rats in hours,Rattus norvegicus,CHEMBL621318,
Intermediate,,A,17735,In vivo,,1,,,N,,7569,BAO_0000218,,1,,10116.0,,50597,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,Rattus norvegicus,CHEMBL621319,
Intermediate,,A,6056,In vivo,,1,,,N,,7570,BAO_0000218,,1,,10116.0,,50597,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,Rattus norvegicus,CHEMBL621377,
Intermediate,,A,5213,,,1,,,N,,7571,BAO_0000218,,1,,10116.0,,50597,Half life was determined,Rattus norvegicus,CHEMBL621378,
Intermediate,,A,6616,In vivo,,1,,,N,,7572,BAO_0000218,,1,,10116.0,,50597,Half life after i.v. administration,Rattus norvegicus,CHEMBL876599,
Intermediate,,A,5937,In vivo,,1,,,N,,7573,BAO_0000218,,1,,10116.0,,50597,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,Rattus norvegicus,CHEMBL621379,
Intermediate,,A,5819,,,1,,,N,,7574,BAO_0000218,,1,,10116.0,1969.0,50597,Half life in rat plasma,Rattus norvegicus,CHEMBL621380,Plasma
Intermediate,,A,5819,,,1,,,N,,7575,BAO_0000218,,1,,10116.0,1969.0,50597,Half life in rat plasma; Not detected,Rattus norvegicus,CHEMBL621381,Plasma
Intermediate,,A,6803,,,1,,,N,,7576,BAO_0000218,,1,,10116.0,,50597,Half life in rats,Rattus norvegicus,CHEMBL618515,
Intermediate,,A,17804,In vivo,,1,,,N,,7577,BAO_0000218,,1,,10116.0,,50597,Half life period of compound was determined after peroral administration,Rattus norvegicus,CHEMBL618516,
Intermediate,,A,17804,In vivo,,1,,,N,,7578,BAO_0000218,,1,,10116.0,,50597,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,Rattus norvegicus,CHEMBL618517,
Intermediate,,A,5948,,,1,,,N,,7579,BAO_0000218,,1,,10116.0,,50597,Half life period in rat,Rattus norvegicus,CHEMBL618518,
Intermediate,,A,1916,In vivo,,1,,,N,,7580,BAO_0000218,,1,,10116.0,,50597,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,Rattus norvegicus,CHEMBL618519,
Intermediate,,A,1916,In vivo,,1,,,N,,7581,BAO_0000218,,1,,10116.0,,50597,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Rattus norvegicus,CHEMBL618698,
Intermediate,,A,1916,In vivo,,1,,,N,,7582,BAO_0000218,,1,,10116.0,,50597,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,Rattus norvegicus,CHEMBL618862,
Intermediate,,A,4890,In vivo,,1,,,N,,7583,BAO_0000218,,1,,10116.0,,50597,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,CHEMBL618863,
Intermediate,,A,17764,In vivo,,1,,,N,,7584,BAO_0000218,,1,,10116.0,,50597,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,Rattus norvegicus,CHEMBL618864,
Intermediate,,A,4727,In vivo,,1,,,N,,7585,BAO_0000218,,1,,10116.0,,50597,Half life time in rat the dose of 2 mg/kg,Rattus norvegicus,CHEMBL618865,
Intermediate,,A,17509,In vivo,,1,,,N,,7586,BAO_0000218,,1,,10116.0,,50597,Half-life 24 hr after 10 mg/kg iv administration in rats,Rattus norvegicus,CHEMBL618866,
Intermediate,,A,17509,In vivo,,1,,,N,,7587,BAO_0000218,,1,,10116.0,,50597,Half-life 24 hr after 2 mg/kg iv administration in rats,Rattus norvegicus,CHEMBL618867,
Intermediate,,A,6597,,,1,,,N,,7588,BAO_0000218,,1,,10116.0,,50597,Half-life consistent with the observed metabolic steady state in rats,Rattus norvegicus,CHEMBL875828,
Intermediate,,A,17735,In vivo,,1,,,N,,7589,BAO_0000218,,1,,10116.0,,50597,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,Rattus norvegicus,CHEMBL618868,
Intermediate,,A,6597,,,1,,,N,,7590,BAO_0000218,,1,,10116.0,,50597,Half-life for oxidative metabolic stability was determined using male human,Rattus norvegicus,CHEMBL618869,
Intermediate,,A,17670,In vivo,,1,,,N,,7591,BAO_0000218,,1,,10116.0,,50597,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",Rattus norvegicus,CHEMBL618870,
Intermediate,,A,1696,,,1,,,N,,7592,BAO_0000218,,1,,10116.0,1969.0,50597,Half-life in rat plasma,Rattus norvegicus,CHEMBL618871,Plasma
Intermediate,,A,1742,,,1,,,N,,7593,BAO_0000218,,1,,10116.0,1969.0,50597,Half-life in rat plasma was determined,Rattus norvegicus,CHEMBL618872,Plasma
Intermediate,,A,17800,,,1,,,N,,7594,BAO_0000218,,1,,10116.0,,50597,Half-life in rats was determined,Rattus norvegicus,CHEMBL873816,
Autocuration,,A,12923,,,1,,,U,,7595,BAO_0000218,,0,,,,22224,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,,CHEMBL618873,
Autocuration,,A,11954,,,1,,,U,,7596,BAO_0000019,,0,,,,22224,Area under curve after oral dose of 0.1 mg//kg,,CHEMBL621602,
Autocuration,,A,11954,,,1,,,U,,7597,BAO_0000218,,0,,,,22224,Area under curve after oral dose of 0.3 mg/kg,,CHEMBL621603,
Autocuration,,A,11954,,,1,,,U,,7598,BAO_0000218,,0,,,,22224,Area under curve after oral dose of 1 mg/kg,,CHEMBL621604,
Autocuration,,A,11954,,,1,,,U,,7599,BAO_0000218,,0,,,,22224,Area under curve after oral dose of 10 mg/kg,,CHEMBL621605,
Autocuration,,A,11954,,,1,,,U,,7600,BAO_0000218,,0,,,,22224,Area under curve after oral dose of 23.4 mg/kg,,CHEMBL621606,
Autocuration,,A,11954,,,1,,,U,,7601,BAO_0000218,,0,,,,22224,Area under curve after oral dose of 3 mg/kg,,CHEMBL621607,
Autocuration,,A,11954,,,1,,,U,,7602,BAO_0000218,,0,,,,22224,Area under curve after oral dose of 3.87 mg/kg,,CHEMBL621608,
Autocuration,,A,5237,,,1,,,U,,7603,BAO_0000019,,0,,,,22224,Area under curve was determined,,CHEMBL621609,
Autocuration,,A,4026,,,1,,,U,,7604,BAO_0000218,,0,,,,22224,Area under curve at a dose of 10 mg/kg,,CHEMBL621610,
Intermediate,,A,5237,,,1,,,N,,7605,BAO_0000218,,1,,10116.0,,50597,Area under curve was determined; ND=No data,Rattus norvegicus,CHEMBL621611,
Intermediate,,A,14793,,,1,,,N,,7606,BAO_0000218,,1,,10116.0,,50597,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,Rattus norvegicus,CHEMBL621612,
Intermediate,,A,14793,,,1,,,N,,7607,BAO_0000218,,1,,10116.0,,50597,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,Rattus norvegicus,CHEMBL622308,
Intermediate,,A,14793,,,1,,,N,,7608,BAO_0000218,,1,,10116.0,,50597,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,Rattus norvegicus,CHEMBL622309,
Intermediate,,A,14793,,,1,,,N,,7609,BAO_0000218,,1,,10116.0,,50597,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,Rattus norvegicus,CHEMBL622310,
Intermediate,,A,14793,,,1,,,N,,7610,BAO_0000218,,1,,10116.0,,50597,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,Rattus norvegicus,CHEMBL622311,
Intermediate,,A,14793,,,1,,,N,,7611,BAO_0000218,,1,,10116.0,,50597,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,Rattus norvegicus,CHEMBL622312,
Intermediate,,A,14793,,,1,,,N,,7612,BAO_0000218,,1,,10116.0,,50597,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,Rattus norvegicus,CHEMBL622931,
Intermediate,,A,14793,,,1,,,N,,7613,BAO_0000218,,1,,10116.0,,50597,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,Rattus norvegicus,CHEMBL622932,
Intermediate,,A,14793,,,1,,,N,,7614,BAO_0000218,,1,,10116.0,1969.0,50597,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,Rattus norvegicus,CHEMBL622736,Plasma
Intermediate,,A,14793,,,1,,,N,,7615,BAO_0000218,,1,,10116.0,1969.0,50597,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,Rattus norvegicus,CHEMBL622737,Plasma
Intermediate,,A,14793,,,1,,,N,,7616,BAO_0000218,,1,,10116.0,1969.0,50597,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,Rattus norvegicus,CHEMBL622738,Plasma
Intermediate,,A,14793,,,1,,,N,,7617,BAO_0000218,,1,,10116.0,1969.0,50597,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,Rattus norvegicus,CHEMBL622739,Plasma
Intermediate,,A,14793,,,1,,,N,,7618,BAO_0000218,,1,,10116.0,1969.0,50597,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,Rattus norvegicus,CHEMBL622740,Plasma
Intermediate,,A,14793,,,1,,,N,,7619,BAO_0000218,,1,,10116.0,1969.0,50597,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,Rattus norvegicus,CHEMBL622741,Plasma
Intermediate,,A,14793,,,1,,,N,,7620,BAO_0000218,,1,,10116.0,1969.0,50597,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,Rattus norvegicus,CHEMBL622742,Plasma
Intermediate,,A,14793,,,1,,,N,,7621,BAO_0000218,,1,,10116.0,1969.0,50597,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,Rattus norvegicus,CHEMBL622743,Plasma
Intermediate,,A,11637,,,1,,,N,,7622,BAO_0000218,,1,,10090.0,1969.0,50594,AUC in mice,Mus musculus,CHEMBL622744,Plasma
Autocuration,,A,11149,,,1,,,U,,7623,BAO_0000019,,0,,,,22224,Area under curve was measured from the graph obtained from concentration Vs time,,CHEMBL624134,
Autocuration,,A,10016,,,1,,,U,,7624,BAO_0000019,,0,,,,22224,Area under curve value of compound per hour after oral administration,,CHEMBL624135,
Intermediate,,A,17796,,,1,,,N,,7625,BAO_0000218,,1,,10116.0,,50597,Area under curve was determined after oral administration in rats,Rattus norvegicus,CHEMBL624136,
Intermediate,,A,17796,,,1,,,N,,7626,BAO_0000218,,1,,10116.0,,50597,Area under curve was determined after oral administration in rats; No data,Rattus norvegicus,CHEMBL624137,
Intermediate,,A,17796,,,1,,,N,,7627,BAO_0000218,,1,,10116.0,,50597,Area under curve was determined after oral administration in rats;No data,Rattus norvegicus,CHEMBL624320,
Intermediate,,A,12923,,,1,,,N,,7628,BAO_0000218,,1,,9615.0,,50588,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,Canis lupus familiaris,CHEMBL624321,
Intermediate,,A,15372,,,1,,,N,,7629,BAO_0000218,,1,,10116.0,,50597,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,Rattus norvegicus,CHEMBL624322,
Intermediate,,A,15372,,,1,,,N,,7630,BAO_0000218,,1,,10116.0,,50597,Area under curve was determined for the compound after iv dose of 5.06 in rats,Rattus norvegicus,CHEMBL624323,
Intermediate,,A,15372,,,1,,,N,,7631,BAO_0000218,,1,,10116.0,,50597,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,Rattus norvegicus,CHEMBL624324,
Intermediate,,A,15372,,,1,,,N,,7632,BAO_0000218,,1,,10116.0,,50597,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,Rattus norvegicus,CHEMBL624325,
Intermediate,,A,15372,,,1,,,N,,7633,BAO_0000218,,1,,10116.0,,50597,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,Rattus norvegicus,CHEMBL624326,
Intermediate,,A,15372,,,1,,,N,,7634,BAO_0000218,,1,,10116.0,,50597,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,Rattus norvegicus,CHEMBL624327,
Intermediate,,A,15372,,,1,,,N,,7635,BAO_0000218,,1,,10116.0,,50597,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,Rattus norvegicus,CHEMBL624328,
Intermediate,,A,14169,,,1,,,N,,7636,BAO_0000218,,1,,9615.0,,50588,Area under curve was determined in Dogs after peroral administration,Canis lupus familiaris,CHEMBL627848,
Intermediate,,A,14169,,,1,,,N,,7637,BAO_0000218,,1,,10116.0,,50597,Area under curve was determined in Rats after peroral administration,Rattus norvegicus,CHEMBL627849,
Intermediate,,A,14258,,,1,,,N,,7638,BAO_0000218,,1,,10116.0,,50597,Area under curve was determined in carotid blood of rat when administered intradermally,Rattus norvegicus,CHEMBL627850,
Intermediate,,A,14258,,,1,,,N,,7639,BAO_0000218,,1,,10116.0,,50597,Area under curve was determined in portal blood of rat when administered intradermally,Rattus norvegicus,CHEMBL627851,
Intermediate,,A,15011,,,1,,,N,,7640,BAO_0000218,,1,,10090.0,,50594,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,Mus musculus,CHEMBL627852,
Intermediate,,A,15011,,,1,,,N,,7641,BAO_0000218,,1,,10090.0,,50594,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,Mus musculus,CHEMBL627853,
Intermediate,,A,15011,,,1,,,N,,7642,BAO_0000218,,1,,10090.0,,50594,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),Mus musculus,CHEMBL627854,
Intermediate,,A,15011,,,1,,,N,,7643,BAO_0000218,,1,,10090.0,,50594,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,Mus musculus,CHEMBL627855,
Intermediate,,A,15011,,,1,,,N,,7644,BAO_0000218,,1,,10090.0,,50594,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),Mus musculus,CHEMBL627856,
Intermediate,,A,15011,,,1,,,N,,7645,BAO_0000218,,1,,10090.0,,50594,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,Mus musculus,CHEMBL875339,
Intermediate,,A,15011,,,1,,,N,,7646,BAO_0000218,,1,,10090.0,,50594,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),Mus musculus,CHEMBL627857,
Intermediate,,A,11195,In vivo,,1,,,N,,7647,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,Rattus norvegicus,CHEMBL627858,Spleen
Intermediate,,A,10130,,,1,,,N,,7648,BAO_0000218,,1,,10116.0,178.0,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL627859,Blood
Intermediate,,A,10130,,,1,,,N,,7649,BAO_0000218,,1,,10116.0,955.0,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL627860,Brain
Intermediate,,A,10130,,,1,,,N,,7650,BAO_0000218,,1,,10116.0,948.0,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL627019,Heart
Intermediate,,A,10130,,,1,,,N,,7651,BAO_0000218,,1,,10116.0,2107.0,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL627020,Liver
Intermediate,,A,10130,,,1,,,N,,7652,BAO_0000218,,1,,10116.0,2048.0,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL627021,Lung
Intermediate,,A,10130,,,1,,,N,,7653,BAO_0000218,,1,,10116.0,2385.0,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL627022,Muscle tissue
Intermediate,,A,10130,,,1,,,N,,7654,BAO_0000218,,1,,10116.0,,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL627023,
Intermediate,,A,10130,,,1,,,N,,7655,BAO_0000218,,1,,10116.0,2106.0,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL627024,Spleen
Intermediate,,A,10130,,,1,,,N,,7656,BAO_0000218,,1,,10116.0,2046.0,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL627025,Thyroid gland
Intermediate,,A,10130,,,1,,,N,,7657,BAO_0000218,,1,,10116.0,2113.0,50597,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL627026,Kidney
Intermediate,,A,10130,,,1,,,N,,7658,BAO_0000218,,1,,10116.0,178.0,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL627027,Blood
Intermediate,,A,10130,,,1,,,N,,7659,BAO_0000218,,1,,10116.0,955.0,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL627028,Brain
Intermediate,,A,10130,,,1,,,N,,7660,BAO_0000218,,1,,10116.0,948.0,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL627029,Heart
Intermediate,,A,10130,,,1,,,N,,7661,BAO_0000218,,1,,10116.0,2113.0,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL627030,Kidney
Intermediate,,A,10130,,,1,,,N,,7662,BAO_0000218,,1,,10116.0,2107.0,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL627031,Liver
Intermediate,,A,10130,,,1,,,N,,7663,BAO_0000218,,1,,10116.0,2048.0,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL627032,Lung
Intermediate,,A,10130,,,1,,,N,,7664,BAO_0000218,,1,,10116.0,2385.0,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL627033,Muscle tissue
Intermediate,,A,10130,,,1,,,N,,7665,BAO_0000218,,1,,10116.0,,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL627034,
Intermediate,,A,10130,,,1,,,N,,7666,BAO_0000218,,1,,10116.0,2106.0,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL627035,Spleen
Intermediate,,A,10130,,,1,,,N,,7667,BAO_0000218,,1,,10116.0,2046.0,50597,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL627036,Thyroid gland
Intermediate,,A,10130,,,1,,,N,,7668,BAO_0000218,,1,,10116.0,178.0,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL875340,Blood
Intermediate,,A,10130,,,1,,,N,,7669,BAO_0000218,,1,,10116.0,948.0,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL627037,Heart
Intermediate,,A,10130,,,1,,,N,,7670,BAO_0000218,,1,,10116.0,2113.0,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL627038,Kidney
Intermediate,,A,10130,,,1,,,N,,7671,BAO_0000218,,1,,10116.0,2107.0,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL627039,Liver
Intermediate,,A,10130,,,1,,,N,,7672,BAO_0000218,,1,,10116.0,2385.0,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL627040,Muscle tissue
Intermediate,,A,10130,,,1,,,N,,7673,BAO_0000218,,1,,10116.0,2106.0,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL624663,Spleen
Intermediate,,A,10130,,,1,,,N,,7674,BAO_0000218,,1,,10116.0,2046.0,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL625963,Thyroid gland
Intermediate,,A,10130,,,1,,,N,,7675,BAO_0000218,,1,,10116.0,955.0,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL876799,Brain
Intermediate,,A,10130,,,1,,,N,,7676,BAO_0000218,,1,,10116.0,2048.0,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL626133,Lung
Intermediate,,A,10130,,,1,,,N,,7677,BAO_0000218,,1,,10116.0,,50597,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,Rattus norvegicus,CHEMBL626134,
Intermediate,,A,6295,,,1,,,N,,7678,BAO_0000218,,1,,10116.0,,50597,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,Rattus norvegicus,CHEMBL626135,
Intermediate,,A,6296,,,1,,,N,,7679,BAO_0000218,,1,,10116.0,,50597,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,Rattus norvegicus,CHEMBL626136,
Intermediate,,A,6296,,,1,,,N,,7680,BAO_0000218,,1,,10116.0,,50597,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,Rattus norvegicus,CHEMBL626137,
Intermediate,,A,6295,,,1,,,N,,7681,BAO_0000218,,1,,10116.0,,50597,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,Rattus norvegicus,CHEMBL626138,
Intermediate,,A,6296,,,1,,,N,,7682,BAO_0000218,,1,,10116.0,,50597,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,Rattus norvegicus,CHEMBL626139,
Intermediate,,A,17260,In vivo,,1,,,N,,7683,BAO_0000218,,1,,10116.0,,50597,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Rattus norvegicus,CHEMBL626140,
Intermediate,,A,17260,In vivo,,1,,,N,,7684,BAO_0000218,,1,,10116.0,,50597,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Rattus norvegicus,CHEMBL626141,
Intermediate,,A,17686,,,1,,,N,,7685,BAO_0000218,,1,,10116.0,,50597,C24h in rat p.o. at 20 mg/kg concentration,Rattus norvegicus,CHEMBL626142,
Intermediate,,A,9866,In vivo,,1,,,N,,7686,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Rattus norvegicus,CHEMBL627930,Muscle tissue
Intermediate,,A,9866,In vivo,,1,,,N,,7687,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,Rattus norvegicus,CHEMBL627931,Muscle tissue
Intermediate,,A,9866,In vivo,,1,,,N,,7688,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,Rattus norvegicus,CHEMBL627932,Muscle tissue
Intermediate,,A,9866,In vivo,,1,,,N,,7689,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Rattus norvegicus,CHEMBL627933,Spleen
Intermediate,,A,9866,In vivo,,1,,,N,,7690,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,Rattus norvegicus,CHEMBL627934,Spleen
Intermediate,,A,9866,In vivo,,1,,,N,,7691,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,Rattus norvegicus,CHEMBL627935,Spleen
Intermediate,,A,9866,In vivo,,1,,,N,,7692,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,Rattus norvegicus,CHEMBL627936,Blood
Intermediate,,A,9866,In vivo,,1,,,N,,7693,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,CHEMBL627937,Blood
Intermediate,,A,9866,In vivo,,1,,,N,,7694,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,Rattus norvegicus,CHEMBL627938,Blood
Intermediate,,A,9866,In vivo,,1,,,N,,7695,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,Rattus norvegicus,CHEMBL627939,Blood
Intermediate,,A,9866,In vivo,,1,,,N,,7696,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,Rattus norvegicus,CHEMBL627940,Blood
Intermediate,,A,9866,In vivo,,1,,,N,,7697,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,Rattus norvegicus,CHEMBL627941,Blood
Intermediate,,A,9866,In vivo,,1,,,N,,7698,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Rattus norvegicus,CHEMBL876800,Blood
Intermediate,,A,9866,In vivo,,1,,,N,,7699,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,CHEMBL627942,Blood
Intermediate,,A,9866,In vivo,,1,,,N,,7700,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,Rattus norvegicus,CHEMBL627943,Blood
Intermediate,,A,9866,In vivo,,1,,,N,,7701,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,Rattus norvegicus,CHEMBL627944,Blood
Intermediate,,A,9866,In vivo,,1,,,N,,7702,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,Rattus norvegicus,CHEMBL627945,Blood
Intermediate,,A,9866,In vivo,,1,,,N,,7703,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,Rattus norvegicus,CHEMBL628584,Blood
Intermediate,,A,9866,In vivo,,1,,,N,,7704,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood in the presence of GdDTPA at 15 min,Rattus norvegicus,CHEMBL628585,Blood
Intermediate,,A,9866,In vivo,,1,,,N,,7705,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,Rattus norvegicus,CHEMBL628586,Blood
Intermediate,,A,9866,In vivo,,1,,,N,,7706,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood in the presence of GdDTPA at 30 min,Rattus norvegicus,CHEMBL628587,Blood
Intermediate,,A,9866,In vivo,,1,,,N,,7707,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,Rattus norvegicus,CHEMBL628588,Blood
Intermediate,,A,9866,In vivo,,1,,,N,,7708,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,Rattus norvegicus,CHEMBL628589,Blood
Intermediate,,A,9866,In vivo,,1,,,N,,7709,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,Rattus norvegicus,CHEMBL625304,Blood
Intermediate,,A,9866,In vivo,,1,,,N,,7710,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,Rattus norvegicus,CHEMBL625305,Blood
Intermediate,,A,9866,In vivo,,1,,,N,,7711,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,Rattus norvegicus,CHEMBL625306,Blood
Intermediate,,A,9866,In vivo,,1,,,N,,7712,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,Rattus norvegicus,CHEMBL625307,Blood
Intermediate,,A,9866,In vivo,,1,,,N,,7713,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,Rattus norvegicus,CHEMBL625308,Blood
Intermediate,,A,9866,In vivo,,1,,,N,,7714,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,Rattus norvegicus,CHEMBL627740,Blood
Intermediate,,A,9866,In vivo,,1,,,N,,7715,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,Rattus norvegicus,CHEMBL627741,Blood
Intermediate,,A,9866,In vivo,,1,,,N,,7716,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Rattus norvegicus,CHEMBL627742,Blood
Intermediate,,A,9866,In vivo,,1,,,N,,7717,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,CHEMBL627743,Blood
Intermediate,,A,9866,In vivo,,1,,,N,,7718,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,Rattus norvegicus,CHEMBL627744,Blood
Intermediate,,A,9866,In vivo,,1,,,N,,7719,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,CHEMBL627745,Bone
Intermediate,,A,9866,In vivo,,1,,,N,,7720,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,Rattus norvegicus,CHEMBL627746,Bone
Intermediate,,A,9866,In vivo,,1,,,N,,7721,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,Rattus norvegicus,CHEMBL627747,Bone
Intermediate,,A,9866,In vivo,,1,,,N,,7722,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,Rattus norvegicus,CHEMBL876810,Bone
Intermediate,,A,9866,In vivo,,1,,,N,,7723,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,Rattus norvegicus,CHEMBL627748,Bone
Intermediate,,A,9866,In vivo,,1,,,N,,7724,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,Rattus norvegicus,CHEMBL627749,Bone
Intermediate,,A,9866,In vivo,,1,,,N,,7725,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Rattus norvegicus,CHEMBL627750,Bone
Intermediate,,A,9866,In vivo,,1,,,N,,7726,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,CHEMBL618728,Bone
Intermediate,,A,9866,In vivo,,1,,,N,,7727,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,Rattus norvegicus,CHEMBL618729,Bone
Intermediate,,A,9866,In vivo,,1,,,N,,7728,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution in rat bone in the presence of GdDTPA at 15 min,Rattus norvegicus,CHEMBL618730,Bone
Intermediate,,A,9866,In vivo,,1,,,N,,7729,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,Rattus norvegicus,CHEMBL618731,Bone
Intermediate,,A,9866,In vivo,,1,,,N,,7730,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution in rat bone in the presence of GdDTPA at 30 min,Rattus norvegicus,CHEMBL618732,Bone
Intermediate,,A,9866,In vivo,,1,,,N,,7731,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,Rattus norvegicus,CHEMBL618733,Bone
Intermediate,,A,9866,In vivo,,1,,,N,,7732,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,Rattus norvegicus,CHEMBL618734,Bone
Intermediate,,A,9866,In vivo,,1,,,N,,7733,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,Rattus norvegicus,CHEMBL618735,Bone
Intermediate,,A,9866,In vivo,,1,,,N,,7734,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,Rattus norvegicus,CHEMBL876602,Bone
Intermediate,,A,9866,In vivo,,1,,,N,,7735,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,Rattus norvegicus,CHEMBL618736,Bone
Intermediate,,A,9866,In vivo,,1,,,N,,7736,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,Rattus norvegicus,CHEMBL618737,Bone
Intermediate,,A,9866,In vivo,,1,,,N,,7737,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,Rattus norvegicus,CHEMBL618738,Bone
Intermediate,,A,9866,In vivo,,1,,,N,,7738,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,Rattus norvegicus,CHEMBL618739,Bone
Intermediate,,A,9866,In vivo,,1,,,N,,7739,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,Rattus norvegicus,CHEMBL618740,Bone
Intermediate,,A,9866,In vivo,,1,,,N,,7740,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Rattus norvegicus,CHEMBL618741,Bone
Intermediate,,A,9866,In vivo,,1,,,N,,7741,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,CHEMBL618742,Bone
Intermediate,,A,9866,In vivo,,1,,,N,,7742,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,Rattus norvegicus,CHEMBL618743,Bone
Intermediate,,A,17752,In vivo,,1,,,N,,7743,BAO_0000218,,1,,10116.0,1969.0,50597,Half-life from rat plasma at a single oral dose of 25 mg/kg,Rattus norvegicus,CHEMBL618744,Plasma
Intermediate,,A,5610,,,1,,,N,,7744,BAO_0000218,,1,,10116.0,,50597,Half-life in male rat,Rattus norvegicus,CHEMBL618745,
Intermediate,,A,5939,In vivo,,1,,,N,,7745,BAO_0000218,,1,,10116.0,,50597,Half-life in rat after peroral administration at 10 mg/kg concentration,Rattus norvegicus,CHEMBL620479,
Intermediate,,A,5939,In vivo,,1,,,N,,7746,BAO_0000218,,1,,10116.0,,50597,Half-life in rat after peroral administration at 5 mg/kg concentration,Rattus norvegicus,CHEMBL620480,
Intermediate,,A,17771,In vivo,,1,,,N,,7747,BAO_0000218,,1,,10116.0,,50597,Half-life in rat at a dose of 3 mg/kg,Rattus norvegicus,CHEMBL620481,
Intermediate,,A,1974,,,1,,,N,,7748,BAO_0000218,,1,,10116.0,,50597,Half-life was evaluated in rats,Rattus norvegicus,CHEMBL620482,
Intermediate,,A,4239,,,1,,,N,,7749,BAO_0000218,,1,,10116.0,,50597,Half-life was measured in rat,Rattus norvegicus,CHEMBL876603,
Intermediate,,A,6681,In vivo,,1,,,N,,7750,BAO_0000218,,1,,10116.0,,50597,Half-life period for the compound was determined in rats at 50 mg/kg dose,Rattus norvegicus,CHEMBL620483,
Intermediate,,A,17752,In vivo,,1,,,N,,7751,BAO_0000218,,1,,10116.0,,50597,Half-life period in rats after intravenous administration at 5 mg/kg,Rattus norvegicus,CHEMBL620484,
Intermediate,,A,6046,In vivo,,1,,,N,,7752,BAO_0000218,,1,,10116.0,,50597,Half-life period in rat at 10 mg/kg,Rattus norvegicus,CHEMBL620485,
Intermediate,,A,6685,In vivo,,1,,,N,,7753,BAO_0000218,,1,,10116.0,,50597,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",Rattus norvegicus,CHEMBL620486,
Intermediate,,A,6685,In vivo,,1,,,N,,7754,BAO_0000218,,1,,10116.0,,50597,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",Rattus norvegicus,CHEMBL620487,
Intermediate,,A,6685,In vivo,,1,,,N,,7755,BAO_0000218,,1,,10116.0,,50597,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",Rattus norvegicus,CHEMBL620488,
Intermediate,,A,4727,In vivo,,1,,,N,,7756,BAO_0000218,,1,,10116.0,,50597,Half-life time in rat the dose of 2 mg/kg,Rattus norvegicus,CHEMBL620489,
Intermediate,,A,1088,In vivo,,1,,,N,,7757,BAO_0000218,,1,,10116.0,,50597,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,Rattus norvegicus,CHEMBL620490,
Intermediate,,A,5610,In vivo,,1,,,N,,7758,BAO_0000218,,1,,10116.0,,50597,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,Rattus norvegicus,CHEMBL620491,
Intermediate,,A,3032,In vivo,,1,,,N,,7759,BAO_0000218,,1,,10116.0,1969.0,50597,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",Rattus norvegicus,CHEMBL876604,Plasma
Intermediate,,A,5199,In vivo,,1,,,N,,7760,BAO_0000218,,1,,10116.0,,50597,Oral half life was determined,Rattus norvegicus,CHEMBL620492,
Intermediate,,A,14941,In vivo,,1,,,N,,7761,BAO_0000218,,1,,10116.0,,50597,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",Rattus norvegicus,CHEMBL620493,
Intermediate,,A,4408,In vivo,,1,,,N,,7762,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (t1/2) in rat,Rattus norvegicus,CHEMBL620494,
Intermediate,,A,2552,,,1,,,N,,7763,BAO_0000218,,1,,10116.0,1969.0,50597,Plasma elimination half-life was determined,Rattus norvegicus,CHEMBL620495,Plasma
Intermediate,,A,5199,In vivo,,1,,,N,,7764,BAO_0000218,,1,,10116.0,1969.0,50597,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Rattus norvegicus,CHEMBL620496,Plasma
Intermediate,,A,15662,In vivo,,1,,,N,,7765,BAO_0000218,,1,,10116.0,1969.0,50597,Plasma half life was observed after intravenous administration in rat,Rattus norvegicus,CHEMBL620497,Plasma
Intermediate,,A,1465,,,1,,,N,,7766,BAO_0000218,,1,,10116.0,1969.0,50597,Plasma half-life was determined,Rattus norvegicus,CHEMBL620498,Plasma
Intermediate,,A,1446,In vivo,,1,,,N,,7767,BAO_0000218,,1,,10116.0,1969.0,50597,Plasma half-life following oral administration in Fisher rats,Rattus norvegicus,CHEMBL620499,Plasma
Intermediate,,A,6824,,,1,,,N,,7768,BAO_0000218,,1,,10116.0,1969.0,50597,Plasma half-life in rat,Rattus norvegicus,CHEMBL620500,Plasma
Intermediate,,A,17533,In vivo,,1,,,N,,7769,BAO_0000218,,1,,10116.0,1969.0,50597,Plasmatic Half-life after intravenous administration to rat,Rattus norvegicus,CHEMBL873809,Plasma
Intermediate,,A,5979,In vivo,,1,,,N,,7770,BAO_0000218,,1,,10116.0,,50597,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,Rattus norvegicus,CHEMBL620501,
Intermediate,,A,4689,In vivo,,1,,,N,,7771,BAO_0000218,,1,,10116.0,,50597,Terminal half life after intravenous administration (1 mg/kg) in rat,Rattus norvegicus,CHEMBL620502,
Intermediate,,A,4689,In vivo,,1,,,N,,7772,BAO_0000218,,1,,10116.0,,50597,Terminal half life in Rat at a oral dose of 5 mg/kg,Rattus norvegicus,CHEMBL620503,
Intermediate,,A,2463,In vivo,,1,,,N,,7773,BAO_0000218,,1,,10116.0,,50597,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,Rattus norvegicus,CHEMBL620504,
Intermediate,,A,4883,In vivo,,1,,,N,,7774,BAO_0000218,,1,,10116.0,,50597,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,Rattus norvegicus,CHEMBL876605,
Intermediate,,A,4883,In vivo,,1,,,N,,7775,BAO_0000218,,1,,10116.0,,50597,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,Rattus norvegicus,CHEMBL620505,
Intermediate,,A,15662,In vivo,,1,,,N,,7776,BAO_0000218,,1,,10116.0,1969.0,50597,plasma half life was observed after intravenous administration in rat,Rattus norvegicus,CHEMBL873811,Plasma
Expert,,A,3598,In vivo,,1,,,N,,7777,BAO_0000218,,1,,10116.0,,50597,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,CHEMBL624016,
Intermediate,,A,4576,,,1,,,N,,7778,BAO_0000218,,1,,10116.0,,50597,Half life of compound determined in rat,Rattus norvegicus,CHEMBL624017,
Intermediate,,A,4576,,,1,,,N,,7779,BAO_0000218,,1,,10116.0,,50597,Mean residence time determined in rat,Rattus norvegicus,CHEMBL624018,
Intermediate,,A,4576,,,1,,,N,,7780,BAO_0000218,,1,,10116.0,,50597,Plasma half life determined in rat,Rattus norvegicus,CHEMBL624019,
Intermediate,,A,4910,In vivo,,1,,,N,,7781,BAO_0000218,,1,,10116.0,955.0,50597,Compound was evaluated for Tmax in brain after intravenous administration in male rats,Rattus norvegicus,CHEMBL624020,Brain
Intermediate,,A,4891,In vivo,,1,,,N,,7782,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for pharmacokinetic parameter maximum time period,Rattus norvegicus,CHEMBL624201,
Intermediate,,A,429,In vivo,,1,,,N,,7783,BAO_0000218,,1,,10116.0,,50597,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,Rattus norvegicus,CHEMBL872528,
Intermediate,,A,5974,In vivo,,1,,,N,,7784,BAO_0000218,,1,,10116.0,,50597,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,CHEMBL624202,
Intermediate,,A,5974,In vivo,,1,,,N,,7785,BAO_0000218,,1,,10116.0,,50597,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,CHEMBL624203,
Intermediate,,A,5974,In vivo,,1,,,N,,7786,BAO_0000218,,1,,10116.0,,50597,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,CHEMBL624350,
Intermediate,,A,5974,In vivo,,1,,,N,,7787,BAO_0000218,,1,,10116.0,,50597,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,CHEMBL621320,
Intermediate,,A,17582,In vivo,,1,,,N,,7788,BAO_0000218,,1,,10116.0,,50597,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,Rattus norvegicus,CHEMBL621321,
Intermediate,,A,4026,,,1,,,N,,7789,BAO_0000218,,1,,10116.0,,50597,Maximum time (Tmax) required to reach Cmax in rats,Rattus norvegicus,CHEMBL621322,
Intermediate,,A,4890,In vivo,,1,,,N,,7790,BAO_0000218,,1,,10116.0,,50597,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,CHEMBL621323,
Intermediate,,A,6571,In vivo,,1,,,N,,7791,BAO_0000218,,1,,10116.0,,50597,Maximum time of clearance of compound in rats after peroral administration,Rattus norvegicus,CHEMBL621324,
Intermediate,,A,4727,,,1,,,N,,7792,BAO_0000218,,1,,10116.0,,50597,Maximum time at the dose of 2 mg/kg in rat,Rattus norvegicus,CHEMBL621325,
Intermediate,,A,17651,In vivo,,1,,,N,,7793,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,Rattus norvegicus,CHEMBL875837,Plasma
Intermediate,,A,17651,In vivo,,1,,,N,,7794,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,Rattus norvegicus,CHEMBL621326,Plasma
Intermediate,,A,14465,In vivo,,1,,,N,,7795,BAO_0000218,,1,,10116.0,,50597,Tmax in Guinea pig (PO dose),Rattus norvegicus,CHEMBL621327,
Intermediate,,A,14941,In vivo,,1,,,N,,7796,BAO_0000218,,1,,10116.0,,50597,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",Rattus norvegicus,CHEMBL621328,
Intermediate,,A,5960,In vivo,,1,,,N,,7797,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter (Tmax) in rat,Rattus norvegicus,CHEMBL621329,
Intermediate,,A,5022,In vivo,,1,,,N,,7798,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter (Tmax) was estimated,Rattus norvegicus,CHEMBL621330,
Intermediate,,A,4408,In vivo,,1,,,N,,7799,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (Tmax) in rat,Rattus norvegicus,CHEMBL621331,
Intermediate,,A,5983,In vivo,,1,,,N,,7800,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,Rattus norvegicus,CHEMBL621332,
Intermediate,,A,4689,In vivo,,1,,,N,,7801,BAO_0000218,,1,,10116.0,,50597,T max in Rat at a oral dose of 5 mg/kg,Rattus norvegicus,CHEMBL621333,
Intermediate,,A,2792,In vivo,,1,,,N,,7802,BAO_0000218,,1,,10116.0,,50597,T max was determined at 10 mg/kg po dose in rats,Rattus norvegicus,CHEMBL621334,
Intermediate,,A,15011,,,1,,,N,,7803,BAO_0000218,,1,,10090.0,,50594,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),Mus musculus,CHEMBL621335,
Intermediate,,A,14180,,,1,,,N,,7804,BAO_0000218,,1,,9615.0,,50588,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,Canis lupus familiaris,CHEMBL621336,
Intermediate,,A,14180,,,1,,,N,,7805,BAO_0000218,,1,,10116.0,,50597,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,Rattus norvegicus,CHEMBL621337,
Intermediate,,A,14599,,,1,,,N,,7806,BAO_0000218,,1,,9615.0,,50588,Area under curve was measured after i.v. administration into Beagle dog.,Canis lupus familiaris,CHEMBL621338,
Intermediate,,A,14599,,,1,,,N,,7807,BAO_0000218,,1,,9615.0,,50588,Area under curve was measured after iv administration into Beagle dog,Canis lupus familiaris,CHEMBL875838,
Intermediate,,A,14599,,,1,,,N,,7808,BAO_0000218,,1,,9615.0,,50588,Area under curve was measured after po administration into Beagle dog,Canis lupus familiaris,CHEMBL621339,
Intermediate,,A,14599,,,1,,,N,,7809,BAO_0000218,,1,,9615.0,,50588,Area under curve was measured after po administration into Beagle dog.,Canis lupus familiaris,CHEMBL621340,
Autocuration,,A,15675,,,1,,,U,,7810,BAO_0000218,,0,,,,22224,Area under curve was measured at peroral dose of 3 mg/kg,,CHEMBL621341,
Autocuration,,A,12706,,,1,,,U,,7811,BAO_0000019,,0,,,,22224,Area under curve was measured by using concentration Vs time,,CHEMBL621342,
Autocuration,,A,12706,,,1,,,U,,7812,BAO_0000019,,0,,,,22224,Area under curve was measured by using concentration Vs time; not tested,,CHEMBL621343,
Intermediate,,A,9750,,,1,,,N,,7813,BAO_0000218,,1,,10090.0,,50594,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),Mus musculus,CHEMBL621344,
Intermediate,,A,9750,,,1,,,N,,7814,BAO_0000218,,1,,10090.0,,50594,Area under curve(AUC) was measured in mice after oral administration.,Mus musculus,CHEMBL621345,
Autocuration,,A,14691,,,1,,,U,,7815,BAO_0000019,,0,,,,22224,Area under curve(AUC) value of the compound,,CHEMBL621346,
Autocuration,,A,14691,,,1,,,U,,7816,BAO_0000218,,0,,,,22224,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,,CHEMBL621347,
Intermediate,,A,14691,,,1,,,N,,7817,BAO_0000218,,1,,9615.0,,50588,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,Canis lupus familiaris,CHEMBL621348,
Autocuration,,A,2939,,,1,,,U,,7818,BAO_0000019,,0,,,178.0,22224,Area under curve(carotid artery) was determined by the availability in blood,,CHEMBL621349,Blood
Autocuration,,A,2939,,,1,,,U,,7819,BAO_0000019,,0,,,178.0,22224,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,,CHEMBL621350,Blood
Autocuration,,A,2939,,,1,,,U,,7820,BAO_0000019,,0,,,178.0,22224,Area under curve(carotid artery) was determined by the availability in blood; No data,,CHEMBL875839,Blood
Autocuration,,A,2939,,,1,,,U,,7821,BAO_0000019,,0,,,178.0,22224,Area under curve(portal vein) was determined by the availability in blood,,CHEMBL620211,Blood
Autocuration,,A,2939,,,1,,,U,,7822,BAO_0000019,,0,,,178.0,22224,Area under curve(portal vein) was determined by the availability in blood; ND means no data,,CHEMBL620212,Blood
Autocuration,,A,2939,,,1,,,U,,7823,BAO_0000019,,0,,,178.0,22224,Area under curve(portal vein) was determined by the availability in blood; No data,,CHEMBL620213,Blood
Intermediate,,A,9552,,,1,,,N,,7824,BAO_0000218,,1,,9544.0,1969.0,50797,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",Macaca mulatta,CHEMBL620214,Plasma
Intermediate,,A,9552,,,1,,,N,,7825,BAO_0000218,,1,,9544.0,1969.0,50797,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",Macaca mulatta,CHEMBL620215,Plasma
Intermediate,,A,9552,,,1,,,N,,7826,BAO_0000218,,1,,9544.0,1969.0,50797,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,Macaca mulatta,CHEMBL620216,Plasma
Intermediate,,A,9552,,,1,,,N,,7827,BAO_0000218,,1,,9615.0,1969.0,50588,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",Canis lupus familiaris,CHEMBL620888,Plasma
Intermediate,,A,9552,,,1,,,N,,7828,BAO_0000218,,1,,9615.0,1969.0,50588,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",Canis lupus familiaris,CHEMBL620889,Plasma
Autocuration,,A,9552,,,1,,,U,,7829,BAO_0000019,,0,,,1969.0,22224,Area under plasma concentration vs time curve observed in rats for 0-3 h,,CHEMBL620890,Plasma
Intermediate,,A,11911,,,1,,,N,,7830,BAO_0000218,,1,,10116.0,1969.0,50597,Area under plasma time curve determined in male rat,Rattus norvegicus,CHEMBL620891,Plasma
Autocuration,,A,16618,,,1,,,U,,7831,BAO_0000019,,0,,,,22224,Area under the MAP curve measured over 5 min.,,CHEMBL620892,
Intermediate,,A,14387,,,1,,,N,,7832,BAO_0000218,,1,,10090.0,,50594,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,Mus musculus,CHEMBL621079,
Intermediate,,A,14387,,,1,,,N,,7833,BAO_0000218,,1,,10090.0,,50594,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,Mus musculus,CHEMBL621080,
Intermediate,,A,12836,,,1,,,N,,7834,BAO_0000218,,1,,9615.0,,50588,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,Canis lupus familiaris,CHEMBL621081,
Intermediate,,A,12836,,,1,,,N,,7835,BAO_0000218,,1,,10026.0,,100712,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,Cricetinae,CHEMBL621082,
Intermediate,,A,12836,,,1,,,N,,7836,BAO_0000218,,1,,10116.0,,50597,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,Rattus norvegicus,CHEMBL621083,
Intermediate,,A,14339,,,1,,,N,,7837,BAO_0000218,,1,,9615.0,,50588,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,Canis lupus familiaris,CHEMBL621084,
Intermediate,,A,14339,,,1,,,N,,7838,BAO_0000218,,1,,9615.0,,50588,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,Canis lupus familiaris,CHEMBL621085,
Intermediate,,A,14339,,,1,,,N,,7839,BAO_0000218,,1,,9615.0,,50588,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,Canis lupus familiaris,CHEMBL621086,
Intermediate,,A,10524,,,1,,,N,,7840,BAO_0000218,,1,,9615.0,,50588,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),Canis lupus familiaris,CHEMBL621087,
Intermediate,,A,9994,,,1,,,N,,7841,BAO_0000218,,1,,9615.0,,50588,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),Canis lupus familiaris,CHEMBL622607,
Intermediate,,A,11325,,,1,,,N,,7842,BAO_0000218,,1,,9615.0,,50588,Serum AUC in marmosets (IV dose),Canis lupus familiaris,CHEMBL622608,
Autocuration,,A,12536,,,1,,,U,,7843,BAO_0000019,,0,,,,22224,Area under the curve after intravenous administration at a dose of 10 umol/kg,,CHEMBL624481,
Autocuration,,A,12536,,,1,,,U,,7844,BAO_0000019,,0,,,,22224,Area under the curve after intravenous administration at a dose of 2 umol/kg,,CHEMBL624482,
Autocuration,,A,12536,,,1,,,U,,7845,BAO_0000019,,0,,,,22224,Area under the curve after intravenous administration at a dose of 4 umol/kg,,CHEMBL624483,
Autocuration,,A,12536,,,1,,,U,,7846,BAO_0000019,,0,,,,22224,Area under the curve after intravenous administration at a dose of 40 umol/kg,,CHEMBL624484,
Autocuration,,A,12536,,,1,,,U,,7847,BAO_0000019,,0,,,,22224,Area under the curve after intravenous administration at a dose of 5 umol/kg,,CHEMBL624485,
Intermediate,,A,15556,,,1,,,N,,7848,BAO_0000218,,1,,10116.0,,50597,Area under the curve for fumarate salt was evaluated in F344 Rats.,Rattus norvegicus,CHEMBL624486,
Autocuration,,A,2809,,,1,,,U,,7849,BAO_0000019,,0,,,,22224,Area under the curve for the compound was calculated.,,CHEMBL624487,
Autocuration,,A,9511,,,1,,,U,,7850,BAO_0000019,,0,,,,22224,Area under the curve in concentration/ time,,CHEMBL624488,
Intermediate,,A,12818,,,1,,,N,,7851,BAO_0000218,,1,,10116.0,,50597,Area under the curve administered intraintestinal in rats.,Rattus norvegicus,CHEMBL624489,
Intermediate,,A,12818,,,1,,,N,,7852,BAO_0000218,,1,,10116.0,,50597,Area under the curve administered intravenously in rats.,Rattus norvegicus,CHEMBL625184,
Autocuration,,A,15118,,,1,,,U,,7853,BAO_0000019,,0,,,,22224,Area under the curve during intravenous administration,,CHEMBL625185,
Autocuration,,A,15118,,,1,,,U,,7854,BAO_0000019,,0,,,,22224,Area under the curve during intravenous administration; Not determined,,CHEMBL875954,
Autocuration,,A,15118,,,1,,,U,,7855,BAO_0000019,,0,,,,22224,Area under the curve during systemic administration,,CHEMBL625186,
Autocuration,,A,15118,,,1,,,U,,7856,BAO_0000019,,0,,,,22224,Area under the curve during systemic administration; Not determined,,CHEMBL625187,
Autocuration,,A,2632,,,1,,,U,,7857,BAO_0000019,,0,,,,22224,Area under the curve was calculated for the compound.,,CHEMBL625188,
Intermediate,,A,14346,,,1,,,N,,7858,BAO_0000218,,1,,9615.0,,50588,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,Canis lupus familiaris,CHEMBL625189,
Intermediate,,A,14346,,,1,,,N,,7859,BAO_0000218,,1,,9615.0,,50588,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,Canis lupus familiaris,CHEMBL625190,
Intermediate,,A,14346,,,1,,,N,,7860,BAO_0000218,,1,,10116.0,,50597,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,Rattus norvegicus,CHEMBL621733,
Intermediate,,A,14346,,,1,,,N,,7861,BAO_0000218,,1,,10116.0,,50597,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,Rattus norvegicus,CHEMBL621734,
Intermediate,,A,11149,,,1,,,N,,7862,BAO_0000218,,1,,10116.0,,50597,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,Rattus norvegicus,CHEMBL621735,
Intermediate,,A,17796,,,1,,,N,,7863,BAO_0000218,,1,,10116.0,1969.0,50597,Clearance of the drug was measured in the plasma of rat; No data,Rattus norvegicus,CHEMBL621736,Plasma
Intermediate,,A,5247,,,1,,,N,,7864,BAO_0000218,,1,,10116.0,1969.0,50597,The pharmacokinetic parameter plasma clearance in vivo in rats,Rattus norvegicus,CHEMBL621737,Plasma
Intermediate,,A,4727,,,1,,,N,,7865,BAO_0000218,,1,,10116.0,,50597,Plasma clearance at the dose of 2 mg/kg in rat,Rattus norvegicus,CHEMBL621738,
Intermediate,,A,5654,In vivo,,1,,,N,,7866,BAO_0000218,,1,,10116.0,,50597,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Rattus norvegicus,CHEMBL622806,
Intermediate,,A,5654,In vivo,,1,,,N,,7867,BAO_0000218,,1,,10116.0,,50597,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Rattus norvegicus,CHEMBL623519,
Intermediate,,A,17260,In vivo,,1,,,N,,7868,BAO_0000218,,1,,10116.0,,50597,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Rattus norvegicus,CHEMBL623520,
Intermediate,,A,17065,In vivo,,1,,,N,,7869,BAO_0000218,,1,,10116.0,,50597,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,Rattus norvegicus,CHEMBL623521,
Intermediate,,A,17671,In vivo,,1,,,N,,7870,BAO_0000218,,1,,10116.0,,50597,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Rattus norvegicus,CHEMBL623522,
Intermediate,,A,6672,In vivo,,1,,,N,,7871,BAO_0000218,,1,,10116.0,,50597,Clearance rate in rat,Rattus norvegicus,CHEMBL623523,
Intermediate,,A,6673,In vivo,,1,,,N,,7872,BAO_0000218,,1,,10116.0,,50597,Clearance rate in rat,Rattus norvegicus,CHEMBL623690,
Intermediate,,A,5978,In vivo,,1,,,N,,7873,BAO_0000218,,1,,10116.0,,50597,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,CHEMBL623691,
Intermediate,,A,5978,In vivo,,1,,,N,,7874,BAO_0000218,,1,,10116.0,,50597,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,CHEMBL623692,
Intermediate,,A,5978,In vivo,,1,,,N,,7875,BAO_0000218,,1,,10116.0,,50597,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,CHEMBL623693,
Intermediate,,A,5978,In vivo,,1,,,N,,7876,BAO_0000218,,1,,10116.0,,50597,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,CHEMBL623694,
Intermediate,,A,4413,In vivo,,1,,,N,,7877,BAO_0000218,,1,,10116.0,,50597,Clearance of compound after iv administration of 20 mg/kg dose in rat,Rattus norvegicus,CHEMBL623695,
Intermediate,,A,2661,In vivo,,1,,,N,,7878,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,Rattus norvegicus,CHEMBL623696,
Intermediate,,A,2661,In vivo,,1,,,N,,7879,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,Rattus norvegicus,CHEMBL623697,
Intermediate,,A,5005,In vivo,,1,,,U,,7880,BAO_0000218,,0,,9544.0,1969.0,22224,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,Macaca mulatta,CHEMBL623698,Plasma
Intermediate,,A,5005,In vivo,,1,,,U,,7881,BAO_0000218,,0,,10116.0,1969.0,22224,Compound was tested for its plasma clearance rate in Sprague Dawley rats,Rattus norvegicus,CHEMBL623699,Plasma
Intermediate,,A,15765,In vivo,,1,,,N,,7882,BAO_0000218,,1,,10116.0,,50597,Mean (%CV) PK parameters for CL(mL/min/kg).,Rattus norvegicus,CHEMBL623700,
Intermediate,,A,3747,In vivo,,1,,,N,,7883,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,Rattus norvegicus,CHEMBL623701,
Intermediate,,A,16366,In vivo,,1,,,N,,7884,BAO_0000218,,1,,10116.0,1969.0,50597,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,Rattus norvegicus,CHEMBL623702,Plasma
Intermediate,,A,4199,In vivo,,1,,,N,,7885,BAO_0000218,,1,,10116.0,,50597,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,Rattus norvegicus,CHEMBL623703,
Intermediate,,A,17267,In vivo,,1,,,N,,7886,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rat was determined,Rattus norvegicus,CHEMBL623704,
Intermediate,,A,6535,In vivo,,1,,,N,,7887,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rat after administration of 2 mg/kg iv,Rattus norvegicus,CHEMBL623705,
Intermediate,,A,6535,In vivo,,1,,,N,,7888,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rat after administration of 2 mg/kg iv,Rattus norvegicus,CHEMBL623706,
Intermediate,,A,5041,In vivo,,1,,,N,,7889,BAO_0000218,,1,,10116.0,,50597,Plasma clearance was determined,Rattus norvegicus,CHEMBL623707,
Intermediate,,A,5960,In vivo,,1,,,N,,7890,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rat,Rattus norvegicus,CHEMBL623708,
Intermediate,,A,5937,In vivo,,1,,,N,,7891,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,Rattus norvegicus,CHEMBL623709,
Intermediate,,A,5871,In vivo,,1,,,N,,7892,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rat by iv administration,Rattus norvegicus,CHEMBL623710,
Intermediate,,A,5874,In vivo,,1,,,N,,7893,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,Rattus norvegicus,CHEMBL623711,
Intermediate,,A,6504,In vivo,,1,,,N,,7894,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rat p.o.,Rattus norvegicus,CHEMBL623712,
Intermediate,,A,6803,In vivo,,1,,,N,,7895,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rats,Rattus norvegicus,CHEMBL623713,
Intermediate,,A,5041,In vivo,,1,,,N,,7896,BAO_0000218,,1,,10116.0,,50597,Plasma clearance was determined; ND denotes no data,Rattus norvegicus,CHEMBL623714,
Intermediate,,A,5041,In vivo,,1,,,N,,7897,BAO_0000218,,1,,10116.0,,50597,Plasma clearance was determined; ND denotes not determined,Rattus norvegicus,CHEMBL623715,
Intermediate,,A,1916,In vivo,,1,,,N,,7898,BAO_0000218,,1,,10116.0,,50597,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,Rattus norvegicus,CHEMBL623716,
Intermediate,,A,5199,In vivo,,1,,,N,,7899,BAO_0000218,,1,,10116.0,,50597,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Rattus norvegicus,CHEMBL622980,
Intermediate,,A,16367,In vivo,,1,,,N,,7900,BAO_0000218,,1,,10116.0,,50597,Plasma administration to rats,Rattus norvegicus,CHEMBL622981,
Intermediate,,A,6362,In vivo,,1,,,N,,7901,BAO_0000218,,1,,10116.0,,50597,Plasma clearance of the compound in female Sprague-Dawley rats,Rattus norvegicus,CHEMBL622982,
Intermediate,,A,15662,In vivo,,1,,,N,,7902,BAO_0000218,,1,,10116.0,,50597,Plasma clearance was observed after intravenous administration in rat,Rattus norvegicus,CHEMBL622983,
Intermediate,,A,6215,In vivo,,1,,,N,,7903,BAO_0000218,,1,,10116.0,,50597,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,Rattus norvegicus,CHEMBL622984,
Intermediate,,A,1466,In vivo,,1,,,N,,7904,BAO_0000218,,1,,10116.0,,50597,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,Rattus norvegicus,CHEMBL622985,
Intermediate,,A,15662,In vivo,,1,,,N,,7905,BAO_0000218,,1,,10116.0,1969.0,50597,plasma clearance was observed after intravenous administration in rat,Rattus norvegicus,CHEMBL623631,Plasma
Intermediate,,A,4723,In vivo,,1,,,N,,7906,BAO_0000218,,1,,10116.0,,50597,In vivo CL/F determined,Rattus norvegicus,CHEMBL623632,
Intermediate,,A,2792,In vivo,,1,,,N,,7907,BAO_0000218,,1,,10116.0,1969.0,50597,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,Rattus norvegicus,CHEMBL623633,Plasma
Intermediate,,A,2792,In vivo,,1,,,N,,7908,BAO_0000218,,1,,10116.0,1969.0,50597,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,Rattus norvegicus,CHEMBL623634,Plasma
Intermediate,,A,5213,In vivo,,1,,,N,,7909,BAO_0000218,,1,,10116.0,,50597,Compound was tested for the lower blood clearance in rat,Rattus norvegicus,CHEMBL623635,
Intermediate,,A,4687,In vivo,,1,,,N,,7910,BAO_0000218,,1,,10116.0,,50597,Evaluated for the low clearance in rat (in vivo),Rattus norvegicus,CHEMBL621195,
Intermediate,,A,3371,In vivo,,1,,,N,,7911,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (CLb)of the compound was determined in rat,Rattus norvegicus,CHEMBL621196,
Intermediate,,A,4690,In vivo,,1,,,N,,7912,BAO_0000218,,1,,10116.0,,50597,Rapid clearance after intravenous administration in rat was determined,Rattus norvegicus,CHEMBL875287,
Intermediate,,A,5702,In vivo,,1,,,N,,7913,BAO_0000218,,1,,10116.0,,50597,Clearance measured in rat,Rattus norvegicus,CHEMBL621197,
Intermediate,,A,740,In vivo,,1,,,N,,7914,BAO_0000218,,1,,10116.0,1969.0,50597,Compound was evaluated for plasma clearance in rat,Rattus norvegicus,CHEMBL621198,Plasma
Intermediate,,A,4853,In vivo,,1,,,N,,7915,BAO_0000218,,1,,10116.0,1969.0,50597,Low plasma clearance was calculated in rat,Rattus norvegicus,CHEMBL621199,Plasma
Intermediate,,A,5789,In vivo,,1,,,N,,7916,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (Clp) in rat,Rattus norvegicus,CHEMBL621200,
Intermediate,,A,4527,In vivo,,1,,,N,,7917,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,Rattus norvegicus,CHEMBL621201,
Intermediate,,A,4527,In vivo,,1,,,N,,7918,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,Rattus norvegicus,CHEMBL621202,
Intermediate,,A,6518,In vivo,,1,,,N,,7919,BAO_0000218,,1,,10116.0,,50597,Plasma clearance after IV dosing at 0.5 mg/kg in rat,Rattus norvegicus,CHEMBL621203,
Intermediate,,A,6518,In vivo,,1,,,N,,7920,BAO_0000218,,1,,10116.0,,50597,Plasma clearance after IV dosing at 1 mg/kg in rat,Rattus norvegicus,CHEMBL621204,
Intermediate,,A,9866,In vivo,,1,,,N,,7921,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,Rattus norvegicus,CHEMBL621205,Heart
Intermediate,,A,9866,In vivo,,1,,,N,,7922,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,CHEMBL621206,Heart
Intermediate,,A,9866,In vivo,,1,,,N,,7923,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,Rattus norvegicus,CHEMBL621207,Heart
Intermediate,,A,9866,In vivo,,1,,,N,,7924,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,Rattus norvegicus,CHEMBL621208,Heart
Intermediate,,A,9866,In vivo,,1,,,N,,7925,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,Rattus norvegicus,CHEMBL621209,Heart
Intermediate,,A,9866,In vivo,,1,,,N,,7926,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,Rattus norvegicus,CHEMBL876484,Heart
Intermediate,,A,9866,In vivo,,1,,,N,,7927,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Rattus norvegicus,CHEMBL621210,Heart
Intermediate,,A,9866,In vivo,,1,,,N,,7928,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,CHEMBL621211,Heart
Intermediate,,A,9866,In vivo,,1,,,N,,7929,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,Rattus norvegicus,CHEMBL621212,Heart
Intermediate,,A,9866,In vivo,,1,,,N,,7930,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart in the presence of GdDTPA at 15 min,Rattus norvegicus,CHEMBL621213,Heart
Intermediate,,A,9866,In vivo,,1,,,N,,7931,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,Rattus norvegicus,CHEMBL621214,Heart
Intermediate,,A,9866,In vivo,,1,,,N,,7932,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart in the presence of GdDTPA at 30 min,Rattus norvegicus,CHEMBL621215,Heart
Intermediate,,A,9866,In vivo,,1,,,N,,7933,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,Rattus norvegicus,CHEMBL621216,Heart
Intermediate,,A,9866,In vivo,,1,,,N,,7934,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,Rattus norvegicus,CHEMBL621217,Heart
Intermediate,,A,9866,In vivo,,1,,,N,,7935,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,Rattus norvegicus,CHEMBL621218,Heart
Intermediate,,A,9866,In vivo,,1,,,N,,7936,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,Rattus norvegicus,CHEMBL621219,Heart
Intermediate,,A,9866,In vivo,,1,,,N,,7937,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,Rattus norvegicus,CHEMBL621220,Heart
Intermediate,,A,9866,In vivo,,1,,,N,,7938,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,Rattus norvegicus,CHEMBL621221,Heart
Intermediate,,A,9866,In vivo,,1,,,N,,7939,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,Rattus norvegicus,CHEMBL621222,Heart
Intermediate,,A,9866,In vivo,,1,,,N,,7940,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,Rattus norvegicus,CHEMBL621223,Heart
Intermediate,,A,9866,In vivo,,1,,,N,,7941,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,Rattus norvegicus,CHEMBL876485,Heart
Intermediate,,A,9866,In vivo,,1,,,N,,7942,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Rattus norvegicus,CHEMBL621224,Heart
Intermediate,,A,9866,In vivo,,1,,,N,,7943,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,CHEMBL621225,Heart
Intermediate,,A,9866,In vivo,,1,,,N,,7944,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,Rattus norvegicus,CHEMBL621226,Heart
Intermediate,,A,9866,In vivo,,1,,,N,,7945,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,CHEMBL621227,Kidney
Intermediate,,A,9866,In vivo,,1,,,N,,7946,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,Rattus norvegicus,CHEMBL621228,Kidney
Intermediate,,A,9866,In vivo,,1,,,N,,7947,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,Rattus norvegicus,CHEMBL621229,Kidney
Intermediate,,A,9866,In vivo,,1,,,N,,7948,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,Rattus norvegicus,CHEMBL621230,Kidney
Intermediate,,A,9866,In vivo,,1,,,N,,7949,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,Rattus norvegicus,CHEMBL621231,Kidney
Intermediate,,A,9866,In vivo,,1,,,N,,7950,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,Rattus norvegicus,CHEMBL621232,Kidney
Intermediate,,A,9866,In vivo,,1,,,N,,7951,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Rattus norvegicus,CHEMBL621233,Kidney
Intermediate,,A,9866,In vivo,,1,,,N,,7952,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,CHEMBL621234,Kidney
Intermediate,,A,9866,In vivo,,1,,,N,,7953,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,Rattus norvegicus,CHEMBL621235,Kidney
Intermediate,,A,9866,In vivo,,1,,,N,,7954,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Rattus norvegicus,CHEMBL621236,Kidney
Intermediate,,A,9866,In vivo,,1,,,N,,7955,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,CHEMBL621237,Kidney
Intermediate,,A,9866,In vivo,,1,,,N,,7956,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,Rattus norvegicus,CHEMBL876486,Kidney
Intermediate,,A,9866,In vivo,,1,,,N,,7957,BAO_0000218,,1,,10116.0,160.0,50597,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,Rattus norvegicus,CHEMBL622436,Intestine
Intermediate,,A,9866,In vivo,,1,,,N,,7958,BAO_0000218,,1,,10116.0,160.0,50597,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,Rattus norvegicus,CHEMBL622437,Intestine
Intermediate,,A,9866,In vivo,,1,,,N,,7959,BAO_0000218,,1,,10116.0,160.0,50597,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,Rattus norvegicus,CHEMBL622438,Intestine
Intermediate,,A,9866,In vivo,,1,,,N,,7960,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,Rattus norvegicus,CHEMBL622439,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,7961,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,Rattus norvegicus,CHEMBL622440,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,7962,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,Rattus norvegicus,CHEMBL622441,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,7963,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,Rattus norvegicus,CHEMBL622442,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,7964,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,CHEMBL622443,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,7965,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,Rattus norvegicus,CHEMBL622444,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,7966,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,Rattus norvegicus,CHEMBL622445,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,7967,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,Rattus norvegicus,CHEMBL622446,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,7968,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Rattus norvegicus,CHEMBL622447,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,7969,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,CHEMBL622448,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,7970,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,Rattus norvegicus,CHEMBL622449,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,7971,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,Rattus norvegicus,CHEMBL622450,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,7972,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,Rattus norvegicus,CHEMBL622451,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,7973,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver in the presence of GdDTPA at 15 min,Rattus norvegicus,CHEMBL622452,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,7974,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,Rattus norvegicus,CHEMBL622453,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,7975,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver in the presence of GdDTPA at 30 min,Rattus norvegicus,CHEMBL622454,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,7976,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,Rattus norvegicus,CHEMBL622455,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,7977,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,Rattus norvegicus,CHEMBL876024,Liver
Intermediate,,A,2792,In vivo,,1,,,N,,7978,BAO_0000218,,1,,10116.0,,50597,T max was determined at 3 mg/kg po dose in rats,Rattus norvegicus,CHEMBL622456,
Intermediate,,A,15078,In vivo,,1,,,N,,7979,BAO_0000218,,1,,10116.0,,50597,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,CHEMBL622457,
Intermediate,,A,15078,In vivo,,1,,,N,,7980,BAO_0000218,,1,,10116.0,,50597,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,CHEMBL622458,
Intermediate,,A,15022,,,1,,,N,,7981,BAO_0000218,,1,,10116.0,,50597,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,Rattus norvegicus,CHEMBL622459,
Intermediate,,A,15022,,,1,,,N,,7982,BAO_0000218,,1,,10116.0,,50597,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,Rattus norvegicus,CHEMBL873343,
Intermediate,,A,15022,,,1,,,N,,7983,BAO_0000218,,1,,10116.0,,50597,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,Rattus norvegicus,CHEMBL622460,
Intermediate,,A,4576,,,1,,,N,,7984,BAO_0000218,,1,,10116.0,1969.0,50597,Time for maximum plasma concentration determined in rat,Rattus norvegicus,CHEMBL622461,Plasma
Intermediate,,A,6681,In vivo,,1,,,N,,7985,BAO_0000218,,1,,10116.0,1969.0,50597,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,Rattus norvegicus,CHEMBL622462,Plasma
Intermediate,,A,16365,In vivo,,1,,,N,,7986,BAO_0000218,,1,,10116.0,,50597,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,Rattus norvegicus,CHEMBL622463,
Intermediate,,A,16365,In vivo,,1,,,N,,7987,BAO_0000218,,1,,10116.0,,50597,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,Rattus norvegicus,CHEMBL622464,
Intermediate,,A,16365,In vivo,,1,,,N,,7988,BAO_0000218,,1,,10116.0,,50597,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,Rattus norvegicus,CHEMBL622465,
Intermediate,,A,16365,In vivo,,1,,,N,,7989,BAO_0000218,,1,,10116.0,,50597,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,Rattus norvegicus,CHEMBL622466,
Intermediate,,A,16365,In vivo,,1,,,N,,7990,BAO_0000218,,1,,10116.0,,50597,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,Rattus norvegicus,CHEMBL622467,
Intermediate,,A,6824,,,1,,,N,,7991,BAO_0000218,,1,,10116.0,1969.0,50597,Time of maximum plasma concentration in rat,Rattus norvegicus,CHEMBL622468,Plasma
Intermediate,,A,6685,,,1,,,N,,7992,BAO_0000218,,1,,10116.0,1969.0,50597,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",Rattus norvegicus,CHEMBL876025,Plasma
Intermediate,,A,6685,,,1,,,N,,7993,BAO_0000218,,1,,10116.0,1969.0,50597,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",Rattus norvegicus,CHEMBL622469,Plasma
Intermediate,,A,6685,,,1,,,N,,7994,BAO_0000218,,1,,10116.0,1969.0,50597,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Rattus norvegicus,CHEMBL622470,Plasma
Intermediate,,A,15662,In vivo,,1,,,N,,7995,BAO_0000218,,1,,10116.0,,50597,Time required to reach maximum concentration (Cmax) after oral administration in rat,Rattus norvegicus,CHEMBL622471,
Intermediate,,A,1742,,,1,,,N,,7996,BAO_0000218,,1,,10116.0,1969.0,50597,Time required to reach maximum concentration in rat plasma,Rattus norvegicus,CHEMBL622472,Plasma
Intermediate,,A,2774,In vivo,,1,,,N,,7997,BAO_0000218,,1,,10116.0,1969.0,50597,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,Rattus norvegicus,CHEMBL622473,Plasma
Intermediate,,A,5199,In vivo,,1,,,N,,7998,BAO_0000218,,1,,10116.0,1969.0,50597,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,Rattus norvegicus,CHEMBL624282,Plasma
Intermediate,,A,12873,In vivo,,1,,,N,,7999,BAO_0000218,,1,,10116.0,1969.0,50597,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,Rattus norvegicus,CHEMBL624283,Plasma
Intermediate,,A,12873,In vivo,,1,,,N,,8000,BAO_0000218,,1,,10116.0,1969.0,50597,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,Rattus norvegicus,CHEMBL624284,Plasma
Intermediate,,A,1916,In vivo,,1,,,N,,8001,BAO_0000218,,1,,10116.0,1969.0,50597,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Rattus norvegicus,CHEMBL624285,Plasma
Intermediate,,A,16367,In vivo,,1,,,N,,8002,BAO_0000218,,1,,10116.0,,50597,Time to reach Cmax after oral administration to rats,Rattus norvegicus,CHEMBL624286,
Intermediate,,A,16366,In vivo,,1,,,N,,8003,BAO_0000218,,1,,10116.0,,50597,Time to reach Cmax when a dose of 1 mg/kg is administered orally,Rattus norvegicus,CHEMBL624287,
Intermediate,,A,216,,,1,,,N,,8004,BAO_0000218,,1,,10116.0,,50597,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,Rattus norvegicus,CHEMBL624288,
Intermediate,,A,6410,In vivo,,1,,,N,,8005,BAO_0000218,,1,,10116.0,1969.0,50597,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,Rattus norvegicus,CHEMBL624289,Plasma
Intermediate,,A,6410,In vivo,,1,,,N,,8006,BAO_0000218,,1,,10116.0,1969.0,50597,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,Rattus norvegicus,CHEMBL873344,Plasma
Intermediate,,A,6215,In vivo,,1,,,N,,8007,BAO_0000218,,1,,10116.0,,50597,Tmax after peroral administration (10 mg/kg) was determined in rat,Rattus norvegicus,CHEMBL619623,
Expert,,A,3598,In vivo,,1,,,N,,8008,BAO_0000218,,1,,10116.0,,50597,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,CHEMBL621399,
Intermediate,,A,4527,In vivo,,1,,,N,,8009,BAO_0000218,,1,,10116.0,,50597,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,Rattus norvegicus,CHEMBL621400,
Intermediate,,A,17670,In vivo,,1,,,N,,8010,BAO_0000218,,1,,10116.0,,50597,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",Rattus norvegicus,CHEMBL621401,
Intermediate,,A,1465,,,1,,,N,,8011,BAO_0000218,,1,,10116.0,,50597,Tmax was determined,Rattus norvegicus,CHEMBL621402,
Intermediate,,A,2552,,,1,,,N,,8012,BAO_0000218,,1,,10116.0,,50597,Tmax was determined,Rattus norvegicus,CHEMBL621403,
Intermediate,,A,5656,In vivo,,1,,,N,,8013,BAO_0000218,,1,,10116.0,,50597,Tmax after oral administration in rat,Rattus norvegicus,CHEMBL621121,
Intermediate,,A,17764,In vivo,,1,,,N,,8014,BAO_0000218,,1,,10116.0,,50597,Tmax after peroral administration in rats at 2.4 uM/kg,Rattus norvegicus,CHEMBL872525,
Intermediate,,A,5610,,,1,,,N,,8015,BAO_0000218,,1,,10116.0,,50597,Tmax in male rat,Rattus norvegicus,CHEMBL621122,
Intermediate,,A,6046,In vivo,,1,,,N,,8016,BAO_0000218,,1,,10116.0,,50597,Tmax in rat at 10 mg/kg,Rattus norvegicus,CHEMBL621123,
Intermediate,,A,5874,In vivo,,1,,,N,,8017,BAO_0000218,,1,,10116.0,,50597,Tmax in rat by po administration at a dose of 40 mg/kg,Rattus norvegicus,CHEMBL621124,
Intermediate,,A,17596,,,1,,,N,,8018,BAO_0000218,,1,,10116.0,,50597,Tmax in rats,Rattus norvegicus,CHEMBL621125,
Intermediate,,A,17804,In vivo,,1,,,N,,8019,BAO_0000218,,1,,10116.0,,50597,Tmax was measured in rats after peroral administration at 5 mg/kg,Rattus norvegicus,CHEMBL621126,
Intermediate,,A,1908,In vivo,,1,,,N,,8020,BAO_0000218,,1,,10116.0,,50597,Tmax value after oral dose at a dose of 10 mg/kg in rats.,Rattus norvegicus,CHEMBL621127,
Intermediate,,A,2959,In vivo,,1,,,N,,8021,BAO_0000218,,1,,10116.0,,50597,Tmax value after administration of 20 mg/Kg oral dose in rat,Rattus norvegicus,CHEMBL621128,
Intermediate,,A,6757,In vivo,,1,,,N,,8022,BAO_0000218,,1,,10116.0,,50597,Tmax value at a dose of 10 mg/kg in male SD rats,Rattus norvegicus,CHEMBL618263,
Intermediate,,A,6757,In vivo,,1,,,N,,8023,BAO_0000218,,1,,10116.0,,50597,Tmax value at a dose of 100 mg/kg in male SD rats,Rattus norvegicus,CHEMBL618264,
Intermediate,,A,6757,In vivo,,1,,,N,,8024,BAO_0000218,,1,,10116.0,,50597,Tmax value at a dose of 50 mg/kg in male SD rats,Rattus norvegicus,CHEMBL618265,
Intermediate,,A,4186,In vivo,,1,,,N,,8025,BAO_0000218,,1,,10116.0,1969.0,50597,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Rattus norvegicus,CHEMBL618266,Plasma
Intermediate,,A,15662,In vivo,,1,,,N,,8026,BAO_0000218,,1,,10116.0,,50597,time required to reach maximum concentration (Cmax) after oral administration in rat,Rattus norvegicus,CHEMBL618267,
Intermediate,,A,429,,,1,,,N,,8027,BAO_0000218,,1,,10116.0,1088.0,50597,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),Rattus norvegicus,CHEMBL618450,Urine
Intermediate,,A,429,,,1,,,N,,8028,BAO_0000218,,1,,10116.0,1088.0,50597,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),Rattus norvegicus,CHEMBL618451,Urine
Intermediate,,A,5546,,,1,,,N,,8029,BAO_0000218,,1,,10116.0,,50597,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,Rattus norvegicus,CHEMBL618452,
Intermediate,,A,3173,,,1,,,N,,8030,BAO_0000218,,1,,10116.0,1088.0,50597,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,Rattus norvegicus,CHEMBL618453,Urine
Intermediate,,A,3173,,,1,,,N,,8031,BAO_0000218,,1,,10116.0,1088.0,50597,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,Rattus norvegicus,CHEMBL618454,Urine
Intermediate,,A,3173,,,1,,,N,,8032,BAO_0000218,,1,,10116.0,1088.0,50597,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,Rattus norvegicus,CHEMBL618455,Urine
Intermediate,,A,4257,In vivo,,1,,,N,,8033,BAO_0000218,,1,,10116.0,,50597,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,Rattus norvegicus,CHEMBL618456,
Intermediate,,A,6011,In vivo,,1,,,N,,8034,BAO_0000218,,1,,10116.0,,50597,Compound distribution in rat tissues was determined,Rattus norvegicus,CHEMBL618457,
Intermediate,,A,5472,In vivo,,1,,,N,,8035,BAO_0000218,,1,,10116.0,,50597,Volume of distribution was evaluated in rat,Rattus norvegicus,CHEMBL618458,
Intermediate,,A,14346,,,1,,,N,,8036,BAO_0000218,,1,,10116.0,,50597,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,Rattus norvegicus,CHEMBL618459,
Intermediate,,A,14346,,,1,,,N,,8037,BAO_0000218,,1,,10116.0,,50597,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,Rattus norvegicus,CHEMBL876733,
Intermediate,,A,14346,,,1,,,N,,8038,BAO_0000218,,1,,9615.0,,50588,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,Canis lupus familiaris,CHEMBL618460,
Intermediate,,A,14346,,,1,,,N,,8039,BAO_0000218,,1,,10116.0,,50597,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,Rattus norvegicus,CHEMBL618461,
Autocuration,,A,15469,,,1,,,U,,8040,BAO_0000019,,0,,,,22224,Area under the curve was determined after oral administration (300 uM/Kg),,CHEMBL618462,
Intermediate,,A,14346,,,1,,,N,,8041,BAO_0000218,,1,,10116.0,,50597,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,Rattus norvegicus,CHEMBL618463,
Intermediate,,A,14346,,,1,,,N,,8042,BAO_0000218,,1,,10116.0,,50597,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,Rattus norvegicus,CHEMBL618464,
Intermediate,,A,14346,,,1,,,N,,8043,BAO_0000218,,1,,10116.0,,50597,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,Rattus norvegicus,CHEMBL618465,
Intermediate,,A,14346,,,1,,,N,,8044,BAO_0000218,,1,,10116.0,,50597,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,Rattus norvegicus,CHEMBL618466,
Intermediate,,A,14346,,,1,,,N,,8045,BAO_0000218,,1,,10116.0,,50597,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,Rattus norvegicus,CHEMBL618467,
Intermediate,,A,15372,,,1,,,N,,8046,BAO_0000218,,1,,10116.0,,50597,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,Rattus norvegicus,CHEMBL618468,
Intermediate,,A,12935,,,1,,,N,,8047,BAO_0000218,,1,,9615.0,1969.0,50588,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,Canis lupus familiaris,CHEMBL618469,Plasma
Intermediate,,A,12935,,,1,,,N,,8048,BAO_0000218,,1,,9615.0,1969.0,50588,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,Canis lupus familiaris,CHEMBL618470,Plasma
Autocuration,,A,14813,,,1,,,U,,8049,BAO_0000218,,0,,,,22224,Plasma drug AUC in rat (PO dose),,CHEMBL618471,
Intermediate,,A,15792,,,1,,,N,,8050,BAO_0000218,,1,,10090.0,,50594,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,Mus musculus,CHEMBL618472,
Autocuration,,A,3579,,,1,,,U,,8051,BAO_0000218,,0,,,,22224,Area under was determined at a dose of 30 mg/kg,,CHEMBL618473,
Intermediate,,A,12487,,,1,,,N,,8052,BAO_0000218,,1,,9669.0,,50506,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,Mustela putorius furo,CHEMBL621699,
Intermediate,,A,12487,,,1,,,N,,8053,BAO_0000218,,1,,10116.0,,50597,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,Rattus norvegicus,CHEMBL621700,
Intermediate,,A,12487,,,1,,,N,,8054,BAO_0000218,,1,,10116.0,,50597,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,Rattus norvegicus,CHEMBL621701,
Intermediate,,A,12487,,,1,,,N,,8055,BAO_0000218,,1,,9669.0,,50506,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,Mustela putorius furo,CHEMBL621702,
Intermediate,,A,12487,,,1,,,N,,8056,BAO_0000218,,1,,9615.0,,50588,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,Canis lupus familiaris,CHEMBL621703,
Intermediate,,A,12487,,,1,,,N,,8057,BAO_0000218,,1,,9615.0,,50588,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,Canis lupus familiaris,CHEMBL621704,
Intermediate,,A,12902,,,1,,,N,,8058,BAO_0000218,,1,,10116.0,,50597,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",Rattus norvegicus,CHEMBL624259,
Intermediate,,A,12902,,,1,,,N,,8059,BAO_0000218,,1,,10116.0,,50597,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",Rattus norvegicus,CHEMBL624260,
Intermediate,,A,12902,,,1,,,N,,8060,BAO_0000218,,1,,10116.0,,50597,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",Rattus norvegicus,CHEMBL624430,
Intermediate,,A,12902,,,1,,,N,,8061,BAO_0000218,,1,,10116.0,,50597,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",Rattus norvegicus,CHEMBL624431,
Intermediate,,A,12902,,,1,,,N,,8062,BAO_0000218,,1,,10116.0,,50597,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",Rattus norvegicus,CHEMBL624432,
Intermediate,,A,12902,,,1,,,N,,8063,BAO_0000218,,1,,10116.0,,50597,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",Rattus norvegicus,CHEMBL624433,
Intermediate,,A,12902,,,1,,,N,,8064,BAO_0000218,,1,,10116.0,,50597,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",Rattus norvegicus,CHEMBL624434,
Intermediate,,A,12902,,,1,,,N,,8065,BAO_0000218,,1,,10116.0,,50597,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",Rattus norvegicus,CHEMBL624435,
Intermediate,,A,12745,,,1,,,N,,8066,BAO_0000218,,1,,10090.0,,50594,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,Mus musculus,CHEMBL618570,
Intermediate,,A,12745,,,1,,,N,,8067,BAO_0000218,,1,,10090.0,,50594,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Mus musculus,CHEMBL618571,
Intermediate,,A,12745,,,1,,,N,,8068,BAO_0000218,,1,,10090.0,,50594,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,Mus musculus,CHEMBL618572,
Intermediate,,A,12745,,,1,,,N,,8069,BAO_0000218,,1,,10090.0,,50594,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Mus musculus,CHEMBL618573,
Intermediate,,A,12745,,,1,,,N,,8070,BAO_0000218,,1,,10090.0,,50594,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,Mus musculus,CHEMBL619267,
Intermediate,,A,12745,,,1,,,N,,8071,BAO_0000218,,1,,10090.0,,50594,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Mus musculus,CHEMBL619431,
Intermediate,,A,12745,,,1,,,N,,8072,BAO_0000218,,1,,10090.0,,50594,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,Mus musculus,CHEMBL619432,
Intermediate,,A,12745,,,1,,,N,,8073,BAO_0000218,,1,,10090.0,,50594,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Mus musculus,CHEMBL619433,
Autocuration,,A,13298,,,1,,,U,,8074,BAO_0000218,,0,,,1969.0,22224,AUC in mice after oral dose (50 mg/kg),,CHEMBL619434,Plasma
Intermediate,,A,12226,,,1,,,N,,8075,BAO_0000218,,1,,10090.0,1977.0,50594,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,Mus musculus,CHEMBL619435,Serum
Autocuration,,A,12634,,,1,,,U,,8076,BAO_0000019,,0,,,1969.0,22224,AUC (0-4 hr) ug/ml/h,,CHEMBL619436,Plasma
Intermediate,,A,14810,,,1,,,N,,8077,BAO_0000218,,1,,10116.0,,50597,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,Rattus norvegicus,CHEMBL619437,
Autocuration,,A,13889,,,1,,,U,,8078,BAO_0000218,,0,,,,22224,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,,CHEMBL619438,
Intermediate,,A,10018,,,1,,,N,,8079,BAO_0000218,,1,,10090.0,,50594,Compound was evaluated for Area under curve in mice,Mus musculus,CHEMBL619439,
Intermediate,,A,8758,,,1,,,N,,8080,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,Rattus norvegicus,CHEMBL619440,
Autocuration,,F,8758,,,1,,,U,,8081,BAO_0000218,,0,,,,22224,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,CHEMBL619441,
Intermediate,,A,8758,,,1,,,N,,8082,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,Rattus norvegicus,CHEMBL619442,
Autocuration,,A,2249,,,1,,,U,,8083,BAO_0000019,,0,,,,22224,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,,CHEMBL875156,
Autocuration,,A,2249,,,1,,,U,,8084,BAO_0000019,,0,,,,22224,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,,CHEMBL619443,
Autocuration,,A,2249,,,1,,,U,,8085,BAO_0000019,,0,,,,22224,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,,CHEMBL619444,
Autocuration,,A,2249,,,1,,,U,,8086,BAO_0000019,,0,,,,22224,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,,CHEMBL623464,
Intermediate,,A,15115,,,1,,,N,,8087,BAO_0000218,,1,,10090.0,,50594,Compound was evaluated for area under curve when administered through oral route in mouse,Mus musculus,CHEMBL623465,
Intermediate,,A,6518,In vivo,,1,,,N,,8088,BAO_0000218,,1,,10116.0,,50597,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,Rattus norvegicus,CHEMBL623466,
Intermediate,,A,6518,In vivo,,1,,,N,,8089,BAO_0000218,,1,,10116.0,,50597,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,Rattus norvegicus,CHEMBL623467,
Intermediate,,A,6249,In vivo,,1,,,N,,8090,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rat,Rattus norvegicus,CHEMBL623468,
Intermediate,,A,2463,In vivo,,1,,,N,,8091,BAO_0000218,,1,,10116.0,,50597,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,Rattus norvegicus,CHEMBL622660,
Intermediate,,A,4969,In vivo,,1,,,N,,8092,BAO_0000218,,1,,10116.0,,50597,Plasma clearance rate in Sprague-Dawley rats,Rattus norvegicus,CHEMBL622661,
Intermediate,,F,17720,In vivo,,1,,,N,,8093,BAO_0000218,,1,,10116.0,,50597,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,CHEMBL622662,
Intermediate,,A,3457,In vivo,,1,,,N,,8094,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (total body clearance) in rat,Rattus norvegicus,CHEMBL622663,
Intermediate,,A,5983,In vivo,,1,,,N,,8095,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,Rattus norvegicus,CHEMBL622664,
Intermediate,,A,6295,,,1,,,N,,8096,BAO_0000218,,1,,10116.0,,50597,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,Rattus norvegicus,CHEMBL622665,
Intermediate,,A,6296,,,1,,,N,,8097,BAO_0000218,,1,,10116.0,,50597,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,Rattus norvegicus,CHEMBL622666,
Intermediate,,A,17686,In vivo,,1,,,N,,8098,BAO_0000218,,1,,10116.0,,50597,Cl in rat i.v. at 2 mg/kg concentration,Rattus norvegicus,CHEMBL621615,
Intermediate,,A,17764,In vivo,,1,,,N,,8099,BAO_0000218,,1,,10116.0,,50597,Clearance of compound after intravenous administration in rats at 24 uM/kg,Rattus norvegicus,CHEMBL621616,
Intermediate,,A,5503,In vivo,,1,,,N,,8100,BAO_0000218,,1,,10116.0,,50597,Clearance was determined,Rattus norvegicus,CHEMBL621617,
Intermediate,,A,4368,In vivo,,1,,,N,,8101,BAO_0000218,,1,,10116.0,,50597,Clearance by intravenous administration of 3.4 mg/kg in rat,Rattus norvegicus,CHEMBL621618,
Intermediate,,A,6005,In vivo,,1,,,N,,8102,BAO_0000218,,1,,10116.0,,50597,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,Rattus norvegicus,CHEMBL621619,
Intermediate,,A,5031,In vivo,,1,,,N,,8103,BAO_0000218,,1,,10116.0,,50597,Clearance rate after i.v. administration in rats,Rattus norvegicus,CHEMBL621620,
Intermediate,,A,4890,In vivo,,1,,,N,,8104,BAO_0000218,,1,,10116.0,,50597,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,CHEMBL621786,
Intermediate,,A,5182,In vivo,,1,,,N,,8105,BAO_0000218,,1,,10116.0,,50597,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,Rattus norvegicus,CHEMBL621787,
Intermediate,,A,5979,In vivo,,1,,,N,,8106,BAO_0000218,,1,,10116.0,,50597,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,Rattus norvegicus,CHEMBL621788,
Intermediate,,A,5656,In vivo,,1,,,N,,8107,BAO_0000218,,1,,10116.0,,50597,Clearance (Cl) after oral administration in rat,Rattus norvegicus,CHEMBL621789,
Intermediate,,A,17804,In vivo,,1,,,N,,8108,BAO_0000218,,1,,10116.0,,50597,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,Rattus norvegicus,CHEMBL621790,
Intermediate,,A,4839,In vivo,,1,,,N,,8109,BAO_0000218,,1,,10116.0,1969.0,50597,Compound was tested for plasma clearance in rat,Rattus norvegicus,CHEMBL621791,Plasma
Intermediate,,A,5041,In vitro,,1,,Microsomes,N,,8110,BAO_0000218,,1,,10116.0,,50597,In vitro microsome metabolism clearance in rat was determined,Rattus norvegicus,CHEMBL621792,
Intermediate,,A,5041,In vitro,,1,,Microsomes,N,,8111,BAO_0000218,,1,,10116.0,,50597,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,Rattus norvegicus,CHEMBL621793,
Intermediate,,A,5974,In vivo,,1,,,N,,8112,BAO_0000218,,1,,10116.0,,50597,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,CHEMBL621794,
Intermediate,,A,5496,In vivo,,1,,,N,,8113,BAO_0000218,,1,,10116.0,1969.0,50597,In vivo plasma clearance was determined,Rattus norvegicus,CHEMBL621795,Plasma
Intermediate,,A,5739,In vivo,,1,,,N,,8114,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,Rattus norvegicus,CHEMBL621796,
Intermediate,Hepatocyte,A,5676,In vivo,,1,,,N,401.0,8115,BAO_0000218,,1,,10116.0,2107.0,50597,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,Rattus norvegicus,CHEMBL621797,Liver
Intermediate,,A,4239,In vivo,,1,,,N,,8116,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (Plasma clearance) was measured in rat,Rattus norvegicus,CHEMBL621798,
Intermediate,,A,5676,In vivo,,1,,,N,,8117,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (clearance) in rat i.v.,Rattus norvegicus,CHEMBL621799,
Intermediate,,A,1918,In vivo,,1,,,N,,8118,BAO_0000218,,1,,10116.0,,50597,"Plasma Clearance was evaluated in rats, iv",Rattus norvegicus,CHEMBL621800,
Intermediate,,A,17800,In vivo,,1,,,N,,8119,BAO_0000218,,1,,10116.0,,50597,Plasma clearance (in vivo) in rats was determined,Rattus norvegicus,CHEMBL621801,
Intermediate,,A,6056,In vivo,,1,,,N,,8120,BAO_0000218,,1,,10116.0,,50597,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,Rattus norvegicus,CHEMBL621802,
Intermediate,,A,5496,In vivo,,1,,,N,,8121,BAO_0000218,,1,,10116.0,,50597,Plasma clearance was determined,Rattus norvegicus,CHEMBL618596,
Intermediate,,A,5939,In vivo,,1,,,N,,8122,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,Rattus norvegicus,CHEMBL618597,
Intermediate,,A,5939,In vivo,,1,,,N,,8123,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,Rattus norvegicus,CHEMBL618598,
Intermediate,,A,17752,In vivo,,1,,,N,,8124,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rats,Rattus norvegicus,CHEMBL618599,
Intermediate,,A,4576,In vivo,,1,,,N,,8125,BAO_0000218,,1,,10116.0,,50597,Plasma clearance rate determined in rat,Rattus norvegicus,CHEMBL618600,
Intermediate,,A,6011,In vivo,,1,,,N,,8126,BAO_0000218,,1,,10116.0,,50597,Plasma clearance was determined in rat,Rattus norvegicus,CHEMBL618601,
Intermediate,,A,5510,In vivo,,1,,,N,,8127,BAO_0000218,,1,,10116.0,,50597,Plasma clearance was determined,Rattus norvegicus,CHEMBL618602,
Intermediate,,A,5948,In vivo,,1,,,N,,8128,BAO_0000218,,1,,10116.0,,50597,Plasma clearance value in rat,Rattus norvegicus,CHEMBL618603,
Intermediate,,A,6125,Ex vivo,,1,,,N,,8129,BAO_0000218,,1,,10116.0,2107.0,50597,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Rattus norvegicus,CHEMBL618604,Liver
Intermediate,,A,4839,In vivo,,1,,,N,,8130,BAO_0000218,,1,,10116.0,,50597,Clearance in rat,Rattus norvegicus,CHEMBL618605,
Intermediate,,A,17686,In vivo,,1,,,N,,8131,BAO_0000218,,1,,10116.0,,50597,Total body clearance in rat i.v. at 2 mg/kg concentration,Rattus norvegicus,CHEMBL618606,
Intermediate,,A,6571,In vivo,,1,,,N,,8132,BAO_0000218,,1,,10116.0,,50597,Clearance of compound in rats after intravenous administration,Rattus norvegicus,CHEMBL618607,
Intermediate,,A,3364,In vivo,,1,,,N,,8133,BAO_0000218,,1,,10116.0,,50597,Clearance after iv administration to rats,Rattus norvegicus,CHEMBL618608,
Intermediate,,A,13569,In vivo,,1,,,N,,8134,BAO_0000218,,1,,10116.0,,50597,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,Rattus norvegicus,CHEMBL618609,
Intermediate,,A,13569,In vivo,,1,,,N,,8135,BAO_0000218,,1,,10116.0,,50597,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,Rattus norvegicus,CHEMBL618610,
Intermediate,,A,13569,In vivo,,1,,,N,,8136,BAO_0000218,,1,,10116.0,,50597,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,Rattus norvegicus,CHEMBL618611,
Intermediate,,A,13569,In vivo,,1,,,N,,8137,BAO_0000218,,1,,10116.0,,50597,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,Rattus norvegicus,CHEMBL618612,
Intermediate,,A,13569,In vivo,,1,,,N,,8138,BAO_0000218,,1,,10116.0,,50597,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,Rattus norvegicus,CHEMBL618613,
Intermediate,,A,13569,In vivo,,1,,,N,,8139,BAO_0000218,,1,,10116.0,,50597,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,Rattus norvegicus,CHEMBL621076,
Intermediate,,A,13569,In vivo,,1,,,N,,8140,BAO_0000218,,1,,10116.0,,50597,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,Rattus norvegicus,CHEMBL621077,
Intermediate,,A,17670,In vivo,,1,,,N,,8141,BAO_0000218,,1,,10116.0,,50597,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",Rattus norvegicus,CHEMBL621078,
Intermediate,,A,5970,In vivo,,1,,,N,,8142,BAO_0000218,,1,,10116.0,,50597,Clearance in rat,Rattus norvegicus,CHEMBL621251,
Intermediate,,A,6495,In vivo,,1,,,N,,8143,BAO_0000218,,1,,10116.0,,50597,Clearance in rat after oral administration at 10 mg/kg,Rattus norvegicus,CHEMBL621252,
Intermediate,,A,4590,In vivo,,1,,,N,,8144,BAO_0000218,,1,,10116.0,,50597,Clearance in rat.,Rattus norvegicus,CHEMBL621253,
Intermediate,,A,6193,In vivo,,1,,,N,,8145,BAO_0000218,,1,,10116.0,,50597,Clearance rate following an oral dose of 20 mg/kg in rats,Rattus norvegicus,CHEMBL621254,
Intermediate,,A,2832,In vivo,,1,,,N,,8146,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,Rattus norvegicus,CHEMBL621255,
Intermediate,,A,1052,In vivo,,1,,,N,,8147,BAO_0000218,,1,,10116.0,1969.0,50597,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,Rattus norvegicus,CHEMBL621256,Plasma
Intermediate,,A,9866,In vivo,,1,,,N,,8148,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,Rattus norvegicus,CHEMBL621257,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,8149,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,Rattus norvegicus,CHEMBL621258,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,8150,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,Rattus norvegicus,CHEMBL621259,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,8151,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,Rattus norvegicus,CHEMBL621260,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,8152,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,Rattus norvegicus,CHEMBL876494,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,8153,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,Rattus norvegicus,CHEMBL621261,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,8154,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,Rattus norvegicus,CHEMBL621262,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,8155,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Rattus norvegicus,CHEMBL621263,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,8156,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,CHEMBL621264,Liver
Intermediate,,A,9866,In vivo,,1,,,N,,8157,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,CHEMBL621265,Muscle tissue
Intermediate,,A,9866,In vivo,,1,,,N,,8158,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,Rattus norvegicus,CHEMBL621266,Muscle tissue
Intermediate,,A,9866,In vivo,,1,,,N,,8159,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,Rattus norvegicus,CHEMBL621267,Muscle tissue
Intermediate,,A,9866,In vivo,,1,,,N,,8160,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,CHEMBL621268,Muscle tissue
Intermediate,,A,9866,In vivo,,1,,,N,,8161,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,Rattus norvegicus,CHEMBL621269,Muscle tissue
Intermediate,,A,9866,In vivo,,1,,,N,,8162,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,Rattus norvegicus,CHEMBL621270,Muscle tissue
Intermediate,,A,9866,In vivo,,1,,,N,,8163,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,Rattus norvegicus,CHEMBL621271,Muscle tissue
Intermediate,,A,9866,In vivo,,1,,,N,,8164,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,Rattus norvegicus,CHEMBL621272,Muscle tissue
Intermediate,,A,9866,In vivo,,1,,,N,,8165,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,Rattus norvegicus,CHEMBL621273,Muscle tissue
Intermediate,,A,9866,In vivo,,1,,,N,,8166,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,Rattus norvegicus,CHEMBL621274,Muscle tissue
Intermediate,,A,9866,In vivo,,1,,,N,,8167,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,Rattus norvegicus,CHEMBL876495,Muscle tissue
Intermediate,,A,9866,In vivo,,1,,,N,,8168,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,Rattus norvegicus,CHEMBL621275,Muscle tissue
Intermediate,,A,9866,In vivo,,1,,,N,,8169,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,CHEMBL621276,Muscle tissue
Intermediate,,A,9866,In vivo,,1,,,N,,8170,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,Rattus norvegicus,CHEMBL621277,Muscle tissue
Intermediate,,A,9866,In vivo,,1,,,N,,8171,BAO_0000218,,1,,10116.0,160.0,50597,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,Rattus norvegicus,CHEMBL621278,Intestine
Intermediate,,A,9866,In vivo,,1,,,N,,8172,BAO_0000218,,1,,10116.0,160.0,50597,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,Rattus norvegicus,CHEMBL621279,Intestine
Intermediate,,A,9866,In vivo,,1,,,N,,8173,BAO_0000218,,1,,10116.0,160.0,50597,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),Rattus norvegicus,CHEMBL621280,Intestine
Intermediate,,A,9866,In vivo,,1,,,N,,8174,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,CHEMBL621281,Spleen
Intermediate,,A,9866,In vivo,,1,,,N,,8175,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,Rattus norvegicus,CHEMBL621282,Spleen
Intermediate,,A,9866,In vivo,,1,,,N,,8176,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,Rattus norvegicus,CHEMBL621283,Spleen
Intermediate,,A,9866,In vivo,,1,,,N,,8177,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,CHEMBL621284,Spleen
Intermediate,,A,9866,In vivo,,1,,,N,,8178,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,Rattus norvegicus,CHEMBL621285,Spleen
Intermediate,,A,9866,In vivo,,1,,,N,,8179,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,Rattus norvegicus,CHEMBL621286,Spleen
Intermediate,,A,9866,In vivo,,1,,,N,,8180,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,Rattus norvegicus,CHEMBL623220,Spleen
Intermediate,,A,9866,In vivo,,1,,,N,,8181,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,CHEMBL623221,Spleen
Intermediate,,A,9866,In vivo,,1,,,N,,8182,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,Rattus norvegicus,CHEMBL876029,Spleen
Intermediate,,A,9866,In vivo,,1,,,N,,8183,BAO_0000218,,1,,10116.0,945.0,50597,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,Rattus norvegicus,CHEMBL623222,Stomach
Intermediate,,A,9866,In vivo,,1,,,N,,8184,BAO_0000218,,1,,10116.0,945.0,50597,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,Rattus norvegicus,CHEMBL623223,Stomach
Intermediate,,A,9866,In vivo,,1,,,N,,8185,BAO_0000218,,1,,10116.0,945.0,50597,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,Rattus norvegicus,CHEMBL621445,Stomach
Intermediate,,A,13950,In vivo,,1,,,N,,8186,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL621446,Blood
Intermediate,,A,13950,In vivo,,1,,,N,,8187,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL621447,Blood
Intermediate,,A,13950,In vivo,,1,,,N,,8188,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL619681,Blood
Intermediate,,A,13950,In vivo,,1,,,N,,8189,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL619682,Blood
Intermediate,,A,13950,In vivo,,1,,,N,,8190,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL619683,Blood
Intermediate,,A,13950,In vivo,,1,,,N,,8191,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL619684,Brain
Intermediate,,A,13950,In vivo,,1,,,N,,8192,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL619685,Brain
Intermediate,,A,13950,In vivo,,1,,,N,,8193,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL619686,Brain
Intermediate,,A,13950,In vivo,,1,,,N,,8194,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL619687,Brain
Intermediate,,A,13950,In vivo,,1,,,N,,8195,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL619688,Brain
Intermediate,,A,13950,In vivo,,1,,,N,,8196,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL619689,Heart
Intermediate,,A,13950,In vivo,,1,,,N,,8197,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL619690,Heart
Intermediate,,A,13950,In vivo,,1,,,N,,8198,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL619691,Heart
Intermediate,,A,6062,In vivo,,1,,,N,,8199,BAO_0000218,,1,,10116.0,,50597,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,Rattus norvegicus,CHEMBL619692,
Expert,,A,3598,,,1,,,N,,8200,BAO_0000218,,1,,10116.0,,50597,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,CHEMBL619693,
Intermediate,,A,1908,In vivo,,1,,,N,,8201,BAO_0000218,,1,,10116.0,,50597,Vc value after IV dose at a dose of 5 mg/kg in rats.,Rattus norvegicus,CHEMBL619694,
Intermediate,,A,17596,In vivo,,1,,,N,,8202,BAO_0000218,,1,,10116.0,,50597,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,Rattus norvegicus,CHEMBL619695,
Intermediate,,A,4891,In vivo,,1,,,N,,8203,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for pharmacokinetic parameter volume of distribution,Rattus norvegicus,CHEMBL619696,
Intermediate,,A,740,In vivo,,1,,,N,,8204,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for volume of distribution in rat,Rattus norvegicus,CHEMBL619697,
Intermediate,,A,16366,In vivo,,1,,,N,,8205,BAO_0000218,,1,,10116.0,,50597,Steady state volume distribution was determined; steady state(ss),Rattus norvegicus,CHEMBL619698,
Intermediate,,A,3364,In vivo,,1,,,N,,8206,BAO_0000218,,1,,10116.0,,50597,Steady state volume of distribution after iv administration to rats,Rattus norvegicus,CHEMBL619699,
Intermediate,,A,2552,In vivo,,1,,,N,,8207,BAO_0000218,,1,,10116.0,,50597,Steady state volume of distribution dosing at 3 mg/kg iv,Rattus norvegicus,CHEMBL619700,
Intermediate,,A,406,In vivo,,1,,,N,,8208,BAO_0000218,,1,,10116.0,,50597,The compound was evaluated for volume of distribution in rat,Rattus norvegicus,CHEMBL619701,
Intermediate,,A,12500,In vivo,,1,,,N,,8209,BAO_0000218,,1,,10116.0,,50597,The compound was tested for volume of distribution in rat,Rattus norvegicus,CHEMBL619702,
Intermediate,,A,12500,In vivo,,1,,,N,,8210,BAO_0000218,,1,,10116.0,,50597,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,Rattus norvegicus,CHEMBL620335,
Intermediate,,A,5656,In vivo,,1,,,N,,8211,BAO_0000218,,1,,10116.0,,50597,Volume distribution (VD) after oral administration in rat,Rattus norvegicus,CHEMBL620336,
Intermediate,,A,17671,In vivo,,1,,,N,,8212,BAO_0000218,,1,,10116.0,,50597,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Rattus norvegicus,CHEMBL620337,
Intermediate,,A,1094,In vivo,,1,,,N,,8213,BAO_0000218,,1,,10116.0,,50597,Volume distribution in rat,Rattus norvegicus,CHEMBL620520,
Intermediate,,A,5833,In vivo,,1,,,N,,8214,BAO_0000218,,1,,10116.0,,50597,Volume distribution in rat,Rattus norvegicus,CHEMBL620521,
Intermediate,,A,5939,In vivo,,1,,,N,,8215,BAO_0000218,,1,,10116.0,,50597,Volume distribution in rat after peroral administration at 10 mg/kg,Rattus norvegicus,CHEMBL875825,
Intermediate,,A,5939,In vivo,,1,,,N,,8216,BAO_0000218,,1,,10116.0,,50597,Volume distribution in rat after peroral administration at 5 mg/kg,Rattus norvegicus,CHEMBL620522,
Intermediate,,A,6005,In vivo,,1,,,N,,8217,BAO_0000218,,1,,10116.0,,50597,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,Rattus norvegicus,CHEMBL620523,
Intermediate,,A,1696,In vivo,,1,,,N,,8218,BAO_0000218,,1,,10116.0,,50597,Volume of distribution in rat.,Rattus norvegicus,CHEMBL620524,
Intermediate,,A,6672,In vivo,,1,,,N,,8219,BAO_0000218,,1,,10116.0,,50597,Volume of distribution in rat,Rattus norvegicus,CHEMBL620525,
Intermediate,,A,6673,In vivo,,1,,,N,,8220,BAO_0000218,,1,,10116.0,,50597,Volume of distribution in rat,Rattus norvegicus,CHEMBL620526,
Intermediate,,A,5871,In vivo,,1,,,N,,8221,BAO_0000218,,1,,10116.0,,50597,Volume of distribution in rat by iv administration,Rattus norvegicus,CHEMBL620527,
Intermediate,,A,6803,In vivo,,1,,,N,,8222,BAO_0000218,,1,,10116.0,,50597,Volume of distribution in rats,Rattus norvegicus,CHEMBL620528,
Intermediate,,A,5199,In vivo,,1,,,N,,8223,BAO_0000218,,1,,10116.0,,50597,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Rattus norvegicus,CHEMBL620529,
Intermediate,,A,4727,,,1,,,N,,8224,BAO_0000218,,1,,10116.0,,50597,Volume distribution at the dose of 2 mg/kg in rat,Rattus norvegicus,CHEMBL620530,
Intermediate,,A,16367,In vivo,,1,,,N,,8225,BAO_0000218,,1,,10116.0,,50597,Steady state volume of distribution was determined,Rattus norvegicus,CHEMBL620531,
Intermediate,,A,5005,In vivo,,1,,,U,,8226,BAO_0000218,,0,,9544.0,,22224,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,Macaca mulatta,CHEMBL620532,
Intermediate,,A,5005,In vivo,,1,,,U,,8227,BAO_0000218,,0,,10116.0,,22224,Compound was tested for its plasma volume distribution in Sprague Dawley rats,Rattus norvegicus,CHEMBL620533,
Intermediate,,A,5005,In vivo,,1,,,U,,8228,BAO_0000218,,0,,10116.0,,22224,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,Rattus norvegicus,CHEMBL620534,
Intermediate,,A,15765,In vivo,,1,,,N,,8229,BAO_0000218,,1,,10116.0,,50597,Mean (%CV) PK parameters for Vdss(mL/kg).,Rattus norvegicus,CHEMBL620535,
Intermediate,,A,2792,In vivo,,1,,,N,,8230,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,Rattus norvegicus,CHEMBL875826,
Intermediate,,A,2792,In vivo,,1,,,N,,8231,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,Rattus norvegicus,CHEMBL620536,
Intermediate,,A,5334,In vivo,,1,,,N,,8232,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Rattus norvegicus,CHEMBL620537,
Intermediate,,A,5334,In vivo,,1,,,N,,8233,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,Rattus norvegicus,CHEMBL618526,
Intermediate,,A,5739,In vivo,,1,,,N,,8234,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,Rattus norvegicus,CHEMBL618527,
Intermediate,,A,5789,In vivo,,1,,,N,,8235,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (Vdss) in rat,Rattus norvegicus,CHEMBL618528,
Intermediate,,A,4239,In vivo,,1,,,N,,8236,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (vdss) was measured in rat,Rattus norvegicus,CHEMBL618529,
Intermediate,,A,4709,In vivo,,1,,,N,,8237,BAO_0000218,,1,,10116.0,,50597,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,Rattus norvegicus,CHEMBL618530,
Intermediate,,A,6642,In vivo,,1,,,N,,8238,BAO_0000218,,1,,10116.0,,50597,Volume of distribution in rat,Rattus norvegicus,CHEMBL618531,
Intermediate,,A,5247,In vivo,,1,,,N,,8239,BAO_0000218,,1,,10116.0,,50597,The pharmacokinetic parameter volume of distribution in vivo in rats,Rattus norvegicus,CHEMBL618532,
Intermediate,,F,17720,In vivo,,1,,,N,,8240,BAO_0000218,,1,,10116.0,,50597,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,CHEMBL618533,
Intermediate,,A,17686,In vivo,,1,,,N,,8241,BAO_0000218,,1,,10116.0,,50597,Vdss in rat i.v. at 2 mg/kg concentration,Rattus norvegicus,CHEMBL618534,
Intermediate,,A,4689,In vivo,,1,,,N,,8242,BAO_0000218,,1,,10116.0,,50597,Volume distribution after intravenous administration (1 mg/kg) in rat,Rattus norvegicus,CHEMBL618535,
Intermediate,,A,5654,In vivo,,1,,,N,,8243,BAO_0000218,,1,,10116.0,,50597,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Rattus norvegicus,CHEMBL618536,
Intermediate,,A,5654,In vivo,,1,,,N,,8244,BAO_0000218,,1,,10116.0,,50597,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Rattus norvegicus,CHEMBL618537,
Intermediate,,A,4527,In vivo,,1,,,N,,8245,BAO_0000218,,1,,10116.0,,50597,Volume distribution at a dose of 10 uM/kg in rat was determined,Rattus norvegicus,CHEMBL618538,
Intermediate,,A,4521,In vivo,,1,,,N,,8246,BAO_0000218,,1,,10116.0,,50597,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Rattus norvegicus,CHEMBL618539,
Intermediate,,A,6057,In vivo,,1,,,N,,8247,BAO_0000218,,1,,10116.0,,50597,Volume distribution was calculated in rat,Rattus norvegicus,CHEMBL618540,
Intermediate,,A,5510,In vivo,,1,,,N,,8248,BAO_0000218,,1,,10116.0,,50597,Volume distribution was determined,Rattus norvegicus,CHEMBL618541,
Intermediate,,A,2938,In vivo,,1,,,N,,8249,BAO_0000218,,1,,10116.0,,50597,Volume of distribution after intravenous administration was evaluated in rat,Rattus norvegicus,CHEMBL618542,
Intermediate,,A,6679,In vivo,,1,,,N,,8250,BAO_0000218,,1,,10116.0,,50597,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Rattus norvegicus,CHEMBL622544,
Intermediate,,A,6685,In vivo,,1,,,N,,8251,BAO_0000218,,1,,10116.0,,50597,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",Rattus norvegicus,CHEMBL622545,
Intermediate,,A,6685,In vivo,,1,,,N,,8252,BAO_0000218,,1,,10116.0,,50597,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",Rattus norvegicus,CHEMBL622546,
Intermediate,,A,6685,In vivo,,1,,,N,,8253,BAO_0000218,,1,,10116.0,,50597,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",Rattus norvegicus,CHEMBL622547,
Intermediate,,A,5145,In vivo,,1,,,N,,8254,BAO_0000218,,1,,10116.0,,50597,Volume of distribution in steady state was determined in rat,Rattus norvegicus,CHEMBL622548,
Intermediate,,A,6467,In vivo,,1,,,N,,8255,BAO_0000218,,1,,10116.0,,50597,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,Rattus norvegicus,CHEMBL622549,
Intermediate,,A,6467,In vivo,,1,,,N,,8256,BAO_0000218,,1,,10116.0,,50597,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,Rattus norvegicus,CHEMBL622550,
Intermediate,,A,15115,,,1,,,N,,8257,BAO_0000218,,1,,10090.0,,50594,Compound was evaluated for area under curve when administered through oral route to mouse,Mus musculus,CHEMBL622551,
Intermediate,,A,8758,,,1,,,N,,8258,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,Rattus norvegicus,CHEMBL622552,
Intermediate,,A,8758,,,1,,,N,,8259,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,Rattus norvegicus,CHEMBL622553,
Autocuration,,F,8267,In vivo,,1,,,U,,8260,BAO_0000218,,0,,,,22224,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,,CHEMBL622554,
Intermediate,,A,8267,,,1,,,N,,8261,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,Canis lupus familiaris,CHEMBL622555,
Intermediate,,A,14239,,,1,,,N,,8262,BAO_0000218,,1,,10090.0,,50594,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,Mus musculus,CHEMBL622556,
Intermediate,,A,14239,,,1,,,N,,8263,BAO_0000218,,1,,10090.0,,50594,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,Mus musculus,CHEMBL622557,
Intermediate,,A,10754,,,1,,,N,,8264,BAO_0000218,,1,,10090.0,178.0,50594,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,Mus musculus,CHEMBL622558,Blood
Intermediate,,A,10754,,,1,,,N,,8265,BAO_0000218,,1,,10090.0,178.0,50594,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,Mus musculus,CHEMBL622559,Blood
Intermediate,,A,10754,,,1,,,N,,8266,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,Canis lupus familiaris,CHEMBL622560,
Intermediate,,A,14681,,,1,,,N,,8267,BAO_0000218,,1,,10116.0,,50597,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,Rattus norvegicus,CHEMBL622561,
Intermediate,,A,14681,,,1,,,N,,8268,BAO_0000218,,1,,10116.0,,50597,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,Rattus norvegicus,CHEMBL622562,
Intermediate,,A,14681,,,1,,,N,,8269,BAO_0000218,,1,,10116.0,,50597,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,Rattus norvegicus,CHEMBL622563,
Autocuration,,A,13118,,,1,,,U,,8270,BAO_0000019,,0,,,,22224,Concentration of compound in Central nervous system,,CHEMBL622564,
Autocuration,,A,13118,,,1,,,U,,8271,BAO_0000019,,0,,,,22224,Concentration of compound in Central nervous system; Not detectable,,CHEMBL622565,
Intermediate,,A,13318,,,1,,,N,,8272,BAO_0000218,,1,,10090.0,,50594,"Concentration of diester in the blood, following oral administration in mice",Mus musculus,CHEMBL622566,
Intermediate,,A,13318,,,1,,,N,,8273,BAO_0000218,,1,,10090.0,,50594,"Concentration of monoester in the blood, following oral administration in mice",Mus musculus,CHEMBL624515,
Intermediate,,A,13318,,,1,,,N,,8274,BAO_0000218,,1,,10090.0,,50594,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,Mus musculus,CHEMBL624516,
Autocuration,,A,15692,,,1,,,U,,8275,BAO_0000019,,0,,,,22224,Evaluated for Pharmacokinetic property: Area under the curve,,CHEMBL624517,
Intermediate,,A,14839,,,1,,,N,,8276,BAO_0000218,,1,,10090.0,,50594,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,Mus musculus,CHEMBL624518,
Intermediate,,A,14839,,,1,,,N,,8277,BAO_0000218,,1,,9541.0,,100710,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,Macaca fascicularis,CHEMBL624519,
Intermediate,,A,14839,,,1,,,N,,8278,BAO_0000218,,1,,9541.0,,100710,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,Macaca fascicularis,CHEMBL624520,
Intermediate,,A,14839,,,1,,,N,,8279,BAO_0000218,,1,,9541.0,,100710,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,Macaca fascicularis,CHEMBL624521,
Intermediate,,A,14839,,,1,,,N,,8280,BAO_0000218,,1,,9541.0,,100710,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,Macaca fascicularis,CHEMBL624522,
Intermediate,,A,14839,,,1,,,N,,8281,BAO_0000218,,1,,9541.0,,100710,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,Macaca fascicularis,CHEMBL624523,
Intermediate,,A,14839,,,1,,,N,,8282,BAO_0000218,,1,,9541.0,,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",Macaca fascicularis,CHEMBL624409,
Intermediate,,A,14839,,,1,,,N,,8283,BAO_0000218,,1,,9541.0,,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",Macaca fascicularis,CHEMBL624410,
Intermediate,,A,14839,,,1,,,N,,8284,BAO_0000218,,1,,9541.0,,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",Macaca fascicularis,CHEMBL624411,
Intermediate,,A,14839,,,1,,,N,,8285,BAO_0000218,,1,,9541.0,,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",Macaca fascicularis,CHEMBL623531,
Intermediate,,A,14839,,,1,,,N,,8286,BAO_0000218,,1,,9541.0,,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",Macaca fascicularis,CHEMBL623532,
Intermediate,,A,14839,,,1,,,N,,8287,BAO_0000218,,1,,9541.0,,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",Macaca fascicularis,CHEMBL623533,
Intermediate,,A,14839,,,1,,,N,,8288,BAO_0000218,,1,,9541.0,,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",Macaca fascicularis,CHEMBL623534,
Intermediate,,A,14839,,,1,,,N,,8289,BAO_0000218,,1,,10090.0,,50594,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,Mus musculus,CHEMBL623535,
Intermediate,,A,14839,,,1,,,N,,8290,BAO_0000218,,1,,10090.0,,50594,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,Mus musculus,CHEMBL623536,
Intermediate,,A,14839,,,1,,,N,,8291,BAO_0000218,,1,,10090.0,,50594,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,Mus musculus,CHEMBL623537,
Intermediate,,A,14839,,,1,,,N,,8292,BAO_0000218,,1,,10090.0,,50594,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,Mus musculus,CHEMBL623538,
Intermediate,,A,14839,,,1,,,N,,8293,BAO_0000218,,1,,10090.0,,50594,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,Mus musculus,CHEMBL623539,
Intermediate,,A,14839,,,1,,,N,,8294,BAO_0000218,,1,,10090.0,,50594,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,Mus musculus,CHEMBL623540,
Intermediate,,A,14839,,,1,,,N,,8295,BAO_0000218,,1,,10090.0,,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",Mus musculus,CHEMBL623541,
Intermediate,,A,14839,,,1,,,N,,8296,BAO_0000218,,1,,10090.0,,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",Mus musculus,CHEMBL623542,
Intermediate,,A,14839,,,1,,,N,,8297,BAO_0000218,,1,,10090.0,,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",Mus musculus,CHEMBL623543,
Intermediate,,A,14839,,,1,,,N,,8298,BAO_0000218,,1,,10090.0,,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",Mus musculus,CHEMBL623544,
Intermediate,,A,14839,,,1,,,N,,8299,BAO_0000218,,1,,10090.0,,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",Mus musculus,CHEMBL623545,
Intermediate,,A,14839,,,1,,,N,,8300,BAO_0000218,,1,,10090.0,,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",Mus musculus,CHEMBL623546,
Intermediate,,A,5408,In vivo,,1,,,N,,8301,BAO_0000218,,1,,10116.0,1969.0,50597,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,CHEMBL623547,Plasma
Intermediate,,A,6827,In vivo,,1,,,N,,8302,BAO_0000218,,1,,10116.0,,50597,High i.v. clearance in Dawley rats,Rattus norvegicus,CHEMBL623548,
Intermediate,,A,17538,In vitro,,1,,Microsomes,N,,8303,BAO_0000218,,1,,10116.0,2107.0,50597,In vitro clearance in rat liver microsomes,Rattus norvegicus,CHEMBL623549,Liver
Intermediate,,A,6331,In vitro,,1,,Microsomes,N,,8304,BAO_0000218,,1,,10116.0,2107.0,50597,Intrinsic clearance in rat liver microsomes was determined,Rattus norvegicus,CHEMBL623550,Liver
Intermediate,Hepatocyte,A,5948,In vitro,,1,,,N,401.0,8305,BAO_0000218,,1,,10116.0,2107.0,50597,Intrinsic clearance in rat hepatocytes was determined,Rattus norvegicus,CHEMBL875276,Liver
Intermediate,,A,4026,In vivo,,1,,,N,,8306,BAO_0000218,,1,,10116.0,,50597,Plasma Clearance was determined,Rattus norvegicus,CHEMBL621872,
Intermediate,,A,6647,In vivo,,1,,,N,,8307,BAO_0000218,,1,,10116.0,,50597,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,Rattus norvegicus,CHEMBL621873,
Intermediate,,A,1696,In vivo,,1,,,N,,8308,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rat.,Rattus norvegicus,CHEMBL621874,
Intermediate,,A,6597,In vivo,,1,,,N,,8309,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rats,Rattus norvegicus,CHEMBL621875,
Intermediate,,A,347,In vivo,,1,,,N,,8310,BAO_0000218,,1,,10116.0,,50597,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,Rattus norvegicus,CHEMBL621876,
Intermediate,,A,16423,In vivo,,1,,,N,,8311,BAO_0000218,,1,,10116.0,,50597,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,Rattus norvegicus,CHEMBL621877,
Intermediate,,A,2879,In vivo,,1,,,N,,8312,BAO_0000218,,1,,10116.0,,50597,Plasma clearance was measured in rat,Rattus norvegicus,CHEMBL621878,
Intermediate,,A,4883,In vivo,,1,,,N,,8313,BAO_0000218,,1,,10116.0,,50597,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,Rattus norvegicus,CHEMBL621879,
Intermediate,,A,5328,In vivo,,1,,,N,,8314,BAO_0000218,,1,,10116.0,1969.0,50597,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",Rattus norvegicus,CHEMBL621880,Plasma
Intermediate,,A,5160,In vivo,,1,,,N,,8315,BAO_0000218,,1,,10116.0,,50597,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,Rattus norvegicus,CHEMBL621881,
Intermediate,,A,17582,In vivo,,1,,,N,,8316,BAO_0000218,,1,,10116.0,,50597,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Rattus norvegicus,CHEMBL621882,
Intermediate,,A,17651,In vivo,,1,,,N,,8317,BAO_0000218,,1,,10116.0,,50597,Total clearance at 1 mg/kg was determined in rat,Rattus norvegicus,CHEMBL875283,
Intermediate,,A,17651,In vivo,,1,,,N,,8318,BAO_0000218,,1,,10116.0,,50597,Total clearance at 10 mg/kg was determined in rat,Rattus norvegicus,CHEMBL621883,
Intermediate,,A,6596,In vivo,,1,,,N,,8319,BAO_0000218,,1,,10116.0,,50597,Clearance in rat,Rattus norvegicus,CHEMBL621884,
Intermediate,,A,4796,In vivo,,1,,,N,,8320,BAO_0000218,,1,,10116.0,,50597,Plasma clearance rate determined in rats,Rattus norvegicus,CHEMBL621885,
Intermediate,,A,6850,In vivo,,1,,,N,,8321,BAO_0000218,,1,,10116.0,,50597,Clearance of compound in rat was evaluated,Rattus norvegicus,CHEMBL621886,
Intermediate,,A,5932,In vivo,,1,,,N,,8322,BAO_0000218,,1,,10116.0,1969.0,50597,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,Rattus norvegicus,CHEMBL621887,Plasma
Intermediate,,A,3371,In vivo,,1,,,N,,8323,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (blood clearance) in rat,Rattus norvegicus,CHEMBL621888,
Intermediate,,A,2083,In vivo,,1,,,N,,8324,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rat,Rattus norvegicus,CHEMBL621889,
Intermediate,,A,4942,In vivo,,1,,,N,,8325,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rats,Rattus norvegicus,CHEMBL621890,
Intermediate,,A,6838,In vitro,,1,,Microsomes,N,,8326,BAO_0000218,,1,,10116.0,2107.0,50597,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,Rattus norvegicus,CHEMBL621891,Liver
Intermediate,,A,5353,In vivo,,1,,,N,,8327,BAO_0000218,,1,,10116.0,,50597,Clearance in Dawley rat,Rattus norvegicus,CHEMBL621892,
Intermediate,,A,6641,In vivo,,1,,,N,,8328,BAO_0000218,,1,,10116.0,,50597,Clearance rat,Rattus norvegicus,CHEMBL621893,
Intermediate,,A,6641,In vivo,,1,,,N,,8329,BAO_0000218,,1,,10116.0,,50597,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),Rattus norvegicus,CHEMBL621894,
Intermediate,,A,6641,In vivo,,1,,,N,,8330,BAO_0000218,,1,,10116.0,,50597,Clearance rat; Not determined,Rattus norvegicus,CHEMBL621895,
Intermediate,,A,6444,In vivo,,1,,,N,,8331,BAO_0000218,,1,,10116.0,,50597,Clearance rate was determined in rat at a dose of 1 mpk i.v.,Rattus norvegicus,CHEMBL875284,
Intermediate,,A,6444,In vivo,,1,,,N,,8332,BAO_0000218,,1,,10116.0,,50597,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,Rattus norvegicus,CHEMBL618699,
Intermediate,,A,6444,In vivo,,1,,,N,,8333,BAO_0000218,,1,,10116.0,,50597,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,Rattus norvegicus,CHEMBL618700,
Intermediate,,A,6211,In vivo,,1,,,N,,8334,BAO_0000218,,1,,10116.0,,50597,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,Rattus norvegicus,CHEMBL618701,
Intermediate,,A,12873,In vivo,,1,,,N,,8335,BAO_0000218,,1,,10116.0,1969.0,50597,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",Rattus norvegicus,CHEMBL876600,Plasma
Intermediate,,A,6570,In vivo,,1,,,N,,8336,BAO_0000218,,1,,10116.0,,50597,Clearance of compound in rat after 1 mg/kg i.v. administration,Rattus norvegicus,CHEMBL618702,
Intermediate,,A,3341,In vivo,,1,,,N,,8337,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for Hepatic clearance in rat,Rattus norvegicus,CHEMBL618703,
Intermediate,,A,4891,In vivo,,1,,,N,,8338,BAO_0000218,,1,,10116.0,,50597,In vivo clearance after 5 mg/kg dose,Rattus norvegicus,CHEMBL618704,
Intermediate,,A,1094,In vivo,,1,,,N,,8339,BAO_0000218,,1,,10116.0,1969.0,50597,Compound was tested for plasma clearance in rats,Rattus norvegicus,CHEMBL618705,Plasma
Intermediate,,A,2938,In vivo,,1,,,N,,8340,BAO_0000218,,1,,10116.0,,50597,Hepatic clearance after intravenous administration was evaluated in rat,Rattus norvegicus,CHEMBL618706,
Intermediate,,A,17853,In vivo,,1,,,N,,8341,BAO_0000218,,1,,10116.0,,50597,Lower clearance in rat (i.v.) at 0.5 mpk,Rattus norvegicus,CHEMBL618707,
Intermediate,,A,6049,In vivo,,1,,,N,,8342,BAO_0000218,,1,,10116.0,1969.0,50597,Pharmacokinetic parameter expressed as plasma clearance in rat,Rattus norvegicus,CHEMBL618708,Plasma
Intermediate,,A,5789,In vivo,,1,,,N,,8343,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (Clp) in rat,Rattus norvegicus,CHEMBL618709,
Intermediate,,A,4514,In vivo,,1,,,N,,8344,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in Sprague-Dawley rats,Rattus norvegicus,CHEMBL618710,
Intermediate,,A,6448,In vivo,,1,,,N,,8345,BAO_0000218,,1,,10116.0,,50597,Plasma clearance (Clp) in rat,Rattus norvegicus,CHEMBL618711,
Intermediate,,A,6062,In vivo,,1,,,N,,8346,BAO_0000218,,1,,10116.0,,50597,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,Rattus norvegicus,CHEMBL618712,
Intermediate,,A,5710,In vivo,,1,,,N,,8347,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,Rattus norvegicus,CHEMBL618713,
Intermediate,,A,4709,In vivo,,1,,,N,,8348,BAO_0000218,,1,,10116.0,,50597,Plasma clearance after intravenous administration of 1 mg/kg in rat,Rattus norvegicus,CHEMBL618714,
Intermediate,,A,4521,In vivo,,1,,,N,,8349,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Rattus norvegicus,CHEMBL618715,
Intermediate,,A,1742,In vivo,,1,,,N,,8350,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rat was determined,Rattus norvegicus,CHEMBL618716,
Intermediate,,A,6057,In vivo,,1,,,N,,8351,BAO_0000218,,1,,10116.0,,50597,Plasma clearance measured in rat,Rattus norvegicus,CHEMBL876601,
Intermediate,,A,6057,In vivo,,1,,,N,,8352,BAO_0000218,,1,,10116.0,,50597,Plasma clearance was calculated in rat,Rattus norvegicus,CHEMBL618717,
Intermediate,,A,5145,In vivo,,1,,,N,,8353,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rat,Rattus norvegicus,CHEMBL618718,
Intermediate,,A,5833,In vivo,,1,,,N,,8354,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rat,Rattus norvegicus,CHEMBL618719,
Intermediate,,A,6453,In vivo,,1,,,N,,8355,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rat,Rattus norvegicus,CHEMBL618720,
Intermediate,,A,6640,In vivo,,1,,,N,,8356,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rat,Rattus norvegicus,CHEMBL618721,
Intermediate,,A,6305,In vivo,,1,,,N,,8357,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rats,Rattus norvegicus,CHEMBL621477,
Intermediate,,A,6642,In vivo,,1,,,N,,8358,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rat,Rattus norvegicus,CHEMBL621478,
Intermediate,,A,5472,In vivo,,1,,,N,,8359,BAO_0000218,,1,,10116.0,,50597,Plasma clearance was evaluated in rat,Rattus norvegicus,CHEMBL621479,
Intermediate,,A,5472,In vivo,,1,,,N,,8360,BAO_0000218,,1,,10116.0,,50597,Plasma clearance was evaluated in rat; Not tested,Rattus norvegicus,CHEMBL621480,
Intermediate,,A,5144,In vivo,,1,,,N,,8361,BAO_0000218,,1,,10116.0,,50597,Plasma clearance rate was determined for the compound in rat,Rattus norvegicus,CHEMBL621481,
Intermediate,,A,6685,In vivo,,1,,,N,,8362,BAO_0000218,,1,,10116.0,,50597,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",Rattus norvegicus,CHEMBL621482,
Intermediate,,A,6685,In vivo,,1,,,N,,8363,BAO_0000218,,1,,10116.0,,50597,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",Rattus norvegicus,CHEMBL621483,
Intermediate,,A,6685,In vivo,,1,,,N,,8364,BAO_0000218,,1,,10116.0,,50597,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",Rattus norvegicus,CHEMBL621484,
Intermediate,,A,13950,In vivo,,1,,,N,,8365,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL621485,Heart
Intermediate,,A,13950,In vivo,,1,,,N,,8366,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL621486,Heart
Intermediate,,A,13950,In vivo,,1,,,N,,8367,BAO_0000218,,1,,10116.0,160.0,50597,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL621487,Intestine
Intermediate,,A,13950,In vivo,,1,,,N,,8368,BAO_0000218,,1,,10116.0,160.0,50597,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL621488,Intestine
Intermediate,,A,13950,In vivo,,1,,,N,,8369,BAO_0000218,,1,,10116.0,160.0,50597,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL621489,Intestine
Intermediate,,A,13950,In vivo,,1,,,N,,8370,BAO_0000218,,1,,10116.0,160.0,50597,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL621490,Intestine
Intermediate,,A,13950,In vivo,,1,,,N,,8371,BAO_0000218,,1,,10116.0,160.0,50597,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL621491,Intestine
Intermediate,,A,13950,In vivo,,1,,,N,,8372,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL621492,Kidney
Intermediate,,A,13950,In vivo,,1,,,N,,8373,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL621493,Kidney
Intermediate,,A,13950,In vivo,,1,,,N,,8374,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL621494,Kidney
Intermediate,,A,13950,In vivo,,1,,,N,,8375,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL621495,Kidney
Intermediate,,A,13950,In vivo,,1,,,N,,8376,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL621496,Kidney
Intermediate,,A,13950,In vivo,,1,,,N,,8377,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL621497,Liver
Intermediate,,A,13950,In vivo,,1,,,N,,8378,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL621498,Liver
Intermediate,,A,13950,In vivo,,1,,,N,,8379,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL621499,Liver
Intermediate,,A,13950,In vivo,,1,,,N,,8380,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL618634,Liver
Intermediate,,A,13950,In vivo,,1,,,N,,8381,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL618635,Liver
Intermediate,,A,13950,In vivo,,1,,,N,,8382,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL618636,Lung
Intermediate,,A,13950,In vivo,,1,,,N,,8383,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL619737,Lung
Intermediate,,A,13950,In vivo,,1,,,N,,8384,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL619738,Lung
Intermediate,,A,13950,In vivo,,1,,,N,,8385,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL624329,Lung
Intermediate,,A,13950,In vivo,,1,,,N,,8386,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL624330,Lung
Intermediate,,A,13950,In vivo,,1,,,N,,8387,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL624331,Muscle tissue
Intermediate,,A,13950,In vivo,,1,,,N,,8388,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL624332,Muscle tissue
Intermediate,,A,13950,In vivo,,1,,,N,,8389,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL624333,Muscle tissue
Intermediate,,A,13950,In vivo,,1,,,N,,8390,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL624334,Muscle tissue
Intermediate,,A,13950,In vivo,,1,,,N,,8391,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL624335,Muscle tissue
Intermediate,,A,13950,In vivo,,1,,,N,,8392,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL620016,Spleen
Intermediate,,A,13950,In vivo,,1,,,N,,8393,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL620169,Spleen
Intermediate,,A,13950,In vivo,,1,,,N,,8394,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL620170,Spleen
Intermediate,,A,13950,In vivo,,1,,,N,,8395,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL620171,Spleen
Intermediate,,A,13950,In vivo,,1,,,N,,8396,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL620172,Spleen
Intermediate,,A,13950,In vivo,,1,,,N,,8397,BAO_0000218,,1,,10116.0,945.0,50597,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL620173,Stomach
Intermediate,,A,13950,In vivo,,1,,,N,,8398,BAO_0000218,,1,,10116.0,945.0,50597,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL620174,Stomach
Intermediate,,A,13950,In vivo,,1,,,N,,8399,BAO_0000218,,1,,10116.0,945.0,50597,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL620175,Stomach
Intermediate,,A,13950,In vivo,,1,,,N,,8400,BAO_0000218,,1,,10116.0,945.0,50597,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL620176,Stomach
Intermediate,,A,13950,In vivo,,1,,,N,,8401,BAO_0000218,,1,,10116.0,945.0,50597,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL620177,Stomach
Intermediate,,A,13950,,,1,,,N,,8402,BAO_0000218,,1,,10116.0,2037.0,50597,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL620178,Cerebellum
Intermediate,,A,13950,,,1,,,N,,8403,BAO_0000218,,1,,10116.0,2037.0,50597,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL620179,Cerebellum
Intermediate,,A,13950,,,1,,,N,,8404,BAO_0000218,,1,,10116.0,,50597,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL620180,
Intermediate,,A,6570,In vivo,,1,,,N,,8405,BAO_0000218,,1,,10116.0,,50597,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,Rattus norvegicus,CHEMBL620181,
Intermediate,,A,6571,In vivo,,1,,,N,,8406,BAO_0000218,,1,,10116.0,,50597,Volume of distribution of compound in rats after intravenous administration,Rattus norvegicus,CHEMBL620182,
Intermediate,,A,6453,In vivo,,1,,,N,,8407,BAO_0000218,,1,,10116.0,,50597,Volume of distribution in rat,Rattus norvegicus,CHEMBL620183,
Intermediate,,A,6444,In vivo,,1,,,N,,8408,BAO_0000218,,1,,10116.0,,50597,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,Rattus norvegicus,CHEMBL620184,
Intermediate,,A,6444,In vivo,,1,,,N,,8409,BAO_0000218,,1,,10116.0,,50597,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,Rattus norvegicus,CHEMBL620185,
Intermediate,,A,6444,In vivo,,1,,,N,,8410,BAO_0000218,,1,,10116.0,,50597,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,Rattus norvegicus,CHEMBL620186,
Intermediate,,A,5353,In vivo,,1,,,N,,8411,BAO_0000218,,1,,10116.0,,50597,Volume of distribution was determined in Dawley rat,Rattus norvegicus,CHEMBL620187,
Intermediate,,A,5334,In vivo,,1,,,N,,8412,BAO_0000218,,1,,10116.0,,50597,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Rattus norvegicus,CHEMBL620188,
Intermediate,,A,5334,In vivo,,1,,,N,,8413,BAO_0000218,,1,,10116.0,,50597,Volume of distribution was reported in Sprague-Dawley rat,Rattus norvegicus,CHEMBL620189,
Intermediate,,A,6641,In vivo,,1,,,N,,8414,BAO_0000218,,1,,10116.0,,50597,Volumes of distribution in rat after peroral administration,Rattus norvegicus,CHEMBL620190,
Intermediate,,A,6641,In vivo,,1,,,N,,8415,BAO_0000218,,1,,10116.0,,50597,Volumes of distribution in rat after po administration,Rattus norvegicus,CHEMBL620191,
Intermediate,,A,6641,In vivo,,1,,,N,,8416,BAO_0000218,,1,,10116.0,,50597,Volumes of distribution in rat after po administration; Not determined,Rattus norvegicus,CHEMBL620192,
Intermediate,,A,5676,In vivo,,1,,,N,,8417,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (Volume) in rat i.v.,Rattus norvegicus,CHEMBL620193,
Intermediate,,A,6410,In vivo,,1,,,N,,8418,BAO_0000218,,1,,10116.0,,50597,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,Rattus norvegicus,CHEMBL620194,
Intermediate,,A,17670,In vivo,,1,,,N,,8419,BAO_0000218,,1,,10116.0,,50597,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",Rattus norvegicus,CHEMBL876730,
Intermediate,,A,6495,In vivo,,1,,,N,,8420,BAO_0000218,,1,,10116.0,,50597,Volume distribution in rat after oral administration at 10 mg/kg,Rattus norvegicus,CHEMBL620195,
Intermediate,,A,5408,In vivo,,1,,,N,,8421,BAO_0000218,,1,,10116.0,,50597,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,CHEMBL620196,
Intermediate,,A,4883,In vivo,,1,,,N,,8422,BAO_0000218,,1,,10116.0,,50597,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,Rattus norvegicus,CHEMBL620197,
Intermediate,,A,6647,In vivo,,1,,,N,,8423,BAO_0000218,,1,,10116.0,,50597,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,Rattus norvegicus,CHEMBL620198,
Intermediate,,A,6495,In vivo,,1,,,N,,8424,BAO_0000218,,1,,10116.0,,50597,Volume of distribution in rats,Rattus norvegicus,CHEMBL620199,
Intermediate,,A,2661,In vivo,,1,,,N,,8425,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,Rattus norvegicus,CHEMBL620200,
Intermediate,,A,2661,In vivo,,1,,,N,,8426,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,Rattus norvegicus,CHEMBL620201,
Intermediate,,A,5974,In vivo,,1,,,N,,8427,BAO_0000218,,1,,10116.0,,50597,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,CHEMBL620202,
Intermediate,,A,5974,In vivo,,1,,,N,,8428,BAO_0000218,,1,,10116.0,,50597,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,CHEMBL620203,
Intermediate,,A,5974,In vivo,,1,,,N,,8429,BAO_0000218,,1,,10116.0,,50597,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,Rattus norvegicus,CHEMBL620204,
Intermediate,,A,5974,In vivo,,1,,,N,,8430,BAO_0000218,,1,,10116.0,,50597,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,CHEMBL620205,
Intermediate,,A,5960,In vivo,,1,,,N,,8431,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter (Vss) in rat,Rattus norvegicus,CHEMBL624664,
Intermediate,,A,5676,In vivo,,1,,,N,,8432,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (Volume) in rat i.v.,Rattus norvegicus,CHEMBL624665,
Intermediate,,A,5948,,,1,,,N,,8433,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (Vss) in rat,Rattus norvegicus,CHEMBL624666,
Intermediate,,A,5979,In vivo,,1,,,N,,8434,BAO_0000218,,1,,10116.0,,50597,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,Rattus norvegicus,CHEMBL624667,
Intermediate,,A,5978,In vivo,,1,,,N,,8435,BAO_0000218,,1,,10116.0,,50597,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,CHEMBL624668,
Intermediate,,A,5978,In vivo,,1,,,N,,8436,BAO_0000218,,1,,10116.0,,50597,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,CHEMBL624669,
Intermediate,,A,5978,In vivo,,1,,,N,,8437,BAO_0000218,,1,,10116.0,,50597,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,CHEMBL624670,
Intermediate,,A,5978,In vivo,,1,,,N,,8438,BAO_0000218,,1,,10116.0,,50597,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,CHEMBL624671,
Intermediate,,A,6448,In vivo,,1,,,N,,8439,BAO_0000218,,1,,10116.0,,50597,Steady state volume distribution in rat,Rattus norvegicus,CHEMBL624672,
Intermediate,,A,12873,In vivo,,1,,,N,,8440,BAO_0000218,,1,,10116.0,1969.0,50597,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",Rattus norvegicus,CHEMBL624673,Plasma
Intermediate,,A,4576,In vivo,,1,,,N,,8441,BAO_0000218,,1,,10116.0,,50597,Steady state volume of distribution determined in rat,Rattus norvegicus,CHEMBL624674,
Intermediate,,A,17582,In vivo,,1,,,N,,8442,BAO_0000218,,1,,10116.0,,50597,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Rattus norvegicus,CHEMBL624675,
Intermediate,,A,1466,In vivo,,1,,,N,,8443,BAO_0000218,,1,,10116.0,,50597,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,Rattus norvegicus,CHEMBL621728,
Intermediate,,A,5182,,,1,,,N,,8444,BAO_0000218,,1,,10116.0,,50597,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,Rattus norvegicus,CHEMBL621729,
Intermediate,,A,5182,,,1,,,N,,8445,BAO_0000218,,1,,10116.0,,50597,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,Rattus norvegicus,CHEMBL621730,
Intermediate,,A,6535,In vivo,,1,,,N,,8446,BAO_0000218,,1,,10116.0,,50597,Volume distribution in rat after administration of 2 mg/kg iv,Rattus norvegicus,CHEMBL621731,
Intermediate,,A,6535,In vivo,,1,,,N,,8447,BAO_0000218,,1,,10116.0,,50597,Volume distribution in rat after administration of 2 mg/kg iv,Rattus norvegicus,CHEMBL621732,
Intermediate,,A,5041,In vivo,,1,,,N,,8448,BAO_0000218,,1,,10116.0,,50597,Volume in steady state distribution value was determined,Rattus norvegicus,CHEMBL621908,
Intermediate,,A,5041,In vivo,,1,,,N,,8449,BAO_0000218,,1,,10116.0,,50597,Volume in steady state distribution value was determined; ND denotes no data,Rattus norvegicus,CHEMBL875347,
Intermediate,,A,5041,In vivo,,1,,,N,,8450,BAO_0000218,,1,,10116.0,,50597,Volume in steady state distribution value was determined; ND denotes not determined,Rattus norvegicus,CHEMBL621909,
Intermediate,,A,17065,In vivo,,1,,,N,,8451,BAO_0000218,,1,,10116.0,,50597,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,Rattus norvegicus,CHEMBL621910,
Intermediate,,A,6597,In vivo,,1,,,N,,8452,BAO_0000218,,1,,10116.0,,50597,Volume of distribution at steady state was evaluated in rats,Rattus norvegicus,CHEMBL621911,
Intermediate,,A,15662,In vivo,,1,,,N,,8453,BAO_0000218,,1,,10116.0,,50597,Volume of distribution at steady state was observed after intravenous administration in rat,Rattus norvegicus,CHEMBL621912,
Intermediate,,A,6485,In vivo,,1,,,N,,8454,BAO_0000218,,1,,10116.0,,50597,Volume of distribution in steady state was determined in rat,Rattus norvegicus,CHEMBL621913,
Intermediate,,A,17655,In vivo,,1,,,N,,8455,BAO_0000218,,1,,10116.0,,50597,Volume of distribution in steady state was determined in rat,Rattus norvegicus,CHEMBL621914,
Intermediate,,A,6616,In vivo,,1,,,N,,8456,BAO_0000218,,1,,10116.0,,50597,Volume of distribution after i.v. administration,Rattus norvegicus,CHEMBL621915,
Intermediate,,A,1916,In vivo,,1,,,N,,8457,BAO_0000218,,1,,10116.0,,50597,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,Rattus norvegicus,CHEMBL621916,
Intermediate,,A,16438,In vivo,,1,,,N,,8458,BAO_0000218,,1,,10090.0,2107.0,50594,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",Mus musculus,CHEMBL621917,Liver
Intermediate,,A,16438,In vivo,,1,,,N,,8459,BAO_0000218,,1,,10090.0,2107.0,50594,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",Mus musculus,CHEMBL621918,Liver
Intermediate,,A,16438,In vivo,,1,,,N,,8460,BAO_0000218,,1,,10090.0,2106.0,50594,Biodistribution of compound (oxidized form) in spleen tissue,Mus musculus,CHEMBL621919,Spleen
Intermediate,,A,16438,In vivo,,1,,,N,,8461,BAO_0000218,,1,,10090.0,2106.0,50594,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",Mus musculus,CHEMBL621920,Spleen
Intermediate,,A,16438,In vivo,,1,,,N,,8462,BAO_0000218,,1,,10090.0,2106.0,50594,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",Mus musculus,CHEMBL621921,Spleen
Intermediate,,A,16438,In vivo,,1,,,N,,8463,BAO_0000218,,1,,10090.0,2106.0,50594,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,CHEMBL622401,Spleen
Intermediate,,A,16438,In vivo,,1,,,N,,8464,BAO_0000218,,1,,10090.0,2106.0,50594,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",Mus musculus,CHEMBL875348,Spleen
Intermediate,,A,16438,In vivo,,1,,,N,,8465,BAO_0000218,,1,,10090.0,2106.0,50594,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",Mus musculus,CHEMBL622402,Spleen
Intermediate,,A,16438,In vivo,,1,,,N,,8466,BAO_0000218,,1,,10090.0,178.0,50594,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,Mus musculus,CHEMBL622403,Blood
Intermediate,,A,16438,In vivo,,1,,,N,,8467,BAO_0000218,,1,,10090.0,178.0,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,CHEMBL622404,Blood
Intermediate,,A,16438,In vivo,,1,,,N,,8468,BAO_0000218,,1,,10090.0,955.0,50594,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,Mus musculus,CHEMBL622405,Brain
Intermediate,,A,16438,In vivo,,1,,,N,,8469,BAO_0000218,,1,,10090.0,955.0,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",Mus musculus,CHEMBL622406,Brain
Intermediate,,A,16438,In vivo,,1,,,N,,8470,BAO_0000218,,1,,10090.0,955.0,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,CHEMBL622407,Brain
Intermediate,,A,16438,In vivo,,1,,,N,,8471,BAO_0000218,,1,,10090.0,948.0,50594,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,Mus musculus,CHEMBL622408,Heart
Intermediate,,A,16438,In vivo,,1,,,N,,8472,BAO_0000218,,1,,10090.0,948.0,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",Mus musculus,CHEMBL622409,Heart
Intermediate,,A,16438,In vivo,,1,,,N,,8473,BAO_0000218,,1,,10090.0,948.0,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,CHEMBL622410,Heart
Intermediate,,A,16438,In vivo,,1,,,N,,8474,BAO_0000218,,1,,10090.0,2113.0,50594,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,Mus musculus,CHEMBL622411,Kidney
Intermediate,,A,16438,In vivo,,1,,,N,,8475,BAO_0000218,,1,,10090.0,2113.0,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",Mus musculus,CHEMBL627864,Kidney
Intermediate,,A,16438,In vivo,,1,,,N,,8476,BAO_0000218,,1,,10090.0,2113.0,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,CHEMBL627865,Kidney
Intermediate,,A,16438,In vivo,,1,,,N,,8477,BAO_0000218,,1,,10090.0,2107.0,50594,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,Mus musculus,CHEMBL627866,Liver
Intermediate,,A,16438,In vivo,,1,,,N,,8478,BAO_0000218,,1,,10090.0,2107.0,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,CHEMBL627751,Liver
Intermediate,,A,16438,In vivo,,1,,,N,,8479,BAO_0000218,,1,,10090.0,2106.0,50594,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,Mus musculus,CHEMBL627752,Spleen
Intermediate,,A,16438,In vivo,,1,,,N,,8480,BAO_0000218,,1,,10090.0,2106.0,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",Mus musculus,CHEMBL627753,Spleen
Intermediate,,A,16438,In vivo,,1,,,N,,8481,BAO_0000218,,1,,10090.0,2106.0,50594,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,CHEMBL627754,Spleen
Intermediate,,A,12467,,,1,,,N,,8482,BAO_0000218,,1,,10090.0,,50594,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,Mus musculus,CHEMBL627755,
Intermediate,,A,17208,In vivo,,1,,,N,,8483,BAO_0000218,,1,,10090.0,955.0,50594,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL627756,Brain
Intermediate,,A,17208,In vivo,,1,,,N,,8484,BAO_0000218,,1,,10090.0,955.0,50594,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL627757,Brain
Intermediate,,A,17208,In vivo,,1,,,N,,8485,BAO_0000218,,1,,10090.0,955.0,50594,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL627758,Brain
Intermediate,,A,17208,In vivo,,1,,,N,,8486,BAO_0000218,,1,,10090.0,955.0,50594,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL627759,Brain
Intermediate,,A,17208,In vivo,,1,,,N,,8487,BAO_0000218,,1,,10090.0,955.0,50594,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL627760,Brain
Intermediate,,A,17208,In vivo,,1,,,N,,8488,BAO_0000218,,1,,10090.0,955.0,50594,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL627761,Brain
Intermediate,,A,17208,In vivo,,1,,,N,,8489,BAO_0000218,,1,,10090.0,948.0,50594,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL876811,Heart
Intermediate,,A,17208,In vivo,,1,,,N,,8490,BAO_0000218,,1,,10090.0,948.0,50594,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL627762,Heart
Intermediate,,A,17208,In vivo,,1,,,N,,8491,BAO_0000218,,1,,10090.0,948.0,50594,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL627763,Heart
Intermediate,,A,17208,In vivo,,1,,,N,,8492,BAO_0000218,,1,,10090.0,948.0,50594,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL627764,Heart
Intermediate,,A,17208,In vivo,,1,,,N,,8493,BAO_0000218,,1,,10090.0,948.0,50594,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL627765,Heart
Intermediate,,A,17208,In vivo,,1,,,N,,8494,BAO_0000218,,1,,10090.0,948.0,50594,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL627766,Heart
Intermediate,,A,17208,In vivo,,1,,,N,,8495,BAO_0000218,,1,,10090.0,2113.0,50594,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL627767,Kidney
Intermediate,,A,17208,In vivo,,1,,,N,,8496,BAO_0000218,,1,,10090.0,2113.0,50594,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL627768,Kidney
Intermediate,,A,17208,In vivo,,1,,,N,,8497,BAO_0000218,,1,,10090.0,2113.0,50594,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL628422,Kidney
Intermediate,,A,17208,In vivo,,1,,,N,,8498,BAO_0000218,,1,,10090.0,2113.0,50594,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL628423,Kidney
Intermediate,,A,5089,In vivo,,1,,,N,,8499,BAO_0000218,,1,,10116.0,,50597,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,Rattus norvegicus,CHEMBL628424,
Intermediate,,A,5089,In vivo,,1,,,N,,8500,BAO_0000218,,1,,10116.0,,50597,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,Rattus norvegicus,CHEMBL628425,
Intermediate,,A,4257,In vivo,,1,,,N,,8501,BAO_0000218,,1,,10116.0,,50597,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,Rattus norvegicus,CHEMBL628426,
Intermediate,,A,6679,In vivo,,1,,,N,,8502,BAO_0000218,,1,,10116.0,,50597,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Rattus norvegicus,CHEMBL628427,
Intermediate,,A,5546,In vivo,,1,,,N,,8503,BAO_0000218,,1,,10116.0,,50597,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,Rattus norvegicus,CHEMBL626938,
Intermediate,,A,6141,In vivo,,1,,,N,,8504,BAO_0000218,,1,,10116.0,,50597,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,Rattus norvegicus,CHEMBL626939,
Intermediate,,A,5334,In vivo,,1,,,N,,8505,BAO_0000218,,1,,10116.0,,50597,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Rattus norvegicus,CHEMBL626940,
Intermediate,,A,5334,In vivo,,1,,,N,,8506,BAO_0000218,,1,,10116.0,,50597,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Rattus norvegicus,CHEMBL626941,
Intermediate,,A,5334,In vivo,,1,,,N,,8507,BAO_0000218,,1,,10116.0,,50597,Plasma clearance was reported in Sprague-Dawley rat,Rattus norvegicus,CHEMBL626942,
Intermediate,,A,4689,In vivo,,1,,,N,,8508,BAO_0000218,,1,,10116.0,,50597,Plasma clearance after intravenous administration (1 mg/kg) in rat,Rattus norvegicus,CHEMBL876812,
Intermediate,,A,6848,In vivo,,1,,,N,,8509,BAO_0000218,,1,,10116.0,,50597,Plasma clearance of compound in rats was evaluated,Rattus norvegicus,CHEMBL626943,
Intermediate,,A,6848,In vivo,,1,,,N,,8510,BAO_0000218,,1,,10116.0,,50597,Plasma clearance of compound in rats was evaluated; ND indicates not determined,Rattus norvegicus,CHEMBL626944,
Intermediate,,A,6467,In vivo,,1,,,N,,8511,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,Rattus norvegicus,CHEMBL626945,
Intermediate,,A,6467,In vivo,,1,,,N,,8512,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,Rattus norvegicus,CHEMBL626946,
Intermediate,,A,4956,In vivo,,1,,,N,,8513,BAO_0000218,,1,,10116.0,,50597,Plasma clearance rate in Sprague-Dawley rats,Rattus norvegicus,CHEMBL626856,
Intermediate,,A,5529,In vivo,,1,,,N,,8514,BAO_0000218,,1,,10116.0,,50597,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),Rattus norvegicus,CHEMBL626857,
Intermediate,,A,406,In vivo,,1,,,N,,8515,BAO_0000218,,1,,10116.0,1969.0,50597,The compound was evaluated for plasma clearance in rat,Rattus norvegicus,CHEMBL626858,Plasma
Intermediate,,A,17655,In vivo,,1,,,N,,8516,BAO_0000218,,1,,10116.0,1969.0,50597,Total plasma clearance in rat,Rattus norvegicus,CHEMBL627018,Plasma
Intermediate,,A,3293,In vivo,,1,,,N,,8517,BAO_0000218,,1,,10116.0,178.0,50597,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,Rattus norvegicus,CHEMBL625331,Blood
Intermediate,,A,4075,In vivo,,1,,,N,,8518,BAO_0000218,,1,,10116.0,178.0,50597,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,Rattus norvegicus,CHEMBL625332,Blood
Intermediate,,A,2792,In vivo,,1,,,N,,8519,BAO_0000218,,1,,10116.0,,50597,C max was determined at 10 mg/kg po dose in rats,Rattus norvegicus,CHEMBL877590,
Intermediate,,A,2792,In vivo,,1,,,N,,8520,BAO_0000218,,1,,10116.0,,50597,C max was determined at 3 mg/kg po dose in rats,Rattus norvegicus,CHEMBL625333,
Intermediate,,A,17594,In vivo,,1,,,N,,8521,BAO_0000218,,1,,10116.0,,50597,Cmax after repeated oral dose of compound at 1 mg/kg in rats,Rattus norvegicus,CHEMBL625334,
Intermediate,,A,17594,In vivo,,1,,,N,,8522,BAO_0000218,,1,,10116.0,,50597,Cmax after single intravenous bolus of 1 mg/kg in rats,Rattus norvegicus,CHEMBL625335,
Intermediate,,A,4762,In vivo,,1,,,N,,8523,BAO_0000218,,1,,10116.0,,50597,Cmax of compound at 5 mg/kg after po administration was determined in rat,Rattus norvegicus,CHEMBL625336,
Intermediate,,A,17509,In vivo,,1,,,N,,8524,BAO_0000218,,1,,10116.0,,50597,Cmax 24 hr after 10 mg/kg oral administration in rats,Rattus norvegicus,CHEMBL625337,
Intermediate,,A,17509,In vivo,,1,,,N,,8525,BAO_0000218,,1,,10116.0,,50597,Cmax 24 hr after 2 mg/kg oral administration in rats,Rattus norvegicus,CHEMBL625338,
Intermediate,,A,1466,In vivo,,1,,,N,,8526,BAO_0000218,,1,,10116.0,1969.0,50597,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,Rattus norvegicus,CHEMBL625339,Plasma
Intermediate,,A,6535,In vivo,,1,,,N,,8527,BAO_0000218,,1,,10116.0,,50597,Cmax in rat after administration of 2 mg/kg iv,Rattus norvegicus,CHEMBL625340,
Intermediate,,A,6535,In vivo,,1,,,N,,8528,BAO_0000218,,1,,10116.0,,50597,Cmax in rat after administration of 2 mg/kg iv,Rattus norvegicus,CHEMBL625341,
Intermediate,,A,3169,In vivo,,1,,,N,,8529,BAO_0000218,,1,,10116.0,,50597,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,Rattus norvegicus,CHEMBL622687,
Intermediate,,A,6515,In vivo,,1,,,N,,8530,BAO_0000218,,1,,10116.0,1969.0,50597,Cmax wa determined in rat plasma at 30 mg/kg after po administration,Rattus norvegicus,CHEMBL622688,Plasma
Intermediate,,A,11149,In vivo,,1,,,N,,8531,BAO_0000218,,1,,10116.0,178.0,50597,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,Rattus norvegicus,CHEMBL622689,Blood
Intermediate,,A,11149,In vivo,,1,,,N,,8532,BAO_0000218,,1,,10116.0,178.0,50597,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,Rattus norvegicus,CHEMBL620295,Blood
Intermediate,,A,17858,In vivo,,1,,,N,,8533,BAO_0000218,,1,,10116.0,,50597,Cmax after 10 mg/kg oral administration in rat,Rattus norvegicus,CHEMBL620296,
Intermediate,,A,6518,In vivo,,1,,,N,,8534,BAO_0000218,,1,,10116.0,,50597,Cmax after IV dosing at 0.5 mg/kg in rat; no data,Rattus norvegicus,CHEMBL620297,
Intermediate,,A,6518,In vivo,,1,,,N,,8535,BAO_0000218,,1,,10116.0,,50597,Cmax after IV dosing at 1 mg/kg in rat; no data,Rattus norvegicus,CHEMBL620298,
Intermediate,,A,4426,In vivo,,1,,,N,,8536,BAO_0000218,,1,,10116.0,,50597,Cmax after oral administration at 20 mpk in rats,Rattus norvegicus,CHEMBL620299,
Intermediate,,A,4426,In vivo,,1,,,N,,8537,BAO_0000218,,1,,10116.0,,50597,Cmax after oral administration at 20 mpk in rats; Not performed.,Rattus norvegicus,CHEMBL620300,
Intermediate,,A,4426,In vivo,,1,,,N,,8538,BAO_0000218,,1,,10116.0,,50597,Cmax after oral administration at 20 mpk in rats d; Not performed.,Rattus norvegicus,CHEMBL620301,
Intermediate,,A,5656,In vivo,,1,,,N,,8539,BAO_0000218,,1,,10116.0,,50597,Cmax after oral administration in rat,Rattus norvegicus,CHEMBL620302,
Intermediate,,A,6518,In vivo,,1,,,N,,8540,BAO_0000218,,1,,10116.0,,50597,Cmax after oral administration at a dose of 2 mg/kg in rat,Rattus norvegicus,CHEMBL620303,
Intermediate,,A,6518,In vivo,,1,,,N,,8541,BAO_0000218,,1,,10116.0,,50597,Cmax after oral administration at a dose of 4 mg/kg in rat,Rattus norvegicus,CHEMBL620304,
Intermediate,,A,6113,In vivo,,1,,,N,,8542,BAO_0000218,,1,,10116.0,,50597,Cmax in rats after 20 mg/kg oral dose,Rattus norvegicus,CHEMBL620305,
Intermediate,,A,17764,In vivo,,1,,,N,,8543,BAO_0000218,,1,,10116.0,,50597,Cmax after peroral administration in rats at 2.4 uM/kg,Rattus norvegicus,CHEMBL620306,
Intermediate,,A,4756,In vivo,,1,,,N,,8544,BAO_0000218,,1,,10116.0,,50597,Cmax at the dose of 2 mg/Kg administered perorally in rats,Rattus norvegicus,CHEMBL620307,
Intermediate,,A,4756,In vivo,,1,,,N,,8545,BAO_0000218,,1,,10116.0,,50597,Cmax at the dose of 5 mg/Kg administered perorally in rats,Rattus norvegicus,CHEMBL620308,
Intermediate,,A,6402,In vivo,,1,,,N,,8546,BAO_0000218,,1,,10116.0,,50597,Cmax by administering at 20 mg/kg p.o. in rats,Rattus norvegicus,CHEMBL620309,
Intermediate,,A,5610,In vivo,,1,,,N,,8547,BAO_0000218,,1,,10116.0,,50597,Cmax in male rat,Rattus norvegicus,CHEMBL620310,
Intermediate,,A,5207,In vivo,,1,,,N,,8548,BAO_0000218,,1,,10116.0,,50597,Cmax in rat,Rattus norvegicus,CHEMBL620311,
Intermediate,,A,6011,In vivo,,1,,,N,,8549,BAO_0000218,,1,,10116.0,,50597,Cmax in rat,Rattus norvegicus,CHEMBL620312,
Intermediate,,A,6504,In vivo,,1,,,N,,8550,BAO_0000218,,1,,10116.0,,50597,Cmax in rat,Rattus norvegicus,CHEMBL620313,
Intermediate,,A,6046,In vivo,,1,,,N,,8551,BAO_0000218,,1,,10116.0,,50597,Cmax in rat at 10 mg/kg,Rattus norvegicus,CHEMBL620314,
Intermediate,,A,6504,In vivo,,1,,,N,,8552,BAO_0000218,,1,,10116.0,,50597,Cmax in rat at the dose of 1 mg/kg i.v.,Rattus norvegicus,CHEMBL620315,
Intermediate,,A,5874,In vivo,,1,,,N,,8553,BAO_0000218,,1,,10116.0,,50597,Cmax in rat by po administration at a dose of 40 mg/kg,Rattus norvegicus,CHEMBL620316,
Intermediate,,A,17686,In vivo,,1,,,N,,8554,BAO_0000218,,1,,10116.0,,50597,Cmax in rat p.o. at 20 mg/kg concentration,Rattus norvegicus,CHEMBL620317,
Intermediate,,A,5836,In vivo,,1,,,N,,8555,BAO_0000218,,1,,10116.0,,50597,Cmax in rats,Rattus norvegicus,CHEMBL620318,
Intermediate,,A,17596,In vivo,,1,,,N,,8556,BAO_0000218,,1,,10116.0,,50597,Cmax in rats,Rattus norvegicus,CHEMBL620319,
Intermediate,,A,16423,In vivo,,1,,,N,,8557,BAO_0000218,,1,,10116.0,,50597,Cmax was evaluated after 20 uM/kg of peroral administration,Rattus norvegicus,CHEMBL620320,
Intermediate,,A,17804,In vivo,,1,,,N,,8558,BAO_0000218,,1,,10116.0,,50597,Cmax was measured in rats after peroral administration at 3 mg/kg,Rattus norvegicus,CHEMBL620321,
Intermediate,,A,1908,In vivo,,1,,,N,,8559,BAO_0000218,,1,,10116.0,,50597,Cmax value after oral dose at a dose of 10 mg/kg in rats.,Rattus norvegicus,CHEMBL620322,
Intermediate,,A,13950,,,1,,,N,,8560,BAO_0000218,,1,,10116.0,,50597,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL620323,
Intermediate,,A,13950,,,1,,,N,,8561,BAO_0000218,,1,,10116.0,1870.0,50597,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL620324,Frontal cortex
Intermediate,,A,13950,,,1,,,N,,8562,BAO_0000218,,1,,10116.0,1870.0,50597,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL620325,Frontal cortex
Intermediate,,A,13950,,,1,,,N,,8563,BAO_0000218,,1,,10116.0,10000000.0,50597,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL620326,Hippocampus
Intermediate,,A,13950,,,1,,,N,,8564,BAO_0000218,,1,,10116.0,10000000.0,50597,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL620327,Hippocampus
Intermediate,,A,13950,,,1,,,N,,8565,BAO_0000218,,1,,10116.0,,50597,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL620328,
Intermediate,,A,13950,,,1,,,N,,8566,BAO_0000218,,1,,10116.0,,50597,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL620329,
Intermediate,,A,13950,,,1,,,N,,8567,BAO_0000218,,1,,10116.0,1891.0,50597,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL620330,Midbrain
Intermediate,,A,13950,,,1,,,N,,8568,BAO_0000218,,1,,10116.0,1891.0,50597,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL875286,Midbrain
Intermediate,,A,13950,,,1,,,N,,8569,BAO_0000218,,1,,10116.0,,50597,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL620331,
Intermediate,,A,13950,,,1,,,N,,8570,BAO_0000218,,1,,10116.0,,50597,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL620332,
Intermediate,,A,13950,,,1,,,N,,8571,BAO_0000218,,1,,10116.0,2435.0,50597,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL620333,Striatum
Intermediate,,A,13950,,,1,,,N,,8572,BAO_0000218,,1,,10116.0,2435.0,50597,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,CHEMBL620334,Striatum
Intermediate,,A,16434,,,1,,,N,,8573,BAO_0000218,,1,,10116.0,178.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,CHEMBL621015,Blood
Intermediate,,A,16434,,,1,,,N,,8574,BAO_0000218,,1,,10116.0,178.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,CHEMBL621016,Blood
Intermediate,,A,16434,,,1,,,N,,8575,BAO_0000218,,1,,10116.0,178.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,CHEMBL621191,Blood
Intermediate,,A,16434,,,1,,,N,,8576,BAO_0000218,,1,,10116.0,178.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,CHEMBL621192,Blood
Intermediate,,A,16434,,,1,,,N,,8577,BAO_0000218,,1,,10116.0,178.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,CHEMBL621193,Blood
Intermediate,,A,16434,,,1,,,N,,8578,BAO_0000218,,1,,10116.0,178.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,CHEMBL621194,Blood
Intermediate,,A,16434,,,1,,,N,,8579,BAO_0000218,,1,,10116.0,178.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,CHEMBL624204,Blood
Intermediate,,A,16434,,,1,,,N,,8580,BAO_0000218,,1,,10116.0,178.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,CHEMBL624205,Blood
Intermediate,,A,16435,,,1,,,N,,8581,BAO_0000218,,1,,10116.0,178.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,CHEMBL624206,Blood
Intermediate,,A,16435,,,1,,,N,,8582,BAO_0000218,,1,,10116.0,178.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,CHEMBL624207,Blood
Intermediate,,A,16435,,,1,,,N,,8583,BAO_0000218,,1,,10116.0,178.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,CHEMBL624208,Blood
Intermediate,,A,16435,,,1,,,N,,8584,BAO_0000218,,1,,10116.0,178.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,CHEMBL624209,Blood
Intermediate,,A,16435,,,1,,,N,,8585,BAO_0000218,,1,,10116.0,178.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,CHEMBL624210,Blood
Intermediate,,A,16435,,,1,,,N,,8586,BAO_0000218,,1,,10116.0,178.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,CHEMBL624211,Blood
Intermediate,,A,16435,,,1,,,N,,8587,BAO_0000218,,1,,10116.0,178.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,CHEMBL624212,Blood
Intermediate,,A,16435,,,1,,,N,,8588,BAO_0000218,,1,,10116.0,178.0,50597,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,CHEMBL624213,Blood
Intermediate,,A,16434,,,1,,,N,,8589,BAO_0000218,,1,,10116.0,178.0,50597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,CHEMBL876611,Blood
Intermediate,,A,16434,,,1,,,N,,8590,BAO_0000218,,1,,10116.0,178.0,50597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,CHEMBL624214,Blood
Intermediate,,A,16434,,,1,,,N,,8591,BAO_0000218,,1,,10116.0,178.0,50597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,CHEMBL624215,Blood
Intermediate,,A,16435,,,1,,,N,,8592,BAO_0000218,,1,,10116.0,178.0,50597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,CHEMBL624216,Blood
Intermediate,,A,16435,,,1,,,N,,8593,BAO_0000218,,1,,10116.0,178.0,50597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,CHEMBL624217,Blood
Intermediate,,A,16435,,,1,,,N,,8594,BAO_0000218,,1,,10116.0,178.0,50597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,CHEMBL624218,Blood
Intermediate,,A,16435,,,1,,,N,,8595,BAO_0000218,,1,,10116.0,178.0,50597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,CHEMBL624219,Blood
Intermediate,,A,16435,,,1,,,N,,8596,BAO_0000218,,1,,10116.0,178.0,50597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,CHEMBL624220,Blood
Intermediate,,A,16435,,,1,,,N,,8597,BAO_0000218,,1,,10116.0,178.0,50597,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,CHEMBL624221,Blood
Intermediate,,A,16434,,,1,,,N,,8598,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,CHEMBL624222,
Intermediate,,A,16434,,,1,,,N,,8599,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,CHEMBL624223,
Intermediate,,A,16434,,,1,,,N,,8600,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,CHEMBL624224,
Intermediate,,A,16434,,,1,,,N,,8601,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,CHEMBL624225,
Intermediate,,A,17764,In vivo,,1,,,N,,8602,BAO_0000218,,1,,10116.0,,50597,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,Rattus norvegicus,CHEMBL622420,
Intermediate,,A,5031,In vivo,,1,,,N,,8603,BAO_0000218,,1,,10116.0,,50597,Volume of steady state distribution after i.v. administration in rats,Rattus norvegicus,CHEMBL622421,
Intermediate,,A,6215,In vivo,,1,,,N,,8604,BAO_0000218,,1,,10116.0,,50597,Vss after intravenous administration (5.0 mg/kg) was determined in rat,Rattus norvegicus,CHEMBL622422,
Intermediate,,A,17671,In vivo,,1,,,N,,8605,BAO_0000218,,1,,10116.0,,50597,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Rattus norvegicus,CHEMBL622423,
Intermediate,,A,17752,In vivo,,1,,,N,,8606,BAO_0000218,,1,,10116.0,,50597,Vss was determined,Rattus norvegicus,CHEMBL622424,
Intermediate,,A,6596,In vivo,,1,,,N,,8607,BAO_0000218,,1,,10116.0,,50597,Vss in rat,Rattus norvegicus,CHEMBL622425,
Intermediate,,A,16423,In vivo,,1,,,N,,8608,BAO_0000218,,1,,10116.0,,50597,Vss was evaluated after 10 uM/kg of intra arterial administration,Rattus norvegicus,CHEMBL876612,
Intermediate,,A,15662,In vivo,,1,,,N,,8609,BAO_0000218,,1,,10116.0,,50597,volume of distribution at steady state was observed after intravenous administration in rat,Rattus norvegicus,CHEMBL622426,
Intermediate,,A,6062,In vivo,,1,,,N,,8610,BAO_0000218,,1,,10116.0,,50597,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,Rattus norvegicus,CHEMBL622427,
Intermediate,,A,5874,In vivo,,1,,,N,,8611,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic (PK) parameter Vz in rat,Rattus norvegicus,CHEMBL622428,
Intermediate,,A,4942,In vivo,,1,,,N,,8612,BAO_0000218,,1,,10116.0,,50597,Volume distribution in rats,Rattus norvegicus,CHEMBL622429,
Intermediate,,A,17796,In vivo,,1,,,N,,8613,BAO_0000218,,1,,10116.0,,50597,Volume of distribution in rat; No data,Rattus norvegicus,CHEMBL622430,
Intermediate,,A,4890,In vivo,,1,,,N,,8614,BAO_0000218,,1,,10116.0,,50597,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,CHEMBL622431,
Intermediate,,A,15765,,,1,,,N,,8615,BAO_0000218,,1,,10116.0,2116.0,50597,% absorption predicted from in vitro rat ileum transport studies,Rattus norvegicus,CHEMBL622432,Ileum
Intermediate,,A,13569,In vivo,,1,,,N,,8616,BAO_0000218,,1,,10116.0,,50597,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,Rattus norvegicus,CHEMBL622433,
Intermediate,,A,13569,In vivo,,1,,,N,,8617,BAO_0000218,,1,,10116.0,,50597,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,Rattus norvegicus,CHEMBL622434,
Intermediate,,A,13569,In vivo,,1,,,N,,8618,BAO_0000218,,1,,10116.0,,50597,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,Rattus norvegicus,CHEMBL622435,
Intermediate,,A,13569,In vivo,,1,,,N,,8619,BAO_0000218,,1,,10116.0,,50597,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),Rattus norvegicus,CHEMBL618748,
Intermediate,,A,13569,In vivo,,1,,,N,,8620,BAO_0000218,,1,,10116.0,,50597,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,Rattus norvegicus,CHEMBL618749,
Intermediate,,A,13569,In vivo,,1,,,N,,8621,BAO_0000218,,1,,10116.0,,50597,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,Rattus norvegicus,CHEMBL618750,
Intermediate,,A,13569,In vivo,,1,,,N,,8622,BAO_0000218,,1,,10116.0,,50597,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,Rattus norvegicus,CHEMBL618751,
Intermediate,,A,13569,In vivo,,1,,,N,,8623,BAO_0000218,,1,,10116.0,,50597,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,Rattus norvegicus,CHEMBL618752,
Intermediate,,A,4576,In vivo,,1,,,N,,8624,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL618753,
Intermediate,,A,750,In vivo,,1,,,N,,8625,BAO_0000218,,1,,10116.0,1969.0,50597,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,Rattus norvegicus,CHEMBL618754,Plasma
Intermediate,,A,750,In vivo,,1,,,N,,8626,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL618755,
Intermediate,,A,4590,In vivo,,1,,,N,,8627,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL618756,
Intermediate,,A,1716,In vivo,,1,,,N,,8628,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL618757,
Intermediate,,A,1974,In vivo,,1,,,N,,8629,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat,Rattus norvegicus,CHEMBL618758,
Intermediate,,A,4502,In vivo,,1,,,N,,8630,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (dose 30 mg/kg),Rattus norvegicus,CHEMBL621088,
Intermediate,,A,3371,,,1,,,N,,8631,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (cLogP) in rat,Rattus norvegicus,CHEMBL621089,
Intermediate,,F,9099,,,1,,,N,,8632,BAO_0000218,,1,,10116.0,178.0,50597,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,Rattus norvegicus,CHEMBL621090,Blood
Intermediate,,F,9099,,,1,,,N,,8633,BAO_0000218,,1,,10116.0,178.0,50597,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,Rattus norvegicus,CHEMBL621091,Blood
Intermediate,,A,4590,In vivo,,1,,,N,,8634,BAO_0000218,,1,,10116.0,,50597,Clearance in rat.,Rattus norvegicus,CHEMBL876731,
Intermediate,,A,3184,In vivo,,1,,,N,,8635,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for its clearance when administered intravenously in rat,Rattus norvegicus,CHEMBL621092,
Intermediate,,A,16456,In vivo,,1,,,N,,8636,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Rattus norvegicus,CHEMBL621093,
Intermediate,,A,4199,,,1,,,N,,8637,BAO_0000218,,1,,10116.0,,50597,Blood: Brain distribution ratio is determined in rat,Rattus norvegicus,CHEMBL621094,
Intermediate,,A,4199,,,1,,,N,,8638,BAO_0000218,,1,,10116.0,,50597,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,Rattus norvegicus,CHEMBL621095,
Intermediate,,A,4199,,,1,,,N,,8639,BAO_0000218,,1,,10116.0,,50597,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,Rattus norvegicus,CHEMBL621096,
Intermediate,,A,8677,In vivo,,1,,,N,,8640,BAO_0000218,,1,,10116.0,2113.0,50597,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,CHEMBL621097,Kidney
Intermediate,,F,7449,,,1,,,N,,8641,BAO_0000218,,1,,10116.0,,50597,Percent dose excreted in 0-48 hours administered ip to male rat,Rattus norvegicus,CHEMBL621098,
Intermediate,,A,11977,,,1,,,N,,8642,BAO_0000218,,1,,10116.0,2037.0,50597,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL621099,Cerebellum
Intermediate,,A,11977,,,1,,,N,,8643,BAO_0000218,,1,,10116.0,2037.0,50597,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL621100,Cerebellum
Intermediate,,A,11977,,,1,,,N,,8644,BAO_0000218,,1,,10116.0,2037.0,50597,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,CHEMBL621101,Cerebellum
Intermediate,,A,11977,,,1,,,N,,8645,BAO_0000218,,1,,10116.0,2037.0,50597,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL621102,Cerebellum
Intermediate,,A,11977,,,1,,,N,,8646,BAO_0000218,,1,,10116.0,2037.0,50597,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL876732,Cerebellum
Intermediate,,A,11977,,,1,,,N,,8647,BAO_0000218,,1,,10116.0,,50597,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL621103,
Intermediate,,A,11977,,,1,,,N,,8648,BAO_0000218,,1,,10116.0,,50597,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL621104,
Intermediate,,A,11977,,,1,,,N,,8649,BAO_0000218,,1,,10116.0,,50597,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,CHEMBL621105,
Intermediate,,A,11977,,,1,,,N,,8650,BAO_0000218,,1,,10116.0,,50597,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL621106,
Intermediate,,A,11977,,,1,,,N,,8651,BAO_0000218,,1,,10116.0,,50597,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL621107,
Intermediate,,A,11977,,,1,,,N,,8652,BAO_0000218,,1,,10116.0,,50597,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL621108,
Intermediate,,A,11977,,,1,,,N,,8653,BAO_0000218,,1,,10116.0,,50597,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL621109,
Intermediate,,A,17208,In vivo,,1,,,N,,8654,BAO_0000218,,1,,10090.0,2113.0,50594,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL621110,Kidney
Intermediate,,A,17208,In vivo,,1,,,N,,8655,BAO_0000218,,1,,10090.0,2113.0,50594,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL621111,Kidney
Intermediate,,A,17208,In vivo,,1,,,N,,8656,BAO_0000218,,1,,10090.0,2107.0,50594,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL622541,Liver
Intermediate,,A,17208,In vivo,,1,,,N,,8657,BAO_0000218,,1,,10090.0,2107.0,50594,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL622542,Liver
Intermediate,,A,17208,In vivo,,1,,,N,,8658,BAO_0000218,,1,,10090.0,2107.0,50594,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL622543,Liver
Intermediate,,A,17208,In vivo,,1,,,N,,8659,BAO_0000218,,1,,10090.0,2107.0,50594,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL624412,Liver
Intermediate,,A,17208,In vivo,,1,,,N,,8660,BAO_0000218,,1,,10090.0,2107.0,50594,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL624413,Liver
Intermediate,,A,17208,In vivo,,1,,,N,,8661,BAO_0000218,,1,,10090.0,2107.0,50594,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL624414,Liver
Intermediate,,A,17208,In vivo,,1,,,N,,8662,BAO_0000218,,1,,10090.0,2048.0,50594,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL624415,Lung
Intermediate,,A,17208,In vivo,,1,,,N,,8663,BAO_0000218,,1,,10090.0,2048.0,50594,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL624416,Lung
Intermediate,,A,17208,In vivo,,1,,,N,,8664,BAO_0000218,,1,,10090.0,2048.0,50594,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL624417,Lung
Intermediate,,A,17208,In vivo,,1,,,N,,8665,BAO_0000218,,1,,10090.0,2048.0,50594,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL624418,Lung
Intermediate,,A,17208,In vivo,,1,,,N,,8666,BAO_0000218,,1,,10090.0,2048.0,50594,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL624419,Lung
Intermediate,,A,17208,In vivo,,1,,,N,,8667,BAO_0000218,,1,,10090.0,2048.0,50594,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL624420,Lung
Intermediate,,A,17208,In vivo,,1,,,N,,8668,BAO_0000218,,1,,10090.0,2385.0,50594,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL624421,Muscle tissue
Intermediate,,A,17208,In vivo,,1,,,N,,8669,BAO_0000218,,1,,10090.0,2385.0,50594,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL624422,Muscle tissue
Intermediate,,A,17208,In vivo,,1,,,N,,8670,BAO_0000218,,1,,10090.0,2385.0,50594,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL624423,Muscle tissue
Intermediate,,A,17208,In vivo,,1,,,N,,8671,BAO_0000218,,1,,10090.0,2385.0,50594,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL625123,Muscle tissue
Intermediate,,A,17208,In vivo,,1,,,N,,8672,BAO_0000218,,1,,10090.0,2385.0,50594,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL625124,Muscle tissue
Intermediate,,A,17208,In vivo,,1,,,N,,8673,BAO_0000218,,1,,10090.0,2385.0,50594,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL625125,Muscle tissue
Intermediate,,A,17208,In vivo,,1,,,N,,8674,BAO_0000218,,1,,10090.0,14.0,50594,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL625126,Zone of skin
Intermediate,,A,17208,In vivo,,1,,,N,,8675,BAO_0000218,,1,,10090.0,14.0,50594,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL626947,Zone of skin
Intermediate,,A,17208,In vivo,,1,,,N,,8676,BAO_0000218,,1,,10090.0,14.0,50594,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL626948,Zone of skin
Intermediate,,A,17208,In vivo,,1,,,N,,8677,BAO_0000218,,1,,10090.0,14.0,50594,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL626949,Zone of skin
Intermediate,,A,17208,In vivo,,1,,,N,,8678,BAO_0000218,,1,,10090.0,14.0,50594,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL626950,Zone of skin
Intermediate,,A,17208,In vivo,,1,,,N,,8679,BAO_0000218,,1,,10090.0,14.0,50594,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL626951,Zone of skin
Intermediate,,A,17208,In vivo,,1,,,N,,8680,BAO_0000218,,1,,10090.0,2106.0,50594,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL626952,Spleen
Intermediate,,A,17208,In vivo,,1,,,N,,8681,BAO_0000218,,1,,10090.0,2106.0,50594,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL626953,Spleen
Intermediate,,A,17208,In vivo,,1,,,N,,8682,BAO_0000218,,1,,10090.0,2106.0,50594,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL626954,Spleen
Intermediate,,A,17208,In vivo,,1,,,N,,8683,BAO_0000218,,1,,10090.0,2106.0,50594,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL626955,Spleen
Intermediate,,A,17208,In vivo,,1,,,N,,8684,BAO_0000218,,1,,10090.0,2106.0,50594,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL626956,Spleen
Intermediate,,A,17208,In vivo,,1,,,N,,8685,BAO_0000218,,1,,10090.0,2106.0,50594,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL626957,Spleen
Intermediate,,A,17208,In vivo,,1,,,N,,8686,BAO_0000218,,1,,10090.0,178.0,50594,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL626958,Blood
Intermediate,,A,17208,In vivo,,1,,,N,,8687,BAO_0000218,,1,,10090.0,178.0,50594,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL626959,Blood
Intermediate,,A,17208,In vivo,,1,,,N,,8688,BAO_0000218,,1,,10090.0,178.0,50594,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL626960,Blood
Intermediate,,A,17208,In vivo,,1,,,N,,8689,BAO_0000218,,1,,10090.0,178.0,50594,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL626961,Blood
Intermediate,,A,17208,In vivo,,1,,,N,,8690,BAO_0000218,,1,,10090.0,178.0,50594,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL627589,Blood
Intermediate,,A,17208,In vivo,,1,,,N,,8691,BAO_0000218,,1,,10090.0,178.0,50594,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,CHEMBL627590,Blood
Intermediate,,A,3132,,,1,,,N,,8692,BAO_0000218,,1,,10090.0,,50594,Time taken for EC90 was determined when tested in mouse,Mus musculus,CHEMBL627591,
Intermediate,,A,3132,,,1,,,N,,8693,BAO_0000218,,1,,10090.0,,50594,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,Mus musculus,CHEMBL627592,
Intermediate,,A,16597,In vivo,,1,,,N,,8694,BAO_0000218,,1,,10090.0,,50594,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),Mus musculus,CHEMBL627593,
Intermediate,,A,5727,,,1,,,N,,8695,BAO_0000218,,1,,10090.0,,50594,Half life in mice,Mus musculus,CHEMBL627594,
Intermediate,,A,5302,In vivo,,1,,,N,,8696,BAO_0000218,,1,,10090.0,,50594,Half life period in mouse after 10 mg/Kg dose,Mus musculus,CHEMBL876813,
Intermediate,,A,5302,In vivo,,1,,,N,,8697,BAO_0000218,,1,,10090.0,,50594,Half life period in mouse after 10 mg/kg dose,Mus musculus,CHEMBL627595,
Intermediate,,A,6348,In vivo,,1,,,N,,8698,BAO_0000218,,1,,10090.0,,50594,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,Mus musculus,CHEMBL627596,
Intermediate,,A,5964,In vivo,,1,,,N,,8699,BAO_0000218,,1,,10116.0,,50597,Cmax value at 5 mg/kg po was determined in rat,Rattus norvegicus,CHEMBL627597,
Intermediate,,A,6078,In vivo,,1,,,N,,8700,BAO_0000218,,1,,10116.0,,50597,Cmax value evaluated in rat,Rattus norvegicus,CHEMBL627598,
Intermediate,,A,5206,In vivo,,1,,,N,,8701,BAO_0000218,,1,,10116.0,955.0,50597,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,Rattus norvegicus,CHEMBL627599,Brain
Intermediate,,A,2959,In vivo,,1,,,N,,8702,BAO_0000218,,1,,10116.0,,50597,Cmax value after administration of 20 mg/Kg oral dose in rat,Rattus norvegicus,CHEMBL627600,
Intermediate,,A,5964,In vivo,,1,,,N,,8703,BAO_0000218,,1,,10116.0,,50597,Cmax value at 1 mg/kg po in rat,Rattus norvegicus,CHEMBL627601,
Intermediate,,A,5964,In vivo,,1,,,N,,8704,BAO_0000218,,1,,10116.0,,50597,Cmax value at 5 mg/kg po in rat,Rattus norvegicus,CHEMBL627776,
Intermediate,,A,6757,In vivo,,1,,,N,,8705,BAO_0000218,,1,,10116.0,,50597,Cmax value at a dose of 10 mg/kg in male SD rats,Rattus norvegicus,CHEMBL627777,
Intermediate,,A,6757,In vivo,,1,,,N,,8706,BAO_0000218,,1,,10116.0,,50597,Cmax value at a dose of 100 mg/kg in male SD rats,Rattus norvegicus,CHEMBL627778,
Intermediate,,A,6757,In vivo,,1,,,N,,8707,BAO_0000218,,1,,10116.0,,50597,Cmax value at a dose of 50 mg/kg in male SD rats,Rattus norvegicus,CHEMBL627779,
Intermediate,,A,17617,In vivo,,1,,,N,,8708,BAO_0000218,,1,,10116.0,,50597,Cmax value in rats at 10 mg/kg,Rattus norvegicus,CHEMBL876814,
Intermediate,,A,1445,In vivo,,1,,,N,,8709,BAO_0000218,,1,,10116.0,,50597,Cmax value was evaluated in rats at a dose of 20 mg/kg,Rattus norvegicus,CHEMBL627780,
Intermediate,,A,6082,In vivo,,1,,,N,,8710,BAO_0000218,,1,,10116.0,,50597,Cmax value was determined after peroral administration of 20 mg/kg in rat,Rattus norvegicus,CHEMBL627781,
Intermediate,,A,1446,In vivo,,1,,,N,,8711,BAO_0000218,,1,,10116.0,,50597,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,Rattus norvegicus,CHEMBL627782,
Intermediate,,A,5407,In vivo,,1,,,N,,8712,BAO_0000218,,1,,10116.0,1969.0,50597,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,Rattus norvegicus,CHEMBL627783,Plasma
Intermediate,,A,2690,In vivo,,1,,,N,,8713,BAO_0000218,,1,,10116.0,1969.0,50597,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,Rattus norvegicus,CHEMBL627784,Plasma
Intermediate,,A,2661,In vivo,,1,,,N,,8714,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,Rattus norvegicus,CHEMBL627785,
Intermediate,,A,2661,In vivo,,1,,,N,,8715,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,Rattus norvegicus,CHEMBL627786,
Intermediate,,A,4891,In vivo,,1,,,N,,8716,BAO_0000218,,1,,10116.0,1969.0,50597,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,Rattus norvegicus,CHEMBL627787,Plasma
Intermediate,,A,2807,In vivo,,1,,,N,,8717,BAO_0000218,,1,,10116.0,1969.0,50597,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,Rattus norvegicus,CHEMBL627788,Plasma
Intermediate,,A,2807,In vivo,,1,,,N,,8718,BAO_0000218,,1,,10116.0,1969.0,50597,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,Rattus norvegicus,CHEMBL626579,Plasma
Intermediate,,A,2807,In vivo,,1,,,N,,8719,BAO_0000218,,1,,10116.0,1969.0,50597,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,Rattus norvegicus,CHEMBL626580,Plasma
Intermediate,,A,3634,In vivo,,1,,,N,,8720,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,Rattus norvegicus,CHEMBL876815,
Intermediate,,A,1881,In vivo,,1,,,N,,8721,BAO_0000218,,1,,10116.0,1969.0,50597,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,Rattus norvegicus,CHEMBL626581,Plasma
Intermediate,,A,1881,In vivo,,1,,,N,,8722,BAO_0000218,,1,,10116.0,1969.0,50597,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,Rattus norvegicus,CHEMBL626582,Plasma
Intermediate,,A,429,In vivo,,1,,,N,,8723,BAO_0000218,,1,,10116.0,,50597,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,Rattus norvegicus,CHEMBL626583,
Intermediate,,A,5974,In vivo,,1,,,N,,8724,BAO_0000218,,1,,10116.0,,50597,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,CHEMBL626205,
Intermediate,,A,5974,In vivo,,1,,,N,,8725,BAO_0000218,,1,,10116.0,,50597,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,CHEMBL626206,
Intermediate,,A,5974,In vivo,,1,,,N,,8726,BAO_0000218,,1,,10116.0,,50597,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,CHEMBL626207,
Intermediate,,A,5974,In vivo,,1,,,N,,8727,BAO_0000218,,1,,10116.0,,50597,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,CHEMBL623882,
Intermediate,,A,17582,In vivo,,1,,,N,,8728,BAO_0000218,,1,,10116.0,,50597,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,Rattus norvegicus,CHEMBL623883,
Intermediate,,A,17582,In vivo,,1,,,N,,8729,BAO_0000218,,1,,10116.0,,50597,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,Rattus norvegicus,CHEMBL623884,
Intermediate,,A,3032,In vivo,,1,,,N,,8730,BAO_0000218,,1,,10116.0,1969.0,50597,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",Rattus norvegicus,CHEMBL623885,Plasma
Intermediate,,A,6295,In vivo,,1,,,N,,8731,BAO_0000218,,1,,10116.0,1969.0,50597,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,Rattus norvegicus,CHEMBL623886,Plasma
Intermediate,,A,6619,In vivo,,1,,,N,,8732,BAO_0000218,,1,,10116.0,,50597,Maximal concentration in rat was determined,Rattus norvegicus,CHEMBL623887,
Intermediate,,A,6616,In vivo,,1,,,N,,8733,BAO_0000218,,1,,10116.0,,50597,Maximal concentration after i.v. administration,Rattus norvegicus,CHEMBL623888,
Intermediate,,A,3249,In vivo,,1,,,N,,8734,BAO_0000218,,1,,10116.0,1969.0,50597,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,Rattus norvegicus,CHEMBL623889,Plasma
Intermediate,,A,17791,In vivo,,1,,,N,,8735,BAO_0000218,,1,,10116.0,1969.0,50597,Maximal plasma concentration in rat after oral administration at 50 mg/kg,Rattus norvegicus,CHEMBL623890,Plasma
Intermediate,,A,17791,In vivo,,1,,,N,,8736,BAO_0000218,,1,,10116.0,1969.0,50597,Cmax in rat plasma after oral dose (50 mg/Kg),Rattus norvegicus,CHEMBL623891,Plasma
Intermediate,,A,1360,In vivo,,1,,,N,,8737,BAO_0000218,,1,,10116.0,1969.0,50597,Maximal plasma concentration was determined.,Rattus norvegicus,CHEMBL623892,Plasma
Intermediate,,A,2552,In vivo,,1,,,N,,8738,BAO_0000218,,1,,10116.0,1969.0,50597,Maximal plasma drug concentration was determined,Rattus norvegicus,CHEMBL623893,Plasma
Intermediate,,A,6571,In vivo,,1,,,N,,8739,BAO_0000218,,1,,10116.0,,50597,Maximal concentration in rats after peroral administration,Rattus norvegicus,CHEMBL877616,
Intermediate,,A,6570,In vivo,,1,,,N,,8740,BAO_0000218,,1,,10116.0,,50597,Maximum concentration in rat after 2 mg/kg peroral administration,Rattus norvegicus,CHEMBL623894,
Intermediate,,A,6567,In vivo,,1,,,N,,8741,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum concentration in rat plasma after 5 mg/kg oral gavage,Rattus norvegicus,CHEMBL623895,Plasma
Intermediate,,A,3031,In vivo,,1,,,N,,8742,BAO_0000218,,1,,10116.0,,50597,Maximum concentration of compound in rat was evaluated.,Rattus norvegicus,CHEMBL623896,
Intermediate,,A,3436,In vivo,,1,,,N,,8743,BAO_0000218,,1,,10116.0,,50597,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,Rattus norvegicus,CHEMBL623897,
Intermediate,,A,3436,In vivo,,1,,,N,,8744,BAO_0000218,,1,,10116.0,,50597,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,Rattus norvegicus,CHEMBL623898,
Intermediate,,A,2083,In vivo,,1,,,N,,8745,BAO_0000218,,1,,10116.0,,50597,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,Rattus norvegicus,CHEMBL623899,
Intermediate,,A,3436,In vivo,,1,,,N,,8746,BAO_0000218,,1,,10116.0,,50597,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,Rattus norvegicus,CHEMBL623900,
Intermediate,,A,4527,In vivo,,1,,,N,,8747,BAO_0000218,,1,,10116.0,,50597,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,Rattus norvegicus,CHEMBL623901,
Intermediate,,A,1974,In vivo,,1,,,N,,8748,BAO_0000218,,1,,10116.0,,50597,Maximum concentration was evaluated in rats,Rattus norvegicus,CHEMBL623902,
Intermediate,,A,3307,In vivo,,1,,,N,,8749,BAO_0000218,,1,,10116.0,1359.0,50597,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,Rattus norvegicus,CHEMBL623903,Cerebrospinal fluid
Intermediate,,A,3307,In vivo,,1,,,N,,8750,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,Rattus norvegicus,CHEMBL623904,Plasma
Intermediate,,A,1916,In vivo,,1,,,N,,8751,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Rattus norvegicus,CHEMBL877617,Plasma
Intermediate,,A,1500,In vivo,,1,,,N,,8752,BAO_0000218,,1,,10116.0,,50597,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,Rattus norvegicus,CHEMBL623905,
Intermediate,,A,1500,In vivo,,1,,,N,,8753,BAO_0000218,,1,,10116.0,,50597,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,Rattus norvegicus,CHEMBL623906,
Intermediate,,A,4186,In vivo,,1,,,N,,8754,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Rattus norvegicus,CHEMBL623907,Plasma
Intermediate,,A,16434,,,1,,,N,,8755,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,CHEMBL623908,
Intermediate,,A,16434,,,1,,,N,,8756,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,CHEMBL623909,
Intermediate,,A,16434,,,1,,,N,,8757,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,CHEMBL623910,
Intermediate,,A,16434,,,1,,,N,,8758,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,CHEMBL623911,
Intermediate,,A,16435,,,1,,,N,,8759,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,CHEMBL623912,
Intermediate,,A,16435,,,1,,,N,,8760,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,CHEMBL624616,
Intermediate,,A,16435,,,1,,,N,,8761,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,CHEMBL624617,
Intermediate,,A,16435,,,1,,,N,,8762,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,CHEMBL624618,
Intermediate,,A,16435,,,1,,,N,,8763,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,CHEMBL624619,
Intermediate,,A,16435,,,1,,,N,,8764,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,CHEMBL624794,
Intermediate,,A,16435,,,1,,,N,,8765,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,CHEMBL624795,
Intermediate,,A,16435,,,1,,,N,,8766,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,CHEMBL623921,
Intermediate,,A,16434,,,1,,,N,,8767,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,CHEMBL623922,
Intermediate,,A,16434,,,1,,,N,,8768,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,CHEMBL623923,
Intermediate,,A,16434,,,1,,,N,,8769,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,CHEMBL623924,
Intermediate,,A,16435,,,1,,,N,,8770,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,CHEMBL623925,
Intermediate,,A,16435,,,1,,,N,,8771,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,CHEMBL623926,
Intermediate,,A,16435,,,1,,,N,,8772,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,CHEMBL623927,
Intermediate,,A,16435,,,1,,,N,,8773,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,CHEMBL623928,
Intermediate,,A,16435,,,1,,,N,,8774,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,CHEMBL623929,
Intermediate,,A,16435,,,1,,,N,,8775,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,CHEMBL623930,
Intermediate,,A,16434,,,1,,,N,,8776,BAO_0000218,,1,,10116.0,955.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,CHEMBL623931,Brain
Intermediate,,A,16434,,,1,,,N,,8777,BAO_0000218,,1,,10116.0,955.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,CHEMBL622165,Brain
Intermediate,,A,16434,,,1,,,N,,8778,BAO_0000218,,1,,10116.0,955.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,CHEMBL621249,Brain
Intermediate,,A,16434,,,1,,,N,,8779,BAO_0000218,,1,,10116.0,955.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,CHEMBL621250,Brain
Intermediate,,A,16434,,,1,,,N,,8780,BAO_0000218,,1,,10116.0,955.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,CHEMBL621448,Brain
Intermediate,,A,16434,,,1,,,N,,8781,BAO_0000218,,1,,10116.0,955.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,CHEMBL621449,Brain
Intermediate,,A,16434,,,1,,,N,,8782,BAO_0000218,,1,,10116.0,955.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,CHEMBL621450,Brain
Intermediate,,A,16434,,,1,,,N,,8783,BAO_0000218,,1,,10116.0,955.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,CHEMBL621451,Brain
Intermediate,,A,16435,,,1,,,N,,8784,BAO_0000218,,1,,10116.0,955.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,CHEMBL621452,Brain
Intermediate,,A,16435,,,1,,,N,,8785,BAO_0000218,,1,,10116.0,955.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,CHEMBL621453,Brain
Intermediate,,A,16435,,,1,,,N,,8786,BAO_0000218,,1,,10116.0,955.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,CHEMBL621454,Brain
Intermediate,,A,16435,,,1,,,N,,8787,BAO_0000218,,1,,10116.0,955.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,CHEMBL621455,Brain
Intermediate,,A,16435,,,1,,,N,,8788,BAO_0000218,,1,,10116.0,955.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,CHEMBL621456,Brain
Intermediate,,A,16435,,,1,,,N,,8789,BAO_0000218,,1,,10116.0,955.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,CHEMBL625145,Brain
Intermediate,,A,16435,,,1,,,N,,8790,BAO_0000218,,1,,10116.0,955.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,CHEMBL875847,Brain
Intermediate,,A,16435,,,1,,,N,,8791,BAO_0000218,,1,,10116.0,955.0,50597,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,CHEMBL625146,Brain
Intermediate,,A,16434,,,1,,,N,,8792,BAO_0000218,,1,,10116.0,955.0,50597,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,CHEMBL625147,Brain
Intermediate,,A,16434,,,1,,,N,,8793,BAO_0000218,,1,,10116.0,955.0,50597,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,CHEMBL625148,Brain
Intermediate,,A,16434,,,1,,,N,,8794,BAO_0000218,,1,,10116.0,955.0,50597,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,CHEMBL625149,Brain
Intermediate,,A,16435,,,1,,,N,,8795,BAO_0000218,,1,,10116.0,955.0,50597,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,CHEMBL625150,Brain
Intermediate,,A,16435,,,1,,,N,,8796,BAO_0000218,,1,,10116.0,955.0,50597,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,CHEMBL625151,Brain
Intermediate,,A,16435,,,1,,,N,,8797,BAO_0000218,,1,,10116.0,955.0,50597,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,CHEMBL625152,Brain
Intermediate,,A,16435,,,1,,,N,,8798,BAO_0000218,,1,,10116.0,955.0,50597,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,CHEMBL625153,Brain
Intermediate,,A,16435,,,1,,,N,,8799,BAO_0000218,,1,,10116.0,955.0,50597,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,CHEMBL625154,Brain
Intermediate,,A,16435,,,1,,,N,,8800,BAO_0000218,,1,,10116.0,955.0,50597,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,CHEMBL625155,Brain
Intermediate,,A,11977,,,1,,,N,,8801,BAO_0000218,,1,,10116.0,,50597,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,CHEMBL625156,
Intermediate,,A,11977,,,1,,,N,,8802,BAO_0000218,,1,,10116.0,,50597,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL624354,
Intermediate,,A,11977,,,1,,,N,,8803,BAO_0000218,,1,,10116.0,10000000.0,50597,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL624355,Hippocampus
Intermediate,,A,11977,,,1,,,N,,8804,BAO_0000218,,1,,10116.0,10000000.0,50597,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL624356,Hippocampus
Intermediate,,A,11977,,,1,,,N,,8805,BAO_0000218,,1,,10116.0,10000000.0,50597,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL624357,Hippocampus
Intermediate,,A,11977,,,1,,,N,,8806,BAO_0000218,,1,,10116.0,10000000.0,50597,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL624358,Hippocampus
Intermediate,,A,11977,,,1,,,N,,8807,BAO_0000218,,1,,10116.0,2435.0,50597,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL624359,Striatum
Intermediate,,A,11977,,,1,,,N,,8808,BAO_0000218,,1,,10116.0,2435.0,50597,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL624360,Striatum
Intermediate,,A,11977,,,1,,,N,,8809,BAO_0000218,,1,,10116.0,2435.0,50597,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,CHEMBL624361,Striatum
Intermediate,,A,11977,,,1,,,N,,8810,BAO_0000218,,1,,10116.0,2435.0,50597,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL624362,Striatum
Intermediate,,A,11977,,,1,,,N,,8811,BAO_0000218,,1,,10116.0,2435.0,50597,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL624363,Striatum
Intermediate,,A,11977,In vivo,,1,,,N,,8812,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL624364,Blood
Intermediate,,A,11977,In vivo,,1,,,N,,8813,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL624365,Blood
Intermediate,,A,11977,In vivo,,1,,,N,,8814,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL624366,Blood
Intermediate,,A,11977,In vivo,,1,,,N,,8815,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL624367,Blood
Intermediate,,A,11977,In vivo,,1,,,N,,8816,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL624368,Brain
Intermediate,,A,11977,In vivo,,1,,,N,,8817,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL624369,Brain
Intermediate,,A,11977,In vivo,,1,,,N,,8818,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,CHEMBL624370,Brain
Intermediate,,A,11977,In vivo,,1,,,N,,8819,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL625069,Brain
Intermediate,,A,11977,In vivo,,1,,,N,,8820,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL625070,Brain
Intermediate,,A,11977,In vivo,,1,,,N,,8821,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL626051,Heart
Intermediate,,A,11977,In vivo,,1,,,N,,8822,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL626052,Heart
Intermediate,,A,11977,In vivo,,1,,,N,,8823,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,CHEMBL626053,Heart
Intermediate,,A,11977,In vivo,,1,,,N,,8824,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL626054,Heart
Intermediate,,A,11977,In vivo,,1,,,N,,8825,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL626055,Heart
Intermediate,,A,11977,In vivo,,1,,,N,,8826,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL626056,Kidney
Intermediate,,A,11977,In vivo,,1,,,N,,8827,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL626057,Kidney
Intermediate,,A,11977,In vivo,,1,,,N,,8828,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL625193,Kidney
Intermediate,,A,11977,In vivo,,1,,,N,,8829,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL625194,Kidney
Intermediate,,A,11977,In vivo,,1,,,N,,8830,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL625195,Liver
Intermediate,,A,11977,In vivo,,1,,,N,,8831,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL625196,Liver
Intermediate,,A,11977,In vivo,,1,,,N,,8832,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,CHEMBL625197,Liver
Intermediate,,A,11977,In vivo,,1,,,N,,8833,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL625198,Liver
Intermediate,,A,11977,In vivo,,1,,,N,,8834,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL627929,Liver
Intermediate,,A,11977,In vivo,,1,,,N,,8835,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL627074,Lung
Intermediate,,A,11977,In vivo,,1,,,N,,8836,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL627075,Lung
Intermediate,,A,11977,In vivo,,1,,,N,,8837,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,CHEMBL627076,Lung
Intermediate,,A,11977,In vivo,,1,,,N,,8838,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL627077,Lung
Intermediate,,A,11977,In vivo,,1,,,N,,8839,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL627078,Lung
Intermediate,,A,11977,In vivo,,1,,,N,,8840,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,CHEMBL627079,Muscle tissue
Intermediate,,A,4573,In vivo,,1,,,N,,8841,BAO_0000218,,1,,10090.0,,50594,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,Mus musculus,CHEMBL873824,
Intermediate,,A,3132,In vivo,,1,,,N,,8842,BAO_0000218,,1,,10090.0,1969.0,50594,Half life in mouse plasma was determined at dose 25 mg/kg,Mus musculus,CHEMBL627080,Plasma
Intermediate,,A,17718,,,1,,,N,,8843,BAO_0000218,,1,,10090.0,,50594,Half life was determined,Mus musculus,CHEMBL627081,
Intermediate,,A,17728,In vivo,,1,,,N,,8844,BAO_0000218,,1,,10090.0,,50594,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,Mus musculus,CHEMBL627082,
Intermediate,,A,5961,In vivo,,1,,,N,,8845,BAO_0000218,,1,,10090.0,,50594,Half-life in male mice after 1 mg/kg intravenous dose,Mus musculus,CHEMBL627083,
Intermediate,,A,17731,,,1,,,N,,8847,BAO_0000218,,1,,10090.0,1969.0,50594,Half life in mice plasma,Mus musculus,CHEMBL627085,Plasma
Intermediate,,A,17592,,,1,,,N,,8848,BAO_0000218,,1,,10090.0,,50594,Half life in mouse,Mus musculus,CHEMBL627086,
Intermediate,,A,3132,In vivo,,1,,,N,,8849,BAO_0000218,,1,,10090.0,1969.0,50594,Half life in mouse plasma at dose 25 mg/kg,Mus musculus,CHEMBL627087,Plasma
Intermediate,,A,17729,In vivo,,1,,,N,,8850,BAO_0000218,,1,,10090.0,,50594,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,Mus musculus,CHEMBL627088,
Intermediate,,A,17729,In vivo,,1,,,N,,8851,BAO_0000218,,1,,10090.0,,50594,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,Mus musculus,CHEMBL627089,
Intermediate,,A,17729,In vivo,,1,,,N,,8852,BAO_0000218,,1,,10090.0,,50594,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,Mus musculus,CHEMBL627090,
Intermediate,,A,3277,In vivo,,1,,,N,,8853,BAO_0000218,,1,,10090.0,,50594,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),Mus musculus,CHEMBL627091,
Intermediate,,A,3760,In vivo,,1,,,N,,8854,BAO_0000218,,1,,10090.0,,50594,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",Mus musculus,CHEMBL627092,
Intermediate,,A,3760,In vivo,,1,,,N,,8855,BAO_0000218,,1,,10090.0,,50594,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",Mus musculus,CHEMBL876785,
Intermediate,,A,2862,In vivo,,1,,,N,,8856,BAO_0000218,,1,,10090.0,,50594,Half-life by iv administration in mouse,Mus musculus,CHEMBL627093,
Intermediate,,A,2862,In vivo,,1,,,N,,8857,BAO_0000218,,1,,10090.0,,50594,Half-life by oral administration in mouse,Mus musculus,CHEMBL627094,
Intermediate,,A,5980,,,1,,,N,,8858,BAO_0000218,,1,,10090.0,,50594,Half-life in mice,Mus musculus,CHEMBL627095,
Intermediate,,A,6159,,,1,,,N,,8859,BAO_0000218,,1,,10090.0,955.0,50594,Half-life using mouse brain homogenate,Mus musculus,CHEMBL627096,Brain
Intermediate,,A,6254,,,1,,,N,,8860,BAO_0000218,,1,,10090.0,,50594,Half-life was measured in mice,Mus musculus,CHEMBL627097,
Intermediate,,A,6062,In vivo,,1,,,N,,8861,BAO_0000218,,1,,10090.0,,50594,Half-life was measured in mouse after an iv dose of 1 mg/kg,Mus musculus,CHEMBL627098,
Intermediate,,A,1574,,,1,,,N,,8862,BAO_0000218,,1,,10090.0,178.0,50594,Half-life period was determined in mouse blood,Mus musculus,CHEMBL627099,Blood
Intermediate,,A,56,,,1,,,N,,8863,BAO_0000218,,1,,10090.0,955.0,50594,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",Mus musculus,CHEMBL627100,Brain
Intermediate,,A,993,,,1,,,N,,8864,BAO_0000218,,1,,10090.0,1969.0,50594,Plasma half life in mouse,Mus musculus,CHEMBL627101,Plasma
Intermediate,,A,6652,,,1,,,N,,8865,BAO_0000218,,1,,10090.0,,50594,Stability of the peptide in the presence of mouse serum,Mus musculus,CHEMBL627102,
Intermediate,,A,17852,,,1,,,N,,8866,BAO_0000218,,1,,10090.0,,50594,Terminal half life of compound was determined in mouse,Mus musculus,CHEMBL627103,
Intermediate,,A,2675,In vivo,,1,,,N,,8867,BAO_0000218,,1,,10090.0,,50594,Terminal half life was evaluated in mice after intravenous administration,Mus musculus,CHEMBL627104,
Intermediate,,A,2675,In vivo,,1,,,N,,8868,BAO_0000218,,1,,10090.0,,50594,Terminal half life was evaluated in mice after oral administration,Mus musculus,CHEMBL627105,
Intermediate,,A,499,,,1,,,N,,8869,BAO_0000218,,1,,10090.0,,50594,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,Mus musculus,CHEMBL876786,
Intermediate,,A,499,,,1,,,N,,8870,BAO_0000218,,1,,10090.0,,50594,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,Mus musculus,CHEMBL873825,
Intermediate,,A,499,,,1,,,N,,8871,BAO_0000218,,1,,10090.0,,50594,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,Mus musculus,CHEMBL627106,
Intermediate,,A,14239,In vivo,,1,,,N,,8872,BAO_0000218,,1,,10090.0,,50594,half life period is evaluated by administering intravenously at 25 mg/kg in mice,Mus musculus,CHEMBL626336,
Intermediate,,A,5506,In vivo,,1,,,N,,8873,BAO_0000218,,1,,10090.0,,50594,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",Mus musculus,CHEMBL877462,
Intermediate,,A,5506,In vivo,,1,,,N,,8874,BAO_0000218,,1,,10090.0,,50594,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",Mus musculus,CHEMBL626337,
Intermediate,,A,17734,,,1,,,N,,8875,BAO_0000218,,1,,10090.0,,50594,Half life after intraperitoneal administration of 100 mg/kg in mice,Mus musculus,CHEMBL626338,
Intermediate,,A,17728,In vivo,,1,,,N,,8876,BAO_0000218,,1,,10090.0,,50594,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,Mus musculus,CHEMBL626339,
Intermediate,,A,17728,In vivo,,1,,,N,,8877,BAO_0000218,,1,,10090.0,,50594,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,Mus musculus,CHEMBL626340,
Intermediate,,A,17728,In vivo,,1,,,N,,8878,BAO_0000218,,1,,10090.0,,50594,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,Mus musculus,CHEMBL625377,
Intermediate,,A,17728,In vivo,,1,,,N,,8879,BAO_0000218,,1,,10090.0,,50594,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,Mus musculus,CHEMBL625378,
Intermediate,,A,17728,In vivo,,1,,,N,,8880,BAO_0000218,,1,,10090.0,,50594,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,Mus musculus,CHEMBL625379,
Autocuration,,A,14294,,,1,,Microsomes,U,,8881,BAO_0000251,,0,,9823.0,,22224,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),Sus scrofa,CHEMBL625380,
Autocuration,,A,14294,,,1,,Microsomes,U,,8882,BAO_0000251,,0,,9823.0,,22224,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),Sus scrofa,CHEMBL625381,
Autocuration,,A,6056,,,1,,,U,,8883,BAO_0000019,,0,,9823.0,,22224,Stability to porcine renal DHP-I,Sus scrofa,CHEMBL625382,
Autocuration,,A,1317,In vivo,,1,,,U,,8884,BAO_0000218,,0,,9823.0,,22224,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,Sus scrofa,CHEMBL873828,
Autocuration,,A,1317,In vivo,,1,,,U,,8885,BAO_0000218,,0,,9823.0,,22224,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,Sus scrofa,CHEMBL625383,
Autocuration,,A,5229,,,1,,,U,,8886,BAO_0000019,,0,,9823.0,,22224,Half-life of the parent prodrug in porcine esterase solution,Sus scrofa,CHEMBL625384,
Autocuration,,A,4231,,,1,,,U,,8887,BAO_0000019,,0,,9823.0,,22224,"First order rate constant, k was determined in in pig liver Esterase",Sus scrofa,CHEMBL625385,
Autocuration,,A,4231,,,1,,,U,,8888,BAO_0000221,,0,,9823.0,2107.0,22224,Half life of the in pig liver Esterase,Sus scrofa,CHEMBL625386,Liver
Autocuration,,A,5318,,,1,,,U,,8889,BAO_0000221,,0,,9823.0,2107.0,22224,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,Sus scrofa,CHEMBL623571,Liver
Autocuration,,A,5318,,,1,,,U,,8890,BAO_0000221,,0,,9823.0,2107.0,22224,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,Sus scrofa,CHEMBL623572,Liver
Autocuration,,A,5318,,,1,,,U,,8891,BAO_0000221,,0,,9823.0,2107.0,22224,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,Sus scrofa,CHEMBL623573,Liver
Autocuration,,A,3305,,,1,,,U,,8892,BAO_0000221,,0,,9823.0,2107.0,22224,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,Sus scrofa,CHEMBL623574,Liver
Autocuration,,A,3305,,,1,,,U,,8893,BAO_0000221,,0,,9823.0,2107.0,22224,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,Sus scrofa,CHEMBL623575,Liver
Autocuration,,A,2842,,,1,,,U,,8894,BAO_0000221,,0,,9823.0,2107.0,22224,Half-life in the presence of pig liver esterase(PLE) was evaluated.,Sus scrofa,CHEMBL623749,Liver
Autocuration,,A,2842,,,1,,,U,,8895,BAO_0000221,,0,,9823.0,2107.0,22224,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,Sus scrofa,CHEMBL623750,Liver
Autocuration,,A,889,In vitro,,1,,,U,,8896,BAO_0000221,,0,,9823.0,2107.0,22224,Half-life in vitro in pig liver,Sus scrofa,CHEMBL623751,Liver
Autocuration,,A,1904,,,1,,,U,,8897,BAO_0000221,,0,,9823.0,2107.0,22224,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,Sus scrofa,CHEMBL623752,Liver
Intermediate,,A,4186,In vivo,,1,,,N,,8898,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,Rattus norvegicus,CHEMBL623753,Plasma
Intermediate,,A,2774,In vivo,,1,,,N,,8899,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,Rattus norvegicus,CHEMBL623754,Plasma
Intermediate,,A,1742,In vivo,,1,,,N,,8900,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum concentration in rat plasma was determined,Rattus norvegicus,CHEMBL623755,Plasma
Intermediate,,A,3169,In vivo,,1,,,N,,8901,BAO_0000218,,1,,10116.0,,50597,Maximum concentration in rats,Rattus norvegicus,CHEMBL623756,
Intermediate,,A,3169,In vivo,,1,,,N,,8902,BAO_0000218,,1,,10116.0,,50597,Maximum concentration in rats at 1-2 hours,Rattus norvegicus,CHEMBL623757,
Intermediate,,A,2081,In vivo,,1,,,N,,8903,BAO_0000218,,1,,10116.0,,50597,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,Rattus norvegicus,CHEMBL623758,
Intermediate,,A,3307,In vivo,,1,,,N,,8904,BAO_0000218,,1,,10116.0,955.0,50597,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,Rattus norvegicus,CHEMBL623759,Brain
Intermediate,,A,4727,In vivo,,1,,,N,,8905,BAO_0000218,,1,,10116.0,,50597,Maximum concentration at the dose of 2 mg/kg in rat,Rattus norvegicus,CHEMBL623760,
Intermediate,,A,6597,In vivo,,1,,,N,,8906,BAO_0000218,,1,,10116.0,,50597,Maximum concentration was evaluated in rats,Rattus norvegicus,CHEMBL623761,
Intermediate,,A,16365,In vivo,,1,,,N,,8907,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,Rattus norvegicus,CHEMBL623762,Plasma
Intermediate,,A,16365,In vivo,,1,,,N,,8908,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,Rattus norvegicus,CHEMBL877594,Plasma
Intermediate,,A,16365,In vivo,,1,,,N,,8909,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,Rattus norvegicus,CHEMBL623763,Plasma
Intermediate,,A,16365,In vivo,,1,,,N,,8910,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,Rattus norvegicus,CHEMBL623764,Plasma
Intermediate,,A,16365,In vivo,,1,,,N,,8911,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,Rattus norvegicus,CHEMBL623765,Plasma
Intermediate,,A,2591,In vivo,,1,,,N,,8912,BAO_0000218,,1,,10116.0,178.0,50597,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,Rattus norvegicus,CHEMBL623766,Blood
Intermediate,,A,2591,In vivo,,1,,,N,,8913,BAO_0000218,,1,,10116.0,178.0,50597,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,Rattus norvegicus,CHEMBL623767,Blood
Intermediate,,A,2591,In vivo,,1,,,N,,8914,BAO_0000218,,1,,10116.0,178.0,50597,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,Rattus norvegicus,CHEMBL623768,Blood
Intermediate,,A,5978,In vivo,,1,,,N,,8915,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,Rattus norvegicus,CHEMBL623769,Plasma
Intermediate,,A,5978,In vivo,,1,,,N,,8916,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,Rattus norvegicus,CHEMBL623770,Plasma
Intermediate,,A,5978,In vivo,,1,,,N,,8917,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,Rattus norvegicus,CHEMBL623771,Plasma
Intermediate,,A,5978,In vivo,,1,,,N,,8918,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,Rattus norvegicus,CHEMBL623772,Plasma
Intermediate,,A,5978,In vivo,,1,,,N,,8919,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,Rattus norvegicus,CHEMBL623773,Plasma
Intermediate,,A,5978,In vivo,,1,,,N,,8920,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,Rattus norvegicus,CHEMBL623774,Plasma
Intermediate,,A,5978,In vivo,,1,,,N,,8921,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,Rattus norvegicus,CHEMBL623775,Plasma
Intermediate,,A,14465,In vivo,,1,,,N,,8922,BAO_0000218,,1,,10116.0,,50597,Cmax in rat (PO dose),Rattus norvegicus,CHEMBL623776,
Intermediate,,A,4723,In vivo,,1,,,N,,8923,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,CHEMBL622191,Plasma
Intermediate,,A,4723,In vivo,,1,,,N,,8924,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,CHEMBL622192,Plasma
Intermediate,,A,4576,In vivo,,1,,,N,,8925,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration determined in rat,Rattus norvegicus,CHEMBL622193,Plasma
Intermediate,,A,12873,In vivo,,1,,,N,,8926,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,Rattus norvegicus,CHEMBL622194,Plasma
Intermediate,,A,12873,In vivo,,1,,,N,,8927,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,Rattus norvegicus,CHEMBL622195,Plasma
Intermediate,,A,6824,In vivo,,1,,,N,,8928,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration in rat,Rattus norvegicus,CHEMBL622196,Plasma
Intermediate,,A,17065,In vivo,,1,,,N,,8929,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,Rattus norvegicus,CHEMBL622197,Plasma
Intermediate,,A,2932,In vivo,,1,,,N,,8930,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,Rattus norvegicus,CHEMBL622198,Plasma
Intermediate,,A,2932,In vivo,,1,,,N,,8931,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,Rattus norvegicus,CHEMBL622199,Plasma
Intermediate,,A,2879,In vivo,,1,,,N,,8932,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration of compound was measured in rat,Rattus norvegicus,CHEMBL622200,Plasma
Intermediate,,A,2864,In vivo,,1,,,N,,8933,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration after 20 mg/kg oral administration in rat,Rattus norvegicus,CHEMBL622201,Plasma
Intermediate,,A,16367,In vivo,,1,,,N,,8934,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration after oral administration to rats,Rattus norvegicus,CHEMBL623990,Plasma
Intermediate,,A,17717,In vivo,,1,,,N,,8935,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Rattus norvegicus,CHEMBL623991,Plasma
Intermediate,,A,17717,In vivo,,1,,,N,,8936,BAO_0000218,,1,,10116.0,1969.0,50597,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",Rattus norvegicus,CHEMBL623992,Plasma
Intermediate,,A,17717,In vivo,,1,,,N,,8937,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Rattus norvegicus,CHEMBL623993,Plasma
Intermediate,,A,17717,In vivo,,1,,,N,,8938,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,Rattus norvegicus,CHEMBL623994,Plasma
Intermediate,,F,17720,In vivo,,1,,,N,,8939,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,CHEMBL623995,Plasma
Intermediate,,F,17720,In vivo,,1,,,N,,8940,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,CHEMBL623996,Plasma
Intermediate,,F,17720,In vivo,,1,,,N,,8941,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,CHEMBL623997,Plasma
Intermediate,,A,4516,In vivo,,1,,,N,,8942,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration dosed orally in rats,Rattus norvegicus,CHEMBL623998,Plasma
Intermediate,,A,4516,In vivo,,1,,,N,,8943,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration dosed orally in rats after 6 hours,Rattus norvegicus,CHEMBL623999,Plasma
Intermediate,,A,4516,In vivo,,1,,,N,,8944,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,Rattus norvegicus,CHEMBL624000,Plasma
Intermediate,,A,5199,In vivo,,1,,,N,,8945,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,Rattus norvegicus,CHEMBL624001,Plasma
Intermediate,,A,17538,In vivo,,1,,,N,,8946,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration in rat after po administration,Rattus norvegicus,CHEMBL624002,Plasma
Intermediate,,A,6685,In vivo,,1,,,N,,8947,BAO_0000218,,1,,10116.0,1969.0,50597,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",Rattus norvegicus,CHEMBL624003,Plasma
Intermediate,,A,6685,In vivo,,1,,,N,,8948,BAO_0000218,,1,,10116.0,1969.0,50597,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",Rattus norvegicus,CHEMBL624004,Plasma
Intermediate,,A,16434,,,1,,,N,,8949,BAO_0000218,,1,,10116.0,948.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,CHEMBL624005,Heart
Intermediate,,A,16434,,,1,,,N,,8950,BAO_0000218,,1,,10116.0,948.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,CHEMBL624006,Heart
Intermediate,,A,16434,,,1,,,N,,8951,BAO_0000218,,1,,10116.0,948.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,CHEMBL624007,Heart
Intermediate,,A,16434,,,1,,,N,,8952,BAO_0000218,,1,,10116.0,948.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,CHEMBL624008,Heart
Intermediate,,A,16434,,,1,,,N,,8953,BAO_0000218,,1,,10116.0,948.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,CHEMBL624009,Heart
Intermediate,,A,16434,,,1,,,N,,8954,BAO_0000218,,1,,10116.0,948.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,CHEMBL874387,Heart
Intermediate,,A,16434,,,1,,,N,,8955,BAO_0000218,,1,,10116.0,948.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,CHEMBL624010,Heart
Intermediate,,A,16434,,,1,,,N,,8956,BAO_0000218,,1,,10116.0,948.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,CHEMBL624011,Heart
Intermediate,,A,16435,,,1,,,N,,8957,BAO_0000218,,1,,10116.0,948.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,CHEMBL624012,Heart
Intermediate,,A,16435,,,1,,,N,,8958,BAO_0000218,,1,,10116.0,948.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,CHEMBL624013,Heart
Intermediate,,A,16435,,,1,,,N,,8959,BAO_0000218,,1,,10116.0,948.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,CHEMBL624736,Heart
Intermediate,,A,16435,,,1,,,N,,8960,BAO_0000218,,1,,10116.0,948.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,CHEMBL624737,Heart
Intermediate,,A,16434,,,1,,,N,,8961,BAO_0000218,,1,,10116.0,948.0,50597,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,CHEMBL624738,Heart
Intermediate,,A,16434,,,1,,,N,,8962,BAO_0000218,,1,,10116.0,948.0,50597,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,CHEMBL624739,Heart
Intermediate,,A,16434,,,1,,,N,,8963,BAO_0000218,,1,,10116.0,948.0,50597,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,CHEMBL624740,Heart
Intermediate,,A,16435,,,1,,,N,,8964,BAO_0000218,,1,,10116.0,948.0,50597,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,CHEMBL624896,Heart
Intermediate,,A,16435,,,1,,,N,,8965,BAO_0000218,,1,,10116.0,948.0,50597,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,CHEMBL624897,Heart
Intermediate,,A,16435,,,1,,,N,,8966,BAO_0000218,,1,,10116.0,948.0,50597,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,CHEMBL624108,Heart
Intermediate,,A,16435,,,1,,,N,,8967,BAO_0000218,,1,,10116.0,948.0,50597,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,CHEMBL624109,Heart
Intermediate,,A,16435,,,1,,,N,,8968,BAO_0000218,,1,,10116.0,948.0,50597,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,CHEMBL624110,Heart
Intermediate,,A,16435,,,1,,,N,,8969,BAO_0000218,,1,,10116.0,948.0,50597,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,CHEMBL624111,Heart
Intermediate,,A,16435,,,1,,,N,,8970,BAO_0000218,,1,,10116.0,948.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,CHEMBL624112,Heart
Intermediate,,A,16435,,,1,,,N,,8971,BAO_0000218,,1,,10116.0,948.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,CHEMBL624113,Heart
Intermediate,,A,16435,,,1,,,N,,8972,BAO_0000218,,1,,10116.0,948.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,CHEMBL619709,Heart
Intermediate,,A,16435,,,1,,,N,,8973,BAO_0000218,,1,,10116.0,948.0,50597,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,CHEMBL619710,Heart
Intermediate,,A,16434,,,1,,,N,,8974,BAO_0000218,,1,,10116.0,2113.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,CHEMBL619711,Kidney
Intermediate,,A,16434,,,1,,,N,,8975,BAO_0000218,,1,,10116.0,2113.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,CHEMBL619712,Kidney
Intermediate,,A,16434,,,1,,,N,,8976,BAO_0000218,,1,,10116.0,2113.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,CHEMBL619713,Kidney
Intermediate,,A,16434,,,1,,,N,,8977,BAO_0000218,,1,,10116.0,2113.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,CHEMBL619714,Kidney
Intermediate,,A,16434,,,1,,,N,,8978,BAO_0000218,,1,,10116.0,2113.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,CHEMBL619715,Kidney
Intermediate,,A,16434,,,1,,,N,,8979,BAO_0000218,,1,,10116.0,2113.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,CHEMBL619716,Kidney
Intermediate,,A,16434,,,1,,,N,,8980,BAO_0000218,,1,,10116.0,2113.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,CHEMBL619717,Kidney
Intermediate,,A,16434,,,1,,,N,,8981,BAO_0000218,,1,,10116.0,2113.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,CHEMBL619718,Kidney
Intermediate,,A,16435,,,1,,,N,,8982,BAO_0000218,,1,,10116.0,2113.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,CHEMBL619719,Kidney
Intermediate,,A,16435,,,1,,,N,,8983,BAO_0000218,,1,,10116.0,2113.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,CHEMBL875329,Kidney
Intermediate,,A,16435,,,1,,,N,,8984,BAO_0000218,,1,,10116.0,2113.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,CHEMBL619720,Kidney
Intermediate,,A,16435,,,1,,,N,,8985,BAO_0000218,,1,,10116.0,2113.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,CHEMBL619721,Kidney
Intermediate,,A,16435,,,1,,,N,,8986,BAO_0000218,,1,,10116.0,2113.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,CHEMBL619722,Kidney
Intermediate,,A,16435,,,1,,,N,,8987,BAO_0000218,,1,,10116.0,2113.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,CHEMBL619723,Kidney
Intermediate,,A,16435,,,1,,,N,,8988,BAO_0000218,,1,,10116.0,2113.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,CHEMBL619724,Kidney
Intermediate,,A,16435,,,1,,,N,,8989,BAO_0000218,,1,,10116.0,2113.0,50597,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,CHEMBL619725,Kidney
Intermediate,,A,16434,,,1,,,N,,8990,BAO_0000218,,1,,10116.0,2113.0,50597,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,CHEMBL619726,Kidney
Intermediate,,A,16434,,,1,,,N,,8991,BAO_0000218,,1,,10116.0,2113.0,50597,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,CHEMBL619727,Kidney
Intermediate,,A,16434,,,1,,,N,,8992,BAO_0000218,,1,,10116.0,2113.0,50597,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,CHEMBL619728,Kidney
Intermediate,,A,16435,,,1,,,N,,8993,BAO_0000218,,1,,10116.0,2113.0,50597,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,CHEMBL619729,Kidney
Intermediate,,A,11977,In vivo,,1,,,N,,8994,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL619730,Muscle tissue
Intermediate,,A,11977,In vivo,,1,,,N,,8995,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL619731,Muscle tissue
Intermediate,,A,11977,In vivo,,1,,,N,,8996,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,CHEMBL619732,Muscle tissue
Intermediate,,A,11977,In vivo,,1,,,N,,8997,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL619733,Muscle tissue
Intermediate,,A,11977,In vivo,,1,,,N,,8998,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL619734,Muscle tissue
Intermediate,,A,11977,In vivo,,1,,,N,,8999,BAO_0000218,,1,,10116.0,14.0,50597,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL619735,Zone of skin
Intermediate,,A,11977,In vivo,,1,,,N,,9000,BAO_0000218,,1,,10116.0,14.0,50597,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL875330,Zone of skin
Intermediate,,A,11977,In vivo,,1,,,N,,9001,BAO_0000218,,1,,10116.0,14.0,50597,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,CHEMBL628465,Zone of skin
Intermediate,,A,11977,In vivo,,1,,,N,,9002,BAO_0000218,,1,,10116.0,14.0,50597,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL628466,Zone of skin
Intermediate,,A,11977,In vivo,,1,,,N,,9003,BAO_0000218,,1,,10116.0,14.0,50597,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL628467,Zone of skin
Intermediate,,A,11977,In vivo,,1,,,N,,9004,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL628468,Spleen
Intermediate,,A,11977,In vivo,,1,,,N,,9005,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL628469,Spleen
Intermediate,,A,11977,In vivo,,1,,,N,,9006,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,CHEMBL628470,Spleen
Intermediate,,A,11977,In vivo,,1,,,N,,9007,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL628471,Spleen
Intermediate,,A,11977,In vivo,,1,,,N,,9008,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL628472,Spleen
Intermediate,,A,11977,In vivo,,1,,,N,,9009,BAO_0000218,,1,,10116.0,2046.0,50597,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL625191,Thyroid gland
Intermediate,,A,11977,In vivo,,1,,,N,,9010,BAO_0000218,,1,,10116.0,2046.0,50597,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL625192,Thyroid gland
Intermediate,,A,11977,In vivo,,1,,,N,,9011,BAO_0000218,,1,,10116.0,2046.0,50597,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,CHEMBL875337,Thyroid gland
Intermediate,,A,11977,In vivo,,1,,,N,,9012,BAO_0000218,,1,,10116.0,2046.0,50597,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL626341,Thyroid gland
Intermediate,,A,11977,In vivo,,1,,,N,,9013,BAO_0000218,,1,,10116.0,2046.0,50597,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL626342,Thyroid gland
Intermediate,,A,11977,In vivo,,1,,,N,,9014,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,CHEMBL621943,Liver
Intermediate,,A,3748,,,1,,,N,,9015,BAO_0000218,,1,,10116.0,,50597,Half life in rats,Rattus norvegicus,CHEMBL621944,
Intermediate,,A,15765,,,1,,,N,,9016,BAO_0000218,,1,,10116.0,,50597,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,Rattus norvegicus,CHEMBL621945,
Intermediate,,A,4871,,,1,,,N,,9017,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),Rattus norvegicus,CHEMBL621946,
Intermediate,,A,4871,,,1,,,N,,9018,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,Rattus norvegicus,CHEMBL621947,
Intermediate,,A,4872,,,1,,,N,,9019,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),Rattus norvegicus,CHEMBL621948,
Intermediate,,A,4872,,,1,,,N,,9020,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,Rattus norvegicus,CHEMBL621949,
Intermediate,,A,5413,,,1,,,N,,9021,BAO_0000218,,1,,10116.0,,50597,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),Rattus norvegicus,CHEMBL621950,
Intermediate,,A,5413,,,1,,,N,,9022,BAO_0000218,,1,,10116.0,,50597,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,Rattus norvegicus,CHEMBL621951,
Intermediate,,A,15272,In vivo,,1,,,N,,9023,BAO_0000218,,1,,10116.0,178.0,50597,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,Rattus norvegicus,CHEMBL621952,Blood
Intermediate,,A,4689,,,1,,,N,,9024,BAO_0000218,,1,,10116.0,2107.0,50597,Stability (%) in rat liver microsomes,Rattus norvegicus,CHEMBL621953,Liver
Intermediate,,A,6057,,,1,,,N,,9025,BAO_0000218,,1,,10116.0,,50597,Area under curve was calculated after intravenous administration,Rattus norvegicus,CHEMBL621954,
Intermediate,,A,6057,,,1,,,N,,9026,BAO_0000218,,1,,10116.0,,50597,Area under the curve was calculated after iv administration in rat,Rattus norvegicus,CHEMBL621955,
Intermediate,,A,6057,,,1,,,N,,9027,BAO_0000218,,1,,10116.0,,50597,Area under the curve was calculated in rat after peroral administration,Rattus norvegicus,CHEMBL621956,
Intermediate,,A,6211,,,1,,,N,,9028,BAO_0000218,,1,,10116.0,,50597,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,Rattus norvegicus,CHEMBL621957,
Intermediate,,A,5710,,,1,,,N,,9029,BAO_0000218,,1,,10116.0,,50597,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,Rattus norvegicus,CHEMBL621958,
Intermediate,,A,5710,,,1,,,N,,9030,BAO_0000218,,1,,10116.0,,50597,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,Rattus norvegicus,CHEMBL621959,
Intermediate,,A,17853,,,1,,,N,,9031,BAO_0000218,,1,,10116.0,,50597,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,Rattus norvegicus,CHEMBL621960,
Intermediate,,A,17853,,,1,,,N,,9032,BAO_0000218,,1,,10116.0,,50597,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,Rattus norvegicus,CHEMBL621961,
Intermediate,,A,15765,,,1,,,N,,9033,BAO_0000218,,1,,10116.0,,50597,p value of the compound,Rattus norvegicus,CHEMBL621962,
Intermediate,,F,15765,,,1,,,N,,9034,BAO_0000218,,1,,10116.0,,50597,p value of the compound,Rattus norvegicus,CHEMBL876787,
Intermediate,,A,15765,,,1,,,N,,9035,BAO_0000218,,1,,10116.0,,50597,p value of the compound,Rattus norvegicus,CHEMBL621963,
Intermediate,,A,6175,,,1,,,N,,9036,BAO_0000218,,1,,10116.0,945.0,50597,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,CHEMBL622637,Stomach
Intermediate,,A,6175,,,1,,,N,,9037,BAO_0000218,,1,,10116.0,945.0,50597,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,CHEMBL622638,Stomach
Intermediate,,A,6175,,,1,,,N,,9038,BAO_0000218,,1,,10116.0,945.0,50597,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,CHEMBL626561,Stomach
Autocuration,,F,7991,,,1,,,U,,9039,BAO_0000019,,0,,9986.0,,22224,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),Oryctolagus cuniculus,CHEMBL626562,
Autocuration,,A,429,,,1,,,U,,9040,BAO_0000218,,0,,9986.0,,22224,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),Oryctolagus cuniculus,CHEMBL626563,
Autocuration,,A,429,,,1,,,U,,9041,BAO_0000218,,0,,9986.0,,22224,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),Oryctolagus cuniculus,CHEMBL626564,
Autocuration,,A,6253,In vivo,,1,,,U,,9042,BAO_0000218,,0,,9986.0,,22224,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,Oryctolagus cuniculus,CHEMBL626565,
Autocuration,,A,6253,In vivo,,1,,,U,,9043,BAO_0000218,,0,,9986.0,,22224,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,Oryctolagus cuniculus,CHEMBL626566,
Autocuration,,A,3615,In vivo,,1,,,U,,9044,BAO_0000218,,0,,9986.0,,22224,Clearance rate in rabbits,Oryctolagus cuniculus,CHEMBL626567,
Autocuration,,A,4059,In vivo,,1,,,U,,9045,BAO_0000218,,0,,9986.0,,22224,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,Oryctolagus cuniculus,CHEMBL626568,
Autocuration,,A,5124,In vivo,,1,,,U,,9046,BAO_0000218,,0,,9986.0,,22224,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Oryctolagus cuniculus,CHEMBL626569,
Autocuration,,A,5124,In vivo,,1,,,U,,9047,BAO_0000218,,0,,9986.0,,22224,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Oryctolagus cuniculus,CHEMBL626570,
Autocuration,,A,5124,In vivo,,1,,,U,,9048,BAO_0000218,,0,,9986.0,,22224,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Oryctolagus cuniculus,CHEMBL626571,
Autocuration,,A,429,In vivo,,1,,,U,,9049,BAO_0000218,,0,,9986.0,,22224,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,Oryctolagus cuniculus,CHEMBL626572,
Autocuration,,A,4059,In vivo,,1,,,U,,9050,BAO_0000218,,0,,9986.0,1969.0,22224,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,Oryctolagus cuniculus,CHEMBL626573,Plasma
Autocuration,,A,9659,,,1,,Microsomes,U,,9051,BAO_0000251,,0,,9986.0,2107.0,22224,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,Oryctolagus cuniculus,CHEMBL626574,Liver
Autocuration,,A,9659,,,1,,Microsomes,U,,9052,BAO_0000251,,0,,9986.0,2107.0,22224,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,Oryctolagus cuniculus,CHEMBL626575,Liver
Autocuration,,A,3639,,,1,,,U,,9053,BAO_0000218,,0,,9986.0,,22224,Dose at which bioavailability of intravenously administered compound was tested in rabbit,Oryctolagus cuniculus,CHEMBL626576,
Autocuration,,A,3639,,,1,,,U,,9054,BAO_0000218,,0,,9986.0,,22224,Dose at which bioavailability of perorally administered compound was tested in rabbit,Oryctolagus cuniculus,CHEMBL626577,
Autocuration,,A,3639,In vivo,,1,,,U,,9055,BAO_0000218,,0,,9986.0,,22224,The compound was tested for its bioavailability in rabbit (by oral dosage).,Oryctolagus cuniculus,CHEMBL626578,
Autocuration,,A,5124,In vivo,,1,,,U,,9056,BAO_0000218,,0,,9986.0,,22224,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Oryctolagus cuniculus,CHEMBL625263,
Autocuration,,A,5124,In vivo,,1,,,U,,9057,BAO_0000218,,0,,9986.0,,22224,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Oryctolagus cuniculus,CHEMBL625264,
Autocuration,,A,5124,In vivo,,1,,,U,,9058,BAO_0000218,,0,,9986.0,,22224,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Oryctolagus cuniculus,CHEMBL625265,
Autocuration,,A,14294,,,1,,Microsomes,U,,9059,BAO_0000251,,0,,9986.0,,22224,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),Oryctolagus cuniculus,CHEMBL625266,
Autocuration,,A,14294,,,1,,Microsomes,U,,9060,BAO_0000251,,0,,9986.0,,22224,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),Oryctolagus cuniculus,CHEMBL876796,
Autocuration,,A,429,In vivo,,1,,,U,,9061,BAO_0000218,,0,,9986.0,,22224,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,Oryctolagus cuniculus,CHEMBL625267,
Autocuration,,A,5124,In vivo,,1,,,U,,9062,BAO_0000218,,0,,9986.0,1969.0,22224,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Oryctolagus cuniculus,CHEMBL625268,Plasma
Autocuration,,A,5124,In vivo,,1,,,U,,9063,BAO_0000218,,0,,9986.0,1969.0,22224,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Oryctolagus cuniculus,CHEMBL625269,Plasma
Autocuration,,A,5124,In vivo,,1,,,U,,9064,BAO_0000218,,0,,9986.0,1969.0,22224,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Oryctolagus cuniculus,CHEMBL624689,Plasma
Autocuration,,A,429,In vivo,,1,,,U,,9065,BAO_0000218,,0,,9986.0,,22224,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,Oryctolagus cuniculus,CHEMBL624690,
Autocuration,,A,429,,,1,,,U,,9066,BAO_0000218,,0,,9986.0,1088.0,22224,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),Oryctolagus cuniculus,CHEMBL624691,Urine
Autocuration,,A,429,,,1,,,U,,9067,BAO_0000218,,0,,9986.0,1088.0,22224,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),Oryctolagus cuniculus,CHEMBL624692,Urine
Autocuration,,A,4059,In vivo,,1,,,U,,9068,BAO_0000218,,0,,9986.0,,22224,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,Oryctolagus cuniculus,CHEMBL624693,
Autocuration,,A,4137,In vivo,,1,,,U,,9069,BAO_0000218,,0,,9986.0,,22224,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,Oryctolagus cuniculus,CHEMBL624694,
Autocuration,,A,11672,In vitro,,1,,,U,,9070,BAO_0000221,,0,,9986.0,,22224,In vitro Biological half-life in crude homogenate of rabbit renal cortex,Oryctolagus cuniculus,CHEMBL877596,
Autocuration,,A,12886,,,1,,,U,,9071,BAO_0000019,,0,,9986.0,,22224,Time within which only 10% of the drug was degraded,Oryctolagus cuniculus,CHEMBL624695,
Autocuration,,A,3853,,,1,,,U,,9072,BAO_0000221,,0,,9986.0,2107.0,22224,Half life period in rabbit liver homogenate,Oryctolagus cuniculus,CHEMBL624696,Liver
Autocuration,,A,3615,,,1,,,U,,9073,BAO_0000019,,0,,9986.0,,22224,Half life value in rabbits,Oryctolagus cuniculus,CHEMBL624697,
Autocuration,,A,6253,In vivo,,1,,,U,,9074,BAO_0000218,,0,,9986.0,178.0,22224,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,Oryctolagus cuniculus,CHEMBL624698,Blood
Autocuration,,A,6253,In vivo,,1,,,U,,9075,BAO_0000218,,0,,9986.0,178.0,22224,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,Oryctolagus cuniculus,CHEMBL624699,Blood
Autocuration,,A,6077,In vivo,,1,,,U,,9076,BAO_0000218,,0,,9986.0,,22224,Half-life period in rabbits following intravenous administration at 2 mg/kg,Oryctolagus cuniculus,CHEMBL624700,
Intermediate,,A,17617,,,1,,,N,,9077,BAO_0000218,,1,,10116.0,1969.0,50597,AUC 0-8 hr value in rats at 10 mg/kg,Rattus norvegicus,CHEMBL622903,Plasma
Intermediate,,A,17594,,,1,,,N,,9078,BAO_0000218,,1,,10116.0,1969.0,50597,AUC after administration at 2000 mg/kg/day in rats,Rattus norvegicus,CHEMBL622904,Plasma
Intermediate,,A,6149,,,1,,,N,,9079,BAO_0000218,,1,,10116.0,1969.0,50597,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,Rattus norvegicus,CHEMBL622905,Plasma
Intermediate,,A,17260,,,1,,,N,,9080,BAO_0000218,,1,,10116.0,1969.0,50597,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Rattus norvegicus,CHEMBL622906,Plasma
Intermediate,,A,17260,,,1,,,N,,9081,BAO_0000218,,1,,10116.0,1969.0,50597,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Rattus norvegicus,CHEMBL622907,Plasma
Intermediate,,A,6644,,,1,,,N,,9082,BAO_0000218,,1,,10116.0,1969.0,50597,AUC in rat after oral administration at 10.5 mg/kg dose,Rattus norvegicus,CHEMBL622908,Plasma
Intermediate,,A,6644,,,1,,,N,,9083,BAO_0000218,,1,,10116.0,1969.0,50597,AUC in rat after oral administration at 11.2 mg/kg dose,Rattus norvegicus,CHEMBL622909,Plasma
Intermediate,,A,6644,,,1,,,N,,9084,BAO_0000218,,1,,10116.0,1969.0,50597,AUC in rat after oral administration at 9.7 mg/kg dose,Rattus norvegicus,CHEMBL622910,Plasma
Intermediate,,A,6495,,,1,,,N,,9085,BAO_0000218,,1,,10116.0,955.0,50597,AUC in rat brain after oral administration at 10 mg/kg,Rattus norvegicus,CHEMBL622911,Brain
Intermediate,,A,6504,,,1,,,N,,9086,BAO_0000218,,1,,10116.0,1969.0,50597,AUC in rat p.o.,Rattus norvegicus,CHEMBL622912,Plasma
Intermediate,,A,17686,,,1,,,N,,9087,BAO_0000218,,1,,10116.0,1969.0,50597,AUC in rat p.o. at 20 mg/kg concentration,Rattus norvegicus,CHEMBL622913,Plasma
Intermediate,,A,6495,,,1,,,N,,9088,BAO_0000218,,1,,10116.0,1969.0,50597,AUC in rat plasma after oral administration at 10 mg/kg,Rattus norvegicus,CHEMBL622914,Plasma
Intermediate,,A,216,,,1,,,N,,9089,BAO_0000218,,1,,10116.0,1969.0,50597,AUC in rats,Rattus norvegicus,CHEMBL622915,Plasma
Intermediate,,A,1908,,,1,,,N,,9090,BAO_0000218,,1,,10116.0,1969.0,50597,AUC value after IV dose at a dose of 5 mg/kg in rats.,Rattus norvegicus,CHEMBL622916,Plasma
Intermediate,,A,1908,,,1,,,N,,9091,BAO_0000218,,1,,10116.0,1969.0,50597,AUC value after oral dose at a dose of 10 mg/kg in rats.,Rattus norvegicus,CHEMBL622917,Plasma
Intermediate,,A,6685,In vivo,,1,,,N,,9092,BAO_0000218,,1,,10116.0,1969.0,50597,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Rattus norvegicus,CHEMBL622918,Plasma
Intermediate,,A,216,In vivo,,1,,,N,,9093,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,Rattus norvegicus,CHEMBL622919,Plasma
Intermediate,,A,6049,In vivo,,1,,,N,,9094,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration was evaluated in rat,Rattus norvegicus,CHEMBL622920,Plasma
Intermediate,,A,2463,In vivo,,1,,,N,,9095,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,Rattus norvegicus,CHEMBL622921,Plasma
Intermediate,,A,6679,In vivo,,1,,,N,,9096,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,Rattus norvegicus,CHEMBL622922,Plasma
Intermediate,,A,6681,In vivo,,1,,,N,,9097,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,Rattus norvegicus,CHEMBL622923,Plasma
Intermediate,,A,4890,In vivo,,1,,,N,,9098,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,CHEMBL877604,Plasma
Intermediate,,A,6410,In vivo,,1,,,N,,9099,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,Rattus norvegicus,CHEMBL622924,Plasma
Intermediate,,A,6410,In vivo,,1,,,N,,9100,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,Rattus norvegicus,CHEMBL622925,Plasma
Intermediate,,A,16366,In vivo,,1,,,N,,9101,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,Rattus norvegicus,CHEMBL622926,Plasma
Intermediate,,A,6227,In vivo,,1,,,N,,9102,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,Rattus norvegicus,CHEMBL623625,Plasma
Expert,,A,3598,In vivo,,1,,,N,,9103,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,CHEMBL623626,Plasma
Intermediate,,A,1465,In vivo,,1,,,N,,9104,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma drug concentration was determined,Rattus norvegicus,CHEMBL623627,Plasma
Intermediate,,A,4368,In vivo,,1,,,N,,9105,BAO_0000218,,1,,10116.0,,50597,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,Rattus norvegicus,CHEMBL623628,
Intermediate,,A,15662,In vivo,,1,,,N,,9106,BAO_0000218,,1,,10116.0,1969.0,50597,Mean peak plasma concentration was observed after intravenous administration in rat,Rattus norvegicus,CHEMBL623629,Plasma
Intermediate,,A,15662,In vivo,,1,,,N,,9107,BAO_0000218,,1,,10116.0,1969.0,50597,Mean peak plasma concentration was observed after oral administration in rat,Rattus norvegicus,CHEMBL623630,Plasma
Intermediate,,A,5355,In vivo,,1,,,N,,9108,BAO_0000218,,1,,10116.0,,50597,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,Rattus norvegicus,CHEMBL623804,
Intermediate,,A,5355,In vivo,,1,,,N,,9109,BAO_0000218,,1,,10116.0,,50597,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,Rattus norvegicus,CHEMBL623805,
Intermediate,,A,1567,In vivo,,1,,,N,,9110,BAO_0000218,,1,,10116.0,1969.0,50597,Peak oral plasma concentration was determined in rats by oral administration,Rattus norvegicus,CHEMBL623806,Plasma
Intermediate,,A,4026,In vivo,,1,,,N,,9111,BAO_0000218,,1,,10116.0,1969.0,50597,Peak plasma concentration (Cmax) was determined,Rattus norvegicus,CHEMBL623807,Plasma
Intermediate,,A,6193,In vivo,,1,,,N,,9112,BAO_0000218,,1,,10116.0,1969.0,50597,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,Rattus norvegicus,CHEMBL623808,Plasma
Intermediate,,A,4026,In vivo,,1,,,N,,9113,BAO_0000218,,1,,10116.0,1969.0,50597,Peak plasma concentration (Cmax) in rats,Rattus norvegicus,CHEMBL623809,Plasma
Intermediate,,A,6485,In vivo,,1,,,N,,9114,BAO_0000218,,1,,10116.0,1969.0,50597,Peak plasma concentration at 1 mg/kg peroral administration,Rattus norvegicus,CHEMBL623810,Plasma
Intermediate,,A,17655,In vivo,,1,,,N,,9115,BAO_0000218,,1,,10116.0,1969.0,50597,Peak plasma concentration in rat,Rattus norvegicus,CHEMBL623811,Plasma
Intermediate,,A,14941,In vivo,,1,,,N,,9116,BAO_0000218,,1,,10116.0,1969.0,50597,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",Rattus norvegicus,CHEMBL623812,Plasma
Intermediate,,A,5394,In vivo,,1,,,N,,9117,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,Rattus norvegicus,CHEMBL877605,
Intermediate,,A,4408,In vivo,,1,,,N,,9118,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (Cmax) in rat,Rattus norvegicus,CHEMBL623813,
Intermediate,,A,5983,In vivo,,1,,,N,,9119,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,Rattus norvegicus,CHEMBL623814,
Intermediate,,A,4878,In vivo,,1,,,N,,9120,BAO_0000218,,1,,10116.0,,50597,Cmax in rat after 3mg/kg oral dose,Rattus norvegicus,CHEMBL623815,
Intermediate,,A,5862,In vivo,,1,,,N,,9121,BAO_0000218,Sprague-Dawley,1,,10116.0,,50597,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,Rattus norvegicus,CHEMBL623816,
Intermediate,,A,4517,In vivo,,1,,,N,,9122,BAO_0000218,,1,,10116.0,,50597,Cmax in rats after 20 mg/kg oral dose,Rattus norvegicus,CHEMBL623145,
Intermediate,,A,5932,In vivo,,1,,,N,,9123,BAO_0000218,,1,,10116.0,1969.0,50597,Cmax in rat plasma after 30mg/kg oral dose,Rattus norvegicus,CHEMBL623146,Plasma
Intermediate,,A,5436,In vivo,,1,,,N,,9124,BAO_0000218,,1,,10116.0,1969.0,50597,Plasma concentration after oral administration of 100 mg/kg to rats,Rattus norvegicus,CHEMBL623147,Plasma
Intermediate,,A,4910,In vivo,,1,,,N,,9125,BAO_0000218,,1,,10116.0,955.0,50597,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,Rattus norvegicus,CHEMBL623042,Brain
Intermediate,,A,4950,In vivo,,1,,,N,,9126,BAO_0000218,,1,,10116.0,,50597,Tested for the Cmax in rat at 10 mg/kg per orally,Rattus norvegicus,CHEMBL623043,
Intermediate,,A,15078,In vivo,,1,,,N,,9127,BAO_0000218,,1,,10116.0,,50597,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,CHEMBL623044,
Intermediate,,A,15078,In vivo,,1,,,N,,9128,BAO_0000218,,1,,10116.0,,50597,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,CHEMBL623045,
Intermediate,,A,3360,In vivo,,1,,,N,,9129,BAO_0000218,,1,,10116.0,,50597,Bioavailability as oral Cmax in rats at 30 mins,Rattus norvegicus,CHEMBL623046,
Intermediate,,A,3360,In vivo,,1,,,N,,9130,BAO_0000218,,1,,10116.0,,50597,Bioavailability as oral Cmax in rats at 6hr,Rattus norvegicus,CHEMBL623226,
Intermediate,,A,15022,In vivo,,1,,,N,,9131,BAO_0000218,,1,,10116.0,,50597,The maximum concentration of compound was measured at the dose of 100 umol/kg,Rattus norvegicus,CHEMBL623227,
Intermediate,,A,15022,In vivo,,1,,,N,,9132,BAO_0000218,,1,,10116.0,,50597,The maximum concentration of compound was measured at the dose of 300 umol/kg,Rattus norvegicus,CHEMBL623228,
Intermediate,,A,15022,In vivo,,1,,,N,,9133,BAO_0000218,,1,,10116.0,,50597,The maximum concentration of compound was measured at the dose of 30 umol/kg,Rattus norvegicus,CHEMBL623229,
Intermediate,,A,5160,In vivo,,1,,,N,,9134,BAO_0000218,,1,,10116.0,1969.0,50597,The maximum plasma levels for the compounds were determined by LC-MS.,Rattus norvegicus,CHEMBL623230,Plasma
Intermediate,,A,15662,In vivo,,1,,,N,,9135,BAO_0000218,,1,,10116.0,1969.0,50597,mean peak plasma concentration was observed after intravenous administration in rat,Rattus norvegicus,CHEMBL623231,Plasma
Intermediate,,A,15662,In vivo,,1,,,N,,9136,BAO_0000218,,1,,10116.0,1969.0,50597,mean peak plasma concentration was observed after oral administration in rat,Rattus norvegicus,CHEMBL623232,Plasma
Intermediate,,A,4709,,,1,,,N,,9137,BAO_0000218,,1,,10116.0,,50597,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,Rattus norvegicus,CHEMBL623233,
Intermediate,,A,3535,,,1,,,N,,9138,BAO_0000218,,1,,10116.0,,50597,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,Rattus norvegicus,CHEMBL623234,
Intermediate,,A,3535,,,1,,,N,,9139,BAO_0000218,,1,,10116.0,,50597,Concentration in plasma (portal) following oral dose in rats at 1 hr,Rattus norvegicus,CHEMBL623235,
Intermediate,,A,3535,,,1,,,N,,9140,BAO_0000218,,1,,10116.0,,50597,Concentration in plasma (portal) following oral dose in rats at 2 hr,Rattus norvegicus,CHEMBL623236,
Intermediate,,A,3535,,,1,,,N,,9141,BAO_0000218,,1,,10116.0,,50597,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,Rattus norvegicus,CHEMBL623237,
Intermediate,,A,3535,,,1,,,N,,9142,BAO_0000218,,1,,10116.0,,50597,Concentration in plasma (systemic) following oral dose in rats at 1 hr,Rattus norvegicus,CHEMBL623238,
Intermediate,,A,3535,,,1,,,N,,9143,BAO_0000218,,1,,10116.0,,50597,Concentration in plasma (systemic) following oral dose in rats at 2 hr,Rattus norvegicus,CHEMBL623239,
Intermediate,,A,5005,In vivo,,1,,,U,,9144,BAO_0000218,,0,,10116.0,1969.0,22224,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,Rattus norvegicus,CHEMBL623240,Plasma
Intermediate,,A,6326,,,1,,,N,,9145,BAO_0000218,,1,,10116.0,1898.0,50597,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",Rattus norvegicus,CHEMBL623241,Hypothalamus
Intermediate,,A,6326,,,1,,,N,,9146,BAO_0000218,,1,,10116.0,1898.0,50597,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",Rattus norvegicus,CHEMBL623242,Hypothalamus
Intermediate,,A,6326,,,1,,,N,,9147,BAO_0000218,,1,,10116.0,,50597,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",Rattus norvegicus,CHEMBL874394,
Intermediate,,A,6326,,,1,,,N,,9148,BAO_0000218,,1,,10116.0,,50597,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",Rattus norvegicus,CHEMBL623243,
Intermediate,,A,17411,,,1,,,N,,9149,BAO_0000218,,1,,10116.0,,50597,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,CHEMBL623244,
Intermediate,,A,16435,,,1,,,N,,9150,BAO_0000218,,1,,10116.0,2113.0,50597,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,CHEMBL623245,Kidney
Intermediate,,A,16435,,,1,,,N,,9151,BAO_0000218,,1,,10116.0,2113.0,50597,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,CHEMBL623246,Kidney
Intermediate,,A,16435,,,1,,,N,,9152,BAO_0000218,,1,,10116.0,2113.0,50597,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,CHEMBL623247,Kidney
Intermediate,,A,16435,,,1,,,N,,9153,BAO_0000218,,1,,10116.0,2113.0,50597,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,CHEMBL623248,Kidney
Intermediate,,A,16435,,,1,,,N,,9154,BAO_0000218,,1,,10116.0,2113.0,50597,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,CHEMBL623249,Kidney
Intermediate,,A,16434,,,1,,,N,,9155,BAO_0000218,,1,,10116.0,2107.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,CHEMBL625072,Liver
Intermediate,,A,16434,,,1,,,N,,9156,BAO_0000218,,1,,10116.0,2107.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,CHEMBL625073,Liver
Intermediate,,A,16434,,,1,,,N,,9157,BAO_0000218,,1,,10116.0,2107.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,CHEMBL625074,Liver
Intermediate,,A,16434,,,1,,,N,,9158,BAO_0000218,,1,,10116.0,2107.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,CHEMBL625075,Liver
Intermediate,,A,16434,,,1,,,N,,9159,BAO_0000218,,1,,10116.0,2107.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,CHEMBL625076,Liver
Intermediate,,A,16434,,,1,,,N,,9160,BAO_0000218,,1,,10116.0,2107.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,CHEMBL625077,Liver
Intermediate,,A,16434,,,1,,,N,,9161,BAO_0000218,,1,,10116.0,2107.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,CHEMBL625078,Liver
Intermediate,,A,16434,,,1,,,N,,9162,BAO_0000218,,1,,10116.0,2107.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,CHEMBL874395,Liver
Intermediate,,A,16435,,,1,,,N,,9163,BAO_0000218,,1,,10116.0,2107.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,CHEMBL625079,Liver
Intermediate,,A,16435,,,1,,,N,,9164,BAO_0000218,,1,,10116.0,2107.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,CHEMBL625080,Liver
Intermediate,,A,16435,,,1,,,N,,9165,BAO_0000218,,1,,10116.0,2107.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,CHEMBL625081,Liver
Intermediate,,A,16435,,,1,,,N,,9166,BAO_0000218,,1,,10116.0,2107.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,CHEMBL625082,Liver
Intermediate,,A,16435,,,1,,,N,,9167,BAO_0000218,,1,,10116.0,2107.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,CHEMBL625083,Liver
Intermediate,,A,16435,,,1,,,N,,9168,BAO_0000218,,1,,10116.0,2107.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,CHEMBL625084,Liver
Intermediate,,A,16435,,,1,,,N,,9169,BAO_0000218,,1,,10116.0,2107.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,CHEMBL625085,Liver
Intermediate,,A,16435,,,1,,,N,,9170,BAO_0000218,,1,,10116.0,2107.0,50597,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,CHEMBL625086,Liver
Intermediate,,A,16434,,,1,,,N,,9171,BAO_0000218,,1,,10116.0,2107.0,50597,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,CHEMBL625087,Liver
Intermediate,,A,16434,,,1,,,N,,9172,BAO_0000218,,1,,10116.0,2107.0,50597,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,CHEMBL625088,Liver
Intermediate,,A,16434,,,1,,,N,,9173,BAO_0000218,,1,,10116.0,2107.0,50597,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,CHEMBL622205,Liver
Intermediate,,A,16435,,,1,,,N,,9174,BAO_0000218,,1,,10116.0,2107.0,50597,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,CHEMBL622206,Liver
Intermediate,,A,16435,,,1,,,N,,9175,BAO_0000218,,1,,10116.0,2107.0,50597,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,CHEMBL622207,Liver
Intermediate,,A,16435,,,1,,,N,,9176,BAO_0000218,,1,,10116.0,2107.0,50597,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,CHEMBL622366,Liver
Intermediate,,A,16435,,,1,,,N,,9177,BAO_0000218,,1,,10116.0,2107.0,50597,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,CHEMBL622367,Liver
Intermediate,,A,16435,,,1,,,N,,9178,BAO_0000218,,1,,10116.0,2107.0,50597,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,CHEMBL875331,Liver
Intermediate,,A,16435,,,1,,,N,,9179,BAO_0000218,,1,,10116.0,2107.0,50597,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,CHEMBL622368,Liver
Intermediate,,A,16434,,,1,,,N,,9180,BAO_0000218,,1,,10116.0,2048.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,CHEMBL622369,Lung
Intermediate,,A,16434,,,1,,,N,,9181,BAO_0000218,,1,,10116.0,2048.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,CHEMBL622370,Lung
Intermediate,,A,16434,,,1,,,N,,9182,BAO_0000218,,1,,10116.0,2048.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,CHEMBL622371,Lung
Intermediate,,A,16434,,,1,,,N,,9183,BAO_0000218,,1,,10116.0,2048.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,CHEMBL622372,Lung
Intermediate,,A,16434,,,1,,,N,,9184,BAO_0000218,,1,,10116.0,2048.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,CHEMBL622373,Lung
Intermediate,,A,16434,,,1,,,N,,9185,BAO_0000218,,1,,10116.0,2048.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,CHEMBL622374,Lung
Intermediate,,A,16434,,,1,,,N,,9186,BAO_0000218,,1,,10116.0,2048.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,CHEMBL622375,Lung
Intermediate,,A,16434,,,1,,,N,,9187,BAO_0000218,,1,,10116.0,2048.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,CHEMBL622376,Lung
Intermediate,,A,16435,,,1,,,N,,9188,BAO_0000218,,1,,10116.0,2048.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,CHEMBL622377,Lung
Intermediate,,A,16435,,,1,,,N,,9189,BAO_0000218,,1,,10116.0,2048.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,CHEMBL622378,Lung
Intermediate,,A,16435,,,1,,,N,,9190,BAO_0000218,,1,,10116.0,2048.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,CHEMBL622379,Lung
Intermediate,,A,16435,,,1,,,N,,9191,BAO_0000218,,1,,10116.0,2048.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,CHEMBL622380,Lung
Intermediate,,A,16435,,,1,,,N,,9192,BAO_0000218,,1,,10116.0,2048.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,CHEMBL622381,Lung
Intermediate,,A,16435,,,1,,,N,,9193,BAO_0000218,,1,,10116.0,2048.0,50597,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,CHEMBL622382,Lung
Intermediate,,A,16434,,,1,,,N,,9194,BAO_0000218,,1,,10116.0,2048.0,50597,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,CHEMBL622383,Lung
Intermediate,,A,6175,,,1,,,N,,9195,BAO_0000218,,1,,10116.0,945.0,50597,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,CHEMBL875332,Stomach
Intermediate,,A,6175,,,1,,,N,,9196,BAO_0000218,,1,,10116.0,945.0,50597,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,CHEMBL622384,Stomach
Intermediate,,A,6175,,,1,,,N,,9197,BAO_0000218,,1,,10116.0,945.0,50597,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,CHEMBL622385,Stomach
Intermediate,,A,6175,,,1,,,N,,9198,BAO_0000218,,1,,10116.0,945.0,50597,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,CHEMBL622386,Stomach
Intermediate,,A,10839,,,1,,,N,,9199,BAO_0000218,,1,,10116.0,,50597,The compound was tested for the plasma binding in rat,Rattus norvegicus,CHEMBL622387,
Intermediate,,A,16459,,,1,,,N,,9200,BAO_0000218,,1,,10116.0,,50597,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",Rattus norvegicus,CHEMBL622388,
Intermediate,,A,16459,,,1,,,N,,9201,BAO_0000218,,1,,10116.0,,50597,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",Rattus norvegicus,CHEMBL622389,
Intermediate,,A,16459,,,1,,,N,,9202,BAO_0000218,,1,,10116.0,,50597,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",Rattus norvegicus,CHEMBL622390,
Intermediate,,A,16459,,,1,,,N,,9203,BAO_0000218,,1,,10116.0,,50597,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),Rattus norvegicus,CHEMBL622391,
Intermediate,,A,16459,,,1,,,N,,9204,BAO_0000218,,1,,10116.0,,50597,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),Rattus norvegicus,CHEMBL622392,
Intermediate,,A,16459,,,1,,,N,,9205,BAO_0000218,,1,,10116.0,,50597,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),Rattus norvegicus,CHEMBL622393,
Intermediate,,A,3278,,,1,,,N,,9206,BAO_0000218,,1,,10116.0,,50597,Plasma level at 2 hr after administration of the compound,Rattus norvegicus,CHEMBL622394,
Intermediate,,A,3278,,,1,,,N,,9207,BAO_0000218,,1,,10116.0,,50597,plasma level at 2 hr after administration of the compound,Rattus norvegicus,CHEMBL622395,
Intermediate,,A,4684,,,1,,,N,,9208,BAO_0000218,,1,,10116.0,1977.0,50597,Stability in rat serum measured as % recovery at 1 min,Rattus norvegicus,CHEMBL622396,Serum
Intermediate,,A,4684,,,1,,,N,,9209,BAO_0000218,,1,,10116.0,1977.0,50597,Stability in rat serum measured as % recovery at 10 min,Rattus norvegicus,CHEMBL624894,Serum
Intermediate,,A,4684,,,1,,,N,,9210,BAO_0000218,,1,,10116.0,1977.0,50597,Stability in rat serum measured as % recovery at 10 mins,Rattus norvegicus,CHEMBL624895,Serum
Intermediate,,A,4684,,,1,,,N,,9211,BAO_0000218,,1,,10116.0,1977.0,50597,Stability in rat serum measured as % recovery at 2 hr,Rattus norvegicus,CHEMBL624058,Serum
Intermediate,,A,4684,,,1,,,N,,9212,BAO_0000218,,1,,10116.0,1977.0,50597,Stability in rat serum measured as % recovery at 3 min,Rattus norvegicus,CHEMBL624059,Serum
Intermediate,,A,4684,,,1,,,N,,9213,BAO_0000218,,1,,10116.0,1977.0,50597,Stability in rat serum measured as % recovery at 3 mins,Rattus norvegicus,CHEMBL624060,Serum
Intermediate,,A,4684,,,1,,,N,,9214,BAO_0000218,,1,,10116.0,1977.0,50597,Stability in rat serum measured as % recovery at 5 min,Rattus norvegicus,CHEMBL624061,Serum
Intermediate,,A,4684,,,1,,,N,,9215,BAO_0000218,,1,,10116.0,1977.0,50597,Stability in rat serum measured as % recovery at 5 mins,Rattus norvegicus,CHEMBL624062,Serum
Intermediate,,A,16456,In vivo,,1,,,N,,9216,BAO_0000218,,1,,10116.0,,50597,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Rattus norvegicus,CHEMBL624063,
Intermediate,,A,16456,In vivo,,1,,,N,,9217,BAO_0000218,,1,,10116.0,,50597,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Rattus norvegicus,CHEMBL624064,
Intermediate,,A,723,,,1,,,N,,9218,BAO_0000218,,1,,10116.0,1969.0,50597,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,Rattus norvegicus,CHEMBL624065,Plasma
Intermediate,,A,723,,,1,,,N,,9219,BAO_0000218,,1,,10116.0,1969.0,50597,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,Rattus norvegicus,CHEMBL624066,Plasma
Intermediate,,A,5160,In vivo,,1,,,N,,9220,BAO_0000218,,1,,10116.0,,50597,Half life tested in mature male rat at a dose of 30 mg/kg,Rattus norvegicus,CHEMBL877490,
Intermediate,,A,4709,In vivo,,1,,,N,,9221,BAO_0000218,,1,,10116.0,,50597,Half life after intravenous administration of 1 mg/kg in rat,Rattus norvegicus,CHEMBL874442,
Intermediate,,A,5633,In vivo,,1,,,N,,9222,BAO_0000218,,1,,10116.0,,50597,Half life period after administration (30 mg/kg) in rat,Rattus norvegicus,CHEMBL626890,
Intermediate,,A,5302,In vivo,,1,,,N,,9223,BAO_0000218,,1,,10116.0,,50597,Half life period in rat after 5 mg/Kg dose,Rattus norvegicus,CHEMBL626891,
Intermediate,,A,5302,In vivo,,1,,,N,,9224,BAO_0000218,,1,,10116.0,,50597,Half life period in rat after 5 mg/kg dose,Rattus norvegicus,CHEMBL626892,
Intermediate,,A,17791,,,1,,,N,,9225,BAO_0000218,,1,,10116.0,,50597,Half life period was determined,Rattus norvegicus,CHEMBL626893,
Intermediate,,A,17791,,,1,,,N,,9226,BAO_0000218,,1,,10116.0,,50597,Half life period was evaluated in rat,Rattus norvegicus,CHEMBL626894,
Intermediate,,A,17791,,,1,,,N,,9227,BAO_0000218,,1,,10116.0,,50597,Half life period was evaluated in rat; 0.5-1.0,Rattus norvegicus,CHEMBL626895,
Intermediate,,A,17791,,,1,,,N,,9228,BAO_0000218,,1,,10116.0,,50597,Half life period was evaluated in rat; 5.9-7.5,Rattus norvegicus,CHEMBL626896,
Intermediate,,A,14512,,,1,,,N,,9229,BAO_0000218,,1,,10116.0,1969.0,50597,Half-life in rat plasma,Rattus norvegicus,CHEMBL626897,Plasma
Intermediate,,A,6230,,,1,,,N,,9230,BAO_0000218,,1,,10116.0,,50597,Half-life time in rat was determined,Rattus norvegicus,CHEMBL626898,
Intermediate,,A,3364,In vivo,,1,,,N,,9231,BAO_0000218,,1,,10116.0,,50597,Terminal half-life after iv administration to rats,Rattus norvegicus,CHEMBL626899,
Intermediate,,A,6874,In vivo,,1,,,N,,9232,BAO_0000218,,1,,10116.0,,50597,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,Rattus norvegicus,CHEMBL626900,
Intermediate,,A,857,,,1,,,N,,9233,BAO_0000218,,1,,10116.0,,50597,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,Rattus norvegicus,CHEMBL626901,
Intermediate,,A,858,In vivo,,1,,,N,,9234,BAO_0000218,,1,,10116.0,,50597,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),Rattus norvegicus,CHEMBL626902,
Intermediate,,A,858,In vivo,,1,,,N,,9235,BAO_0000218,,1,,10116.0,,50597,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),Rattus norvegicus,CHEMBL626903,
Intermediate,,A,5355,In vivo,,1,,,N,,9236,BAO_0000218,,1,,10116.0,,50597,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,Rattus norvegicus,CHEMBL874443,
Intermediate,,A,5355,In vivo,,1,,,N,,9237,BAO_0000218,,1,,10116.0,,50597,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,Rattus norvegicus,CHEMBL626904,
Intermediate,,A,6305,,,1,,,N,,9238,BAO_0000218,,1,,10116.0,,50597,Half life in rats,Rattus norvegicus,CHEMBL626905,
Intermediate,,A,13501,In vivo,,1,,,N,,9239,BAO_0000218,,1,,10116.0,1969.0,50597,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,Rattus norvegicus,CHEMBL873830,Plasma
Intermediate,,A,17594,In vivo,,1,,,N,,9240,BAO_0000218,,1,,10116.0,,50597,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,Rattus norvegicus,CHEMBL626906,
Intermediate,,A,4186,In vivo,,1,,,N,,9241,BAO_0000218,,1,,10116.0,1969.0,50597,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Rattus norvegicus,CHEMBL631076,Plasma
Intermediate,,A,2932,,,1,,,N,,9242,BAO_0000218,,1,,10116.0,1969.0,50597,Biological half-life was measured in plasma of rats,Rattus norvegicus,CHEMBL631077,Plasma
Intermediate,,A,17065,In vivo,,1,,,N,,9243,BAO_0000218,,1,,10116.0,,50597,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,Rattus norvegicus,CHEMBL631078,
Intermediate,,A,15765,In vivo,,1,,,N,,9244,BAO_0000218,,1,,10116.0,,50597,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,Rattus norvegicus,CHEMBL631079,
Intermediate,,A,2713,In vivo,,1,,,N,,9245,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,Rattus norvegicus,CHEMBL631080,
Intermediate,,A,2661,In vivo,,1,,,N,,9246,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,Rattus norvegicus,CHEMBL631081,
Intermediate,,A,2661,In vivo,,1,,,N,,9247,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,Rattus norvegicus,CHEMBL631239,
Intermediate,,A,740,,,1,,,N,,9248,BAO_0000218,,1,,10116.0,1969.0,50597,Compound was evaluated for plasma half life in rat,Rattus norvegicus,CHEMBL631240,Plasma
Intermediate,,A,6597,,,1,,,N,,9249,BAO_0000218,,1,,10116.0,1969.0,50597,AUC value at a dose of 5 mg/kg (p.o.) in rats,Rattus norvegicus,CHEMBL631241,Plasma
Intermediate,,A,2959,,,1,,,N,,9250,BAO_0000218,,1,,10116.0,1969.0,50597,AUC value after administration of 20 mg/Kg oral dose in rat,Rattus norvegicus,CHEMBL631242,Plasma
Intermediate,,A,17594,,,1,,,N,,9251,BAO_0000218,,1,,10116.0,1969.0,50597,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,Rattus norvegicus,CHEMBL631243,Plasma
Intermediate,,A,17596,,,1,,,N,,9252,BAO_0000218,,1,,10116.0,1969.0,50597,AUC0-96 after administration at 50 mg/kg,Rattus norvegicus,CHEMBL874444,Plasma
Intermediate,,A,17594,,,1,,,N,,9253,BAO_0000218,,1,,10116.0,1969.0,50597,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,Rattus norvegicus,CHEMBL631244,Plasma
Intermediate,,A,3293,,,1,,,N,,9254,BAO_0000218,,1,,10116.0,,50597,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",Rattus norvegicus,CHEMBL631245,
Intermediate,,A,6757,,,1,,,N,,9255,BAO_0000218,,1,,10116.0,,50597,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,Rattus norvegicus,CHEMBL627162,
Intermediate,,A,6757,,,1,,,N,,9256,BAO_0000218,,1,,10116.0,,50597,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,Rattus norvegicus,CHEMBL627163,
Intermediate,,A,6757,,,1,,,N,,9257,BAO_0000218,,1,,10116.0,,50597,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,Rattus norvegicus,CHEMBL627164,
Intermediate,,A,5979,,,1,,,N,,9258,BAO_0000218,,1,,10116.0,2113.0,50597,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,Rattus norvegicus,CHEMBL627165,Kidney
Intermediate,,A,5979,,,1,,,N,,9259,BAO_0000218,,1,,10116.0,,50597,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,Rattus norvegicus,CHEMBL627166,
Intermediate,,A,5979,,,1,,,N,,9260,BAO_0000218,,1,,10116.0,,50597,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,Rattus norvegicus,CHEMBL627167,
Intermediate,,A,4026,,,1,,,N,,9261,BAO_0000218,,1,,10116.0,,50597,Area under curve (AUC) at a dose of 30 mg/kg in rats,Rattus norvegicus,CHEMBL627822,
Intermediate,,A,5355,,,1,,,N,,9262,BAO_0000218,,1,,10116.0,,50597,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,Rattus norvegicus,CHEMBL627823,
Intermediate,,A,5355,,,1,,,N,,9263,BAO_0000218,,1,,10116.0,,50597,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,Rattus norvegicus,CHEMBL627824,
Intermediate,,A,5355,,,1,,,N,,9264,BAO_0000218,,1,,10116.0,,50597,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,Rattus norvegicus,CHEMBL627825,
Intermediate,,A,5633,,,1,,,N,,9265,BAO_0000218,,1,,10116.0,,50597,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,Rattus norvegicus,CHEMBL627826,
Intermediate,,A,1716,,,1,,,N,,9266,BAO_0000218,,1,,10116.0,,50597,Area under curve (Pharmacokinetic property) was determined,Rattus norvegicus,CHEMBL627827,
Intermediate,,A,1716,,,1,,,N,,9267,BAO_0000218,,1,,10116.0,,50597,Area under curve (Pharmacokinetic property) of the compound; Not determined,Rattus norvegicus,CHEMBL627828,
Intermediate,,A,4689,,,1,,,N,,9268,BAO_0000218,,1,,10116.0,,50597,Area under curve after intravenous administration (1 mg/kg) in rat,Rattus norvegicus,CHEMBL627829,
Intermediate,,A,4527,,,1,,,N,,9269,BAO_0000218,,1,,10116.0,,50597,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,Rattus norvegicus,CHEMBL627830,
Intermediate,,A,4527,,,1,,,N,,9270,BAO_0000218,,1,,10116.0,,50597,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,Rattus norvegicus,CHEMBL627831,
Intermediate,,A,15662,,,1,,,N,,9271,BAO_0000218,,1,,10116.0,,50597,Area under curve in male SD rats was observed after oral administration in rat,Rattus norvegicus,CHEMBL627832,
Intermediate,,A,4413,,,1,,,N,,9272,BAO_0000218,,1,,10116.0,,50597,Area under curve of compound after iv administration of 20 mg/kg dose in rat,Rattus norvegicus,CHEMBL627833,
Expert,,A,3598,,,1,,,N,,9273,BAO_0000218,,1,,10116.0,,50597,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,CHEMBL627834,
Expert,,A,3598,,,1,,,N,,9274,BAO_0000218,,1,,10116.0,,50597,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,CHEMBL628004,
Intermediate,,A,5964,,,1,,,N,,9275,BAO_0000218,,1,,10116.0,,50597,Area under curve at 5 mg/kg po was determined in rat,Rattus norvegicus,CHEMBL628005,
Intermediate,,A,4689,,,1,,,N,,9276,BAO_0000218,,1,,10116.0,,50597,Area under curve in Rat at a oral dose of 5 mg/kg,Rattus norvegicus,CHEMBL628006,
Intermediate,,A,4186,,,1,,,N,,9277,BAO_0000218,,1,,10116.0,,50597,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Rattus norvegicus,CHEMBL628007,
Intermediate,,A,5510,,,1,,,N,,9278,BAO_0000218,,1,,10116.0,,50597,Area under curve was determined,Rattus norvegicus,CHEMBL625676,
Intermediate,,A,17858,,,1,,,N,,9279,BAO_0000218,,1,,10116.0,,50597,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,Rattus norvegicus,CHEMBL631309,
Intermediate,,A,17804,,,1,,,N,,9280,BAO_0000218,,1,,10116.0,,50597,Area under curve after intravenous administration at 3 mg/kg,Rattus norvegicus,CHEMBL631310,
Intermediate,,A,6106,,,1,,,N,,9281,BAO_0000218,,1,,10116.0,,50597,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,Rattus norvegicus,CHEMBL631311,
Intermediate,,A,5964,,,1,,,N,,9282,BAO_0000218,,1,,10116.0,,50597,Area under curve at 4 hr in rat,Rattus norvegicus,CHEMBL631312,
Intermediate,,A,4026,,,1,,,N,,9283,BAO_0000218,,1,,10116.0,,50597,Area under curve at a dose of 30 mg/kg,Rattus norvegicus,CHEMBL631313,
Intermediate,,A,4756,,,1,,,N,,9284,BAO_0000218,,1,,10116.0,,50597,Area under curve at the dose of 2 mg/Kg administered perorally in rats,Rattus norvegicus,CHEMBL631314,
Intermediate,,A,4756,,,1,,,N,,9285,BAO_0000218,,1,,10116.0,,50597,Area under curve at the dose of 5 mg/Kg administered perorally in rats,Rattus norvegicus,CHEMBL631315,
Intermediate,,A,5862,,,1,,,N,,9286,BAO_0000218,,1,,10116.0,,50597,Area under curve for a 2-mpk po dose in SD rats,Rattus norvegicus,CHEMBL631316,
Intermediate,,A,5862,,,1,,,N,,9287,BAO_0000218,,1,,10116.0,,50597,Area under curve in SD rats,Rattus norvegicus,CHEMBL631317,
Intermediate,,A,6644,,,1,,,N,,9288,BAO_0000218,,1,,10116.0,,50597,Area under curve in rat after oral administration at 13 mg/kg dose,Rattus norvegicus,CHEMBL874471,
Intermediate,,A,5871,,,1,,,N,,9289,BAO_0000218,,1,,10116.0,,50597,Area under curve in rat by po administration at 0-24 hr,Rattus norvegicus,CHEMBL631318,
Intermediate,,A,5919,,,1,,,N,,9290,BAO_0000218,,1,,10116.0,1969.0,50597,Area under curve in rat plasma,Rattus norvegicus,CHEMBL631319,Plasma
Intermediate,,A,5939,,,1,,,N,,9291,BAO_0000218,,1,,10116.0,,50597,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,Rattus norvegicus,CHEMBL631320,
Intermediate,,A,5939,,,1,,,N,,9292,BAO_0000218,,1,,10116.0,,50597,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,Rattus norvegicus,CHEMBL631321,
Intermediate,,A,10,,,1,,,N,,9293,BAO_0000218,,1,,10116.0,,50597,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,Rattus norvegicus,CHEMBL631322,
Intermediate,,A,11149,,,1,,,N,,9294,BAO_0000218,,1,,10116.0,,50597,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,Rattus norvegicus,CHEMBL631323,
Intermediate,,A,5302,,,1,,,N,,9295,BAO_0000218,,1,,10116.0,,50597,Area under curve value in rat at a dose of 5 mg/kg,Rattus norvegicus,CHEMBL631324,
Intermediate,,A,17796,,,1,,,N,,9296,BAO_0000218,,1,,10116.0,,50597,Area under curve was determined after oral administration in rats,Rattus norvegicus,CHEMBL631325,
Intermediate,,A,4890,,,1,,,N,,9297,BAO_0000218,,1,,10116.0,,50597,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,CHEMBL631326,
Intermediate,,A,6011,,,1,,,N,,9298,BAO_0000218,,1,,10116.0,,50597,Area under curve was determined after peroral administration in rat,Rattus norvegicus,CHEMBL631327,
Intermediate,,A,5375,,,1,,,N,,9299,BAO_0000218,,1,,10116.0,,50597,Area under curve was determined at a dose 30 mpk administered orally.,Rattus norvegicus,CHEMBL631328,
Intermediate,,A,17764,,,1,,,N,,9300,BAO_0000218,,1,,10116.0,,50597,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,Rattus norvegicus,CHEMBL631329,
Intermediate,,A,4368,,,1,,,N,,9301,BAO_0000218,,1,,10116.0,,50597,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,Rattus norvegicus,CHEMBL627217,
Intermediate,,A,5610,,,1,,,N,,9302,BAO_0000218,,1,,10116.0,,50597,Area under curve was determined in male rat,Rattus norvegicus,CHEMBL626352,
Intermediate,,A,5833,,,1,,,N,,9303,BAO_0000218,,1,,10116.0,,50597,Area under curve was determined in rat after PO administration,Rattus norvegicus,CHEMBL626353,
Intermediate,,A,4257,,,1,,,N,,9304,BAO_0000218,,1,,10116.0,,50597,Area under curve was determined in rat after a 3 mg/kg of oral dose,Rattus norvegicus,CHEMBL626354,
Intermediate,,A,5937,,,1,,,N,,9305,BAO_0000218,,1,,10116.0,,50597,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,Rattus norvegicus,CHEMBL626355,
Intermediate,,A,5932,,,1,,,N,,9306,BAO_0000218,,1,,10116.0,,50597,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,Rattus norvegicus,CHEMBL626356,
Intermediate,,A,5932,,,1,,,N,,9307,BAO_0000218,,1,,10116.0,,50597,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,Rattus norvegicus,CHEMBL626357,
Intermediate,,A,17411,,,1,,,N,,9308,BAO_0000218,,1,,10116.0,,50597,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,CHEMBL626358,
Intermediate,,A,17411,,,1,,,N,,9309,BAO_0000218,,1,,10116.0,,50597,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,CHEMBL626359,
Intermediate,,A,17771,,,1,,,N,,9310,BAO_0000218,,1,,10116.0,1969.0,50597,Peak plasma concentration in rat at a dose of 3 mg/kg,Rattus norvegicus,CHEMBL626360,Plasma
Intermediate,,A,1628,,,1,,,N,,9311,BAO_0000218,,1,,10116.0,,50597,Plasma concentration at 2 hr in rats was evaluated.,Rattus norvegicus,CHEMBL626361,
Intermediate,,A,1628,,,1,,,N,,9312,BAO_0000218,,1,,10116.0,,50597,Plasma concentration at 2 hr in rats was evaluated; Not available,Rattus norvegicus,CHEMBL626362,
Intermediate,,A,17411,,,1,,,N,,9313,BAO_0000218,,1,,10116.0,,50597,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,CHEMBL626363,
Intermediate,,A,4910,,,1,,,N,,9314,BAO_0000218,,1,,10116.0,,50597,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,CHEMBL626970,
Intermediate,,A,4910,,,1,,,N,,9315,BAO_0000218,,1,,10116.0,,50597,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,CHEMBL626971,
Intermediate,,A,4910,,,1,,,N,,9316,BAO_0000218,,1,,10116.0,1969.0,50597,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,CHEMBL626972,Plasma
Intermediate,,A,4910,,,1,,,N,,9317,BAO_0000218,,1,,10116.0,1969.0,50597,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,CHEMBL626973,Plasma
Intermediate,,A,4910,,,1,,,N,,9318,BAO_0000218,,1,,10116.0,1969.0,50597,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,CHEMBL626974,Plasma
Intermediate,,A,4910,,,1,,,N,,9319,BAO_0000218,,1,,10116.0,1969.0,50597,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,CHEMBL874592,Plasma
Intermediate,,A,5510,,,1,,,N,,9320,BAO_0000218,,1,,10116.0,,50597,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,Rattus norvegicus,CHEMBL626975,
Intermediate,,A,5510,,,1,,,N,,9321,BAO_0000218,,1,,10116.0,,50597,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,Rattus norvegicus,CHEMBL626976,
Intermediate,,A,5510,,,1,,,N,,9322,BAO_0000218,,1,,10116.0,,50597,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,Rattus norvegicus,CHEMBL626977,
Intermediate,,A,5510,,,1,,,N,,9323,BAO_0000218,,1,,10116.0,,50597,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,Rattus norvegicus,CHEMBL626978,
Intermediate,,A,16427,,,1,,,N,,9324,BAO_0000218,,1,,10116.0,,50597,PK study was carried to determine the relative absorption ranking in rat.,Rattus norvegicus,CHEMBL626979,
Intermediate,,A,4689,In vivo,,1,,,N,,9325,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,Rattus norvegicus,CHEMBL626980,Plasma
Intermediate,,A,11450,,,1,,,N,,9326,BAO_0000218,,1,,10116.0,178.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",Rattus norvegicus,CHEMBL626981,Blood
Intermediate,,A,11450,,,1,,,N,,9327,BAO_0000218,,1,,10116.0,178.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",Rattus norvegicus,CHEMBL626982,Blood
Intermediate,,A,11450,,,1,,,N,,9328,BAO_0000218,,1,,10116.0,178.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",Rattus norvegicus,CHEMBL626983,Blood
Intermediate,,A,11450,,,1,,,N,,9329,BAO_0000218,,1,,10116.0,178.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",Rattus norvegicus,CHEMBL622522,Blood
Intermediate,,A,11450,,,1,,,N,,9330,BAO_0000218,,1,,10116.0,178.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",Rattus norvegicus,CHEMBL622523,Blood
Intermediate,,A,11450,,,1,,,N,,9331,BAO_0000218,,1,,10116.0,178.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",Rattus norvegicus,CHEMBL622524,Blood
Intermediate,,A,11450,,,1,,,N,,9332,BAO_0000218,,1,,10116.0,955.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",Rattus norvegicus,CHEMBL622525,Brain
Intermediate,,A,11450,,,1,,,N,,9333,BAO_0000218,,1,,10116.0,955.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",Rattus norvegicus,CHEMBL622526,Brain
Intermediate,,A,11450,,,1,,,N,,9334,BAO_0000218,,1,,10116.0,955.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",Rattus norvegicus,CHEMBL619849,Brain
Intermediate,,A,11450,,,1,,,N,,9335,BAO_0000218,,1,,10116.0,955.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",Rattus norvegicus,CHEMBL619850,Brain
Intermediate,,A,11450,,,1,,,N,,9336,BAO_0000218,,1,,10116.0,955.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",Rattus norvegicus,CHEMBL623864,Brain
Intermediate,,A,11450,,,1,,,N,,9337,BAO_0000218,,1,,10116.0,955.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",Rattus norvegicus,CHEMBL623865,Brain
Intermediate,,A,11450,,,1,,,N,,9338,BAO_0000218,,1,,10116.0,948.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",Rattus norvegicus,CHEMBL623866,Heart
Intermediate,,A,11450,,,1,,,N,,9339,BAO_0000218,,1,,10116.0,948.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",Rattus norvegicus,CHEMBL623867,Heart
Intermediate,,A,11450,,,1,,,N,,9340,BAO_0000218,,1,,10116.0,948.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",Rattus norvegicus,CHEMBL877615,Heart
Intermediate,,A,11450,,,1,,,N,,9341,BAO_0000218,,1,,10116.0,948.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",Rattus norvegicus,CHEMBL623868,Heart
Intermediate,,A,11450,,,1,,,N,,9342,BAO_0000218,,1,,10116.0,948.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",Rattus norvegicus,CHEMBL623869,Heart
Intermediate,,A,11450,,,1,,,N,,9343,BAO_0000218,,1,,10116.0,948.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",Rattus norvegicus,CHEMBL623870,Heart
Intermediate,,A,16434,,,1,,,N,,9344,BAO_0000218,,1,,10116.0,2048.0,50597,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,CHEMBL623871,Lung
Intermediate,,A,16434,,,1,,,N,,9345,BAO_0000218,,1,,10116.0,2048.0,50597,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,CHEMBL623872,Lung
Intermediate,,A,16435,,,1,,,N,,9346,BAO_0000218,,1,,10116.0,2048.0,50597,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,CHEMBL622129,Lung
Intermediate,,A,16435,,,1,,,N,,9347,BAO_0000218,,1,,10116.0,2048.0,50597,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,CHEMBL622130,Lung
Intermediate,,A,16435,,,1,,,N,,9348,BAO_0000218,,1,,10116.0,2048.0,50597,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,CHEMBL622131,Lung
Intermediate,,A,16435,,,1,,,N,,9349,BAO_0000218,,1,,10116.0,2048.0,50597,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,CHEMBL622132,Lung
Intermediate,,A,16435,,,1,,,N,,9350,BAO_0000218,,1,,10116.0,2048.0,50597,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,CHEMBL622133,Lung
Intermediate,,A,16435,,,1,,,N,,9351,BAO_0000218,,1,,10116.0,2048.0,50597,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,CHEMBL622134,Lung
Intermediate,,A,16435,,,1,,,N,,9352,BAO_0000218,,1,,10116.0,2048.0,50597,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,CHEMBL622135,Lung
Intermediate,,A,16435,,,1,,,N,,9353,BAO_0000218,,1,,10116.0,2048.0,50597,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,CHEMBL622136,Lung
Intermediate,,A,16434,,,1,,,N,,9354,BAO_0000218,,1,,10116.0,2385.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,CHEMBL622137,Muscle tissue
Intermediate,,A,16434,,,1,,,N,,9355,BAO_0000218,,1,,10116.0,2385.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,CHEMBL622138,Muscle tissue
Intermediate,,A,16434,,,1,,,N,,9356,BAO_0000218,,1,,10116.0,2385.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,CHEMBL623017,Muscle tissue
Intermediate,,A,16434,,,1,,,N,,9357,BAO_0000218,,1,,10116.0,2385.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,CHEMBL623018,Muscle tissue
Intermediate,,A,16434,,,1,,,N,,9358,BAO_0000218,,1,,10116.0,2385.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,CHEMBL623019,Muscle tissue
Intermediate,,A,16434,,,1,,,N,,9359,BAO_0000218,,1,,10116.0,2385.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,CHEMBL623020,Muscle tissue
Intermediate,,A,16434,,,1,,,N,,9360,BAO_0000218,,1,,10116.0,2385.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,CHEMBL623021,Muscle tissue
Intermediate,,A,16434,,,1,,,N,,9361,BAO_0000218,,1,,10116.0,2385.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,CHEMBL623022,Muscle tissue
Intermediate,,A,16435,,,1,,,N,,9362,BAO_0000218,,1,,10116.0,2385.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,CHEMBL623023,Muscle tissue
Intermediate,,A,16435,,,1,,,N,,9363,BAO_0000218,,1,,10116.0,2385.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,CHEMBL623024,Muscle tissue
Intermediate,,A,16435,,,1,,,N,,9364,BAO_0000218,,1,,10116.0,2385.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,CHEMBL623025,Muscle tissue
Intermediate,,A,16435,,,1,,,N,,9365,BAO_0000218,,1,,10116.0,2385.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,CHEMBL620545,Muscle tissue
Intermediate,,A,16435,,,1,,,N,,9366,BAO_0000218,,1,,10116.0,2385.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,CHEMBL620546,Muscle tissue
Intermediate,,A,16435,,,1,,,N,,9367,BAO_0000218,,1,,10116.0,2385.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,CHEMBL620547,Muscle tissue
Intermediate,,A,16435,,,1,,,N,,9368,BAO_0000218,,1,,10116.0,2385.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,CHEMBL620548,Muscle tissue
Intermediate,,A,16435,,,1,,,N,,9369,BAO_0000218,,1,,10116.0,2385.0,50597,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,CHEMBL620549,Muscle tissue
Intermediate,,A,16434,,,1,,,N,,9370,BAO_0000218,,1,,10116.0,2385.0,50597,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,CHEMBL620550,Muscle tissue
Intermediate,,A,16434,,,1,,,N,,9371,BAO_0000218,,1,,10116.0,2385.0,50597,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,CHEMBL620551,Muscle tissue
Intermediate,,A,16434,,,1,,,N,,9372,BAO_0000218,,1,,10116.0,2385.0,50597,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,CHEMBL620552,Muscle tissue
Intermediate,,A,16435,,,1,,,N,,9373,BAO_0000218,,1,,10116.0,2385.0,50597,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,CHEMBL620553,Muscle tissue
Intermediate,,A,16435,,,1,,,N,,9374,BAO_0000218,,1,,10116.0,2385.0,50597,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,CHEMBL620554,Muscle tissue
Intermediate,,A,16435,,,1,,,N,,9375,BAO_0000218,,1,,10116.0,2385.0,50597,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,CHEMBL875845,Muscle tissue
Intermediate,,A,16435,,,1,,,N,,9376,BAO_0000218,,1,,10116.0,2385.0,50597,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,CHEMBL620555,Muscle tissue
Intermediate,,A,16435,,,1,,,N,,9377,BAO_0000218,,1,,10116.0,2385.0,50597,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,CHEMBL620556,Muscle tissue
Intermediate,,A,16435,,,1,,,N,,9378,BAO_0000218,,1,,10116.0,2385.0,50597,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,CHEMBL620557,Muscle tissue
Intermediate,,A,16434,,,1,,,N,,9379,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,CHEMBL620558,
Intermediate,,A,16434,,,1,,,N,,9380,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,CHEMBL620559,
Intermediate,,A,16434,,,1,,,N,,9381,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,CHEMBL622939,
Intermediate,,A,16434,,,1,,,N,,9382,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,CHEMBL622940,
Intermediate,,A,16434,,,1,,,N,,9383,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,CHEMBL622941,
Intermediate,,A,16434,,,1,,,N,,9384,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,CHEMBL622942,
Intermediate,,A,16434,,,1,,,N,,9385,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,CHEMBL622943,
Intermediate,,A,16434,,,1,,,N,,9386,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,CHEMBL622944,
Intermediate,,A,16435,,,1,,,N,,9387,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,CHEMBL622945,
Intermediate,,A,16435,,,1,,,N,,9388,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,CHEMBL622946,
Intermediate,,A,3341,,,1,,,N,,9389,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for terminal half life in rat,Rattus norvegicus,CHEMBL622947,
Intermediate,,A,3634,In vivo,,1,,,N,,9390,BAO_0000218,,1,,10116.0,1969.0,50597,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,Rattus norvegicus,CHEMBL622948,Plasma
Intermediate,,A,3634,In vivo,,1,,,N,,9391,BAO_0000218,,1,,10116.0,1969.0,50597,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,Rattus norvegicus,CHEMBL622949,Plasma
Intermediate,,A,4839,,,1,,,N,,9392,BAO_0000218,,1,,10116.0,,50597,Compound was tested for its half life in rat,Rattus norvegicus,CHEMBL622950,
Intermediate,,A,5005,In vivo,,1,,,U,,9393,BAO_0000218,,0,,9544.0,1969.0,22224,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,Macaca mulatta,CHEMBL622951,Plasma
Intermediate,,A,5005,,,1,,,U,,9394,BAO_0000366,,0,,10116.0,1969.0,22224,Compound was tested for its plasma half life in Sprague Dawley rats,Rattus norvegicus,CHEMBL622952,Plasma
Intermediate,,A,5005,,,1,,,U,,9395,BAO_0000366,,0,,10116.0,1969.0,22224,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,Rattus norvegicus,CHEMBL622953,Plasma
Intermediate,,A,1094,,,1,,,N,,9396,BAO_0000218,,1,,10116.0,1969.0,50597,Compound was tested for plasma half-life period in rat,Rattus norvegicus,CHEMBL873818,Plasma
Intermediate,,A,5031,In vivo,,1,,,N,,9397,BAO_0000218,,1,,10116.0,,50597,Elimination half life after i.v. administration of compound in rats,Rattus norvegicus,CHEMBL622954,
Intermediate,,A,6518,In vivo,,1,,,N,,9398,BAO_0000218,,1,,10116.0,,50597,Elimination half-life after IV dosing at 0.5 mg/kg in rat,Rattus norvegicus,CHEMBL622955,
Intermediate,,A,6518,In vivo,,1,,,N,,9399,BAO_0000218,,1,,10116.0,,50597,Elimination half-life after IV dosing at 1 mg/kg in rat,Rattus norvegicus,CHEMBL875229,
Intermediate,,A,6518,In vivo,,1,,,N,,9400,BAO_0000218,,1,,10116.0,,50597,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,Rattus norvegicus,CHEMBL622956,
Intermediate,,A,6518,In vivo,,1,,,N,,9401,BAO_0000218,,1,,10116.0,,50597,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,Rattus norvegicus,CHEMBL622957,
Intermediate,,A,5408,In vivo,,1,,,N,,9402,BAO_0000218,,1,,10116.0,955.0,50597,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,Rattus norvegicus,CHEMBL622958,Brain
Intermediate,,A,5408,In vivo,,1,,,N,,9403,BAO_0000218,,1,,10116.0,1969.0,50597,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,Rattus norvegicus,CHEMBL622959,Plasma
Intermediate,,A,5408,In vivo,,1,,,N,,9404,BAO_0000218,,1,,10116.0,955.0,50597,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,Rattus norvegicus,CHEMBL622960,Brain
Intermediate,,A,5408,In vivo,,1,,,N,,9405,BAO_0000218,,1,,10116.0,1969.0,50597,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,Rattus norvegicus,CHEMBL622961,Plasma
Intermediate,,A,4687,In vivo,,1,,,N,,9406,BAO_0000218,,1,,10116.0,,50597,Evaluated for the half life in rat (in vivo),Rattus norvegicus,CHEMBL622962,
Intermediate,,A,6640,,,1,,,N,,9407,BAO_0000218,,1,,10116.0,,50597,Hafl life in rat,Rattus norvegicus,CHEMBL622963,
Intermediate,,A,6640,,,1,,,N,,9408,BAO_0000218,,1,,10116.0,,50597,Hafl life rat,Rattus norvegicus,CHEMBL622964,
Intermediate,,A,6641,,,1,,,N,,9409,BAO_0000218,,1,,10116.0,,50597,Hafl life rat,Rattus norvegicus,CHEMBL622965,
Intermediate,,A,6640,,,1,,,N,,9410,BAO_0000218,,1,,10116.0,,50597,Hafl life rat; Not determined,Rattus norvegicus,CHEMBL622966,
Intermediate,,A,6641,,,1,,,N,,9411,BAO_0000218,,1,,10116.0,,50597,Hafl life rat; Not determined,Rattus norvegicus,CHEMBL622967,
Intermediate,,A,17411,In vivo,,1,,,N,,9412,BAO_0000218,,1,,10116.0,2113.0,50597,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,CHEMBL622968,Kidney
Intermediate,,A,17411,In vivo,,1,,,N,,9413,BAO_0000218,,1,,10116.0,2107.0,50597,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,CHEMBL622969,Liver
Intermediate,,A,17411,In vivo,,1,,,N,,9414,BAO_0000218,,1,,10116.0,2048.0,50597,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,CHEMBL875327,Lung
Intermediate,,A,6570,In vivo,,1,,,N,,9415,BAO_0000218,,1,,10116.0,,50597,Half life in rat after 1 mg/kg i.v. administration,Rattus norvegicus,CHEMBL628638,
Intermediate,,A,6570,In vivo,,1,,,N,,9416,BAO_0000218,,1,,10116.0,,50597,Half life in rat after 2 mg/kg peroral administration,Rattus norvegicus,CHEMBL628639,
Intermediate,,A,17411,In vivo,,1,,,N,,9417,BAO_0000218,,1,,10116.0,,50597,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,CHEMBL625840,
Intermediate,,A,4722,In vivo,,1,,,N,,9418,BAO_0000218,,1,,10116.0,,50597,Half life of 10 mg/kg oral dose determined in rats,Rattus norvegicus,CHEMBL625841,
Intermediate,,A,5978,In vivo,,1,,,N,,9419,BAO_0000218,,1,,10116.0,,50597,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,CHEMBL625842,
Intermediate,,A,5978,In vivo,,1,,,N,,9420,BAO_0000218,,1,,10116.0,,50597,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,CHEMBL625843,
Intermediate,,A,5978,In vivo,,1,,,N,,9421,BAO_0000218,,1,,10116.0,,50597,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,CHEMBL625844,
Intermediate,,A,5978,In vivo,,1,,,N,,9422,BAO_0000218,,1,,10116.0,,50597,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,CHEMBL873822,
Intermediate,,A,5978,In vivo,,1,,,N,,9423,BAO_0000218,,1,,10116.0,,50597,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,CHEMBL625845,
Intermediate,,A,5978,In vivo,,1,,,N,,9424,BAO_0000218,,1,,10116.0,,50597,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,CHEMBL627059,
Intermediate,,A,5978,In vivo,,1,,,N,,9425,BAO_0000218,,1,,10116.0,,50597,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,CHEMBL627060,
Intermediate,,A,5978,In vivo,,1,,,N,,9426,BAO_0000218,,1,,10116.0,,50597,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,CHEMBL627061,
Intermediate,,A,4762,In vivo,,1,,,N,,9427,BAO_0000218,,1,,10116.0,,50597,Half life of compound at 5 mg/kg after po administration was determined in rat,Rattus norvegicus,CHEMBL627709,
Intermediate,,A,5327,In vivo,,1,,,N,,9428,BAO_0000218,,1,,10116.0,,50597,Half life of compound determined after intravenous administration to rat,Rattus norvegicus,CHEMBL627710,
Intermediate,,A,4847,,,1,,,N,,9429,BAO_0000218,,1,,10116.0,,50597,Half life of compound was determined in rat,Rattus norvegicus,CHEMBL627711,
Intermediate,,A,17720,In vivo,,1,,,N,,9430,BAO_0000218,,1,,10116.0,1969.0,50597,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,CHEMBL627712,Plasma
Intermediate,,A,4723,In vivo,,1,,,N,,9431,BAO_0000218,,1,,10116.0,,50597,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,CHEMBL627713,
Intermediate,,A,4723,In vivo,,1,,,N,,9432,BAO_0000218,,1,,10116.0,,50597,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,CHEMBL627714,
Intermediate,,A,4256,In vivo,,1,,,U,,9433,BAO_0000218,,0,,9541.0,,22224,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,Macaca fascicularis,CHEMBL627889,
Intermediate,,A,4256,In vivo,,1,,,U,,9434,BAO_0000218,,0,,10116.0,,22224,Half life determined in rat by intravenous administration,Rattus norvegicus,CHEMBL627890,
Intermediate,,A,4722,In vivo,,1,,,N,,9435,BAO_0000218,,1,,10116.0,,50597,Half life determined in rats after iv administration,Rattus norvegicus,CHEMBL627891,
Intermediate,,A,6535,In vivo,,1,,,N,,9436,BAO_0000218,,1,,10116.0,1969.0,50597,Half life in rat plasma after administration of 2 mg/kg iv,Rattus norvegicus,CHEMBL627892,Plasma
Intermediate,,A,6535,In vivo,,1,,,N,,9437,BAO_0000218,,1,,10116.0,1969.0,50597,Half life in rat plasma after administration of 2 mg/kg iv,Rattus norvegicus,CHEMBL627893,Plasma
Intermediate,,A,1435,,,1,,,N,,9438,BAO_0000218,,1,,10116.0,1969.0,50597,Half life in rat plasma was determined,Rattus norvegicus,CHEMBL627894,Plasma
Intermediate,,A,1435,,,1,,,N,,9439,BAO_0000218,,1,,10116.0,1969.0,50597,Half life in rat plasma was determined; NA means not applicable,Rattus norvegicus,CHEMBL627895,Plasma
Intermediate,,A,5206,,,1,,,N,,9440,BAO_0000218,,1,,10116.0,,50597,Half life in rat was tested,Rattus norvegicus,CHEMBL627896,
Intermediate,,A,6080,,,1,,,N,,9441,BAO_0000218,,1,,10116.0,1969.0,50597,Half life measured in rat plasma,Rattus norvegicus,CHEMBL627897,Plasma
Intermediate,,A,4449,,,1,,,N,,9442,BAO_0000218,,1,,10116.0,,50597,Half life recorded in rats,Rattus norvegicus,CHEMBL627898,
Intermediate,,A,6057,,,1,,,N,,9443,BAO_0000218,,1,,10116.0,,50597,Half life was calculated,Rattus norvegicus,CHEMBL627899,
Intermediate,,A,6057,,,1,,,N,,9444,BAO_0000218,,1,,10116.0,,50597,Half life was calculated in rat,Rattus norvegicus,CHEMBL873823,
Intermediate,,A,3747,,,1,,,N,,9445,BAO_0000218,,1,,10116.0,,50597,Half life was determined,Rattus norvegicus,CHEMBL627900,
Intermediate,,A,17858,In vivo,,1,,,N,,9446,BAO_0000218,,1,,10116.0,,50597,Half life after 10 mg/kg oral administration in rat,Rattus norvegicus,CHEMBL627901,
Intermediate,,A,16365,In vivo,,1,,,N,,9447,BAO_0000218,,1,,10116.0,,50597,Half life after administering orally a dose of 10 mg/kg to a fasting rat,Rattus norvegicus,CHEMBL627902,
Intermediate,,A,16365,In vivo,,1,,,N,,9448,BAO_0000218,,1,,10116.0,,50597,Half life after administering orally a dose of 30 mg/kg,Rattus norvegicus,CHEMBL627903,
Intermediate,,A,5031,,,1,,,N,,9449,BAO_0000218,,1,,10116.0,,50597,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,Rattus norvegicus,CHEMBL627904,
Intermediate,,A,4722,,,1,,,N,,9450,BAO_0000218,,1,,10116.0,,50597,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,Rattus norvegicus,CHEMBL627905,
Intermediate,,A,6078,,,1,,,N,,9451,BAO_0000218,,1,,10116.0,,50597,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,Rattus norvegicus,CHEMBL627906,
Intermediate,,A,6078,,,1,,,N,,9452,BAO_0000218,,1,,10116.0,,50597,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,Rattus norvegicus,CHEMBL627907,
Intermediate,,A,6078,,,1,,,N,,9453,BAO_0000218,,1,,10116.0,,50597,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,Rattus norvegicus,CHEMBL876783,
Intermediate,,A,6078,,,1,,,N,,9454,BAO_0000218,,1,,10116.0,,50597,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,Rattus norvegicus,CHEMBL627908,
Intermediate,,A,17065,,,1,,,N,,9455,BAO_0000218,,1,,10116.0,,50597,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,Rattus norvegicus,CHEMBL627909,
Intermediate,,A,1353,,,1,,,N,,9456,BAO_0000218,,1,,10116.0,,50597,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,Rattus norvegicus,CHEMBL627910,
Intermediate,,A,1353,,,1,,,N,,9457,BAO_0000218,,1,,10116.0,,50597,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),Rattus norvegicus,CHEMBL627911,
Intermediate,,A,1353,,,1,,,N,,9458,BAO_0000218,,1,,10116.0,,50597,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),Rattus norvegicus,CHEMBL627912,
Intermediate,,A,1353,,,1,,,N,,9459,BAO_0000218,,1,,10116.0,,50597,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),Rattus norvegicus,CHEMBL627913,
Intermediate,,A,1353,,,1,,,N,,9460,BAO_0000218,,1,,10116.0,,50597,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),Rattus norvegicus,CHEMBL627914,
Intermediate,,A,16423,,,1,,,N,,9461,BAO_0000218,,1,,10116.0,,50597,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,Rattus norvegicus,CHEMBL627915,
Intermediate,,A,16423,,,1,,,N,,9462,BAO_0000218,,1,,10116.0,,50597,Area under the curve was evaluated after 20 uM/kg of peroral administration,Rattus norvegicus,CHEMBL627916,
Intermediate,,A,6062,,,1,,,N,,9463,BAO_0000218,,1,,10116.0,,50597,Area under the curve was measured in rat after an iv dose of 1 mg/kg,Rattus norvegicus,CHEMBL627917,
Intermediate,,A,6056,,,1,,,N,,9464,BAO_0000218,,1,,10116.0,,50597,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,Rattus norvegicus,CHEMBL627918,
Intermediate,,A,5182,,,1,,,N,,9465,BAO_0000218,,1,,10116.0,,50597,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,Rattus norvegicus,CHEMBL627919,
Intermediate,,A,6410,,,1,,,N,,9466,BAO_0000218,,1,,10116.0,,50597,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,Rattus norvegicus,CHEMBL627920,
Intermediate,,A,6410,,,1,,,N,,9467,BAO_0000218,,1,,10116.0,,50597,Area under the curve was evaluated at an oral dose of 30 mg/kg,Rattus norvegicus,CHEMBL627921,
Intermediate,,A,4723,,,1,,,N,,9468,BAO_0000218,,1,,10116.0,,50597,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,CHEMBL627922,
Intermediate,,A,4723,,,1,,,N,,9469,BAO_0000218,,1,,10116.0,,50597,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,CHEMBL876784,
Intermediate,,A,4723,,,1,,,N,,9470,BAO_0000218,,1,,10116.0,,50597,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,CHEMBL627923,
Intermediate,,A,4723,,,1,,,N,,9471,BAO_0000218,,1,,10116.0,,50597,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,CHEMBL626208,
Intermediate,,A,4723,,,1,,,N,,9472,BAO_0000218,,1,,10116.0,,50597,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,CHEMBL626209,
Intermediate,,A,4723,,,1,,,N,,9473,BAO_0000218,,1,,10116.0,,50597,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,CHEMBL626210,
Intermediate,,A,2463,,,1,,,N,,9474,BAO_0000218,,1,,10116.0,1969.0,50597,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,Rattus norvegicus,CHEMBL627994,Plasma
Intermediate,,A,4709,,,1,,,N,,9475,BAO_0000218,,1,,10116.0,,50597,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,Rattus norvegicus,CHEMBL627995,
Intermediate,,A,4075,,,1,,,N,,9476,BAO_0000218,,1,,10116.0,,50597,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,Rattus norvegicus,CHEMBL627996,
Intermediate,,A,5394,,,1,,,N,,9477,BAO_0000218,,1,,10116.0,,50597,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,Rattus norvegicus,CHEMBL627997,
Intermediate,,A,2661,,,1,,,N,,9478,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,Rattus norvegicus,CHEMBL627998,
Intermediate,,A,2661,,,1,,,N,,9479,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,Rattus norvegicus,CHEMBL628640,
Intermediate,,A,2661,,,1,,,N,,9480,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,Rattus norvegicus,CHEMBL628641,
Intermediate,,A,2661,,,1,,,N,,9481,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,Rattus norvegicus,CHEMBL628642,
Intermediate,,A,17791,,,1,,,N,,9482,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for area under the curve expressed as (h*ug/ml),Rattus norvegicus,CHEMBL628643,
Intermediate,,A,2591,,,1,,,N,,9483,BAO_0000218,,1,,10116.0,,50597,Compound was tested for area under curve in rat,Rattus norvegicus,CHEMBL628644,
Intermediate,,A,6567,,,1,,,N,,9484,BAO_0000218,,1,,10116.0,,50597,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,Rattus norvegicus,CHEMBL628645,
Intermediate,,A,6211,,,1,,,N,,9485,BAO_0000218,,1,,10116.0,,50597,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,Rattus norvegicus,CHEMBL628646,
Intermediate,,A,5529,,,1,,,N,,9486,BAO_0000218,,1,,10116.0,,50597,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),Rattus norvegicus,CHEMBL628647,
Intermediate,,A,5408,,,1,,,N,,9487,BAO_0000218,,1,,10116.0,,50597,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,Rattus norvegicus,CHEMBL628648,
Intermediate,,A,5408,,,1,,,N,,9488,BAO_0000218,,1,,10116.0,,50597,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,Rattus norvegicus,CHEMBL625358,
Intermediate,,A,5408,,,1,,,N,,9489,BAO_0000218,,1,,10116.0,,50597,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,Rattus norvegicus,CHEMBL625359,
Intermediate,,A,5408,,,1,,,N,,9490,BAO_0000218,,1,,10116.0,,50597,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,Rattus norvegicus,CHEMBL625360,
Intermediate,,A,429,,,1,,,N,,9491,BAO_0000218,,1,,10116.0,,50597,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),Rattus norvegicus,CHEMBL625361,
Intermediate,,A,429,,,1,,,N,,9492,BAO_0000218,,1,,10116.0,,50597,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),Rattus norvegicus,CHEMBL625362,
Intermediate,,A,429,,,1,,,N,,9493,BAO_0000218,,1,,10116.0,,50597,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),Rattus norvegicus,CHEMBL625363,
Intermediate,,A,4796,,,1,,,N,,9494,BAO_0000218,,1,,10116.0,,50597,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,Rattus norvegicus,CHEMBL625364,
Intermediate,,A,5974,,,1,,,N,,9495,BAO_0000218,,1,,10116.0,,50597,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,CHEMBL625365,
Intermediate,,A,5974,,,1,,,N,,9496,BAO_0000218,,1,,10116.0,,50597,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,CHEMBL625366,
Intermediate,,A,5974,,,1,,,N,,9497,BAO_0000218,,1,,10116.0,,50597,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,CHEMBL625367,
Intermediate,,A,11450,,,1,,,N,,9498,BAO_0000218,,1,,10116.0,2113.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",Rattus norvegicus,CHEMBL625368,Kidney
Intermediate,,A,11450,,,1,,,N,,9499,BAO_0000218,,1,,10116.0,2113.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",Rattus norvegicus,CHEMBL625369,Kidney
Intermediate,,A,11450,,,1,,,N,,9500,BAO_0000218,,1,,10116.0,2113.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",Rattus norvegicus,CHEMBL625370,Kidney
Intermediate,,A,11450,,,1,,,N,,9501,BAO_0000218,,1,,10116.0,2113.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",Rattus norvegicus,CHEMBL625371,Kidney
Intermediate,,A,11450,,,1,,,N,,9502,BAO_0000218,,1,,10116.0,2113.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",Rattus norvegicus,CHEMBL625372,Kidney
Intermediate,,A,11450,,,1,,,N,,9503,BAO_0000218,,1,,10116.0,2113.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",Rattus norvegicus,CHEMBL625373,Kidney
Intermediate,,A,11450,,,1,,,N,,9504,BAO_0000218,,1,,10116.0,2107.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",Rattus norvegicus,CHEMBL625374,Liver
Intermediate,,A,11450,,,1,,,N,,9505,BAO_0000218,,1,,10116.0,2107.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",Rattus norvegicus,CHEMBL877593,Liver
Intermediate,,A,11450,,,1,,,N,,9506,BAO_0000218,,1,,10116.0,2107.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",Rattus norvegicus,CHEMBL625375,Liver
Intermediate,,A,11450,,,1,,,N,,9507,BAO_0000218,,1,,10116.0,2107.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",Rattus norvegicus,CHEMBL625376,Liver
Intermediate,,A,11450,,,1,,,N,,9508,BAO_0000218,,1,,10116.0,2107.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",Rattus norvegicus,CHEMBL621973,Liver
Intermediate,,A,11450,,,1,,,N,,9509,BAO_0000218,,1,,10116.0,2107.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",Rattus norvegicus,CHEMBL621974,Liver
Intermediate,,A,11450,,,1,,,N,,9510,BAO_0000218,,1,,10116.0,2048.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",Rattus norvegicus,CHEMBL621975,Lung
Intermediate,,A,11450,,,1,,,N,,9511,BAO_0000218,,1,,10116.0,2048.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",Rattus norvegicus,CHEMBL622166,Lung
Intermediate,,A,11450,,,1,,,N,,9512,BAO_0000218,,1,,10116.0,2048.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",Rattus norvegicus,CHEMBL622167,Lung
Intermediate,,A,11450,,,1,,,N,,9513,BAO_0000218,,1,,10116.0,2048.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",Rattus norvegicus,CHEMBL622168,Lung
Intermediate,,A,11450,,,1,,,N,,9514,BAO_0000218,,1,,10116.0,2048.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",Rattus norvegicus,CHEMBL622169,Lung
Intermediate,,A,11450,,,1,,,N,,9515,BAO_0000218,,1,,10116.0,2048.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",Rattus norvegicus,CHEMBL622170,Lung
Intermediate,,A,11450,,,1,,,N,,9516,BAO_0000218,,1,,10116.0,2046.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",Rattus norvegicus,CHEMBL622171,Thyroid gland
Intermediate,,A,11450,,,1,,,N,,9517,BAO_0000218,,1,,10116.0,2046.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",Rattus norvegicus,CHEMBL622172,Thyroid gland
Intermediate,,A,11450,,,1,,,N,,9518,BAO_0000218,,1,,10116.0,2046.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",Rattus norvegicus,CHEMBL622173,Thyroid gland
Intermediate,,A,11450,,,1,,,N,,9519,BAO_0000218,,1,,10116.0,2046.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",Rattus norvegicus,CHEMBL622174,Thyroid gland
Intermediate,,A,11450,,,1,,,N,,9520,BAO_0000218,,1,,10116.0,2046.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",Rattus norvegicus,CHEMBL622175,Thyroid gland
Intermediate,,A,11450,,,1,,,N,,9521,BAO_0000218,,1,,10116.0,2046.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",Rattus norvegicus,CHEMBL622176,Thyroid gland
Intermediate,,A,11450,,,1,,,N,,9522,BAO_0000218,,1,,10116.0,2046.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",Rattus norvegicus,CHEMBL622177,Thyroid gland
Intermediate,,A,11450,,,1,,,N,,9523,BAO_0000218,,1,,10116.0,2046.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",Rattus norvegicus,CHEMBL622178,Thyroid gland
Intermediate,,A,11450,,,1,,,N,,9524,BAO_0000218,,1,,10116.0,2046.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",Rattus norvegicus,CHEMBL622179,Thyroid gland
Intermediate,,A,11450,,,1,,,N,,9525,BAO_0000218,,1,,10116.0,2046.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",Rattus norvegicus,CHEMBL622180,Thyroid gland
Intermediate,,A,16435,,,1,,,N,,9526,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,CHEMBL622181,
Intermediate,,A,16435,,,1,,,N,,9527,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,CHEMBL622182,
Intermediate,,A,16435,,,1,,,N,,9528,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,CHEMBL622183,
Intermediate,,A,16435,,,1,,,N,,9529,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,CHEMBL622184,
Intermediate,,A,16435,,,1,,,N,,9530,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,CHEMBL622185,
Intermediate,,A,16435,,,1,,,N,,9531,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,CHEMBL622186,
Intermediate,,A,16434,,,1,,,N,,9532,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,CHEMBL622187,
Intermediate,,A,16434,,,1,,,N,,9533,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,CHEMBL625002,
Intermediate,,A,16434,,,1,,,N,,9534,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,CHEMBL622090,
Intermediate,,A,16435,,,1,,,N,,9535,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,CHEMBL622091,
Intermediate,,A,16435,,,1,,,N,,9536,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,CHEMBL622092,
Intermediate,,A,16435,,,1,,,N,,9537,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,CHEMBL622093,
Intermediate,,A,16435,,,1,,,N,,9538,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,CHEMBL622094,
Intermediate,,A,16435,,,1,,,N,,9539,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,CHEMBL622095,
Intermediate,,A,16435,,,1,,,N,,9540,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,CHEMBL622264,
Intermediate,,A,16434,,,1,,,N,,9541,BAO_0000218,,1,,10116.0,2106.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,CHEMBL622265,Spleen
Intermediate,,A,16434,,,1,,,N,,9542,BAO_0000218,,1,,10116.0,2106.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,CHEMBL622266,Spleen
Intermediate,,A,16434,,,1,,,N,,9543,BAO_0000218,,1,,10116.0,2106.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,CHEMBL622267,Spleen
Intermediate,,A,16434,,,1,,,N,,9544,BAO_0000218,,1,,10116.0,2106.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,CHEMBL622268,Spleen
Intermediate,,A,16434,,,1,,,N,,9545,BAO_0000218,,1,,10116.0,2106.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,CHEMBL622269,Spleen
Intermediate,,A,16434,,,1,,,N,,9546,BAO_0000218,,1,,10116.0,2106.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,CHEMBL625071,Spleen
Intermediate,,A,16434,,,1,,,N,,9547,BAO_0000218,,1,,10116.0,2106.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,CHEMBL621621,Spleen
Intermediate,,A,16434,,,1,,,N,,9548,BAO_0000218,,1,,10116.0,2106.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,CHEMBL621622,Spleen
Intermediate,,A,16435,,,1,,,N,,9549,BAO_0000218,,1,,10116.0,2106.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,CHEMBL621623,Spleen
Intermediate,,A,16435,,,1,,,N,,9550,BAO_0000218,,1,,10116.0,2106.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,CHEMBL621624,Spleen
Intermediate,,A,16435,,,1,,,N,,9551,BAO_0000218,,1,,10116.0,2106.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,CHEMBL621625,Spleen
Intermediate,,A,16435,,,1,,,N,,9552,BAO_0000218,,1,,10116.0,2106.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,CHEMBL621626,Spleen
Intermediate,,A,16435,,,1,,,N,,9553,BAO_0000218,,1,,10116.0,2106.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,CHEMBL621627,Spleen
Intermediate,,A,16435,,,1,,,N,,9554,BAO_0000218,,1,,10116.0,2106.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,CHEMBL621628,Spleen
Intermediate,,A,16435,,,1,,,N,,9555,BAO_0000218,,1,,10116.0,2106.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,CHEMBL875328,Spleen
Intermediate,,A,16435,,,1,,,N,,9556,BAO_0000218,,1,,10116.0,2106.0,50597,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,CHEMBL621629,Spleen
Intermediate,,A,16434,,,1,,,N,,9557,BAO_0000218,,1,,10116.0,2106.0,50597,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,CHEMBL621630,Spleen
Intermediate,,A,16434,,,1,,,N,,9558,BAO_0000218,,1,,10116.0,2106.0,50597,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,CHEMBL621631,Spleen
Intermediate,,A,16434,,,1,,,N,,9559,BAO_0000218,,1,,10116.0,2106.0,50597,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,CHEMBL621632,Spleen
Intermediate,,A,16435,,,1,,,N,,9560,BAO_0000218,,1,,10116.0,2106.0,50597,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,CHEMBL621633,Spleen
Intermediate,,A,16435,,,1,,,N,,9561,BAO_0000218,,1,,10116.0,2106.0,50597,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,CHEMBL621634,Spleen
Intermediate,,A,16435,,,1,,,N,,9562,BAO_0000218,,1,,10116.0,2106.0,50597,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,CHEMBL621635,Spleen
Intermediate,,A,16435,,,1,,,N,,9563,BAO_0000218,,1,,10116.0,2106.0,50597,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,CHEMBL621636,Spleen
Intermediate,,A,16435,,,1,,,N,,9564,BAO_0000218,,1,,10116.0,2106.0,50597,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,CHEMBL621637,Spleen
Intermediate,,A,16435,,,1,,,N,,9565,BAO_0000218,,1,,10116.0,2106.0,50597,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,CHEMBL621638,Spleen
Intermediate,,A,16434,,,1,,,N,,9566,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,CHEMBL618883,
Intermediate,,A,16434,,,1,,,N,,9567,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,CHEMBL618884,
Intermediate,,A,16434,,,1,,,N,,9568,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,CHEMBL628627,
Intermediate,,A,16434,,,1,,,N,,9569,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,CHEMBL628628,
Intermediate,,A,16434,,,1,,,N,,9570,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,CHEMBL628629,
Intermediate,,A,16365,In vivo,,1,,,N,,9571,BAO_0000218,,1,,10116.0,,50597,Half life after administering orally a dose of 3 mg/kg,Rattus norvegicus,CHEMBL628630,
Intermediate,,A,16365,In vivo,,1,,,N,,9572,BAO_0000218,,1,,10116.0,,50597,Half life after administering orally a dose of 3 mg/kg to a fasting rat,Rattus norvegicus,CHEMBL628631,
Intermediate,,A,16365,In vivo,,1,,,N,,9573,BAO_0000218,,1,,10116.0,,50597,Half life after administering intravenously a dose of 1 mg/kg,Rattus norvegicus,CHEMBL628632,
Intermediate,,A,526,In vivo,,1,,,N,,9574,BAO_0000218,,1,,10116.0,,50597,Half life after oral dosing in rats,Rattus norvegicus,CHEMBL628633,
Intermediate,,A,16365,In vivo,,1,,,N,,9575,BAO_0000218,,1,,10116.0,,50597,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,Rattus norvegicus,CHEMBL628634,
Intermediate,,A,4368,In vivo,,1,,,N,,9576,BAO_0000218,,1,,10116.0,,50597,Half life by intravenous administration of 3.4 mg/kg in rat,Rattus norvegicus,CHEMBL627789,
Intermediate,,A,3371,,,1,,,N,,9577,BAO_0000218,,1,,10116.0,,50597,Half life in rat,Rattus norvegicus,CHEMBL627790,
Intermediate,,A,6448,,,1,,,N,,9578,BAO_0000218,,1,,10116.0,,50597,Half life in rat,Rattus norvegicus,CHEMBL627791,
Intermediate,,A,6453,,,1,,,N,,9579,BAO_0000218,,1,,10116.0,,50597,Half life in rat,Rattus norvegicus,CHEMBL627792,
Intermediate,,A,4353,In vivo,,1,,,N,,9580,BAO_0000218,,1,,10116.0,,50597,Half life in rat after intravenous administration of the compound,Rattus norvegicus,CHEMBL627793,
Intermediate,,A,4353,In vivo,,1,,,N,,9581,BAO_0000218,,1,,10116.0,1969.0,50597,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,Rattus norvegicus,CHEMBL627794,Plasma
Intermediate,,A,4353,In vivo,,1,,,N,,9582,BAO_0000218,,1,,10116.0,,50597,Half life in rat after po administration of the compound,Rattus norvegicus,CHEMBL627795,
Intermediate,,A,4353,In vivo,,1,,,N,,9583,BAO_0000218,,1,,10116.0,,50597,Half life in rat after po administration of the compound; ND means Not determined,Rattus norvegicus,CHEMBL627796,
Intermediate,,A,4353,In vivo,,1,,,N,,9584,BAO_0000218,,1,,10116.0,1969.0,50597,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,Rattus norvegicus,CHEMBL875335,Plasma
Intermediate,,A,4353,In vivo,,1,,,N,,9585,BAO_0000218,,1,,10116.0,1969.0,50597,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,Rattus norvegicus,CHEMBL627797,Plasma
Intermediate,,A,5789,In vivo,,1,,,N,,9586,BAO_0000218,,1,,10116.0,,50597,Half life in rat i.v.,Rattus norvegicus,CHEMBL627798,
Intermediate,,A,17686,In vivo,,1,,,N,,9587,BAO_0000218,,1,,10116.0,,50597,Half life in rat i.v. at 2 mg/kg concentration,Rattus norvegicus,CHEMBL627799,
Intermediate,,A,6495,,,1,,,N,,9588,BAO_0000218,,1,,10116.0,,50597,Half life in rats,Rattus norvegicus,CHEMBL627800,
Intermediate,,A,484,In vivo,,1,,,N,,9589,BAO_0000218,,1,,10116.0,,50597,Half life in rats after intravenous administration,Rattus norvegicus,CHEMBL627801,
Intermediate,,A,6467,In vivo,,1,,,N,,9590,BAO_0000218,,1,,10116.0,,50597,Half life in rats at the dose of 1.0 mpk by i.v. administration,Rattus norvegicus,CHEMBL627802,
Expert,,A,6642,,,1,,,N,,9591,BAO_0000218,,1,,10116.0,,50597,Half life in rat,Rattus norvegicus,CHEMBL627803,
Intermediate,,A,16367,In vivo,,1,,,N,,9592,BAO_0000218,,1,,10116.0,,50597,Half life was evaluated after intravenous administration to rats,Rattus norvegicus,CHEMBL873820,
Intermediate,,A,1369,,,1,,,N,,9593,BAO_0000218,,1,,10116.0,,50597,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),Rattus norvegicus,CHEMBL627804,
Intermediate,,A,5472,,,1,,,N,,9594,BAO_0000218,,1,,10116.0,,50597,Half life was evaluated in rat,Rattus norvegicus,CHEMBL627805,
Intermediate,,A,6049,,,1,,,N,,9595,BAO_0000218,,1,,10116.0,,50597,Half life was evaluated in rat,Rattus norvegicus,CHEMBL627806,
Intermediate,,A,5472,,,1,,,N,,9596,BAO_0000218,,1,,10116.0,,50597,Half life was evaluated in rat; Not tested,Rattus norvegicus,CHEMBL627107,
Intermediate,,A,16366,In vivo,,1,,,N,,9597,BAO_0000218,,1,,10116.0,,50597,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,Rattus norvegicus,CHEMBL627108,
Intermediate,,A,11149,In vivo,,1,,,N,,9598,BAO_0000218,,1,,10116.0,,50597,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,Rattus norvegicus,CHEMBL627109,
Intermediate,,A,11149,In vivo,,1,,,N,,9599,BAO_0000218,,1,,10116.0,178.0,50597,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,Rattus norvegicus,CHEMBL627110,Blood
Intermediate,,A,2891,In vivo,,1,,,U,,9600,BAO_0000218,,0,,9443.0,,22224,Half life was measured in monkey at dose of 10 mg/kg by po administration,Primates,CHEMBL627111,
Intermediate,,A,2891,In vivo,,1,,,U,,9601,BAO_0000218,,0,,9443.0,,22224,Half life was measured in monkey at dose of 10 mg/kg by po administration,Primates,CHEMBL627112,
Intermediate,,A,2891,In vivo,,1,,,U,,9602,BAO_0000218,,0,,10116.0,,22224,Half life was measured in rat at dose of 30 mg/kg by iv administration,Rattus norvegicus,CHEMBL627113,
Intermediate,,A,2891,In vivo,,1,,,U,,9603,BAO_0000218,,0,,10116.0,,22224,Half life was measured in rat at dose of 30 mg/kg by po administration,Rattus norvegicus,CHEMBL627114,
Intermediate,,A,4026,,,1,,,N,,9604,BAO_0000218,,1,,10116.0,,50597,Half life (t1/2) was determined,Rattus norvegicus,CHEMBL627115,
Intermediate,,A,4527,,,1,,,N,,9605,BAO_0000218,,1,,10116.0,,50597,Half life period at a dose of 10 uM/kg in rat was determined,Rattus norvegicus,CHEMBL627116,
Intermediate,,A,4527,In vivo,,1,,,N,,9606,BAO_0000218,,1,,10116.0,,50597,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,Rattus norvegicus,CHEMBL627117,
Intermediate,,A,5503,,,1,,,N,,9607,BAO_0000218,,1,,10116.0,,50597,Half life period was determined,Rattus norvegicus,CHEMBL627118,
Intermediate,,A,4426,In vivo,,1,,,N,,9608,BAO_0000218,,1,,10116.0,,50597,Half life period after intravenous administration at 20 mpk in rats,Rattus norvegicus,CHEMBL627119,
Intermediate,,A,4426,In vivo,,1,,,N,,9609,BAO_0000218,,1,,10116.0,,50597,Half life period after intravenous administration at 20 mpk in rats; Not performed.,Rattus norvegicus,CHEMBL627120,
Intermediate,,A,6109,In vivo,,1,,,N,,9610,BAO_0000218,,1,,10116.0,,50597,Half life period after intravenous administration in rat,Rattus norvegicus,CHEMBL626922,
Intermediate,,A,5654,In vivo,,1,,,N,,9611,BAO_0000218,,1,,10116.0,,50597,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Rattus norvegicus,CHEMBL626923,
Intermediate,,A,5654,In vivo,,1,,,N,,9612,BAO_0000218,,1,,10116.0,,50597,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Rattus norvegicus,CHEMBL626924,
Intermediate,,A,4755,,,1,,,N,,9613,BAO_0000218,,1,,10116.0,1969.0,50597,Half life period in 80% rat plasma at 37 degree Centigrade,Rattus norvegicus,CHEMBL626925,Plasma
Intermediate,,A,5862,,,1,,,N,,9614,BAO_0000218,,1,,10116.0,,50597,Half life period in SD rats,Rattus norvegicus,CHEMBL626926,
Intermediate,,A,1515,,,1,,,N,,9615,BAO_0000218,,1,,10116.0,1969.0,50597,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),Rattus norvegicus,CHEMBL626927,Plasma
Intermediate,,A,1515,,,1,,,N,,9616,BAO_0000218,,1,,10116.0,1969.0,50597,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),Rattus norvegicus,CHEMBL626928,Plasma
Intermediate,,A,1515,,,1,,,N,,9617,BAO_0000218,,1,,10116.0,1969.0,50597,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Rattus norvegicus,CHEMBL626929,Plasma
Intermediate,,A,1515,,,1,,,N,,9618,BAO_0000218,,1,,10116.0,1969.0,50597,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Rattus norvegicus,CHEMBL626930,Plasma
Intermediate,,A,5960,,,1,,,N,,9619,BAO_0000218,,1,,10116.0,,50597,Half life period in rat,Rattus norvegicus,CHEMBL626931,
Intermediate,,A,6103,,,1,,,N,,9620,BAO_0000218,,1,,10116.0,,50597,Half life period in rat,Rattus norvegicus,CHEMBL626932,
Intermediate,,A,6317,,,1,,,N,,9621,BAO_0000218,,1,,10116.0,,50597,Half life period in rat,Rattus norvegicus,CHEMBL626933,
Intermediate,,A,6644,In vivo,,1,,,N,,9622,BAO_0000218,,1,,10116.0,,50597,Half life period in rat after oral administration at 10.5 mg/kg dose,Rattus norvegicus,CHEMBL873826,
Intermediate,,A,6644,In vivo,,1,,,N,,9623,BAO_0000218,,1,,10116.0,,50597,Half life period in rat after oral administration at 11.2 mg/kg dose,Rattus norvegicus,CHEMBL626934,
Intermediate,,A,6644,In vivo,,1,,,N,,9624,BAO_0000218,,1,,10116.0,,50597,Half life period in rat after oral administration at 13 mg/kg dose,Rattus norvegicus,CHEMBL626935,
Intermediate,,A,6644,In vivo,,1,,,N,,9625,BAO_0000218,,1,,10116.0,,50597,Half life period in rat after oral administration at 9.7 mg/kg dose,Rattus norvegicus,CHEMBL626936,
Intermediate,,A,5974,,,1,,,N,,9626,BAO_0000218,,1,,10116.0,,50597,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,CHEMBL626937,
Intermediate,,A,6295,,,1,,,N,,9627,BAO_0000218,,1,,10116.0,,50597,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,Rattus norvegicus,CHEMBL625906,
Intermediate,,A,6296,,,1,,,N,,9628,BAO_0000218,,1,,10116.0,,50597,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,Rattus norvegicus,CHEMBL625907,
Intermediate,,A,16427,,,1,,,N,,9629,BAO_0000218,,1,,10116.0,,50597,PK study was carried to determine AUC (area under curve) value in rat,Rattus norvegicus,CHEMBL625908,
Intermediate,,A,16367,,,1,,,N,,9630,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter AUC after intravenous administration to rats,Rattus norvegicus,CHEMBL625909,
Intermediate,,A,16367,,,1,,,N,,9631,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter AUC after oral administration to rats,Rattus norvegicus,CHEMBL625910,
Intermediate,,A,16365,,,1,,,N,,9632,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,Rattus norvegicus,CHEMBL625911,
Intermediate,,A,16365,,,1,,,N,,9633,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,Rattus norvegicus,CHEMBL625912,
Intermediate,,A,16365,,,1,,,N,,9634,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,Rattus norvegicus,CHEMBL626538,
Intermediate,,A,16365,,,1,,,N,,9635,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,Rattus norvegicus,CHEMBL876794,
Intermediate,,A,16365,,,1,,,N,,9636,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,Rattus norvegicus,CHEMBL626539,
Intermediate,,A,16365,,,1,,,N,,9637,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,Rattus norvegicus,CHEMBL626540,
Intermediate,,A,5394,,,1,,,N,,9638,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,Rattus norvegicus,CHEMBL626541,
Intermediate,,A,5394,,,1,,,N,,9639,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,Rattus norvegicus,CHEMBL626542,
Intermediate,,A,2792,,,1,,,N,,9640,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,Rattus norvegicus,CHEMBL626543,
Intermediate,,A,2792,,,1,,,N,,9641,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,Rattus norvegicus,CHEMBL626544,
Intermediate,,A,2792,,,1,,,N,,9642,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,Rattus norvegicus,CHEMBL626545,
Intermediate,,A,2792,,,1,,,N,,9643,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,Rattus norvegicus,CHEMBL626546,
Intermediate,,A,5334,,,1,,,N,,9644,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter area under curve was reported,Rattus norvegicus,CHEMBL626547,
Intermediate,,A,4408,,,1,,,N,,9645,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (AUC) in rat,Rattus norvegicus,CHEMBL626548,
Intermediate,,A,5983,,,1,,,N,,9646,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,Rattus norvegicus,CHEMBL626549,
Intermediate,,A,4397,,,1,,,N,,9647,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,Rattus norvegicus,CHEMBL626550,
Intermediate,,A,4397,,,1,,,N,,9648,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,Rattus norvegicus,CHEMBL626551,
Intermediate,,A,5491,,,1,,,N,,9649,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property was determined,Rattus norvegicus,CHEMBL623777,
Intermediate,,A,5491,,,1,,,N,,9650,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,Rattus norvegicus,CHEMBL623778,
Intermediate,,A,5491,,,1,,,N,,9651,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,Rattus norvegicus,CHEMBL623779,
Intermediate,,A,4199,,,1,,,N,,9652,BAO_0000218,,1,,10116.0,1969.0,50597,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,Rattus norvegicus,CHEMBL623780,Plasma
Intermediate,,A,4199,,,1,,,N,,9653,BAO_0000218,,1,,10116.0,1969.0,50597,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,Rattus norvegicus,CHEMBL622015,Plasma
Intermediate,,A,4199,,,1,,,N,,9654,BAO_0000218,,1,,10116.0,1969.0,50597,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,Rattus norvegicus,CHEMBL622016,Plasma
Intermediate,,A,5173,,,1,,,N,,9655,BAO_0000218,,1,,10116.0,,50597,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",Rattus norvegicus,CHEMBL622017,
Intermediate,,A,5173,,,1,,,N,,9656,BAO_0000218,,1,,10116.0,,50597,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",Rattus norvegicus,CHEMBL622018,
Intermediate,,A,5173,,,1,,,N,,9657,BAO_0000218,,1,,10116.0,,50597,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",Rattus norvegicus,CHEMBL622019,
Intermediate,,A,5173,,,1,,,N,,9658,BAO_0000218,,1,,10116.0,,50597,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",Rattus norvegicus,CHEMBL622020,
Intermediate,,A,16366,,,1,,,N,,9659,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,Rattus norvegicus,CHEMBL622021,
Intermediate,,A,16366,,,1,,,N,,9660,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,Rattus norvegicus,CHEMBL622022,
Intermediate,,A,5327,,,1,,,N,,9661,BAO_0000218,,1,,10116.0,,50597,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,Rattus norvegicus,CHEMBL622023,
Intermediate,,A,6681,,,1,,,N,,9662,BAO_0000218,,1,,10116.0,,50597,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,Rattus norvegicus,CHEMBL622024,
Intermediate,,A,12873,,,1,,,N,,9663,BAO_0000218,,1,,10116.0,,50597,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),Rattus norvegicus,CHEMBL622693,
Intermediate,,A,12873,,,1,,,N,,9664,BAO_0000218,,1,,10116.0,,50597,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),Rattus norvegicus,CHEMBL622694,
Intermediate,,A,6685,,,1,,,N,,9665,BAO_0000218,,1,,10116.0,,50597,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",Rattus norvegicus,CHEMBL622695,
Intermediate,,A,6685,,,1,,,N,,9666,BAO_0000218,,1,,10116.0,,50597,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",Rattus norvegicus,CHEMBL622696,
Intermediate,,A,6685,,,1,,,N,,9667,BAO_0000218,,1,,10116.0,,50597,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",Rattus norvegicus,CHEMBL622697,
Intermediate,,A,6619,,,1,,,N,,9668,BAO_0000218,,1,,10116.0,,50597,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",Rattus norvegicus,CHEMBL622874,
Intermediate,,A,6619,,,1,,,N,,9669,BAO_0000218,,1,,10116.0,,50597,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",Rattus norvegicus,CHEMBL622875,
Intermediate,,A,10363,,,1,,,N,,9670,BAO_0000218,,1,,10116.0,,50597,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,Rattus norvegicus,CHEMBL622876,
Intermediate,,A,4796,,,1,,,N,,9671,BAO_0000218,,1,,10116.0,,50597,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,Rattus norvegicus,CHEMBL622877,
Intermediate,,A,4910,,,1,,,N,,9672,BAO_0000218,,1,,10116.0,,50597,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,Rattus norvegicus,CHEMBL622878,
Intermediate,,A,4910,,,1,,,N,,9673,BAO_0000218,,1,,10116.0,1969.0,50597,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,Rattus norvegicus,CHEMBL622879,Plasma
Intermediate,,A,4839,,,1,,,N,,9674,BAO_0000218,,1,,10116.0,,50597,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,Rattus norvegicus,CHEMBL877602,
Intermediate,,A,15078,,,1,,,N,,9675,BAO_0000218,,1,,10116.0,,50597,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,CHEMBL622880,
Intermediate,,A,15078,,,1,,,N,,9676,BAO_0000218,,1,,10116.0,,50597,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,CHEMBL622881,
Intermediate,,A,15078,,,1,,,N,,9677,BAO_0000218,,1,,10116.0,,50597,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,CHEMBL622882,
Intermediate,,A,15078,,,1,,,N,,9678,BAO_0000218,,1,,10116.0,,50597,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,CHEMBL622883,
Intermediate,,A,11450,,,1,,,N,,9679,BAO_0000218,,1,,10116.0,2046.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",Rattus norvegicus,CHEMBL622884,Thyroid gland
Intermediate,,A,11450,,,1,,,N,,9680,BAO_0000218,,1,,10116.0,2046.0,50597,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",Rattus norvegicus,CHEMBL622885,Thyroid gland
Intermediate,,A,8151,,,1,,,N,,9681,BAO_0000218,,1,,10116.0,,50597,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,Rattus norvegicus,CHEMBL622886,
Intermediate,,A,8151,,,1,,,N,,9682,BAO_0000218,,1,,10116.0,,50597,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Rattus norvegicus,CHEMBL622887,
Intermediate,,A,8151,,,1,,,N,,9683,BAO_0000218,,1,,10116.0,1088.0,50597,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Rattus norvegicus,CHEMBL622888,Urine
Intermediate,,A,8677,In vivo,,1,,,N,,9684,BAO_0000218,,1,,10116.0,178.0,50597,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,CHEMBL622889,Blood
Intermediate,,A,8677,In vivo,,1,,,N,,9685,BAO_0000218,,1,,10116.0,178.0,50597,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,CHEMBL622890,Blood
Intermediate,,A,8677,In vivo,,1,,,N,,9686,BAO_0000218,,1,,10116.0,178.0,50597,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,CHEMBL622891,Blood
Intermediate,,A,8677,In vivo,,1,,,N,,9687,BAO_0000218,,1,,10116.0,178.0,50597,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,CHEMBL877603,Blood
Intermediate,,A,8677,In vivo,,1,,,N,,9688,BAO_0000218,,1,,10116.0,955.0,50597,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,CHEMBL622892,Brain
Intermediate,,A,8677,In vivo,,1,,,N,,9689,BAO_0000218,,1,,10116.0,955.0,50597,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,CHEMBL622893,Brain
Intermediate,,A,8677,In vivo,,1,,,N,,9690,BAO_0000218,,1,,10116.0,955.0,50597,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,CHEMBL622894,Brain
Intermediate,,A,8677,In vivo,,1,,,N,,9691,BAO_0000218,,1,,10116.0,955.0,50597,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,CHEMBL622895,Brain
Intermediate,,A,8677,In vivo,,1,,,N,,9692,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,Rattus norvegicus,CHEMBL622896,Brain
Intermediate,,A,8677,In vivo,,1,,,N,,9693,BAO_0000218,,1,,10116.0,948.0,50597,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,CHEMBL622897,Heart
Intermediate,,A,8677,In vivo,,1,,,N,,9694,BAO_0000218,,1,,10116.0,948.0,50597,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,CHEMBL622898,Heart
Intermediate,,A,8677,In vivo,,1,,,N,,9695,BAO_0000218,,1,,10116.0,948.0,50597,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,CHEMBL622899,Heart
Intermediate,,A,8677,In vivo,,1,,,N,,9696,BAO_0000218,,1,,10116.0,2113.0,50597,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,CHEMBL622900,Kidney
Intermediate,,A,8677,In vivo,,1,,,N,,9697,BAO_0000218,,1,,10116.0,2113.0,50597,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,CHEMBL624114,Kidney
Intermediate,,A,8677,In vivo,,1,,,N,,9698,BAO_0000218,,1,,10116.0,2113.0,50597,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,CHEMBL624115,Kidney
Intermediate,,A,8677,In vivo,,1,,,N,,9699,BAO_0000218,,1,,10116.0,2113.0,50597,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,CHEMBL624116,Kidney
Intermediate,,A,8677,In vivo,,1,,,N,,9700,BAO_0000218,,1,,10116.0,2107.0,50597,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,CHEMBL624117,Liver
Intermediate,,A,8677,In vivo,,1,,,N,,9701,BAO_0000218,,1,,10116.0,2107.0,50597,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,CHEMBL624118,Liver
Intermediate,,A,8677,In vivo,,1,,,N,,9702,BAO_0000218,,1,,10116.0,2107.0,50597,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,CHEMBL624119,Liver
Intermediate,,A,8677,In vivo,,1,,,N,,9703,BAO_0000218,,1,,10116.0,2107.0,50597,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,CHEMBL624120,Liver
Intermediate,,A,8677,In vivo,,1,,,N,,9704,BAO_0000218,,1,,10116.0,2048.0,50597,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,CHEMBL624121,Lung
Intermediate,,A,8677,In vivo,,1,,,N,,9705,BAO_0000218,,1,,10116.0,2048.0,50597,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,CHEMBL624122,Lung
Intermediate,,A,8677,In vivo,,1,,,N,,9706,BAO_0000218,,1,,10116.0,2048.0,50597,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,CHEMBL624123,Lung
Intermediate,,A,8677,In vivo,,1,,,N,,9707,BAO_0000218,,1,,10116.0,2048.0,50597,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,CHEMBL624124,Lung
Intermediate,,A,8677,In vivo,,1,,,N,,9708,BAO_0000218,,1,,10116.0,2385.0,50597,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,CHEMBL624125,Muscle tissue
Intermediate,,A,8677,In vivo,,1,,,N,,9709,BAO_0000218,,1,,10116.0,2385.0,50597,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,CHEMBL624126,Muscle tissue
Intermediate,,A,8677,In vivo,,1,,,N,,9710,BAO_0000218,,1,,10116.0,2385.0,50597,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,CHEMBL624127,Muscle tissue
Intermediate,,A,8677,In vivo,,1,,,N,,9711,BAO_0000218,,1,,10116.0,2385.0,50597,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,CHEMBL624128,Muscle tissue
Intermediate,,A,8677,In vivo,,1,,,N,,9712,BAO_0000218,,1,,10116.0,14.0,50597,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,CHEMBL624129,Zone of skin
Intermediate,,A,8677,In vivo,,1,,,N,,9713,BAO_0000218,,1,,10116.0,14.0,50597,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,CHEMBL624130,Zone of skin
Intermediate,,A,8677,In vivo,,1,,,N,,9714,BAO_0000218,,1,,10116.0,14.0,50597,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,CHEMBL622340,Zone of skin
Intermediate,,A,8677,In vivo,,1,,,N,,9715,BAO_0000218,,1,,10116.0,14.0,50597,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,CHEMBL622341,Zone of skin
Intermediate,,A,8677,In vivo,,1,,,N,,9716,BAO_0000218,,1,,10116.0,160.0,50597,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,CHEMBL622342,Intestine
Intermediate,,A,8677,In vivo,,1,,,N,,9717,BAO_0000218,,1,,10116.0,160.0,50597,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,CHEMBL622343,Intestine
Intermediate,,A,8677,In vivo,,1,,,N,,9718,BAO_0000218,,1,,10116.0,160.0,50597,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,CHEMBL622344,Intestine
Intermediate,,A,8677,In vivo,,1,,,N,,9719,BAO_0000218,,1,,10116.0,160.0,50597,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,CHEMBL622345,Intestine
Intermediate,,A,8677,In vivo,,1,,,N,,9720,BAO_0000218,,1,,10116.0,2106.0,50597,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,CHEMBL622346,Spleen
Intermediate,,A,8677,In vivo,,1,,,N,,9721,BAO_0000218,,1,,10116.0,2106.0,50597,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,CHEMBL622347,Spleen
Intermediate,,A,8677,In vivo,,1,,,N,,9722,BAO_0000218,,1,,10116.0,2106.0,50597,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,CHEMBL622348,Spleen
Intermediate,,A,8677,In vivo,,1,,,N,,9723,BAO_0000218,,1,,10116.0,2106.0,50597,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,CHEMBL622349,Spleen
Intermediate,,A,16434,,,1,,,N,,9724,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,CHEMBL622350,
Intermediate,,A,16434,,,1,,,N,,9725,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,CHEMBL622351,
Intermediate,,A,16434,,,1,,,N,,9726,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,CHEMBL622352,
Intermediate,,A,16435,,,1,,,N,,9727,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,CHEMBL622353,
Intermediate,,A,16435,,,1,,,N,,9728,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,CHEMBL622354,
Intermediate,,A,16435,,,1,,,N,,9729,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,CHEMBL622355,
Intermediate,,A,16435,,,1,,,N,,9730,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,CHEMBL622356,
Intermediate,,A,16435,,,1,,,N,,9731,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,CHEMBL622357,
Intermediate,,A,16435,,,1,,,N,,9732,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,CHEMBL622358,
Intermediate,,A,16435,,,1,,,N,,9733,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,CHEMBL622359,
Intermediate,,A,16435,,,1,,,N,,9734,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,CHEMBL874393,
Intermediate,,A,16434,,,1,,,N,,9735,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,CHEMBL622872,
Intermediate,,A,16434,,,1,,,N,,9736,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,CHEMBL622873,
Intermediate,,A,16434,,,1,,,N,,9737,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,CHEMBL623047,
Intermediate,,A,16435,,,1,,,N,,9738,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,CHEMBL623048,
Intermediate,,A,16435,,,1,,,N,,9739,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,CHEMBL623049,
Intermediate,,A,16435,,,1,,,N,,9740,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,CHEMBL623050,
Intermediate,,A,16435,,,1,,,N,,9741,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,CHEMBL623051,
Intermediate,,A,16435,,,1,,,N,,9742,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,CHEMBL623052,
Intermediate,,A,16435,,,1,,,N,,9743,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,CHEMBL626343,
Intermediate,,A,16434,,,1,,,N,,9744,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,CHEMBL626344,
Intermediate,,A,16434,,,1,,,N,,9745,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,CHEMBL626345,
Intermediate,,A,16434,,,1,,,N,,9746,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,CHEMBL626346,
Intermediate,,A,16434,,,1,,,N,,9747,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,CHEMBL626347,
Intermediate,,A,16434,,,1,,,N,,9748,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,CHEMBL626348,
Intermediate,,A,16434,,,1,,,N,,9749,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,CHEMBL626349,
Intermediate,,F,16435,,,1,,,N,,9750,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,CHEMBL626350,
Intermediate,,A,16435,,,1,,,N,,9751,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,CHEMBL626351,
Intermediate,,A,16435,,,1,,,N,,9752,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,CHEMBL627650,
Intermediate,,F,16435,,,1,,,N,,9753,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,CHEMBL627651,
Intermediate,,A,16435,,,1,,,N,,9754,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,CHEMBL627652,
Intermediate,,A,16435,,,1,,,N,,9755,BAO_0000218,,1,,10116.0,,50597,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,CHEMBL627653,
Intermediate,,A,13091,,,1,,,N,,9756,BAO_0000218,,1,,10116.0,,50597,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,Rattus norvegicus,CHEMBL627654,
Intermediate,,A,13091,,,1,,,N,,9757,BAO_0000218,,1,,10116.0,,50597,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,Rattus norvegicus,CHEMBL627835,
Intermediate,,A,13091,,,1,,,N,,9758,BAO_0000218,,1,,10116.0,,50597,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,Rattus norvegicus,CHEMBL627836,
Intermediate,,A,13091,,,1,,,N,,9759,BAO_0000218,,1,,10116.0,,50597,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,Rattus norvegicus,CHEMBL627837,
Intermediate,,A,13091,,,1,,,N,,9760,BAO_0000218,,1,,10116.0,,50597,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,Rattus norvegicus,CHEMBL627838,
Intermediate,,A,13091,,,1,,,N,,9761,BAO_0000218,,1,,10116.0,,50597,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,Rattus norvegicus,CHEMBL875338,
Intermediate,,A,13091,,,1,,,N,,9762,BAO_0000218,,1,,10116.0,,50597,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,Rattus norvegicus,CHEMBL627839,
Intermediate,,A,13091,,,1,,,N,,9763,BAO_0000218,,1,,10116.0,,50597,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,Rattus norvegicus,CHEMBL627840,
Intermediate,,A,13091,,,1,,,N,,9764,BAO_0000218,,1,,10116.0,,50597,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,Rattus norvegicus,CHEMBL627841,
Intermediate,,A,13091,,,1,,,N,,9765,BAO_0000218,,1,,10116.0,,50597,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,Rattus norvegicus,CHEMBL627842,
Intermediate,,A,13091,,,1,,,N,,9766,BAO_0000218,,1,,10116.0,,50597,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,Rattus norvegicus,CHEMBL627843,
Intermediate,,A,13091,,,1,,,N,,9767,BAO_0000218,,1,,10116.0,,50597,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,Rattus norvegicus,CHEMBL627844,
Intermediate,,A,13091,,,1,,,N,,9768,BAO_0000218,,1,,10116.0,,50597,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,Rattus norvegicus,CHEMBL627845,
Intermediate,,A,5874,In vivo,,1,,,N,,9769,BAO_0000218,,1,,10116.0,,50597,Half life period in rat by iv administration at a dose of 3 mg/kg,Rattus norvegicus,CHEMBL627846,
Intermediate,,A,1515,,,1,,,N,,9770,BAO_0000218,,1,,10116.0,1969.0,50597,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),Rattus norvegicus,CHEMBL627847,Plasma
Intermediate,,A,1515,,,1,,,N,,9771,BAO_0000218,,1,,10116.0,1969.0,50597,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),Rattus norvegicus,CHEMBL873821,Plasma
Intermediate,,A,1515,,,1,,,N,,9772,BAO_0000218,,1,,10116.0,1969.0,50597,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Rattus norvegicus,CHEMBL626079,Plasma
Intermediate,,A,1515,,,1,,,N,,9773,BAO_0000218,,1,,10116.0,1969.0,50597,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Rattus norvegicus,CHEMBL626080,Plasma
Intermediate,,A,5491,,,1,,,N,,9774,BAO_0000218,,1,,10116.0,1969.0,50597,Half life period was evaluated in rat plasma,Rattus norvegicus,CHEMBL626081,Plasma
Intermediate,,A,5491,,,1,,,N,,9775,BAO_0000218,,1,,10116.0,1969.0,50597,Half life period was evaluated in rat plasma; Not tested,Rattus norvegicus,CHEMBL875344,Plasma
Intermediate,,A,1918,,,1,,,N,,9776,BAO_0000218,,1,,10116.0,,50597,Half life period was evaluated in rats,Rattus norvegicus,CHEMBL626082,
Intermediate,,A,1918,In vivo,,1,,,N,,9777,BAO_0000218,,1,,10116.0,,50597,"Half life period was evaluated in rats, iv",Rattus norvegicus,CHEMBL626250,
Intermediate,,A,6113,In vivo,,1,,,N,,9778,BAO_0000218,,1,,10116.0,,50597,Half life period after intravenous administration at 5 mg/kg in rat,Rattus norvegicus,CHEMBL626251,
Intermediate,,A,5546,In vivo,,1,,,N,,9779,BAO_0000218,,1,,10116.0,,50597,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,Rattus norvegicus,CHEMBL626252,
Intermediate,,A,5553,In vivo,,1,,,N,,9780,BAO_0000218,,1,,10116.0,,50597,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,Rattus norvegicus,CHEMBL626253,
Intermediate,,A,4188,,,1,,,N,,9781,BAO_0000218,,1,,10116.0,1969.0,50597,Half life stability of compound was evaluated in rat plasma,Rattus norvegicus,CHEMBL626254,Plasma
Intermediate,,A,6215,In vivo,,1,,,N,,9782,BAO_0000218,,1,,10116.0,,50597,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,Rattus norvegicus,CHEMBL626255,
Intermediate,,A,6141,In vivo,,1,,,N,,9783,BAO_0000218,,1,,10116.0,,50597,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,Rattus norvegicus,CHEMBL626256,
Intermediate,,A,5182,In vivo,,1,,,N,,9784,BAO_0000218,,1,,10116.0,,50597,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,Rattus norvegicus,CHEMBL626257,
Intermediate,,A,5182,In vivo,,1,,,N,,9785,BAO_0000218,,1,,10116.0,,50597,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,Rattus norvegicus,CHEMBL626258,
Intermediate,,A,5710,In vivo,,1,,,N,,9786,BAO_0000218,,1,,10116.0,,50597,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,Rattus norvegicus,CHEMBL626259,
Intermediate,,A,5789,In vivo,,1,,,N,,9787,BAO_0000218,,1,,10116.0,,50597,Half in rat i.v.,Rattus norvegicus,CHEMBL626260,
Intermediate,,A,6011,In vivo,,1,,,N,,9788,BAO_0000218,,1,,10116.0,,50597,Half period in rat after intravenous administration,Rattus norvegicus,CHEMBL875345,
Intermediate,,A,17594,In vivo,,1,,,N,,9789,BAO_0000218,,1,,10116.0,,50597,Half-life after repeated oral dose of compound at 1 mg/kg in rats,Rattus norvegicus,CHEMBL626261,
Intermediate,,A,12357,In vitro,,1,,,N,,9790,BAO_0000218,,1,,10116.0,2107.0,50597,Half-life measured in in vitro Cathepsin B assay in rat liver,Rattus norvegicus,CHEMBL626262,Liver
Intermediate,,A,5210,,,1,,,N,,9791,BAO_0000218,,1,,10116.0,,50597,Half-life of compound was determined in rats,Rattus norvegicus,CHEMBL626263,
Intermediate,,A,17596,In vivo,,1,,,N,,9792,BAO_0000218,,1,,10116.0,,50597,Half-life at 10 mg/kg in rat upon intravenous administration,Rattus norvegicus,CHEMBL625270,
Intermediate,,A,6672,,,1,,,N,,9793,BAO_0000218,,1,,10116.0,,50597,Half-life determined in rat,Rattus norvegicus,CHEMBL625271,
Intermediate,,A,6673,,,1,,,N,,9794,BAO_0000218,,1,,10116.0,,50597,Half-life determined in rat,Rattus norvegicus,CHEMBL625272,
Intermediate,,A,4910,In vivo,,1,,,N,,9795,BAO_0000218,,1,,10116.0,955.0,50597,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,Rattus norvegicus,CHEMBL625273,Brain
Intermediate,,A,3741,,,1,,,N,,9796,BAO_0000218,,1,,10116.0,1969.0,50597,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",Rattus norvegicus,CHEMBL625274,Plasma
Intermediate,,A,17671,In vivo,,1,,,N,,9797,BAO_0000218,,1,,10116.0,,50597,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Rattus norvegicus,CHEMBL625275,
Intermediate,,A,4910,In vivo,,1,,,N,,9798,BAO_0000218,,1,,10116.0,1969.0,50597,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,Rattus norvegicus,CHEMBL625276,Plasma
Intermediate,,A,17537,,,1,,,N,,9799,BAO_0000218,,1,,10116.0,1969.0,50597,Half-life in rat plasma,Rattus norvegicus,CHEMBL625277,Plasma
Intermediate,,A,4965,,,1,,,N,,9800,BAO_0000218,,1,,10116.0,1969.0,50597,Half-life in rat plasma was determined,Rattus norvegicus,CHEMBL625278,Plasma
Intermediate,,A,17537,,,1,,,N,,9801,BAO_0000218,,1,,10116.0,1969.0,50597,Half-life in rat plasma; Not tested,Rattus norvegicus,CHEMBL625279,Plasma
Intermediate,,A,6124,,,1,,,N,,9802,BAO_0000218,,1,,10116.0,1977.0,50597,Half-life in rat serum,Rattus norvegicus,CHEMBL625280,Serum
Intermediate,,A,6124,,,1,,,N,,9803,BAO_0000218,,1,,10116.0,1977.0,50597,Half-life in rat serum; na is not available,Rattus norvegicus,CHEMBL876797,Serum
Intermediate,,A,6078,,,1,,,N,,9804,BAO_0000218,,1,,10116.0,,50597,Half-life was calculated in rat,Rattus norvegicus,CHEMBL625281,
Intermediate,,A,17668,,,1,,,N,,9805,BAO_0000218,,1,,10116.0,1969.0,50597,Half-life was calculated in rat plasma,Rattus norvegicus,CHEMBL873827,Plasma
Intermediate,,A,3185,,,1,,,N,,9806,BAO_0000218,,1,,10116.0,,50597,Half-life was determined,Rattus norvegicus,CHEMBL625282,
Intermediate,,A,4883,,,1,,,N,,9807,BAO_0000218,,1,,10116.0,,50597,Half-life was determined,Rattus norvegicus,CHEMBL625283,
Intermediate,,A,2959,In vivo,,1,,,N,,9808,BAO_0000218,,1,,10116.0,,50597,Half-life after administration of 20 mg/Kg oral dose in rat,Rattus norvegicus,CHEMBL625284,
Intermediate,,A,4029,In vivo,,1,,,N,,9809,BAO_0000218,,1,,10116.0,,50597,Half-life after administration of 3.2 mg/kg intravenously in male rat,Rattus norvegicus,CHEMBL625285,
Intermediate,,A,4029,In vivo,,1,,,N,,9810,BAO_0000218,,1,,10116.0,,50597,Half-life after intravenous administration in female rat,Rattus norvegicus,CHEMBL625286,
Intermediate,,A,4029,In vivo,,1,,,N,,9811,BAO_0000218,,1,,10116.0,,50597,Half-life after intravenous administration in male rat,Rattus norvegicus,CHEMBL625287,
Intermediate,,A,6180,In vivo,,1,,,N,,9812,BAO_0000218,,1,,10116.0,,50597,Half-life after intravenous dose in rat,Rattus norvegicus,CHEMBL625288,
Intermediate,,A,1557,,,1,,,N,,9813,BAO_0000218,,1,,10116.0,2107.0,50597,Half-life in a rat liver homogenate preparation,Rattus norvegicus,CHEMBL625289,Liver
Intermediate,,A,12500,,,1,,,N,,9814,BAO_0000218,,1,,10116.0,1969.0,50597,Half-life in plasma of rat,Rattus norvegicus,CHEMBL625290,Plasma
Intermediate,,A,12500,,,1,,,N,,9815,BAO_0000218,,1,,10116.0,1969.0,50597,Half-life in plasma of rat at dose of 3-10 mgkg,Rattus norvegicus,CHEMBL876798,Plasma
Intermediate,,A,5064,,,1,,,N,,9816,BAO_0000218,,1,,10116.0,,50597,Half-life in rat,Rattus norvegicus,CHEMBL625291,
Intermediate,,A,5145,,,1,,,N,,9817,BAO_0000218,,1,,10116.0,,50597,Half-life in rat,Rattus norvegicus,CHEMBL625292,
Intermediate,,A,5147,,,1,,,N,,9818,BAO_0000218,,1,,10116.0,,50597,Half-life in rat,Rattus norvegicus,CHEMBL625293,
Intermediate,,A,5833,,,1,,,N,,9819,BAO_0000218,,1,,10116.0,,50597,Half-life in rat,Rattus norvegicus,CHEMBL622832,
Intermediate,,A,6596,,,1,,,N,,9820,BAO_0000218,,1,,10116.0,,50597,Half-life in rat,Rattus norvegicus,CHEMBL622833,
Intermediate,,A,17655,,,1,,,N,,9821,BAO_0000218,,1,,10116.0,,50597,Half-life in rat,Rattus norvegicus,CHEMBL622834,
Intermediate,,A,6495,In vivo,,1,,,N,,9822,BAO_0000218,,1,,10116.0,,50597,Half-life in rat after oral administration at 10 mg/kg,Rattus norvegicus,CHEMBL622835,
Intermediate,,A,17538,In vivo,,1,,,N,,9823,BAO_0000218,,1,,10116.0,,50597,Half-life in rat after po administration at a dose of 10 mg/kg,Rattus norvegicus,CHEMBL622836,
Intermediate,,A,17538,In vivo,,1,,,N,,9824,BAO_0000218,,1,,10116.0,,50597,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,Rattus norvegicus,CHEMBL622837,
Intermediate,,A,10,In vivo,,1,,,N,,9825,BAO_0000218,,1,,10116.0,,50597,Half-life in rat at 3 mg/kg dose administered intravenously,Rattus norvegicus,CHEMBL622838,
Intermediate,,A,17669,,,1,,,N,,9826,BAO_0000218,,1,,10116.0,955.0,50597,Half-life in rat brain homogenate,Rattus norvegicus,CHEMBL622839,Brain
Intermediate,,A,17065,,,1,,,N,,9827,BAO_0000218,,1,,10116.0,1969.0,50597,Half-life in rat plasma,Rattus norvegicus,CHEMBL622840,Plasma
Intermediate,,A,4333,,,1,,,N,,9828,BAO_0000218,,1,,10116.0,,50597,Half-life in rats,Rattus norvegicus,CHEMBL622841,
Intermediate,,A,6827,,,1,,,N,,9829,BAO_0000218,,1,,10116.0,,50597,Half-life in Dawley rats,Rattus norvegicus,CHEMBL622842,
Intermediate,,A,889,In vitro,,1,,,N,,9830,BAO_0000218,,1,,10116.0,1969.0,50597,Half-life in vitro in rat plasma,Rattus norvegicus,CHEMBL622843,Plasma
Intermediate,,A,889,In vitro,,1,,,N,,9831,BAO_0000218,,1,,10116.0,1969.0,50597,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,Rattus norvegicus,CHEMBL622844,Plasma
Intermediate,,A,3747,,,1,,,N,,9832,BAO_0000218,,1,,10116.0,,50597,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",Rattus norvegicus,CHEMBL622845,
Intermediate,,A,15022,,,1,,,N,,9833,BAO_0000218,,1,,10116.0,,50597,The area under the curve of compound was measured at the dose of 100 umol/kg,Rattus norvegicus,CHEMBL622846,
Intermediate,,A,15022,,,1,,,N,,9834,BAO_0000218,,1,,10116.0,,50597,The area under the curve of compound was measured at the dose of 300 umol/kg,Rattus norvegicus,CHEMBL622847,
Intermediate,,A,15022,,,1,,,N,,9835,BAO_0000218,,1,,10116.0,,50597,The area under the curve of compound was measured at the dose of 30 umol/kg,Rattus norvegicus,CHEMBL622848,
Intermediate,,A,3360,In vivo,,1,,,N,,9836,BAO_0000218,,1,,10116.0,,50597,Bioavailability as oral AUC in rats,Rattus norvegicus,CHEMBL622849,
Intermediate,,A,5334,,,1,,,N,,9837,BAO_0000218,,1,,10116.0,1969.0,50597,The plasma concentration versus time curve (AUC) was determined,Rattus norvegicus,CHEMBL622850,Plasma
Intermediate,,A,17411,,,1,,,N,,9838,BAO_0000218,,1,,10116.0,,50597,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,CHEMBL876807,
Intermediate,,A,17411,,,1,,,N,,9839,BAO_0000218,,1,,10116.0,,50597,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,CHEMBL622851,
Intermediate,,A,17411,,,1,,,N,,9840,BAO_0000218,,1,,10116.0,,50597,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,CHEMBL622852,
Intermediate,,A,6570,,,1,,,N,,9841,BAO_0000218,,1,,10116.0,,50597,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,Rattus norvegicus,CHEMBL622853,
Intermediate,,A,6570,,,1,,,N,,9842,BAO_0000218,,1,,10116.0,,50597,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,Rattus norvegicus,CHEMBL622854,
Intermediate,,A,17411,,,1,,,N,,9843,BAO_0000218,,1,,10116.0,,50597,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,CHEMBL622855,
Intermediate,,A,14941,,,1,,,N,,9844,BAO_0000218,,1,,10116.0,1969.0,50597,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",Rattus norvegicus,CHEMBL622856,Plasma
Intermediate,,A,14941,,,1,,,N,,9845,BAO_0000218,,1,,10116.0,1969.0,50597,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",Rattus norvegicus,CHEMBL622857,Plasma
Intermediate,,A,17538,,,1,,,N,,9846,BAO_0000218,,1,,10116.0,1969.0,50597,AUC in rat after po administration at a dose of 10 mg/kg,Rattus norvegicus,CHEMBL622858,Plasma
Intermediate,,A,17752,,,1,,,N,,9847,BAO_0000218,,1,,10116.0,1969.0,50597,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,Rattus norvegicus,CHEMBL622859,Plasma
Intermediate,,A,17509,,,1,,,N,,9848,BAO_0000218,,1,,10116.0,,50597,Area under curve value 24 hr after 10 mg/kg iv administration in rats,Rattus norvegicus,CHEMBL622860,
Intermediate,,A,17509,,,1,,,N,,9849,BAO_0000218,,1,,10116.0,,50597,Area under curve value 24 hr after 10 mg/kg oral administration in rats,Rattus norvegicus,CHEMBL622861,
Intermediate,,A,17509,,,1,,,N,,9850,BAO_0000218,,1,,10116.0,,50597,Area under curve value 24 hr after 2 mg/kg iv administration in rats,Rattus norvegicus,CHEMBL622862,
Intermediate,,A,17509,,,1,,,N,,9851,BAO_0000218,,1,,10116.0,,50597,Area under curve value 24 hr after 2 mg/kg oral administration in rats,Rattus norvegicus,CHEMBL622863,
Intermediate,,A,17509,,,1,,,N,,9852,BAO_0000218,,1,,10116.0,,50597,Area under curve value 6 hr after po administration in rat,Rattus norvegicus,CHEMBL623817,
Intermediate,,A,17717,,,1,,,N,,9853,BAO_0000218,,1,,10116.0,,50597,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Rattus norvegicus,CHEMBL623818,
Intermediate,,A,17717,,,1,,,N,,9854,BAO_0000218,,1,,10116.0,,50597,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",Rattus norvegicus,CHEMBL623819,
Intermediate,,A,17717,,,1,,,N,,9855,BAO_0000218,,1,,10116.0,,50597,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Rattus norvegicus,CHEMBL623820,
Intermediate,,A,17717,,,1,,,N,,9856,BAO_0000218,,1,,10116.0,,50597,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,Rattus norvegicus,CHEMBL623821,
Intermediate,,A,6642,,,1,,,N,,9857,BAO_0000218,,1,,10116.0,1969.0,50597,AUC normalized for dose (AUCN) in rat,Rattus norvegicus,CHEMBL623822,Plasma
Intermediate,,A,6640,,,1,,,N,,9858,BAO_0000218,,1,,10116.0,,50597,Area under curve in rat after p.o. administration,Rattus norvegicus,CHEMBL623823,
Intermediate,,A,6641,,,1,,,N,,9859,BAO_0000218,,1,,10116.0,,50597,Area under curve in rat after p.o. administration,Rattus norvegicus,CHEMBL623824,
Intermediate,,A,6641,,,1,,,N,,9860,BAO_0000218,,1,,10116.0,,50597,Area under curve in rat after p.o. administration; Not determined,Rattus norvegicus,CHEMBL623825,
Intermediate,,A,6641,,,1,,,N,,9861,BAO_0000218,,1,,10116.0,,50597,Area under curve in rat after peroral administration,Rattus norvegicus,CHEMBL622070,
Intermediate,,A,3603,,,1,,,N,,9862,BAO_0000218,,1,,10116.0,,50597,Area under curve (carotid artery) value of the compound,Rattus norvegicus,CHEMBL622071,
Intermediate,,A,3550,,,1,,,N,,9863,BAO_0000218,,1,,10116.0,,50597,Bioavailability expressed as the area under curve of rat carotid artery,Rattus norvegicus,CHEMBL622072,
Intermediate,,A,15662,,,1,,,N,,9864,BAO_0000218,,1,,10116.0,,50597,Area under curve in male SD rats was observed after intravenous administration in rat,Rattus norvegicus,CHEMBL622073,
Intermediate,,A,17720,,,1,,,N,,9865,BAO_0000218,,1,,10116.0,,50597,Area under curve of the compound was determined,Rattus norvegicus,CHEMBL622074,
Intermediate,,A,5407,,,1,,,N,,9866,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,Rattus norvegicus,CHEMBL622075,
Intermediate,,A,17752,,,1,,,N,,9867,BAO_0000218,,1,,10116.0,1969.0,50597,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,Rattus norvegicus,CHEMBL622076,Plasma
Intermediate,,A,17752,,,1,,,N,,9868,BAO_0000218,,1,,10116.0,1969.0,50597,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,Rattus norvegicus,CHEMBL622077,Plasma
Intermediate,,A,3603,,,1,,,N,,9869,BAO_0000218,,1,,10116.0,,50597,Area under curve (portal vein) value of the compound,Rattus norvegicus,CHEMBL622078,
Intermediate,,A,3550,,,1,,,N,,9870,BAO_0000218,,1,,10116.0,,50597,Bioavailability expressed as the area under curve of rat portal vein,Rattus norvegicus,CHEMBL622079,
Intermediate,,A,17655,,,1,,,N,,9871,BAO_0000218,,1,,10116.0,1969.0,50597,Area Under plasma concentration time curve in rat upon peroral administration,Rattus norvegicus,CHEMBL622080,Plasma
Intermediate,,A,17582,,,1,,,N,,9872,BAO_0000218,,1,,10116.0,,50597,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,Rattus norvegicus,CHEMBL877612,
Intermediate,,A,17582,,,1,,,N,,9873,BAO_0000218,,1,,10116.0,,50597,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,Rattus norvegicus,CHEMBL622081,
Intermediate,,A,17791,,,1,,,N,,9874,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for oral bioavailability in rats,Rattus norvegicus,CHEMBL622082,
Intermediate,,A,17791,,,1,,,N,,9875,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for oral bioavailability in rats after iv administration,Rattus norvegicus,CHEMBL622083,
Intermediate,,A,17791,,,1,,,N,,9876,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for oral bioavailability in rats; 30-80,Rattus norvegicus,CHEMBL622084,
Intermediate,,A,17791,,,1,,,N,,9877,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for oral bioavailability in rats; 50-60,Rattus norvegicus,CHEMBL622085,
Intermediate,,A,17791,,,1,,,N,,9878,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for oral bioavailability in rats; no data,Rattus norvegicus,CHEMBL622086,
Intermediate,,A,17791,,,1,,,N,,9879,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for oral bioavailability in rats; peptide,Rattus norvegicus,CHEMBL622087,
Intermediate,,A,7768,,,1,,,N,,9880,BAO_0000218,,1,,10116.0,178.0,50597,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",Rattus norvegicus,CHEMBL622088,Blood
Intermediate,,A,7768,,,1,,,N,,9881,BAO_0000218,,1,,10116.0,178.0,50597,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",Rattus norvegicus,CHEMBL622089,Blood
Intermediate,,A,7768,,,1,,,N,,9882,BAO_0000218,,1,,10116.0,178.0,50597,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",Rattus norvegicus,CHEMBL623685,Blood
Intermediate,,A,7768,,,1,,,N,,9883,BAO_0000218,,1,,10116.0,178.0,50597,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",Rattus norvegicus,CHEMBL623686,Blood
Intermediate,,A,8677,In vivo,,1,,,N,,9884,BAO_0000218,,1,,10116.0,945.0,50597,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,CHEMBL623687,Stomach
Intermediate,,A,8677,In vivo,,1,,,N,,9885,BAO_0000218,,1,,10116.0,945.0,50597,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,CHEMBL623688,Stomach
Intermediate,,A,8677,In vivo,,1,,,N,,9886,BAO_0000218,,1,,10116.0,945.0,50597,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,CHEMBL623689,Stomach
Intermediate,,A,8677,In vivo,,1,,,N,,9887,BAO_0000218,,1,,10116.0,945.0,50597,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,CHEMBL622485,Stomach
Intermediate,,A,8677,In vivo,,1,,,N,,9888,BAO_0000218,,1,,10116.0,2046.0,50597,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,CHEMBL622486,Thyroid gland
Intermediate,,A,8677,In vivo,,1,,,N,,9889,BAO_0000218,,1,,10116.0,2046.0,50597,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,CHEMBL877613,Thyroid gland
Intermediate,,A,8677,In vivo,,1,,,N,,9890,BAO_0000218,,1,,10116.0,2046.0,50597,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,CHEMBL622487,Thyroid gland
Intermediate,,A,8677,In vivo,,1,,,N,,9891,BAO_0000218,,1,,10116.0,2046.0,50597,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,CHEMBL622488,Thyroid gland
Intermediate,,A,8677,In vivo,,1,,,N,,9892,BAO_0000218,,1,,10116.0,948.0,50597,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,CHEMBL622489,Heart
Intermediate,,A,6899,,,1,,,N,,9893,BAO_0000218,,1,,10116.0,1088.0,50597,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Rattus norvegicus,CHEMBL622490,Urine
Intermediate,,A,6899,,,1,,,N,,9894,BAO_0000218,,1,,10116.0,1088.0,50597,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,Rattus norvegicus,CHEMBL622491,Urine
Intermediate,,A,6899,,,1,,,N,,9895,BAO_0000218,,1,,10116.0,2107.0,50597,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,Rattus norvegicus,CHEMBL622492,Liver
Intermediate,,A,6899,,,1,,,N,,9896,BAO_0000218,,1,,10116.0,1088.0,50597,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Rattus norvegicus,CHEMBL622493,Urine
Intermediate,,A,6899,,,1,,,N,,9897,BAO_0000218,,1,,10116.0,1088.0,50597,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,Rattus norvegicus,CHEMBL622494,Urine
Intermediate,,A,8677,,,1,,,N,,9898,BAO_0000218,,1,,10116.0,2385.0,50597,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,CHEMBL622495,Muscle tissue
Intermediate,,A,6899,,,1,,,N,,9899,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,Rattus norvegicus,CHEMBL622496,
Intermediate,,A,6899,,,1,,,N,,9900,BAO_0000218,,1,,10116.0,1088.0,50597,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Rattus norvegicus,CHEMBL622497,Urine
Intermediate,,A,2189,,,1,,,N,,9901,BAO_0000218,,1,,10116.0,,50597,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,Rattus norvegicus,CHEMBL622498,
Intermediate,,A,2189,,,1,,,N,,9902,BAO_0000218,,1,,10116.0,1088.0,50597,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,Rattus norvegicus,CHEMBL624918,Urine
Intermediate,,A,2189,,,1,,,N,,9903,BAO_0000218,,1,,10116.0,1088.0,50597,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,Rattus norvegicus,CHEMBL624919,Urine
Intermediate,,A,10839,In vivo,,1,,,N,,9904,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution of compound in rat blood after 5 min of administration,Rattus norvegicus,CHEMBL624920,Blood
Intermediate,,A,10839,In vivo,,1,,,N,,9905,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution of compound in rat blood after 5 min of administration.,Rattus norvegicus,CHEMBL624921,Blood
Intermediate,,A,10839,In vivo,,1,,,N,,9906,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution of compound in rat brain after 5 min of administration,Rattus norvegicus,CHEMBL624922,Brain
Intermediate,,A,10839,In vivo,,1,,,N,,9907,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution of compound in rat heart after 5 min of administration,Rattus norvegicus,CHEMBL624923,Heart
Intermediate,,A,10839,In vivo,,1,,,N,,9908,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution of compound in rat heart after 5 min of administration.,Rattus norvegicus,CHEMBL624924,Heart
Intermediate,,A,10839,In vivo,,1,,,N,,9909,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution of compound in rat kidney after 5 min of administration,Rattus norvegicus,CHEMBL624925,Kidney
Intermediate,,A,10839,In vivo,,1,,,N,,9910,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution of compound in rat kidney after 5 min of administration.,Rattus norvegicus,CHEMBL624926,Kidney
Intermediate,,A,10839,In vivo,,1,,,N,,9911,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution of compound in rat liver after 5 min of administration,Rattus norvegicus,CHEMBL624927,Liver
Intermediate,,A,10839,In vivo,,1,,,N,,9912,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution of compound in rat liver after 5 min of administration.,Rattus norvegicus,CHEMBL874402,Liver
Intermediate,,A,10839,In vivo,,1,,,N,,9913,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution of compound in rat lung after 5 min of administration,Rattus norvegicus,CHEMBL624928,Lung
Intermediate,,A,10839,In vivo,,1,,,N,,9914,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution of compound in rat lung after 5 min of administration.,Rattus norvegicus,CHEMBL624929,Lung
Intermediate,,A,10839,In vivo,,1,,,N,,9915,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution of compound in rat muscle after 5 min of administration,Rattus norvegicus,CHEMBL624930,Muscle tissue
Intermediate,,A,10839,In vivo,,1,,,N,,9916,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution of compound in rat muscle after 5 min of administration.,Rattus norvegicus,CHEMBL624931,Muscle tissue
Intermediate,,A,4043,,,1,,,N,,9917,BAO_0000218,,1,,10116.0,948.0,50597,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,CHEMBL624932,Heart
Intermediate,,A,4043,,,1,,,N,,9918,BAO_0000218,,1,,10116.0,948.0,50597,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,CHEMBL624933,Heart
Intermediate,,A,4043,,,1,,,N,,9919,BAO_0000218,,1,,10116.0,2107.0,50597,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,CHEMBL624934,Liver
Intermediate,,A,4043,,,1,,,N,,9920,BAO_0000218,,1,,10116.0,2107.0,50597,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,CHEMBL624935,Liver
Intermediate,,A,4043,,,1,,,N,,9921,BAO_0000218,,1,,10116.0,,50597,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,CHEMBL624936,
Intermediate,,A,4043,,,1,,,N,,9922,BAO_0000218,,1,,10116.0,,50597,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,CHEMBL624937,
Intermediate,,A,4043,,,1,,,N,,9923,BAO_0000218,,1,,10116.0,2106.0,50597,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,CHEMBL624938,Spleen
Intermediate,,A,4043,,,1,,,N,,9924,BAO_0000218,,1,,10116.0,2106.0,50597,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,CHEMBL624939,Spleen
Intermediate,,A,4043,,,1,,,N,,9925,BAO_0000218,,1,,10116.0,,50597,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,CHEMBL624940,
Intermediate,,A,4043,,,1,,,N,,9926,BAO_0000218,,1,,10116.0,,50597,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,CHEMBL874403,
Intermediate,,A,1446,,,1,,,N,,9927,BAO_0000218,,1,,10116.0,,50597,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,Rattus norvegicus,CHEMBL624941,
Intermediate,,A,9971,,,1,,,N,,9928,BAO_0000218,,1,,10116.0,1088.0,50597,Dose required to lower urine osmolality to 300 mOsm/kg in rat,Rattus norvegicus,CHEMBL624942,Urine
Intermediate,,A,9971,,,1,,,N,,9929,BAO_0000218,,1,,10116.0,1088.0,50597,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,Rattus norvegicus,CHEMBL624943,Urine
Intermediate,,A,5765,In vivo,,1,,,N,,9930,BAO_0000218,,1,,10116.0,,50597,% Bioavailability after 1 day of the drug administration in rats,Rattus norvegicus,CHEMBL624944,
Intermediate,,A,5765,In vivo,,1,,,N,,9931,BAO_0000218,,1,,10116.0,,50597,% Bioavailability after 4 day of the drug administration in rats,Rattus norvegicus,CHEMBL624945,
Intermediate,,A,4257,In vivo,,1,,,N,,9932,BAO_0000218,,1,,10116.0,,50597,Absolute bioavailability was evaluated in rat,Rattus norvegicus,CHEMBL624946,
Intermediate,,A,13091,,,1,,,N,,9933,BAO_0000218,,1,,10116.0,,50597,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,Rattus norvegicus,CHEMBL624947,
Intermediate,,A,13091,,,1,,,N,,9934,BAO_0000218,,1,,10116.0,,50597,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,Rattus norvegicus,CHEMBL624948,
Intermediate,,A,13091,,,1,,,N,,9935,BAO_0000218,,1,,10116.0,,50597,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,Rattus norvegicus,CHEMBL624949,
Intermediate,,A,13091,,,1,,,N,,9936,BAO_0000218,,1,,10116.0,2113.0,50597,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,Rattus norvegicus,CHEMBL622025,Kidney
Intermediate,,A,13091,,,1,,,N,,9937,BAO_0000218,,1,,10116.0,2113.0,50597,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,Rattus norvegicus,CHEMBL622026,Kidney
Intermediate,,A,13091,,,1,,,N,,9938,BAO_0000218,,1,,10116.0,2113.0,50597,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,Rattus norvegicus,CHEMBL622027,Kidney
Intermediate,,A,13091,,,1,,,N,,9939,BAO_0000218,,1,,10116.0,2113.0,50597,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,Rattus norvegicus,CHEMBL622028,Kidney
Intermediate,,A,13091,,,1,,,N,,9940,BAO_0000218,,1,,10116.0,2107.0,50597,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,Rattus norvegicus,CHEMBL622029,Liver
Intermediate,,A,13091,,,1,,,N,,9941,BAO_0000218,,1,,10116.0,2107.0,50597,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,Rattus norvegicus,CHEMBL622208,Liver
Intermediate,,A,13091,,,1,,,N,,9942,BAO_0000218,,1,,10116.0,2107.0,50597,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,Rattus norvegicus,CHEMBL622209,Liver
Intermediate,,A,13091,,,1,,,N,,9943,BAO_0000218,,1,,10116.0,2107.0,50597,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,Rattus norvegicus,CHEMBL622210,Liver
Intermediate,,A,13091,,,1,,,N,,9944,BAO_0000218,,1,,10116.0,,50597,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,Rattus norvegicus,CHEMBL622211,
Intermediate,,A,13091,,,1,,,N,,9945,BAO_0000218,,1,,10116.0,,50597,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,Rattus norvegicus,CHEMBL622212,
Intermediate,,A,13091,,,1,,,N,,9946,BAO_0000218,,1,,10116.0,,50597,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,Rattus norvegicus,CHEMBL622213,
Intermediate,,A,13091,,,1,,,N,,9947,BAO_0000218,,1,,10116.0,,50597,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,Rattus norvegicus,CHEMBL874404,
Intermediate,,A,13091,,,1,,,N,,9948,BAO_0000218,,1,,10116.0,2385.0,50597,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,Rattus norvegicus,CHEMBL620452,Muscle tissue
Intermediate,,A,13091,,,1,,,N,,9949,BAO_0000218,,1,,10116.0,2385.0,50597,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,Rattus norvegicus,CHEMBL620453,Muscle tissue
Intermediate,,A,13091,,,1,,,N,,9950,BAO_0000218,,1,,10116.0,2385.0,50597,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,Rattus norvegicus,CHEMBL620454,Muscle tissue
Intermediate,,A,13091,,,1,,,N,,9951,BAO_0000218,,1,,10116.0,2385.0,50597,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,Rattus norvegicus,CHEMBL624067,Muscle tissue
Intermediate,,A,13091,,,1,,,N,,9952,BAO_0000218,,1,,10116.0,,50597,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,Rattus norvegicus,CHEMBL624068,
Intermediate,,A,13091,,,1,,,N,,9953,BAO_0000218,,1,,10116.0,992.0,50597,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,Rattus norvegicus,CHEMBL624069,Female gonad
Intermediate,,A,13091,,,1,,,N,,9954,BAO_0000218,,1,,10116.0,992.0,50597,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,Rattus norvegicus,CHEMBL624070,Female gonad
Intermediate,,A,13091,,,1,,,N,,9955,BAO_0000218,,1,,10116.0,992.0,50597,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,Rattus norvegicus,CHEMBL624071,Female gonad
Intermediate,,A,13091,,,1,,,N,,9956,BAO_0000218,,1,,10116.0,995.0,50597,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,Rattus norvegicus,CHEMBL624072,Uterus
Intermediate,,A,13091,,,1,,,N,,9957,BAO_0000218,,1,,10116.0,995.0,50597,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,Rattus norvegicus,CHEMBL624073,Uterus
Intermediate,,A,13091,,,1,,,N,,9958,BAO_0000218,,1,,10116.0,995.0,50597,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,Rattus norvegicus,CHEMBL624788,Uterus
Intermediate,,A,13091,,,1,,,N,,9959,BAO_0000218,,1,,10116.0,995.0,50597,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,Rattus norvegicus,CHEMBL624789,Uterus
Intermediate,,A,13091,,,1,,,N,,9960,BAO_0000218,,1,,10116.0,,50597,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,Rattus norvegicus,CHEMBL624790,
Intermediate,,A,13091,,,1,,,N,,9961,BAO_0000218,,1,,10116.0,,50597,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,Rattus norvegicus,CHEMBL624791,
Intermediate,,A,13091,,,1,,,N,,9962,BAO_0000218,,1,,10116.0,,50597,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,Rattus norvegicus,CHEMBL624792,
Intermediate,,A,13091,,,1,,,N,,9963,BAO_0000218,,1,,10116.0,,50597,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,Rattus norvegicus,CHEMBL624793,
Intermediate,,A,13091,,,1,,,N,,9964,BAO_0000218,,1,,10116.0,2385.0,50597,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,Rattus norvegicus,CHEMBL877491,Muscle tissue
Intermediate,,A,13091,,,1,,,N,,9965,BAO_0000218,,1,,10116.0,2385.0,50597,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,Rattus norvegicus,CHEMBL624957,Muscle tissue
Intermediate,,A,13091,,,1,,,N,,9966,BAO_0000218,,1,,10116.0,2385.0,50597,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,Rattus norvegicus,CHEMBL624958,Muscle tissue
Intermediate,,A,13091,,,1,,,N,,9967,BAO_0000218,,1,,10116.0,2385.0,50597,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,Rattus norvegicus,CHEMBL624959,Muscle tissue
Intermediate,,A,11977,,,1,,,N,,9968,BAO_0000218,,1,,10116.0,,50597,Dissociation constant was determined,Rattus norvegicus,CHEMBL624960,
Intermediate,,A,14941,,,1,,,N,,9969,BAO_0000218,,1,,10116.0,,50597,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",Rattus norvegicus,CHEMBL624961,
Intermediate,,A,15078,,,1,,,N,,9970,BAO_0000218,,1,,10116.0,,50597,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,CHEMBL624962,
Intermediate,,A,15078,,,1,,,N,,9971,BAO_0000218,,1,,10116.0,,50597,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,CHEMBL624963,
Intermediate,,A,4755,,,1,,,N,,9972,BAO_0000218,,1,,10116.0,,50597,Observed rate constant in 80% rat plasma at 37 degree Centigrade,Rattus norvegicus,CHEMBL624964,
Intermediate,,A,589,,,1,,,N,,9973,BAO_0000218,,1,,10116.0,,50597,LogP value was evaluated in the in situ rat gut perfusion assay,Rattus norvegicus,CHEMBL624965,
Intermediate,,A,17582,In vivo,,1,,,N,,9974,BAO_0000218,,1,,10116.0,,50597,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Rattus norvegicus,CHEMBL624966,
Intermediate,,A,5031,In vivo,,1,,,N,,9975,BAO_0000218,,1,,10116.0,,50597,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,Rattus norvegicus,CHEMBL624967,
Intermediate,,A,17764,In vivo,,1,,,N,,9976,BAO_0000218,,1,,10116.0,,50597,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,Rattus norvegicus,CHEMBL624968,
Intermediate,,A,17720,,,1,,,N,,9977,BAO_0000218,,1,,10116.0,,50597,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,CHEMBL624969,
Expert,,F,2862,,,1,,,N,,9978,BAO_0000218,,1,,10116.0,,50597,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,Rattus norvegicus,CHEMBL624970,
Intermediate,,A,16423,,,1,,,N,,9979,BAO_0000218,,1,,10116.0,,50597,Half-life was evaluated after 10 uM/kg of intra arterial administration,Rattus norvegicus,CHEMBL624971,
Intermediate,,A,16423,In vivo,,1,,,N,,9980,BAO_0000218,,1,,10116.0,,50597,Half-life was evaluated after 20 uM/kg of peroral administration,Rattus norvegicus,CHEMBL624972,
Intermediate,,A,6005,In vivo,,1,,,N,,9981,BAO_0000218,,1,,10116.0,,50597,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,Rattus norvegicus,CHEMBL624973,
Intermediate,,A,2938,,,1,,,N,,9982,BAO_0000218,,1,,10116.0,1969.0,50597,Half-life was evaluated in plasma of rat,Rattus norvegicus,CHEMBL624974,Plasma
Intermediate,,A,6410,In vivo,,1,,,N,,9983,BAO_0000218,,1,,10116.0,,50597,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,Rattus norvegicus,CHEMBL624975,
Intermediate,,A,6410,In vivo,,1,,,N,,9984,BAO_0000218,,1,,10116.0,,50597,Half-life was evaluated in rats at an oral dose of 30 mg/kg,Rattus norvegicus,CHEMBL877492,
Intermediate,,A,6062,In vivo,,1,,,N,,9985,BAO_0000218,,1,,10116.0,,50597,Half-life was measured in rat after an iv dose of 1 mg/kg,Rattus norvegicus,CHEMBL624976,
Intermediate,,A,6571,In vivo,,1,,,N,,9986,BAO_0000218,,1,,10116.0,,50597,Half-life period of compound in rats after peroral administration,Rattus norvegicus,CHEMBL624977,
Intermediate,,A,3136,,,1,,,N,,9987,BAO_0000218,,1,,10116.0,1969.0,50597,Half-life period of compound was measured in rat plasma.,Rattus norvegicus,CHEMBL626848,Plasma
Intermediate,,A,3136,,,1,,,N,,9988,BAO_0000218,,1,,10116.0,1969.0,50597,Half-life period of compound was measured in rat plasma; ND is not determined,Rattus norvegicus,CHEMBL626849,Plasma
Intermediate,,A,3136,,,1,,,N,,9989,BAO_0000218,,1,,10116.0,1969.0,50597,Half-life period of compound was measured in rat plasma; not determined,Rattus norvegicus,CHEMBL626850,Plasma
Intermediate,,A,4521,In vivo,,1,,,N,,9990,BAO_0000218,,1,,10116.0,,50597,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Rattus norvegicus,CHEMBL626851,
Intermediate,,A,5871,In vivo,,1,,,N,,9991,BAO_0000218,,1,,10116.0,,50597,Half-life period in rat by iv administration,Rattus norvegicus,CHEMBL626852,
Intermediate,,A,6077,In vivo,,1,,,N,,9992,BAO_0000218,,1,,10116.0,,50597,Half-life period in rats following intravenous administration at 2 mg/kg,Rattus norvegicus,CHEMBL626853,
Intermediate,,A,6679,In vivo,,1,,,N,,9993,BAO_0000218,,1,,10116.0,,50597,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Rattus norvegicus,CHEMBL626854,
Intermediate,,A,5144,,,1,,,N,,9994,BAO_0000218,,1,,10116.0,,50597,Half-life period was determined for the compound in rat,Rattus norvegicus,CHEMBL627486,
Intermediate,,A,4498,In vivo,,1,,,N,,9995,BAO_0000218,,1,,10116.0,,50597,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",Rattus norvegicus,CHEMBL627487,
Intermediate,,A,4498,In vivo,,1,,,N,,9996,BAO_0000218,,1,,10116.0,,50597,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",Rattus norvegicus,CHEMBL627488,
Intermediate,,A,1908,In vivo,,1,,,N,,9997,BAO_0000218,,1,,10116.0,,50597,Half-life value after IV dose at a dose of 5 mg/kg in rats.,Rattus norvegicus,CHEMBL627489,
Intermediate,,A,6211,In vivo,,1,,,N,,9998,BAO_0000218,,1,,10116.0,,50597,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,Rattus norvegicus,CHEMBL627490,
Intermediate,,A,5529,In vivo,,1,,,N,,9999,BAO_0000218,,1,,10116.0,,50597,Half-life was determined in rat after intravenous administration (0.5 mg/kg),Rattus norvegicus,CHEMBL873829,
Intermediate,,A,6444,In vivo,,1,,,N,,10000,BAO_0000218,,1,,10116.0,,50597,Half-life was determined in rat at a dose of 1 mpk i.v.,Rattus norvegicus,CHEMBL627655,
Intermediate,,A,6444,In vivo,,1,,,N,,10001,BAO_0000218,,1,,10116.0,,50597,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,Rattus norvegicus,CHEMBL625994,
Intermediate,,A,6444,In vivo,,1,,,N,,10002,BAO_0000218,,1,,10116.0,,50597,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,Rattus norvegicus,CHEMBL625995,
Intermediate,,A,5207,,,1,,,N,,10003,BAO_0000218,,1,,10116.0,,50597,Half-life in rat,Rattus norvegicus,CHEMBL625996,
Intermediate,,A,530,In vitro,,1,,,N,,10004,BAO_0000218,,1,,10116.0,1969.0,50597,In vitro half life in rat plasma,Rattus norvegicus,CHEMBL625850,Plasma
Intermediate,,A,1116,In vitro,,1,,,N,,10005,BAO_0000218,,1,,10116.0,1969.0,50597,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",Rattus norvegicus,CHEMBL625851,Plasma
Intermediate,,A,3219,In vitro,,1,,,N,,10006,BAO_0000218,,1,,10116.0,,50597,In vitro half life in rat,Rattus norvegicus,CHEMBL625852,
Intermediate,,A,6109,In vivo,,1,,,N,,10007,BAO_0000218,,1,,10116.0,,50597,In vivo half life period after intravenous administration in rat,Rattus norvegicus,CHEMBL625853,
Intermediate,,A,17582,In vivo,,1,,,N,,10008,BAO_0000218,,1,,10116.0,,50597,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Rattus norvegicus,CHEMBL625854,
Intermediate,,A,17582,In vivo,,1,,,N,,10009,BAO_0000218,,1,,10116.0,,50597,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,Rattus norvegicus,CHEMBL874450,
Intermediate,,A,5974,In vivo,,1,,,N,,10010,BAO_0000218,,1,,10116.0,,50597,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,CHEMBL625855,
Intermediate,,A,5974,In vivo,,1,,,N,,10011,BAO_0000218,,1,,10116.0,,50597,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,CHEMBL625856,
Intermediate,,A,5974,In vivo,,1,,,N,,10012,BAO_0000218,,1,,10116.0,,50597,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,CHEMBL625857,
Intermediate,,A,5974,In vivo,,1,,,N,,10013,BAO_0000218,,1,,10116.0,,50597,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,CHEMBL873831,
Intermediate,,A,17853,In vivo,,1,,,N,,10014,BAO_0000218,,1,,10116.0,,50597,Longer half-life in rat (i.v.) at 0.5 mpk,Rattus norvegicus,CHEMBL625858,
Intermediate,,A,17853,In vivo,,1,,,N,,10015,BAO_0000218,,1,,10116.0,,50597,Longer half-life in rat (p.o.) at 2.0 mpk,Rattus norvegicus,CHEMBL625859,
Intermediate,,A,3457,,,1,,,N,,10016,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (half life) in rat,Rattus norvegicus,CHEMBL625860,
Intermediate,,A,2792,In vivo,,1,,,N,,10017,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,Rattus norvegicus,CHEMBL625861,
Intermediate,,A,2792,In vivo,,1,,,N,,10018,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,Rattus norvegicus,CHEMBL625862,
Intermediate,,A,2792,In vivo,,1,,,N,,10019,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,Rattus norvegicus,CHEMBL625863,
Intermediate,,A,2792,In vivo,,1,,,N,,10020,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,Rattus norvegicus,CHEMBL625864,
Intermediate,,A,5739,In vivo,,1,,,N,,10021,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,Rattus norvegicus,CHEMBL625865,
Intermediate,,A,15765,In vivo,,1,,,N,,10022,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic half time was determined intravenously in rats.,Rattus norvegicus,CHEMBL625866,
Intermediate,,A,6567,In vivo,,1,,,N,,10023,BAO_0000218,,1,,10116.0,1969.0,50597,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,Rattus norvegicus,CHEMBL625867,Plasma
Intermediate,,A,2448,,,1,,,N,,10024,BAO_0000218,,1,,10116.0,1969.0,50597,Plasma half life of hydrolysis of the compound,Rattus norvegicus,CHEMBL625868,Plasma
Intermediate,,A,5423,In vivo,,1,,,N,,10025,BAO_0000218,,1,,10116.0,1969.0,50597,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,Rattus norvegicus,CHEMBL625869,Plasma
Intermediate,,A,4853,,,1,,,N,,10026,BAO_0000218,,1,,10116.0,1969.0,50597,Plasma half life period was calculated in rat,Rattus norvegicus,CHEMBL874451,Plasma
Intermediate,,A,4514,,,1,,,N,,10027,BAO_0000218,,1,,10116.0,1969.0,50597,Plasma half-life in Sprague-Dawley rats,Rattus norvegicus,CHEMBL625870,Plasma
Intermediate,,A,4514,,,1,,,N,,10028,BAO_0000218,,1,,10116.0,1969.0,50597,Plasma half-life in Sprague-Dawley rats; Not determined,Rattus norvegicus,CHEMBL625871,Plasma
Intermediate,,A,1500,,,1,,,N,,10029,BAO_0000218,,1,,10116.0,1969.0,50597,Plasma half-life in rats,Rattus norvegicus,CHEMBL625872,Plasma
Intermediate,,A,1500,,,1,,,N,,10030,BAO_0000218,,1,,10116.0,1969.0,50597,Plasma half-life in rats; <MQL,Rattus norvegicus,CHEMBL625873,Plasma
Intermediate,,A,5334,,,1,,,N,,10031,BAO_0000218,,1,,10116.0,1969.0,50597,Plasma half-life period (0-8 h) was determined,Rattus norvegicus,CHEMBL625874,Plasma
Intermediate,,A,5334,,,1,,,N,,10032,BAO_0000218,,1,,10116.0,1969.0,50597,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,Rattus norvegicus,CHEMBL625875,Plasma
Intermediate,,A,5334,In vivo,,1,,,N,,10033,BAO_0000218,,1,,10116.0,1969.0,50597,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Rattus norvegicus,CHEMBL625876,Plasma
Intermediate,,A,5334,In vivo,,1,,,N,,10034,BAO_0000218,,1,,10116.0,1969.0,50597,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Rattus norvegicus,CHEMBL631258,Plasma
Intermediate,,A,4956,,,1,,,N,,10035,BAO_0000218,,1,,10116.0,1969.0,50597,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,Rattus norvegicus,CHEMBL631259,Plasma
Intermediate,,A,4956,,,1,,,N,,10036,BAO_0000218,,1,,10116.0,1969.0,50597,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,Rattus norvegicus,CHEMBL631260,Plasma
Intermediate,,A,7768,,,1,,,N,,10037,BAO_0000218,,1,,10116.0,178.0,50597,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",Rattus norvegicus,CHEMBL631261,Blood
Intermediate,,A,7768,,,1,,,N,,10038,BAO_0000218,,1,,10116.0,178.0,50597,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",Rattus norvegicus,CHEMBL631262,Blood
Intermediate,,A,7768,,,1,,,N,,10039,BAO_0000218,,1,,10116.0,178.0,50597,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",Rattus norvegicus,CHEMBL631263,Blood
Intermediate,,A,7768,,,1,,,N,,10040,BAO_0000218,,1,,10116.0,,50597,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",Rattus norvegicus,CHEMBL631264,
Intermediate,,A,7768,,,1,,,N,,10041,BAO_0000218,,1,,10116.0,,50597,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",Rattus norvegicus,CHEMBL631265,
Intermediate,,A,7768,,,1,,,N,,10042,BAO_0000218,,1,,10116.0,,50597,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",Rattus norvegicus,CHEMBL631266,
Intermediate,,A,7768,,,1,,,N,,10043,BAO_0000218,,1,,10116.0,,50597,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",Rattus norvegicus,CHEMBL631267,
Intermediate,,A,7768,,,1,,,N,,10044,BAO_0000218,,1,,10116.0,,50597,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",Rattus norvegicus,CHEMBL631268,
Intermediate,,A,7768,,,1,,,N,,10045,BAO_0000218,,1,,10116.0,,50597,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",Rattus norvegicus,CHEMBL631269,
Intermediate,,A,7768,,,1,,,N,,10046,BAO_0000218,,1,,10116.0,,50597,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",Rattus norvegicus,CHEMBL631270,
Intermediate,,A,7768,,,1,,,N,,10047,BAO_0000218,,1,,10116.0,948.0,50597,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",Rattus norvegicus,CHEMBL631271,Heart
Intermediate,,A,7768,,,1,,,N,,10048,BAO_0000218,,1,,10116.0,948.0,50597,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",Rattus norvegicus,CHEMBL631272,Heart
Intermediate,,A,7768,,,1,,,N,,10049,BAO_0000218,,1,,10116.0,948.0,50597,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",Rattus norvegicus,CHEMBL631273,Heart
Intermediate,,A,7768,,,1,,,N,,10050,BAO_0000218,,1,,10116.0,948.0,50597,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",Rattus norvegicus,CHEMBL631274,Heart
Intermediate,,A,7768,,,1,,,N,,10051,BAO_0000218,,1,,10116.0,948.0,50597,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",Rattus norvegicus,CHEMBL631275,Heart
Intermediate,,A,7768,,,1,,,N,,10052,BAO_0000218,,1,,10116.0,948.0,50597,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",Rattus norvegicus,CHEMBL626984,Heart
Intermediate,,A,7768,,,1,,,N,,10053,BAO_0000218,,1,,10116.0,948.0,50597,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",Rattus norvegicus,CHEMBL626985,Heart
Intermediate,,A,7768,,,1,,,N,,10054,BAO_0000218,,1,,10116.0,2107.0,50597,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",Rattus norvegicus,CHEMBL626986,Liver
Intermediate,,A,7768,,,1,,,N,,10055,BAO_0000218,,1,,10116.0,2107.0,50597,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",Rattus norvegicus,CHEMBL626987,Liver
Intermediate,,A,7768,,,1,,,N,,10056,BAO_0000218,,1,,10116.0,2107.0,50597,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",Rattus norvegicus,CHEMBL626988,Liver
Intermediate,,A,7768,,,1,,,N,,10057,BAO_0000218,,1,,10116.0,2107.0,50597,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",Rattus norvegicus,CHEMBL626989,Liver
Intermediate,,A,7768,,,1,,,N,,10058,BAO_0000218,,1,,10116.0,2107.0,50597,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",Rattus norvegicus,CHEMBL626990,Liver
Intermediate,,A,7768,,,1,,,N,,10059,BAO_0000218,,1,,10116.0,2107.0,50597,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",Rattus norvegicus,CHEMBL626991,Liver
Intermediate,,A,7768,,,1,,,N,,10060,BAO_0000218,,1,,10116.0,2107.0,50597,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",Rattus norvegicus,CHEMBL626992,Liver
Intermediate,,A,7768,,,1,,,N,,10061,BAO_0000218,,1,,10116.0,2048.0,50597,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",Rattus norvegicus,CHEMBL626993,Lung
Intermediate,,A,7768,,,1,,,N,,10062,BAO_0000218,,1,,10116.0,2048.0,50597,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",Rattus norvegicus,CHEMBL874593,Lung
Intermediate,,A,7768,,,1,,,N,,10063,BAO_0000218,,1,,10116.0,2048.0,50597,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",Rattus norvegicus,CHEMBL626994,Lung
Intermediate,,A,7768,,,1,,,N,,10064,BAO_0000218,,1,,10116.0,2048.0,50597,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",Rattus norvegicus,CHEMBL626995,Lung
Intermediate,,A,7768,,,1,,,N,,10065,BAO_0000218,,1,,10116.0,2048.0,50597,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",Rattus norvegicus,CHEMBL626190,Lung
Intermediate,,A,7768,,,1,,,N,,10066,BAO_0000218,,1,,10116.0,2048.0,50597,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",Rattus norvegicus,CHEMBL626191,Lung
Intermediate,,A,7768,,,1,,,N,,10067,BAO_0000218,,1,,10116.0,2048.0,50597,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",Rattus norvegicus,CHEMBL626364,Lung
Intermediate,,A,7768,,,1,,,N,,10068,BAO_0000218,,1,,10116.0,2046.0,50597,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",Rattus norvegicus,CHEMBL626365,Thyroid gland
Intermediate,,A,7768,,,1,,,N,,10069,BAO_0000218,,1,,10116.0,2046.0,50597,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",Rattus norvegicus,CHEMBL626366,Thyroid gland
Intermediate,,A,7768,,,1,,,N,,10070,BAO_0000218,,1,,10116.0,2046.0,50597,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",Rattus norvegicus,CHEMBL626367,Thyroid gland
Intermediate,,A,7768,,,1,,,N,,10071,BAO_0000218,,1,,10116.0,2046.0,50597,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",Rattus norvegicus,CHEMBL626368,Thyroid gland
Intermediate,,A,7768,,,1,,,N,,10072,BAO_0000218,,1,,10116.0,2046.0,50597,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",Rattus norvegicus,CHEMBL626369,Thyroid gland
Intermediate,,A,7768,,,1,,,N,,10073,BAO_0000218,,1,,10116.0,2046.0,50597,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",Rattus norvegicus,CHEMBL626370,Thyroid gland
Intermediate,,A,4498,In vivo,,1,,,N,,10074,BAO_0000218,,1,,10116.0,,50597,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",Rattus norvegicus,CHEMBL626371,
Intermediate,,A,4498,In vivo,,1,,,N,,10075,BAO_0000218,,1,,10116.0,,50597,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",Rattus norvegicus,CHEMBL626372,
Intermediate,,A,3603,In vivo,,1,,,N,,10076,BAO_0000218,,1,,10116.0,,50597,Bioavailability after a dose of 10 mg/kg p.o.,Rattus norvegicus,CHEMBL626373,
Intermediate,,A,6215,In vivo,,1,,,N,,10077,BAO_0000218,,1,,10116.0,,50597,Bioavailability after peroral administration (10 mg/kg) was determined in rat,Rattus norvegicus,CHEMBL626374,
Intermediate,,A,5710,In vivo,,1,,,N,,10078,BAO_0000218,,1,,10116.0,,50597,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,Rattus norvegicus,CHEMBL626375,
Intermediate,,A,5710,In vivo,,1,,,N,,10079,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),Rattus norvegicus,CHEMBL626376,
Intermediate,,A,5676,In vivo,,1,,,N,,10080,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat po was determined,Rattus norvegicus,CHEMBL626377,
Intermediate,,A,17667,In vivo,,1,,,N,,10081,BAO_0000218,,1,,10116.0,,50597,Bioavailability of compound at 10 mg/kg in rat after oral administration,Rattus norvegicus,CHEMBL626378,
Intermediate,,A,17667,In vivo,,1,,,N,,10082,BAO_0000218,,1,,10116.0,,50597,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,Rattus norvegicus,CHEMBL626379,
Intermediate,,A,6848,In vivo,,1,,,N,,10083,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Rattus norvegicus,CHEMBL626380,
Intermediate,,A,6848,In vivo,,1,,,N,,10084,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Rattus norvegicus,CHEMBL626381,
Intermediate,,A,17267,In vivo,,1,,,N,,10085,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat,Rattus norvegicus,CHEMBL626382,
Intermediate,,A,6362,In vivo,,1,,,N,,10086,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat (Sprague-Dawley) (female),Rattus norvegicus,CHEMBL626383,
Intermediate,,A,17671,In vivo,,1,,,N,,10087,BAO_0000218,,1,,10116.0,,50597,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Rattus norvegicus,CHEMBL874652,
Intermediate,,A,17671,In vivo,,1,,,N,,10088,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),Rattus norvegicus,CHEMBL626384,
Intermediate,,A,4333,In vivo,,1,,,N,,10089,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,Rattus norvegicus,CHEMBL626385,
Intermediate,,A,6077,In vivo,,1,,,N,,10090,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat at an oral dose of 2 mg/kg,Rattus norvegicus,CHEMBL626386,
Intermediate,,A,3278,In vivo,,1,,,N,,10091,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat,Rattus norvegicus,CHEMBL626387,
Intermediate,,A,5964,In vivo,,1,,,N,,10092,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat,Rattus norvegicus,CHEMBL626388,
Intermediate,,A,4884,In vivo,,1,,,N,,10093,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat,Rattus norvegicus,CHEMBL626389,
Intermediate,,A,4905,In vivo,,1,,,N,,10094,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat,Rattus norvegicus,CHEMBL626390,
Intermediate,,A,4884,In vivo,,1,,,N,,10095,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,Rattus norvegicus,CHEMBL626391,
Intermediate,,A,6850,In vivo,,1,,,N,,10096,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat,Rattus norvegicus,CHEMBL626392,
Intermediate,,A,2864,In vivo,,1,,,N,,10097,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL626393,
Intermediate,,A,5780,In vivo,,1,,,N,,10098,BAO_0000218,,1,,10116.0,,50597,Bioavailability was determined in rat,Rattus norvegicus,CHEMBL623026,
Intermediate,,A,1465,In vivo,,1,,,N,,10099,BAO_0000218,,1,,10116.0,,50597,Bioavailability,Rattus norvegicus,CHEMBL623027,
Intermediate,,A,5199,In vivo,,1,,,N,,10100,BAO_0000218,,1,,10116.0,,50597,Bioavailability,Rattus norvegicus,CHEMBL623028,
Intermediate,,A,5765,In vivo,,1,,,N,,10101,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat after 1 day dosing,Rattus norvegicus,CHEMBL623029,
Intermediate,,A,5765,In vivo,,1,,,N,,10102,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat after 4 day dosing,Rattus norvegicus,CHEMBL623030,
Intermediate,,A,6518,In vivo,,1,,,N,,10103,BAO_0000218,,1,,10116.0,,50597,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,Rattus norvegicus,CHEMBL623031,
Intermediate,,A,6518,In vivo,,1,,,N,,10104,BAO_0000218,,1,,10116.0,,50597,Bioavailability after IV dosing at 1 mg/kg in rat; no data,Rattus norvegicus,CHEMBL623032,
Intermediate,,A,6518,In vivo,,1,,,N,,10105,BAO_0000218,,1,,10116.0,,50597,Bioavailability after oral administration at a dose of 2 mg/kg in rat,Rattus norvegicus,CHEMBL623033,
Intermediate,,A,6518,In vivo,,1,,,N,,10106,BAO_0000218,,1,,10116.0,,50597,Bioavailability after oral administration at a dose of 4 mg/kg in rat,Rattus norvegicus,CHEMBL623034,
Intermediate,,A,2083,In vivo,,1,,,N,,10107,BAO_0000218,,1,,10116.0,,50597,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,Rattus norvegicus,CHEMBL623035,
Intermediate,,A,17260,In vivo,,1,,,N,,10108,BAO_0000218,,1,,10116.0,,50597,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Rattus norvegicus,CHEMBL623036,
Intermediate,,A,4956,In vivo,,1,,,N,,10109,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Rattus norvegicus,CHEMBL623037,
Intermediate,,A,4368,In vivo,,1,,,N,,10110,BAO_0000218,,1,,10116.0,,50597,Bioavailability by intravenous administration of 3.4 mg/kg in rat,Rattus norvegicus,CHEMBL623038,
Intermediate,,A,17752,In vivo,,1,,,N,,10111,BAO_0000218,,1,,10116.0,1969.0,50597,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,Rattus norvegicus,CHEMBL874385,Plasma
Intermediate,,A,1446,In vivo,,1,,,N,,10112,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat (Fisher) (fasted),Rattus norvegicus,CHEMBL623039,
Intermediate,,A,2891,In vivo,,1,,,U,,10113,BAO_0000218,,0,,9443.0,,22224,Bioavailability in monkey after po administration of 10 mg/kg dose,Primates,CHEMBL623040,
Intermediate,,A,2891,In vivo,,1,,,U,,10114,BAO_0000218,,0,,9443.0,,22224,Oral bioavailability in monkey (dose 10 mg/kg),Primates,CHEMBL623041,
Intermediate,,A,6672,In vivo,,1,,,N,,10115,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat,Rattus norvegicus,CHEMBL623741,
Intermediate,,A,6673,In vivo,,1,,,N,,10116,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat,Rattus norvegicus,CHEMBL623742,
Intermediate,,A,17655,In vivo,,1,,,N,,10117,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat,Rattus norvegicus,CHEMBL623743,
Intermediate,,A,17796,In vivo,,1,,,N,,10118,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat,Rattus norvegicus,CHEMBL623744,
Intermediate,,A,17853,In vivo,,1,,,N,,10119,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat (dose 2.0 mg/kg p.o.),Rattus norvegicus,CHEMBL623745,
Intermediate,,A,4521,In vivo,,1,,,N,,10120,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),Rattus norvegicus,CHEMBL623746,
Intermediate,,A,4940,In vivo,,1,,,N,,10121,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (dose 5 mg/kg p.o.),Rattus norvegicus,CHEMBL623747,
Intermediate,,A,2891,In vivo,,1,,,U,,10122,BAO_0000218,,0,,10116.0,,22224,Bioavailability in rat after po administration of 30 mg/kg dose,Rattus norvegicus,CHEMBL623748,
Intermediate,,A,2891,In vivo,,1,,,U,,10123,BAO_0000218,,0,,10116.0,,22224,Bioavailability in rat after po administration of 30 mg/kg dose,Rattus norvegicus,CHEMBL623916,
Intermediate,,A,4521,In vivo,,1,,,N,,10124,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Rattus norvegicus,CHEMBL623917,
Intermediate,,A,17686,In vivo,,1,,,N,,10125,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat (dose 2 mg/kg i.v.),Rattus norvegicus,CHEMBL623918,
Intermediate,,A,17796,In vivo,,1,,,N,,10126,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat,Rattus norvegicus,CHEMBL874386,
Intermediate,,A,17796,In vivo,,1,,,N,,10127,BAO_0000218,,1,,10116.0,1969.0,50597,Bioavailability in rat; Only traces detected in rat plasma,Rattus norvegicus,CHEMBL623919,Plasma
Intermediate,,A,5064,In vivo,,1,,,N,,10128,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat,Rattus norvegicus,CHEMBL623920,
Intermediate,,A,5147,In vivo,,1,,,N,,10129,BAO_0000218,,1,,10116.0,,50597,Bioavailability upon oral administration of compound,Rattus norvegicus,CHEMBL623148,
Intermediate,,A,1916,In vivo,,1,,,N,,10130,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),Rattus norvegicus,CHEMBL623149,
Intermediate,,A,6049,In vivo,,1,,,N,,10131,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat,Rattus norvegicus,CHEMBL623150,
Intermediate,,A,1445,In vivo,,1,,,N,,10132,BAO_0000218,,1,,10116.0,,50597,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",Rattus norvegicus,CHEMBL623151,
Intermediate,,A,1445,In vivo,,1,,,N,,10133,BAO_0000218,,1,,10116.0,,50597,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",Rattus norvegicus,CHEMBL623152,
Expert,,F,2862,,,1,,,N,,10134,BAO_0000218,,1,,10116.0,,50597,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,Rattus norvegicus,CHEMBL623153,
Expert,,F,2862,,,1,,,N,,10135,BAO_0000218,,1,,10116.0,,50597,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,Rattus norvegicus,CHEMBL623154,
Intermediate,,A,4194,,,1,,,N,,10136,BAO_0000218,,1,,10116.0,,50597,In vitro and metabolic stability was determined,Rattus norvegicus,CHEMBL623155,
Intermediate,,A,4194,,,1,,,N,,10137,BAO_0000218,,1,,10116.0,,50597,In vitro metabolic stability in rat hepatocytes,Rattus norvegicus,CHEMBL623156,
Intermediate,,A,5486,,,1,,,N,,10138,BAO_0000218,,1,,10116.0,,50597,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,Rattus norvegicus,CHEMBL623157,
Intermediate,Hepatocyte,A,17582,In vitro,,1,,,N,401.0,10139,BAO_0000218,,1,,10116.0,2107.0,50597,Metabolic rate for compound was observed in rat hepatocytes,Rattus norvegicus,CHEMBL623158,Liver
Intermediate,,A,5600,,,1,,,N,,10140,BAO_0000218,,1,,10116.0,,50597,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,Rattus norvegicus,CHEMBL623159,
Intermediate,,A,14294,,,1,,,N,,10141,BAO_0000218,,1,,10116.0,,50597,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),Rattus norvegicus,CHEMBL874390,
Intermediate,,A,14294,,,1,,,N,,10142,BAO_0000218,,1,,10116.0,,50597,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),Rattus norvegicus,CHEMBL623160,
Intermediate,,A,14294,,,1,,,N,,10143,BAO_0000218,,1,,10116.0,,50597,Metabolism of compound in rat S9 microsomes; Trace,Rattus norvegicus,CHEMBL623161,
Intermediate,,A,17847,,,1,,,N,,10144,BAO_0000218,,1,,10116.0,,50597,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,Rattus norvegicus,CHEMBL623162,
Intermediate,,A,11020,,,1,,,N,,10145,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,Rattus norvegicus,CHEMBL623163,
Intermediate,,A,11020,,,1,,,N,,10146,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,Rattus norvegicus,CHEMBL623164,
Intermediate,,A,11020,,,1,,,N,,10147,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,Rattus norvegicus,CHEMBL623165,
Intermediate,,A,11020,,,1,,,N,,10148,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,Rattus norvegicus,CHEMBL623166,
Intermediate,,A,11020,,,1,,,N,,10149,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,Rattus norvegicus,CHEMBL624983,
Intermediate,,A,11020,,,1,,,N,,10150,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,Rattus norvegicus,CHEMBL624984,
Intermediate,,A,11020,,,1,,,N,,10151,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,Rattus norvegicus,CHEMBL624985,
Intermediate,,A,11020,,,1,,,N,,10152,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,Rattus norvegicus,CHEMBL622970,
Intermediate,,A,11020,,,1,,,N,,10153,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,Rattus norvegicus,CHEMBL622971,
Intermediate,,A,11020,,,1,,,N,,10154,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,Rattus norvegicus,CHEMBL622972,
Intermediate,,A,11020,,,1,,,N,,10155,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,Rattus norvegicus,CHEMBL622973,
Intermediate,,A,11020,,,1,,,N,,10156,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,Rattus norvegicus,CHEMBL622974,
Intermediate,,A,11020,,,1,,,N,,10157,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,Rattus norvegicus,CHEMBL622975,
Intermediate,,A,11020,,,1,,,N,,10158,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,Rattus norvegicus,CHEMBL622976,
Intermediate,,A,11020,,,1,,,N,,10159,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,Rattus norvegicus,CHEMBL622977,
Intermediate,,A,11020,,,1,,,N,,10160,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,Rattus norvegicus,CHEMBL624351,
Intermediate,,A,11020,,,1,,,N,,10161,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,Rattus norvegicus,CHEMBL624352,
Intermediate,,A,11020,,,1,,,N,,10162,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,Rattus norvegicus,CHEMBL624353,
Intermediate,,A,11020,,,1,,,N,,10163,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,Rattus norvegicus,CHEMBL622397,
Intermediate,,A,11020,,,1,,,N,,10164,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,Rattus norvegicus,CHEMBL622398,
Intermediate,,A,11020,,,1,,,N,,10165,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,Rattus norvegicus,CHEMBL622399,
Intermediate,,A,11020,,,1,,,N,,10166,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,Rattus norvegicus,CHEMBL622400,
Intermediate,,A,11020,,,1,,,N,,10167,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,Rattus norvegicus,CHEMBL628428,
Intermediate,,A,11020,,,1,,,N,,10168,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,Rattus norvegicus,CHEMBL628590,
Intermediate,,A,11020,,,1,,,N,,10169,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,Rattus norvegicus,CHEMBL628591,
Intermediate,,A,11020,,,1,,,N,,10170,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,Rattus norvegicus,CHEMBL628592,
Intermediate,,A,11020,,,1,,,N,,10171,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,Rattus norvegicus,CHEMBL628593,
Intermediate,,A,11020,,,1,,,N,,10172,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,Rattus norvegicus,CHEMBL875333,
Intermediate,,A,11020,,,1,,,N,,10173,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,Rattus norvegicus,CHEMBL628594,
Intermediate,,A,4969,,,1,,,N,,10174,BAO_0000218,,1,,10116.0,1969.0,50597,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,Rattus norvegicus,CHEMBL628595,Plasma
Intermediate,,A,6737,,,1,,,N,,10175,BAO_0000218,,1,,10116.0,1969.0,50597,Stability in rat plasma was determined,Rattus norvegicus,CHEMBL628596,Plasma
Intermediate,,A,6737,,,1,,,N,,10176,BAO_0000218,,1,,10116.0,1969.0,50597,Stability in rat plasma was determined; ND= no data,Rattus norvegicus,CHEMBL628597,Plasma
Intermediate,,A,5089,,,1,,,N,,10177,BAO_0000218,,1,,10116.0,1969.0,50597,Tested for plasma half life period in rat (0-8 hr),Rattus norvegicus,CHEMBL628598,Plasma
Intermediate,,A,5089,,,1,,,N,,10178,BAO_0000218,,1,,10116.0,1969.0,50597,Tested for plasma half life period in rat (0-8 hr); Not determined,Rattus norvegicus,CHEMBL628599,Plasma
Intermediate,,A,1466,In vivo,,1,,,N,,10179,BAO_0000218,,1,,10116.0,,50597,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,Rattus norvegicus,CHEMBL628600,
Intermediate,,A,1466,In vivo,,1,,,N,,10180,BAO_0000218,,1,,10116.0,,50597,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,Rattus norvegicus,CHEMBL628601,
Intermediate,,A,4950,,,1,,,N,,10181,BAO_0000218,,1,,10116.0,,50597,Tested for the half life in rat,Rattus norvegicus,CHEMBL628602,
Intermediate,,A,2412,In vitro,,1,,,N,,10182,BAO_0000218,,1,,10116.0,,50597,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,Rattus norvegicus,CHEMBL628603,
Intermediate,,A,2412,In vitro,,1,,,N,,10183,BAO_0000218,,1,,10116.0,,50597,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,Rattus norvegicus,CHEMBL628604,
Intermediate,,A,2412,In vitro,,1,,,N,,10184,BAO_0000218,,1,,10116.0,,50597,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,Rattus norvegicus,CHEMBL628605,
Intermediate,,A,2412,In vitro,,1,,,N,,10185,BAO_0000218,,1,,10116.0,,50597,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,Rattus norvegicus,CHEMBL628606,
Intermediate,,A,2412,In vitro,,1,,,N,,10186,BAO_0000218,,1,,10116.0,,50597,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,Rattus norvegicus,CHEMBL628607,
Intermediate,,A,15022,,,1,,,N,,10187,BAO_0000218,,1,,10116.0,,50597,The biological half life the compound was measured at the dose of 100 umol/kg,Rattus norvegicus,CHEMBL628608,
Intermediate,,A,15022,,,1,,,N,,10188,BAO_0000218,,1,,10116.0,,50597,The biological half life the compound was measured at the dose of 30 umol/kg,Rattus norvegicus,CHEMBL628609,
Intermediate,,A,406,,,1,,,N,,10189,BAO_0000218,,1,,10116.0,1969.0,50597,The compound was evaluated for plasma half life period in rat,Rattus norvegicus,CHEMBL628610,Plasma
Intermediate,,A,15078,In vivo,,1,,,N,,10190,BAO_0000218,,1,,10116.0,,50597,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,CHEMBL873819,
Intermediate,,A,15078,In vivo,,1,,,N,,10191,BAO_0000218,,1,,10116.0,,50597,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,CHEMBL628611,
Intermediate,,A,5247,In vivo,,1,,,N,,10192,BAO_0000218,,1,,10116.0,,50597,The pharmacokinetic parameter half-life period in vivo in rats,Rattus norvegicus,CHEMBL628612,
Intermediate,,A,5041,In vivo,,1,,,N,,10193,BAO_0000218,,1,,10116.0,,50597,"The pharmacokinetic property, Half-life was determined",Rattus norvegicus,CHEMBL628613,
Intermediate,,A,5041,In vivo,,1,,,N,,10194,BAO_0000218,,1,,10116.0,,50597,"The pharmacokinetic property, Half-life in rat in vivo",Rattus norvegicus,CHEMBL628614,
Intermediate,,A,5041,In vivo,,1,,,N,,10195,BAO_0000218,,1,,10116.0,,50597,"The pharmacokinetic property, Half-life was determined; ND denotes no data",Rattus norvegicus,CHEMBL628615,
Intermediate,,A,5041,In vivo,,1,,,N,,10196,BAO_0000218,,1,,10116.0,,50597,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",Rattus norvegicus,CHEMBL628616,
Intermediate,,A,3918,,,1,,,N,,10197,BAO_0000218,,1,,10116.0,1969.0,50597,The plasma half life period in rats,Rattus norvegicus,CHEMBL627924,Plasma
Intermediate,,A,2906,,,1,,,N,,10198,BAO_0000218,,1,,10116.0,2107.0,50597,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,Rattus norvegicus,CHEMBL627925,Liver
Intermediate,,A,6467,In vivo,,1,,,N,,10199,BAO_0000218,,1,,10116.0,,50597,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,Rattus norvegicus,CHEMBL627926,
Intermediate,,A,5510,,,1,,,N,,10200,BAO_0000218,,1,,10116.0,,50597,t1/2 (apparent elimination)of the compound was determined,Rattus norvegicus,CHEMBL627927,
Intermediate,,A,3788,,,1,,,N,,10201,BAO_0000218,,1,,10116.0,,50597,t1/2 value in rat,Rattus norvegicus,CHEMBL627928,
Intermediate,,A,17796,,,1,,,N,,10202,BAO_0000218,,1,,10116.0,,50597,Half life in rat,Rattus norvegicus,CHEMBL627539,
Intermediate,,A,12873,In vivo,,1,,,N,,10203,BAO_0000218,,1,,10116.0,1969.0,50597,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",Rattus norvegicus,CHEMBL876790,Plasma
Intermediate,,A,5983,In vivo,,1,,,N,,10204,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,Rattus norvegicus,CHEMBL858186,
Intermediate,,A,15765,,,1,,,N,,10205,BAO_0000218,,1,,10116.0,,50597,Half-life period in fasted rats,Rattus norvegicus,CHEMBL627540,
Intermediate,,A,2661,In vivo,,1,,,N,,10206,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,Rattus norvegicus,CHEMBL627541,
Intermediate,,A,2661,In vivo,,1,,,N,,10207,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,Rattus norvegicus,CHEMBL627715,
Intermediate,,A,429,In vivo,,1,,,N,,10208,BAO_0000218,,1,,10116.0,,50597,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,Rattus norvegicus,CHEMBL627716,
Intermediate,,A,17655,,,1,,,N,,10209,BAO_0000218,,1,,10116.0,,50597,Maximum time required to achieve Cmax was determined in rat,Rattus norvegicus,CHEMBL627717,
Intermediate,,A,17717,In vivo,,1,,,N,,10210,BAO_0000218,,1,,10116.0,,50597,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Rattus norvegicus,CHEMBL627718,
Intermediate,,A,17717,In vivo,,1,,,N,,10211,BAO_0000218,,1,,10116.0,,50597,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Rattus norvegicus,CHEMBL627719,
Intermediate,,A,17717,In vivo,,1,,,N,,10212,BAO_0000218,,1,,10116.0,,50597,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,Rattus norvegicus,CHEMBL627720,
Intermediate,,A,6570,In vivo,,1,,,N,,10213,BAO_0000218,,1,,10116.0,,50597,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,Rattus norvegicus,CHEMBL627721,
Intermediate,,A,6570,In vivo,,1,,,N,,10214,BAO_0000218,,1,,10116.0,,50597,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,Rattus norvegicus,CHEMBL627722,
Intermediate,,A,5978,In vivo,,1,,,N,,10215,BAO_0000218,,1,,10116.0,,50597,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,CHEMBL627723,
Intermediate,,A,5978,In vivo,,1,,,N,,10216,BAO_0000218,,1,,10116.0,,50597,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,CHEMBL626058,
Intermediate,,A,5978,In vivo,,1,,,N,,10217,BAO_0000218,,1,,10116.0,,50597,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,CHEMBL626059,
Intermediate,,A,5978,In vivo,,1,,,N,,10218,BAO_0000218,,1,,10116.0,,50597,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,CHEMBL626060,
Intermediate,,A,17720,In vivo,,1,,,N,,10219,BAO_0000218,,1,,10116.0,1969.0,50597,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,CHEMBL626061,Plasma
Intermediate,,A,4723,In vivo,,1,,,N,,10220,BAO_0000218,,1,,10116.0,,50597,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,CHEMBL876791,
Intermediate,,A,4723,In vivo,,1,,,N,,10221,BAO_0000218,,1,,10116.0,,50597,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,CHEMBL626062,
Intermediate,,A,4756,In vivo,,1,,,N,,10222,BAO_0000218,,1,,10116.0,,50597,Tmax at the dose of 2 mg/Kg administered perorally in rats,Rattus norvegicus,CHEMBL626063,
Intermediate,,A,4756,In vivo,,1,,,N,,10223,BAO_0000218,,1,,10116.0,,50597,Tmax at the dose of 5 mg/Kg administered perorally in rats,Rattus norvegicus,CHEMBL626064,
Intermediate,,A,17720,In vivo,,1,,,N,,10224,BAO_0000218,,1,,10116.0,1969.0,50597,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,CHEMBL626065,Plasma
Intermediate,,A,17720,In vivo,,1,,,N,,10225,BAO_0000218,,1,,10116.0,1969.0,50597,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,CHEMBL626066,Plasma
Intermediate,,A,1466,In vivo,,1,,,N,,10226,BAO_0000218,,1,,10116.0,,50597,tmax upon peroral administration of 10.0 mg/Kg dose in rat,Rattus norvegicus,CHEMBL626067,
Intermediate,,F,7449,,,1,,,N,,10227,BAO_0000218,,1,,10116.0,,50597,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,Rattus norvegicus,CHEMBL626068,
Intermediate,,F,7449,,,1,,,N,,10228,BAO_0000218,,1,,10116.0,,50597,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,Rattus norvegicus,CHEMBL626069,
Intermediate,,F,7449,,,1,,,N,,10229,BAO_0000218,,1,,10116.0,,50597,Percent total excretion of 3-methoxyacetaminophen glucuronide,Rattus norvegicus,CHEMBL626070,
Intermediate,,F,7449,,,1,,,N,,10230,BAO_0000218,,1,,10116.0,,50597,Percent total excretion of N-methoxyacetaminophen glucuronide,Rattus norvegicus,CHEMBL626071,
Intermediate,,F,7449,,,1,,,N,,10231,BAO_0000218,,1,,10116.0,,50597,Percent total excretion of N-methoxyacetaminophen sulfate,Rattus norvegicus,CHEMBL626072,
Intermediate,,F,7449,,,1,,,N,,10232,BAO_0000218,,1,,10116.0,,50597,Percent total excretion of acetaminophen,Rattus norvegicus,CHEMBL626073,
Intermediate,,A,7768,,,1,,,N,,10233,BAO_0000218,,1,,10116.0,2046.0,50597,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",Rattus norvegicus,CHEMBL626741,Thyroid gland
Intermediate,,A,17655,,,1,,,N,,10234,BAO_0000218,,1,,10116.0,,50597,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",Rattus norvegicus,CHEMBL626742,
Intermediate,,A,17735,,,1,,,N,,10235,BAO_0000218,,1,,10116.0,,50597,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,Rattus norvegicus,CHEMBL626743,
Intermediate,,A,5960,,,1,,,N,,10236,BAO_0000218,,1,,10116.0,,50597,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,Rattus norvegicus,CHEMBL876792,
Intermediate,,A,17735,,,1,,,N,,10237,BAO_0000218,,1,,10116.0,,50597,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,Rattus norvegicus,CHEMBL626744,
Intermediate,,A,7116,,,1,,,N,,10238,BAO_0000218,,1,,10116.0,,50597,Compound was tested for antidiuretic activity in rats,Rattus norvegicus,CHEMBL626745,
Intermediate,,A,4878,In vivo,,1,,,N,,10239,BAO_0000218,,1,,10116.0,1969.0,50597,AUC in rat after 3mg/kg oral dose,Rattus norvegicus,CHEMBL626746,Plasma
Intermediate,,A,5939,,,1,,,N,,10240,BAO_0000218,,1,,10116.0,,50597,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,Rattus norvegicus,CHEMBL626747,
Intermediate,,A,5939,,,1,,,N,,10241,BAO_0000218,,1,,10116.0,,50597,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,Rattus norvegicus,CHEMBL626748,
Intermediate,,A,16367,,,1,,,N,,10242,BAO_0000218,,1,,10116.0,,50597,Bioavailability administered orally at a dose of 10 mg/kg to rats,Rattus norvegicus,CHEMBL626749,
Intermediate,,A,16366,,,1,,,N,,10243,BAO_0000218,,1,,10116.0,,50597,Oral Bioavailability was determined,Rattus norvegicus,CHEMBL626750,
Intermediate,,A,4426,,,1,,,N,,10244,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL626751,
Intermediate,,A,4426,,,1,,,N,,10245,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat; Not performed.,Rattus norvegicus,CHEMBL626913,
Intermediate,,A,5041,,,1,,,N,,10246,BAO_0000218,,1,,10116.0,,50597,Bioavailability,Rattus norvegicus,CHEMBL626914,
Intermediate,,A,5041,,,1,,,N,,10247,BAO_0000218,,1,,10116.0,,50597,Bioavailability was determined; ND denotes no data,Rattus norvegicus,CHEMBL626915,
Intermediate,,A,1500,,,1,,,N,,10248,BAO_0000218,,1,,10116.0,,50597,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,Rattus norvegicus,CHEMBL626916,
Intermediate,,A,1500,,,1,,,N,,10249,BAO_0000218,,1,,10116.0,,50597,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,Rattus norvegicus,CHEMBL626917,
Intermediate,,A,17409,,,1,,,N,,10250,BAO_0000218,,1,,10116.0,,50597,Binding towards rat plasma protein at 10 uM,Rattus norvegicus,CHEMBL626918,
Intermediate,,A,17409,,,1,,,N,,10251,BAO_0000218,,1,,10116.0,,50597,Binding towards rat plasma protein at 100 uM,Rattus norvegicus,CHEMBL626919,
Intermediate,,A,2959,In vivo,,1,,,N,,10252,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat (dose 20 mg/kg p.o.),Rattus norvegicus,CHEMBL626920,
Intermediate,,A,13501,In vivo,,1,,,N,,10253,BAO_0000218,,1,,10116.0,,50597,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,Rattus norvegicus,CHEMBL621976,
Intermediate,,A,6567,In vivo,,1,,,N,,10254,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat after 5 mg/kg oral gavage,Rattus norvegicus,CHEMBL877599,
Intermediate,,A,6571,In vivo,,1,,,N,,10255,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat,Rattus norvegicus,CHEMBL621977,
Intermediate,,A,6715,In vivo,,1,,,N,,10256,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat (dose 1 mg/kg i.v.),Rattus norvegicus,CHEMBL621978,
Intermediate,,A,6715,In vivo,,1,,,N,,10257,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat (dose 3 mg/kg p.o.),Rattus norvegicus,CHEMBL621979,
Intermediate,,A,2932,In vivo,,1,,,N,,10258,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL621980,
Intermediate,,A,4171,In vivo,,1,,,N,,10259,BAO_0000218,,1,,10116.0,,50597,Bioavailability of the compound in rats after administration of 30 mg/kg,Rattus norvegicus,CHEMBL621981,
Intermediate,,A,17509,In vivo,,1,,,N,,10260,BAO_0000218,,1,,10116.0,,50597,Bioavailability after administration of 10 mg/kg in rats,Rattus norvegicus,CHEMBL621982,
Intermediate,,A,17509,In vivo,,1,,,N,,10261,BAO_0000218,,1,,10116.0,,50597,Bioavailability after administration of 2 mg/kg in rats,Rattus norvegicus,CHEMBL882953,
Intermediate,,A,4527,In vivo,,1,,,N,,10262,BAO_0000218,,1,,10116.0,,50597,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,Rattus norvegicus,CHEMBL621983,
Intermediate,,A,4026,In vivo,,1,,,N,,10263,BAO_0000218,,1,,10116.0,,50597,Bioavailability in dogs was determined; high,Rattus norvegicus,CHEMBL621984,
Intermediate,,A,6659,In vivo,,1,,,N,,10264,BAO_0000218,,1,,10116.0,,50597,Bioavailability in monkey after intravenous administration at 1 mpk,Rattus norvegicus,CHEMBL621985,
Intermediate,,A,6659,In vivo,,1,,,N,,10265,BAO_0000218,,1,,10116.0,,50597,Bioavailability in monkey after peroral administration at 10 mpk,Rattus norvegicus,CHEMBL621986,
Intermediate,,A,6659,In vivo,,1,,,N,,10266,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat after intravenous administration at 1 mpk,Rattus norvegicus,CHEMBL621987,
Intermediate,,F,6659,In vivo,,1,,,N,,10267,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat after intravenous administration at 2 mpk,Rattus norvegicus,CHEMBL877600,
Intermediate,,A,6659,In vivo,,1,,,N,,10268,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat after peroral administration at 30 mpk,Rattus norvegicus,CHEMBL621988,
Intermediate,,F,6659,In vivo,,1,,,N,,10269,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat after peroral administration at at 100 mpk,Rattus norvegicus,CHEMBL621989,
Intermediate,,A,6597,In vivo,,1,,,N,,10270,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rats was evaluated,Rattus norvegicus,CHEMBL621990,
Intermediate,,A,1202,In vivo,,1,,,N,,10271,BAO_0000218,,1,,10116.0,,50597,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,Rattus norvegicus,CHEMBL621991,
Intermediate,,A,1202,In vivo,,1,,,N,,10272,BAO_0000218,,1,,10116.0,,50597,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,Rattus norvegicus,CHEMBL621992,
Intermediate,,A,1202,In vivo,,1,,,N,,10273,BAO_0000218,,1,,10116.0,,50597,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,Rattus norvegicus,CHEMBL621993,
Intermediate,,A,1202,In vivo,,1,,,N,,10274,BAO_0000218,,1,,10116.0,,50597,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,Rattus norvegicus,CHEMBL621994,
Intermediate,,A,5207,In vivo,,1,,,N,,10275,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat,Rattus norvegicus,CHEMBL621995,
Intermediate,,A,5970,In vivo,,1,,,N,,10276,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat,Rattus norvegicus,CHEMBL621996,
Intermediate,,A,17538,In vivo,,1,,,N,,10277,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (dose 10 mg/kg),Rattus norvegicus,CHEMBL621997,
Intermediate,,A,17538,In vivo,,1,,,N,,10278,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,Rattus norvegicus,CHEMBL621998,
Intermediate,,A,1466,In vivo,,1,,,N,,10279,BAO_0000218,,1,,10116.0,,50597,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,Rattus norvegicus,CHEMBL621999,
Intermediate,,A,2879,In vivo,,1,,,N,,10280,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL622000,
Intermediate,,A,2879,In vivo,,1,,,N,,10281,BAO_0000218,,1,,10116.0,,50597,Bioavailability was measured in rat after oral administration; 2-4,Rattus norvegicus,CHEMBL622001,
Intermediate,,A,2879,In vivo,,1,,,N,,10282,BAO_0000218,,1,,10116.0,,50597,Bioavailability was measured in rat after oral administration; 3-7,Rattus norvegicus,CHEMBL622002,
Intermediate,,A,3777,In vivo,,1,,,N,,10283,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat (intraduodenal administration),Rattus norvegicus,CHEMBL622003,
Intermediate,,A,3777,In vivo,,1,,,N,,10284,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat (intraduodenal administration),Rattus norvegicus,CHEMBL877601,
Intermediate,,A,3777,In vivo,,1,,,N,,10285,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL624871,
Intermediate,,A,3777,In vivo,,1,,,N,,10286,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL622004,
Intermediate,,A,5423,In vivo,,1,,,N,,10287,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),Rattus norvegicus,CHEMBL882954,
Intermediate,,A,16365,In vivo,,1,,,N,,10288,BAO_0000218,,1,,10116.0,,50597,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,Rattus norvegicus,CHEMBL622005,
Intermediate,,A,16365,In vivo,,1,,,N,,10289,BAO_0000218,,1,,10116.0,,50597,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,Rattus norvegicus,CHEMBL622006,
Intermediate,,A,4239,In vivo,,1,,,N,,10290,BAO_0000218,,1,,10116.0,,50597,Bioavailability was measured in rat,Rattus norvegicus,CHEMBL622007,
Intermediate,,A,5438,In vivo,,1,,,N,,10291,BAO_0000218,,1,,10116.0,,50597,Bioavailability was reported,Rattus norvegicus,CHEMBL622008,
Intermediate,,A,5334,In vivo,,1,,,N,,10292,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Rattus norvegicus,CHEMBL622009,
Intermediate,,A,5334,In vivo,,1,,,N,,10293,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Rattus norvegicus,CHEMBL622010,
Intermediate,,A,4199,In vivo,,1,,,N,,10294,BAO_0000218,,1,,10116.0,,50597,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,Rattus norvegicus,CHEMBL622011,
Intermediate,,A,4199,In vivo,,1,,,N,,10295,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),Rattus norvegicus,CHEMBL622012,
Intermediate,,A,4199,In vivo,,1,,,N,,10296,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),Rattus norvegicus,CHEMBL622013,
Intermediate,,A,4890,In vivo,,1,,,N,,10297,BAO_0000218,,1,,10116.0,,50597,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,CHEMBL622014,
Intermediate,,A,2792,In vivo,,1,,,N,,10298,BAO_0000218,,1,,10116.0,,50597,Bioavailability was determined at 3 mg/kg po dose in rats,Rattus norvegicus,CHEMBL624749,
Intermediate,,A,5529,In vivo,,1,,,N,,10299,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (dose 2 mg/kg),Rattus norvegicus,CHEMBL624750,
Intermediate,,A,6685,In vivo,,1,,,N,,10300,BAO_0000218,,1,,10116.0,,50597,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",Rattus norvegicus,CHEMBL624751,
Intermediate,,A,6685,In vivo,,1,,,N,,10301,BAO_0000218,,1,,10116.0,,50597,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",Rattus norvegicus,CHEMBL624752,
Intermediate,,A,6685,In vivo,,1,,,N,,10302,BAO_0000218,,1,,10116.0,,50597,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Rattus norvegicus,CHEMBL624753,
Intermediate,,A,6005,In vivo,,1,,,N,,10303,BAO_0000218,,1,,10116.0,,50597,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,Rattus norvegicus,CHEMBL624754,
Intermediate,,A,6410,In vivo,,1,,,N,,10304,BAO_0000218,,1,,10116.0,,50597,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,Rattus norvegicus,CHEMBL624755,
Intermediate,,A,6410,In vivo,,1,,,N,,10305,BAO_0000218,,1,,10116.0,,50597,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,Rattus norvegicus,CHEMBL624756,
Intermediate,,A,6103,In vivo,,1,,,N,,10306,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat,Rattus norvegicus,CHEMBL624757,
Intermediate,,A,6410,In vivo,,1,,,N,,10307,BAO_0000218,,1,,10116.0,,50597,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,Rattus norvegicus,CHEMBL624758,
Intermediate,,A,6410,In vivo,,1,,,N,,10308,BAO_0000218,,1,,10116.0,,50597,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,Rattus norvegicus,CHEMBL622270,
Intermediate,,A,5353,In vivo,,1,,,N,,10309,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat (Sprague-Dawley),Rattus norvegicus,CHEMBL622271,
Intermediate,,A,4727,In vivo,,1,,,N,,10310,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat at the dose of 2 mg/kg,Rattus norvegicus,CHEMBL622272,
Intermediate,,A,17804,In vivo,,1,,,N,,10311,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL622273,
Intermediate,,A,5809,In vivo,,1,,,N,,10312,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat (cannulated) (dose 2 mg/kg),Rattus norvegicus,CHEMBL622274,
Intermediate,,A,17804,In vivo,,1,,,N,,10313,BAO_0000218,,1,,10116.0,,50597,Bioavailability value of compound in rats was determined after peroral administration,Rattus norvegicus,CHEMBL622275,
Intermediate,,A,3634,In vivo,,1,,,N,,10314,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (dose 20 mg/kg),Rattus norvegicus,CHEMBL622276,
Intermediate,,A,3341,In vivo,,1,,,N,,10315,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL622277,
Intermediate,,A,2690,In vivo,,1,,,N,,10316,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (dose 5 mg/kg),Rattus norvegicus,CHEMBL622278,
Intermediate,,A,3184,In vivo,,1,,,N,,10317,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL622279,
Intermediate,,A,740,In vivo,,1,,,N,,10318,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL622280,
Intermediate,,A,1806,In vivo,,1,,,N,,10319,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for oral bioavailability in rats; 15-27 %,Rattus norvegicus,CHEMBL624083,
Intermediate,,A,4891,In vivo,,1,,,N,,10320,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,Rattus norvegicus,CHEMBL624084,
Intermediate,,A,3634,In vivo,,1,,,N,,10321,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),Rattus norvegicus,CHEMBL624085,
Intermediate,,A,64,In vivo,,1,,,N,,10322,BAO_0000218,,1,,10116.0,,50597,Compound was tested for bioavailability in rats,Rattus norvegicus,CHEMBL624086,
Intermediate,,A,4839,In vivo,,1,,,N,,10323,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat,Rattus norvegicus,CHEMBL624087,
Intermediate,,A,1094,In vivo,,1,,,N,,10324,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL624088,
Intermediate,,A,5005,In vivo,,1,,,U,,10325,BAO_0000218,,0,,9544.0,,22224,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,Macaca mulatta,CHEMBL624089,
Intermediate,,A,5005,In vivo,,1,,,U,,10326,BAO_0000218,,0,,10116.0,,22224,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Rattus norvegicus,CHEMBL624090,
Intermediate,,A,4687,In vivo,,1,,,N,,10327,BAO_0000218,,1,,10116.0,,50597,Evaluated for the bioavailability in rat (in vivo),Rattus norvegicus,CHEMBL624091,
Intermediate,,A,17804,In vivo,,1,,,N,,10328,BAO_0000218,,1,,10116.0,,50597,F value of compound in rats was determined after peroral administration,Rattus norvegicus,CHEMBL624092,
Intermediate,,A,5974,In vivo,,1,,,N,,10329,BAO_0000218,,1,,10116.0,,50597,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,CHEMBL624093,
Intermediate,,A,5974,In vivo,,1,,,N,,10330,BAO_0000218,,1,,10116.0,,50597,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,CHEMBL624094,
Intermediate,,A,5974,In vivo,,1,,,N,,10331,BAO_0000218,,1,,10116.0,,50597,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,CHEMBL624095,
Intermediate,,A,5974,In vivo,,1,,,N,,10332,BAO_0000218,,1,,10116.0,,50597,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,CHEMBL624096,
Intermediate,,A,1088,In vivo,,1,,,N,,10333,BAO_0000218,,1,,10116.0,,50597,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",Rattus norvegicus,CHEMBL624097,
Intermediate,,A,1742,In vivo,,1,,,N,,10334,BAO_0000218,,1,,10116.0,,50597,Maximum fall in carotid flow in rat,Rattus norvegicus,CHEMBL624098,
Intermediate,,A,4689,In vivo,,1,,,N,,10335,BAO_0000218,,1,,10116.0,,50597,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,Rattus norvegicus,CHEMBL874392,
Intermediate,,A,2463,In vivo,,1,,,N,,10336,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (dose 5 mg/kg),Rattus norvegicus,CHEMBL624099,
Intermediate,,A,5654,In vivo,,1,,,N,,10337,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Rattus norvegicus,CHEMBL624100,
Intermediate,,A,5654,In vivo,,1,,,N,,10338,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Rattus norvegicus,CHEMBL624101,
Intermediate,,A,6874,In vivo,,1,,,N,,10339,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (male Wistar),Rattus norvegicus,CHEMBL624102,
Intermediate,,A,5633,In vivo,,1,,,N,,10340,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability after administration (30 mg/kg) in rat; good,Rattus norvegicus,CHEMBL624103,
Intermediate,,A,5496,In vivo,,1,,,N,,10341,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability at the dose of 2 mg/kg in rat,Rattus norvegicus,CHEMBL624104,
Intermediate,,A,2358,In vivo,,1,,,N,,10342,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability determined in rats,Rattus norvegicus,CHEMBL624105,
Intermediate,,A,16456,In vivo,,1,,,N,,10343,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),Rattus norvegicus,CHEMBL624106,
Intermediate,,A,5302,In vivo,,1,,,N,,10344,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (dose single 10 mg/kg),Rattus norvegicus,CHEMBL624107,
Intermediate,,A,5302,In vivo,,1,,,N,,10345,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (dose single 10 mg/kg),Rattus norvegicus,CHEMBL623943,
Intermediate,,A,5302,In vivo,,1,,,N,,10346,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (dose 5 mg/kg,Rattus norvegicus,CHEMBL623944,
Intermediate,,A,11020,,,1,,,N,,10347,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,Rattus norvegicus,CHEMBL623945,
Intermediate,,A,11020,,,1,,,N,,10348,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,Rattus norvegicus,CHEMBL623946,
Intermediate,,A,11020,,,1,,,N,,10349,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,Rattus norvegicus,CHEMBL623947,
Intermediate,,A,11020,,,1,,,N,,10350,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,Rattus norvegicus,CHEMBL623948,
Intermediate,,A,11020,,,1,,,N,,10351,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,Rattus norvegicus,CHEMBL623949,
Intermediate,,A,11020,,,1,,,N,,10352,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,Rattus norvegicus,CHEMBL623950,
Intermediate,,A,11020,,,1,,,N,,10353,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,Rattus norvegicus,CHEMBL874398,
Intermediate,,A,11020,,,1,,,N,,10354,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,Rattus norvegicus,CHEMBL623951,
Intermediate,,A,11020,,,1,,,N,,10355,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,Rattus norvegicus,CHEMBL623952,
Intermediate,,A,11020,,,1,,,N,,10356,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,Rattus norvegicus,CHEMBL623953,
Intermediate,,A,11020,,,1,,,N,,10357,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,Rattus norvegicus,CHEMBL623954,
Intermediate,,A,11020,,,1,,,N,,10358,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,Rattus norvegicus,CHEMBL623955,
Intermediate,,A,11020,,,1,,,N,,10359,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,Rattus norvegicus,CHEMBL623956,
Intermediate,,A,11020,,,1,,,N,,10360,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,Rattus norvegicus,CHEMBL627807,
Intermediate,,A,11020,,,1,,,N,,10361,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,Rattus norvegicus,CHEMBL627808,
Intermediate,,A,11020,,,1,,,N,,10362,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,Rattus norvegicus,CHEMBL627809,
Intermediate,,A,11020,,,1,,,N,,10363,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,Rattus norvegicus,CHEMBL627810,
Intermediate,,A,11020,,,1,,,N,,10364,BAO_0000218,,1,,10116.0,,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",Rattus norvegicus,CHEMBL627811,
Intermediate,,A,11020,,,1,,,N,,10365,BAO_0000218,,1,,10116.0,,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",Rattus norvegicus,CHEMBL627812,
Intermediate,,A,11020,,,1,,,N,,10366,BAO_0000218,,1,,10116.0,,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",Rattus norvegicus,CHEMBL627813,
Intermediate,,A,11020,,,1,,,N,,10367,BAO_0000218,,1,,10116.0,,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",Rattus norvegicus,CHEMBL627814,
Intermediate,,A,11020,,,1,,,N,,10368,BAO_0000218,,1,,10116.0,,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",Rattus norvegicus,CHEMBL875336,
Intermediate,,A,11020,,,1,,,N,,10369,BAO_0000218,,1,,10116.0,,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",Rattus norvegicus,CHEMBL627815,
Intermediate,,A,11020,,,1,,,N,,10370,BAO_0000218,,1,,10116.0,,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",Rattus norvegicus,CHEMBL627816,
Intermediate,,A,11020,,,1,,,N,,10371,BAO_0000218,,1,,10116.0,,50597,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",Rattus norvegicus,CHEMBL627817,
Intermediate,,A,11020,,,1,,,N,,10372,BAO_0000218,,1,,10116.0,,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",Rattus norvegicus,CHEMBL627818,
Intermediate,,A,11020,,,1,,,N,,10373,BAO_0000218,,1,,10116.0,,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",Rattus norvegicus,CHEMBL627819,
Intermediate,,A,11020,,,1,,,N,,10374,BAO_0000218,,1,,10116.0,,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",Rattus norvegicus,CHEMBL627820,
Intermediate,,A,11020,,,1,,,N,,10375,BAO_0000218,,1,,10116.0,,50597,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",Rattus norvegicus,CHEMBL627821,
Intermediate,,A,11020,,,1,,,N,,10376,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,Rattus norvegicus,CHEMBL628464,
Intermediate,,A,11020,,,1,,,N,,10377,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,Rattus norvegicus,CHEMBL626239,
Intermediate,,A,11020,,,1,,,N,,10378,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,Rattus norvegicus,CHEMBL626240,
Intermediate,,A,11020,,,1,,,N,,10379,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,Rattus norvegicus,CHEMBL626241,
Intermediate,,A,11020,,,1,,,N,,10380,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,Rattus norvegicus,CHEMBL626242,
Intermediate,,A,11020,,,1,,,N,,10381,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,Rattus norvegicus,CHEMBL626243,
Intermediate,,A,11020,,,1,,,N,,10382,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,Rattus norvegicus,CHEMBL626244,
Intermediate,,A,11020,,,1,,,N,,10383,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,Rattus norvegicus,CHEMBL626907,
Intermediate,,A,11020,,,1,,,N,,10384,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,Rattus norvegicus,CHEMBL626908,
Intermediate,,A,11020,,,1,,,N,,10385,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,Rattus norvegicus,CHEMBL626909,
Intermediate,,A,11020,,,1,,,N,,10386,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,Rattus norvegicus,CHEMBL626910,
Intermediate,,F,7449,,,1,,,N,,10387,BAO_0000218,,1,,10116.0,,50597,Percent total excretion of acetaminophen cysteine conjugate,Rattus norvegicus,CHEMBL875342,
Intermediate,,F,7449,,,1,,,N,,10388,BAO_0000218,,1,,10116.0,,50597,Percent total excretion of acetaminophen glucuronide,Rattus norvegicus,CHEMBL626911,
Intermediate,,F,7449,,,1,,,N,,10389,BAO_0000218,,1,,10116.0,,50597,Percent total excretion of acetaminophen sulfate,Rattus norvegicus,CHEMBL626912,
Intermediate,,F,7449,,,1,,,N,,10390,BAO_0000218,,1,,10116.0,,50597,Percent total excretion of acetaminophen-mercapturic acid,Rattus norvegicus,CHEMBL627065,
Intermediate,,A,3172,,,1,,,N,,10391,BAO_0000218,,1,,10116.0,1088.0,50597,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,Rattus norvegicus,CHEMBL627066,Urine
Intermediate,,A,16456,In vivo,,1,,,N,,10392,BAO_0000218,,1,,10116.0,,50597,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Rattus norvegicus,CHEMBL627067,
Autocuration,,A,10839,In vivo,,1,,,U,,10393,BAO_0000218,,0,,8656.0,2385.0,22224,Biodistribution of compound in rat muscle after 5 min of administration,ratrat,CHEMBL627068,Muscle tissue
Autocuration,,A,10839,In vivo,,1,,,U,,10394,BAO_0000218,,0,,8656.0,2385.0,22224,Biodistribution of compound in rat muscle after 5 min of administration.,ratrat,CHEMBL627069,Muscle tissue
Autocuration,,A,5334,In vivo,,1,,,U,,10395,BAO_0000218,,0,,9940.0,,22224,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Ovis aries,CHEMBL627070,
Autocuration,,A,5334,In vivo,,1,,,U,,10396,BAO_0000218,,0,,9940.0,,22224,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Ovis aries,CHEMBL627071,
Autocuration,,A,5334,In vivo,,1,,,U,,10397,BAO_0000218,,0,,9940.0,,22224,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Ovis aries,CHEMBL627072,
Autocuration,,A,5334,In vivo,,1,,,U,,10398,BAO_0000218,,0,,9940.0,,22224,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Ovis aries,CHEMBL627073,
Autocuration,,A,5334,In vivo,,1,,,U,,10399,BAO_0000218,,0,,9940.0,,22224,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Ovis aries,CHEMBL625387,
Autocuration,,A,5334,In vivo,,1,,,U,,10400,BAO_0000218,,0,,9940.0,,22224,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Ovis aries,CHEMBL625388,
Autocuration,,A,5334,In vivo,,1,,,U,,10401,BAO_0000218,,0,,9940.0,1969.0,22224,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Ovis aries,CHEMBL625389,Plasma
Autocuration,,A,5334,In vivo,,1,,,U,,10402,BAO_0000218,,0,,9940.0,1969.0,22224,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Ovis aries,CHEMBL875343,Plasma
Intermediate,,A,1735,,,1,,,N,,10403,BAO_0000218,,1,,8570.0,,50497,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),Serpentes,CHEMBL876795,
Intermediate,,A,1469,,,1,,,N,,10404,BAO_0000218,,1,,8570.0,,50497,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,Serpentes,CHEMBL626552,
Intermediate,,A,1336,,,1,,,N,,10405,BAO_0000218,,1,,8570.0,,50497,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,Serpentes,CHEMBL626553,
Autocuration,,A,12403,,,1,,,U,,10406,BAO_0000366,,0,,9606.0,1969.0,22224,The human biological plasma half life of the compound,Homo sapiens,CHEMBL626554,Plasma
Intermediate,,A,8151,,,1,,,N,,10407,BAO_0000218,,1,,10116.0,1088.0,50597,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Rattus norvegicus,CHEMBL626555,Urine
Intermediate,,A,8004,,,1,,,N,,10408,BAO_0000218,,1,,10116.0,,50597,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,Rattus norvegicus,CHEMBL626556,
Intermediate,,A,8004,,,1,,,N,,10409,BAO_0000218,,1,,10116.0,,50597,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,Rattus norvegicus,CHEMBL626557,
Intermediate,,A,8004,,,1,,,N,,10410,BAO_0000218,,1,,10116.0,,50597,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,Rattus norvegicus,CHEMBL626558,
Intermediate,,A,8004,,,1,,,N,,10411,BAO_0000218,,1,,10116.0,,50597,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,Rattus norvegicus,CHEMBL626559,
Intermediate,,A,8004,,,1,,,N,,10412,BAO_0000218,,1,,10116.0,,50597,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,Rattus norvegicus,CHEMBL626560,
Intermediate,,A,8004,,,1,,,N,,10413,BAO_0000218,,1,,10116.0,,50597,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,Rattus norvegicus,CHEMBL876803,
Intermediate,,A,8004,,,1,,,N,,10414,BAO_0000218,,1,,10116.0,,50597,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,Rattus norvegicus,CHEMBL627964,
Intermediate,,A,8004,,,1,,,N,,10415,BAO_0000218,,1,,10116.0,,50597,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,Rattus norvegicus,CHEMBL627965,
Intermediate,,A,8004,,,1,,,N,,10416,BAO_0000218,,1,,10116.0,,50597,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,Rattus norvegicus,CHEMBL627966,
Intermediate,,A,8004,,,1,,,N,,10417,BAO_0000218,,1,,10116.0,,50597,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,Rattus norvegicus,CHEMBL627967,
Intermediate,,A,8004,,,1,,,N,,10418,BAO_0000218,,1,,10116.0,,50597,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,Rattus norvegicus,CHEMBL627968,
Intermediate,,A,8004,,,1,,,N,,10419,BAO_0000218,,1,,10116.0,,50597,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,Rattus norvegicus,CHEMBL627969,
Intermediate,,A,8004,,,1,,,N,,10420,BAO_0000218,,1,,10116.0,,50597,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,Rattus norvegicus,CHEMBL627970,
Intermediate,,A,8004,,,1,,,N,,10421,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,Rattus norvegicus,CHEMBL627971,Blood
Intermediate,,A,8004,,,1,,,N,,10422,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,Rattus norvegicus,CHEMBL627972,Blood
Expert,,B,15917,,,1,,,D,,10423,BAO_0000357,,9,,9606.0,,180,Dissociation constant against binding to human cyclophilin A,Homo sapiens,CHEMBL856029,
Expert,,B,12396,,,1,,,H,,10424,BAO_0000019,,8,,9913.0,,11591,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,Bos taurus,CHEMBL627973,
Autocuration,,A,7065,,,1,,,U,,10425,BAO_0000019,,0,,,,22224,-Log C was determined by performing the electroshock minimum test,,CHEMBL627974,
Autocuration,,A,7065,,,1,,,U,,10426,BAO_0000019,,0,,,,22224,-Log C was determined by performing the foot shock test,,CHEMBL627975,
Autocuration,,A,7065,,,1,,,U,,10427,BAO_0000019,,0,,,,22224,-Log C was determined by performing the incl screen test,,CHEMBL627976,
Autocuration,,A,7065,,,1,,,U,,10428,BAO_0000019,,0,,,,22224,-Log C was determined by performing the maximum electroshock test,,CHEMBL627977,
Autocuration,,A,7065,,,1,,,U,,10429,BAO_0000019,,0,,,,22224,-Log C was determined by performing the pentylenetetrazole test,,CHEMBL627978,
Autocuration,,A,12415,,,1,,,U,,10430,BAO_0000019,,0,,,,22224,Tested for experimental arotinoid inhibitory dose,,CHEMBL627979,
Autocuration,,A,10256,,,1,,,U,,10431,BAO_0000019,,0,,,,22224,Negative log transformed activity,,CHEMBL876804,
Autocuration,,A,7991,,,1,,,U,,10432,BAO_0000019,,0,,,,22224,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",,CHEMBL627980,
Intermediate,,A,14342,,,1,,,N,,10433,BAO_0000218,,1,,10141.0,,50512,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,Cavia porcellus,CHEMBL627981,
Intermediate,,A,14342,,,1,,,N,,10434,BAO_0000218,,1,,10141.0,,50512,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,Cavia porcellus,CHEMBL627982,
Intermediate,,A,14342,,,1,,,N,,10435,BAO_0000218,,1,,10141.0,,50512,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,Cavia porcellus,CHEMBL627983,
Intermediate,,A,14342,,,1,,,N,,10436,BAO_0000218,,1,,10141.0,2116.0,50512,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,Cavia porcellus,CHEMBL627984,Ileum
Autocuration,,P,6047,,,1,,,U,,10437,BAO_0000100,,0,,,,22229,Solubility in water was determined; values expressed as -log,,CHEMBL627985,
Autocuration,,A,17269,,,1,,,U,,10438,BAO_0000019,,0,,,,22224,Ratio of Kcat to that of Km was determined,,CHEMBL627986,
Autocuration,,A,10026,,,1,,,U,,10439,BAO_0000019,,0,,,,22224,Observed first order rate constant,,CHEMBL627987,
Autocuration,,A,14583,,,1,,,U,,10440,BAO_0000019,,0,,,,22224,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,,CHEMBL627988,
Intermediate,,A,2661,In vivo,,1,,,N,,10441,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,Rattus norvegicus,CHEMBL627989,
Intermediate,,A,2661,In vivo,,1,,,N,,10442,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,Rattus norvegicus,CHEMBL627990,
Intermediate,,A,4029,In vivo,,1,,,N,,10443,BAO_0000218,,1,,10116.0,,50597,Oral Bioavailability after administration of 10 mg/kg in male rat,Rattus norvegicus,CHEMBL876805,
Intermediate,,A,17735,In vivo,,1,,,N,,10444,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),Rattus norvegicus,CHEMBL627991,
Intermediate,,A,4576,In vivo,,1,,,N,,10445,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL627992,
Intermediate,,A,17582,In vivo,,1,,,N,,10446,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,Rattus norvegicus,CHEMBL627993,
Intermediate,,A,17651,In vivo,,1,,,N,,10447,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability at 1 mg/kg was determined in rat,Rattus norvegicus,CHEMBL622817,
Intermediate,,A,17651,In vivo,,1,,,N,,10448,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability at 10 mg/kg was determined in rat,Rattus norvegicus,CHEMBL622818,
Intermediate,,A,17670,In vivo,,1,,,N,,10449,BAO_0000218,,1,,10116.0,,50597,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",Rattus norvegicus,CHEMBL622819,
Intermediate,,A,5045,In vivo,,1,,,N,,10450,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL872267,
Intermediate,,A,1696,In vivo,,1,,,N,,10451,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL622820,
Intermediate,,A,17764,In vivo,,1,,,N,,10452,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability after intravenous administration in rats at 24 uM/kg,Rattus norvegicus,CHEMBL622821,
Intermediate,,A,6448,In vivo,,1,,,N,,10453,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL622822,
Intermediate,,A,6596,In vivo,,1,,,N,,10454,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL622823,
Intermediate,,A,17547,In vivo,,1,,,N,,10455,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL622824,
Intermediate,,A,17771,In vivo,,1,,,N,,10456,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat at a dose of 3 mg/kg,Rattus norvegicus,CHEMBL622825,
Intermediate,,A,6495,In vivo,,1,,,N,,10457,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat after oral administration at 10 mg/kg,Rattus norvegicus,CHEMBL622901,
Intermediate,,A,4558,In vivo,,1,,,N,,10458,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL622902,
Intermediate,,A,17596,In vivo,,1,,,N,,10459,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL621844,
Intermediate,,A,6827,In vivo,,1,,,N,,10460,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in Dawley rats,Rattus norvegicus,CHEMBL621845,
Intermediate,,A,4026,In vivo,,1,,,N,,10461,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability,Rattus norvegicus,CHEMBL621846,
Intermediate,,A,10,In vivo,,1,,,N,,10462,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (dose 30 mg/kg),Rattus norvegicus,CHEMBL621847,
Intermediate,,A,17717,In vivo,,1,,,N,,10463,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,Rattus norvegicus,CHEMBL877609,
Intermediate,,A,17717,In vivo,,1,,,N,,10464,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat (dose 3 mg/kg i.v.),Rattus norvegicus,CHEMBL621848,
Intermediate,,A,17717,In vivo,,1,,,N,,10465,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,Rattus norvegicus,CHEMBL621849,
Intermediate,,A,17717,In vivo,,1,,,N,,10466,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (dose 60 mg/kg p.o.),Rattus norvegicus,CHEMBL622030,
Intermediate,,A,4796,In vivo,,1,,,N,,10467,BAO_0000218,,1,,10116.0,,50597,Percent oral bioavailability determined in rats,Rattus norvegicus,CHEMBL622031,
Intermediate,,A,4883,In vivo,,1,,,N,,10468,BAO_0000218,,1,,10116.0,,50597,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,Rattus norvegicus,CHEMBL622032,
Intermediate,,A,2137,In vivo,,1,,,N,,10469,BAO_0000218,,1,,10116.0,,50597,The compound was evaluated for bioavailability in rats; 32-51,Rattus norvegicus,CHEMBL622033,
Intermediate,,A,2959,In vivo,,1,,,N,,10470,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat (dose 20 mg/kg p.o.),Rattus norvegicus,CHEMBL622034,
Intermediate,,A,1361,In vivo,,1,,,N,,10471,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL622035,
Intermediate,,A,4727,In vivo,,1,,,N,,10472,BAO_0000218,,1,,10116.0,,50597,Bioavailability percent in rat at the dose of 2 mg/kg,Rattus norvegicus,CHEMBL882966,
Intermediate,,A,16423,In vivo,,1,,,N,,10473,BAO_0000218,,1,,10116.0,,50597,Bioavailability was evaluated after 20 uM/kg of peroral administration,Rattus norvegicus,CHEMBL622036,
Intermediate,,A,5206,In vivo,,1,,,N,,10474,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL622037,
Intermediate,,A,6448,In vivo,,1,,,N,,10475,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL622038,
Intermediate,,A,17723,In vivo,,1,,,N,,10476,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rats,Rattus norvegicus,CHEMBL622039,
Intermediate,,A,17738,In vivo,,1,,,N,,10477,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL622040,Blood
Intermediate,,A,17738,In vivo,,1,,,N,,10478,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL622041,Blood
Intermediate,,A,17738,In vivo,,1,,,N,,10479,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL622042,Blood
Intermediate,,A,17738,In vivo,,1,,,N,,10480,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL622043,Blood
Intermediate,,A,17738,In vivo,,1,,,N,,10481,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL622044,Blood
Intermediate,,A,17738,In vivo,,1,,,N,,10482,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL622045,Bone
Intermediate,,A,17738,In vivo,,1,,,N,,10483,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL622046,Bone
Intermediate,,A,17738,In vivo,,1,,,N,,10484,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL622047,Bone
Intermediate,,A,17738,In vivo,,1,,,N,,10485,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL877610,Bone
Intermediate,,A,17738,In vivo,,1,,,N,,10486,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL622048,Brain
Intermediate,,A,17738,In vivo,,1,,,N,,10487,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL622049,Brain
Intermediate,,A,17738,In vivo,,1,,,N,,10488,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL622050,Brain
Intermediate,,A,17738,In vivo,,1,,,N,,10489,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL622051,Brain
Intermediate,,A,17738,In vivo,,1,,,N,,10490,BAO_0000218,,1,,10116.0,,50597,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL622052,
Intermediate,,A,17738,In vivo,,1,,,N,,10491,BAO_0000218,,1,,10116.0,,50597,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL622053,
Intermediate,,A,17738,In vivo,,1,,,N,,10492,BAO_0000218,,1,,10116.0,,50597,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL622054,
Intermediate,,A,17738,In vivo,,1,,,N,,10493,BAO_0000218,,1,,10116.0,,50597,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL622055,
Intermediate,,A,5237,In vivo,,1,,,N,,10494,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rats was determined; High,Rattus norvegicus,CHEMBL622056,
Intermediate,,A,5503,In vivo,,1,,,N,,10495,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in the rat was determined,Rattus norvegicus,CHEMBL622057,
Intermediate,,A,15765,In vivo,,1,,,N,,10496,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,Rattus norvegicus,CHEMBL628008,
Intermediate,,A,15660,In vivo,,1,,,N,,10497,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),Rattus norvegicus,CHEMBL622058,
Intermediate,,A,5978,In vivo,,1,,,N,,10498,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,CHEMBL622059,
Intermediate,,A,5978,In vivo,,1,,,N,,10499,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,CHEMBL622060,
Intermediate,,A,5978,In vivo,,1,,,N,,10500,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,CHEMBL622061,
Intermediate,,A,5978,In vivo,,1,,,N,,10501,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,CHEMBL622062,
Intermediate,,A,5656,In vivo,,1,,,N,,10502,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,Rattus norvegicus,CHEMBL622063,
Expert,,A,3598,In vivo,,1,,,N,,10503,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,CHEMBL877611,
Intermediate,,A,4216,In vivo,,1,,,N,,10504,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability of compound in Sprague Dawley rats,Rattus norvegicus,CHEMBL622064,
Intermediate,,A,17839,In vivo,,1,,,N,,10505,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability of compound in rat,Rattus norvegicus,CHEMBL622065,
Intermediate,,A,6570,In vivo,,1,,,N,,10506,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (dose 2 mg/kg),Rattus norvegicus,CHEMBL622066,
Intermediate,,A,5334,In vivo,,1,,,N,,10507,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability of compound in rat was determined,Rattus norvegicus,CHEMBL622067,
Intermediate,,A,6886,In vivo,,1,,,N,,10508,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability of compound in rats,Rattus norvegicus,CHEMBL622068,
Intermediate,,A,5210,In vivo,,1,,,N,,10509,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability of compound was determined in rats,Rattus norvegicus,CHEMBL622069,
Intermediate,,A,4170,In vivo,,1,,,N,,10510,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability at a dose of 30 mg/kg in rats,Rattus norvegicus,CHEMBL624796,
Intermediate,,A,6028,In vivo,,1,,,N,,10511,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (dose 10 mg/kg),Rattus norvegicus,CHEMBL624797,
Intermediate,,A,6028,In vivo,,1,,,N,,10512,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (dose 10 mg/kg),Rattus norvegicus,CHEMBL623053,
Intermediate,,A,6078,In vivo,,1,,,N,,10513,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability evaluated in rat,Rattus norvegicus,CHEMBL623054,
Intermediate,,A,6168,In vivo,,1,,,N,,10514,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in fasted rat,Rattus norvegicus,CHEMBL623055,
Intermediate,,A,6168,In vivo,,1,,,N,,10515,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in fed rat,Rattus norvegicus,CHEMBL623056,
Intermediate,,A,5160,In vivo,,1,,,N,,10516,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (mature male) (dose 30 mg/kg),Rattus norvegicus,CHEMBL623057,
Intermediate,,A,6057,In vivo,,1,,,N,,10517,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL623058,
Intermediate,,A,6535,In vivo,,1,,,N,,10518,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (dose 10 mg/kg p.o.),Rattus norvegicus,CHEMBL623059,
Intermediate,,A,6535,In vivo,,1,,,N,,10519,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat after administration of 10 mg/kg po,Rattus norvegicus,CHEMBL623060,
Intermediate,,A,4194,In vivo,,1,,,N,,10520,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL623061,
Intermediate,,A,6230,In vivo,,1,,,N,,10521,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL623062,
Intermediate,,A,6619,In vivo,,1,,,N,,10522,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL623063,
Intermediate,,A,17607,In vivo,,1,,,N,,10523,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL623064,
Intermediate,,A,4942,In vivo,,1,,,N,,10524,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in ratrs,Rattus norvegicus,CHEMBL623065,
Intermediate,,A,4942,In vivo,,1,,,N,,10525,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL623066,
Intermediate,,A,6646,In vivo,,1,,,N,,10526,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL623067,
Intermediate,,A,5237,In vivo,,1,,,N,,10527,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rats was determined; High,Rattus norvegicus,CHEMBL623068,
Intermediate,,A,6646,In vivo,,1,,,N,,10528,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL623069,
Intermediate,,A,4449,In vivo,,1,,,N,,10529,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL623070,
Intermediate,,A,6057,In vivo,,1,,,N,,10530,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability was calculated in rat,Rattus norvegicus,CHEMBL623071,
Intermediate,,A,2552,In vivo,,1,,,N,,10531,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability,Rattus norvegicus,CHEMBL623072,
Intermediate,,A,5496,In vivo,,1,,,N,,10532,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability,Rattus norvegicus,CHEMBL623073,
Intermediate,,A,6484,In vivo,,1,,,N,,10533,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability,Rattus norvegicus,CHEMBL623074,
Intermediate,,A,6485,In vivo,,1,,,N,,10534,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability,Rattus norvegicus,CHEMBL623075,
Intermediate,,A,6616,In vivo,,1,,,N,,10535,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability after i.v. administration,Rattus norvegicus,CHEMBL623076,
Intermediate,,A,4969,In vivo,,1,,,N,,10536,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Rattus norvegicus,CHEMBL623077,
Intermediate,,A,5862,In vivo,,1,,,N,,10537,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (Sprague-Dawley),Rattus norvegicus,CHEMBL623078,
Intermediate,,A,4514,In vivo,,1,,,N,,10538,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in Sprague-Dawley rats,Rattus norvegicus,CHEMBL623079,
Intermediate,,A,4514,In vivo,,1,,,N,,10539,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Rattus norvegicus,CHEMBL623080,
Intermediate,,A,4514,In vivo,,1,,,N,,10540,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Rattus norvegicus,CHEMBL623081,
Intermediate,,A,5546,In vivo,,1,,,N,,10541,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,Rattus norvegicus,CHEMBL623082,
Intermediate,,A,6168,In vivo,,1,,,N,,10542,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in fasted rat,Rattus norvegicus,CHEMBL874400,
Intermediate,,A,6168,In vivo,,1,,,N,,10543,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in fed rat,Rattus norvegicus,CHEMBL623083,
Intermediate,,A,3624,In vivo,,1,,,N,,10544,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL623084,
Intermediate,,A,5213,In vivo,,1,,,N,,10545,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL623085,
Intermediate,,A,5496,In vivo,,1,,,N,,10546,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL623086,
Intermediate,,A,5553,In vivo,,1,,,N,,10547,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL623087,
Intermediate,,A,5833,In vivo,,1,,,N,,10548,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL623088,
Intermediate,,A,5836,In vivo,,1,,,N,,10549,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL623089,
Intermediate,,A,5865,In vivo,,1,,,N,,10550,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL623090,
Intermediate,,A,5960,In vivo,,1,,,N,,10551,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL623091,
Intermediate,,A,6249,In vivo,,1,,,N,,10552,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL623092,
Intermediate,,A,6448,In vivo,,1,,,N,,10553,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL623093,
Intermediate,,A,6453,In vivo,,1,,,N,,10554,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL874401,
Intermediate,,A,6640,In vivo,,1,,,N,,10555,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL623094,
Intermediate,,A,17607,In vivo,,1,,,N,,10556,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL623095,
Intermediate,,A,5939,In vivo,,1,,,N,,10557,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat after peroral administration at 10 mg/kg,Rattus norvegicus,CHEMBL623096,
Intermediate,,A,5939,In vivo,,1,,,N,,10558,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat after peroral administration at 5 mg/kg,Rattus norvegicus,CHEMBL624913,
Intermediate,,A,6281,In vivo,,1,,,N,,10559,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),Rattus norvegicus,CHEMBL624914,
Intermediate,,A,5874,In vivo,,1,,,N,,10560,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,Rattus norvegicus,CHEMBL624915,
Intermediate,,A,5213,In vivo,,1,,,N,,10561,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat; Not measured,Rattus norvegicus,CHEMBL624916,
Intermediate,,A,4964,In vivo,,1,,,N,,10562,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL624917,
Intermediate,,A,11020,,,1,,,N,,10563,BAO_0000218,,1,,10116.0,,50597,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,Rattus norvegicus,CHEMBL625157,
Intermediate,,A,6251,,,1,,,N,,10564,BAO_0000218,,1,,10116.0,2107.0,50597,In vitro metabolic potential in rat liver microsomes,Rattus norvegicus,CHEMBL625158,Liver
Intermediate,,A,1568,In vivo,,1,,,N,,10565,BAO_0000218,,1,,10116.0,,50597,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",Rattus norvegicus,CHEMBL625159,
Intermediate,,A,3032,In vivo,,1,,,N,,10566,BAO_0000218,,1,,10116.0,,50597,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",Rattus norvegicus,CHEMBL625160,
Intermediate,,A,3748,In vivo,,1,,,N,,10567,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,Rattus norvegicus,CHEMBL625161,
Intermediate,,A,401,In vivo,,1,,,N,,10568,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL625162,
Intermediate,,A,6512,In vivo,,1,,,N,,10569,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL625163,
Intermediate,,A,17617,In vivo,,1,,,N,,10570,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rats at 10 mg/kg,Rattus norvegicus,CHEMBL625164,
Intermediate,,A,6679,In vivo,,1,,,N,,10571,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Rattus norvegicus,CHEMBL625165,
Intermediate,,A,6742,In vivo,,1,,,N,,10572,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL625166,
Intermediate,,A,589,,,1,,,N,,10573,BAO_0000218,,1,,10116.0,,50597,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,Rattus norvegicus,CHEMBL625167,
Intermediate,,A,589,,,1,,,N,,10574,BAO_0000218,,1,,10116.0,,50597,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,Rattus norvegicus,CHEMBL625168,
Intermediate,,A,3185,In vivo,,1,,,N,,10575,BAO_0000218,,1,,10116.0,,50597,Plasma clearance of the compound,Rattus norvegicus,CHEMBL625169,
Intermediate,,A,17596,In vivo,,1,,,N,,10576,BAO_0000218,,1,,10116.0,,50597,Plasma clearance at 10 mg/kg in rat upon intravenous administration,Rattus norvegicus,CHEMBL626264,
Intermediate,,A,2713,In vivo,,1,,,N,,10577,BAO_0000218,,1,,10116.0,,50597,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,Rattus norvegicus,CHEMBL626265,
Intermediate,,A,12500,In vivo,,1,,,N,,10578,BAO_0000218,,1,,10116.0,1969.0,50597,The compound was tested for plasma clearance in rat,Rattus norvegicus,CHEMBL626266,Plasma
Intermediate,,A,12500,In vivo,,1,,,N,,10579,BAO_0000218,,1,,10116.0,1969.0,50597,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,Rattus norvegicus,CHEMBL626267,Plasma
Intermediate,,A,2713,,,1,,,N,,10580,BAO_0000218,,1,,10116.0,,50597,Plasma concentration upon oral administration of 1 mg/Kg in rats,Rattus norvegicus,CHEMBL626268,
Intermediate,,A,1446,,,1,,,N,,10581,BAO_0000218,,1,,10116.0,,50597,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,Rattus norvegicus,CHEMBL626269,
Intermediate,,A,6227,,,1,,,N,,10582,BAO_0000218,,1,,10116.0,,50597,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,Rattus norvegicus,CHEMBL626270,
Intermediate,,A,4709,,,1,,,N,,10583,BAO_0000218,,1,,10116.0,,50597,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,Rattus norvegicus,CHEMBL626271,
Intermediate,,A,5510,,,1,,,N,,10584,BAO_0000218,,1,,10116.0,,50597,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",Rattus norvegicus,CHEMBL626272,
Intermediate,,A,5510,,,1,,,N,,10585,BAO_0000218,,1,,10116.0,,50597,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",Rattus norvegicus,CHEMBL626273,
Intermediate,,A,5510,,,1,,,N,,10586,BAO_0000218,,1,,10116.0,,50597,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",Rattus norvegicus,CHEMBL875346,
Intermediate,,A,5510,,,1,,,N,,10587,BAO_0000218,,1,,10116.0,,50597,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",Rattus norvegicus,CHEMBL626274,
Intermediate,,A,4514,,,1,,,N,,10588,BAO_0000218,,1,,10116.0,,50597,Compound was tested for protein binding in rat plasma,Rattus norvegicus,CHEMBL626275,
Intermediate,,A,2713,,,1,,,N,,10589,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,Rattus norvegicus,CHEMBL624646,
Intermediate,,A,2713,,,1,,,N,,10590,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,Rattus norvegicus,CHEMBL624647,
Intermediate,,A,5340,,,1,,,N,,10591,BAO_0000218,,1,,10116.0,2107.0,50597,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,Rattus norvegicus,CHEMBL624648,Liver
Intermediate,,A,12058,,,1,,,N,,10592,BAO_0000218,,1,,10116.0,,50597,Area under curve ratio was determined (po/iv) in rat,Rattus norvegicus,CHEMBL624649,
Intermediate,,A,11195,,,1,,,N,,10593,BAO_0000218,,1,,10116.0,,50597,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,Rattus norvegicus,CHEMBL624650,
Intermediate,,A,11195,,,1,,,N,,10594,BAO_0000218,,1,,10116.0,,50597,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,Rattus norvegicus,CHEMBL624651,
Intermediate,,A,11195,,,1,,,N,,10595,BAO_0000218,,1,,10116.0,,50597,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,Rattus norvegicus,CHEMBL624652,
Intermediate,,A,6495,,,1,,,N,,10596,BAO_0000218,,1,,10116.0,,50597,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,Rattus norvegicus,CHEMBL624653,
Intermediate,,A,6078,,,1,,,N,,10597,BAO_0000218,,1,,10116.0,,50597,Ratio of AUCbrain to AUCplasma,Rattus norvegicus,CHEMBL624654,
Intermediate,,A,5656,,,1,,,N,,10598,BAO_0000218,,1,,10116.0,,50597,Ratio of brain to plasma,Rattus norvegicus,CHEMBL624655,
Intermediate,,A,4910,,,1,,,N,,10599,BAO_0000218,,1,,10116.0,,50597,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,Rattus norvegicus,CHEMBL624656,
Intermediate,,A,4910,,,1,,,N,,10600,BAO_0000218,,1,,10116.0,,50597,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,Rattus norvegicus,CHEMBL624657,
Intermediate,,A,4910,,,1,,,N,,10601,BAO_0000218,,1,,10116.0,,50597,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,Rattus norvegicus,CHEMBL624658,
Intermediate,,A,10130,,,1,,,N,,10602,BAO_0000218,,1,,10116.0,,50597,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,Rattus norvegicus,CHEMBL624659,
Intermediate,,A,10130,,,1,,,N,,10603,BAO_0000218,,1,,10116.0,,50597,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,Rattus norvegicus,CHEMBL624660,
Intermediate,,A,10130,,,1,,,N,,10604,BAO_0000218,,1,,10116.0,,50597,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,Rattus norvegicus,CHEMBL624661,
Intermediate,,A,5213,,,1,,,N,,10605,BAO_0000218,,1,,10116.0,,50597,Steady state brain :blood ratio was determined,Rattus norvegicus,CHEMBL624662,
Intermediate,,A,4910,,,1,,,N,,10606,BAO_0000218,,1,,10116.0,,50597,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,CHEMBL625199,
Intermediate,,A,4910,,,1,,,N,,10607,BAO_0000218,,1,,10116.0,,50597,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,Rattus norvegicus,CHEMBL625200,
Intermediate,,A,4910,,,1,,,N,,10608,BAO_0000218,,1,,10116.0,,50597,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,CHEMBL625201,
Intermediate,,A,4910,,,1,,,N,,10609,BAO_0000218,,1,,10116.0,,50597,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,Rattus norvegicus,CHEMBL625202,
Intermediate,,A,2083,,,1,,,N,,10610,BAO_0000218,,1,,10116.0,,50597,Percentage recovery after 3h incubation with rat hapatocytes was determined,Rattus norvegicus,CHEMBL625203,
Intermediate,,A,2082,,,1,,,N,,10611,BAO_0000218,,1,,10116.0,,50597,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,Rattus norvegicus,CHEMBL625204,
Intermediate,,A,2082,,,1,,,N,,10612,BAO_0000218,,1,,10116.0,,50597,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,Rattus norvegicus,CHEMBL625205,
Intermediate,,A,6351,,,1,,,N,,10613,BAO_0000218,,1,,10116.0,,50597,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,Rattus norvegicus,CHEMBL625206,
Autocuration,,A,14583,,,1,,,U,,10614,BAO_0000019,,0,,,,22224,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",,CHEMBL625207,
Autocuration,,A,14583,,,1,,,U,,10615,BAO_0000019,,0,,,,22224,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,,CHEMBL625208,
Intermediate,Caco-2,A,4608,,,1,,,N,495.0,10616,BAO_0000218,,1,,9606.0,,50587,In vivo absorption in Caco-2 cell line monolayers was determined,Homo sapiens,CHEMBL625209,
Autocuration,,P,13668,,,1,,,U,,10617,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625210,
Intermediate,,A,5669,,,1,,,N,,10618,BAO_0000218,,1,,10116.0,,50597,Area under curve was determine after peroral administration at 10 mpk in Rat,Rattus norvegicus,CHEMBL625211,
Intermediate,,A,5669,,,1,,,N,,10619,BAO_0000218,,1,,9544.0,,50797,Area under curve was determine after peroral administration at 10 mpk in Rhesus,Macaca mulatta,CHEMBL625212,
Intermediate,,A,5669,,,1,,,N,,10620,BAO_0000218,,1,,10116.0,,50597,Area under curve was determine after peroral administration at 160 mpk in Rat,Rattus norvegicus,CHEMBL625213,
Intermediate,,A,5669,,,1,,,N,,10621,BAO_0000218,,1,,10116.0,,50597,Area under curve was determine after peroral administration at 20 mpk in Rat,Rattus norvegicus,CHEMBL625214,
Intermediate,,A,5669,,,1,,,N,,10622,BAO_0000218,,1,,10116.0,,50597,Area under curve was determine after peroral administration at 50 mpk in Rat,Rattus norvegicus,CHEMBL874542,
Autocuration,,P,6472,,,1,,,U,,10623,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP) (AlogP),,CHEMBL625215,
Autocuration,,A,15106,,,1,,,U,,10624,BAO_0000019,,0,,,,22224,Activated partial thromboplastin time measured,,CHEMBL625216,
Autocuration,,P,15207,,,1,,,U,,10625,BAO_0000100,,0,,,,22224,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),,CHEMBL625217,
Autocuration,,P,15207,,,1,,,U,,10626,BAO_0000100,,0,,,,22224,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),,CHEMBL625218,
Intermediate,,A,13941,,,1,,,N,,10627,BAO_0000218,,1,,9615.0,1969.0,50588,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,Canis lupus familiaris,CHEMBL622864,Plasma
Intermediate,,A,13941,,,1,,,N,,10628,BAO_0000218,,1,,10116.0,1969.0,50597,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,Rattus norvegicus,CHEMBL622865,Plasma
Intermediate,,A,13941,,,1,,,N,,10629,BAO_0000218,,1,,10116.0,1969.0,50597,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,Rattus norvegicus,CHEMBL622866,Plasma
Intermediate,,A,13941,,,1,,,N,,10630,BAO_0000218,,1,,9615.0,1969.0,50588,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,Canis lupus familiaris,CHEMBL622867,Plasma
Intermediate,,A,15240,,,1,,,N,,10631,BAO_0000218,,1,,10141.0,1969.0,50512,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,Cavia porcellus,CHEMBL876808,Plasma
Autocuration,,A,10655,,,1,,,U,,10632,BAO_0000019,,0,,,955.0,22224,AUC in brain,,CHEMBL627725,Brain
Autocuration,,A,10655,,,1,,,U,,10633,BAO_0000019,,0,,,1977.0,22224,AUC in serum,,CHEMBL627726,Serum
Autocuration,,A,6504,,,1,,,U,,10634,BAO_0000019,,0,,,1969.0,22224,AUC was determined,,CHEMBL627727,Plasma
Autocuration,,A,10615,,,1,,,U,,10635,BAO_0000019,,0,,,1969.0,22224,AUC of the compound.,,CHEMBL627728,Plasma
Autocuration,,A,10353,,,1,,,U,,10636,BAO_0000019,,0,,,1969.0,22224,AUC value (0-4 hr),,CHEMBL627729,Plasma
Autocuration,,A,14907,,,1,,,U,,10637,BAO_0000019,,0,,,1969.0,22224,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",,CHEMBL627730,Plasma
Autocuration,,A,14907,,,1,,,U,,10638,BAO_0000019,,0,,,1969.0,22224,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,,CHEMBL627731,Plasma
Autocuration,,A,14907,,,1,,,U,,10639,BAO_0000019,,0,,,1969.0,22224,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",,CHEMBL627732,Plasma
Autocuration,,A,14907,,,1,,,U,,10640,BAO_0000019,,0,,,1969.0,22224,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",,CHEMBL627733,Plasma
Intermediate,,A,16359,,,1,,,N,,10641,BAO_0000218,,1,,10116.0,1969.0,50597,AUC(area under curve) was determined after intravenous administration in rats,Rattus norvegicus,CHEMBL627734,Plasma
Intermediate,,A,16359,,,1,,,N,,10642,BAO_0000218,,1,,10116.0,1969.0,50597,AUC(area under curve) was determined after oral administration in rats,Rattus norvegicus,CHEMBL627735,Plasma
Intermediate,,A,15240,,,1,,,N,,10643,BAO_0000218,,1,,10141.0,1969.0,50512,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,Cavia porcellus,CHEMBL627736,Plasma
Intermediate,,A,15240,,,1,,,N,,10644,BAO_0000218,,1,,10116.0,1969.0,50597,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,Rattus norvegicus,CHEMBL876809,Plasma
Autocuration,,A,15469,,,1,,,U,,10645,BAO_0000019,,0,,,,22224,Area Under Curve after oral dosing of 100 uM/Kg,,CHEMBL627737,
Autocuration,,A,15469,,,1,,,U,,10646,BAO_0000019,,0,,,,22224,Area Under Curve after oral dosing of 30 uM/Kg,,CHEMBL627738,
Autocuration,,A,13520,,,1,,,U,,10647,BAO_0000019,,0,,,,22224,Area Under Curve was measured by ploting the graph between concentration verses time,,CHEMBL627739,
Intermediate,,A,17025,,,1,,,N,,10648,BAO_0000218,,1,,9615.0,,50588,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,Canis lupus familiaris,CHEMBL626143,
Autocuration,,A,17025,,,1,,,U,,10649,BAO_0000218,,0,,314293.0,,22224,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,Simiiformes,CHEMBL626144,
Intermediate,,A,17025,,,1,,,N,,10650,BAO_0000218,,1,,9986.0,,50592,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,Oryctolagus cuniculus,CHEMBL626145,
Intermediate,,A,17025,,,1,,,N,,10651,BAO_0000218,,1,,10116.0,,50597,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,Rattus norvegicus,CHEMBL626146,
Intermediate,,A,12032,,,1,,,N,,10652,BAO_0000218,,1,,10116.0,178.0,50597,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,Rattus norvegicus,CHEMBL626147,Blood
Autocuration,,A,10291,,,1,,,U,,10653,BAO_0000019,,0,,,,22224,Area under curve (AUC) was determined,,CHEMBL626148,
Autocuration,,A,5767,,,1,,,U,,10654,BAO_0000218,,0,,,,22224,Area under curve (AUC) following ip administration at 1 mg/kg,,CHEMBL626149,
Autocuration,,A,1434,,,1,,,U,,10655,BAO_0000019,,0,,,,22224,Area under curve (AUC) was determined; ND is Not determined,,CHEMBL626150,
Intermediate,,A,14925,,,1,,,N,,10656,BAO_0000218,,1,,9615.0,,50588,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,Canis lupus familiaris,CHEMBL626151,
Intermediate,,A,14925,,,1,,,N,,10657,BAO_0000218,,1,,9615.0,,50588,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,Canis lupus familiaris,CHEMBL626152,
Intermediate,,A,14925,,,1,,,N,,10658,BAO_0000218,,1,,9615.0,,50588,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,Canis lupus familiaris,CHEMBL626153,
Autocuration,,A,1434,,,1,,,U,,10659,BAO_0000019,,0,,,,22224,Area under curve (AUR) was determined,,CHEMBL626154,
Autocuration,,A,11883,,,1,,,U,,10660,BAO_0000019,,0,,,,22224,Area under curve at 1 uM/dg administered intravenously,,CHEMBL626155,
Autocuration,,A,11883,,,1,,,U,,10661,BAO_0000019,,0,,,,22224,Area under curve at 10 uM/dg administered perorally,,CHEMBL626156,
Autocuration,,A,11883,,,1,,,U,,10662,BAO_0000019,,0,,,,22224,Area under curve at 2 uM/dg administered intravenously,,CHEMBL626157,
Autocuration,,A,11883,,,1,,,U,,10663,BAO_0000019,,0,,,,22224,Area under curve at 20 uM/dg administered perorally,,CHEMBL626158,
Intermediate,,A,15233,,,1,,,N,,10664,BAO_0000218,,1,,9615.0,,50588,Area under curve at a peroral dose of 3 mg/kg in dog,Canis lupus familiaris,CHEMBL626159,
Intermediate,,A,15233,,,1,,,N,,10665,BAO_0000218,,1,,10116.0,,50597,Area under curve at a peroral dose of 3 mg/kg in rat,Rattus norvegicus,CHEMBL626160,
Intermediate,,A,15233,,,1,,,N,,10666,BAO_0000218,,1,,9615.0,,50588,Area under curve at an iv dose of 1 mg/kg in dog,Canis lupus familiaris,CHEMBL626161,
Intermediate,,A,15233,,,1,,,N,,10667,BAO_0000218,,1,,10116.0,,50597,Area under curve at an iv dose of 1 mg/kg in rat,Rattus norvegicus,CHEMBL626162,
Autocuration,,A,12978,,,1,,,U,,10668,BAO_0000019,,0,,,,22224,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,,CHEMBL626163,
Autocuration,,A,12978,,,1,,,U,,10669,BAO_0000019,,0,,,,22224,Area under curve gives the effective duration for the angiotensin II antagonist effect.,,CHEMBL626164,
Intermediate,,A,11355,,,1,,,N,,10670,BAO_0000218,,1,,10090.0,,50594,Area under curve measured as conc vs time after intravenous administration to mice.,Mus musculus,CHEMBL626165,
Intermediate,,A,11355,,,1,,,N,,10671,BAO_0000218,,1,,10090.0,,50594,Area under curve measured as conc vs time after peroral administration to mice.,Mus musculus,CHEMBL626166,
Intermediate,,A,12923,,,1,,,N,,10672,BAO_0000218,,1,,9615.0,,50588,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,Canis lupus familiaris,CHEMBL626167,
Intermediate,,A,12923,,,1,,,N,,10673,BAO_0000218,,1,,9615.0,,50588,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,Canis lupus familiaris,CHEMBL626168,
Intermediate,,A,12923,,,1,,,N,,10674,BAO_0000218,,1,,9615.0,,50588,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,Canis lupus familiaris,CHEMBL877463,
Intermediate,,A,12923,,,1,,,N,,10675,BAO_0000218,,1,,9615.0,,50588,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,Canis lupus familiaris,CHEMBL626169,
Intermediate,,A,17738,In vivo,,1,,,N,,10676,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL626170,Heart
Intermediate,,A,17738,In vivo,,1,,,N,,10677,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL626171,Heart
Intermediate,,A,17738,In vivo,,1,,,N,,10678,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL626172,Heart
Intermediate,,A,17738,In vivo,,1,,,N,,10679,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL626173,Heart
Intermediate,,A,17738,In vivo,,1,,,N,,10680,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL626174,Kidney
Intermediate,,A,17738,In vivo,,1,,,N,,10681,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL626175,Kidney
Intermediate,,A,17738,In vivo,,1,,,N,,10682,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL626176,Kidney
Intermediate,,A,17738,In vivo,,1,,,N,,10683,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL626177,Kidney
Intermediate,,A,17738,In vivo,,1,,,N,,10684,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL622499,Kidney
Intermediate,,A,17738,In vivo,,1,,,N,,10685,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL622500,Liver
Intermediate,,A,17738,In vivo,,1,,,N,,10686,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL622501,Liver
Intermediate,,A,17738,In vivo,,1,,,N,,10687,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL622502,Liver
Intermediate,,A,17738,In vivo,,1,,,N,,10688,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL622503,Liver
Intermediate,,A,17738,In vivo,,1,,,N,,10689,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL877614,Liver
Intermediate,,A,17738,In vivo,,1,,,N,,10690,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL624839,Lung
Intermediate,,A,17738,In vivo,,1,,,N,,10691,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL624840,Lung
Intermediate,,A,17738,In vivo,,1,,,N,,10692,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL624841,Lung
Intermediate,,A,17738,In vivo,,1,,,N,,10693,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL624842,Lung
Intermediate,,A,17738,In vivo,,1,,,N,,10694,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL624843,Muscle tissue
Intermediate,,A,17738,In vivo,,1,,,N,,10695,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL624844,Muscle tissue
Intermediate,,A,17738,In vivo,,1,,,N,,10696,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL624845,Muscle tissue
Intermediate,,A,17738,In vivo,,1,,,N,,10697,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,Rattus norvegicus,CHEMBL621904,Muscle tissue
Intermediate,,A,11195,In vivo,,1,,,N,,10698,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,Rattus norvegicus,CHEMBL621905,Blood
Intermediate,,A,11195,In vivo,,1,,,N,,10699,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,Rattus norvegicus,CHEMBL874382,Blood
Intermediate,,A,11195,In vivo,,1,,,N,,10700,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,Rattus norvegicus,CHEMBL621906,Blood
Intermediate,,A,11195,In vivo,,1,,,N,,10701,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,Rattus norvegicus,CHEMBL621907,Brain
Intermediate,,A,11195,In vivo,,1,,,N,,10702,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,Rattus norvegicus,CHEMBL622096,Brain
Intermediate,,A,11195,In vivo,,1,,,N,,10703,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,Rattus norvegicus,CHEMBL622097,Brain
Intermediate,,A,11195,In vivo,,1,,,N,,10704,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,Rattus norvegicus,CHEMBL622098,Heart
Intermediate,,A,11195,In vivo,,1,,,N,,10705,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,Rattus norvegicus,CHEMBL622099,Heart
Intermediate,,A,11195,In vivo,,1,,,N,,10706,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,Rattus norvegicus,CHEMBL622100,Heart
Intermediate,,A,11195,In vivo,,1,,,N,,10707,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,Rattus norvegicus,CHEMBL622101,Kidney
Intermediate,,A,11195,In vivo,,1,,,N,,10708,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,Rattus norvegicus,CHEMBL622102,Kidney
Intermediate,,A,11195,In vivo,,1,,,N,,10709,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,Rattus norvegicus,CHEMBL622103,Kidney
Intermediate,,A,11195,In vivo,,1,,,N,,10710,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,Rattus norvegicus,CHEMBL622104,Liver
Intermediate,,A,11195,In vivo,,1,,,N,,10711,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,Rattus norvegicus,CHEMBL622105,Liver
Intermediate,,A,11195,In vivo,,1,,,N,,10712,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,Rattus norvegicus,CHEMBL622106,Liver
Intermediate,,A,11195,In vivo,,1,,,N,,10713,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,Rattus norvegicus,CHEMBL622107,Lung
Intermediate,,A,11195,In vivo,,1,,,N,,10714,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,Rattus norvegicus,CHEMBL622108,Lung
Intermediate,,A,11195,In vivo,,1,,,N,,10715,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,Rattus norvegicus,CHEMBL622109,Lung
Intermediate,,A,11195,In vivo,,1,,,N,,10716,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,Rattus norvegicus,CHEMBL622110,Muscle tissue
Intermediate,,A,11195,In vivo,,1,,,N,,10717,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,Rattus norvegicus,CHEMBL622111,Muscle tissue
Intermediate,,A,11195,In vivo,,1,,,N,,10718,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,Rattus norvegicus,CHEMBL874383,Muscle tissue
Intermediate,,A,11195,In vivo,,1,,,N,,10719,BAO_0000218,,1,,10116.0,14.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,Rattus norvegicus,CHEMBL622112,Zone of skin
Intermediate,,A,11195,In vivo,,1,,,N,,10720,BAO_0000218,,1,,10116.0,14.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,Rattus norvegicus,CHEMBL622113,Zone of skin
Intermediate,,A,11195,In vivo,,1,,,N,,10721,BAO_0000218,,1,,10116.0,14.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,Rattus norvegicus,CHEMBL622114,Zone of skin
Intermediate,,A,11195,In vivo,,1,,,N,,10722,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,Rattus norvegicus,CHEMBL622115,Spleen
Intermediate,,A,11195,In vivo,,1,,,N,,10723,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,Rattus norvegicus,CHEMBL622116,Spleen
Intermediate,,A,6193,In vivo,,1,,,N,,10724,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL622117,
Intermediate,,A,6803,In vivo,,1,,,N,,10725,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL622118,
Intermediate,,A,6647,In vivo,,1,,,N,,10726,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rats at 6 mg/kg,Rattus norvegicus,CHEMBL622119,
Intermediate,,A,6647,In vivo,,1,,,N,,10727,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (dose 6 mg/kg),Rattus norvegicus,CHEMBL622120,
Intermediate,,A,6647,In vivo,,1,,,N,,10728,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rats at 6 mg/kg dose; Not tested,Rattus norvegicus,CHEMBL622121,
Intermediate,,A,6640,In vivo,,1,,,N,,10729,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL622122,
Intermediate,,A,6641,In vivo,,1,,,N,,10730,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL622123,
Intermediate,,A,6641,In vivo,,1,,,N,,10731,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL622124,
Intermediate,,A,6642,In vivo,,1,,,N,,10732,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat,Rattus norvegicus,CHEMBL622125,
Intermediate,,A,5472,In vivo,,1,,,N,,10733,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability,Rattus norvegicus,CHEMBL622126,
Intermediate,,A,6141,In vivo,,1,,,N,,10734,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Rattus norvegicus,CHEMBL620455,
Intermediate,,A,4390,In vivo,,1,,,N,,10735,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL620456,
Intermediate,,A,5472,In vivo,,1,,,N,,10736,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL620457,
Intermediate,,A,5472,In vivo,,1,,,N,,10737,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability was evaluated; Not tested,Rattus norvegicus,CHEMBL620458,
Intermediate,,A,5438,In vivo,,1,,,N,,10738,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability,Rattus norvegicus,CHEMBL620459,
Intermediate,,A,4883,In vivo,,1,,,N,,10739,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat by oral dosing,Rattus norvegicus,CHEMBL620460,
Intermediate,,A,1908,In vivo,,1,,,N,,10740,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (dose 10 mg/kg p.o.),Rattus norvegicus,CHEMBL620461,
Intermediate,,A,4853,In vivo,,1,,,N,,10741,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (Sprague-Dawley),Rattus norvegicus,CHEMBL620462,
Intermediate,,A,4853,In vivo,,1,,,N,,10742,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Rattus norvegicus,CHEMBL620463,
Intermediate,,A,4853,In vivo,,1,,,N,,10743,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Rattus norvegicus,CHEMBL620464,
Intermediate,,A,4853,In vivo,,1,,,N,,10744,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Rattus norvegicus,CHEMBL620465,
Intermediate,,A,4853,In vivo,,1,,,N,,10745,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),Rattus norvegicus,CHEMBL620466,
Intermediate,,A,4853,In vivo,,1,,,N,,10746,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,Rattus norvegicus,CHEMBL620467,
Intermediate,,A,4853,In vivo,,1,,,N,,10747,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,Rattus norvegicus,CHEMBL620468,
Intermediate,,A,12873,In vivo,,1,,,N,,10748,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,Rattus norvegicus,CHEMBL620469,
Intermediate,,A,12873,In vivo,,1,,,N,,10749,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,Rattus norvegicus,CHEMBL620470,
Intermediate,,A,3169,In vivo,,1,,,N,,10750,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL620471,
Intermediate,,A,6305,In vivo,,1,,,N,,10751,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL620472,
Intermediate,,A,4762,In vivo,,1,,,N,,10752,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,Rattus norvegicus,CHEMBL620473,
Intermediate,,A,17847,In vivo,,1,,,N,,10753,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL620474,
Intermediate,,A,6211,In vivo,,1,,,N,,10754,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),Rattus norvegicus,CHEMBL620475,
Intermediate,,A,6011,In vivo,,1,,,N,,10755,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL620476,
Intermediate,,A,6317,In vivo,,1,,,N,,10756,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL620477,
Intermediate,,A,6644,In vivo,,1,,,N,,10757,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,Rattus norvegicus,CHEMBL620478,
Intermediate,,A,6644,In vivo,,1,,,N,,10758,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,Rattus norvegicus,CHEMBL618768,
Intermediate,,A,6644,In vivo,,1,,,N,,10759,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat after oral administration at 13 mg/kg dose,Rattus norvegicus,CHEMBL618769,
Intermediate,,A,6644,In vivo,,1,,,N,,10760,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,Rattus norvegicus,CHEMBL618770,
Intermediate,,A,6113,In vivo,,1,,,N,,10761,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability (dose 20 mg/kg p.o.),Rattus norvegicus,CHEMBL618771,
Intermediate,,A,5937,In vivo,,1,,,N,,10762,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,Rattus norvegicus,CHEMBL618772,
Intermediate,,A,5711,In vivo,,1,,,N,,10763,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat at 10 mg/kg of the compound,Rattus norvegicus,CHEMBL618773,
Intermediate,,A,17717,In vivo,,1,,,N,,10764,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,Rattus norvegicus,CHEMBL875842,
Intermediate,,A,17717,In vivo,,1,,,N,,10765,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat (dose 3 mg/kg i.v.),Rattus norvegicus,CHEMBL618774,
Intermediate,,A,17717,In vivo,,1,,,N,,10766,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,Rattus norvegicus,CHEMBL618775,
Intermediate,,A,17717,In vivo,,1,,,N,,10767,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (dose 60 mg/kg p.o.),Rattus norvegicus,CHEMBL618776,
Intermediate,,A,4722,In vivo,,1,,,N,,10768,BAO_0000218,,1,,10116.0,,50597,Percent bioavailability (F) in rats after iv administration,Rattus norvegicus,CHEMBL618777,
Intermediate,,A,4722,In vivo,,1,,,N,,10769,BAO_0000218,,1,,10116.0,,50597,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,Rattus norvegicus,CHEMBL618778,
Intermediate,,A,4353,In vivo,,1,,,N,,10770,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat (dose 5 uM/kg p.o.),Rattus norvegicus,CHEMBL618779,
Intermediate,,A,15662,In vivo,,1,,,N,,10771,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability,Rattus norvegicus,CHEMBL618780,
Intermediate,,A,4756,In vivo,,1,,,N,,10772,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat (dose 2 mg/kg p.o.),Rattus norvegicus,CHEMBL618781,
Intermediate,,A,4756,In vivo,,1,,,N,,10773,BAO_0000218,,1,,10116.0,,50597,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,Rattus norvegicus,CHEMBL618782,
Intermediate,,A,3436,In vivo,,1,,,N,,10774,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (dose 20 mg/kg),Rattus norvegicus,CHEMBL618783,
Intermediate,,A,17800,In vivo,,1,,,N,,10775,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL618784,
Intermediate,,A,15762,In vivo,,1,,,N,,10776,BAO_0000218,,1,,10116.0,,50597,Percent oral bioavailability evaluated in rat,Rattus norvegicus,CHEMBL618785,
Intermediate,,A,5089,In vivo,,1,,,N,,10777,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL618786,
Intermediate,,A,5089,In vivo,,1,,,N,,10778,BAO_0000218,,1,,10116.0,,50597,Percent oral bioavailability in rat; Not determined,Rattus norvegicus,CHEMBL618787,
Intermediate,,A,3185,In vivo,,1,,,N,,10779,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat,Rattus norvegicus,CHEMBL618788,
Intermediate,,A,5145,In vivo,,1,,,N,,10780,BAO_0000218,,1,,10116.0,,50597,Bioavailability in rat,Rattus norvegicus,CHEMBL618789,
Intermediate,,A,3457,In vivo,,1,,,N,,10781,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),Rattus norvegicus,CHEMBL618790,
Intermediate,,A,3457,In vivo,,1,,,N,,10782,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),Rattus norvegicus,CHEMBL618791,
Intermediate,,A,5983,In vivo,,1,,,N,,10783,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,Rattus norvegicus,CHEMBL875843,
Intermediate,,A,5739,In vivo,,1,,,N,,10784,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat (dose 20 mg/kg p.o.),Rattus norvegicus,CHEMBL618792,
Intermediate,,A,3579,In vivo,,1,,,N,,10785,BAO_0000218,,1,,10116.0,,50597,Cmax at a dose of 30 mg/kg in rat,Rattus norvegicus,CHEMBL623395,
Autocuration,,A,17788,In vivo,,1,,,U,,10786,BAO_0000218,,0,,314293.0,,22224,Cmax in monkeys at a dose of 1 mg/kg,Simiiformes,CHEMBL623396,
Intermediate,,A,14956,In vivo,,1,,,N,,10787,BAO_0000218,,1,,10116.0,,50597,Cmax in rat,Rattus norvegicus,CHEMBL623397,
Intermediate,,A,17788,In vivo,,1,,,N,,10788,BAO_0000218,,1,,10116.0,,50597,Cmax in rats at a dose of 1 mg/kg,Rattus norvegicus,CHEMBL623398,
Intermediate,,A,9750,In vivo,,1,,,N,,10789,BAO_0000218,,1,,10090.0,,50594,Cmax was measured in mice after an oral dose of 50 mg/kg.,Mus musculus,CHEMBL623399,
Autocuration,,A,12767,In vivo,,1,,,U,,10790,BAO_0000218,,0,,,,22224,"Cmax value at a dose of 12.7 uM/kg, po",,CHEMBL623400,
Autocuration,,A,12767,In vivo,,1,,,U,,10791,BAO_0000218,,0,,,,22224,"Cmax value at a dose of 6.3 uM/kg, iv",,CHEMBL623401,
Autocuration,,A,12767,In vivo,,1,,,U,,10792,BAO_0000218,,0,,,,22224,"Cmax value at a dose of 7.1 uM/kg, iv",,CHEMBL623402,
Autocuration,,A,12703,In vivo,,1,,,U,,10793,BAO_0000218,,0,,,,22224,Cmax value of compound was determined after 1 hr,,CHEMBL623403,
Autocuration,,A,15778,In vivo,,1,,,U,,10794,BAO_0000218,,0,,,,22224,Cmax value of the compound,,CHEMBL623404,
Intermediate,,A,12818,In vivo,,1,,,N,,10795,BAO_0000218,,1,,10116.0,,50597,Cmax value administered intraintestinal in rats.,Rattus norvegicus,CHEMBL625997,
Intermediate,,A,14964,In vivo,,1,,,N,,10796,BAO_0000218,,1,,10116.0,,50597,Cmax value administered perorally was determined in rat; Not determined,Rattus norvegicus,CHEMBL625998,
Autocuration,,A,15808,In vivo,,1,,,U,,10797,BAO_0000218,,0,,,,22224,Cmax value at the dose of 2.3 mg/kg,,CHEMBL625999,
Autocuration,,A,15808,In vivo,,1,,,U,,10798,BAO_0000218,,0,,,,22224,Cmax value at the dose of 5 mg/kg,,CHEMBL626000,
Autocuration,,A,15778,In vivo,,1,,,U,,10799,BAO_0000218,,0,,,,22224,Cmax value in the period of 8 hr after dosing. ,,CHEMBL626001,
Autocuration,,A,3715,In vivo,,1,,,U,,10800,BAO_0000218,,0,,,,22224,Cmax value at a oral dose of 20 mg/kg; Not tested,,CHEMBL626002,
Autocuration,,A,3715,In vivo,,1,,,U,,10801,BAO_0000218,,0,,,,22224,Cmax value at a oral dose of 20 mg/kg,,CHEMBL626003,
Intermediate,,A,1446,In vivo,,1,,,N,,10802,BAO_0000218,,1,,10116.0,,50597,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,Rattus norvegicus,CHEMBL626004,
Intermediate,,A,15240,In vivo,,1,,,N,,10803,BAO_0000218,,1,,10141.0,,50512,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,Cavia porcellus,CHEMBL626005,
Intermediate,,A,15240,In vivo,,1,,,N,,10804,BAO_0000218,,1,,10116.0,,50597,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,Rattus norvegicus,CHEMBL626006,
Intermediate,,A,14810,In vivo,,1,,,N,,10805,BAO_0000218,,1,,10116.0,1969.0,50597,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,Rattus norvegicus,CHEMBL626007,Plasma
Intermediate,,A,14239,In vivo,,1,,,N,,10806,BAO_0000218,,1,,10090.0,1969.0,50594,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,Mus musculus,CHEMBL626008,Plasma
Intermediate,,A,12555,In vivo,,1,,,N,,10807,BAO_0000218,,1,,9615.0,2107.0,50588,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,Canis lupus familiaris,CHEMBL626009,Liver
Intermediate,,A,10754,In vivo,,1,,,N,,10808,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,Canis lupus familiaris,CHEMBL626010,
Intermediate,,A,10754,In vivo,,1,,,N,,10809,BAO_0000218,,1,,10090.0,178.0,50594,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,Mus musculus,CHEMBL626011,Blood
Intermediate,,A,10754,In vivo,,1,,,N,,10810,BAO_0000218,,1,,10090.0,178.0,50594,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,Mus musculus,CHEMBL626012,Blood
Intermediate,,A,10754,In vivo,,1,,,N,,10811,BAO_0000218,,1,,10090.0,178.0,50594,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,Mus musculus,CHEMBL626013,Blood
Intermediate,,A,10754,In vivo,,1,,,N,,10812,BAO_0000218,,1,,10090.0,178.0,50594,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,Mus musculus,CHEMBL626014,Blood
Intermediate,,A,10754,In vivo,,1,,,N,,10813,BAO_0000218,,1,,10090.0,178.0,50594,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,Mus musculus,CHEMBL877496,Blood
Intermediate,,F,14600,In vivo,,1,,,N,,10814,BAO_0000218,,1,,9615.0,,50588,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,Canis lupus familiaris,CHEMBL626015,
Intermediate,,F,14600,In vivo,,1,,,N,,10815,BAO_0000218,,1,,9615.0,,50588,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,Canis lupus familiaris,CHEMBL626016,
Intermediate,,F,14600,In vivo,,1,,,N,,10816,BAO_0000218,,1,,9615.0,,50588,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,Canis lupus familiaris,CHEMBL626017,
Intermediate,,A,13543,In vivo,,1,,,N,,10817,BAO_0000218,,1,,9615.0,1969.0,50588,Bioavailability as maximal plasma concentration in dogs,Canis lupus familiaris,CHEMBL626018,Plasma
Intermediate,,A,13543,In vivo,,1,,,N,,10818,BAO_0000218,,1,,9615.0,1969.0,50588,Bioavailability as maximal plasma concentration in dogs,Canis lupus familiaris,CHEMBL626692,Plasma
Intermediate,,A,13543,In vivo,,1,,,N,,10819,BAO_0000218,,1,,10116.0,1969.0,50597,Bioavailability as maximal plasma concentration in rats,Rattus norvegicus,CHEMBL626693,Plasma
Autocuration,,A,13543,In vivo,,1,,,U,,10820,BAO_0000218,,0,,10116.0,1969.0,22224,Bioavailability as maximal plasma concentration in rats,Rattus norvegicus,CHEMBL626694,Plasma
Intermediate,,A,14600,In vivo,,1,,,N,,10821,BAO_0000218,,1,,9615.0,178.0,50588,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Canis lupus familiaris,CHEMBL626695,Blood
Intermediate,,A,14600,In vivo,,1,,,N,,10822,BAO_0000218,,1,,9615.0,178.0,50588,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Canis lupus familiaris,CHEMBL626696,Blood
Intermediate,,A,14600,In vivo,,1,,,N,,10823,BAO_0000218,,1,,9615.0,178.0,50588,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Canis lupus familiaris,CHEMBL626697,Blood
Intermediate,,A,14600,In vivo,,1,,,N,,10824,BAO_0000218,,1,,9615.0,178.0,50588,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,Canis lupus familiaris,CHEMBL626859,Blood
Intermediate,,A,14600,In vivo,,1,,,N,,10825,BAO_0000218,,1,,9615.0,178.0,50588,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Canis lupus familiaris,CHEMBL626860,Blood
Intermediate,,A,14600,In vivo,,1,,,N,,10826,BAO_0000218,,1,,9615.0,178.0,50588,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Canis lupus familiaris,CHEMBL626861,Blood
Intermediate,,A,14681,In vivo,,1,,,N,,10827,BAO_0000218,,1,,10116.0,,50597,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,Rattus norvegicus,CHEMBL626296,
Autocuration,,A,15905,In vivo,,1,,,U,,10828,BAO_0000218,,0,,,,22224,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,,CHEMBL626297,
Autocuration,,A,15905,In vivo,,1,,,U,,10829,BAO_0000218,,0,,,1969.0,22224,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,,CHEMBL626298,Plasma
Intermediate,,A,13304,In vivo,,1,,,N,,10830,BAO_0000218,,1,,10116.0,1969.0,50597,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",Rattus norvegicus,CHEMBL626299,Plasma
Intermediate,,A,15137,In vivo,,1,,,N,,10831,BAO_0000218,,1,,10116.0,1969.0,50597,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,Rattus norvegicus,CHEMBL626300,Plasma
Intermediate,,A,15137,In vivo,,1,,,N,,10832,BAO_0000218,,1,,10116.0,1969.0,50597,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,Rattus norvegicus,CHEMBL626301,Plasma
Intermediate,,A,15137,In vivo,,1,,,N,,10833,BAO_0000218,,1,,10116.0,1969.0,50597,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,Rattus norvegicus,CHEMBL626962,Plasma
Intermediate,,A,15137,In vivo,,1,,,N,,10834,BAO_0000218,,1,,10116.0,1969.0,50597,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,Rattus norvegicus,CHEMBL626963,Plasma
Intermediate,,A,15137,In vivo,,1,,,N,,10835,BAO_0000218,,1,,10116.0,1969.0,50597,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,Rattus norvegicus,CHEMBL626964,Plasma
Intermediate,,A,14839,In vivo,,1,,,N,,10836,BAO_0000218,,1,,9541.0,1969.0,100710,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,Macaca fascicularis,CHEMBL626965,Plasma
Intermediate,,A,14839,In vivo,,1,,,N,,10837,BAO_0000218,,1,,10090.0,1969.0,50594,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Mus musculus,CHEMBL626966,Plasma
Intermediate,,A,14839,In vivo,,1,,,N,,10838,BAO_0000218,,1,,10090.0,1969.0,50594,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Mus musculus,CHEMBL626967,Plasma
Intermediate,,A,14839,In vivo,,1,,,N,,10839,BAO_0000218,,1,,9541.0,1969.0,100710,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,Macaca fascicularis,CHEMBL626968,Plasma
Intermediate,,A,8418,,,1,,,N,,10840,BAO_0000218,,1,,10116.0,948.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,Rattus norvegicus,CHEMBL626969,Heart
Intermediate,,A,8418,,,1,,,N,,10841,BAO_0000218,,1,,10116.0,948.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,Rattus norvegicus,CHEMBL627126,Heart
Intermediate,,A,8418,,,1,,,N,,10842,BAO_0000218,,1,,10116.0,948.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,Rattus norvegicus,CHEMBL631276,Heart
Intermediate,,A,8418,,,1,,,N,,10843,BAO_0000218,,1,,10116.0,948.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,Rattus norvegicus,CHEMBL631277,Heart
Intermediate,,A,8418,,,1,,,N,,10844,BAO_0000218,,1,,10116.0,948.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,Rattus norvegicus,CHEMBL631278,Heart
Intermediate,,A,8418,,,1,,,N,,10845,BAO_0000218,,1,,10116.0,948.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,Rattus norvegicus,CHEMBL874457,Heart
Intermediate,,A,8418,,,1,,,N,,10846,BAO_0000218,,1,,10116.0,948.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,Rattus norvegicus,CHEMBL631279,Heart
Intermediate,,A,8418,,,1,,,N,,10847,BAO_0000218,,1,,10116.0,948.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,Rattus norvegicus,CHEMBL631280,Heart
Intermediate,,A,8418,,,1,,,N,,10848,BAO_0000218,,1,,10116.0,948.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,Rattus norvegicus,CHEMBL631281,Heart
Intermediate,,A,8418,,,1,,,N,,10849,BAO_0000218,,1,,10116.0,948.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,Rattus norvegicus,CHEMBL631968,Heart
Intermediate,,A,8418,,,1,,,N,,10850,BAO_0000218,,1,,10116.0,948.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,Rattus norvegicus,CHEMBL631969,Heart
Intermediate,,A,8418,,,1,,,N,,10851,BAO_0000218,,1,,10116.0,948.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,Rattus norvegicus,CHEMBL631970,Heart
Intermediate,,A,8418,,,1,,,N,,10852,BAO_0000218,,1,,10116.0,948.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,Rattus norvegicus,CHEMBL631971,Heart
Intermediate,,A,8418,,,1,,,N,,10853,BAO_0000218,,1,,10116.0,948.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,Rattus norvegicus,CHEMBL631972,Heart
Intermediate,,A,8418,,,1,,,N,,10854,BAO_0000218,,1,,10116.0,948.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,Rattus norvegicus,CHEMBL630435,Heart
Intermediate,,A,8418,,,1,,,N,,10855,BAO_0000218,,1,,10116.0,948.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,Rattus norvegicus,CHEMBL630436,Heart
Intermediate,,A,8418,,,1,,,N,,10856,BAO_0000218,,1,,10116.0,948.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,Rattus norvegicus,CHEMBL630437,Heart
Intermediate,,A,8418,,,1,,,N,,10857,BAO_0000218,,1,,10116.0,948.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,Rattus norvegicus,CHEMBL630438,Heart
Intermediate,,A,8418,,,1,,,N,,10858,BAO_0000218,,1,,10116.0,948.0,50597,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,Rattus norvegicus,CHEMBL630439,Heart
Intermediate,,A,8418,,,1,,,N,,10859,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,Rattus norvegicus,CHEMBL630440,Kidney
Intermediate,,A,8418,,,1,,,N,,10860,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,Rattus norvegicus,CHEMBL630441,Kidney
Intermediate,,A,8418,,,1,,,N,,10861,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,Rattus norvegicus,CHEMBL630442,Kidney
Intermediate,,A,8418,,,1,,,N,,10862,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,Rattus norvegicus,CHEMBL625234,Kidney
Intermediate,,A,8418,,,1,,,N,,10863,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,Rattus norvegicus,CHEMBL625235,Kidney
Intermediate,,A,8418,,,1,,,N,,10864,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,Rattus norvegicus,CHEMBL625236,Kidney
Intermediate,,A,8418,,,1,,,N,,10865,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,Rattus norvegicus,CHEMBL625237,Kidney
Intermediate,,A,8418,,,1,,,N,,10866,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,Rattus norvegicus,CHEMBL626125,Kidney
Intermediate,,A,8418,,,1,,,N,,10867,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,Rattus norvegicus,CHEMBL626126,Kidney
Intermediate,,A,8418,,,1,,,N,,10868,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,Rattus norvegicus,CHEMBL626127,Kidney
Intermediate,,A,8418,,,1,,,N,,10869,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,Rattus norvegicus,CHEMBL626128,Kidney
Intermediate,,A,8418,,,1,,,N,,10870,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,Rattus norvegicus,CHEMBL626129,Kidney
Intermediate,,A,8418,,,1,,,N,,10871,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,Rattus norvegicus,CHEMBL626130,Kidney
Intermediate,,A,8418,,,1,,,N,,10872,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,Rattus norvegicus,CHEMBL626131,Kidney
Intermediate,,A,8418,,,1,,,N,,10873,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,Rattus norvegicus,CHEMBL626132,Kidney
Intermediate,,A,8418,,,1,,,N,,10874,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,Rattus norvegicus,CHEMBL626752,Kidney
Intermediate,,A,8418,,,1,,,N,,10875,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,Rattus norvegicus,CHEMBL626753,Kidney
Intermediate,,A,8418,,,1,,,N,,10876,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,Rattus norvegicus,CHEMBL626754,Kidney
Intermediate,,A,8418,,,1,,,N,,10877,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,Rattus norvegicus,CHEMBL626755,Kidney
Intermediate,,A,8418,,,1,,,N,,10878,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,Rattus norvegicus,CHEMBL626756,Liver
Intermediate,,A,8418,,,1,,,N,,10879,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,Rattus norvegicus,CHEMBL626757,Liver
Intermediate,,A,8418,,,1,,,N,,10880,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,Rattus norvegicus,CHEMBL626758,Liver
Intermediate,,A,8418,,,1,,,N,,10881,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,Rattus norvegicus,CHEMBL626759,Liver
Intermediate,,A,8418,,,1,,,N,,10882,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,Rattus norvegicus,CHEMBL626760,Liver
Intermediate,,A,6996,,,1,,,N,,10883,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,CHEMBL626394,
Intermediate,,A,6996,,,1,,,N,,10884,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,Canis lupus familiaris,CHEMBL626395,
Intermediate,,A,6996,,,1,,,N,,10885,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,CHEMBL626396,
Intermediate,,A,6996,,,1,,,N,,10886,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,CHEMBL626397,
Intermediate,,A,6996,,,1,,,N,,10887,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),Canis lupus familiaris,CHEMBL626398,
Intermediate,,A,6996,,,1,,,N,,10888,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,CHEMBL626399,
Intermediate,,A,6996,,,1,,,N,,10889,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,Rattus norvegicus,CHEMBL874653,
Intermediate,,A,6996,,,1,,,N,,10890,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,CHEMBL626400,
Intermediate,,A,6996,,,1,,,N,,10891,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),Rattus norvegicus,CHEMBL626401,
Intermediate,,A,6996,,,1,,,N,,10892,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,CHEMBL626402,
Intermediate,,A,6996,,,1,,,N,,10893,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,CHEMBL626403,
Intermediate,,A,6996,,,1,,,N,,10894,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,CHEMBL626404,
Intermediate,,A,6996,,,1,,,N,,10895,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,Rattus norvegicus,CHEMBL626405,
Intermediate,,A,6996,,,1,,,N,,10896,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,CHEMBL625529,
Intermediate,,A,6996,,,1,,,N,,10897,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),Rattus norvegicus,CHEMBL625530,
Intermediate,,A,6996,,,1,,,N,,10898,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,CHEMBL625531,
Intermediate,,A,6996,,,1,,,N,,10899,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,CHEMBL625532,
Intermediate,,A,6996,,,1,,,N,,10900,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,CHEMBL625533,
Intermediate,,A,6996,,,1,,,N,,10901,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,Rattus norvegicus,CHEMBL875474,
Intermediate,,A,6996,,,1,,,N,,10902,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,CHEMBL625534,
Intermediate,,A,6996,,,1,,,N,,10903,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),Rattus norvegicus,CHEMBL625535,
Intermediate,,A,6996,,,1,,,N,,10904,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,CHEMBL625536,
Intermediate,,A,6996,,,1,,,N,,10905,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,CHEMBL625537,
Intermediate,,A,6996,,,1,,,N,,10906,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,CHEMBL625538,
Intermediate,,A,6996,,,1,,,N,,10907,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,Rattus norvegicus,CHEMBL625539,
Intermediate,,A,6996,,,1,,,N,,10908,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,CHEMBL625540,
Intermediate,,A,6996,,,1,,,N,,10909,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Rattus norvegicus,CHEMBL625541,
Intermediate,,A,6996,,,1,,,N,,10910,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,CHEMBL625542,
Intermediate,,A,6996,,,1,,,N,,10911,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,CHEMBL625543,
Intermediate,,A,6996,,,1,,,N,,10912,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,CHEMBL625544,
Intermediate,,A,6996,,,1,,,N,,10913,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,Canis lupus familiaris,CHEMBL625545,
Intermediate,,A,6996,,,1,,,N,,10914,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,CHEMBL625546,
Intermediate,,A,6996,,,1,,,N,,10915,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,Canis lupus familiaris,CHEMBL625547,
Intermediate,,A,6996,,,1,,,N,,10916,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,CHEMBL625548,
Intermediate,,A,6996,,,1,,,N,,10917,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,CHEMBL625549,
Intermediate,,A,6996,,,1,,,N,,10918,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,CHEMBL625550,
Intermediate,,A,6996,,,1,,,N,,10919,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,CHEMBL625551,
Intermediate,,A,6996,,,1,,,N,,10920,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,CHEMBL875475,
Intermediate,,A,6996,,,1,,,N,,10921,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,CHEMBL625552,
Intermediate,,A,6996,,,1,,,N,,10922,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,CHEMBL625553,
Intermediate,,A,6996,,,1,,,N,,10923,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,CHEMBL625554,
Intermediate,,A,6996,,,1,,,N,,10924,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),Canis lupus familiaris,CHEMBL625555,
Intermediate,,A,6996,,,1,,,N,,10925,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,CHEMBL625556,
Intermediate,,A,6996,,,1,,,N,,10926,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,Canis lupus familiaris,CHEMBL624986,
Intermediate,,A,6996,,,1,,,N,,10927,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,CHEMBL624987,
Intermediate,,A,6996,,,1,,,N,,10928,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,CHEMBL624988,
Intermediate,,A,9025,In vivo,,1,,,N,,10929,BAO_0000218,,1,,9615.0,1637.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,Canis lupus familiaris,CHEMBL624989,Artery
Intermediate,,A,9025,In vivo,,1,,,N,,10930,BAO_0000218,,1,,9615.0,1637.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,Canis lupus familiaris,CHEMBL624990,Artery
Intermediate,,A,9025,In vivo,,1,,,N,,10931,BAO_0000218,,1,,9615.0,1637.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,Canis lupus familiaris,CHEMBL874391,Artery
Intermediate,,A,9025,In vivo,,1,,,N,,10932,BAO_0000218,,1,,9615.0,1637.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,Canis lupus familiaris,CHEMBL624991,Artery
Intermediate,,A,9025,In vivo,,1,,,N,,10933,BAO_0000218,,1,,9615.0,1637.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,Canis lupus familiaris,CHEMBL624992,Artery
Intermediate,,A,9025,In vivo,,1,,,N,,10934,BAO_0000218,,1,,9615.0,1637.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,Canis lupus familiaris,CHEMBL624993,Artery
Intermediate,,A,9025,In vivo,,1,,,N,,10935,BAO_0000218,,1,,9615.0,1637.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,Canis lupus familiaris,CHEMBL624994,Artery
Intermediate,,A,9025,In vivo,,1,,,N,,10936,BAO_0000218,,1,,9615.0,1637.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,Canis lupus familiaris,CHEMBL624995,Artery
Intermediate,,A,9025,In vivo,,1,,,N,,10937,BAO_0000218,,1,,9615.0,1637.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,Canis lupus familiaris,CHEMBL624996,Artery
Intermediate,,A,9025,In vivo,,1,,,N,,10938,BAO_0000218,,1,,9615.0,1637.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,Canis lupus familiaris,CHEMBL624997,Artery
Intermediate,,A,9025,In vivo,,1,,,N,,10939,BAO_0000218,,1,,9615.0,1637.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,Canis lupus familiaris,CHEMBL624998,Artery
Intermediate,,A,9025,In vivo,,1,,,N,,10940,BAO_0000218,,1,,9615.0,1637.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,Canis lupus familiaris,CHEMBL624999,Artery
Intermediate,,A,9025,In vivo,,1,,,N,,10941,BAO_0000218,,1,,9615.0,1637.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,Canis lupus familiaris,CHEMBL882955,Artery
Intermediate,,A,9025,In vivo,,1,,,N,,10942,BAO_0000218,,1,,9615.0,1637.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,Canis lupus familiaris,CHEMBL625000,Artery
Intermediate,,A,9025,In vivo,,1,,,N,,10943,BAO_0000218,,1,,9615.0,1637.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,Canis lupus familiaris,CHEMBL625001,Artery
Intermediate,,A,9025,In vivo,,1,,,N,,10944,BAO_0000218,,1,,9615.0,1637.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,Canis lupus familiaris,CHEMBL625089,Artery
Intermediate,,A,9025,In vivo,,1,,,N,,10945,BAO_0000218,,1,,9615.0,1637.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,Canis lupus familiaris,CHEMBL625090,Artery
Intermediate,,A,9025,In vivo,,1,,,N,,10946,BAO_0000218,,1,,9615.0,1637.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,Canis lupus familiaris,CHEMBL625091,Artery
Intermediate,,A,9025,In vivo,,1,,,N,,10947,BAO_0000218,,1,,9615.0,1637.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,Canis lupus familiaris,CHEMBL625092,Artery
Intermediate,,A,9025,In vivo,,1,,,N,,10948,BAO_0000218,,1,,9615.0,1637.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,Canis lupus familiaris,CHEMBL625093,Artery
Intermediate,,A,9025,In vivo,,1,,,N,,10949,BAO_0000218,,1,,9615.0,1637.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,Canis lupus familiaris,CHEMBL625094,Artery
Intermediate,,A,9025,In vivo,,1,,,N,,10950,BAO_0000218,,1,,9615.0,1637.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,Canis lupus familiaris,CHEMBL625095,Artery
Intermediate,,A,2249,In vivo,,1,,,N,,10951,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for its bioavailability in the dogs,Canis lupus familiaris,CHEMBL625096,
Intermediate,,A,2249,In vivo,,1,,,N,,10952,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for its bioavailability in the rats,Rattus norvegicus,CHEMBL625097,
Autocuration,,A,17515,In vivo,,1,,,U,,10953,BAO_0000218,,0,,,,22224,Compound was evaluated for oral bioavailability,,CHEMBL882956,
Intermediate,,A,14541,In vivo,,1,,,N,,10954,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for percentage of Oral bioavailability in rats,Rattus norvegicus,CHEMBL625098,
Autocuration,,A,12797,In vivo,,1,,,U,,10955,BAO_0000218,,0,,10141.0,,22224,Bioavailability in guinea pig,Cavia porcellus,CHEMBL625099,
Intermediate,,A,12797,In vivo,,1,,,N,,10956,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for the oral bioavailability in rat,Rattus norvegicus,CHEMBL625100,
Intermediate,,A,12797,In vivo,,1,,,N,,10957,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for the oral bioavailability in dog,Canis lupus familiaris,CHEMBL625101,
Intermediate,,A,12797,In vivo,,1,,,N,,10958,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for the oral bioavailability in rat,Rattus norvegicus,CHEMBL874396,
Autocuration,,F,11727,In vivo,,1,,,U,,10959,BAO_0000218,,0,,9615.0,,22224,Bioavailability in dog (dosed i.v.),Canis lupus familiaris,CHEMBL625102,
Intermediate,,A,13249,In vivo,,1,,,N,,10960,BAO_0000218,,1,,9615.0,,50588,Compound was tested for in vivo bioavailability in dog,Canis lupus familiaris,CHEMBL625103,
Intermediate,,A,13249,In vivo,,1,,,N,,10961,BAO_0000218,,1,,10026.0,,100712,Compound was tested for in vivo bioavailability in hamsters,Cricetinae,CHEMBL625104,
Autocuration,,A,13249,In vivo,,1,,,U,,10962,BAO_0000218,,0,,314293.0,,22224,Compound was tested for in vivo bioavailability in monkey,Simiiformes,CHEMBL625105,
Intermediate,,A,13249,In vivo,,1,,,N,,10963,BAO_0000218,,1,,10116.0,,50597,Compound was tested for in vivo bioavailability in rat,Rattus norvegicus,CHEMBL625106,
Autocuration,,A,9552,In vivo,,1,,,U,,10964,BAO_0000218,,0,,10090.0,,22224,Oral bioavailability in mouse,Mus musculus,CHEMBL625107,
Intermediate,,A,9552,In vivo,,1,,,N,,10965,BAO_0000218,,1,,10090.0,,50594,Compound was tested for percent of oral bioavailability in mice; 56-74,Mus musculus,CHEMBL625108,
Autocuration,,A,14839,In vivo,,1,,,U,,10966,BAO_0000218,,0,,10090.0,,22224,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),Mus musculus,CHEMBL625109,
Autocuration,,A,14839,In vivo,,1,,,U,,10967,BAO_0000218,,0,,9541.0,,22224,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),Macaca fascicularis,CHEMBL625110,
Autocuration,,A,14839,In vivo,,1,,,U,,10968,BAO_0000218,,0,,9541.0,,22224,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),Macaca fascicularis,CHEMBL625111,
Intermediate,,A,14839,In vivo,,1,,,N,,10969,BAO_0000218,,1,,10090.0,,50594,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),Mus musculus,CHEMBL625112,
Intermediate,,A,14839,In vivo,,1,,,N,,10970,BAO_0000218,,1,,10090.0,,50594,Oral bioavailability in nude mice,Mus musculus,CHEMBL875334,
Autocuration,,A,11219,In vivo,,1,,,U,,10971,BAO_0000218,,0,,9443.0,,22224,Bioavailability in monkey (i.d. dosing),Primates,CHEMBL628617,
Autocuration,,A,9552,In vivo,,1,,,U,,10972,BAO_0000218,,0,,10116.0,,22224,Bioavailability in rat,Rattus norvegicus,CHEMBL628618,
Autocuration,,A,11732,In vivo,,1,,,U,,10973,BAO_0000218,,0,,,,22224,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,,CHEMBL628619,
Autocuration,,A,11732,In vivo,,1,,,U,,10974,BAO_0000218,,0,,,,22224,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,,CHEMBL628620,
Intermediate,,A,14839,In vivo,,1,,,N,,10975,BAO_0000218,,1,,9541.0,,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",Macaca fascicularis,CHEMBL628621,
Intermediate,,A,14839,In vivo,,1,,,N,,10976,BAO_0000218,,1,,9541.0,,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",Macaca fascicularis,CHEMBL628622,
Intermediate,,A,14839,In vivo,,1,,,N,,10977,BAO_0000218,,1,,9541.0,,100710,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",Macaca fascicularis,CHEMBL628623,
Intermediate,,A,14839,In vivo,,1,,,N,,10978,BAO_0000218,,1,,9541.0,1969.0,100710,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,Macaca fascicularis,CHEMBL628624,Plasma
Intermediate,,A,14839,In vivo,,1,,,N,,10979,BAO_0000218,,1,,10090.0,1969.0,50594,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Mus musculus,CHEMBL628625,Plasma
Intermediate,,A,14839,In vivo,,1,,,N,,10980,BAO_0000218,,1,,9541.0,1969.0,100710,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,Macaca fascicularis,CHEMBL628626,Plasma
Intermediate,,A,14839,In vivo,,1,,,N,,10981,BAO_0000218,,1,,10090.0,1969.0,50594,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Mus musculus,CHEMBL627041,Plasma
Intermediate,,A,14839,In vivo,,1,,,N,,10982,BAO_0000218,,1,,10090.0,1969.0,50594,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Mus musculus,CHEMBL627042,Plasma
Intermediate,,A,14839,In vivo,,1,,,N,,10983,BAO_0000218,,1,,10090.0,1969.0,50594,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Mus musculus,CHEMBL627043,Plasma
Autocuration,,A,13932,In vivo,,1,,,U,,10984,BAO_0000218,,0,,,1969.0,22224,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,,CHEMBL627044,Plasma
Intermediate,,A,11637,In vivo,,1,,,N,,10985,BAO_0000218,,1,,10090.0,1969.0,50594,Cmax in mouse plasma,Mus musculus,CHEMBL627045,Plasma
Autocuration,,A,11637,In vivo,,1,,,U,,10986,BAO_0000218,,0,,,1969.0,22224,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,,CHEMBL627046,Plasma
Intermediate,,A,13960,In vivo,,1,,,N,,10987,BAO_0000218,,1,,10116.0,1969.0,50597,Maximal plasma concentration in rat,Rattus norvegicus,CHEMBL627047,Plasma
Intermediate,,A,15905,In vivo,,1,,,N,,10988,BAO_0000218,,1,,10116.0,1969.0,50597,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,Rattus norvegicus,CHEMBL627048,Plasma
Intermediate,,A,14062,In vivo,,1,,,N,,10989,BAO_0000218,,1,,10116.0,,50597,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,Rattus norvegicus,CHEMBL627049,
Intermediate,,A,14062,In vivo,,1,,,N,,10990,BAO_0000218,,1,,10116.0,,50597,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,Rattus norvegicus,CHEMBL627050,
Intermediate,,A,14062,In vivo,,1,,,N,,10991,BAO_0000218,,1,,10116.0,,50597,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,Rattus norvegicus,CHEMBL627051,
Intermediate,,A,14062,In vivo,,1,,,N,,10992,BAO_0000218,,1,,10116.0,,50597,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,Rattus norvegicus,CHEMBL627052,
Intermediate,,A,14062,In vivo,,1,,,N,,10993,BAO_0000218,,1,,10116.0,,50597,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,Rattus norvegicus,CHEMBL627053,
Intermediate,,A,14062,In vivo,,1,,,N,,10994,BAO_0000218,,1,,10116.0,,50597,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,Rattus norvegicus,CHEMBL627054,
Intermediate,,A,15011,In vivo,,1,,,N,,10995,BAO_0000218,,1,,10090.0,,50594,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,Mus musculus,CHEMBL627055,
Intermediate,,A,15011,In vivo,,1,,,N,,10996,BAO_0000218,,1,,10090.0,,50594,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,Mus musculus,CHEMBL627056,
Intermediate,,A,15011,In vivo,,1,,,N,,10997,BAO_0000218,,1,,10090.0,,50594,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),Mus musculus,CHEMBL627057,
Intermediate,,A,15011,In vivo,,1,,,N,,10998,BAO_0000218,,1,,10090.0,,50594,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,Mus musculus,CHEMBL627058,
Intermediate,,A,15011,In vivo,,1,,,N,,10999,BAO_0000218,,1,,10090.0,,50594,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,Mus musculus,CHEMBL626211,
Autocuration,,A,10291,In vivo,,1,,,U,,11000,BAO_0000218,,0,,,,22224,Maximum Concentration of the compound.,,CHEMBL626212,
Intermediate,,A,14599,In vivo,,1,,,N,,11001,BAO_0000218,,1,,9615.0,,50588,Maximum Concentration was measured after iv administration into Beagle dog,Canis lupus familiaris,CHEMBL626213,
Intermediate,,A,14599,In vivo,,1,,,N,,11002,BAO_0000218,,1,,9615.0,,50588,Maximum Concentration was measured after iv administration into Beagle dog.,Canis lupus familiaris,CHEMBL626214,
Intermediate,,A,14599,In vivo,,1,,,N,,11003,BAO_0000218,,1,,9615.0,,50588,Maximum Concentration was measured after po administration into Beagle dog,Canis lupus familiaris,CHEMBL626215,
Intermediate,,A,14599,In vivo,,1,,,N,,11004,BAO_0000218,,1,,9615.0,,50588,Maximum Concentration was measured after po administration into Beagle dog.,Canis lupus familiaris,CHEMBL626216,
Autocuration,,A,12767,In vivo,,1,,,U,,11005,BAO_0000218,,0,,,178.0,22224,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,,CHEMBL626217,Blood
Autocuration,,A,12767,In vivo,,1,,,U,,11006,BAO_0000218,,0,,,178.0,22224,Maximum blood level reached after an iv dose of 12.2 uM/kg,,CHEMBL626218,Blood
Autocuration,,A,12767,In vivo,,1,,,U,,11007,BAO_0000218,,0,,,178.0,22224,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,,CHEMBL626219,Blood
Autocuration,,A,12767,In vivo,,1,,,U,,11008,BAO_0000218,,0,,,178.0,22224,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,,CHEMBL626220,Blood
Autocuration,,A,12767,In vivo,,1,,,U,,11009,BAO_0000218,,0,,,178.0,22224,Maximum blood level reached after an oral dose of 5.0 mg/kg,,CHEMBL626221,Blood
Autocuration,,A,12767,In vivo,,1,,,U,,11010,BAO_0000218,,0,,,178.0,22224,Maximum blood level reached at dose of 10.6 uM/kg orally,,CHEMBL626222,Blood
Intermediate,,A,14706,In vivo,,1,,,N,,11011,BAO_0000218,,1,,10141.0,,50512,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,Cavia porcellus,CHEMBL626223,
Intermediate,,A,14706,In vivo,,1,,,N,,11012,BAO_0000218,,1,,10141.0,,50512,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,Cavia porcellus,CHEMBL626224,
Intermediate,,A,14793,In vivo,,1,,,N,,11013,BAO_0000218,,1,,10116.0,955.0,50597,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,Rattus norvegicus,CHEMBL626225,Brain
Intermediate,,A,14793,In vivo,,1,,,N,,11014,BAO_0000218,,1,,10116.0,955.0,50597,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,Rattus norvegicus,CHEMBL626226,Brain
Intermediate,,A,14793,In vivo,,1,,,N,,11015,BAO_0000218,,1,,10116.0,955.0,50597,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,Rattus norvegicus,CHEMBL626227,Brain
Intermediate,,A,14793,In vivo,,1,,,N,,11016,BAO_0000218,,1,,10116.0,955.0,50597,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,Rattus norvegicus,CHEMBL626228,Brain
Intermediate,,A,14793,In vivo,,1,,,N,,11017,BAO_0000218,,1,,10116.0,,50597,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Rattus norvegicus,CHEMBL626229,
Intermediate,,A,14793,In vivo,,1,,,N,,11018,BAO_0000218,,1,,10116.0,,50597,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,Rattus norvegicus,CHEMBL626921,
Intermediate,,A,14793,In vivo,,1,,,N,,11019,BAO_0000218,,1,,10116.0,,50597,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,Rattus norvegicus,CHEMBL876793,
Intermediate,,A,14793,In vivo,,1,,,N,,11020,BAO_0000218,,1,,10116.0,,50597,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,Rattus norvegicus,CHEMBL625309,
Intermediate,,A,10524,In vivo,,1,,,N,,11021,BAO_0000218,,1,,1423.0,,50278,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),Bacillus subtilis,CHEMBL625310,
Autocuration,,A,11871,In vivo,,1,,,U,,11022,BAO_0000218,,0,,314293.0,,22224,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,Simiiformes,CHEMBL625311,
Intermediate,,A,11871,In vivo,,1,,,N,,11023,BAO_0000218,,1,,10116.0,,50597,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,Rattus norvegicus,CHEMBL625312,
Autocuration,,A,3437,In vivo,,1,,,U,,11024,BAO_0000218,,0,,,,22224,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,,CHEMBL625313,
Intermediate,,A,12038,In vivo,,1,,,N,,11025,BAO_0000218,,1,,10090.0,,50594,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,Mus musculus,CHEMBL625314,
Intermediate,,A,12038,In vivo,,1,,,N,,11026,BAO_0000218,,1,,10116.0,,50597,Maximum concentration in male rats after iv administration of 20 mg/kg,Rattus norvegicus,CHEMBL625315,
Intermediate,,A,8418,,,1,,,N,,11027,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,Rattus norvegicus,CHEMBL625316,Liver
Intermediate,,A,8418,,,1,,,N,,11028,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,Rattus norvegicus,CHEMBL625317,Liver
Intermediate,,A,8418,,,1,,,N,,11029,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,Rattus norvegicus,CHEMBL625318,Liver
Intermediate,,A,8418,,,1,,,N,,11030,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,Rattus norvegicus,CHEMBL625319,Liver
Intermediate,,A,8418,,,1,,,N,,11031,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,Rattus norvegicus,CHEMBL625320,Liver
Intermediate,,A,8418,,,1,,,N,,11032,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,Rattus norvegicus,CHEMBL625321,Liver
Intermediate,,A,8418,,,1,,,N,,11033,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,Rattus norvegicus,CHEMBL625322,Liver
Intermediate,,A,8418,,,1,,,N,,11034,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,Rattus norvegicus,CHEMBL876801,Liver
Intermediate,,A,8418,,,1,,,N,,11035,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,Rattus norvegicus,CHEMBL625323,Liver
Intermediate,,A,8418,,,1,,,N,,11036,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,Rattus norvegicus,CHEMBL625324,Liver
Intermediate,,A,8418,,,1,,,N,,11037,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,Rattus norvegicus,CHEMBL625325,Liver
Intermediate,,A,8418,,,1,,,N,,11038,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,Rattus norvegicus,CHEMBL625326,Liver
Intermediate,,A,8418,,,1,,,N,,11039,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,Rattus norvegicus,CHEMBL625327,Liver
Intermediate,,A,8418,,,1,,,N,,11040,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,Rattus norvegicus,CHEMBL625328,Liver
Intermediate,,A,8418,,,1,,,N,,11041,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,Rattus norvegicus,CHEMBL625329,Lung
Intermediate,,A,8418,,,1,,,N,,11042,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,Rattus norvegicus,CHEMBL625330,Lung
Intermediate,,A,8418,,,1,,,N,,11043,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,Rattus norvegicus,CHEMBL627774,Lung
Intermediate,,A,8418,,,1,,,N,,11044,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,Rattus norvegicus,CHEMBL627775,Lung
Intermediate,,A,8418,,,1,,,N,,11045,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,Rattus norvegicus,CHEMBL627949,Lung
Intermediate,,A,8418,,,1,,,N,,11046,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,Rattus norvegicus,CHEMBL627950,Lung
Intermediate,,A,8418,,,1,,,N,,11047,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,Rattus norvegicus,CHEMBL627951,Lung
Intermediate,,A,8418,,,1,,,N,,11048,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,Rattus norvegicus,CHEMBL627952,Lung
Intermediate,,A,8418,,,1,,,N,,11049,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,Rattus norvegicus,CHEMBL627953,Lung
Intermediate,,A,8418,,,1,,,N,,11050,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,Rattus norvegicus,CHEMBL627954,Lung
Intermediate,,A,8418,,,1,,,N,,11051,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,Rattus norvegicus,CHEMBL627955,Lung
Intermediate,,A,8418,,,1,,,N,,11052,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,Rattus norvegicus,CHEMBL627956,Lung
Intermediate,,A,8418,,,1,,,N,,11053,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,Rattus norvegicus,CHEMBL876802,Lung
Intermediate,,A,8418,,,1,,,N,,11054,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,Rattus norvegicus,CHEMBL627957,Lung
Intermediate,,A,8418,,,1,,,N,,11055,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,Rattus norvegicus,CHEMBL627958,Lung
Intermediate,,A,8418,,,1,,,N,,11056,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,Rattus norvegicus,CHEMBL627959,Lung
Intermediate,,A,8418,,,1,,,N,,11057,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,Rattus norvegicus,CHEMBL627960,Lung
Intermediate,,A,8418,,,1,,,N,,11058,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,Rattus norvegicus,CHEMBL627961,Lung
Intermediate,,A,8418,,,1,,,N,,11059,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,Rattus norvegicus,CHEMBL627962,Lung
Intermediate,,A,9796,,,1,,,N,,11060,BAO_0000218,,1,,10116.0,,50597,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Rattus norvegicus,CHEMBL627963,
Intermediate,,A,9796,,,1,,,N,,11061,BAO_0000218,,1,,10116.0,,50597,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,CHEMBL624759,
Intermediate,,A,9796,,,1,,,N,,11062,BAO_0000218,,1,,10116.0,,50597,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,CHEMBL624760,
Intermediate,,A,9796,,,1,,,N,,11063,BAO_0000218,,1,,10116.0,,50597,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,CHEMBL624761,
Intermediate,,A,9796,,,1,,,N,,11064,BAO_0000218,,1,,10116.0,,50597,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,CHEMBL877607,
Intermediate,,A,9796,,,1,,,N,,11065,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Rattus norvegicus,CHEMBL624762,Liver
Intermediate,,A,9796,,,1,,,N,,11066,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,CHEMBL624763,Liver
Intermediate,,A,9796,,,1,,,N,,11067,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,CHEMBL624764,Liver
Intermediate,,A,9796,,,1,,,N,,11068,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,CHEMBL624765,Liver
Intermediate,,A,9796,,,1,,,N,,11069,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,CHEMBL624766,Liver
Intermediate,,A,6996,,,1,,,N,,11070,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,CHEMBL624767,
Intermediate,,A,6996,,,1,,,N,,11071,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,Canis lupus familiaris,CHEMBL624768,
Intermediate,,A,6996,,,1,,,N,,11072,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,CHEMBL624769,
Intermediate,,A,6996,,,1,,,N,,11073,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,CHEMBL624770,
Intermediate,,A,6996,,,1,,,N,,11074,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),Canis lupus familiaris,CHEMBL624771,
Intermediate,,A,6996,,,1,,,N,,11075,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,CHEMBL624772,
Intermediate,,A,6996,,,1,,,N,,11076,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,Rattus norvegicus,CHEMBL624773,
Intermediate,,A,6996,,,1,,,N,,11077,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,CHEMBL624774,
Intermediate,,A,6996,,,1,,,N,,11078,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),Rattus norvegicus,CHEMBL624775,
Intermediate,,A,6996,,,1,,,N,,11079,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,CHEMBL624776,
Intermediate,,A,6996,,,1,,,N,,11080,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,CHEMBL624777,
Intermediate,,A,6996,,,1,,,N,,11081,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,CHEMBL624778,
Intermediate,,A,6996,,,1,,,N,,11082,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,Rattus norvegicus,CHEMBL624779,
Intermediate,,A,6996,,,1,,,N,,11083,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,CHEMBL624780,
Intermediate,,A,6996,,,1,,,N,,11084,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,CHEMBL624781,
Intermediate,,A,6996,,,1,,,N,,11085,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,CHEMBL877608,
Intermediate,,A,6996,,,1,,,N,,11086,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),Rattus norvegicus,CHEMBL624782,
Intermediate,,A,6996,,,1,,,N,,11087,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,CHEMBL624783,
Intermediate,,A,6996,,,1,,,N,,11088,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,Rattus norvegicus,CHEMBL624784,
Intermediate,,A,6996,,,1,,,N,,11089,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,CHEMBL624785,
Intermediate,,A,6996,,,1,,,N,,11090,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),Rattus norvegicus,CHEMBL624786,
Intermediate,,A,6996,,,1,,,N,,11091,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,CHEMBL624787,
Intermediate,,A,6996,,,1,,,N,,11092,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,CHEMBL628676,
Intermediate,,A,6996,,,1,,,N,,11093,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,Rattus norvegicus,CHEMBL621842,
Intermediate,,A,6996,,,1,,,N,,11094,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,CHEMBL621843,
Intermediate,,A,6996,,,1,,,N,,11095,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Rattus norvegicus,CHEMBL623873,
Intermediate,,A,6996,,,1,,,N,,11096,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,CHEMBL623874,
Intermediate,,A,6996,,,1,,,N,,11097,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,CHEMBL623875,
Intermediate,,A,6996,,,1,,,N,,11098,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,CHEMBL623876,
Intermediate,,A,6996,,,1,,,N,,11099,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,Canis lupus familiaris,CHEMBL623877,
Intermediate,,A,6996,,,1,,,N,,11100,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,CHEMBL623878,
Intermediate,,A,6996,,,1,,,N,,11101,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,Canis lupus familiaris,CHEMBL623879,
Intermediate,,A,6996,,,1,,,N,,11102,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,CHEMBL623880,
Intermediate,,A,6996,,,1,,,N,,11103,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,CHEMBL623881,
Intermediate,,A,6996,,,1,,,N,,11104,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,CHEMBL623957,
Intermediate,,A,6996,,,1,,,N,,11105,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,CHEMBL623958,
Intermediate,,A,6996,,,1,,,N,,11106,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,CHEMBL623959,
Intermediate,,A,6996,,,1,,,N,,11107,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,CHEMBL623960,
Intermediate,,A,6996,,,1,,,N,,11108,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,CHEMBL623961,
Intermediate,,A,6996,,,1,,,N,,11109,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,CHEMBL623962,
Intermediate,,A,6996,,,1,,,N,,11110,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),Canis lupus familiaris,CHEMBL624676,
Intermediate,,A,6996,,,1,,,N,,11111,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,CHEMBL624677,
Intermediate,,A,6996,,,1,,,N,,11112,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,Canis lupus familiaris,CHEMBL624678,
Intermediate,,A,6996,,,1,,,N,,11113,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,CHEMBL624679,
Intermediate,,A,6996,,,1,,,N,,11114,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,CHEMBL624680,
Autocuration,,A,11732,In vivo,,1,,,U,,11115,BAO_0000218,,0,,,,22224,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,,CHEMBL624849,
Autocuration,,A,11732,In vivo,,1,,,U,,11116,BAO_0000218,,0,,,,22224,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,,CHEMBL624850,
Autocuration,,A,11732,In vivo,,1,,,U,,11117,BAO_0000218,,0,,,,22224,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,,CHEMBL874399,
Autocuration,,A,11732,In vivo,,1,,,U,,11118,BAO_0000218,,0,,,,22224,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,,CHEMBL624851,
Autocuration,,A,11732,In vivo,,1,,,U,,11119,BAO_0000218,,0,,,,22224,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,,CHEMBL624852,
Autocuration,,A,13359,In vivo,,1,,,U,,11120,BAO_0000218,,0,,10116.0,,22224,Oral bioavailability in rat (dose 10 mg/kg),Rattus norvegicus,CHEMBL624853,
Autocuration,,A,16618,In vivo,,1,,,U,,11121,BAO_0000218,,0,,10116.0,,22224,Oral bioavailability in rat (Sprague-Dawley),Rattus norvegicus,CHEMBL624854,
Autocuration,,A,13960,In vivo,,1,,,U,,11122,BAO_0000218,,0,,10116.0,,22224,Oral bioavailability in rat,Rattus norvegicus,CHEMBL624855,
Autocuration,,A,13917,In vivo,,1,,,U,,11123,BAO_0000218,,0,,10116.0,,22224,Oral bioavailability in rats was determined in vivo,Rattus norvegicus,CHEMBL624856,
Autocuration,,A,14266,In vivo,,1,,,U,,11124,BAO_0000218,,0,,9615.0,,22224,Oral bioavailability in dog,Canis lupus familiaris,CHEMBL882957,
Autocuration,,A,12359,In vivo,,1,,,U,,11125,BAO_0000218,,0,,314293.0,,22224,Oral bioavailability of compound in monkey,Simiiformes,CHEMBL624857,
Intermediate,,A,12359,In vivo,,1,,,N,,11126,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability of compound in rat,Rattus norvegicus,CHEMBL622202,
Autocuration,,A,12359,In vivo,,1,,,U,,11127,BAO_0000218,,0,,10116.0,,22224,Bioavailability in rat of PMEA prodrug,Rattus norvegicus,CHEMBL622203,
Intermediate,,A,12359,In vivo,,1,,,N,,11128,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,Rattus norvegicus,CHEMBL625522,
Autocuration,,A,10791,In vivo,,1,,,U,,11129,BAO_0000218,,0,,9544.0,,22224,Serum conc at 3 hours following 25 mg/kg dose,Macaca mulatta,CHEMBL622868,
Autocuration,,A,10791,In vivo,,1,,,U,,11130,BAO_0000218,,0,,9544.0,1088.0,22224,Urine conc 0-5 hours following 25 mg/kg dose,Macaca mulatta,CHEMBL622869,Urine
Autocuration,,A,10791,In vivo,,1,,,U,,11131,BAO_0000218,,0,,9544.0,1088.0,22224,Urine conc 0-24 hours following 25 mg/kg dose,Macaca mulatta,CHEMBL622870,Urine
Autocuration,,A,138,In vivo,,1,,,U,,11132,BAO_0000218,,0,,9534.0,,22224,Oral bioavailability in African green monkeys; 20-25,Chlorocebus aethiops,CHEMBL622871,
Intermediate,,A,14521,In vivo,,1,,,N,,11133,BAO_0000218,,1,,9541.0,,100710,Oral bioavailability in cynomolgus monkey.,Macaca fascicularis,CHEMBL620560,
Autocuration,,A,13953,In vivo,,1,,,U,,11134,BAO_0000218,,0,,9615.0,,22224,Oral bioavailability in dog,Canis lupus familiaris,CHEMBL620561,
Intermediate,,A,12836,In vivo,,1,,,N,,11135,BAO_0000218,,1,,9615.0,,50588,Oral bioavailability in dog at 10 mg/kg oral dose,Canis lupus familiaris,CHEMBL620562,
Intermediate,,A,12836,In vivo,,1,,,N,,11136,BAO_0000218,,1,,10026.0,,100712,Oral bioavailability in hamster at 10 mg/kg oral dose,Cricetinae,CHEMBL620563,
Intermediate,,A,12836,In vivo,,1,,,N,,11137,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability in rat at 10 mg/kg oral dose,Rattus norvegicus,CHEMBL620564,
Autocuration,,A,14521,In vivo,,1,,,U,,11138,BAO_0000218,,0,,10116.0,,22224,Oral bioavailability in rat,Rattus norvegicus,CHEMBL872265,
Autocuration,,A,13953,In vivo,,1,,,U,,11139,BAO_0000218,,0,,10116.0,,22224,Oral bioavailability in rat,Rattus norvegicus,CHEMBL620565,
Autocuration,,A,6799,In vivo,,1,,,U,,11140,BAO_0000218,,0,,9347.0,,22224,Oral bioavailability,Eutheria,CHEMBL620566,
Autocuration,,A,11311,In vivo,,1,,,U,,11141,BAO_0000218,,0,,,,22224,Oral bioavailability was determined; range 49-102%,,CHEMBL620567,
Intermediate,,A,4013,In vivo,,1,,,N,,11142,BAO_0000218,,1,,9615.0,,50588,Oral bioavailability was determined in dogs,Canis lupus familiaris,CHEMBL620568,
Autocuration,,A,4013,In vivo,,1,,,U,,11143,BAO_0000218,,0,,10116.0,,22224,Oral bioavailability in rat,Rattus norvegicus,CHEMBL620569,
Autocuration,,A,17591,In vivo,,1,,,U,,11144,BAO_0000218,,0,,9347.0,,22224,Oral bioavailability,Eutheria,CHEMBL620570,
Autocuration,,A,17591,In vivo,,1,,,U,,11145,BAO_0000218,,0,,,,22224,Oral bioavailability was determined; Not orally available,,CHEMBL620571,
Intermediate,,A,15011,In vivo,,1,,,N,,11146,BAO_0000218,,1,,10090.0,,50594,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),Mus musculus,CHEMBL620572,
Autocuration,,A,15011,In vivo,,1,,,U,,11147,BAO_0000218,,0,,10090.0,,22224,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),Mus musculus,CHEMBL620573,
Autocuration,,A,15011,In vivo,,1,,,U,,11148,BAO_0000218,,0,,10090.0,,22224,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,Mus musculus,CHEMBL620574,
Autocuration,,A,9552,In vivo,,1,,,U,,11149,BAO_0000218,,0,,9544.0,,22224,Oral bioavailability in Rhesus monkey,Macaca mulatta,CHEMBL620575,
Autocuration,,A,9552,In vivo,,1,,,U,,11150,BAO_0000218,,0,,9615.0,,22224,Oral bioavailability in dog (female mongrel),Canis lupus familiaris,CHEMBL620576,
Autocuration,,A,3639,In vivo,,1,,,U,,11151,BAO_0000218,,0,,,,22224,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,,CHEMBL875846,
Autocuration,,A,13397,In vivo,,1,,,U,,11152,BAO_0000218,,0,,9615.0,,22224,Oral bioavailability in dog,Canis lupus familiaris,CHEMBL620577,
Autocuration,,A,3031,In vivo,,1,,,U,,11153,BAO_0000218,,0,,,,22224,Percentage Bioavailability was evaluated.,,CHEMBL620578,
Autocuration,,A,12818,In vivo,,1,,,U,,11154,BAO_0000218,,0,,10116.0,,22224,Bioavailability in rat administered i.d.,Rattus norvegicus,CHEMBL620579,
Autocuration,,A,4847,In vivo,,1,,,U,,11155,BAO_0000218,,0,,9347.0,,22224,Bioavailability,Eutheria,CHEMBL621248,
Autocuration,,A,12421,In vivo,,1,,,U,,11156,BAO_0000218,,0,,9615.0,,22224,Bioavailability in dog (male Beagle) i.v. administration,Canis lupus familiaris,CHEMBL625390,
Autocuration,,A,11966,In vivo,,1,,,U,,11157,BAO_0000218,,0,,10116.0,,22224,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",Rattus norvegicus,CHEMBL625391,
Autocuration,,A,11218,In vivo,,1,,,U,,11158,BAO_0000218,,0,,9443.0,,22224,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),Primates,CHEMBL872266,
Autocuration,,A,13129,In vivo,,1,,,U,,11159,BAO_0000218,,0,,10116.0,,22224,Oral bioavailability in rat (Sprague-Dawley) (male),Rattus norvegicus,CHEMBL625392,
Intermediate,,A,12350,In vivo,,1,,,N,,11160,BAO_0000218,,1,,10116.0,,50597,The oral bioavailability was measured on rats after oral administration,Rattus norvegicus,CHEMBL625393,
Intermediate,,A,2231,In vivo,,1,,,N,,11161,BAO_0000218,,1,,10116.0,,50597,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,Rattus norvegicus,CHEMBL625394,
Intermediate,,A,2231,In vivo,,1,,,N,,11162,BAO_0000218,,1,,9544.0,,50797,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,Macaca mulatta,CHEMBL625395,
Autocuration,,A,12187,In vivo,,1,,,U,,11163,BAO_0000218,,0,,10116.0,,22224,Bioavailability in rat (dose 10 mg/kg i.d.),Rattus norvegicus,CHEMBL625396,
Autocuration,,A,12421,In vivo,,1,,,U,,11164,BAO_0000218,,0,,9615.0,,22224,Bioavailability in dog (male Beagle) i.v. administration,Canis lupus familiaris,CHEMBL625397,
Intermediate,,A,13256,In vivo,,1,,,N,,11165,BAO_0000218,,1,,10090.0,,50594,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL625398,
Intermediate,,A,13256,In vivo,,1,,,N,,11166,BAO_0000218,,1,,10090.0,178.0,50594,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL625399,Blood
Intermediate,,A,13256,In vivo,,1,,,N,,11167,BAO_0000218,,1,,10090.0,2037.0,50594,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL626074,Cerebellum
Intermediate,,A,13256,In vivo,,1,,,N,,11168,BAO_0000218,,1,,10090.0,,50594,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL626075,
Intermediate,,A,2231,In vivo,,1,,,N,,11169,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,Rattus norvegicus,CHEMBL626076,Plasma
Intermediate,,A,2231,In vivo,,1,,,N,,11170,BAO_0000218,,1,,9544.0,1969.0,50797,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,Macaca mulatta,CHEMBL626077,Plasma
Intermediate,,A,12178,In vivo,,1,,,N,,11171,BAO_0000218,,1,,10116.0,178.0,50597,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),Rattus norvegicus,CHEMBL626078,Blood
Autocuration,,A,12178,In vivo,,1,,,U,,11172,BAO_0000218,,0,,,178.0,22224,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),,CHEMBL625846,Blood
Autocuration,,A,12178,In vivo,,1,,,U,,11173,BAO_0000218,,0,,,178.0,22224,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),,CHEMBL625847,Blood
Expert,,A,15633,In vivo,,1,,,N,,11174,BAO_0000218,,1,,10116.0,,50597,Maximum concentration observed in rats at an oral dose of 50 mg/kg,Rattus norvegicus,CHEMBL625848,
Intermediate,,A,14258,In vivo,,1,,,N,,11175,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum concentration of compound in plasma administered orally to rats,Rattus norvegicus,CHEMBL625849,Plasma
Intermediate,,A,14224,In vivo,,1,,,N,,11176,BAO_0000218,,1,,9615.0,1969.0,50588,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",Canis lupus familiaris,CHEMBL626023,Plasma
Intermediate,,A,14224,In vivo,,1,,,N,,11177,BAO_0000218,,1,,9615.0,1969.0,50588,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",Canis lupus familiaris,CHEMBL626024,Plasma
Intermediate,,A,14224,In vivo,,1,,,N,,11178,BAO_0000218,,1,,9615.0,1969.0,50588,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",Canis lupus familiaris,CHEMBL626025,Plasma
Autocuration,,A,5566,In vivo,,1,,,U,,11179,BAO_0000218,,0,,,,22224,Maximum concentration after 10 mg/kg by oral administration,,CHEMBL626026,
Autocuration,,A,16935,In vivo,,1,,,U,,11180,BAO_0000218,,0,,,,22224,Maximum concentration at a dose of 1.5 mg/kg,,CHEMBL626027,
Autocuration,,A,16935,In vivo,,1,,,U,,11181,BAO_0000218,,0,,,,22224,Maximum concentration at a dose of 2.0 mg/kg,,CHEMBL626028,
Intermediate,,A,14224,In vivo,,1,,,N,,11182,BAO_0000218,,1,,9615.0,1969.0,50588,Maximum concentration in dog plasma,Canis lupus familiaris,CHEMBL626029,Plasma
Autocuration,,A,12536,In vivo,,1,,,U,,11183,BAO_0000218,,0,,,1969.0,22224,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,,CHEMBL626030,Plasma
Autocuration,,A,12536,In vivo,,1,,,U,,11184,BAO_0000218,,0,,,1969.0,22224,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,,CHEMBL626031,Plasma
Autocuration,,A,12536,In vivo,,1,,,U,,11185,BAO_0000218,,0,,,1969.0,22224,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,,CHEMBL626032,Plasma
Autocuration,,A,12536,In vivo,,1,,,U,,11186,BAO_0000218,,0,,,1969.0,22224,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,,CHEMBL626033,Plasma
Autocuration,,A,12536,In vivo,,1,,,U,,11187,BAO_0000218,,0,,,1969.0,22224,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,,CHEMBL626034,Plasma
Intermediate,,A,9994,In vivo,,1,,,N,,11188,BAO_0000218,,1,,9615.0,1969.0,50588,Maximum concentration in plasma after oral administration in dog (25 mg/kg),Canis lupus familiaris,CHEMBL626035,Plasma
Autocuration,,A,1434,In vivo,,1,,,U,,11189,BAO_0000218,,0,,,1969.0,22224,Maximum concentration in plasma at Tmax,,CHEMBL626036,Plasma
Expert,,A,12836,In vivo,,1,,,N,,11190,BAO_0000218,,1,,9615.0,1969.0,50588,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,Canis lupus familiaris,CHEMBL626037,Plasma
Intermediate,,A,12836,In vivo,,1,,,N,,11191,BAO_0000218,,1,,10026.0,1969.0,100712,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,Cricetinae,CHEMBL626038,Plasma
Intermediate,,A,12836,In vivo,,1,,,N,,11192,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,Rattus norvegicus,CHEMBL626039,Plasma
Intermediate,,A,12545,In vivo,,1,,,N,,11193,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,Rattus norvegicus,CHEMBL626040,Plasma
Intermediate,,A,13856,In vivo,,1,,,N,,11194,BAO_0000218,,1,,9986.0,1969.0,50592,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,Oryctolagus cuniculus,CHEMBL626041,Plasma
Autocuration,,A,3550,In vivo,,1,,,U,,11195,BAO_0000218,,0,,,,22224,Maximum concentration was calculated,,CHEMBL626042,
Autocuration,,A,2632,In vivo,,1,,,U,,11196,BAO_0000218,,0,,,,22224,Maximum concentration was calculated.,,CHEMBL626043,
Autocuration,,A,5566,In vivo,,1,,,U,,11197,BAO_0000218,,0,,,,22224,Maximum concentration at a peroral dose of 10 mg/kg,,CHEMBL626044,
Autocuration,,A,11883,In vivo,,1,,,U,,11198,BAO_0000218,,0,,,,22224,Maximum concentration of the drug at 10 uM/dg administered perorally,,CHEMBL626045,
Autocuration,,A,11883,In vivo,,1,,,U,,11199,BAO_0000218,,0,,,,22224,Maximum concentration of the drug at 2 uM/dg administered intravenously,,CHEMBL626046,
Intermediate,,A,14122,In vivo,,1,,,N,,11200,BAO_0000218,,1,,9615.0,1969.0,50588,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",Canis lupus familiaris,CHEMBL626047,Plasma
Intermediate,,A,14122,In vivo,,1,,,N,,11201,BAO_0000218,,1,,10026.0,1969.0,100712,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",Cricetinae,CHEMBL626048,Plasma
Intermediate,,A,14122,In vivo,,1,,,N,,11202,BAO_0000218,,1,,10116.0,1969.0,50597,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",Rattus norvegicus,CHEMBL626049,Plasma
Intermediate,,A,12542,In vivo,,1,,,N,,11203,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,Rattus norvegicus,CHEMBL626050,Plasma
Intermediate,,A,12542,In vivo,,1,,,N,,11204,BAO_0000218,,1,,9615.0,1969.0,50588,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,Canis lupus familiaris,CHEMBL874541,Plasma
Intermediate,,A,12542,In vivo,,1,,,N,,11205,BAO_0000218,,1,,10026.0,1969.0,100712,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,Cricetinae,CHEMBL622826,Plasma
Intermediate,,A,12542,In vivo,,1,,,N,,11206,BAO_0000218,,1,,10026.0,1969.0,100712,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,Cricetinae,CHEMBL622827,Plasma
Intermediate,,A,12542,In vivo,,1,,,N,,11207,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,Rattus norvegicus,CHEMBL622828,Plasma
Intermediate,,A,14080,In vivo,,1,,,N,,11208,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,Rattus norvegicus,CHEMBL622829,Plasma
Intermediate,,A,11911,In vivo,,1,,,N,,11209,BAO_0000218,,1,,10116.0,,50597,Maximum concentration reached following intravenous administration in male rat,Rattus norvegicus,CHEMBL876806,
Intermediate,,A,13204,In vivo,,1,,,N,,11210,BAO_0000218,,1,,9615.0,,50588,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,Canis lupus familiaris,CHEMBL622830,
Intermediate,,A,13204,In vivo,,1,,,N,,11211,BAO_0000218,,1,,10116.0,,50597,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,Rattus norvegicus,CHEMBL622831,
Intermediate,,A,14346,In vivo,,1,,,N,,11212,BAO_0000218,,1,,9615.0,,50588,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,Canis lupus familiaris,CHEMBL626794,
Intermediate,,A,14346,In vivo,,1,,,N,,11213,BAO_0000218,,1,,10116.0,,50597,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,Rattus norvegicus,CHEMBL626795,
Intermediate,,A,14346,In vivo,,1,,,N,,11214,BAO_0000218,,1,,10116.0,,50597,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,Rattus norvegicus,CHEMBL626796,
Intermediate,,A,14346,In vivo,,1,,,N,,11215,BAO_0000218,,1,,10116.0,,50597,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,Rattus norvegicus,CHEMBL626797,
Intermediate,,A,14127,In vivo,,1,,,N,,11216,BAO_0000218,,1,,10116.0,,50597,Maximum drug concentration is determined after oral dosing in rats.,Rattus norvegicus,CHEMBL626798,
Intermediate,,A,14339,In vivo,,1,,,N,,11217,BAO_0000218,,1,,9615.0,,50588,Maximum observed concentration in oral (5 mg/kg) fasted dogs,Canis lupus familiaris,CHEMBL626799,
Intermediate,,A,14339,In vivo,,1,,,N,,11218,BAO_0000218,,1,,9615.0,,50588,Maximum observed concentration in oral (5 mg/kg) fed dogs,Canis lupus familiaris,CHEMBL626800,
Autocuration,,A,13494,In vivo,,1,,,U,,11219,BAO_0000218,,0,,,1969.0,22224,Maximum plasma concentration,,CHEMBL626801,Plasma
Intermediate,,A,14925,In vivo,,1,,,N,,11220,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,Rattus norvegicus,CHEMBL876816,Plasma
Intermediate,,A,14474,In vivo,,1,,,N,,11221,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,Rattus norvegicus,CHEMBL626802,Plasma
Intermediate,,A,14474,In vivo,,1,,,N,,11222,BAO_0000218,,1,,9615.0,1969.0,50588,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,Canis lupus familiaris,CHEMBL626803,Plasma
Autocuration,,A,13917,In vivo,,1,,,U,,11223,BAO_0000218,,0,,,1969.0,22224,Maximum plasma concentration following oral administration of 30 umol/kg,,CHEMBL626804,Plasma
Intermediate,,A,9796,,,1,,,N,,11224,BAO_0000218,,1,,10116.0,1969.0,50597,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,Rattus norvegicus,CHEMBL626805,Plasma
Intermediate,,A,9796,,,1,,,N,,11225,BAO_0000218,,1,,10116.0,1969.0,50597,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Rattus norvegicus,CHEMBL626309,Plasma
Intermediate,,A,9796,,,1,,,N,,11226,BAO_0000218,,1,,10116.0,1969.0,50597,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,CHEMBL626310,Plasma
Intermediate,,A,9796,,,1,,,N,,11227,BAO_0000218,,1,,10116.0,1969.0,50597,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,CHEMBL626311,Plasma
Intermediate,,A,9796,,,1,,,N,,11228,BAO_0000218,,1,,10116.0,1969.0,50597,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,CHEMBL626312,Plasma
Intermediate,,A,9796,,,1,,,N,,11229,BAO_0000218,,1,,10116.0,995.0,50597,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,CHEMBL626313,Uterus
Intermediate,,A,9796,,,1,,,N,,11230,BAO_0000218,,1,,10116.0,995.0,50597,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Rattus norvegicus,CHEMBL626314,Uterus
Intermediate,,A,9796,,,1,,,N,,11231,BAO_0000218,,1,,10116.0,995.0,50597,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,CHEMBL626315,Uterus
Intermediate,,A,9796,,,1,,,N,,11232,BAO_0000218,,1,,10116.0,995.0,50597,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,CHEMBL626316,Uterus
Intermediate,,A,9796,,,1,,,N,,11233,BAO_0000218,,1,,10116.0,995.0,50597,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,CHEMBL626317,Uterus
Intermediate,,A,8363,,,1,,,N,,11234,BAO_0000218,,1,,10116.0,,50597,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),Rattus norvegicus,CHEMBL626318,
Intermediate,,A,8363,,,1,,,N,,11235,BAO_0000218,,1,,10116.0,,50597,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),Rattus norvegicus,CHEMBL626319,
Intermediate,,A,8363,,,1,,,N,,11236,BAO_0000218,,1,,10116.0,,50597,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),Rattus norvegicus,CHEMBL626320,
Intermediate,,A,8363,,,1,,,N,,11237,BAO_0000218,,1,,10116.0,,50597,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),Rattus norvegicus,CHEMBL875053,
Intermediate,,A,8363,,,1,,,N,,11238,BAO_0000218,,1,,10116.0,,50597,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),Rattus norvegicus,CHEMBL626321,
Intermediate,,A,8363,,,1,,,N,,11239,BAO_0000218,,1,,10116.0,,50597,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),Rattus norvegicus,CHEMBL626322,
Intermediate,,A,8363,,,1,,,N,,11240,BAO_0000218,,1,,10116.0,,50597,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),Rattus norvegicus,CHEMBL626323,
Intermediate,,A,8363,,,1,,,N,,11241,BAO_0000218,,1,,10116.0,,50597,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),Rattus norvegicus,CHEMBL626324,
Intermediate,,A,8363,,,1,,,N,,11242,BAO_0000218,,1,,10116.0,,50597,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),Rattus norvegicus,CHEMBL626325,
Intermediate,,A,8363,,,1,,,N,,11243,BAO_0000218,,1,,10116.0,,50597,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),Rattus norvegicus,CHEMBL626326,
Intermediate,,A,8363,,,1,,,N,,11244,BAO_0000218,,1,,10116.0,,50597,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),Rattus norvegicus,CHEMBL626327,
Intermediate,,A,8363,,,1,,,N,,11245,BAO_0000218,,1,,10116.0,,50597,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),Rattus norvegicus,CHEMBL626328,
Intermediate,,A,8684,,,1,,,N,,11246,BAO_0000218,,1,,10116.0,178.0,50597,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL626329,Blood
Intermediate,,A,8684,,,1,,,N,,11247,BAO_0000218,,1,,10116.0,178.0,50597,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL626330,Blood
Intermediate,,A,8684,,,1,,,N,,11248,BAO_0000218,,1,,10116.0,178.0,50597,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL626331,Blood
Intermediate,,A,8684,,,1,,,N,,11249,BAO_0000218,,1,,10116.0,178.0,50597,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL626332,Blood
Intermediate,,A,8684,,,1,,,N,,11250,BAO_0000218,,1,,10116.0,178.0,50597,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL626333,Blood
Intermediate,,A,8684,,,1,,,N,,11251,BAO_0000218,,1,,10116.0,178.0,50597,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL626334,Blood
Intermediate,,A,8684,,,1,,,N,,11252,BAO_0000218,,1,,10116.0,178.0,50597,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL626335,Blood
Intermediate,,A,8684,,,1,,,N,,11253,BAO_0000218,,1,,10116.0,178.0,50597,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624798,Blood
Intermediate,,A,8684,,,1,,,N,,11254,BAO_0000218,,1,,10116.0,955.0,50597,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",Rattus norvegicus,CHEMBL624799,Brain
Intermediate,,A,8684,,,1,,,N,,11255,BAO_0000218,,1,,10116.0,955.0,50597,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",Rattus norvegicus,CHEMBL624800,Brain
Intermediate,,A,8684,,,1,,,N,,11256,BAO_0000218,,1,,10116.0,955.0,50597,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",Rattus norvegicus,CHEMBL624801,Brain
Intermediate,,A,8684,,,1,,,N,,11257,BAO_0000218,,1,,10116.0,955.0,50597,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",Rattus norvegicus,CHEMBL624802,Brain
Intermediate,,A,8684,,,1,,,N,,11258,BAO_0000218,,1,,10116.0,955.0,50597,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",Rattus norvegicus,CHEMBL624803,Brain
Intermediate,,A,8684,,,1,,,N,,11259,BAO_0000218,,1,,10116.0,955.0,50597,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",Rattus norvegicus,CHEMBL624804,Brain
Intermediate,,A,8684,,,1,,,N,,11260,BAO_0000218,,1,,10116.0,955.0,50597,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",Rattus norvegicus,CHEMBL624805,Brain
Intermediate,,A,8684,,,1,,,N,,11261,BAO_0000218,,1,,10116.0,955.0,50597,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",Rattus norvegicus,CHEMBL624806,Brain
Intermediate,,A,8684,,,1,,,N,,11262,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624807,
Intermediate,,A,8684,,,1,,,N,,11263,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624808,
Intermediate,,A,8684,,,1,,,N,,11264,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624809,
Intermediate,,A,8684,,,1,,,N,,11265,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624810,
Intermediate,,A,8684,,,1,,,N,,11266,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL877618,
Intermediate,,A,8684,,,1,,,N,,11267,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624811,
Intermediate,,A,8684,,,1,,,N,,11268,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624812,
Intermediate,,A,8684,,,1,,,N,,11269,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624813,
Intermediate,,A,8684,,,1,,,N,,11270,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624814,
Intermediate,,A,8684,,,1,,,N,,11271,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624815,
Intermediate,,A,8684,,,1,,,N,,11272,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624816,
Intermediate,,A,8684,,,1,,,N,,11273,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624817,
Intermediate,,A,6996,,,1,,,N,,11274,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,CHEMBL624818,
Intermediate,,A,6996,,,1,,,N,,11275,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,Canis lupus familiaris,CHEMBL624819,
Intermediate,,A,6996,,,1,,,N,,11276,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,CHEMBL624820,
Intermediate,,A,6996,,,1,,,N,,11277,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,CHEMBL624821,
Intermediate,,A,6996,,,1,,,N,,11278,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),Canis lupus familiaris,CHEMBL624822,
Intermediate,,A,6996,,,1,,,N,,11279,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,CHEMBL624823,
Intermediate,,A,15599,,,1,,,N,,11280,BAO_0000218,,1,,562.0,,50212,Observed diffusion coefficient in organic solvent for Escherichia coli,Escherichia coli,CHEMBL624824,
Intermediate,,A,9614,,,1,,,N,,11281,BAO_0000218,,1,,10116.0,178.0,50597,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,CHEMBL624825,Blood
Intermediate,,A,9614,,,1,,,N,,11282,BAO_0000218,,1,,10116.0,178.0,50597,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,CHEMBL624826,Blood
Intermediate,,A,9614,,,1,,,N,,11283,BAO_0000218,,1,,10116.0,2081.0,50597,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,CHEMBL876817,Cardiac atrium
Intermediate,,A,9614,,,1,,,N,,11284,BAO_0000218,,1,,10116.0,2081.0,50597,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,CHEMBL624827,Cardiac atrium
Intermediate,,A,9614,,,1,,,N,,11285,BAO_0000218,,1,,10116.0,,50597,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,CHEMBL624828,
Intermediate,,A,9614,,,1,,,N,,11286,BAO_0000218,,1,,10116.0,,50597,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,CHEMBL624829,
Intermediate,,A,9614,,,1,,,N,,11287,BAO_0000218,,1,,10116.0,2107.0,50597,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,CHEMBL624830,Liver
Intermediate,,A,9614,,,1,,,N,,11288,BAO_0000218,,1,,10116.0,2107.0,50597,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,CHEMBL624831,Liver
Intermediate,,A,9614,,,1,,,N,,11289,BAO_0000218,,1,,10116.0,2081.0,50597,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,CHEMBL624832,Cardiac atrium
Intermediate,,A,9614,,,1,,,N,,11290,BAO_0000218,,1,,10116.0,2081.0,50597,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,CHEMBL624833,Cardiac atrium
Intermediate,,A,9614,,,1,,,N,,11291,BAO_0000218,,1,,10116.0,,50597,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,CHEMBL624834,
Intermediate,,A,9614,,,1,,,N,,11292,BAO_0000218,,1,,10116.0,,50597,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,CHEMBL624835,
Intermediate,,A,9614,,,1,,,N,,11293,BAO_0000218,,1,,10116.0,2106.0,50597,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,CHEMBL624836,Spleen
Intermediate,,A,9614,,,1,,,N,,11294,BAO_0000218,,1,,10116.0,2106.0,50597,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,CHEMBL624837,Spleen
Intermediate,,A,9071,,,1,,,N,,11295,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,Rattus norvegicus,CHEMBL624838,Blood
Intermediate,,A,9071,,,1,,,N,,11296,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,Rattus norvegicus,CHEMBL622188,Blood
Intermediate,,A,9071,,,1,,,N,,11297,BAO_0000218,,1,,10116.0,948.0,50597,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,Rattus norvegicus,CHEMBL622189,Heart
Intermediate,,A,9071,,,1,,,N,,11298,BAO_0000218,,1,,10116.0,948.0,50597,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,Rattus norvegicus,CHEMBL622190,Heart
Intermediate,,A,9071,,,1,,,N,,11299,BAO_0000218,,1,,10116.0,948.0,50597,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,Rattus norvegicus,CHEMBL625170,Heart
Intermediate,,A,9071,,,1,,,N,,11300,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,Rattus norvegicus,CHEMBL625171,Kidney
Intermediate,,A,9071,,,1,,,N,,11301,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,Rattus norvegicus,CHEMBL625172,Kidney
Intermediate,,A,9071,,,1,,,N,,11302,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,Rattus norvegicus,CHEMBL625173,Kidney
Intermediate,,A,9071,,,1,,,N,,11303,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,Rattus norvegicus,CHEMBL625174,Liver
Intermediate,,A,9071,,,1,,,N,,11304,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,Rattus norvegicus,CHEMBL625175,Liver
Intermediate,,A,9071,,,1,,,N,,11305,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,Rattus norvegicus,CHEMBL625176,Liver
Intermediate,,A,9071,,,1,,,N,,11306,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,Rattus norvegicus,CHEMBL625177,Lung
Intermediate,,A,9071,,,1,,,N,,11307,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,Rattus norvegicus,CHEMBL625178,Lung
Intermediate,,A,9071,,,1,,,N,,11308,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,Rattus norvegicus,CHEMBL625179,Lung
Intermediate,,A,9071,,,1,,,N,,11309,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,Rattus norvegicus,CHEMBL625180,Lung
Autocuration,,A,10677,,,1,,,U,,11310,BAO_0000218,,0,,,,22224,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",,CHEMBL625181,
Intermediate,,A,9750,,,1,,,N,,11311,BAO_0000218,,1,,10090.0,1088.0,50594,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,Mus musculus,CHEMBL625182,Urine
Intermediate,,A,8319,,,1,,,N,,11312,BAO_0000218,,1,,10116.0,,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Rattus norvegicus,CHEMBL625183,
Intermediate,,A,8319,,,1,,,N,,11313,BAO_0000218,,1,,10116.0,,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,Rattus norvegicus,CHEMBL875848,
Intermediate,,A,8319,,,1,,,N,,11314,BAO_0000218,,1,,10116.0,,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Rattus norvegicus,CHEMBL622260,
Intermediate,,A,8319,,,1,,,N,,11315,BAO_0000218,,1,,10116.0,,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,Rattus norvegicus,CHEMBL622261,
Intermediate,,A,8319,,,1,,,N,,11316,BAO_0000218,,1,,10116.0,,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Rattus norvegicus,CHEMBL622262,
Intermediate,,A,8319,,,1,,,N,,11317,BAO_0000218,,1,,10116.0,2113.0,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,Rattus norvegicus,CHEMBL622263,Kidney
Intermediate,,A,8319,,,1,,,N,,11318,BAO_0000218,,1,,10116.0,2113.0,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Rattus norvegicus,CHEMBL622418,Kidney
Intermediate,,A,8319,,,1,,,N,,11319,BAO_0000218,,1,,10116.0,2107.0,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,Rattus norvegicus,CHEMBL622419,Liver
Intermediate,,A,13256,In vivo,,1,,,N,,11320,BAO_0000218,,1,,10090.0,,50594,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL623388,
Intermediate,,A,13256,In vivo,,1,,,N,,11321,BAO_0000218,,1,,10090.0,2107.0,50594,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL623389,Liver
Intermediate,,A,13256,In vivo,,1,,,N,,11322,BAO_0000218,,1,,10090.0,,50594,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL623390,
Intermediate,,A,13256,In vivo,,1,,,N,,11323,BAO_0000218,,1,,10090.0,,50594,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL623391,
Intermediate,,A,13256,In vivo,,1,,,N,,11324,BAO_0000218,,1,,10090.0,178.0,50594,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL623392,Blood
Intermediate,,A,13256,In vivo,,1,,,N,,11325,BAO_0000218,,1,,10090.0,2037.0,50594,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL623393,Cerebellum
Intermediate,,A,13256,In vivo,,1,,,N,,11326,BAO_0000218,,1,,10090.0,,50594,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL623394,
Intermediate,,A,13256,In vivo,,1,,,N,,11327,BAO_0000218,,1,,10090.0,,50594,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL618885,
Intermediate,,A,13256,In vivo,,1,,,N,,11328,BAO_0000218,,1,,10090.0,2107.0,50594,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL618886,Liver
Intermediate,,A,13256,In vivo,,1,,,N,,11329,BAO_0000218,,1,,10090.0,,50594,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL618887,
Intermediate,,A,13256,In vivo,,1,,,N,,11330,BAO_0000218,,1,,10090.0,,50594,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL619535,
Intermediate,,A,13256,In vivo,,1,,,N,,11331,BAO_0000218,,1,,10090.0,178.0,50594,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL619536,Blood
Intermediate,,A,13256,In vivo,,1,,,N,,11332,BAO_0000218,,1,,10090.0,2037.0,50594,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL619537,Cerebellum
Intermediate,,A,13256,In vivo,,1,,,N,,11333,BAO_0000218,,1,,10090.0,,50594,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL619705,
Intermediate,,A,13256,In vivo,,1,,,N,,11334,BAO_0000218,,1,,10090.0,,50594,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL619706,
Intermediate,,A,13256,In vivo,,1,,,N,,11335,BAO_0000218,,1,,10090.0,2107.0,50594,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL619707,Liver
Intermediate,,A,13256,In vivo,,1,,,N,,11336,BAO_0000218,,1,,10090.0,,50594,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL619708,
Intermediate,,A,13256,In vivo,,1,,,N,,11337,BAO_0000218,,1,,10090.0,,50594,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL625219,
Intermediate,,A,13256,In vivo,,1,,,N,,11338,BAO_0000218,,1,,10090.0,178.0,50594,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL625220,Blood
Intermediate,,A,13256,In vivo,,1,,,N,,11339,BAO_0000218,,1,,10090.0,2037.0,50594,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL625221,Cerebellum
Intermediate,,A,13256,In vivo,,1,,,N,,11340,BAO_0000218,,1,,10090.0,,50594,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL625222,
Intermediate,,A,13256,In vivo,,1,,,N,,11341,BAO_0000218,,1,,10090.0,,50594,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL625223,
Intermediate,,A,13256,In vivo,,1,,,N,,11342,BAO_0000218,,1,,10090.0,2107.0,50594,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL625224,Liver
Intermediate,,A,13256,In vivo,,1,,,N,,11343,BAO_0000218,,1,,10090.0,,50594,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,CHEMBL625225,
Intermediate,,A,8829,In vivo,,1,,,N,,11344,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in Rat blood after 24 hours of iv administration,Rattus norvegicus,CHEMBL625226,Blood
Intermediate,,A,8829,In vivo,,1,,,N,,11345,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,Rattus norvegicus,CHEMBL625227,Blood
Intermediate,,A,8829,In vivo,,1,,,N,,11346,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in Rat blood after 30 minutes of iv administration,Rattus norvegicus,CHEMBL625228,Blood
Intermediate,,A,8829,In vivo,,1,,,N,,11347,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,Rattus norvegicus,CHEMBL875354,Blood
Intermediate,,A,8829,In vivo,,1,,,N,,11348,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in Rat blood after 5 minutes of iv administration,Rattus norvegicus,CHEMBL625229,Blood
Intermediate,,A,8829,In vivo,,1,,,N,,11349,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,Rattus norvegicus,CHEMBL625230,Blood
Intermediate,,A,8829,In vivo,,1,,,N,,11350,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in Rat heart after 24 hours of iv administration,Rattus norvegicus,CHEMBL625231,Heart
Intermediate,,A,8829,In vivo,,1,,,N,,11351,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,Rattus norvegicus,CHEMBL625900,Heart
Intermediate,,A,8829,In vivo,,1,,,N,,11352,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in Rat heart after 30 minutes of iv administration,Rattus norvegicus,CHEMBL625901,Heart
Intermediate,,A,8829,In vivo,,1,,,N,,11353,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,Rattus norvegicus,CHEMBL625902,Heart
Intermediate,,A,8829,In vivo,,1,,,N,,11354,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in Rat heart after 5 minutes of iv administration,Rattus norvegicus,CHEMBL625903,Heart
Intermediate,,A,8829,In vivo,,1,,,N,,11355,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,Rattus norvegicus,CHEMBL625904,Heart
Intermediate,,A,8829,In vivo,,1,,,N,,11356,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in Rat liver after 24 hours of iv administration,Rattus norvegicus,CHEMBL625905,Liver
Intermediate,,A,8829,In vivo,,1,,,N,,11357,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,Rattus norvegicus,CHEMBL627861,Liver
Intermediate,,A,8829,In vivo,,1,,,N,,11358,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in Rat liver after 30 minutes of iv administration,Rattus norvegicus,CHEMBL627862,Liver
Intermediate,,A,8829,In vivo,,1,,,N,,11359,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,Rattus norvegicus,CHEMBL627863,Liver
Intermediate,,A,8829,In vivo,,1,,,N,,11360,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in Rat liver after 30 minutes of iv administration,Rattus norvegicus,CHEMBL627769,Liver
Intermediate,,A,13249,In vivo,,1,,,N,,11361,BAO_0000218,,1,,9615.0,1969.0,50588,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,Canis lupus familiaris,CHEMBL627770,Plasma
Intermediate,,A,13622,In vivo,,1,,,N,,11362,BAO_0000218,,1,,9541.0,,100710,Cmax in cynomolgus monkey (PO dose),Macaca fascicularis,CHEMBL627771,
Intermediate,,A,13622,In vivo,,1,,,N,,11363,BAO_0000218,,1,,10116.0,,50597,Cmax in rat (PO dose),Rattus norvegicus,CHEMBL627772,
Intermediate,,A,13622,In vivo,,1,,,N,,11364,BAO_0000218,,1,,10116.0,,50597,Cmax in rat (PO dose),Rattus norvegicus,CHEMBL627773,
Intermediate,,A,13494,In vivo,,1,,,N,,11365,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,Rattus norvegicus,CHEMBL621922,Plasma
Intermediate,,A,12170,In vivo,,1,,,N,,11366,BAO_0000218,,1,,10116.0,1969.0,50597,Cmax in rat plasma after oral dose (10 mg/kg),Rattus norvegicus,CHEMBL621923,Plasma
Autocuration,,A,12170,In vivo,,1,,,U,,11367,BAO_0000218,,0,,,1969.0,22224,Cmax in plasma after oral dose (10 mg/kg),,CHEMBL621924,Plasma
Intermediate,,A,17025,In vivo,,1,,,N,,11368,BAO_0000218,,1,,9615.0,1969.0,50588,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,Canis lupus familiaris,CHEMBL621925,Plasma
Autocuration,,A,17025,In vivo,,1,,,U,,11369,BAO_0000218,,0,,314293.0,1969.0,22224,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,Simiiformes,CHEMBL621926,Plasma
Intermediate,,A,17025,In vivo,,1,,,N,,11370,BAO_0000218,,1,,9986.0,1969.0,50592,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,Oryctolagus cuniculus,CHEMBL621927,Plasma
Intermediate,,A,17025,In vivo,,1,,,N,,11371,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,Rattus norvegicus,CHEMBL621928,Plasma
Intermediate,,A,14187,In vivo,,1,,,N,,11372,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,Rattus norvegicus,CHEMBL621929,Plasma
Intermediate,,A,14816,In vivo,,1,,,N,,11373,BAO_0000218,,1,,10090.0,1969.0,50594,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,Mus musculus,CHEMBL621930,Plasma
Intermediate,,A,17820,In vivo,,1,,,N,,11374,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration after oral dosing in rat,Rattus norvegicus,CHEMBL621931,Plasma
Autocuration,,A,14380,In vivo,,1,,,U,,11375,BAO_0000218,,0,,,1969.0,22224,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,CHEMBL621932,Plasma
Autocuration,,A,14380,In vivo,,1,,,U,,11376,BAO_0000218,,0,,,1969.0,22224,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,CHEMBL621933,Plasma
Intermediate,,A,14691,In vivo,,1,,,N,,11377,BAO_0000218,,1,,9615.0,1969.0,50588,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,Canis lupus familiaris,CHEMBL621934,Plasma
Intermediate,,A,14691,In vivo,,1,,,N,,11378,BAO_0000218,,1,,9615.0,1969.0,50588,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,Canis lupus familiaris,CHEMBL621935,Plasma
Intermediate,,A,13375,In vivo,,1,,,N,,11379,BAO_0000218,,1,,10116.0,1969.0,50597,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,Rattus norvegicus,CHEMBL621936,Plasma
Autocuration,,A,6236,In vivo,,1,,,U,,11380,BAO_0000218,,0,,,1969.0,22224,Maximum plasma concentration was determined,,CHEMBL621937,Plasma
Autocuration,,A,14380,In vivo,,1,,,U,,11381,BAO_0000218,,0,,,1969.0,22224,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,CHEMBL621938,Plasma
Autocuration,,A,14380,In vivo,,1,,,U,,11382,BAO_0000218,,0,,,1969.0,22224,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,CHEMBL621939,Plasma
Autocuration,,A,14380,In vivo,,1,,,U,,11383,BAO_0000218,,0,,,1969.0,22224,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,,CHEMBL621940,Plasma
Autocuration,,A,14380,In vivo,,1,,,U,,11384,BAO_0000218,,0,,,1969.0,22224,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,,CHEMBL621941,Plasma
Autocuration,,A,14380,In vivo,,1,,,U,,11385,BAO_0000218,,0,,,1969.0,22224,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,CHEMBL621942,Plasma
Autocuration,,A,14380,In vivo,,1,,,U,,11386,BAO_0000218,,0,,,1969.0,22224,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,CHEMBL626178,Plasma
Autocuration,,A,14380,In vivo,,1,,,U,,11387,BAO_0000218,,0,,,1969.0,22224,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,,CHEMBL626179,Plasma
Autocuration,,A,14380,In vivo,,1,,,U,,11388,BAO_0000218,,0,,,1969.0,22224,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,,CHEMBL626180,Plasma
Intermediate,,A,13622,In vivo,,1,,,N,,11389,BAO_0000218,,1,,10116.0,1969.0,50597,Plasma Cmax in rat (PO dose),Rattus norvegicus,CHEMBL626181,Plasma
Intermediate,,A,15372,In vivo,,1,,,N,,11390,BAO_0000218,,1,,10116.0,,50597,Maximum serum concentration after po dose of 5.22 mg/kg in rats,Rattus norvegicus,CHEMBL626182,
Intermediate,,A,15372,In vivo,,1,,,N,,11391,BAO_0000218,,1,,10116.0,,50597,Maximum serum concentration after po dose of 5.46 mg/kg in rats,Rattus norvegicus,CHEMBL626183,
Intermediate,,A,15372,In vivo,,1,,,N,,11392,BAO_0000218,,1,,10116.0,,50597,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,Rattus norvegicus,CHEMBL626184,
Intermediate,,A,15372,In vivo,,1,,,N,,11393,BAO_0000218,,1,,10116.0,,50597,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,Rattus norvegicus,CHEMBL626185,
Intermediate,,A,14925,In vivo,,1,,,N,,11394,BAO_0000218,,1,,9615.0,1969.0,50588,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,Canis lupus familiaris,CHEMBL626186,Plasma
Intermediate,,A,14925,In vivo,,1,,,N,,11395,BAO_0000218,,1,,9615.0,1969.0,50588,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,Canis lupus familiaris,CHEMBL877589,Plasma
Autocuration,,A,11883,In vivo,,1,,,U,,11396,BAO_0000218,,0,,,,22224,Maximum concentration of the drug at 1 uM/dg administered intravenously,,CHEMBL626187,
Autocuration,,A,11883,In vivo,,1,,,U,,11397,BAO_0000218,,0,,,,22224,Maximum concentration of the drug at 20 uM/dg administered perorally,,CHEMBL626188,
Autocuration,,A,13391,In vivo,,1,,,U,,11398,BAO_0000218,,0,,,,22224,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,,CHEMBL626189,
Autocuration,,A,13391,In vivo,,1,,,U,,11399,BAO_0000218,,0,,,178.0,22224,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,CHEMBL626855,Blood
Autocuration,,A,13391,In vivo,,1,,,U,,11400,BAO_0000218,,0,,,178.0,22224,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,CHEMBL623781,Blood
Autocuration,,A,13391,In vivo,,1,,,U,,11401,BAO_0000218,,0,,,178.0,22224,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,CHEMBL623782,Blood
Intermediate,,A,16360,In vivo,,1,,,N,,11402,BAO_0000218,,1,,10116.0,1969.0,50597,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,Rattus norvegicus,CHEMBL623783,Plasma
Intermediate,,A,3673,In vivo,,1,,,N,,11403,BAO_0000218,,1,,9615.0,1969.0,50588,Cmax in dog plasma after 1mg/kg oral dose,Canis lupus familiaris,CHEMBL623784,Plasma
Intermediate,,A,14431,In vivo,,1,,,N,,11404,BAO_0000218,,1,,9615.0,1969.0,50588,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,Canis lupus familiaris,CHEMBL623785,Plasma
Intermediate,,A,14431,In vivo,,1,,,N,,11405,BAO_0000218,,1,,10116.0,1969.0,50597,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,Rattus norvegicus,CHEMBL623786,Plasma
Intermediate,,A,14964,In vivo,,1,,,N,,11406,BAO_0000218,,1,,10116.0,,50597,Oral maximum concentration in rat,Rattus norvegicus,CHEMBL623787,
Intermediate,,A,14964,In vivo,,1,,,N,,11407,BAO_0000218,,1,,10116.0,,50597,Oral maximum concentration in rat,Rattus norvegicus,CHEMBL623788,
Intermediate,,A,14209,In vivo,,1,,,N,,11408,BAO_0000218,,1,,10090.0,1969.0,50594,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,Mus musculus,CHEMBL623789,Plasma
Intermediate,,A,11355,In vivo,,1,,,N,,11409,BAO_0000218,,1,,10090.0,178.0,50594,Peak concentration in blood after intravenous administration to mice,Mus musculus,CHEMBL623790,Blood
Intermediate,,A,11355,In vivo,,1,,,N,,11410,BAO_0000218,,1,,10090.0,178.0,50594,Peak concentration in blood after peroral administration to mice,Mus musculus,CHEMBL623791,Blood
Intermediate,,A,11966,In vivo,,1,,,N,,11411,BAO_0000218,,1,,10116.0,1969.0,50597,Peak concentration in rat plasma was determined,Rattus norvegicus,CHEMBL623792,Plasma
Autocuration,,A,8918,In vivo,,1,,,U,,11412,BAO_0000218,,0,,314293.0,1969.0,22224,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,Simiiformes,CHEMBL623793,Plasma
Intermediate,,A,8918,In vivo,,1,,,N,,11413,BAO_0000218,,1,,10090.0,1969.0,50594,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,Mus musculus,CHEMBL623794,Plasma
Intermediate,,A,8918,In vivo,,1,,,N,,11414,BAO_0000218,,1,,10116.0,1969.0,50597,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,Rattus norvegicus,CHEMBL623795,Plasma
Intermediate,,A,8684,,,1,,,N,,11415,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL623796,
Intermediate,,A,8684,,,1,,,N,,11416,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL623797,
Intermediate,,A,8684,,,1,,,N,,11417,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL623798,
Intermediate,,A,8684,,,1,,,N,,11418,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL623799,
Intermediate,,A,8684,,,1,,,N,,11419,BAO_0000218,,1,,10116.0,160.0,50597,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624490,Intestine
Intermediate,,A,8684,,,1,,,N,,11420,BAO_0000218,,1,,10116.0,160.0,50597,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624491,Intestine
Intermediate,,A,8684,,,1,,,N,,11421,BAO_0000218,,1,,10116.0,160.0,50597,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624492,Intestine
Intermediate,,A,8684,,,1,,,N,,11422,BAO_0000218,,1,,10116.0,160.0,50597,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624493,Intestine
Intermediate,,A,8684,,,1,,,N,,11423,BAO_0000218,,1,,10116.0,160.0,50597,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL877595,Intestine
Intermediate,,A,8684,,,1,,,N,,11424,BAO_0000218,,1,,10116.0,160.0,50597,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624494,Intestine
Intermediate,,A,8684,,,1,,,N,,11425,BAO_0000218,,1,,10116.0,160.0,50597,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624495,Intestine
Intermediate,,A,8684,,,1,,,N,,11426,BAO_0000218,,1,,10116.0,160.0,50597,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624681,Intestine
Intermediate,,A,8684,,,1,,,N,,11427,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624682,
Intermediate,,A,8684,,,1,,,N,,11428,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624683,
Intermediate,,A,8684,,,1,,,N,,11429,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624684,
Intermediate,,A,8684,,,1,,,N,,11430,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624685,
Intermediate,,A,8684,,,1,,,N,,11431,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624686,
Intermediate,,A,8684,,,1,,,N,,11432,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624687,
Intermediate,,A,8684,,,1,,,N,,11433,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624688,
Intermediate,,A,8684,,,1,,,N,,11434,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL627161,
Intermediate,,A,8684,,,1,,,N,,11435,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL622127,
Intermediate,,A,8684,,,1,,,N,,11436,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL622128,
Intermediate,,A,8684,,,1,,,N,,11437,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL874384,
Intermediate,,A,8684,,,1,,,N,,11438,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624898,
Intermediate,,A,8684,,,1,,,N,,11439,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624899,
Intermediate,,A,8684,,,1,,,N,,11440,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624900,
Intermediate,,A,8684,,,1,,,N,,11441,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624901,
Intermediate,,A,8684,,,1,,,N,,11442,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624902,
Intermediate,,A,8684,,,1,,,N,,11443,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624903,
Intermediate,,A,8684,,,1,,,N,,11444,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624904,
Intermediate,,A,8684,,,1,,,N,,11445,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624905,
Intermediate,,A,8684,,,1,,,N,,11446,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624906,
Intermediate,,A,8684,,,1,,,N,,11447,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624907,
Intermediate,,A,8684,,,1,,,N,,11448,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624908,
Intermediate,,A,8684,,,1,,,N,,11449,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624909,
Intermediate,,A,8684,,,1,,,N,,11450,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624910,
Intermediate,,A,8684,,,1,,,N,,11451,BAO_0000218,,1,,10116.0,2385.0,50597,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624911,Muscle tissue
Intermediate,,A,8684,,,1,,,N,,11452,BAO_0000218,,1,,10116.0,2385.0,50597,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL874388,Muscle tissue
Intermediate,,A,8684,,,1,,,N,,11453,BAO_0000218,,1,,10116.0,2385.0,50597,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL624912,Muscle tissue
Intermediate,,A,8684,,,1,,,N,,11454,BAO_0000218,,1,,10116.0,2385.0,50597,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL622930,Muscle tissue
Intermediate,,A,8684,,,1,,,N,,11455,BAO_0000218,,1,,10116.0,2385.0,50597,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL623121,Muscle tissue
Intermediate,,A,8684,,,1,,,N,,11456,BAO_0000218,,1,,10116.0,2385.0,50597,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL623122,Muscle tissue
Intermediate,,A,8684,,,1,,,N,,11457,BAO_0000218,,1,,10116.0,2385.0,50597,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL623123,Muscle tissue
Intermediate,,A,8684,,,1,,,N,,11458,BAO_0000218,,1,,10116.0,2385.0,50597,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL623124,Muscle tissue
Intermediate,,A,8684,,,1,,,N,,11459,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL623125,
Intermediate,,A,8684,,,1,,,N,,11460,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL623126,
Intermediate,,A,8684,,,1,,,N,,11461,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL623127,
Intermediate,,A,8684,,,1,,,N,,11462,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL623128,
Intermediate,,A,8684,,,1,,,N,,11463,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL623129,
Intermediate,,A,8684,,,1,,,N,,11464,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL623130,
Intermediate,,A,8684,,,1,,,N,,11465,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL623131,
Intermediate,,A,8684,,,1,,,N,,11466,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL623132,
Intermediate,,A,8319,,,1,,,N,,11467,BAO_0000218,,1,,10116.0,2107.0,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Rattus norvegicus,CHEMBL623133,Liver
Intermediate,,A,8319,,,1,,,N,,11468,BAO_0000218,,1,,10116.0,,50597,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Rattus norvegicus,CHEMBL623134,
Intermediate,,A,8319,,,1,,,N,,11469,BAO_0000218,,1,,10116.0,,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Rattus norvegicus,CHEMBL874389,
Intermediate,,A,8319,,,1,,,N,,11470,BAO_0000218,,1,,10116.0,,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,Rattus norvegicus,CHEMBL623135,
Intermediate,,A,8319,,,1,,,N,,11471,BAO_0000218,,1,,10116.0,,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Rattus norvegicus,CHEMBL623136,
Intermediate,,A,8319,,,1,,,N,,11472,BAO_0000218,,1,,10116.0,,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,Rattus norvegicus,CHEMBL623137,
Intermediate,,A,8319,,,1,,,N,,11473,BAO_0000218,,1,,10116.0,,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Rattus norvegicus,CHEMBL623138,
Intermediate,,A,8319,,,1,,,N,,11474,BAO_0000218,,1,,10116.0,2113.0,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,Rattus norvegicus,CHEMBL623139,Kidney
Intermediate,,A,8319,,,1,,,N,,11475,BAO_0000218,,1,,10116.0,2113.0,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Rattus norvegicus,CHEMBL623140,Kidney
Intermediate,,A,8319,,,1,,,N,,11476,BAO_0000218,,1,,10116.0,2107.0,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,Rattus norvegicus,CHEMBL623141,Liver
Intermediate,,A,8319,,,1,,,N,,11477,BAO_0000218,,1,,10116.0,2107.0,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Rattus norvegicus,CHEMBL623142,Liver
Intermediate,,A,8319,,,1,,,N,,11478,BAO_0000218,,1,,10116.0,,50597,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Rattus norvegicus,CHEMBL623143,
Intermediate,,A,14571,,,1,,,N,,11479,BAO_0000218,,1,,10090.0,1088.0,50594,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,Mus musculus,CHEMBL623144,Urine
Intermediate,,A,14571,,,1,,,N,,11480,BAO_0000218,,1,,10116.0,1088.0,50597,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,Rattus norvegicus,CHEMBL623405,Urine
Intermediate,,A,8319,,,1,,,N,,11481,BAO_0000218,,1,,10116.0,,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Rattus norvegicus,CHEMBL624074,
Intermediate,,A,8319,,,1,,,N,,11482,BAO_0000218,,1,,10116.0,,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,Rattus norvegicus,CHEMBL624075,
Intermediate,,A,8319,,,1,,,N,,11483,BAO_0000218,,1,,10116.0,,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Rattus norvegicus,CHEMBL624076,
Intermediate,,A,8319,,,1,,,N,,11484,BAO_0000218,,1,,10116.0,,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,Rattus norvegicus,CHEMBL624077,
Intermediate,,A,8319,,,1,,,N,,11485,BAO_0000218,,1,,10116.0,,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Rattus norvegicus,CHEMBL624078,
Intermediate,,A,8319,,,1,,,N,,11486,BAO_0000218,,1,,10116.0,2113.0,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,Rattus norvegicus,CHEMBL624079,Kidney
Intermediate,,A,8319,,,1,,,N,,11487,BAO_0000218,,1,,10116.0,2113.0,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Rattus norvegicus,CHEMBL624261,Kidney
Intermediate,,A,8319,,,1,,,N,,11488,BAO_0000218,,1,,10116.0,,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,Rattus norvegicus,CHEMBL624262,
Intermediate,,A,8319,,,1,,,N,,11489,BAO_0000218,,1,,10116.0,,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Rattus norvegicus,CHEMBL624263,
Intermediate,,A,8319,,,1,,,N,,11490,BAO_0000218,,1,,10116.0,,50597,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Rattus norvegicus,CHEMBL624264,
Intermediate,,A,8319,,,1,,,N,,11491,BAO_0000218,,1,,10116.0,,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Rattus norvegicus,CHEMBL624265,
Intermediate,,A,8319,,,1,,,N,,11492,BAO_0000218,,1,,10116.0,,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,Rattus norvegicus,CHEMBL624266,
Intermediate,,A,8319,,,1,,,N,,11493,BAO_0000218,,1,,10116.0,,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Rattus norvegicus,CHEMBL624267,
Intermediate,,A,8319,,,1,,,N,,11494,BAO_0000218,,1,,10116.0,,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,Rattus norvegicus,CHEMBL624268,
Intermediate,,A,8319,,,1,,,N,,11495,BAO_0000218,,1,,10116.0,,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Rattus norvegicus,CHEMBL875227,
Intermediate,,A,8319,,,1,,,N,,11496,BAO_0000218,,1,,10116.0,2113.0,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,Rattus norvegicus,CHEMBL624269,Kidney
Intermediate,,A,8319,,,1,,,N,,11497,BAO_0000218,,1,,10116.0,2113.0,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Rattus norvegicus,CHEMBL624270,Kidney
Intermediate,,A,8319,,,1,,,N,,11498,BAO_0000218,,1,,10116.0,,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,Rattus norvegicus,CHEMBL624271,
Intermediate,,A,8319,,,1,,,N,,11499,BAO_0000218,,1,,10116.0,,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Rattus norvegicus,CHEMBL624272,
Intermediate,,A,8319,,,1,,,N,,11500,BAO_0000218,,1,,10116.0,,50597,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Rattus norvegicus,CHEMBL624273,
Intermediate,,A,12064,,,1,,,N,,11501,BAO_0000218,,1,,10116.0,1088.0,50597,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,Rattus norvegicus,CHEMBL624274,Urine
Intermediate,,A,12064,,,1,,,N,,11502,BAO_0000218,,1,,10116.0,1088.0,50597,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,Rattus norvegicus,CHEMBL624275,Urine
Intermediate,,A,12064,,,1,,,N,,11503,BAO_0000218,,1,,10116.0,1088.0,50597,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,Rattus norvegicus,CHEMBL624276,Urine
Intermediate,,A,12038,,,1,,,N,,11504,BAO_0000218,,1,,10116.0,1088.0,50597,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,Rattus norvegicus,CHEMBL624277,Urine
Autocuration,,A,14314,,,1,,,U,,11505,BAO_0000019,,0,,,,22224,% dose converted to 2-amino-5-chlorophenyl sulfate,,CHEMBL624278,
Autocuration,,A,14314,,,1,,,U,,11506,BAO_0000019,,0,,,,22224,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),,CHEMBL624279,
Intermediate,,A,11488,,,1,,,N,,11507,BAO_0000218,,1,,10116.0,1988.0,50597,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",Rattus norvegicus,CHEMBL624280,Feces
Intermediate,,A,11488,,,1,,,N,,11508,BAO_0000218,,1,,10116.0,1988.0,50597,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",Rattus norvegicus,CHEMBL624281,Feces
Intermediate,,A,11488,,,1,,,N,,11509,BAO_0000218,,1,,10116.0,1988.0,50597,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",Rattus norvegicus,CHEMBL622933,Feces
Intermediate,,A,11488,,,1,,,N,,11510,BAO_0000218,,1,,10116.0,1988.0,50597,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",Rattus norvegicus,CHEMBL622934,Feces
Intermediate,,A,8829,In vivo,,1,,,N,,11511,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,Rattus norvegicus,CHEMBL622935,Liver
Intermediate,,A,8829,In vivo,,1,,,N,,11512,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in Rat liver after 5 minutes of iv administration,Rattus norvegicus,CHEMBL622936,Liver
Intermediate,,A,8829,In vivo,,1,,,N,,11513,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,Rattus norvegicus,CHEMBL875228,Liver
Intermediate,,A,8829,In vivo,,1,,,N,,11514,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in Rat lung after 24 hours of iv administration,Rattus norvegicus,CHEMBL622937,Lung
Intermediate,,A,8829,In vivo,,1,,,N,,11515,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,Rattus norvegicus,CHEMBL622938,Lung
Intermediate,,A,8829,In vivo,,1,,,N,,11516,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in Rat lung after 30 minutes of iv administration,Rattus norvegicus,CHEMBL619736,Lung
Intermediate,,A,8829,In vivo,,1,,,N,,11517,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,Rattus norvegicus,CHEMBL625117,Lung
Intermediate,,A,8829,In vivo,,1,,,N,,11518,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in Rat lung after 5 minutes of iv administration,Rattus norvegicus,CHEMBL625118,Lung
Intermediate,,A,8829,In vivo,,1,,,N,,11519,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,Rattus norvegicus,CHEMBL625119,Lung
Intermediate,,A,14972,In vivo,,1,,,N,,11520,BAO_0000218,,1,,10116.0,2037.0,50597,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",Rattus norvegicus,CHEMBL625120,Cerebellum
Intermediate,,A,14972,In vivo,,1,,,N,,11521,BAO_0000218,,1,,10116.0,,50597,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",Rattus norvegicus,CHEMBL625121,
Intermediate,,A,14972,In vivo,,1,,,N,,11522,BAO_0000218,,1,,10116.0,10000006.0,50597,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",Rattus norvegicus,CHEMBL625122,Thalamus
Intermediate,,A,14608,In vivo,,1,,,N,,11523,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,CHEMBL622204,Blood
Intermediate,,A,14608,In vivo,,1,,,N,,11524,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,CHEMBL877503,Blood
Intermediate,,A,14608,In vivo,,1,,,N,,11525,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,CHEMBL627127,Blood
Autocuration,,A,14608,In vivo,,1,,,U,,11526,BAO_0000218,,0,,,10000000.0,22224,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,,CHEMBL627128,Hippocampus
Autocuration,,A,14608,In vivo,,1,,,U,,11527,BAO_0000218,,0,,,10000000.0,22224,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,,CHEMBL627129,Hippocampus
Autocuration,,A,14608,In vivo,,1,,,U,,11528,BAO_0000218,,0,,,10000000.0,22224,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,,CHEMBL627130,Hippocampus
Intermediate,,A,14608,In vivo,,1,,,N,,11529,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,CHEMBL627131,Brain
Intermediate,,A,14608,In vivo,,1,,,N,,11530,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,CHEMBL627132,Brain
Intermediate,,A,14608,In vivo,,1,,,N,,11531,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,CHEMBL627133,Brain
Intermediate,,A,14608,In vivo,,1,,,N,,11532,BAO_0000218,,1,,10116.0,2037.0,50597,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,CHEMBL627134,Cerebellum
Intermediate,,A,14608,In vivo,,1,,,N,,11533,BAO_0000218,,1,,10116.0,2037.0,50597,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,CHEMBL627135,Cerebellum
Intermediate,,A,14608,In vivo,,1,,,N,,11534,BAO_0000218,,1,,10116.0,2037.0,50597,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,CHEMBL627136,Cerebellum
Intermediate,,A,14608,In vivo,,1,,,N,,11535,BAO_0000218,,1,,10116.0,,50597,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,CHEMBL628435,
Intermediate,,A,14608,In vivo,,1,,,N,,11536,BAO_0000218,,1,,10116.0,,50597,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,CHEMBL628436,
Intermediate,,A,14608,In vivo,,1,,,N,,11537,BAO_0000218,,1,,10116.0,,50597,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,CHEMBL628437,
Intermediate,,A,14608,In vivo,,1,,,N,,11538,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,CHEMBL628438,Heart
Intermediate,,A,14608,In vivo,,1,,,N,,11539,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,CHEMBL628439,Heart
Intermediate,,A,14608,In vivo,,1,,,N,,11540,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,CHEMBL628440,Heart
Intermediate,,A,14608,In vivo,,1,,,N,,11541,BAO_0000218,,1,,10116.0,10000000.0,50597,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,CHEMBL628441,Hippocampus
Intermediate,,A,14608,In vivo,,1,,,N,,11542,BAO_0000218,,1,,10116.0,10000000.0,50597,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,CHEMBL628442,Hippocampus
Intermediate,,A,14608,In vivo,,1,,,N,,11543,BAO_0000218,,1,,10116.0,10000000.0,50597,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,CHEMBL628443,Hippocampus
Intermediate,,A,14608,In vivo,,1,,,N,,11544,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,CHEMBL628444,Kidney
Intermediate,,A,14608,In vivo,,1,,,N,,11545,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,CHEMBL628445,Kidney
Intermediate,,A,14608,In vivo,,1,,,N,,11546,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,CHEMBL877504,Kidney
Intermediate,,A,14608,In vivo,,1,,,N,,11547,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,CHEMBL628446,Liver
Intermediate,,A,14608,In vivo,,1,,,N,,11548,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,CHEMBL626874,Liver
Intermediate,,A,14608,In vivo,,1,,,N,,11549,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,CHEMBL626875,Liver
Intermediate,,A,14608,In vivo,,1,,,N,,11550,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,CHEMBL626876,Lung
Intermediate,,A,14608,In vivo,,1,,,N,,11551,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,CHEMBL626877,Lung
Intermediate,,A,14608,In vivo,,1,,,N,,11552,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,CHEMBL626878,Lung
Intermediate,,A,14608,In vivo,,1,,,N,,11553,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,CHEMBL626879,Muscle tissue
Autocuration,,A,8918,In vivo,,1,,,U,,11554,BAO_0000218,,0,,314293.0,1969.0,22224,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,Simiiformes,CHEMBL626880,Plasma
Intermediate,,A,8918,In vivo,,1,,,N,,11555,BAO_0000218,,1,,10090.0,1969.0,50594,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,Mus musculus,CHEMBL626881,Plasma
Intermediate,,A,8918,In vivo,,1,,,N,,11556,BAO_0000218,,1,,10116.0,1969.0,50597,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,Rattus norvegicus,CHEMBL626882,Plasma
Intermediate,,A,14470,In vivo,,1,,,N,,11557,BAO_0000218,,1,,9615.0,1969.0,50588,Peak plasma concentration was measured in dogs,Canis lupus familiaris,CHEMBL626883,Plasma
Intermediate,,A,14393,In vivo,,1,,,N,,11558,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,Rattus norvegicus,CHEMBL626884,
Intermediate,,A,14886,In vivo,,1,,,N,,11559,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,Rattus norvegicus,CHEMBL626885,
Intermediate,,A,14886,In vivo,,1,,,N,,11560,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,Rattus norvegicus,CHEMBL626886,
Intermediate,,A,14886,In vivo,,1,,,N,,11561,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,Rattus norvegicus,CHEMBL626887,
Intermediate,,A,14393,In vivo,,1,,,N,,11562,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,Rattus norvegicus,CHEMBL626888,
Intermediate,,A,13465,In vivo,,1,,,N,,11563,BAO_0000218,,1,,9615.0,,50588,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,Canis lupus familiaris,CHEMBL626889,
Autocuration,,A,13465,In vivo,,1,,,U,,11564,BAO_0000218,,0,,314293.0,,22224,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,Simiiformes,CHEMBL626761,
Intermediate,,A,13465,In vivo,,1,,,N,,11565,BAO_0000218,,1,,9615.0,,50588,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,Canis lupus familiaris,CHEMBL626762,
Intermediate,,A,13465,In vivo,,1,,,N,,11566,BAO_0000218,,1,,9615.0,,50588,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,Canis lupus familiaris,CHEMBL626763,
Intermediate,,A,13465,In vivo,,1,,,N,,11567,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,Rattus norvegicus,CHEMBL626764,
Intermediate,,A,13465,In vivo,,1,,,N,,11568,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,Rattus norvegicus,CHEMBL626765,
Intermediate,,A,13465,In vivo,,1,,,N,,11569,BAO_0000218,,1,,9615.0,,50588,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,Canis lupus familiaris,CHEMBL626766,
Intermediate,,A,13465,In vivo,,1,,,N,,11570,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,Rattus norvegicus,CHEMBL626767,
Intermediate,,A,13465,In vivo,,1,,,N,,11571,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,Rattus norvegicus,CHEMBL626768,
Intermediate,,A,13465,In vivo,,1,,,N,,11572,BAO_0000218,,1,,9615.0,,50588,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,Canis lupus familiaris,CHEMBL626769,
Intermediate,,A,13465,In vivo,,1,,,N,,11573,BAO_0000218,,1,,9615.0,,50588,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,Canis lupus familiaris,CHEMBL874463,
Autocuration,,A,13465,In vivo,,1,,,U,,11574,BAO_0000218,,0,,314293.0,,22224,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,Simiiformes,CHEMBL626770,
Autocuration,,A,13465,In vivo,,1,,,U,,11575,BAO_0000218,,0,,314293.0,,22224,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,Simiiformes,CHEMBL626771,
Intermediate,,A,13465,In vivo,,1,,,N,,11576,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,Rattus norvegicus,CHEMBL626772,
Intermediate,,A,14731,In vivo,,1,,,N,,11577,BAO_0000218,,1,,9541.0,,100710,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,Macaca fascicularis,CHEMBL626773,
Intermediate,,A,14731,In vivo,,1,,,N,,11578,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,Mus musculus,CHEMBL626774,
Intermediate,,A,13376,In vivo,,1,,,N,,11579,BAO_0000218,,1,,9615.0,,50588,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,Canis lupus familiaris,CHEMBL626775,
Intermediate,,A,13376,In vivo,,1,,,N,,11580,BAO_0000218,,1,,9615.0,,50588,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,Canis lupus familiaris,CHEMBL626776,
Intermediate,,A,14443,In vivo,,1,,,N,,11581,BAO_0000218,,1,,10116.0,,50597,Maximum concentration (Cmax) in rat when administered orally,Rattus norvegicus,CHEMBL626777,
Autocuration,,A,13465,In vivo,,1,,,U,,11582,BAO_0000218,,0,,314293.0,1969.0,22224,Maximal concentration in monkey plasma after 25 mg/kg oral dose,Simiiformes,CHEMBL626778,Plasma
Autocuration,,A,16359,In vivo,,1,,,U,,11583,BAO_0000218,,0,,10116.0,,22224,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",Rattus norvegicus,CHEMBL626779,
Autocuration,,A,16359,In vivo,,1,,,U,,11584,BAO_0000218,,0,,10116.0,,22224,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",Rattus norvegicus,CHEMBL626780,
Autocuration,,A,15618,In vivo,,1,,,U,,11585,BAO_0000218,,0,,,1969.0,22224,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,,CHEMBL626781,Plasma
Intermediate,,A,14554,In vivo,,1,,,N,,11586,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic profile Cmax was evaluated in rats,Rattus norvegicus,CHEMBL632164,
Intermediate,,A,11537,In vivo,,1,,,N,,11587,BAO_0000218,,1,,9615.0,,50588,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),Canis lupus familiaris,CHEMBL632165,
Intermediate,,A,11537,In vivo,,1,,,N,,11588,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),Mus musculus,CHEMBL632166,
Intermediate,,A,11537,In vivo,,1,,,N,,11589,BAO_0000218,,1,,9615.0,,50588,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),Canis lupus familiaris,CHEMBL632167,
Intermediate,,A,11537,In vivo,,1,,,N,,11590,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),Mus musculus,CHEMBL632168,
Autocuration,,A,2021,In vivo,,1,,,U,,11591,BAO_0000218,,0,,10116.0,1969.0,22224,Cmax in rat plasma,Rattus norvegicus,CHEMBL632169,Plasma
Intermediate,,A,5932,In vivo,,1,,,N,,11592,BAO_0000218,,1,,9615.0,1969.0,50588,Cmax in dog plasma after 30mg/kg oral dose,Canis lupus familiaris,CHEMBL632170,Plasma
Intermediate,,A,5932,In vivo,,1,,,N,,11593,BAO_0000218,,1,,10116.0,1969.0,50597,Cmax in rat plasma after 30mg/kg oral dose,Rattus norvegicus,CHEMBL632171,Plasma
Intermediate,,A,17320,In vivo,,1,,,N,,11594,BAO_0000218,,1,,10116.0,1969.0,50597,Plasma level in rats at 30 mg/kg,Rattus norvegicus,CHEMBL632172,Plasma
Intermediate,,A,15831,In vivo,,1,,,N,,11595,BAO_0000218,,1,,10090.0,1969.0,50594,Tested for maximum plasma concentration in mice,Mus musculus,CHEMBL632173,Plasma
Intermediate,,A,15078,In vivo,,1,,,N,,11596,BAO_0000218,,1,,10116.0,,50597,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,CHEMBL632174,
Intermediate,,A,14941,In vivo,,1,,,N,,11597,BAO_0000218,,1,,10116.0,,50597,The Cmax values in female wistar rats.,Rattus norvegicus,CHEMBL632175,
Intermediate,,A,15343,In vivo,,1,,,N,,11598,BAO_0000218,,1,,9615.0,1969.0,50588,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,Canis lupus familiaris,CHEMBL632176,Plasma
Intermediate,,A,15343,In vivo,,1,,,N,,11599,BAO_0000218,,1,,10116.0,1969.0,50597,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,Rattus norvegicus,CHEMBL632177,Plasma
Intermediate,,A,14856,In vivo,,1,,,N,,11600,BAO_0000218,,1,,10116.0,1969.0,50597,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,Rattus norvegicus,CHEMBL632178,Plasma
Intermediate,,A,13129,In vivo,,1,,,N,,11601,BAO_0000218,,1,,10116.0,,50597,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,Rattus norvegicus,CHEMBL632179,
Intermediate,,A,13098,In vivo,,1,,,N,,11602,BAO_0000218,,1,,10116.0,178.0,50597,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,Rattus norvegicus,CHEMBL632180,Blood
Intermediate,,A,13098,In vivo,,1,,,N,,11603,BAO_0000218,,1,,10116.0,178.0,50597,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,Rattus norvegicus,CHEMBL632181,Blood
Intermediate,,A,13098,In vivo,,1,,,N,,11604,BAO_0000218,,1,,10116.0,178.0,50597,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,Rattus norvegicus,CHEMBL632182,Blood
Autocuration,,A,15478,In vivo,,1,,,U,,11605,BAO_0000218,,0,,10090.0,178.0,22224,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,Mus musculus,CHEMBL632183,Blood
Intermediate,,A,15341,In vivo,,1,,,N,,11606,BAO_0000218,,1,,9615.0,,50588,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,Canis lupus familiaris,CHEMBL632184,
Intermediate,,A,15341,In vivo,,1,,,N,,11607,BAO_0000218,,1,,10116.0,,50597,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,Rattus norvegicus,CHEMBL874470,
Intermediate,,A,8684,,,1,,,N,,11608,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL631302,
Intermediate,,A,8684,,,1,,,N,,11609,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL631303,
Intermediate,,A,8684,,,1,,,N,,11610,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL631304,
Intermediate,,A,8684,,,1,,,N,,11611,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL631305,
Intermediate,,A,8684,,,1,,,N,,11612,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL631306,
Intermediate,,A,8684,,,1,,,N,,11613,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL631307,
Intermediate,,A,8684,,,1,,,N,,11614,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL631308,
Intermediate,,A,8684,,,1,,,N,,11615,BAO_0000218,,1,,10116.0,,50597,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL625557,
Intermediate,,A,8684,,,1,,,N,,11616,BAO_0000218,,1,,10116.0,2106.0,50597,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL625558,Spleen
Intermediate,,A,8684,,,1,,,N,,11617,BAO_0000218,,1,,10116.0,2106.0,50597,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL625559,Spleen
Intermediate,,A,8684,,,1,,,N,,11618,BAO_0000218,,1,,10116.0,2106.0,50597,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL625560,Spleen
Intermediate,,A,8684,,,1,,,N,,11619,BAO_0000218,,1,,10116.0,2106.0,50597,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL625561,Spleen
Intermediate,,A,8684,,,1,,,N,,11620,BAO_0000218,,1,,10116.0,2106.0,50597,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL625562,Spleen
Intermediate,,A,8684,,,1,,,N,,11621,BAO_0000218,,1,,10116.0,2106.0,50597,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL875320,Spleen
Intermediate,,A,8684,,,1,,,N,,11622,BAO_0000218,,1,,10116.0,2106.0,50597,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL625563,Spleen
Intermediate,,A,8684,,,1,,,N,,11623,BAO_0000218,,1,,10116.0,2106.0,50597,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL625564,Spleen
Intermediate,,A,8684,,,1,,,N,,11624,BAO_0000218,,1,,10116.0,995.0,50597,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL625565,Uterus
Intermediate,,A,8684,,,1,,,N,,11625,BAO_0000218,,1,,10116.0,995.0,50597,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL625566,Uterus
Intermediate,,A,8684,,,1,,,N,,11626,BAO_0000218,,1,,10116.0,995.0,50597,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL625567,Uterus
Intermediate,,A,8684,,,1,,,N,,11627,BAO_0000218,,1,,10116.0,995.0,50597,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL625568,Uterus
Intermediate,,A,8684,,,1,,,N,,11628,BAO_0000218,,1,,10116.0,995.0,50597,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL628217,Uterus
Intermediate,,A,8684,,,1,,,N,,11629,BAO_0000218,,1,,10116.0,995.0,50597,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL628218,Uterus
Intermediate,,A,8684,,,1,,,N,,11630,BAO_0000218,,1,,10116.0,995.0,50597,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL628219,Uterus
Intermediate,,A,8684,,,1,,,N,,11631,BAO_0000218,,1,,10116.0,995.0,50597,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,CHEMBL628220,Uterus
Autocuration,,A,8926,,,1,,,U,,11632,BAO_0000019,,0,,,,22224,Distribution in the blood after 120 min of intravenous administration,,CHEMBL628221,
Autocuration,,A,8926,,,1,,,U,,11633,BAO_0000019,,0,,,,22224,Distribution in the blood after 15 min of intravenous administration,,CHEMBL628222,
Autocuration,,A,8926,,,1,,,U,,11634,BAO_0000019,,0,,,,22224,Distribution in the blood after 30 min of intravenous administration,,CHEMBL628223,
Autocuration,,A,8926,,,1,,,U,,11635,BAO_0000019,,0,,,,22224,Distribution in the blood after 5 min of intravenous administration,,CHEMBL628224,
Autocuration,,A,8926,,,1,,,U,,11636,BAO_0000019,,0,,,,22224,Distribution in the blood after 60 min of intravenous administration,,CHEMBL628225,
Autocuration,,A,8926,,,1,,,U,,11637,BAO_0000019,,0,,,,22224,Distribution in the blood after 90 min of intravenous administration,,CHEMBL628226,
Autocuration,,A,8926,,,1,,,U,,11638,BAO_0000019,,0,,,,22224,Distribution in the bone after 120 min of intravenous administration,,CHEMBL628227,
Autocuration,,A,8926,,,1,,,U,,11639,BAO_0000019,,0,,,,22224,Distribution in the bone after 15 min of intravenous administration,,CHEMBL875481,
Autocuration,,A,8926,,,1,,,U,,11640,BAO_0000019,,0,,,,22224,Distribution in the bone after 30 min of intravenous administration,,CHEMBL628228,
Autocuration,,A,8926,,,1,,,U,,11641,BAO_0000019,,0,,,,22224,Distribution in the bone after 5 min of intravenous administration,,CHEMBL628229,
Autocuration,,A,8926,,,1,,,U,,11642,BAO_0000019,,0,,,,22224,Distribution in the bone after 60 min of intravenous administration,,CHEMBL628230,
Autocuration,,A,8926,,,1,,,U,,11643,BAO_0000019,,0,,,,22224,Distribution in the bone after 90 min of intravenous administration,,CHEMBL628231,
Autocuration,,A,8926,,,1,,,U,,11644,BAO_0000019,,0,,,,22224,Distribution in the heart after 120 min of intravenous administration,,CHEMBL628232,
Autocuration,,A,8926,,,1,,,U,,11645,BAO_0000019,,0,,,,22224,Distribution in the heart after 15 min of intravenous administration,,CHEMBL628233,
Autocuration,,A,8926,,,1,,,U,,11646,BAO_0000019,,0,,,,22224,Distribution in the heart after 30 min of intravenous administration,,CHEMBL628234,
Autocuration,,A,8926,,,1,,,U,,11647,BAO_0000019,,0,,,,22224,Distribution in the heart after 5 min of intravenous administration,,CHEMBL628235,
Autocuration,,A,8926,,,1,,,U,,11648,BAO_0000019,,0,,,,22224,Distribution in the heart after 60 min of intravenous administration,,CHEMBL628236,
Autocuration,,A,8926,,,1,,,U,,11649,BAO_0000019,,0,,,,22224,Distribution in the heart after 90 min of intravenous administration,,CHEMBL628237,
Autocuration,,A,8926,,,1,,,U,,11650,BAO_0000019,,0,,,,22224,Distribution in the kidneys after 120 min of intravenous administration,,CHEMBL628238,
Autocuration,,A,8926,,,1,,,U,,11651,BAO_0000019,,0,,,,22224,Distribution in the kidneys after 15 min of intravenous administration,,CHEMBL628239,
Autocuration,,A,8926,,,1,,,U,,11652,BAO_0000019,,0,,,,22224,Distribution in the kidneys after 30 min of intravenous administration,,CHEMBL628240,
Autocuration,,A,8926,,,1,,,U,,11653,BAO_0000019,,0,,,,22224,Distribution in the kidneys after 5 min of intravenous administration,,CHEMBL628241,
Autocuration,,A,8926,,,1,,,U,,11654,BAO_0000019,,0,,,,22224,Distribution in the kidneys after 60 min of intravenous administration,,CHEMBL628242,
Autocuration,,A,8926,,,1,,,U,,11655,BAO_0000019,,0,,,,22224,Distribution in the kidneys after 90 min of intravenous administration,,CHEMBL875482,
Autocuration,,A,8926,,,1,,,U,,11656,BAO_0000019,,0,,,,22224,Distribution in the liver after 120 min of intravenous administration,,CHEMBL628243,
Autocuration,,A,8926,,,1,,,U,,11657,BAO_0000019,,0,,,,22224,Distribution in the liver after 15 min of intravenous administration,,CHEMBL628244,
Autocuration,,A,8926,,,1,,,U,,11658,BAO_0000019,,0,,,,22224,Distribution in the liver after 30 min of intravenous administration,,CHEMBL628245,
Autocuration,,A,8926,,,1,,,U,,11659,BAO_0000019,,0,,,,22224,Distribution in the liver after 5 min of intravenous administration,,CHEMBL628246,
Autocuration,,A,8926,,,1,,,U,,11660,BAO_0000019,,0,,,,22224,Distribution in the liver after 60 min of intravenous administration,,CHEMBL628247,
Autocuration,,A,8926,,,1,,,U,,11661,BAO_0000019,,0,,,,22224,Distribution in the liver after 90 min of intravenous administration,,CHEMBL628248,
Autocuration,,A,8926,,,1,,,U,,11662,BAO_0000019,,0,,,,22224,Distribution in the lung after 120 min of intravenous administration,,CHEMBL628249,
Intermediate,,A,14839,,,1,,,N,,11663,BAO_0000218,,1,,10090.0,,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",Mus musculus,CHEMBL625452,
Intermediate,,A,14839,,,1,,,N,,11664,BAO_0000218,,1,,10090.0,,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",Mus musculus,CHEMBL625453,
Intermediate,,A,14839,,,1,,,N,,11665,BAO_0000218,,1,,10090.0,,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",Mus musculus,CHEMBL625454,
Intermediate,,A,14839,,,1,,,N,,11666,BAO_0000218,,1,,10090.0,,50594,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",Mus musculus,CHEMBL623844,
Intermediate,,A,12178,,,1,,,N,,11667,BAO_0000218,,1,,10116.0,,50597,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,Rattus norvegicus,CHEMBL623845,
Intermediate,,A,12178,,,1,,,N,,11668,BAO_0000218,,1,,10116.0,,50597,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,Rattus norvegicus,CHEMBL623846,
Autocuration,,A,12178,,,1,,,U,,11669,BAO_0000218,,0,,,,22224,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,,CHEMBL623847,
Intermediate,,A,12186,,,1,,,N,,11670,BAO_0000218,,1,,9541.0,,100710,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,Macaca fascicularis,CHEMBL623848,
Intermediate,,A,12186,,,1,,,N,,11671,BAO_0000218,,1,,9541.0,,100710,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,Macaca fascicularis,CHEMBL623849,
Intermediate,,A,12186,,,1,,,N,,11672,BAO_0000218,,1,,9541.0,,100710,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,Macaca fascicularis,CHEMBL623850,
Intermediate,,A,12186,,,1,,,N,,11673,BAO_0000218,,1,,9541.0,,100710,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,Macaca fascicularis,CHEMBL623851,
Autocuration,,A,12187,,,1,,,U,,11674,BAO_0000218,,0,,314293.0,,22224,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,Simiiformes,CHEMBL623852,
Intermediate,,A,12187,,,1,,,N,,11675,BAO_0000218,,1,,9669.0,,50506,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,Mustela putorius furo,CHEMBL624551,
Intermediate,,A,12187,,,1,,,N,,11676,BAO_0000218,,1,,9669.0,,50506,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",Mustela putorius furo,CHEMBL624552,
Autocuration,,A,12187,,,1,,,U,,11677,BAO_0000218,,0,,314293.0,,22224,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,Simiiformes,CHEMBL624553,
Autocuration,,A,12187,,,1,,,U,,11678,BAO_0000218,,0,,314293.0,,22224,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,Simiiformes,CHEMBL624554,
Intermediate,,A,12187,,,1,,,N,,11679,BAO_0000218,,1,,10116.0,,50597,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,Rattus norvegicus,CHEMBL624555,
Intermediate,,A,12187,,,1,,,N,,11680,BAO_0000218,,1,,10116.0,,50597,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",Rattus norvegicus,CHEMBL624741,
Intermediate,,A,14122,,,1,,,N,,11681,BAO_0000218,,1,,9615.0,,50588,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",Canis lupus familiaris,CHEMBL624742,
Intermediate,,A,14122,,,1,,,N,,11682,BAO_0000218,,1,,10026.0,,100712,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",Cricetinae,CHEMBL624743,
Intermediate,,A,14122,,,1,,,N,,11683,BAO_0000218,,1,,10116.0,,50597,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",Rattus norvegicus,CHEMBL877606,
Autocuration,,A,13391,,,1,,,U,,11684,BAO_0000218,,0,,,,22224,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,,CHEMBL624744,
Autocuration,,A,13391,,,1,,,U,,11685,BAO_0000218,,0,,,178.0,22224,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,CHEMBL624745,Blood
Autocuration,,A,13391,,,1,,,U,,11686,BAO_0000218,,0,,,178.0,22224,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,CHEMBL624746,Blood
Autocuration,,A,13391,,,1,,,U,,11687,BAO_0000218,,0,,,178.0,22224,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,CHEMBL624747,Blood
Autocuration,,A,16360,,,1,,,U,,11688,BAO_0000019,,0,,,,22224,Oral absorption expressed as Area under curve was determined,,CHEMBL624748,
Intermediate,,A,3673,,,1,,,N,,11689,BAO_0000218,,1,,9615.0,,50588,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,Canis lupus familiaris,CHEMBL622504,
Intermediate,,A,14122,,,1,,,N,,11690,BAO_0000218,,1,,9615.0,,50588,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",Canis lupus familiaris,CHEMBL622505,
Intermediate,,A,14122,,,1,,,N,,11691,BAO_0000218,,1,,10026.0,,100712,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",Cricetinae,CHEMBL622506,
Intermediate,,A,14122,,,1,,,N,,11692,BAO_0000218,,1,,10026.0,,100712,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",Cricetinae,CHEMBL622507,
Intermediate,,A,14122,,,1,,,N,,11693,BAO_0000218,,1,,10116.0,,50597,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",Rattus norvegicus,CHEMBL622508,
Autocuration,,A,13889,,,1,,,U,,11694,BAO_0000019,,0,,,,22224,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,,CHEMBL622509,
Intermediate,,A,14393,,,1,,,N,,11695,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Rattus norvegicus,CHEMBL622510,
Intermediate,,A,17279,,,1,,,N,,11696,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),Rattus norvegicus,CHEMBL622511,
Intermediate,,A,14548,,,1,,,N,,11697,BAO_0000218,,1,,9541.0,,100710,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,Macaca fascicularis,CHEMBL622512,
Intermediate,,A,14548,,,1,,,N,,11698,BAO_0000218,,1,,9541.0,,100710,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,Macaca fascicularis,CHEMBL622513,
Intermediate,,A,14548,,,1,,,N,,11699,BAO_0000218,,1,,9541.0,,100710,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,Macaca fascicularis,CHEMBL622514,
Intermediate,,A,14548,,,1,,,N,,11700,BAO_0000218,,1,,9615.0,,50588,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,Canis lupus familiaris,CHEMBL622515,
Intermediate,,A,14548,,,1,,,N,,11701,BAO_0000218,,1,,9615.0,,50588,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,Canis lupus familiaris,CHEMBL622516,
Intermediate,,A,14548,,,1,,,N,,11702,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,Rattus norvegicus,CHEMBL622517,
Intermediate,,A,14548,,,1,,,N,,11703,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,Rattus norvegicus,CHEMBL622518,
Intermediate,,A,14548,,,1,,,N,,11704,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,Rattus norvegicus,CHEMBL622519,
Intermediate,,A,14608,In vivo,,1,,,N,,11705,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,CHEMBL622520,Muscle tissue
Intermediate,,A,14608,In vivo,,1,,,N,,11706,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,CHEMBL622521,Muscle tissue
Intermediate,,A,14608,In vivo,,1,,,N,,11707,BAO_0000218,,1,,10090.0,14.0,50594,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,Mus musculus,CHEMBL625113,Zone of skin
Intermediate,,A,14608,In vivo,,1,,,N,,11708,BAO_0000218,,1,,10116.0,14.0,50597,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,CHEMBL625114,Zone of skin
Intermediate,,A,14608,In vivo,,1,,,N,,11709,BAO_0000218,,1,,10116.0,14.0,50597,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,CHEMBL874397,Zone of skin
Intermediate,,A,14608,In vivo,,1,,,N,,11710,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,CHEMBL625115,Spleen
Intermediate,,A,14608,In vivo,,1,,,N,,11711,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,CHEMBL625116,Spleen
Intermediate,,A,14608,In vivo,,1,,,N,,11712,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,CHEMBL623932,Spleen
Intermediate,,A,14608,In vivo,,1,,,N,,11713,BAO_0000218,,1,,10116.0,2435.0,50597,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,CHEMBL623933,Striatum
Intermediate,,A,14608,In vivo,,1,,,N,,11714,BAO_0000218,,1,,10116.0,2435.0,50597,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,CHEMBL623934,Striatum
Intermediate,,A,14608,In vivo,,1,,,N,,11715,BAO_0000218,,1,,10116.0,2435.0,50597,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,CHEMBL623935,Striatum
Intermediate,,A,14608,In vivo,,1,,,N,,11716,BAO_0000218,,1,,10116.0,2046.0,50597,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,CHEMBL623936,Thyroid gland
Intermediate,,A,14608,In vivo,,1,,,N,,11717,BAO_0000218,,1,,10116.0,2046.0,50597,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,CHEMBL623937,Thyroid gland
Intermediate,,A,14608,In vivo,,1,,,N,,11718,BAO_0000218,,1,,10116.0,2046.0,50597,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,CHEMBL623938,Thyroid gland
Intermediate,,A,15383,,,1,,,N,,11719,BAO_0000218,,1,,10090.0,,50594,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,CHEMBL623939,
Intermediate,,A,15383,,,1,,,N,,11720,BAO_0000218,,1,,10090.0,,50594,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Mus musculus,CHEMBL623940,
Intermediate,,A,15383,,,1,,,N,,11721,BAO_0000218,,1,,10090.0,,50594,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Mus musculus,CHEMBL623941,
Intermediate,,A,15383,,,1,,,N,,11722,BAO_0000218,,1,,10090.0,,50594,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,CHEMBL627216,
Intermediate,,A,15383,,,1,,,N,,11723,BAO_0000218,,1,,10090.0,,50594,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,CHEMBL623942,
Intermediate,,A,15383,,,1,,,N,,11724,BAO_0000218,,1,,10090.0,955.0,50594,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,CHEMBL618793,Brain
Intermediate,,A,15383,,,1,,,N,,11725,BAO_0000218,,1,,10090.0,955.0,50594,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,CHEMBL618794,Brain
Intermediate,,A,15383,,,1,,,N,,11726,BAO_0000218,,1,,10090.0,955.0,50594,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,CHEMBL618795,Brain
Intermediate,,A,15383,,,1,,,N,,11727,BAO_0000218,,1,,10090.0,,50594,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,CHEMBL618796,
Intermediate,,A,15383,,,1,,,N,,11728,BAO_0000218,,1,,10090.0,,50594,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,CHEMBL618797,
Intermediate,,A,15383,,,1,,,N,,11729,BAO_0000218,,1,,10090.0,2113.0,50594,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,Mus musculus,CHEMBL618798,Kidney
Intermediate,,A,15383,,,1,,,N,,11730,BAO_0000218,,1,,10090.0,2113.0,50594,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,CHEMBL618799,Kidney
Intermediate,,A,15383,,,1,,,N,,11731,BAO_0000218,,1,,10090.0,2113.0,50594,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Mus musculus,CHEMBL618800,Kidney
Intermediate,,A,15383,,,1,,,N,,11732,BAO_0000218,,1,,10090.0,2113.0,50594,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Mus musculus,CHEMBL618801,Kidney
Intermediate,,A,15383,,,1,,,N,,11733,BAO_0000218,,1,,10090.0,2113.0,50594,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,CHEMBL618802,Kidney
Intermediate,,A,15383,,,1,,,N,,11734,BAO_0000218,,1,,10090.0,2113.0,50594,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,CHEMBL618803,Kidney
Intermediate,,A,15383,,,1,,,N,,11735,BAO_0000218,,1,,10090.0,2107.0,50594,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,Mus musculus,CHEMBL618804,Liver
Intermediate,,A,15383,,,1,,,N,,11736,BAO_0000218,,1,,10090.0,2107.0,50594,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,CHEMBL618805,Liver
Intermediate,,A,15383,,,1,,,N,,11737,BAO_0000218,,1,,10090.0,2107.0,50594,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Mus musculus,CHEMBL618806,Liver
Intermediate,,A,15383,,,1,,,N,,11738,BAO_0000218,,1,,10090.0,2107.0,50594,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Mus musculus,CHEMBL618807,Liver
Intermediate,,A,15383,,,1,,,N,,11739,BAO_0000218,,1,,10090.0,2107.0,50594,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,CHEMBL618808,Liver
Intermediate,,A,15383,,,1,,,N,,11740,BAO_0000218,,1,,10090.0,2107.0,50594,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,CHEMBL618809,Liver
Intermediate,,A,15383,,,1,,,N,,11741,BAO_0000218,,1,,10090.0,2385.0,50594,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,CHEMBL618810,Muscle tissue
Intermediate,,A,15383,,,1,,,N,,11742,BAO_0000218,,1,,10090.0,2385.0,50594,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Mus musculus,CHEMBL618811,Muscle tissue
Intermediate,,A,15383,,,1,,,N,,11743,BAO_0000218,,1,,10090.0,2385.0,50594,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Mus musculus,CHEMBL875844,Muscle tissue
Intermediate,,A,15383,,,1,,,N,,11744,BAO_0000218,,1,,10090.0,2385.0,50594,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,CHEMBL618812,Muscle tissue
Intermediate,,A,15383,,,1,,,N,,11745,BAO_0000218,,1,,10090.0,2385.0,50594,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,CHEMBL618813,Muscle tissue
Intermediate,,A,15383,,,1,,,N,,11746,BAO_0000218,,1,,10090.0,,50594,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,CHEMBL618814,
Intermediate,,A,15383,,,1,,,N,,11747,BAO_0000218,,1,,10090.0,,50594,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,CHEMBL618815,
Intermediate,,A,15383,,,1,,,N,,11748,BAO_0000218,,1,,10090.0,,50594,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,CHEMBL618816,
Intermediate,,A,15383,,,1,,,N,,11749,BAO_0000218,,1,,10090.0,,50594,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,CHEMBL618817,
Intermediate,,A,15383,,,1,,,N,,11750,BAO_0000218,,1,,10090.0,,50594,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,CHEMBL620544,
Intermediate,,A,15341,In vivo,,1,,,N,,11751,BAO_0000218,,1,,10116.0,,50597,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,Rattus norvegicus,CHEMBL626230,
Intermediate,,A,15341,In vivo,,1,,,N,,11752,BAO_0000218,,1,,10116.0,,50597,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,Rattus norvegicus,CHEMBL626231,
Intermediate,,A,15341,In vivo,,1,,,N,,11753,BAO_0000218,,1,,10116.0,,50597,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,Rattus norvegicus,CHEMBL626232,
Intermediate,,A,14906,In vivo,,1,,,N,,11754,BAO_0000218,,1,,9615.0,1969.0,50588,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,Canis lupus familiaris,CHEMBL626233,Plasma
Intermediate,,A,14906,In vivo,,1,,,N,,11755,BAO_0000218,,1,,10116.0,1969.0,50597,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,Rattus norvegicus,CHEMBL626234,Plasma
Intermediate,,A,14906,In vivo,,1,,,N,,11756,BAO_0000218,,1,,10116.0,1969.0,50597,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,Rattus norvegicus,CHEMBL875341,Plasma
Intermediate,,A,14215,In vivo,,1,,,N,,11757,BAO_0000218,,1,,9606.0,1969.0,50587,The maximum plasma concentration (100 mg/kg) administered orally in human,Homo sapiens,CHEMBL626235,Plasma
Autocuration,,A,14215,In vivo,,1,,,U,,11758,BAO_0000218,,0,,9481.0,1969.0,22224,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,Callithrix,CHEMBL626236,Plasma
Autocuration,,A,14215,In vivo,,1,,,U,,11759,BAO_0000218,,0,,314293.0,1969.0,22224,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,Simiiformes,CHEMBL626237,Plasma
Intermediate,,A,14215,In vivo,,1,,,N,,11760,BAO_0000218,,1,,9615.0,1969.0,50588,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,Canis lupus familiaris,CHEMBL626238,Plasma
Intermediate,,A,14215,In vivo,,1,,,N,,11761,BAO_0000218,,1,,9606.0,1969.0,50587,The maximum plasma concentration (200 mg/kg) administered orally in human,Homo sapiens,CHEMBL622412,Plasma
Intermediate,,A,14215,In vivo,,1,,,N,,11762,BAO_0000218,,1,,10116.0,1969.0,50597,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,Rattus norvegicus,CHEMBL623114,Plasma
Autocuration,,A,14215,In vivo,,1,,,U,,11763,BAO_0000218,,0,,9481.0,1969.0,22224,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,Callithrix,CHEMBL623115,Plasma
Autocuration,,A,14215,In vivo,,1,,,U,,11764,BAO_0000218,,0,,314293.0,1969.0,22224,The maximum plasma concentration (25 mg/kg) administered orally in monkey,Simiiformes,CHEMBL623116,Plasma
Autocuration,,A,14215,In vivo,,1,,,U,,11765,BAO_0000218,,0,,9615.0,1969.0,22224,The maximum plasma concentration (30 mg/kg) administered orally in dog,Canis lupus familiaris,CHEMBL623117,Plasma
Intermediate,,A,14215,In vivo,,1,,,N,,11766,BAO_0000218,,1,,9606.0,1969.0,50587,The maximum plasma concentration (400 mg/kg) administered orally in human,Homo sapiens,CHEMBL623118,Plasma
Intermediate,,A,14215,In vivo,,1,,,N,,11767,BAO_0000218,,1,,10116.0,1969.0,50597,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,Rattus norvegicus,CHEMBL623119,Plasma
Intermediate,,A,14215,In vivo,,1,,,N,,11768,BAO_0000218,,1,,10116.0,1969.0,50597,The maximum plasma concentration (50 mg/kg) administered orally in rat,Rattus norvegicus,CHEMBL623120,Plasma
Intermediate,,A,14215,In vivo,,1,,,N,,11769,BAO_0000218,,1,,9606.0,1969.0,50587,The maximum plasma concentration (800 mg/kg) administered orally in human,Homo sapiens,CHEMBL623286,Plasma
Intermediate,,A,14067,In vivo,,1,,,N,,11770,BAO_0000218,,1,,10116.0,1969.0,50597,The maximum plasma concentration was measured on rats,Rattus norvegicus,CHEMBL623287,Plasma
Intermediate,,A,12350,In vivo,,1,,,N,,11771,BAO_0000218,,1,,10116.0,1969.0,50597,The maximum plasma concentration was measured on rats after oral administration,Rattus norvegicus,CHEMBL623288,Plasma
Intermediate,,A,14813,In vivo,,1,,,N,,11772,BAO_0000218,,1,,10116.0,1969.0,50597,Plasma drug Cmax in rat (PO dose),Rattus norvegicus,CHEMBL623289,Plasma
Autocuration,,A,12536,In vivo,,1,,,U,,11773,BAO_0000218,,0,,,,22224,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,,CHEMBL623290,
Intermediate,,A,14169,In vivo,,1,,,N,,11774,BAO_0000218,,1,,9615.0,1969.0,50588,maximum Plasma concentration in Dog was determined after Peroral administration,Canis lupus familiaris,CHEMBL623291,Plasma
Intermediate,,A,14169,In vivo,,1,,,N,,11775,BAO_0000218,,1,,10116.0,1969.0,50597,maximum Plasma concentration in Rats was determined after Peroral administration,Rattus norvegicus,CHEMBL623292,Plasma
Intermediate,,A,15604,In vivo,,1,,,N,,11776,BAO_0000218,,1,,9615.0,1969.0,50588,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,Canis lupus familiaris,CHEMBL623293,Plasma
Autocuration,,A,15604,In vivo,,1,,,U,,11777,BAO_0000218,,0,,314293.0,1969.0,22224,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,Simiiformes,CHEMBL623294,Plasma
Intermediate,,A,15604,In vivo,,1,,,N,,11778,BAO_0000218,,1,,10116.0,1969.0,50597,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,Rattus norvegicus,CHEMBL623295,Plasma
Intermediate,,A,14387,In vivo,,1,,,N,,11779,BAO_0000218,,1,,10090.0,,50594,maximum concentration was measured when administered through oral route in mice,Mus musculus,CHEMBL623296,
Intermediate,,A,15115,,,1,,,N,,11780,BAO_0000218,,1,,10090.0,,50594,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,Mus musculus,CHEMBL875349,
Autocuration,,A,15115,,,1,,,U,,11781,BAO_0000019,,0,,314293.0,,22224,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,Simiiformes,CHEMBL623297,
Autocuration,,A,15115,,,1,,,U,,11782,BAO_0000019,,0,,314293.0,,22224,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,Simiiformes,CHEMBL623298,
Autocuration,,A,15115,,,1,,,U,,11783,BAO_0000019,,0,,314293.0,,22224,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,Simiiformes,CHEMBL623299,
Intermediate,,A,16359,,,1,,,N,,11784,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter was evaluated in rats,Rattus norvegicus,CHEMBL623300,
Intermediate,,A,12829,,,1,,,N,,11785,BAO_0000218,,1,,10090.0,,50594,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,Mus musculus,CHEMBL623301,
Intermediate,,A,12829,,,1,,,N,,11786,BAO_0000218,,1,,10090.0,,50594,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,Mus musculus,CHEMBL623302,
Intermediate,,A,12829,,,1,,,N,,11787,BAO_0000218,,1,,10090.0,,50594,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,Mus musculus,CHEMBL623303,
Intermediate,,A,12829,,,1,,,N,,11788,BAO_0000218,,1,,10090.0,,50594,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,Mus musculus,CHEMBL623304,
Intermediate,,A,12829,,,1,,,N,,11789,BAO_0000218,,1,,10090.0,,50594,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,Mus musculus,CHEMBL623305,
Intermediate,,A,15137,,,1,,,N,,11790,BAO_0000218,,1,,10116.0,1969.0,50597,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,Rattus norvegicus,CHEMBL623306,Plasma
Intermediate,,A,15137,,,1,,,N,,11791,BAO_0000218,,1,,10116.0,1969.0,50597,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,Rattus norvegicus,CHEMBL623307,Plasma
Intermediate,,A,15137,,,1,,,N,,11792,BAO_0000218,,1,,10116.0,1969.0,50597,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,Rattus norvegicus,CHEMBL623308,Plasma
Intermediate,,A,15137,,,1,,,N,,11793,BAO_0000218,,1,,10090.0,1969.0,50594,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,Mus musculus,CHEMBL623309,Plasma
Intermediate,,A,13509,,,1,,,N,,11794,BAO_0000218,,1,,10090.0,,50594,Plasma Concentration after 120 min of oral administration to mice,Mus musculus,CHEMBL623310,
Intermediate,,A,13509,,,1,,,N,,11795,BAO_0000218,,1,,10090.0,,50594,Plasma Concentration after 30 min of oral administration to mice,Mus musculus,CHEMBL623311,
Intermediate,,A,13509,,,1,,,N,,11796,BAO_0000218,,1,,9541.0,,100710,Plasma Concentration after 60 min of oral administration to mice,Macaca fascicularis,CHEMBL623312,
Intermediate,,A,13509,,,1,,,N,,11797,BAO_0000218,,1,,10090.0,,50594,Plasma Concentration after 60 min of oral administration to mice; Not determined,Mus musculus,CHEMBL875350,
Intermediate,,A,13509,,,1,,,N,,11798,BAO_0000218,,1,,10090.0,,50594,Plasma Concentration after 90 min of oral administration to mice,Mus musculus,CHEMBL628635,
Intermediate,,A,12064,,,1,,,N,,11799,BAO_0000218,,1,,10116.0,,50597,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,Rattus norvegicus,CHEMBL628636,
Intermediate,,A,12064,,,1,,,N,,11800,BAO_0000218,,1,,10116.0,,50597,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,Rattus norvegicus,CHEMBL628637,
Intermediate,,A,12064,,,1,,,N,,11801,BAO_0000218,,1,,10116.0,,50597,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,Rattus norvegicus,CHEMBL628058,
Intermediate,,A,10677,,,1,,,N,,11802,BAO_0000218,,1,,10116.0,,50597,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,Rattus norvegicus,CHEMBL628059,
Intermediate,,A,10677,,,1,,,N,,11803,BAO_0000218,,1,,10116.0,,50597,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,Rattus norvegicus,CHEMBL628060,
Autocuration,,A,8926,,,1,,,U,,11804,BAO_0000019,,0,,,,22224,Distribution in the lung after 15 min of intravenous administration,,CHEMBL628061,
Autocuration,,A,8926,,,1,,,U,,11805,BAO_0000019,,0,,,,22224,Distribution in the lung after 30 min of intravenous administration,,CHEMBL628062,
Autocuration,,A,8926,,,1,,,U,,11806,BAO_0000019,,0,,,,22224,Distribution in the lung after 5 min of intravenous administration,,CHEMBL628063,
Autocuration,,A,8926,,,1,,,U,,11807,BAO_0000019,,0,,,,22224,Distribution in the lung after 60 min of intravenous administration,,CHEMBL628064,
Autocuration,,A,8926,,,1,,,U,,11808,BAO_0000019,,0,,,,22224,Distribution in the lung after 90 min of intravenous administration,,CHEMBL628065,
Autocuration,,A,8926,,,1,,,U,,11809,BAO_0000019,,0,,,2385.0,22224,Distribution in the muscle after 120 min of intravenous administration,,CHEMBL628066,Muscle tissue
Autocuration,,A,8926,,,1,,,U,,11810,BAO_0000019,,0,,,2385.0,22224,Distribution in the muscle after 15 min of intravenous administration,,CHEMBL628067,Muscle tissue
Intermediate,,A,8926,,,1,,,N,,11811,BAO_0000218,,1,,10090.0,2385.0,50594,Distribution in the muscle after 30 min of intravenous administration,Mus musculus,CHEMBL874646,Muscle tissue
Autocuration,,A,8926,,,1,,,U,,11812,BAO_0000019,,0,,,2385.0,22224,Distribution in the muscle after 5 min of intravenous administration,,CHEMBL628068,Muscle tissue
Autocuration,,A,8926,,,1,,,U,,11813,BAO_0000019,,0,,,2385.0,22224,Distribution in the muscle after 60 min of intravenous administration,,CHEMBL628069,Muscle tissue
Autocuration,,A,8926,,,1,,,U,,11814,BAO_0000019,,0,,,2385.0,22224,Distribution in the muscle after 90 min of intravenous administration,,CHEMBL628070,Muscle tissue
Autocuration,,A,8926,,,1,,,U,,11815,BAO_0000019,,0,,,2106.0,22224,Distribution in the spleen after 120 min of intravenous administration,,CHEMBL628071,Spleen
Autocuration,,A,8926,,,1,,,U,,11816,BAO_0000019,,0,,,2106.0,22224,Distribution in the spleen after 15 min of intravenous administration,,CHEMBL628072,Spleen
Autocuration,,A,8926,,,1,,,U,,11817,BAO_0000019,,0,,,2106.0,22224,Distribution in the spleen after 30 min of intravenous administration,,CHEMBL628073,Spleen
Autocuration,,A,8926,,,1,,,U,,11818,BAO_0000019,,0,,,2106.0,22224,Distribution in the spleen after 5 min of intravenous administration,,CHEMBL628074,Spleen
Autocuration,,A,8926,,,1,,,U,,11819,BAO_0000019,,0,,,2106.0,22224,Distribution in the spleen after 60 min of intravenous administration,,CHEMBL628075,Spleen
Autocuration,,A,8926,,,1,,,U,,11820,BAO_0000019,,0,,,2106.0,22224,Distribution in the spleen after 90 min of intravenous administration,,CHEMBL628076,Spleen
Intermediate,,A,7570,,,1,,,N,,11821,BAO_0000218,,1,,10116.0,1235.0,50597,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,Rattus norvegicus,CHEMBL628077,Adrenal cortex
Intermediate,,A,7570,,,1,,,N,,11822,BAO_0000218,,1,,10116.0,178.0,50597,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,Rattus norvegicus,CHEMBL628078,Blood
Intermediate,,A,7570,,,1,,,N,,11823,BAO_0000218,,1,,10116.0,2107.0,50597,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,Rattus norvegicus,CHEMBL628079,Liver
Intermediate,,A,7570,,,1,,,N,,11824,BAO_0000218,,1,,10116.0,992.0,50597,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,Rattus norvegicus,CHEMBL628080,Female gonad
Intermediate,,A,7570,,,1,,,N,,11825,BAO_0000218,,1,,10116.0,2046.0,50597,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,Rattus norvegicus,CHEMBL628081,Thyroid gland
Intermediate,,A,7570,,,1,,,N,,11826,BAO_0000218,,1,,10116.0,1235.0,50597,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,Rattus norvegicus,CHEMBL628082,Adrenal cortex
Intermediate,,A,7570,,,1,,,N,,11827,BAO_0000218,,1,,10116.0,178.0,50597,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,Rattus norvegicus,CHEMBL874647,Blood
Intermediate,,A,7570,,,1,,,N,,11828,BAO_0000218,,1,,10116.0,2107.0,50597,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,Rattus norvegicus,CHEMBL626406,Liver
Intermediate,,A,7570,,,1,,,N,,11829,BAO_0000218,,1,,10116.0,992.0,50597,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,Rattus norvegicus,CHEMBL626407,Female gonad
Intermediate,,A,7570,,,1,,,N,,11830,BAO_0000218,,1,,10116.0,2046.0,50597,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,Rattus norvegicus,CHEMBL626408,Thyroid gland
Intermediate,,A,8608,,,1,,,N,,11831,BAO_0000218,,1,,10116.0,178.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",Rattus norvegicus,CHEMBL626409,Blood
Intermediate,,A,8608,,,1,,,N,,11832,BAO_0000218,,1,,10116.0,178.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",Rattus norvegicus,CHEMBL626410,Blood
Intermediate,,A,8608,,,1,,,N,,11833,BAO_0000218,,1,,10116.0,178.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",Rattus norvegicus,CHEMBL626411,Blood
Intermediate,,A,8608,,,1,,,N,,11834,BAO_0000218,,1,,10116.0,178.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",Rattus norvegicus,CHEMBL626412,Blood
Intermediate,,A,8608,,,1,,,N,,11835,BAO_0000218,,1,,10116.0,178.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",Rattus norvegicus,CHEMBL626413,Blood
Intermediate,,A,8608,,,1,,,N,,11836,BAO_0000218,,1,,10116.0,178.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",Rattus norvegicus,CHEMBL626414,Blood
Intermediate,,A,8608,,,1,,,N,,11837,BAO_0000218,,1,,10116.0,178.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",Rattus norvegicus,CHEMBL626415,Blood
Intermediate,,A,8608,,,1,,,N,,11838,BAO_0000218,,1,,10116.0,178.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",Rattus norvegicus,CHEMBL626416,Blood
Intermediate,,A,8608,,,1,,,N,,11839,BAO_0000218,,1,,10116.0,178.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",Rattus norvegicus,CHEMBL627062,Blood
Intermediate,,A,8608,,,1,,,N,,11840,BAO_0000218,,1,,10116.0,178.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",Rattus norvegicus,CHEMBL627063,Blood
Intermediate,,A,8608,,,1,,,N,,11841,BAO_0000218,,1,,10116.0,178.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",Rattus norvegicus,CHEMBL627064,Blood
Intermediate,,A,8608,,,1,,,N,,11842,BAO_0000218,,1,,10116.0,178.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",Rattus norvegicus,CHEMBL627227,Blood
Intermediate,,A,8608,,,1,,,N,,11843,BAO_0000218,,1,,10116.0,178.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",Rattus norvegicus,CHEMBL627228,Blood
Intermediate,,A,8608,,,1,,,N,,11844,BAO_0000218,,1,,10116.0,178.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",Rattus norvegicus,CHEMBL627229,Blood
Intermediate,,A,8608,,,1,,,N,,11845,BAO_0000218,,1,,10116.0,178.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",Rattus norvegicus,CHEMBL625792,Blood
Intermediate,,A,8608,,,1,,,N,,11846,BAO_0000218,,1,,10116.0,178.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",Rattus norvegicus,CHEMBL625793,Blood
Intermediate,,A,8608,,,1,,,N,,11847,BAO_0000218,,1,,10116.0,178.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",Rattus norvegicus,CHEMBL625794,Blood
Intermediate,,A,8608,,,1,,,N,,11848,BAO_0000218,,1,,10116.0,178.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",Rattus norvegicus,CHEMBL625795,Blood
Intermediate,,A,13792,,,1,,,N,,11849,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,Mus musculus,CHEMBL625796,
Intermediate,,A,13376,,,1,,,N,,11850,BAO_0000218,,1,,9615.0,,50588,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,Canis lupus familiaris,CHEMBL625797,
Intermediate,,A,13376,,,1,,,N,,11851,BAO_0000218,,1,,9615.0,,50588,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,Canis lupus familiaris,CHEMBL625798,
Autocuration,,A,14380,,,1,,,U,,11852,BAO_0000218,,0,,,,22224,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,CHEMBL875613,
Autocuration,,A,14380,,,1,,,U,,11853,BAO_0000218,,0,,,,22224,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,CHEMBL625799,
Autocuration,,A,14380,,,1,,,U,,11854,BAO_0000218,,0,,,,22224,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,,CHEMBL625800,
Autocuration,,A,14380,,,1,,,U,,11855,BAO_0000218,,0,,,,22224,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,CHEMBL625801,
Autocuration,,A,14380,,,1,,,U,,11856,BAO_0000218,,0,,,,22224,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,CHEMBL625802,
Autocuration,,A,14380,,,1,,,U,,11857,BAO_0000218,,0,,,,22224,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,CHEMBL625803,
Autocuration,,A,14380,,,1,,,U,,11858,BAO_0000019,,0,,,,22224,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,,CHEMBL625804,
Autocuration,,A,14380,,,1,,,U,,11859,BAO_0000218,,0,,,,22224,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,,CHEMBL622530,
Intermediate,,A,13701,,,1,,,N,,11860,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,Mus musculus,CHEMBL622531,
Intermediate,,A,13701,,,1,,,N,,11861,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),Mus musculus,CHEMBL622532,
Intermediate,,A,13701,,,1,,,N,,11862,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),Mus musculus,CHEMBL623176,
Intermediate,,A,13701,,,1,,,N,,11863,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),Mus musculus,CHEMBL623177,
Intermediate,,A,13701,,,1,,,N,,11864,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),Mus musculus,CHEMBL623178,
Intermediate,,A,13701,,,1,,,N,,11865,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,Mus musculus,CHEMBL623179,
Intermediate,,A,13701,,,1,,,N,,11866,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),Mus musculus,CHEMBL623180,
Intermediate,,A,13701,,,1,,,N,,11867,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),Mus musculus,CHEMBL623181,
Intermediate,,A,13701,,,1,,,N,,11868,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),Mus musculus,CHEMBL624131,
Intermediate,,A,13701,,,1,,,N,,11869,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),Mus musculus,CHEMBL624132,
Intermediate,,A,13701,,,1,,,N,,11870,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),Mus musculus,CHEMBL624133,
Intermediate,,A,13701,,,1,,,N,,11871,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,Mus musculus,CHEMBL624846,
Intermediate,,A,13701,,,1,,,N,,11872,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),Mus musculus,CHEMBL624847,
Intermediate,,A,13701,,,1,,,N,,11873,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),Mus musculus,CHEMBL624848,
Intermediate,,A,13701,,,1,,,N,,11874,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),Mus musculus,CHEMBL625012,
Intermediate,,A,13701,,,1,,,N,,11875,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),Mus musculus,CHEMBL625013,
Intermediate,,A,13701,,,1,,,N,,11876,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,Mus musculus,CHEMBL625014,
Intermediate,,A,13701,,,1,,,N,,11877,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),Mus musculus,CHEMBL625015,
Intermediate,,A,13701,,,1,,,N,,11878,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),Mus musculus,CHEMBL625016,
Intermediate,,A,13701,,,1,,,N,,11879,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,Mus musculus,CHEMBL625017,
Intermediate,,A,13701,,,1,,,N,,11880,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),Mus musculus,CHEMBL625018,
Intermediate,,A,13701,,,1,,,N,,11881,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),Mus musculus,CHEMBL625019,
Intermediate,,A,13701,,,1,,,N,,11882,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),Mus musculus,CHEMBL625020,
Intermediate,,A,13701,,,1,,,N,,11883,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,Mus musculus,CHEMBL625021,
Intermediate,,A,14393,,,1,,,N,,11884,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Rattus norvegicus,CHEMBL625022,
Intermediate,,A,14731,,,1,,,N,,11885,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,Mus musculus,CHEMBL625023,
Intermediate,,A,14731,,,1,,,N,,11886,BAO_0000218,,1,,9541.0,,100710,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,Macaca fascicularis,CHEMBL625024,
Intermediate,,A,14731,,,1,,,N,,11887,BAO_0000218,,1,,9541.0,,100710,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,Macaca fascicularis,CHEMBL627626,
Autocuration,,A,13758,,,1,,,U,,11888,BAO_0000218,,0,,,955.0,22224,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,CHEMBL627627,Brain
Autocuration,,A,13758,,,1,,,U,,11889,BAO_0000218,,0,,,1977.0,22224,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,,CHEMBL627628,Serum
Autocuration,,A,13758,,,1,,,U,,11890,BAO_0000218,,0,,,955.0,22224,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,CHEMBL627629,Brain
Autocuration,,A,13758,,,1,,,U,,11891,BAO_0000218,,0,,,1977.0,22224,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,,CHEMBL627630,Serum
Autocuration,,A,16359,,,1,,,U,,11892,BAO_0000019,,0,,,,22224,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),,CHEMBL627631,
Autocuration,,A,16359,,,1,,,U,,11893,BAO_0000218,,0,,,,22224,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),,CHEMBL629515,
Intermediate,,A,15383,,,1,,,N,,11894,BAO_0000218,,1,,10090.0,2106.0,50594,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,CHEMBL629516,Spleen
Intermediate,,A,15383,,,1,,,N,,11895,BAO_0000218,,1,,10090.0,2106.0,50594,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,CHEMBL629517,Spleen
Intermediate,,A,15383,,,1,,,N,,11896,BAO_0000218,,1,,10090.0,2106.0,50594,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,CHEMBL629518,Spleen
Intermediate,,A,15383,,,1,,,N,,11897,BAO_0000218,,1,,10090.0,,50594,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,CHEMBL877499,
Intermediate,,A,15383,,,1,,,N,,11898,BAO_0000218,,1,,10090.0,,50594,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Mus musculus,CHEMBL629519,
Intermediate,,A,15383,,,1,,,N,,11899,BAO_0000218,,1,,10090.0,,50594,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,CHEMBL629520,
Intermediate,,A,15383,,,1,,,N,,11900,BAO_0000218,,1,,10090.0,,50594,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,CHEMBL629521,
Intermediate,,A,14439,,,1,,,N,,11901,BAO_0000218,,1,,10090.0,,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),Mus musculus,CHEMBL629522,
Intermediate,,A,14439,,,1,,,N,,11902,BAO_0000218,,1,,10090.0,,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),Mus musculus,CHEMBL629523,
Intermediate,,A,14439,,,1,,,N,,11903,BAO_0000218,,1,,10090.0,,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),Mus musculus,CHEMBL629524,
Intermediate,,A,14439,,,1,,,N,,11904,BAO_0000218,,1,,10090.0,,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),Mus musculus,CHEMBL629525,
Intermediate,,A,14439,,,1,,,N,,11905,BAO_0000218,,1,,10090.0,,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),Mus musculus,CHEMBL629526,
Intermediate,,A,14439,,,1,,,N,,11906,BAO_0000218,,1,,10090.0,,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),Mus musculus,CHEMBL629527,
Intermediate,,A,14439,,,1,,,N,,11907,BAO_0000218,,1,,10090.0,,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),Mus musculus,CHEMBL629528,
Intermediate,,A,14439,,,1,,,N,,11908,BAO_0000218,,1,,10090.0,,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),Mus musculus,CHEMBL629529,
Intermediate,,A,14439,,,1,,,N,,11909,BAO_0000218,,1,,10090.0,,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),Mus musculus,CHEMBL629530,
Intermediate,,A,14439,,,1,,,N,,11910,BAO_0000218,,1,,10090.0,,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),Mus musculus,CHEMBL629531,
Intermediate,,A,14439,,,1,,,N,,11911,BAO_0000218,,1,,10090.0,,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),Mus musculus,CHEMBL628656,
Intermediate,,A,14439,,,1,,,N,,11912,BAO_0000218,,1,,10090.0,,50594,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),Mus musculus,CHEMBL628657,
Intermediate,,A,13751,In vivo,,1,,,N,,11913,BAO_0000218,,1,,10116.0,,50597,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL628658,
Intermediate,,A,13751,In vivo,,1,,,N,,11914,BAO_0000218,,1,,10116.0,,50597,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL628659,
Intermediate,,A,13751,In vivo,,1,,,N,,11915,BAO_0000218,,1,,10116.0,,50597,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL877500,
Intermediate,,A,13751,In vivo,,1,,,N,,11916,BAO_0000218,,1,,10116.0,,50597,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL628660,
Intermediate,,A,13751,In vivo,,1,,,N,,11917,BAO_0000218,,1,,10116.0,,50597,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL628661,
Intermediate,,A,13751,In vivo,,1,,,N,,11918,BAO_0000218,,1,,10116.0,,50597,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL628662,
Intermediate,,A,13751,In vivo,,1,,,N,,11919,BAO_0000218,,1,,10116.0,,50597,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL628663,
Intermediate,,A,13751,In vivo,,1,,,N,,11920,BAO_0000218,,1,,10116.0,,50597,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL628664,
Intermediate,,A,13751,In vivo,,1,,,N,,11921,BAO_0000218,,1,,10116.0,178.0,50597,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL628665,Blood
Intermediate,,A,13751,In vivo,,1,,,N,,11922,BAO_0000218,,1,,10116.0,178.0,50597,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL628666,Blood
Intermediate,,A,13751,In vivo,,1,,,N,,11923,BAO_0000218,,1,,10116.0,178.0,50597,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL628667,Blood
Intermediate,,A,13751,In vivo,,1,,,N,,11924,BAO_0000218,,1,,10116.0,178.0,50597,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL628668,Blood
Intermediate,,A,13751,In vivo,,1,,,N,,11925,BAO_0000218,,1,,10116.0,178.0,50597,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL628669,Blood
Intermediate,,A,13751,In vivo,,1,,,N,,11926,BAO_0000218,,1,,10116.0,178.0,50597,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL628670,Blood
Intermediate,,A,13751,In vivo,,1,,,N,,11927,BAO_0000218,,1,,10116.0,178.0,50597,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL628671,Blood
Intermediate,,A,13751,In vivo,,1,,,N,,11928,BAO_0000218,,1,,10116.0,10000001.0,50597,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL628672,Bone
Intermediate,,A,13751,In vivo,,1,,,N,,11929,BAO_0000218,,1,,10116.0,10000001.0,50597,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL630300,Bone
Intermediate,,A,13751,In vivo,,1,,,N,,11930,BAO_0000218,,1,,10116.0,10000001.0,50597,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL629787,Bone
Intermediate,,A,13751,In vivo,,1,,,N,,11931,BAO_0000218,,1,,10116.0,10000001.0,50597,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL629788,Bone
Intermediate,,A,13751,In vivo,,1,,,N,,11932,BAO_0000218,,1,,10116.0,955.0,50597,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL629789,Brain
Intermediate,,A,13751,In vivo,,1,,,N,,11933,BAO_0000218,,1,,10116.0,955.0,50597,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL629790,Brain
Intermediate,,A,13751,In vivo,,1,,,N,,11934,BAO_0000218,,1,,10116.0,955.0,50597,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL629791,Brain
Intermediate,,A,13751,In vivo,,1,,,N,,11935,BAO_0000218,,1,,10116.0,955.0,50597,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL629792,Brain
Intermediate,,A,13751,In vivo,,1,,,N,,11936,BAO_0000218,,1,,10116.0,955.0,50597,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL629793,Brain
Intermediate,,A,13751,In vivo,,1,,,N,,11937,BAO_0000218,,1,,10116.0,955.0,50597,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL629794,Brain
Intermediate,,A,10677,,,1,,,N,,11938,BAO_0000218,,1,,10116.0,,50597,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,Rattus norvegicus,CHEMBL874459,
Intermediate,,A,10677,,,1,,,N,,11939,BAO_0000218,,1,,10116.0,,50597,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,Rattus norvegicus,CHEMBL629795,
Intermediate,,A,10677,,,1,,,N,,11940,BAO_0000218,,1,,10116.0,,50597,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,Rattus norvegicus,CHEMBL629796,
Intermediate,,A,10677,,,1,,,N,,11941,BAO_0000218,,1,,10116.0,,50597,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,Rattus norvegicus,CHEMBL629797,
Intermediate,,A,10677,,,1,,,N,,11942,BAO_0000218,,1,,10116.0,,50597,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,Rattus norvegicus,CHEMBL629798,
Intermediate,,A,10911,In vivo,,1,,,N,,11943,BAO_0000218,,1,,10116.0,2369.0,50597,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL629799,Adrenal gland
Intermediate,,A,10911,In vivo,,1,,,N,,11944,BAO_0000218,,1,,10116.0,2369.0,50597,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL629800,Adrenal gland
Intermediate,,A,10911,In vivo,,1,,,N,,11945,BAO_0000218,,1,,10116.0,2369.0,50597,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL629801,Adrenal gland
Intermediate,,A,10911,In vivo,,1,,,N,,11946,BAO_0000218,,1,,10116.0,2369.0,50597,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,Rattus norvegicus,CHEMBL629802,Adrenal gland
Intermediate,,A,10911,In vivo,,1,,,N,,11947,BAO_0000218,,1,,10116.0,2369.0,50597,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL629803,Adrenal gland
Intermediate,,A,10911,In vivo,,1,,,N,,11948,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL629804,Blood
Intermediate,,A,10911,In vivo,,1,,,N,,11949,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL629805,Blood
Intermediate,,A,10911,In vivo,,1,,,N,,11950,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL629806,Blood
Intermediate,,A,10911,In vivo,,1,,,N,,11951,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL629807,Blood
Intermediate,,A,10911,In vivo,,1,,,N,,11952,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL629808,Blood
Intermediate,,A,10911,In vivo,,1,,,N,,11953,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL629809,Brain
Intermediate,,A,10911,In vivo,,1,,,N,,11954,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL629810,Brain
Intermediate,,A,10911,In vivo,,1,,,N,,11955,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL629811,Brain
Intermediate,,A,10911,In vivo,,1,,,N,,11956,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL629812,Brain
Intermediate,,A,10911,In vivo,,1,,,N,,11957,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL629813,Brain
Intermediate,,A,10911,In vivo,,1,,,N,,11958,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL874460,Brain
Intermediate,,A,10911,In vivo,,1,,,N,,11959,BAO_0000218,,1,,10116.0,,50597,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL629814,
Intermediate,,A,10911,In vivo,,1,,,N,,11960,BAO_0000218,,1,,10116.0,,50597,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL629815,
Intermediate,,A,10911,In vivo,,1,,,N,,11961,BAO_0000218,,1,,10116.0,,50597,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL629816,
Intermediate,,A,10911,In vivo,,1,,,N,,11962,BAO_0000218,,1,,10116.0,,50597,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL629817,
Intermediate,,A,10911,In vivo,,1,,,N,,11963,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL626643,Kidney
Intermediate,,A,10911,In vivo,,1,,,N,,11964,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL626644,Kidney
Intermediate,,A,10911,In vivo,,1,,,N,,11965,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL626806,Kidney
Intermediate,,A,10911,In vivo,,1,,,N,,11966,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL626807,Kidney
Intermediate,,A,10911,In vivo,,1,,,N,,11967,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627261,Liver
Intermediate,,A,10911,In vivo,,1,,,N,,11968,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627262,Liver
Intermediate,,A,10911,In vivo,,1,,,N,,11969,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627263,Liver
Intermediate,,A,10911,In vivo,,1,,,N,,11970,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627264,Liver
Intermediate,,A,10911,In vivo,,1,,,N,,11971,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627265,Lung
Intermediate,,A,10911,In vivo,,1,,,N,,11972,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627266,Lung
Intermediate,,A,10911,In vivo,,1,,,N,,11973,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627267,Lung
Intermediate,,A,10911,In vivo,,1,,,N,,11974,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627268,Lung
Intermediate,,A,10911,In vivo,,1,,,N,,11975,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627269,Muscle tissue
Intermediate,,A,10911,In vivo,,1,,,N,,11976,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627270,Muscle tissue
Intermediate,,A,8608,,,1,,,N,,11977,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",Rattus norvegicus,CHEMBL627271,
Intermediate,,A,8608,,,1,,,N,,11978,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",Rattus norvegicus,CHEMBL627946,
Intermediate,,A,8608,,,1,,,N,,11979,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",Rattus norvegicus,CHEMBL875472,
Intermediate,,A,8608,,,1,,,N,,11980,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",Rattus norvegicus,CHEMBL627947,
Intermediate,,A,8608,,,1,,,N,,11981,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",Rattus norvegicus,CHEMBL627948,
Intermediate,,A,8608,,,1,,,N,,11982,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",Rattus norvegicus,CHEMBL628113,
Intermediate,,A,8608,,,1,,,N,,11983,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",Rattus norvegicus,CHEMBL628114,
Intermediate,,A,8608,,,1,,,N,,11984,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",Rattus norvegicus,CHEMBL628115,
Intermediate,,A,8608,,,1,,,N,,11985,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",Rattus norvegicus,CHEMBL628116,
Intermediate,,A,8608,,,1,,,N,,11986,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",Rattus norvegicus,CHEMBL628117,
Intermediate,,A,8608,,,1,,,N,,11987,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",Rattus norvegicus,CHEMBL628118,
Intermediate,,A,8608,,,1,,,N,,11988,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",Rattus norvegicus,CHEMBL628119,
Intermediate,,A,8608,,,1,,,N,,11989,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",Rattus norvegicus,CHEMBL628120,
Intermediate,,A,8608,,,1,,,N,,11990,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",Rattus norvegicus,CHEMBL628121,
Intermediate,,A,8608,,,1,,,N,,11991,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",Rattus norvegicus,CHEMBL628122,
Intermediate,,A,8608,,,1,,,N,,11992,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",Rattus norvegicus,CHEMBL627297,
Intermediate,,A,8608,,,1,,,N,,11993,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",Rattus norvegicus,CHEMBL627298,
Intermediate,,A,8608,,,1,,,N,,11994,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",Rattus norvegicus,CHEMBL627299,
Intermediate,,A,8608,,,1,,,N,,11995,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",Rattus norvegicus,CHEMBL627300,
Intermediate,,A,8608,,,1,,,N,,11996,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",Rattus norvegicus,CHEMBL627301,
Intermediate,,A,8608,,,1,,,N,,11997,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",Rattus norvegicus,CHEMBL627302,
Intermediate,,A,8608,,,1,,,N,,11998,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",Rattus norvegicus,CHEMBL627303,
Intermediate,,A,8608,,,1,,,N,,11999,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",Rattus norvegicus,CHEMBL627304,
Intermediate,,A,8608,,,1,,,N,,12000,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",Rattus norvegicus,CHEMBL627305,
Intermediate,,A,8608,,,1,,,N,,12001,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",Rattus norvegicus,CHEMBL627306,
Intermediate,,A,8608,,,1,,,N,,12002,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",Rattus norvegicus,CHEMBL623982,
Intermediate,,A,8608,,,1,,,N,,12003,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",Rattus norvegicus,CHEMBL623983,
Intermediate,,A,8608,,,1,,,N,,12004,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",Rattus norvegicus,CHEMBL623984,
Intermediate,,A,8608,,,1,,,N,,12005,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",Rattus norvegicus,CHEMBL623985,
Intermediate,,A,8608,,,1,,,N,,12006,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",Rattus norvegicus,CHEMBL623986,
Intermediate,,A,8608,,,1,,,N,,12007,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",Rattus norvegicus,CHEMBL623987,
Intermediate,,A,8608,,,1,,,N,,12008,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",Rattus norvegicus,CHEMBL623988,
Intermediate,,A,8608,,,1,,,N,,12009,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",Rattus norvegicus,CHEMBL623989,
Intermediate,,A,8608,,,1,,,N,,12010,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",Rattus norvegicus,CHEMBL622215,
Intermediate,,A,8608,,,1,,,N,,12011,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",Rattus norvegicus,CHEMBL622216,
Intermediate,,A,8608,,,1,,,N,,12012,BAO_0000218,,1,,10116.0,,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",Rattus norvegicus,CHEMBL877481,
Autocuration,,A,16359,,,1,,,U,,12013,BAO_0000218,,0,,,,22224,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),,CHEMBL622217,
Intermediate,,A,13701,,,1,,,N,,12014,BAO_0000218,,1,,10090.0,,50594,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),Mus musculus,CHEMBL622218,
Intermediate,,A,14554,,,1,,,N,,12015,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic profile AUC was evaluated in rats,Rattus norvegicus,CHEMBL622219,
Autocuration,,A,6241,,,1,,,U,,12016,BAO_0000019,,0,,,,22224,Pharmacokinetic property (Area under curve),,CHEMBL622220,
Intermediate,,A,11537,,,1,,,N,,12017,BAO_0000218,,1,,9615.0,,50588,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",Canis lupus familiaris,CHEMBL622221,
Intermediate,,A,11537,,,1,,,N,,12018,BAO_0000218,,1,,10090.0,,50594,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",Mus musculus,CHEMBL622222,
Intermediate,,A,11537,,,1,,,N,,12019,BAO_0000218,,1,,9615.0,,50588,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",Canis lupus familiaris,CHEMBL622223,
Intermediate,,A,11537,,,1,,,N,,12020,BAO_0000218,,1,,10090.0,,50594,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",Mus musculus,CHEMBL622224,
Autocuration,,A,13118,,,1,,,U,,12021,BAO_0000019,,0,,,,22224,Plasma concentration (AUC) was determined,,CHEMBL622225,
Autocuration,,A,13118,,,1,,,U,,12022,BAO_0000019,,0,,,,22224,Plasma concentration (AUC) was determined; Not detectable,,CHEMBL622226,
Intermediate,,A,9562,,,1,,,N,,12023,BAO_0000218,,1,,10141.0,,50512,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),Cavia porcellus,CHEMBL624154,
Intermediate,,A,10363,,,1,,,N,,12024,BAO_0000218,,1,,10116.0,,50597,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,Rattus norvegicus,CHEMBL624155,
Intermediate,,A,10363,,,1,,,N,,12025,BAO_0000218,,1,,10116.0,,50597,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,Rattus norvegicus,CHEMBL624156,
Intermediate,,A,10363,,,1,,,N,,12026,BAO_0000218,,1,,10116.0,,50597,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,Rattus norvegicus,CHEMBL624157,
Intermediate,,A,10363,,,1,,,N,,12027,BAO_0000218,,1,,10116.0,,50597,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,Rattus norvegicus,CHEMBL624158,
Intermediate,,A,12504,,,1,,,N,,12028,BAO_0000218,,1,,10116.0,,50597,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,Rattus norvegicus,CHEMBL624159,
Intermediate,,A,12504,,,1,,,N,,12029,BAO_0000218,,1,,10116.0,,50597,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,Rattus norvegicus,CHEMBL624160,
Intermediate,,A,12504,,,1,,,N,,12030,BAO_0000218,,1,,10116.0,,50597,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,Rattus norvegicus,CHEMBL624161,
Intermediate,,A,12504,,,1,,,N,,12031,BAO_0000218,,1,,10116.0,,50597,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,Rattus norvegicus,CHEMBL624162,
Intermediate,,A,13317,,,1,,,N,,12032,BAO_0000218,,1,,9615.0,,50588,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,Canis lupus familiaris,CHEMBL624163,
Intermediate,,A,15078,,,1,,,N,,12033,BAO_0000218,,1,,10116.0,,50597,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,CHEMBL624164,
Intermediate,,A,14941,,,1,,,N,,12034,BAO_0000218,,1,,10116.0,,50597,The AUC(0-infinity) values in female wistar rats.,Rattus norvegicus,CHEMBL624165,
Intermediate,,A,15078,,,1,,,N,,12035,BAO_0000218,,1,,10116.0,,50597,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,CHEMBL624166,
Intermediate,,A,15078,,,1,,,N,,12036,BAO_0000218,,1,,10116.0,,50597,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",Rattus norvegicus,CHEMBL624167,
Intermediate,,A,14941,,,1,,,N,,12037,BAO_0000218,,1,,10116.0,,50597,The AUC(0-t)values in female wistar rats.,Rattus norvegicus,CHEMBL624168,
Intermediate,,A,14067,,,1,,,N,,12038,BAO_0000218,,1,,10116.0,,50597,The Area under the concentration time curve of compound was measured on rats,Rattus norvegicus,CHEMBL624169,
Intermediate,,A,14215,,,1,,,N,,12039,BAO_0000218,,1,,9606.0,,50587,The area under curve (100 mg/kg) administered orally in humans,Homo sapiens,CHEMBL624170,
Autocuration,,A,14215,,,1,,,U,,12040,BAO_0000218,,0,,9481.0,,22224,The area under curve (12.5 mg/kg) administered intravenously in marmoset,Callithrix,CHEMBL624171,
Autocuration,,A,14215,,,1,,,U,,12041,BAO_0000218,,0,,314293.0,,22224,The area under curve (12.5 mg/kg) administered intravenously in monkey,Simiiformes,CHEMBL624172,
Intermediate,,A,14215,,,1,,,N,,12042,BAO_0000218,,1,,9615.0,,50588,The area under curve (15 mg/kg) administered intravenously in dog,Canis lupus familiaris,CHEMBL624173,
Intermediate,,A,14215,,,1,,,N,,12043,BAO_0000218,,1,,9606.0,,50587,The area under curve (200 mg/kg) administered orally in humans,Homo sapiens,CHEMBL877488,
Intermediate,,A,14215,,,1,,,N,,12044,BAO_0000218,,1,,10116.0,,50597,The area under curve (25 mg/kg) administered intravenously in rat,Rattus norvegicus,CHEMBL624174,
Autocuration,,A,14215,,,1,,,U,,12045,BAO_0000218,,0,,9481.0,,22224,The area under curve (25 mg/kg) administered orally in marmoset,Callithrix,CHEMBL624175,
Autocuration,,A,14215,,,1,,,U,,12046,BAO_0000218,,0,,314293.0,,22224,The area under curve (25 mg/kg) administered orally in monkey,Simiiformes,CHEMBL624176,
Intermediate,,A,14215,,,1,,,N,,12047,BAO_0000218,,1,,9615.0,,50588,The area under curve (30 mg/kg) administered orally in dog,Canis lupus familiaris,CHEMBL624177,
Intermediate,,A,14215,,,1,,,N,,12048,BAO_0000218,,1,,9606.0,,50587,The area under curve (400 mg/kg) administered orally in humans,Homo sapiens,CHEMBL624178,
Intermediate,,A,14215,,,1,,,N,,12049,BAO_0000218,,1,,10116.0,,50597,The area under curve (50 mg/kg) administered orally in fasted rat,Rattus norvegicus,CHEMBL624179,
Intermediate,,A,14215,,,1,,,N,,12050,BAO_0000218,,1,,10116.0,,50597,The area under curve (50 mg/kg) administered orally in rat,Rattus norvegicus,CHEMBL627689,
Intermediate,,A,14215,,,1,,,N,,12051,BAO_0000218,,1,,9606.0,,50587,The area under curve (800 mg/kg) administered orally in humans,Homo sapiens,CHEMBL627690,
Autocuration,,A,11324,,,1,,,U,,12052,BAO_0000019,,0,,,,22224,The compound was evaluated for area under the curve,,CHEMBL627691,
Autocuration,,A,11324,,,1,,,U,,12053,BAO_0000019,,0,,9481.0,,22224,The compound was evaluated for area under the curve in marmosets,Callithrix,CHEMBL627692,
Autocuration,,A,11324,,,1,,,U,,12054,BAO_0000019,,0,,9481.0,,22224,The compound was evaluated for area under the curve in marmosets,Callithrix,CHEMBL627693,
Intermediate,,A,13875,,,1,,,N,,12055,BAO_0000218,,1,,10116.0,,50597,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,Rattus norvegicus,CHEMBL627694,
Intermediate,,A,13875,,,1,,,N,,12056,BAO_0000218,,1,,10116.0,,50597,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,Rattus norvegicus,CHEMBL627695,
Autocuration,,A,13875,,,1,,,U,,12057,BAO_0000218,,0,,,,22224,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),,CHEMBL627696,
Intermediate,,A,13875,,,1,,,N,,12058,BAO_0000218,,1,,10116.0,,50597,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,Rattus norvegicus,CHEMBL627697,
Intermediate,,A,13875,,,1,,,N,,12059,BAO_0000218,,1,,10116.0,,50597,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,Rattus norvegicus,CHEMBL627698,
Intermediate,,A,13875,,,1,,,N,,12060,BAO_0000218,,1,,10116.0,,50597,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,Rattus norvegicus,CHEMBL627699,
Intermediate,,A,13807,,,1,,,N,,12061,BAO_0000218,,1,,10116.0,,50597,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,Rattus norvegicus,CHEMBL627700,
Intermediate,,A,14127,,,1,,,N,,12062,BAO_0000218,,1,,10116.0,,50597,Total drug exposure is determined after oral dosing in rats.,Rattus norvegicus,CHEMBL627701,
Autocuration,,A,15116,,,1,,,U,,12063,BAO_0000218,,0,,,,22224,Total drug exposure (5 mg/kg) when administered intravenously,,CHEMBL627702,
Autocuration,,A,15116,,,1,,,U,,12064,BAO_0000218,,0,,,,22224,Total drug exposure (5 mg/kg) when administered orally,,CHEMBL627703,
Autocuration,,A,15604,,,1,,,U,,12065,BAO_0000218,,0,,314293.0,,22224,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,Simiiformes,CHEMBL626873,
Intermediate,,A,15604,,,1,,,N,,12066,BAO_0000218,,1,,10116.0,,50597,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,Rattus norvegicus,CHEMBL629583,
Intermediate,,A,15604,,,1,,,N,,12067,BAO_0000218,,1,,9615.0,,50588,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,Canis lupus familiaris,CHEMBL629584,
Intermediate,,A,15604,,,1,,,N,,12068,BAO_0000218,,1,,9615.0,,50588,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,Canis lupus familiaris,CHEMBL629585,
Intermediate,,A,13751,In vivo,,1,,,N,,12069,BAO_0000218,,1,,10116.0,955.0,50597,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL629586,Brain
Intermediate,,A,13751,In vivo,,1,,,N,,12070,BAO_0000218,,1,,10116.0,955.0,50597,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL629587,Brain
Intermediate,,A,13751,In vivo,,1,,,N,,12071,BAO_0000218,,1,,10116.0,,50597,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL629588,
Intermediate,,A,13751,In vivo,,1,,,N,,12072,BAO_0000218,,1,,10116.0,,50597,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL629589,
Intermediate,,A,13751,In vivo,,1,,,N,,12073,BAO_0000218,,1,,10116.0,,50597,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL629590,
Intermediate,,A,13751,In vivo,,1,,,N,,12074,BAO_0000218,,1,,10116.0,,50597,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL629591,
Intermediate,,A,13751,In vivo,,1,,,N,,12075,BAO_0000218,,1,,10116.0,,50597,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL629592,
Intermediate,,A,13751,In vivo,,1,,,N,,12076,BAO_0000218,,1,,10116.0,,50597,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL629593,
Intermediate,,A,13751,In vivo,,1,,,N,,12077,BAO_0000218,,1,,10116.0,,50597,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL629594,
Intermediate,,A,13751,In vivo,,1,,,N,,12078,BAO_0000218,,1,,10116.0,948.0,50597,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL629595,Heart
Intermediate,,A,13751,In vivo,,1,,,N,,12079,BAO_0000218,,1,,10116.0,948.0,50597,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL630290,Heart
Intermediate,,A,13751,In vivo,,1,,,N,,12080,BAO_0000218,,1,,10116.0,948.0,50597,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL627137,Heart
Intermediate,,A,13751,In vivo,,1,,,N,,12081,BAO_0000218,,1,,10116.0,948.0,50597,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL627138,Heart
Intermediate,,A,13751,In vivo,,1,,,N,,12082,BAO_0000218,,1,,10116.0,948.0,50597,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL627139,Heart
Intermediate,,A,13751,In vivo,,1,,,N,,12083,BAO_0000218,,1,,10116.0,948.0,50597,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL627140,Heart
Intermediate,,A,13751,In vivo,,1,,,N,,12084,BAO_0000218,,1,,10116.0,948.0,50597,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL627141,Heart
Intermediate,,A,13751,In vivo,,1,,,N,,12085,BAO_0000218,,1,,10116.0,2113.0,50597,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL627142,Kidney
Intermediate,,A,13751,In vivo,,1,,,N,,12086,BAO_0000218,,1,,10116.0,2113.0,50597,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL627143,Kidney
Intermediate,,A,13751,In vivo,,1,,,N,,12087,BAO_0000218,,1,,10116.0,2113.0,50597,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL874449,Kidney
Intermediate,,A,13751,In vivo,,1,,,N,,12088,BAO_0000218,,1,,10116.0,2113.0,50597,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL627144,Kidney
Intermediate,,A,13751,In vivo,,1,,,N,,12089,BAO_0000218,,1,,10116.0,2113.0,50597,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL627145,Kidney
Intermediate,,A,13751,In vivo,,1,,,N,,12090,BAO_0000218,,1,,10116.0,2113.0,50597,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL627146,Kidney
Intermediate,,A,13751,In vivo,,1,,,N,,12091,BAO_0000218,,1,,10116.0,2113.0,50597,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL627147,Kidney
Intermediate,,A,13751,In vivo,,1,,,N,,12092,BAO_0000218,,1,,10116.0,2107.0,50597,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL627148,Liver
Intermediate,,A,13751,In vivo,,1,,,N,,12093,BAO_0000218,,1,,10116.0,2048.0,50597,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL627149,Lung
Intermediate,,A,13751,In vivo,,1,,,N,,12094,BAO_0000218,,1,,10116.0,2048.0,50597,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL632160,Lung
Intermediate,,A,13751,In vivo,,1,,,N,,12095,BAO_0000218,,1,,10116.0,2048.0,50597,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL632161,Lung
Intermediate,,A,13751,In vivo,,1,,,N,,12096,BAO_0000218,,1,,10116.0,2048.0,50597,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL632162,Lung
Intermediate,,A,13751,In vivo,,1,,,N,,12097,BAO_0000218,,1,,10116.0,2048.0,50597,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL632163,Lung
Intermediate,,A,13751,In vivo,,1,,,N,,12098,BAO_0000218,,1,,10116.0,2048.0,50597,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL874469,Lung
Intermediate,,A,13751,In vivo,,1,,,N,,12099,BAO_0000218,,1,,10116.0,2048.0,50597,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL627182,Lung
Intermediate,,A,13751,In vivo,,1,,,N,,12100,BAO_0000218,,1,,10116.0,2385.0,50597,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL627183,Muscle tissue
Intermediate,,A,13751,In vivo,,1,,,N,,12101,BAO_0000218,,1,,10116.0,2385.0,50597,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL627184,Muscle tissue
Intermediate,,A,13751,In vivo,,1,,,N,,12102,BAO_0000218,,1,,10116.0,2385.0,50597,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL627185,Muscle tissue
Intermediate,,A,13751,In vivo,,1,,,N,,12103,BAO_0000218,,1,,10116.0,2385.0,50597,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL627186,Muscle tissue
Intermediate,,A,13751,In vivo,,1,,,N,,12104,BAO_0000218,,1,,10116.0,2385.0,50597,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL627187,Muscle tissue
Intermediate,,A,13751,In vivo,,1,,,N,,12105,BAO_0000218,,1,,10116.0,2385.0,50597,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL627188,Muscle tissue
Intermediate,,A,13751,In vivo,,1,,,N,,12106,BAO_0000218,,1,,10116.0,2385.0,50597,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL627189,Muscle tissue
Intermediate,,A,13751,In vivo,,1,,,N,,12107,BAO_0000218,,1,,10116.0,,50597,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL627190,
Intermediate,,A,13751,In vivo,,1,,,N,,12108,BAO_0000218,,1,,10116.0,2107.0,50597,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL627191,Liver
Intermediate,,A,13751,In vivo,,1,,,N,,12109,BAO_0000218,,1,,10116.0,2107.0,50597,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL627192,Liver
Intermediate,,A,13751,In vivo,,1,,,N,,12110,BAO_0000218,,1,,10116.0,2107.0,50597,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL627193,Liver
Intermediate,,A,10911,In vivo,,1,,,N,,12111,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL874590,Muscle tissue
Intermediate,,A,10911,In vivo,,1,,,N,,12112,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627194,Muscle tissue
Intermediate,,A,10911,In vivo,,1,,,N,,12113,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627195,Muscle tissue
Intermediate,,A,10911,In vivo,,1,,,N,,12114,BAO_0000218,,1,,10116.0,992.0,50597,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627196,Female gonad
Intermediate,,A,10911,In vivo,,1,,,N,,12115,BAO_0000218,,1,,10116.0,992.0,50597,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627197,Female gonad
Intermediate,,A,10911,In vivo,,1,,,N,,12116,BAO_0000218,,1,,10116.0,992.0,50597,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627198,Female gonad
Intermediate,,A,10911,In vivo,,1,,,N,,12117,BAO_0000218,,1,,10116.0,992.0,50597,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,Rattus norvegicus,CHEMBL627199,Female gonad
Intermediate,,A,10911,In vivo,,1,,,N,,12118,BAO_0000218,,1,,10116.0,992.0,50597,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627200,Female gonad
Intermediate,,A,10911,In vivo,,1,,,N,,12119,BAO_0000218,,1,,10116.0,1969.0,50597,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627201,Plasma
Intermediate,,A,10911,In vivo,,1,,,N,,12120,BAO_0000218,,1,,10116.0,1969.0,50597,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627202,Plasma
Intermediate,,A,10911,In vivo,,1,,,N,,12121,BAO_0000218,,1,,10116.0,1969.0,50597,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627203,Plasma
Intermediate,,A,10911,In vivo,,1,,,N,,12122,BAO_0000218,,1,,10116.0,1969.0,50597,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627204,Plasma
Intermediate,,A,10911,In vivo,,1,,,N,,12123,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627205,Spleen
Intermediate,,A,10911,In vivo,,1,,,N,,12124,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627206,Spleen
Intermediate,,A,10911,In vivo,,1,,,N,,12125,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627207,Spleen
Intermediate,,A,10911,In vivo,,1,,,N,,12126,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627208,Spleen
Intermediate,,A,10911,In vivo,,1,,,N,,12127,BAO_0000218,,1,,10116.0,2046.0,50597,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627209,Thyroid gland
Intermediate,,A,10911,In vivo,,1,,,N,,12128,BAO_0000218,,1,,10116.0,2046.0,50597,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627210,Thyroid gland
Intermediate,,A,10911,In vivo,,1,,,N,,12129,BAO_0000218,,1,,10116.0,2046.0,50597,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627211,Thyroid gland
Intermediate,,A,10911,In vivo,,1,,,N,,12130,BAO_0000218,,1,,10116.0,2046.0,50597,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627212,Thyroid gland
Intermediate,,A,10911,In vivo,,1,,,N,,12131,BAO_0000218,,1,,10116.0,995.0,50597,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL627213,Uterus
Intermediate,,A,10911,In vivo,,1,,,N,,12132,BAO_0000218,,1,,10116.0,995.0,50597,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL626599,Uterus
Intermediate,,A,10911,In vivo,,1,,,N,,12133,BAO_0000218,,1,,10116.0,995.0,50597,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL626600,Uterus
Intermediate,,A,10911,In vivo,,1,,,N,,12134,BAO_0000218,,1,,10116.0,995.0,50597,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,CHEMBL626601,Uterus
Autocuration,,A,8081,,,1,,,U,,12135,BAO_0000019,,0,,,,22224,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,,CHEMBL627484,
Intermediate,,A,17248,,,1,,,N,,12136,BAO_0000218,,1,,9541.0,1969.0,100710,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),Macaca fascicularis,CHEMBL627485,Plasma
Intermediate,,A,17248,,,1,,,N,,12137,BAO_0000218,,1,,9541.0,1969.0,100710,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,Macaca fascicularis,CHEMBL628147,Plasma
Intermediate,,A,17248,,,1,,,N,,12138,BAO_0000218,,1,,9541.0,1969.0,100710,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,Macaca fascicularis,CHEMBL628148,Plasma
Intermediate,,A,17248,,,1,,,N,,12139,BAO_0000218,,1,,9615.0,1969.0,50588,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),Canis lupus familiaris,CHEMBL628149,Plasma
Intermediate,,A,17248,,,1,,,N,,12140,BAO_0000218,,1,,9615.0,1969.0,50588,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,Canis lupus familiaris,CHEMBL628150,Plasma
Intermediate,,A,17248,,,1,,,N,,12141,BAO_0000218,,1,,9615.0,1969.0,50588,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,Canis lupus familiaris,CHEMBL628318,Plasma
Intermediate,,A,17248,,,1,,,N,,12142,BAO_0000218,,1,,9615.0,1969.0,50588,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,Canis lupus familiaris,CHEMBL628319,Plasma
Intermediate,,A,15592,,,1,,,N,,12143,BAO_0000218,,1,,9615.0,,50588,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",Canis lupus familiaris,CHEMBL875609,
Autocuration,,A,7040,,,1,,,U,,12144,BAO_0000019,,0,,,,22224,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,,CHEMBL628320,
Autocuration,,A,7040,,,1,,,U,,12145,BAO_0000019,,0,,,,22224,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,,CHEMBL628321,
Autocuration,,A,7040,,,1,,,U,,12146,BAO_0000019,,0,,,,22224,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,,CHEMBL628322,
Autocuration,,A,7040,,,1,,,U,,12147,BAO_0000019,,0,,,,22224,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,,CHEMBL628323,
Autocuration,,A,7040,,,1,,,U,,12148,BAO_0000019,,0,,,,22224,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,,CHEMBL628324,
Autocuration,,A,7040,,,1,,,U,,12149,BAO_0000019,,0,,,,22224,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,,CHEMBL628325,
Autocuration,,A,7040,,,1,,,U,,12150,BAO_0000019,,0,,,,22224,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,,CHEMBL628326,
Intermediate,,A,9614,,,1,,,N,,12151,BAO_0000218,,1,,9615.0,1236.0,50588,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",Canis lupus familiaris,CHEMBL628327,Adrenal medulla
Intermediate,,A,9614,,,1,,,N,,12152,BAO_0000218,,1,,9615.0,1236.0,50588,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",Canis lupus familiaris,CHEMBL628328,Adrenal medulla
Intermediate,,A,9614,,,1,,,N,,12153,BAO_0000218,,1,,9615.0,178.0,50588,"Concentration of compound in blood of dog 1, after administering intravenously",Canis lupus familiaris,CHEMBL628329,Blood
Intermediate,,A,8608,,,1,,,N,,12154,BAO_0000218,,1,,10116.0,2107.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",Rattus norvegicus,CHEMBL628330,Liver
Intermediate,,A,8608,,,1,,,N,,12155,BAO_0000218,,1,,10116.0,2107.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",Rattus norvegicus,CHEMBL628331,Liver
Intermediate,,A,8608,,,1,,,N,,12156,BAO_0000218,,1,,10116.0,2107.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",Rattus norvegicus,CHEMBL628332,Liver
Intermediate,,A,8608,,,1,,,N,,12157,BAO_0000218,,1,,10116.0,2107.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",Rattus norvegicus,CHEMBL628333,Liver
Intermediate,,A,8608,,,1,,,N,,12158,BAO_0000218,,1,,10116.0,2107.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",Rattus norvegicus,CHEMBL628334,Liver
Intermediate,,A,8608,,,1,,,N,,12159,BAO_0000218,,1,,10116.0,2107.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",Rattus norvegicus,CHEMBL628335,Liver
Intermediate,,A,8608,,,1,,,N,,12160,BAO_0000218,,1,,10116.0,2107.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",Rattus norvegicus,CHEMBL628336,Liver
Intermediate,,A,8608,,,1,,,N,,12161,BAO_0000218,,1,,10116.0,2107.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",Rattus norvegicus,CHEMBL628337,Liver
Intermediate,,A,8608,,,1,,,N,,12162,BAO_0000218,,1,,10116.0,2107.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",Rattus norvegicus,CHEMBL628338,Liver
Intermediate,,A,8608,,,1,,,N,,12163,BAO_0000218,,1,,10116.0,2107.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",Rattus norvegicus,CHEMBL875610,Liver
Intermediate,,A,8608,,,1,,,N,,12164,BAO_0000218,,1,,10116.0,2107.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",Rattus norvegicus,CHEMBL628339,Liver
Intermediate,,A,8608,,,1,,,N,,12165,BAO_0000218,,1,,10116.0,2107.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",Rattus norvegicus,CHEMBL628340,Liver
Intermediate,,A,8608,,,1,,,N,,12166,BAO_0000218,,1,,10116.0,2107.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",Rattus norvegicus,CHEMBL628341,Liver
Intermediate,,A,8608,,,1,,,N,,12167,BAO_0000218,,1,,10116.0,2107.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",Rattus norvegicus,CHEMBL622214,Liver
Intermediate,,A,8608,,,1,,,N,,12168,BAO_0000218,,1,,10116.0,2107.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",Rattus norvegicus,CHEMBL623167,Liver
Intermediate,,A,8608,,,1,,,N,,12169,BAO_0000218,,1,,10116.0,2107.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",Rattus norvegicus,CHEMBL623168,Liver
Intermediate,,A,8608,,,1,,,N,,12170,BAO_0000218,,1,,10116.0,2107.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",Rattus norvegicus,CHEMBL623169,Liver
Intermediate,,A,8608,,,1,,,N,,12171,BAO_0000218,,1,,10116.0,2107.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",Rattus norvegicus,CHEMBL623170,Liver
Intermediate,,A,8608,,,1,,,N,,12172,BAO_0000218,,1,,10116.0,2048.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",Rattus norvegicus,CHEMBL627224,Lung
Intermediate,,A,8608,,,1,,,N,,12173,BAO_0000218,,1,,10116.0,2048.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",Rattus norvegicus,CHEMBL875634,Lung
Intermediate,,A,8608,,,1,,,N,,12174,BAO_0000218,,1,,10116.0,2048.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",Rattus norvegicus,CHEMBL627225,Lung
Intermediate,,A,8608,,,1,,,N,,12175,BAO_0000218,,1,,10116.0,2048.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",Rattus norvegicus,CHEMBL627226,Lung
Intermediate,,A,8608,,,1,,,N,,12176,BAO_0000218,,1,,10116.0,2048.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",Rattus norvegicus,CHEMBL626083,Lung
Intermediate,,A,8608,,,1,,,N,,12177,BAO_0000218,,1,,10116.0,2048.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",Rattus norvegicus,CHEMBL626084,Lung
Intermediate,,A,8608,,,1,,,N,,12178,BAO_0000218,,1,,10116.0,2048.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",Rattus norvegicus,CHEMBL626085,Lung
Intermediate,,A,8608,,,1,,,N,,12179,BAO_0000218,,1,,10116.0,2048.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",Rattus norvegicus,CHEMBL626086,Lung
Intermediate,,A,8608,,,1,,,N,,12180,BAO_0000218,,1,,10116.0,2048.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",Rattus norvegicus,CHEMBL626087,Lung
Intermediate,,A,8608,,,1,,,N,,12181,BAO_0000218,,1,,10116.0,2048.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",Rattus norvegicus,CHEMBL626088,Lung
Intermediate,,A,8608,,,1,,,N,,12182,BAO_0000218,,1,,10116.0,2048.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",Rattus norvegicus,CHEMBL626089,Lung
Intermediate,,A,8608,,,1,,,N,,12183,BAO_0000218,,1,,10116.0,2048.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",Rattus norvegicus,CHEMBL626090,Lung
Intermediate,,A,8608,,,1,,,N,,12184,BAO_0000218,,1,,10116.0,2048.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",Rattus norvegicus,CHEMBL626091,Lung
Intermediate,,A,8608,,,1,,,N,,12185,BAO_0000218,,1,,10116.0,2048.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",Rattus norvegicus,CHEMBL626092,Lung
Intermediate,,A,8608,,,1,,,N,,12186,BAO_0000218,,1,,10116.0,2048.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",Rattus norvegicus,CHEMBL626093,Lung
Intermediate,,A,8608,,,1,,,N,,12187,BAO_0000218,,1,,10116.0,2048.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",Rattus norvegicus,CHEMBL626094,Lung
Intermediate,,A,8608,,,1,,,N,,12188,BAO_0000218,,1,,10116.0,2048.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",Rattus norvegicus,CHEMBL626095,Lung
Intermediate,,A,8608,,,1,,,N,,12189,BAO_0000218,,1,,10116.0,2048.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",Rattus norvegicus,CHEMBL626096,Lung
Autocuration,,A,15604,,,1,,,U,,12190,BAO_0000218,,0,,314293.0,,22224,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,Simiiformes,CHEMBL626097,
Intermediate,,A,15604,,,1,,,N,,12191,BAO_0000218,,1,,10116.0,,50597,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,Rattus norvegicus,CHEMBL626098,
Autocuration,,A,1806,,,1,,,U,,12192,BAO_0000218,,0,,,1969.0,22224,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,,CHEMBL626099,Plasma
Autocuration,,A,1806,,,1,,,U,,12193,BAO_0000218,,0,,,1969.0,22224,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,,CHEMBL626100,Plasma
Intermediate,,A,17237,,,1,,,N,,12194,BAO_0000218,,1,,9615.0,1969.0,50588,AUC 0-inf in dog,Canis lupus familiaris,CHEMBL626101,Plasma
Intermediate,,A,17237,,,1,,,N,,12195,BAO_0000218,,1,,10141.0,1969.0,50512,AUC 0-inf in guinea pig,Cavia porcellus,CHEMBL626102,Plasma
Intermediate,,A,17237,,,1,,,N,,12196,BAO_0000218,,1,,9615.0,1969.0,50588,AUC 0-t in dog,Canis lupus familiaris,CHEMBL626103,Plasma
Intermediate,,A,17237,,,1,,,N,,12197,BAO_0000218,,1,,10141.0,1969.0,50512,AUC 0-t in guinea pig,Cavia porcellus,CHEMBL628391,Plasma
Intermediate,,A,15194,,,1,,,N,,12198,BAO_0000218,,1,,10116.0,,50597,The compound was tested for brain to plasma partition in rat,Rattus norvegicus,CHEMBL628392,
Intermediate,,A,15194,,,1,,,N,,12199,BAO_0000218,,1,,10116.0,,50597,The compound was tested for brain to plasma partition in rat.,Rattus norvegicus,CHEMBL628393,
Autocuration,,A,8787,,,1,,,U,,12200,BAO_0000019,,0,,,178.0,22224,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,,CHEMBL628394,Blood
Intermediate,,A,17025,,,1,,,N,,12201,BAO_0000218,,1,,9615.0,,50588,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,Canis lupus familiaris,CHEMBL628395,
Autocuration,,A,17025,,,1,,,U,,12202,BAO_0000218,,0,,314293.0,,22224,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,Simiiformes,CHEMBL628396,
Intermediate,,A,17025,,,1,,,N,,12203,BAO_0000218,,1,,9986.0,,50592,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,Oryctolagus cuniculus,CHEMBL628397,
Intermediate,,A,17025,,,1,,,N,,12204,BAO_0000218,,1,,10116.0,,50597,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,Rattus norvegicus,CHEMBL628398,
Intermediate,,A,4236,,,1,,,N,,12205,BAO_0000218,,1,,9544.0,,50797,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,Macaca mulatta,CHEMBL628399,
Intermediate,,A,15343,,,1,,,N,,12206,BAO_0000218,,1,,9615.0,,50588,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,Canis lupus familiaris,CHEMBL628400,
Intermediate,,A,15343,,,1,,,N,,12207,BAO_0000218,,1,,10116.0,,50597,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,Rattus norvegicus,CHEMBL874907,
Autocuration,,A,17720,,,1,,,U,,12208,BAO_0000019,,0,,,,22224,Area under curve of the compound was determined,,CHEMBL628401,
Autocuration,,A,17788,,,1,,,U,,12209,BAO_0000218,,0,,314293.0,1969.0,22224,AUC in monkeys at a dose of 1 mg/kg,Simiiformes,CHEMBL628402,Plasma
Intermediate,,A,17788,,,1,,,N,,12210,BAO_0000218,,1,,10116.0,1969.0,50597,AUC in rats at a dose of 1 mg/kg,Rattus norvegicus,CHEMBL628403,Plasma
Autocuration,,A,8778,,,1,,,U,,12211,BAO_0000019,,0,,,,22224,Compound was evaluated for the overall absorbance loss at pH of 2,,CHEMBL628404,
Autocuration,,A,8778,,,1,,,U,,12212,BAO_0000019,,0,,,,22224,Compound was evaluated for the overall absorbance loss at pH of 4,,CHEMBL628405,
Autocuration,,A,8778,,,1,,,U,,12213,BAO_0000019,,0,,,,22224,Compound was evaluated for the overall absorbance loss at pH of 7,,CHEMBL628406,
Intermediate,,A,2249,,,1,,,N,,12214,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for its absorption in the rats,Rattus norvegicus,CHEMBL628407,
Intermediate,,A,8881,,,1,,,N,,12215,BAO_0000218,,1,,10116.0,1088.0,50597,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,Rattus norvegicus,CHEMBL628408,Urine
Intermediate,,A,8881,,,1,,,N,,12216,BAO_0000218,,1,,10116.0,1088.0,50597,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,Rattus norvegicus,CHEMBL629171,Urine
Intermediate,,A,8881,,,1,,,N,,12217,BAO_0000218,,1,,10116.0,1088.0,50597,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,Rattus norvegicus,CHEMBL629172,Urine
Intermediate,,A,8881,,,1,,,N,,12218,BAO_0000218,,1,,10116.0,1088.0,50597,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,Rattus norvegicus,CHEMBL629173,Urine
Intermediate,,A,15286,,,1,,,N,,12219,BAO_0000218,,1,,10116.0,,50597,In vitro percent permeability into rat ileum,Rattus norvegicus,CHEMBL629174,
Intermediate,,A,15286,,,1,,,N,,12220,BAO_0000218,,1,,10116.0,,50597,In vitro percent permeability into rat ileum; Range is 10-17,Rattus norvegicus,CHEMBL629175,
Intermediate,,A,15286,,,1,,,N,,12221,BAO_0000218,,1,,10116.0,,50597,In vitro percent permeability into rat ileum; Range is 10-18,Rattus norvegicus,CHEMBL629176,
Intermediate,,A,15286,,,1,,,N,,12222,BAO_0000218,,1,,10116.0,,50597,In vitro percent permeability into rat ileum; Range is 10-19,Rattus norvegicus,CHEMBL629177,
Intermediate,,A,15286,,,1,,,N,,12223,BAO_0000218,,1,,10116.0,,50597,In vitro percent permeability into rat ileum; Range is 12-15,Rattus norvegicus,CHEMBL629178,
Intermediate,,A,15286,,,1,,,N,,12224,BAO_0000218,,1,,10116.0,,50597,In vitro percent permeability into rat ileum; Range is 13-19,Rattus norvegicus,CHEMBL631869,
Intermediate,,A,15286,,,1,,,N,,12225,BAO_0000218,,1,,10116.0,,50597,In vitro percent permeability into rat ileum; Range is 14-17,Rattus norvegicus,CHEMBL631870,
Intermediate,,A,15286,,,1,,,N,,12226,BAO_0000218,,1,,10116.0,,50597,In vitro percent permeability into rat ileum; Range is 15-18,Rattus norvegicus,CHEMBL631871,
Intermediate,,A,15286,,,1,,,N,,12227,BAO_0000218,,1,,10116.0,,50597,In vitro percent permeability into rat ileum; Range is 2-5,Rattus norvegicus,CHEMBL631872,
Autocuration,,A,15286,,,1,,,U,,12228,BAO_0000221,,0,,,2116.0,22224,In vitro percent permeability into rat ileum; Range is 23-42,,CHEMBL875775,Ileum
Intermediate,,A,15286,,,1,,,N,,12229,BAO_0000218,,1,,10116.0,,50597,In vitro percent permeability into rat ileum; Range is 28-36,Rattus norvegicus,CHEMBL631873,
Intermediate,,A,15286,,,1,,,N,,12230,BAO_0000218,,1,,10116.0,,50597,In vitro percent permeability into rat ileum; Range is 29-35,Rattus norvegicus,CHEMBL631874,
Intermediate,,A,15286,,,1,,,N,,12231,BAO_0000218,,1,,10116.0,,50597,In vitro percent permeability into rat ileum; Range is 46-66,Rattus norvegicus,CHEMBL631875,
Intermediate,,A,15286,,,1,,,N,,12232,BAO_0000218,,1,,10116.0,,50597,In vitro percent permeability into rat ileum; Range is 50-68,Rattus norvegicus,CHEMBL631876,
Intermediate,,A,15286,,,1,,,N,,12233,BAO_0000218,,1,,10116.0,,50597,In vitro percent permeability into rat ileum; Range is 78-81,Rattus norvegicus,CHEMBL631877,
Intermediate,,A,15286,,,1,,,N,,12234,BAO_0000218,,1,,10116.0,,50597,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,Rattus norvegicus,CHEMBL631878,
Intermediate,,A,15286,,,1,,,N,,12235,BAO_0000218,,1,,10116.0,,50597,In vitro percent permeability into rat ileum; nd indicates not detected,Rattus norvegicus,CHEMBL631879,
Intermediate,,A,15286,,,1,,,N,,12236,BAO_0000218,,1,,10116.0,,50597,In vitro percent permeability into rat ileum; nt indicates not detected,Rattus norvegicus,CHEMBL631880,
Intermediate,,A,15286,,,1,,,N,,12237,BAO_0000218,,1,,10116.0,,50597,In vitro percent permeability into rat ileum; nt indicates not tested,Rattus norvegicus,CHEMBL631881,
Intermediate,,A,13770,,,1,,,N,,12238,BAO_0000218,,1,,10116.0,,50597,Compound was tested for oral absorption in bile-duct cannulated rats,Rattus norvegicus,CHEMBL631882,
Intermediate,,A,13770,,,1,,,N,,12239,BAO_0000218,,1,,10116.0,,50597,Compound was tested for oral absorption in bile-duct cannulated rats.,Rattus norvegicus,CHEMBL630749,
Intermediate,,A,5202,,,1,,,N,,12240,BAO_0000218,,1,,9606.0,,50587,Oral absorption using Caco-2 cell monolayers.,Homo sapiens,CHEMBL630750,
Intermediate,,A,14920,,,1,,,N,,12241,BAO_0000218,,1,,9606.0,,50587,Percent of the drug absorbed after administration to humans was determined,Homo sapiens,CHEMBL630253,
Intermediate,,A,14103,,,1,,,N,,12242,BAO_0000218,,1,,10116.0,1969.0,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,Rattus norvegicus,CHEMBL630254,Plasma
Intermediate,,A,14103,,,1,,,N,,12243,BAO_0000218,,1,,10116.0,1969.0,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,Rattus norvegicus,CHEMBL630255,Plasma
Intermediate,,A,14103,,,1,,,N,,12244,BAO_0000218,,1,,10116.0,1969.0,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,Rattus norvegicus,CHEMBL630256,Plasma
Intermediate,,A,13751,In vivo,,1,,,N,,12245,BAO_0000218,,1,,10116.0,2107.0,50597,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL875781,Liver
Intermediate,,A,13751,In vivo,,1,,,N,,12246,BAO_0000218,,1,,10116.0,2107.0,50597,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL630257,Liver
Intermediate,,A,13751,In vivo,,1,,,N,,12247,BAO_0000218,,1,,10116.0,2107.0,50597,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,CHEMBL630258,Liver
Intermediate,,A,15807,,,1,,,N,,12248,BAO_0000218,,1,,10116.0,,50597,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",Rattus norvegicus,CHEMBL630259,
Intermediate,,A,15807,,,1,,,N,,12249,BAO_0000218,,1,,10116.0,2435.0,50597,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",Rattus norvegicus,CHEMBL630260,Striatum
Intermediate,,A,15807,,,1,,,N,,12250,BAO_0000218,,1,,10116.0,2435.0,50597,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",Rattus norvegicus,CHEMBL630261,Striatum
Intermediate,,A,14950,,,1,,,N,,12251,BAO_0000218,,1,,10116.0,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,Rattus norvegicus,CHEMBL630262,
Intermediate,,A,14950,,,1,,,N,,12252,BAO_0000218,,1,,10116.0,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,Rattus norvegicus,CHEMBL630263,
Intermediate,,A,14950,,,1,,,N,,12253,BAO_0000218,,1,,10116.0,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,Rattus norvegicus,CHEMBL630264,
Intermediate,,A,14950,,,1,,,N,,12254,BAO_0000218,,1,,10116.0,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,Rattus norvegicus,CHEMBL630265,
Intermediate,,A,14950,,,1,,,N,,12255,BAO_0000218,,1,,10116.0,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,Rattus norvegicus,CHEMBL630266,
Intermediate,,A,14950,,,1,,,N,,12256,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,Rattus norvegicus,CHEMBL630267,Kidney
Intermediate,,A,14950,,,1,,,N,,12257,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,Rattus norvegicus,CHEMBL630268,Kidney
Intermediate,,A,14950,,,1,,,N,,12258,BAO_0000218,,1,,10116.0,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,Rattus norvegicus,CHEMBL630269,
Intermediate,,A,14950,,,1,,,N,,12259,BAO_0000218,,1,,10116.0,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,Rattus norvegicus,CHEMBL630270,
Intermediate,,A,14950,,,1,,,N,,12260,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,Rattus norvegicus,CHEMBL630141,Lung
Intermediate,,A,14950,,,1,,,N,,12261,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,Rattus norvegicus,CHEMBL630142,Lung
Intermediate,,A,14950,,,1,,,N,,12262,BAO_0000218,,1,,10116.0,2385.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,Rattus norvegicus,CHEMBL630143,Muscle tissue
Intermediate,,A,14950,,,1,,,N,,12263,BAO_0000218,,1,,10116.0,2385.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,Rattus norvegicus,CHEMBL630144,Muscle tissue
Intermediate,,A,14950,,,1,,,N,,12264,BAO_0000218,,1,,10116.0,2367.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,Rattus norvegicus,CHEMBL630145,Prostate gland
Intermediate,,A,14950,,,1,,,N,,12265,BAO_0000218,,1,,10116.0,2367.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,Rattus norvegicus,CHEMBL630146,Prostate gland
Intermediate,,A,14950,,,1,,,N,,12266,BAO_0000218,,1,,10116.0,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,Rattus norvegicus,CHEMBL630147,
Intermediate,,A,14950,,,1,,,N,,12267,BAO_0000218,,1,,10116.0,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,Rattus norvegicus,CHEMBL630148,
Intermediate,,A,14950,,,1,,,N,,12268,BAO_0000218,,1,,10116.0,,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,Rattus norvegicus,CHEMBL630149,
Intermediate,,A,14950,,,1,,,N,,12269,BAO_0000218,,1,,10116.0,2106.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,Rattus norvegicus,CHEMBL630150,Spleen
Intermediate,,A,14950,,,1,,,N,,12270,BAO_0000218,,1,,10116.0,2106.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,Rattus norvegicus,CHEMBL630151,Spleen
Intermediate,,A,14950,,,1,,,N,,12271,BAO_0000218,,1,,10116.0,2046.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,Rattus norvegicus,CHEMBL632031,Thyroid gland
Intermediate,,A,14950,,,1,,,N,,12272,BAO_0000218,,1,,10116.0,2046.0,50597,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,Rattus norvegicus,CHEMBL632032,Thyroid gland
Intermediate,,A,14950,,,1,,,N,,12273,BAO_0000218,,1,,10116.0,,50597,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,Rattus norvegicus,CHEMBL632033,
Intermediate,,A,14950,,,1,,,N,,12274,BAO_0000218,,1,,10116.0,,50597,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,Rattus norvegicus,CHEMBL632034,
Intermediate,,A,14950,,,1,,,N,,12275,BAO_0000218,,1,,10116.0,2385.0,50597,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,Rattus norvegicus,CHEMBL632035,Muscle tissue
Intermediate,,A,14950,,,1,,,N,,12276,BAO_0000218,,1,,10116.0,,50597,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,Rattus norvegicus,CHEMBL632036,
Intermediate,,A,14950,,,1,,,N,,12277,BAO_0000218,,1,,10116.0,2046.0,50597,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,Rattus norvegicus,CHEMBL632037,Thyroid gland
Intermediate,,A,8631,,,1,,,N,,12278,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,Rattus norvegicus,CHEMBL632038,Blood
Intermediate,,A,8631,,,1,,,N,,12279,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,Rattus norvegicus,CHEMBL632039,Blood
Intermediate,,A,8631,,,1,,,N,,12280,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,Rattus norvegicus,CHEMBL632040,Blood
Intermediate,,A,8631,,,1,,,N,,12281,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,Rattus norvegicus,CHEMBL632041,Blood
Intermediate,,A,9614,,,1,,,N,,12282,BAO_0000218,,1,,9615.0,178.0,50588,"Concentration of compound in blood of dog 2, after administering intravenously",Canis lupus familiaris,CHEMBL632042,Blood
Intermediate,,A,9614,,,1,,,N,,12283,BAO_0000218,,1,,9615.0,,50588,"Concentration of compound in left ventricle of dog 1, after administering intravenously",Canis lupus familiaris,CHEMBL632043,
Intermediate,,A,9614,,,1,,,N,,12284,BAO_0000218,,1,,9615.0,,50588,"Concentration of compound in left ventricle of dog 2, after administering intravenously",Canis lupus familiaris,CHEMBL632044,
Intermediate,,A,9614,,,1,,,N,,12285,BAO_0000218,,1,,9615.0,2107.0,50588,"Concentration of compound in liver of dog 1, after administering intravenously",Canis lupus familiaris,CHEMBL632045,Liver
Intermediate,,A,9614,,,1,,,N,,12286,BAO_0000218,,1,,9615.0,2107.0,50588,"Concentration of compound in liver of dog 2, after administering intravenously",Canis lupus familiaris,CHEMBL632046,Liver
Intermediate,,A,9614,,,1,,,N,,12287,BAO_0000218,,1,,9615.0,2048.0,50588,"Concentration of compound in lung of dog 1, after administering intravenously",Canis lupus familiaris,CHEMBL632047,Lung
Intermediate,,A,9614,,,1,,,N,,12288,BAO_0000218,,1,,9615.0,2048.0,50588,"Concentration of compound in lung of dog 2, after administering intravenously",Canis lupus familiaris,CHEMBL632048,Lung
Intermediate,,A,9614,,,1,,,N,,12289,BAO_0000218,,1,,9615.0,2385.0,50588,"Concentration of compound in muscle of dog 1, after administering intravenously",Canis lupus familiaris,CHEMBL632049,Muscle tissue
Intermediate,,A,9614,,,1,,,N,,12290,BAO_0000218,,1,,9615.0,2385.0,50588,"Concentration of compound in muscle of dog 2, after administering intravenously",Canis lupus familiaris,CHEMBL876418,Muscle tissue
Intermediate,,A,9614,,,1,,,N,,12291,BAO_0000218,,1,,9615.0,2106.0,50588,"Concentration of compound in spleen of dog 1,after administering intravenously",Canis lupus familiaris,CHEMBL632050,Spleen
Intermediate,,A,9614,,,1,,,N,,12292,BAO_0000218,,1,,9615.0,2106.0,50588,"Concentration of compound in spleen of dog 2, after administering intravenously",Canis lupus familiaris,CHEMBL632051,Spleen
Autocuration,,F,10353,,,1,,,U,,12293,BAO_0000218,,0,,,,22224,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,,CHEMBL632052,
Autocuration,,F,10353,,,1,,,U,,12294,BAO_0000218,,0,,,,22224,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,,CHEMBL632053,
Autocuration,,A,10353,,,1,,,U,,12295,BAO_0000218,,0,,,,22224,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,CHEMBL632054,
Autocuration,,F,10353,,,1,,,U,,12296,BAO_0000218,,0,,,,22224,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,CHEMBL632055,
Autocuration,,F,10353,,,1,,,U,,12297,BAO_0000218,,0,,,,22224,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,,CHEMBL631181,
Autocuration,,A,9196,,,1,,,U,,12298,BAO_0000218,,0,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,,CHEMBL631182,
Autocuration,,A,9196,,,1,,,U,,12299,BAO_0000218,,0,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,CHEMBL631183,
Autocuration,,A,9196,,,1,,,U,,12300,BAO_0000218,,0,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,CHEMBL631184,
Autocuration,,A,9196,,,1,,,U,,12301,BAO_0000218,,0,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,CHEMBL629774,
Autocuration,,A,9196,,,1,,,U,,12302,BAO_0000218,,0,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,CHEMBL629775,
Autocuration,,A,9196,,,1,,,U,,12303,BAO_0000218,,0,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,CHEMBL876549,
Autocuration,,A,9196,,,1,,,U,,12304,BAO_0000218,,0,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,CHEMBL628172,
Autocuration,,A,9196,,,1,,,U,,12305,BAO_0000218,,0,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,CHEMBL628173,
Autocuration,,A,9196,,,1,,,U,,12306,BAO_0000218,,0,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,,CHEMBL628174,
Autocuration,,A,9196,,,1,,,U,,12307,BAO_0000218,,0,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,,CHEMBL628175,
Autocuration,,A,9196,,,1,,,U,,12308,BAO_0000218,,0,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,CHEMBL628176,
Autocuration,,A,9196,,,1,,,U,,12309,BAO_0000218,,0,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,CHEMBL628177,
Autocuration,,A,9196,,,1,,,U,,12310,BAO_0000218,,0,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,CHEMBL628178,
Autocuration,,A,9196,,,1,,,U,,12311,BAO_0000218,,0,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,CHEMBL628179,
Autocuration,,A,9196,,,1,,,U,,12312,BAO_0000218,,0,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,,CHEMBL628180,
Autocuration,,A,9196,,,1,,,U,,12313,BAO_0000218,,0,,,,22224,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,,CHEMBL628181,
Autocuration,,A,9196,,,1,,,U,,12314,BAO_0000218,,0,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,CHEMBL628182,
Autocuration,,A,9196,,,1,,,U,,12315,BAO_0000218,,0,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,CHEMBL628183,
Autocuration,,A,9196,,,1,,,U,,12316,BAO_0000218,,0,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,,CHEMBL628184,
Autocuration,,A,9196,,,1,,,U,,12317,BAO_0000218,,0,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,CHEMBL628185,
Autocuration,,A,9196,,,1,,,U,,12318,BAO_0000218,,0,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,CHEMBL875617,
Autocuration,,A,9196,,,1,,,U,,12319,BAO_0000218,,0,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,CHEMBL628186,
Autocuration,,A,9196,,,1,,,U,,12320,BAO_0000218,,0,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,CHEMBL628187,
Autocuration,,A,9196,,,1,,,U,,12321,BAO_0000218,,0,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,CHEMBL628188,
Autocuration,,A,9196,,,1,,,U,,12322,BAO_0000218,,0,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,CHEMBL628189,
Autocuration,,A,9196,,,1,,,U,,12323,BAO_0000218,,0,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,,CHEMBL628190,
Autocuration,,A,9196,,,1,,,U,,12324,BAO_0000218,,0,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,CHEMBL628191,
Autocuration,,A,9196,,,1,,,U,,12325,BAO_0000218,,0,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,,CHEMBL626513,
Intermediate,,A,8608,,,1,,,N,,12326,BAO_0000218,,1,,10116.0,2046.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",Rattus norvegicus,CHEMBL626514,Thyroid gland
Intermediate,,A,8608,,,1,,,N,,12327,BAO_0000218,,1,,10116.0,2046.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",Rattus norvegicus,CHEMBL626515,Thyroid gland
Intermediate,,A,8608,,,1,,,N,,12328,BAO_0000218,,1,,10116.0,2046.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",Rattus norvegicus,CHEMBL626516,Thyroid gland
Intermediate,,A,8608,,,1,,,N,,12329,BAO_0000218,,1,,10116.0,2046.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",Rattus norvegicus,CHEMBL626517,Thyroid gland
Intermediate,,A,8608,,,1,,,N,,12330,BAO_0000218,,1,,10116.0,2046.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",Rattus norvegicus,CHEMBL626518,Thyroid gland
Intermediate,,A,8608,,,1,,,N,,12331,BAO_0000218,,1,,10116.0,2046.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",Rattus norvegicus,CHEMBL626519,Thyroid gland
Intermediate,,A,8608,,,1,,,N,,12332,BAO_0000218,,1,,10116.0,2046.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",Rattus norvegicus,CHEMBL626520,Thyroid gland
Intermediate,,A,8608,,,1,,,N,,12333,BAO_0000218,,1,,10116.0,2046.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",Rattus norvegicus,CHEMBL626521,Thyroid gland
Intermediate,,A,8608,,,1,,,N,,12334,BAO_0000218,,1,,10116.0,2046.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",Rattus norvegicus,CHEMBL626522,Thyroid gland
Intermediate,,A,8608,,,1,,,N,,12335,BAO_0000218,,1,,10116.0,2046.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",Rattus norvegicus,CHEMBL626523,Thyroid gland
Intermediate,,A,8608,,,1,,,N,,12336,BAO_0000218,,1,,10116.0,2046.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",Rattus norvegicus,CHEMBL626524,Thyroid gland
Intermediate,,A,8608,,,1,,,N,,12337,BAO_0000218,,1,,10116.0,2046.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",Rattus norvegicus,CHEMBL626688,Thyroid gland
Intermediate,,A,8608,,,1,,,N,,12338,BAO_0000218,,1,,10116.0,2046.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",Rattus norvegicus,CHEMBL626689,Thyroid gland
Intermediate,,A,8608,,,1,,,N,,12339,BAO_0000218,,1,,10116.0,2046.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",Rattus norvegicus,CHEMBL626690,Thyroid gland
Intermediate,,A,8608,,,1,,,N,,12340,BAO_0000218,,1,,10116.0,2046.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",Rattus norvegicus,CHEMBL626691,Thyroid gland
Intermediate,,A,8608,,,1,,,N,,12341,BAO_0000218,,1,,10116.0,2046.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",Rattus norvegicus,CHEMBL627319,Thyroid gland
Intermediate,,A,8608,,,1,,,N,,12342,BAO_0000218,,1,,10116.0,2046.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",Rattus norvegicus,CHEMBL624052,Thyroid gland
Intermediate,,A,8608,,,1,,,N,,12343,BAO_0000218,,1,,10116.0,2046.0,50597,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",Rattus norvegicus,CHEMBL624053,Thyroid gland
Intermediate,,A,8085,,,1,,,N,,12344,BAO_0000218,,1,,10116.0,,50597,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,CHEMBL624054,
Intermediate,,A,8085,,,1,,,N,,12345,BAO_0000218,,1,,10116.0,,50597,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,CHEMBL624055,
Intermediate,,A,8085,,,1,,,N,,12346,BAO_0000218,,1,,10116.0,,50597,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,CHEMBL624056,
Intermediate,,A,8085,,,1,,,N,,12347,BAO_0000218,,1,,10116.0,995.0,50597,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,CHEMBL624057,Uterus
Intermediate,,A,8085,,,1,,,N,,12348,BAO_0000218,,1,,10116.0,995.0,50597,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,CHEMBL622281,Uterus
Intermediate,,A,8085,,,1,,,N,,12349,BAO_0000218,,1,,10116.0,995.0,50597,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,CHEMBL622282,Uterus
Intermediate,,A,8085,,,1,,,N,,12350,BAO_0000218,,1,,10116.0,995.0,50597,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,CHEMBL622283,Uterus
Intermediate,,A,8085,,,1,,,N,,12351,BAO_0000218,,1,,10116.0,995.0,50597,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,CHEMBL622284,Uterus
Intermediate,,A,8085,,,1,,,N,,12352,BAO_0000218,,1,,10116.0,995.0,50597,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,CHEMBL622285,Uterus
Intermediate,,A,8085,,,1,,,N,,12353,BAO_0000218,,1,,10116.0,995.0,50597,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,CHEMBL622286,Uterus
Autocuration,,P,7657,,,1,,,U,,12354,BAO_0000100,,0,,,,22224,Distribution coefficient (D %) between octanol and buffer of pH 7.4,,CHEMBL622287,
Intermediate,,A,8935,,,1,,,N,,12355,BAO_0000218,,1,,10090.0,,50594,Partition coefficient (logD7.4),Mus musculus,CHEMBL622288,
Intermediate,,A,13792,,,1,,,N,,12356,BAO_0000218,,1,,10090.0,,50594,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",Mus musculus,CHEMBL622289,
Intermediate,,A,13792,,,1,,,N,,12357,BAO_0000218,,1,,10090.0,955.0,50594,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",Mus musculus,CHEMBL622290,Brain
Intermediate,,A,13792,,,1,,,N,,12358,BAO_0000218,,1,,10090.0,,50594,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,Mus musculus,CHEMBL622291,
Intermediate,,A,13792,,,1,,,N,,12359,BAO_0000218,,1,,10090.0,955.0,50594,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,Mus musculus,CHEMBL622292,Brain
Intermediate,,A,13792,,,1,,,N,,12360,BAO_0000218,,1,,10090.0,,50594,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",Mus musculus,CHEMBL622293,
Intermediate,,A,13792,,,1,,,N,,12361,BAO_0000218,,1,,10090.0,955.0,50594,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",Mus musculus,CHEMBL622294,Brain
Intermediate,,A,13792,,,1,,,N,,12362,BAO_0000218,,1,,10090.0,,50594,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,Mus musculus,CHEMBL622295,
Intermediate,,A,13792,,,1,,,N,,12363,BAO_0000218,,1,,10116.0,955.0,50597,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,Rattus norvegicus,CHEMBL622296,Brain
Intermediate,,A,14103,,,1,,,N,,12364,BAO_0000218,,1,,10116.0,1969.0,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,Rattus norvegicus,CHEMBL874409,Plasma
Intermediate,,A,14103,,,1,,,N,,12365,BAO_0000218,,1,,10116.0,1969.0,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,Rattus norvegicus,CHEMBL622297,Plasma
Intermediate,,A,14103,,,1,,,N,,12366,BAO_0000218,,1,,10116.0,1969.0,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,Rattus norvegicus,CHEMBL622298,Plasma
Intermediate,,A,14103,,,1,,,N,,12367,BAO_0000218,,1,,10116.0,1969.0,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,Rattus norvegicus,CHEMBL622299,Plasma
Intermediate,,A,14103,,,1,,,N,,12368,BAO_0000218,,1,,10116.0,1969.0,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,Rattus norvegicus,CHEMBL622300,Plasma
Intermediate,,A,14103,,,1,,,N,,12369,BAO_0000218,,1,,10116.0,1969.0,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,Rattus norvegicus,CHEMBL622301,Plasma
Intermediate,,A,14103,,,1,,,N,,12370,BAO_0000218,,1,,10116.0,1969.0,50597,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,Rattus norvegicus,CHEMBL622302,Plasma
Intermediate,,A,14103,,,1,,,N,,12371,BAO_0000218,,1,,10116.0,1969.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,Rattus norvegicus,CHEMBL622303,Plasma
Intermediate,,A,14103,,,1,,,N,,12372,BAO_0000218,,1,,10116.0,1969.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,Rattus norvegicus,CHEMBL622304,Plasma
Intermediate,,A,14103,,,1,,,N,,12373,BAO_0000218,,1,,10116.0,1969.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,Rattus norvegicus,CHEMBL622305,Plasma
Intermediate,,A,14103,,,1,,,N,,12374,BAO_0000218,,1,,10116.0,1969.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,Rattus norvegicus,CHEMBL622306,Plasma
Intermediate,,A,14103,,,1,,,N,,12375,BAO_0000218,,1,,10116.0,1969.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,Rattus norvegicus,CHEMBL626864,Plasma
Intermediate,,A,14103,,,1,,,N,,12376,BAO_0000218,,1,,10116.0,1969.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,Rattus norvegicus,CHEMBL626865,Plasma
Intermediate,,A,14103,,,1,,,N,,12377,BAO_0000218,,1,,10116.0,1969.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,Rattus norvegicus,CHEMBL626866,Plasma
Intermediate,,A,14103,,,1,,,N,,12378,BAO_0000218,,1,,10116.0,1969.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,Rattus norvegicus,CHEMBL626867,Plasma
Intermediate,,A,14103,,,1,,,N,,12379,BAO_0000218,,1,,10116.0,1969.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,Rattus norvegicus,CHEMBL626868,Plasma
Intermediate,,A,14103,,,1,,,N,,12380,BAO_0000218,,1,,10116.0,1969.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,Rattus norvegicus,CHEMBL626869,Plasma
Intermediate,,A,14103,,,1,,,N,,12381,BAO_0000218,,1,,10116.0,1969.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,Rattus norvegicus,CHEMBL626870,Plasma
Intermediate,,A,14103,,,1,,,N,,12382,BAO_0000218,,1,,10116.0,1969.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,Rattus norvegicus,CHEMBL626871,Plasma
Intermediate,,A,14103,,,1,,,N,,12383,BAO_0000218,,1,,10116.0,1969.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,Rattus norvegicus,CHEMBL626872,Plasma
Intermediate,,A,14103,,,1,,,N,,12384,BAO_0000218,,1,,10116.0,1969.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,Rattus norvegicus,CHEMBL632185,Plasma
Intermediate,,A,14103,,,1,,,N,,12385,BAO_0000218,,1,,10116.0,1969.0,50597,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,Rattus norvegicus,CHEMBL632186,Plasma
Autocuration,,A,12904,,,1,,,U,,12386,BAO_0000019,,0,,,,22224,Amount of acetic acid produced by the compound,,CHEMBL629310,
Autocuration,,A,12904,,,1,,,U,,12387,BAO_0000019,,0,,,,22224,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,,CHEMBL629311,
Intermediate,,A,9663,,,1,,,N,,12388,BAO_0000218,,1,,10116.0,,50597,Log of (Cbrain/Cblood) in rats,Rattus norvegicus,CHEMBL629312,
Autocuration,,A,7652,,,1,,,U,,12389,BAO_0000221,,0,,,,22224,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),,CHEMBL629313,
Autocuration,,A,7652,,,1,,,U,,12390,BAO_0000221,,0,,,,22224,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,CHEMBL629314,
Autocuration,,A,7652,,,1,,,U,,12391,BAO_0000221,,0,,,,22224,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),,CHEMBL629315,
Autocuration,,B,7652,,,1,,,U,,12392,BAO_0000219,,0,,,,22224,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),,CHEMBL629316,
Autocuration,,A,7652,,,1,,,U,,12393,BAO_0000221,,0,,,,22224,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,CHEMBL629317,
Autocuration,,A,7652,,,1,,,U,,12394,BAO_0000019,,0,,,,22224,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),,CHEMBL629318,
Autocuration,,A,7652,,,1,,,U,,12395,BAO_0000019,,0,,,,22224,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),,CHEMBL877497,
Autocuration,,A,7652,,,1,,,U,,12396,BAO_0000019,,0,,,,22224,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),,CHEMBL629319,
Autocuration,,A,7652,,,1,,,U,,12397,BAO_0000019,,0,,,,22224,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,CHEMBL629320,
Autocuration,,A,7652,,,1,,,U,,12398,BAO_0000019,,0,,,,22224,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),,CHEMBL629496,
Autocuration,,A,7652,,,1,,,U,,12399,BAO_0000019,,0,,,,22224,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),,CHEMBL629497,
Autocuration,,A,7652,,,1,,,U,,12400,BAO_0000019,,0,,,,22224,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),,CHEMBL629498,
Autocuration,,A,7652,,,1,,,U,,12401,BAO_0000019,,0,,,,22224,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),,CHEMBL629499,
Autocuration,,A,7652,,,1,,,U,,12402,BAO_0000019,,0,,,,22224,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),,CHEMBL629500,
Autocuration,,A,7652,,,1,,,U,,12403,BAO_0000019,,0,,,,22224,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),,CHEMBL629501,
Autocuration,,A,7652,,,1,,,U,,12404,BAO_0000019,,0,,,,22224,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),,CHEMBL629502,
Autocuration,,F,8267,In vivo,,1,,,U,,12405,BAO_0000218,,0,,,,22224,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,,CHEMBL629503,
Intermediate,,A,8267,,,1,,,N,,12406,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,Canis lupus familiaris,CHEMBL629504,
Autocuration,,A,14479,,,1,,,U,,12407,BAO_0000019,,0,,,,22224,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,,CHEMBL629505,
Autocuration,,A,17515,,,1,,,U,,12408,BAO_0000019,,0,,,,22224,Compound was evaluated for total body clearance,,CHEMBL629506,
Autocuration,,A,17515,,,1,,,U,,12409,BAO_0000019,,0,,,,22224,Compound was evaluated for volume of distribution at steady state,,CHEMBL629507,
Autocuration,,A,8142,,,1,,,U,,12410,BAO_0000019,,0,,,,22224,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,,CHEMBL877498,
Autocuration,,A,14849,,,1,,,U,,12411,BAO_0000019,,0,,,,22224,Percentage of the diamine which is monoprotonated at pH 7.4,,CHEMBL629508,
Autocuration,,A,7653,,,1,,,U,,12412,BAO_0000019,,0,,,,22224,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,,CHEMBL629509,
Intermediate,,A,8631,,,1,,,N,,12413,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,Rattus norvegicus,CHEMBL629510,Blood
Intermediate,,A,8631,,,1,,,N,,12414,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Rattus norvegicus,CHEMBL629511,Blood
Intermediate,,A,8631,,,1,,,N,,12415,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Rattus norvegicus,CHEMBL629512,Blood
Intermediate,,A,8631,,,1,,,N,,12416,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Rattus norvegicus,CHEMBL629513,Blood
Intermediate,,A,8631,,,1,,,N,,12417,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,Rattus norvegicus,CHEMBL629514,Blood
Intermediate,,A,8631,,,1,,,N,,12418,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Rattus norvegicus,CHEMBL628447,Blood
Intermediate,,A,8631,,,1,,,N,,12419,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,Rattus norvegicus,CHEMBL628448,Blood
Intermediate,,A,8631,,,1,,,N,,12420,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,Rattus norvegicus,CHEMBL628449,Blood
Intermediate,,A,8631,,,1,,,N,,12421,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,Rattus norvegicus,CHEMBL631119,Blood
Intermediate,,A,8631,,,1,,,N,,12422,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,Rattus norvegicus,CHEMBL631120,Blood
Intermediate,,A,8631,,,1,,,N,,12423,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,Rattus norvegicus,CHEMBL631121,Blood
Intermediate,,A,8631,,,1,,,N,,12424,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,Rattus norvegicus,CHEMBL874458,Blood
Intermediate,,A,8631,,,1,,,N,,12425,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Rattus norvegicus,CHEMBL631122,Blood
Intermediate,,A,8631,,,1,,,N,,12426,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Rattus norvegicus,CHEMBL631123,Blood
Intermediate,,A,8631,,,1,,,N,,12427,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Rattus norvegicus,CHEMBL631124,Blood
Intermediate,,A,8631,,,1,,,N,,12428,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Rattus norvegicus,CHEMBL631125,Blood
Intermediate,,A,8631,,,1,,,N,,12429,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Rattus norvegicus,CHEMBL631290,Blood
Intermediate,,A,8631,,,1,,,N,,12430,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Rattus norvegicus,CHEMBL631291,Blood
Intermediate,,A,8631,,,1,,,N,,12431,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Rattus norvegicus,CHEMBL631292,Blood
Intermediate,,A,8631,,,1,,,N,,12432,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Rattus norvegicus,CHEMBL631293,Blood
Intermediate,,A,8631,,,1,,,N,,12433,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Rattus norvegicus,CHEMBL631294,Blood
Intermediate,,A,8631,,,1,,,N,,12434,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Rattus norvegicus,CHEMBL631295,Blood
Intermediate,,A,8631,,,1,,,N,,12435,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,Rattus norvegicus,CHEMBL631296,Blood
Intermediate,,A,8631,,,1,,,N,,12436,BAO_0000218,,1,,10116.0,178.0,50597,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Rattus norvegicus,CHEMBL631297,Blood
Autocuration,,A,10263,,,1,,,U,,12437,BAO_0000218,,0,,,,22224,Maximum biodistribution (Bmax) was determined.,,CHEMBL631298,
Intermediate,,A,12364,,,1,,,N,,12438,BAO_0000218,,1,,10090.0,,50594,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,Mus musculus,CHEMBL631299,
Intermediate,,A,12364,,,1,,,N,,12439,BAO_0000218,,1,,10090.0,,50594,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,Mus musculus,CHEMBL631300,
Intermediate,,A,12364,,,1,,,N,,12440,BAO_0000218,,1,,10090.0,,50594,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,Mus musculus,CHEMBL631301,
Intermediate,,A,12364,,,1,,,N,,12441,BAO_0000218,,1,,10090.0,,50594,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,Mus musculus,CHEMBL630291,
Autocuration,,A,14793,,,1,,,U,,12442,BAO_0000218,,0,,,,22224,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,,CHEMBL630292,
Autocuration,,A,14793,,,1,,,U,,12443,BAO_0000218,,0,,,,22224,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,,CHEMBL630293,
Autocuration,,A,14793,,,1,,,U,,12444,BAO_0000218,,0,,,,22224,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,,CHEMBL630294,
Autocuration,,A,14793,,,1,,,U,,12445,BAO_0000218,,0,,,,22224,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,,CHEMBL630295,
Autocuration,,A,14793,,,1,,,U,,12446,BAO_0000218,,0,,,,22224,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,,CHEMBL630296,
Autocuration,,A,14793,,,1,,,U,,12447,BAO_0000218,,0,,,,22224,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,,CHEMBL626782,
Autocuration,,A,14793,,,1,,,U,,12448,BAO_0000218,,0,,,,22224,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,,CHEMBL626783,
Autocuration,,A,14793,,,1,,,U,,12449,BAO_0000218,,0,,,,22224,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,,CHEMBL626784,
Autocuration,,A,14793,,,1,,,U,,12450,BAO_0000218,,0,,,,22224,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,,CHEMBL626785,
Autocuration,,A,14793,,,1,,,U,,12451,BAO_0000218,,0,,,,22224,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,,CHEMBL626786,
Autocuration,,A,9196,,,1,,,U,,12452,BAO_0000218,,0,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,CHEMBL626787,
Autocuration,,A,9196,,,1,,,U,,12453,BAO_0000218,,0,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,CHEMBL626788,
Autocuration,,A,9196,,,1,,,U,,12454,BAO_0000218,,0,,,,22224,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,CHEMBL625927,
Intermediate,,A,8374,,,1,,,N,,12455,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,CHEMBL625928,Blood
Intermediate,,A,8374,,,1,,,N,,12456,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,Rattus norvegicus,CHEMBL625929,Blood
Intermediate,,A,8374,,,1,,,N,,12457,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,Rattus norvegicus,CHEMBL625930,Blood
Intermediate,,A,8374,,,1,,,N,,12458,BAO_0000218,,1,,10116.0,178.0,50597,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",Rattus norvegicus,CHEMBL625931,Blood
Intermediate,,A,8374,,,1,,,N,,12459,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,Rattus norvegicus,CHEMBL627230,Blood
Intermediate,,A,8374,,,1,,,N,,12460,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,CHEMBL627231,Blood
Intermediate,,A,8374,,,1,,,N,,12461,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Rattus norvegicus,CHEMBL627232,Blood
Intermediate,,A,8374,,,1,,,N,,12462,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,Rattus norvegicus,CHEMBL627233,Blood
Intermediate,,A,8374,,,1,,,N,,12463,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,CHEMBL875470,Blood
Intermediate,,A,8374,,,1,,,N,,12464,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,CHEMBL627234,Blood
Intermediate,,A,8374,,,1,,,N,,12465,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,CHEMBL627235,Blood
Intermediate,,A,8374,,,1,,,N,,12466,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,CHEMBL627236,Blood
Intermediate,,A,8374,,,1,,,N,,12467,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,CHEMBL627237,Blood
Intermediate,,A,8374,,,1,,,N,,12468,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,CHEMBL627238,Blood
Intermediate,,A,8374,,,1,,,N,,12469,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,CHEMBL627239,Blood
Intermediate,,A,8374,,,1,,,N,,12470,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,CHEMBL627240,Blood
Intermediate,,A,8374,,,1,,,N,,12471,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,CHEMBL627241,Blood
Intermediate,,A,8374,,,1,,,N,,12472,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,CHEMBL627242,Blood
Intermediate,,A,8374,,,1,,,N,,12473,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,Rattus norvegicus,CHEMBL627243,Blood
Intermediate,,A,8374,,,1,,,N,,12474,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Rattus norvegicus,CHEMBL627244,Blood
Intermediate,,A,8374,,,1,,,N,,12475,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,CHEMBL627245,Blood
Intermediate,,A,8374,,,1,,,N,,12476,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,CHEMBL627246,Blood
Intermediate,,A,8374,,,1,,,N,,12477,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,CHEMBL627247,Blood
Intermediate,,A,8374,,,1,,,N,,12478,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,CHEMBL627248,Blood
Intermediate,,A,8374,,,1,,,N,,12479,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,CHEMBL627249,Blood
Intermediate,,A,8374,,,1,,,N,,12480,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,CHEMBL625569,Blood
Intermediate,,A,8374,,,1,,,N,,12481,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,CHEMBL625570,Blood
Intermediate,,A,8374,,,1,,,N,,12482,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,CHEMBL625571,Blood
Intermediate,,A,8374,,,1,,,N,,12483,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,Rattus norvegicus,CHEMBL625572,Blood
Intermediate,,A,8374,,,1,,,N,,12484,BAO_0000218,,1,,10116.0,178.0,50597,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Rattus norvegicus,CHEMBL625573,Blood
Intermediate,,A,8374,,,1,,,N,,12485,BAO_0000218,,1,,10116.0,178.0,50597,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,Rattus norvegicus,CHEMBL625574,Blood
Intermediate,,A,8374,,,1,,,N,,12486,BAO_0000218,,1,,10116.0,178.0,50597,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Rattus norvegicus,CHEMBL626245,Blood
Intermediate,,A,8374,,,1,,,N,,12487,BAO_0000218,,1,,10116.0,178.0,50597,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,CHEMBL626246,Blood
Autocuration,,A,9196,,,1,,,U,,12488,BAO_0000218,,0,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,CHEMBL626247,
Autocuration,,A,9196,,,1,,,U,,12489,BAO_0000218,,0,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,CHEMBL626248,
Autocuration,,A,9196,,,1,,,U,,12490,BAO_0000218,,0,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,CHEMBL626249,
Autocuration,,A,9196,,,1,,,U,,12491,BAO_0000218,,0,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,CHEMBL626420,
Autocuration,,A,9196,,,1,,,U,,12492,BAO_0000218,,0,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,CHEMBL626421,
Autocuration,,A,9196,,,1,,,U,,12493,BAO_0000218,,0,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,CHEMBL626422,
Autocuration,,A,9196,,,1,,,U,,12494,BAO_0000218,,0,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,CHEMBL626423,
Autocuration,,A,9196,,,1,,,U,,12495,BAO_0000218,,0,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,CHEMBL626424,
Intermediate,,A,12023,,,1,,,N,,12496,BAO_0000218,,1,,9615.0,,50588,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,Canis lupus familiaris,CHEMBL626425,
Intermediate,,A,12023,,,1,,,N,,12497,BAO_0000218,,1,,10116.0,,50597,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,Rattus norvegicus,CHEMBL875476,
Intermediate,,A,12023,,,1,,,N,,12498,BAO_0000218,,1,,9541.0,,100710,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,Macaca fascicularis,CHEMBL626426,
Autocuration,,P,10580,,,1,,,U,,12499,BAO_0000100,,0,,,,22224,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,,CHEMBL626427,
Autocuration,,P,10580,,,1,,,U,,12500,BAO_0000100,,0,,,,22224,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,,CHEMBL626428,
Autocuration,,A,16032,,,1,,,U,,12501,BAO_0000019,,0,,,,22224,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,,CHEMBL626429,
Autocuration,,A,16032,,,1,,,U,,12502,BAO_0000019,,0,,,1088.0,22224,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,,CHEMBL625025,Urine
Intermediate,,A,8594,,,1,,,N,,12503,BAO_0000218,,1,,10116.0,178.0,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL625026,Blood
Intermediate,,A,8594,,,1,,,N,,12504,BAO_0000218,,1,,10116.0,178.0,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL625027,Blood
Intermediate,,A,8594,,,1,,,N,,12505,BAO_0000218,,1,,10116.0,178.0,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL874410,Blood
Intermediate,,A,8594,,,1,,,N,,12506,BAO_0000218,,1,,10116.0,178.0,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL625028,Blood
Intermediate,,A,8594,,,1,,,N,,12507,BAO_0000218,,1,,10116.0,178.0,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL625029,Blood
Intermediate,,A,8594,,,1,,,N,,12508,BAO_0000218,,1,,10116.0,178.0,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL625030,Blood
Intermediate,,A,8594,,,1,,,N,,12509,BAO_0000218,,1,,10116.0,178.0,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL625031,Blood
Intermediate,,A,8594,,,1,,,N,,12510,BAO_0000218,,1,,10116.0,178.0,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL625032,Blood
Intermediate,,A,8594,,,1,,,N,,12511,BAO_0000218,,1,,10116.0,178.0,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL625033,Blood
Intermediate,,A,8594,,,1,,,N,,12512,BAO_0000218,,1,,10116.0,178.0,50597,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL625034,Blood
Intermediate,,A,8594,,,1,,,N,,12513,BAO_0000218,,1,,10116.0,948.0,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL624872,Heart
Intermediate,,A,8594,,,1,,,N,,12514,BAO_0000218,,1,,10116.0,948.0,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL624873,Heart
Intermediate,,A,8594,,,1,,,N,,12515,BAO_0000218,,1,,10116.0,948.0,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL624874,Heart
Intermediate,,A,8594,,,1,,,N,,12516,BAO_0000218,,1,,10116.0,948.0,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL624875,Heart
Intermediate,,A,8594,,,1,,,N,,12517,BAO_0000218,,1,,10116.0,948.0,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL624876,Heart
Intermediate,,A,8594,,,1,,,N,,12518,BAO_0000218,,1,,10116.0,948.0,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL624877,Heart
Intermediate,,A,8594,,,1,,,N,,12519,BAO_0000218,,1,,10116.0,948.0,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL624878,Heart
Intermediate,,A,8594,,,1,,,N,,12520,BAO_0000218,,1,,10116.0,948.0,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL624879,Heart
Intermediate,,A,8594,,,1,,,N,,12521,BAO_0000218,,1,,10116.0,948.0,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL624880,Heart
Intermediate,,A,8594,,,1,,,N,,12522,BAO_0000218,,1,,10116.0,948.0,50597,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL624881,Heart
Intermediate,,A,8594,,,1,,,N,,12523,BAO_0000218,,1,,10116.0,948.0,50597,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",Rattus norvegicus,CHEMBL624882,Heart
Intermediate,,A,8594,,,1,,,N,,12524,BAO_0000218,,1,,10116.0,2113.0,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL624883,Kidney
Intermediate,,A,8594,,,1,,,N,,12525,BAO_0000218,,1,,10116.0,2113.0,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL624884,Kidney
Intermediate,,A,8594,,,1,,,N,,12526,BAO_0000218,,1,,10116.0,2113.0,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL624885,Kidney
Intermediate,,A,8594,,,1,,,N,,12527,BAO_0000218,,1,,10116.0,2113.0,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL624886,Kidney
Intermediate,,A,8594,,,1,,,N,,12528,BAO_0000218,,1,,10116.0,2113.0,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL624887,Kidney
Intermediate,,A,8594,,,1,,,N,,12529,BAO_0000218,,1,,10116.0,2113.0,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL624888,Kidney
Intermediate,,A,8594,,,1,,,N,,12530,BAO_0000218,,1,,10116.0,2113.0,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL624889,Kidney
Intermediate,,A,8594,,,1,,,N,,12531,BAO_0000218,,1,,10116.0,2113.0,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL624890,Kidney
Intermediate,,A,8594,,,1,,,N,,12532,BAO_0000218,,1,,10116.0,2113.0,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL621964,Kidney
Intermediate,,A,8594,,,1,,,N,,12533,BAO_0000218,,1,,10116.0,2113.0,50597,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL621965,Kidney
Intermediate,,A,8594,,,1,,,N,,12534,BAO_0000218,,1,,10116.0,2107.0,50597,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL621966,Liver
Intermediate,,A,8594,,,1,,,N,,12535,BAO_0000218,,1,,10116.0,2107.0,50597,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL621967,Liver
Intermediate,,A,8594,,,1,,,N,,12536,BAO_0000218,,1,,10116.0,2107.0,50597,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL622164,Liver
Autocuration,,A,7653,,,1,,,U,,12537,BAO_0000019,,0,,,,22224,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),,CHEMBL623097,
Autocuration,,A,7653,,,1,,,U,,12538,BAO_0000019,,0,,,,22224,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),,CHEMBL623098,
Autocuration,,A,7653,,,1,,,U,,12539,BAO_0000019,,0,,,,22224,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,,CHEMBL623099,
Autocuration,,A,7653,,,1,,,U,,12540,BAO_0000019,,0,,,,22224,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,,CHEMBL623100,
Intermediate,,A,9104,,,1,,,N,,12541,BAO_0000218,,1,,10116.0,,50597,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",Rattus norvegicus,CHEMBL628673,
Intermediate,,A,9104,,,1,,,N,,12542,BAO_0000218,,1,,10116.0,,50597,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",Rattus norvegicus,CHEMBL628674,
Intermediate,,A,9104,,,1,,,N,,12543,BAO_0000218,,1,,10116.0,,50597,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",Rattus norvegicus,CHEMBL628675,
Intermediate,,A,9104,,,1,,,N,,12544,BAO_0000218,,1,,10116.0,,50597,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",Rattus norvegicus,CHEMBL627644,
Intermediate,,A,9104,,,1,,,N,,12545,BAO_0000218,,1,,10116.0,,50597,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",Rattus norvegicus,CHEMBL627645,
Intermediate,,A,9104,,,1,,,N,,12546,BAO_0000218,,1,,10116.0,,50597,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",Rattus norvegicus,CHEMBL627646,
Intermediate,,A,9104,,,1,,,N,,12547,BAO_0000218,,1,,10116.0,,50597,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",Rattus norvegicus,CHEMBL627647,
Intermediate,,A,9104,,,1,,,N,,12548,BAO_0000218,,1,,10116.0,,50597,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",Rattus norvegicus,CHEMBL627648,
Intermediate,,A,12902,,,1,,,N,,12549,BAO_0000218,,1,,10116.0,,50597,Free level in rat plasma,Rattus norvegicus,CHEMBL627649,
Autocuration,,A,6614,,,1,,,U,,12550,BAO_0000019,,0,,,,22224,Level reaching in blood plasma of rat or human was determined,,CHEMBL628313,
Intermediate,,A,9663,,,1,,,N,,12551,BAO_0000218,,1,,10116.0,,50597,Log (Cbrain/Cblood) in rats,Rattus norvegicus,CHEMBL628314,
Autocuration,,A,17658,,,1,,,U,,12552,BAO_0000019,,0,,,,22224,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,,CHEMBL628315,
Autocuration,,A,17658,,,1,,,U,,12553,BAO_0000019,,0,,,,22224,Mean percentage of compound transport through membrane; expressed as membrane transport,,CHEMBL628316,
Autocuration,,A,14314,,,1,,,U,,12554,BAO_0000218,,0,,,,22224,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,,CHEMBL628317,
Autocuration,,A,7385,,,1,,,U,,12555,BAO_0000019,,0,,,,22224,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,,CHEMBL628473,
Autocuration,,A,7385,,,1,,,U,,12556,BAO_0000019,,0,,,,22224,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",,CHEMBL628474,
Autocuration,,A,7385,,,1,,,U,,12557,BAO_0000019,,0,,,,22224,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,,CHEMBL628475,
Autocuration,,A,1329,,,1,,,U,,12558,BAO_0000019,,0,,,,22224,Net water uptake by a carrier mediated transport (%cm) mechanism,,CHEMBL628476,
Autocuration,,A,12187,,,1,,,U,,12559,BAO_0000218,,0,,314293.0,,22224,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,Simiiformes,CHEMBL628477,
Intermediate,,A,12187,,,1,,,N,,12560,BAO_0000218,,1,,9669.0,,50506,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,Mustela putorius furo,CHEMBL628478,
Intermediate,,A,12187,,,1,,,N,,12561,BAO_0000218,,1,,9669.0,,50506,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",Mustela putorius furo,CHEMBL628479,
Autocuration,,A,12187,,,1,,,U,,12562,BAO_0000218,,0,,314293.0,,22224,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,Simiiformes,CHEMBL628480,
Autocuration,,A,12187,,,1,,,U,,12563,BAO_0000218,,0,,314293.0,,22224,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",Simiiformes,CHEMBL628481,
Intermediate,,A,12187,,,1,,,N,,12564,BAO_0000218,,1,,10116.0,,50597,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,Rattus norvegicus,CHEMBL628482,
Intermediate,,A,12187,,,1,,,N,,12565,BAO_0000218,,1,,10116.0,,50597,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",Rattus norvegicus,CHEMBL628483,
Intermediate,,A,9278,,,1,,,N,,12566,BAO_0000218,,1,,10116.0,1969.0,50597,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",Rattus norvegicus,CHEMBL628484,Plasma
Intermediate,,A,9278,,,1,,,N,,12567,BAO_0000218,,1,,10116.0,1969.0,50597,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Rattus norvegicus,CHEMBL628485,Plasma
Intermediate,,A,9278,,,1,,,N,,12568,BAO_0000218,,1,,9541.0,1969.0,100710,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",Macaca fascicularis,CHEMBL628486,Plasma
Intermediate,,A,9278,,,1,,,N,,12569,BAO_0000218,,1,,9606.0,1969.0,50587,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",Homo sapiens,CHEMBL628487,Plasma
Intermediate,,A,9278,,,1,,,N,,12570,BAO_0000218,,1,,10116.0,1969.0,50597,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",Rattus norvegicus,CHEMBL628488,Plasma
Intermediate,,A,9278,,,1,,,N,,12571,BAO_0000218,,1,,10116.0,1969.0,50597,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Rattus norvegicus,CHEMBL628489,Plasma
Intermediate,,A,9278,,,1,,,N,,12572,BAO_0000218,,1,,10116.0,1969.0,50597,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Rattus norvegicus,CHEMBL628490,Plasma
Intermediate,,A,12186,,,1,,,N,,12573,BAO_0000218,,1,,9541.0,,100710,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,Macaca fascicularis,CHEMBL628491,
Intermediate,,A,12186,,,1,,,N,,12574,BAO_0000218,,1,,9541.0,,100710,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,Macaca fascicularis,CHEMBL877507,
Autocuration,,A,12186,,,1,,,U,,12575,BAO_0000218,,0,,,,22224,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,CHEMBL628492,
Autocuration,,A,12041,,,1,,,U,,12576,BAO_0000019,,0,,314293.0,,22224,% metabolized in monkey S-9 after 2 hours (10 ug/mL),Simiiformes,CHEMBL628493,
Autocuration,,A,12041,,,1,,,U,,12577,BAO_0000019,,0,,314293.0,,22224,% metabolized in monkey S-9 after 2 hours (1 ug/ml),Simiiformes,CHEMBL628494,
Autocuration,,A,12041,,,1,,,U,,12578,BAO_0000019,,0,,314293.0,,22224,% metabolized in monkey S-9 after 2 hours (10 ug/ml),Simiiformes,CHEMBL628495,
Intermediate,,A,6737,,,1,,,N,,12579,BAO_0000218,,1,,9606.0,,50587,Permeability in Caco-2 assay at 10E-6,Homo sapiens,CHEMBL628496,
Autocuration,,A,13758,,,1,,,U,,12580,BAO_0000218,,0,,,955.0,22224,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,CHEMBL628497,Brain
Autocuration,,A,13758,,,1,,,U,,12581,BAO_0000218,,0,,,955.0,22224,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,CHEMBL628498,Brain
Autocuration,,A,5676,,,1,,,U,,12582,BAO_0000019,,0,,,,22224,Plasma protein binding was determined,,CHEMBL628499,
Autocuration,,A,14793,,,1,,,U,,12583,BAO_0000218,,0,,,,22224,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,,CHEMBL627656,
Autocuration,,A,14793,,,1,,,U,,12584,BAO_0000218,,0,,,,22224,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,,CHEMBL627657,
Autocuration,,A,14793,,,1,,,U,,12585,BAO_0000218,,0,,,,22224,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,,CHEMBL626808,
Autocuration,,A,14793,,,1,,,U,,12586,BAO_0000218,,0,,,,22224,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,,CHEMBL626809,
Autocuration,,A,14793,,,1,,,U,,12587,BAO_0000218,,0,,,,22224,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,,CHEMBL626810,
Autocuration,,A,14793,,,1,,,U,,12588,BAO_0000218,,0,,,,22224,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,,CHEMBL626811,
Autocuration,,A,14793,,,1,,,U,,12589,BAO_0000218,,0,,,,22224,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,,CHEMBL874465,
Autocuration,,A,14793,,,1,,,U,,12590,BAO_0000218,,0,,,,22224,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,,CHEMBL626812,
Autocuration,,A,14793,,,1,,,U,,12591,BAO_0000218,,0,,,,22224,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,,CHEMBL626813,
Autocuration,,A,14793,,,1,,,U,,12592,BAO_0000218,,0,,,,22224,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,,CHEMBL626814,
Autocuration,,A,14000,,,1,,,U,,12593,BAO_0000019,,0,,,,22224,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,,CHEMBL626815,
Autocuration,,A,5948,,,1,,,U,,12594,BAO_0000019,,0,,,,22224,Partition coefficient (logP),,CHEMBL628566,
Autocuration,,P,13824,,,1,,,U,,12595,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,CHEMBL628567,
Autocuration,,P,10778,,,1,,,U,,12596,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL628568,
Intermediate,,A,17237,In vivo,,1,,,N,,12597,BAO_0000218,,1,,9615.0,,50588,C max in dog,Canis lupus familiaris,CHEMBL628569,
Intermediate,,A,17237,In vivo,,1,,,N,,12598,BAO_0000218,,1,,10141.0,,50512,C max in guinea pig,Cavia porcellus,CHEMBL628570,
Autocuration,,A,2809,In vivo,,1,,,U,,12599,BAO_0000218,,0,,,,22224,C max value was evaluated,,CHEMBL628571,
Autocuration,,A,11954,In vivo,,1,,,U,,12600,BAO_0000218,,0,,,,22224,Cmax value after oral dose of 0.1 mg//kg,,CHEMBL628572,
Autocuration,,A,11954,In vivo,,1,,,U,,12601,BAO_0000218,,0,,,,22224,Cmax value after oral dose of 0.3 mg/kg,,CHEMBL628573,
Autocuration,,A,11954,In vivo,,1,,,U,,12602,BAO_0000218,,0,,,,22224,Cmax value after oral dose of 1 mg/kg,,CHEMBL628574,
Autocuration,,A,11954,In vivo,,1,,,U,,12603,BAO_0000218,,0,,,,22224,Cmax value after oral dose of 10 mg/kg,,CHEMBL628575,
Autocuration,,A,11954,In vivo,,1,,,U,,12604,BAO_0000218,,0,,,,22224,Cmax value after oral dose of 23.4 mg/kg,,CHEMBL628576,
Autocuration,,A,11954,In vivo,,1,,,U,,12605,BAO_0000218,,0,,,,22224,Cmax value after oral dose of 3 mg/kg,,CHEMBL628577,
Autocuration,,A,11954,In vivo,,1,,,U,,12606,BAO_0000218,,0,,,,22224,Cmax value after oral dose of 3.87 mg/kg,,CHEMBL628578,
Intermediate,,A,12768,In vivo,,1,,,N,,12607,BAO_0000218,,1,,9615.0,,50588,Cmax value in female Beagle dogs,Canis lupus familiaris,CHEMBL874466,
Intermediate,,A,12768,In vivo,,1,,,N,,12608,BAO_0000218,,1,,10116.0,,50597,Cmax value in male rats,Rattus norvegicus,CHEMBL628579,
Intermediate,,A,12780,In vivo,,1,,,N,,12609,BAO_0000218,,1,,10116.0,1969.0,50597,Cmax value in rat plasma when administered 20 mg/kg perorally,Rattus norvegicus,CHEMBL628580,Plasma
Intermediate,,A,15592,In vivo,,1,,,N,,12610,BAO_0000218,,1,,9615.0,1969.0,50588,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Canis lupus familiaris,CHEMBL628581,Plasma
Intermediate,,A,15592,In vivo,,1,,,N,,12611,BAO_0000218,,1,,9615.0,1969.0,50588,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Canis lupus familiaris,CHEMBL628582,Plasma
Intermediate,,A,17025,,,1,,,N,,12612,BAO_0000218,,1,,9615.0,,50588,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,Canis lupus familiaris,CHEMBL628583,
Autocuration,,A,17025,,,1,,,U,,12613,BAO_0000218,,0,,314293.0,,22224,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,Simiiformes,CHEMBL625782,
Intermediate,,A,17025,,,1,,,N,,12614,BAO_0000218,,1,,9986.0,,50592,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,Oryctolagus cuniculus,CHEMBL625783,
Intermediate,,A,17025,,,1,,,N,,12615,BAO_0000218,,1,,10116.0,,50597,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,Rattus norvegicus,CHEMBL625784,
Intermediate,,A,4236,,,1,,,N,,12616,BAO_0000218,,1,,9544.0,1969.0,50797,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,Macaca mulatta,CHEMBL625785,Plasma
Intermediate,,A,15791,,,1,,,N,,12617,BAO_0000218,,1,,10116.0,,50597,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,Rattus norvegicus,CHEMBL625786,
Autocuration,,A,11149,,,1,,,U,,12618,BAO_0000019,,0,,,,22224,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,,CHEMBL874467,
Intermediate,,A,15592,,,1,,,N,,12619,BAO_0000218,,1,,9615.0,,50588,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",Canis lupus familiaris,CHEMBL625787,
Intermediate,,A,15778,,,1,,,N,,12620,BAO_0000218,,1,,12721.0,,50677,cytotoxicity against HIV protease enzyme.,Human immunodeficiency virus,CHEMBL625964,
Intermediate,,A,12745,,,1,,,N,,12621,BAO_0000218,,1,,10090.0,,50594,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,Mus musculus,CHEMBL625965,
Intermediate,,A,12745,,,1,,,N,,12622,BAO_0000218,,1,,10090.0,,50594,Apparent clearance in mice after oral administration of 100 mg/kg of dose,Mus musculus,CHEMBL625966,
Intermediate,,A,13941,In vivo,,1,,,N,,12623,BAO_0000218,,1,,9615.0,1969.0,50588,The plasma clearance in dog.,Canis lupus familiaris,CHEMBL625967,Plasma
Intermediate,,A,13941,In vivo,,1,,,N,,12624,BAO_0000218,,1,,10116.0,1969.0,50597,The plasma clearance in rat.,Rattus norvegicus,CHEMBL625968,Plasma
Intermediate,,A,16449,In vivo,,1,,,N,,12625,BAO_0000218,,1,,10116.0,1969.0,50597,Clearance from plasma in male Sprague-Dawley rats,Rattus norvegicus,CHEMBL625969,Plasma
Intermediate,,A,16449,In vivo,,1,,,N,,12626,BAO_0000218,,1,,9541.0,1969.0,100710,Clearance from plasma in male cynomolgus monkeys,Macaca fascicularis,CHEMBL625970,Plasma
Intermediate,,A,14224,In vivo,,1,,,N,,12627,BAO_0000218,,1,,9615.0,1969.0,50588,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",Canis lupus familiaris,CHEMBL625971,Plasma
Intermediate,,A,14224,In vivo,,1,,,N,,12628,BAO_0000218,,1,,9615.0,1969.0,50588,Clearance of compound in dog plasma,Canis lupus familiaris,CHEMBL625972,Plasma
Intermediate,,A,14224,In vivo,,1,,,N,,12629,BAO_0000218,,1,,9606.0,1969.0,50587,Clearance of compound in human plasma,Homo sapiens,CHEMBL625973,Plasma
Intermediate,,A,14317,In vivo,,1,,,N,,12630,BAO_0000218,,1,,9615.0,,50588,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,Canis lupus familiaris,CHEMBL625974,
Intermediate,,A,14317,In vivo,,1,,,N,,12631,BAO_0000218,,1,,9615.0,,50588,Clearance of compound when administered intravenously as an individual dose to a single dog.,Canis lupus familiaris,CHEMBL625975,
Intermediate,,A,14224,In vivo,,1,,,N,,12632,BAO_0000218,,1,,9615.0,1969.0,50588,"Clearance (10 mg/kg, intravenously) in dog plasma",Canis lupus familiaris,CHEMBL625976,Plasma
Intermediate,,A,17237,In vivo,,1,,,N,,12633,BAO_0000218,,1,,9615.0,,50588,Clearance value in dog,Canis lupus familiaris,CHEMBL625977,
Intermediate,,A,17237,In vivo,,1,,,N,,12634,BAO_0000218,,1,,10141.0,,50512,Clearance value in guinea pig,Cavia porcellus,CHEMBL625978,
Intermediate,,A,14187,In vivo,,1,,,N,,12635,BAO_0000218,,1,,10116.0,,50597,Clearance values in rats after iv administration.,Rattus norvegicus,CHEMBL874468,
Autocuration,,A,4806,In vivo,,1,,,U,,12636,BAO_0000218,,0,,,1969.0,22224,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,,CHEMBL625421,Plasma
Intermediate,,A,15025,In vivo,,1,,,N,,12637,BAO_0000218,,1,,9986.0,,50592,In vivo clearance (5 mg/kg) was determined in rabbits,Oryctolagus cuniculus,CHEMBL625422,
Intermediate,,A,13197,In vivo,,1,,,N,,12638,BAO_0000218,,1,,10116.0,,50597,Plasma Clearance rate was determined for the compound in rats,Rattus norvegicus,CHEMBL625423,
Autocuration,,A,13197,In vivo,,1,,,U,,12639,BAO_0000218,,0,,9520.0,,22224,Plasma Clearance rate was determined for the compound in squirrel monkeys,Saimiri,CHEMBL625424,
Intermediate,,A,13960,In vivo,,1,,,N,,12640,BAO_0000218,,1,,10116.0,,50597,Plasma clearance in rat,Rattus norvegicus,CHEMBL625425,
Autocuration,,A,17820,In vivo,,1,,,U,,12641,BAO_0000218,,0,,,,22224,Plasma clearance of the compound,,CHEMBL625426,
Intermediate,,A,14706,In vivo,,1,,,N,,12642,BAO_0000218,,1,,10141.0,,50512,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,Cavia porcellus,CHEMBL625427,
Intermediate,,A,14706,In vivo,,1,,,N,,12643,BAO_0000218,,1,,10141.0,,50512,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,Cavia porcellus,CHEMBL625428,
Autocuration,,A,6504,In vivo,,1,,,U,,12644,BAO_0000218,,0,,,,22224,Plasma clearance was determined,,CHEMBL625429,
Intermediate,,A,14925,In vivo,,1,,,N,,12645,BAO_0000218,,1,,9615.0,,50588,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,Canis lupus familiaris,CHEMBL625430,
Intermediate,,A,13197,In vivo,,1,,,N,,12646,BAO_0000218,,1,,10116.0,,50597,Plasma clearance rate was determined for the compound in rats,Rattus norvegicus,CHEMBL625431,
Autocuration,,A,13197,In vivo,,1,,,U,,12647,BAO_0000218,,0,,9520.0,,22224,Plasma clearance rate was determined for the compound in squirrel monkeys,Saimiri,CHEMBL627307,
Autocuration,,A,3437,In vivo,,1,,,U,,12648,BAO_0000218,,0,,,,22224,Slow clearance (CL) was determined,,CHEMBL627308,
Autocuration,,A,9196,,,1,,,U,,12649,BAO_0000218,,0,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,CHEMBL627309,
Autocuration,,A,9196,,,1,,,U,,12650,BAO_0000218,,0,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,,CHEMBL627310,
Autocuration,,A,9196,,,1,,,U,,12651,BAO_0000218,,0,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,CHEMBL627311,
Autocuration,,A,9196,,,1,,,U,,12652,BAO_0000218,,0,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,CHEMBL627312,
Autocuration,,A,9196,,,1,,,U,,12653,BAO_0000218,,0,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,CHEMBL627313,
Autocuration,,A,9196,,,1,,,U,,12654,BAO_0000218,,0,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,CHEMBL627314,
Autocuration,,A,9196,,,1,,,U,,12655,BAO_0000218,,0,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,CHEMBL627315,
Autocuration,,A,9196,,,1,,,U,,12656,BAO_0000218,,0,,,,22224,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,CHEMBL627316,
Autocuration,,A,9196,,,1,,,U,,12657,BAO_0000218,,0,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,CHEMBL627317,
Autocuration,,A,9196,,,1,,,U,,12658,BAO_0000218,,0,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,CHEMBL627318,
Autocuration,,A,9196,,,1,,,U,,12659,BAO_0000218,,0,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,CHEMBL627999,
Autocuration,,A,9196,,,1,,,U,,12660,BAO_0000218,,0,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,CHEMBL628000,
Autocuration,,A,9196,,,1,,,U,,12661,BAO_0000218,,0,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,CHEMBL628001,
Autocuration,,A,9196,,,1,,,U,,12662,BAO_0000218,,0,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,CHEMBL628002,
Autocuration,,A,9196,,,1,,,U,,12663,BAO_0000218,,0,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,CHEMBL625610,
Autocuration,,A,9196,,,1,,,U,,12664,BAO_0000218,,0,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,CHEMBL625611,
Autocuration,,A,9196,,,1,,,U,,12665,BAO_0000218,,0,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,CHEMBL625612,
Autocuration,,A,9196,,,1,,,U,,12666,BAO_0000218,,0,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,CHEMBL625613,
Autocuration,,A,9196,,,1,,,U,,12667,BAO_0000218,,0,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,CHEMBL875479,
Autocuration,,A,9196,,,1,,,U,,12668,BAO_0000218,,0,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,CHEMBL625614,
Autocuration,,A,9196,,,1,,,U,,12669,BAO_0000218,,0,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,CHEMBL625615,
Autocuration,,A,9196,,,1,,,U,,12670,BAO_0000218,,0,,,,22224,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,CHEMBL626302,
Intermediate,,A,8374,,,1,,,N,,12671,BAO_0000218,,1,,10116.0,178.0,50597,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,CHEMBL626303,Blood
Intermediate,,A,8374,,,1,,,N,,12672,BAO_0000218,,1,,10116.0,178.0,50597,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,CHEMBL627420,Blood
Intermediate,,A,13477,,,1,,,N,,12673,BAO_0000218,,1,,10116.0,,50597,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,Rattus norvegicus,CHEMBL627421,
Intermediate,,A,13477,,,1,,,N,,12674,BAO_0000218,,1,,10116.0,,50597,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,Rattus norvegicus,CHEMBL625695,
Intermediate,,A,13477,,,1,,,N,,12675,BAO_0000218,,1,,10116.0,,50597,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,Rattus norvegicus,CHEMBL625696,
Intermediate,,A,10009,,,1,,,N,,12676,BAO_0000218,,1,,10090.0,955.0,50594,Distribution of compound in mice brain was measured after 1 hr,Mus musculus,CHEMBL875606,Brain
Intermediate,,A,10009,,,1,,,N,,12677,BAO_0000218,,1,,10090.0,955.0,50594,Distribution of compound in mice brain was measured after 24 hr r,Mus musculus,CHEMBL625697,Brain
Intermediate,,A,10009,,,1,,,N,,12678,BAO_0000218,,1,,10090.0,955.0,50594,Distribution of compound in mice brain was measured after 2 hr,Mus musculus,CHEMBL625698,Brain
Intermediate,,A,10009,,,1,,,N,,12679,BAO_0000218,,1,,10090.0,955.0,50594,Distribution of compound in mice brain was measured after 3 hr,Mus musculus,CHEMBL625699,Brain
Intermediate,,A,10009,,,1,,,N,,12680,BAO_0000218,,1,,10090.0,955.0,50594,Distribution of compound in mice brain was measured after 6 hr,Mus musculus,CHEMBL625700,Brain
Intermediate,,A,10009,,,1,,,N,,12681,BAO_0000218,,1,,10090.0,,50594,Distribution of compound in mice liver was measured after 1 hr,Mus musculus,CHEMBL625701,
Intermediate,,A,10009,,,1,,,N,,12682,BAO_0000218,,1,,10090.0,,50594,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,Mus musculus,CHEMBL625702,
Intermediate,,A,10009,,,1,,,N,,12683,BAO_0000218,,1,,10090.0,,50594,Distribution of compound in mice liver was measured after 2 hr,Mus musculus,CHEMBL625703,
Intermediate,,A,10009,,,1,,,N,,12684,BAO_0000218,,1,,10090.0,,50594,Distribution of compound in mice liver was measured after 3 hr,Mus musculus,CHEMBL625704,
Intermediate,,A,10009,,,1,,,N,,12685,BAO_0000218,,1,,10090.0,,50594,Distribution of compound in mice liver was measured after 6 hr,Mus musculus,CHEMBL625705,
Intermediate,,A,8170,,,1,,,N,,12686,BAO_0000218,,1,,9615.0,1236.0,50588,Distribution in dog adrenal medulla 30 min after administration.,Canis lupus familiaris,CHEMBL625706,Adrenal medulla
Intermediate,,A,8170,,,1,,,N,,12687,BAO_0000218,,1,,9615.0,1236.0,50588,Distribution in dog adrenal medulla 72 hours after administration.,Canis lupus familiaris,CHEMBL625707,Adrenal medulla
Intermediate,,A,8170,,,1,,,N,,12688,BAO_0000218,,1,,9615.0,,50588,Distribution in female dog Ovary 24 hours after administration.,Canis lupus familiaris,CHEMBL625708,
Intermediate,,A,8170,,,1,,,N,,12689,BAO_0000218,,1,,9615.0,,50588,Distribution in female dog Ovary 72 hours after administration.,Canis lupus familiaris,CHEMBL625709,
Intermediate,,A,8170,,,1,,,N,,12690,BAO_0000218,,1,,9615.0,,50588,Distribution in female dog adipose 24 hours after administration.,Canis lupus familiaris,CHEMBL624180,
Intermediate,,A,8170,,,1,,,N,,12691,BAO_0000218,,1,,9615.0,,50588,Distribution in female dog adipose 72 hours after administration.,Canis lupus familiaris,CHEMBL624181,
Intermediate,,A,8170,,,1,,,N,,12692,BAO_0000218,,1,,9615.0,1235.0,50588,Distribution in female dog adrenal cortex 72 hours after administration.,Canis lupus familiaris,CHEMBL624182,Adrenal cortex
Intermediate,,A,8170,,,1,,,N,,12693,BAO_0000218,,1,,9615.0,1235.0,50588,Distribution in female dog adrenal cortex 72 hours after administration.,Canis lupus familiaris,CHEMBL624183,Adrenal cortex
Intermediate,,A,8594,,,1,,,N,,12694,BAO_0000218,,1,,10116.0,2107.0,50597,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL624184,Liver
Intermediate,,A,8594,,,1,,,N,,12695,BAO_0000218,,1,,10116.0,2107.0,50597,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL877489,Liver
Intermediate,,A,8594,,,1,,,N,,12696,BAO_0000218,,1,,10116.0,2107.0,50597,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL624185,Liver
Intermediate,,A,8594,,,1,,,N,,12697,BAO_0000218,,1,,10116.0,2107.0,50597,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL624186,Liver
Intermediate,,A,8594,,,1,,,N,,12698,BAO_0000218,,1,,10116.0,2107.0,50597,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL624187,Liver
Intermediate,,A,8594,,,1,,,N,,12699,BAO_0000218,,1,,10116.0,2107.0,50597,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL624188,Liver
Intermediate,,A,8594,,,1,,,N,,12700,BAO_0000218,,1,,10116.0,2048.0,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL624189,Lung
Intermediate,,A,8594,,,1,,,N,,12701,BAO_0000218,,1,,10116.0,2048.0,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL624190,Lung
Intermediate,,A,8594,,,1,,,N,,12702,BAO_0000218,,1,,10116.0,2048.0,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL624191,Lung
Intermediate,,A,8594,,,1,,,N,,12703,BAO_0000218,,1,,10116.0,2048.0,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL624192,Lung
Intermediate,,A,8594,,,1,,,N,,12704,BAO_0000218,,1,,10116.0,2048.0,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL624193,Lung
Intermediate,,A,8594,,,1,,,N,,12705,BAO_0000218,,1,,10116.0,2048.0,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL624194,Lung
Intermediate,,A,8594,,,1,,,N,,12706,BAO_0000218,,1,,10116.0,2048.0,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL624891,Lung
Intermediate,,A,8594,,,1,,,N,,12707,BAO_0000218,,1,,10116.0,2048.0,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL624892,Lung
Intermediate,,A,8594,,,1,,,N,,12708,BAO_0000218,,1,,10116.0,2048.0,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL624893,Lung
Intermediate,,A,8594,,,1,,,N,,12709,BAO_0000218,,1,,10116.0,2048.0,50597,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL627632,Lung
Intermediate,,A,8594,,,1,,,N,,12710,BAO_0000218,,1,,10116.0,,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL627633,
Intermediate,,A,8594,,,1,,,N,,12711,BAO_0000218,,1,,10116.0,,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL627634,
Intermediate,,A,8594,,,1,,,N,,12712,BAO_0000218,,1,,10116.0,,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL627635,
Intermediate,,A,8594,,,1,,,N,,12713,BAO_0000218,,1,,10116.0,,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL627636,
Intermediate,,A,8594,,,1,,,N,,12714,BAO_0000218,,1,,10116.0,,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL626816,
Intermediate,,A,8594,,,1,,,N,,12715,BAO_0000218,,1,,10116.0,,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL626817,
Intermediate,,A,8594,,,1,,,N,,12716,BAO_0000218,,1,,10116.0,,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL626818,
Intermediate,,A,8594,,,1,,,N,,12717,BAO_0000218,,1,,10116.0,,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL626819,
Intermediate,,A,8594,,,1,,,N,,12718,BAO_0000218,,1,,10116.0,,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL626820,
Intermediate,,A,8594,,,1,,,N,,12719,BAO_0000218,,1,,10116.0,,50597,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL626821,
Intermediate,,A,8594,,,1,,,N,,12720,BAO_0000218,,1,,10116.0,2046.0,50597,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL626822,Thyroid gland
Intermediate,,A,8594,,,1,,,N,,12721,BAO_0000218,,1,,10116.0,2046.0,50597,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL626823,Thyroid gland
Intermediate,,A,8594,,,1,,,N,,12722,BAO_0000218,,1,,10116.0,2046.0,50597,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL626824,Thyroid gland
Intermediate,,A,8594,,,1,,,N,,12723,BAO_0000218,,1,,10116.0,2046.0,50597,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL626825,Thyroid gland
Intermediate,,A,8594,,,1,,,N,,12724,BAO_0000218,,1,,10116.0,2046.0,50597,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL626826,Thyroid gland
Intermediate,,A,8594,,,1,,,N,,12725,BAO_0000218,,1,,10116.0,2046.0,50597,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL626827,Thyroid gland
Intermediate,,A,8594,,,1,,,N,,12726,BAO_0000218,,1,,10116.0,2046.0,50597,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL626828,Thyroid gland
Intermediate,,A,8594,,,1,,,N,,12727,BAO_0000218,,1,,10116.0,2046.0,50597,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL626829,Thyroid gland
Intermediate,,A,8594,,,1,,,N,,12728,BAO_0000218,,1,,10116.0,2046.0,50597,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL626830,Thyroid gland
Intermediate,,A,8594,,,1,,,N,,12729,BAO_0000218,,1,,10116.0,,50597,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL627150,
Intermediate,,A,8594,,,1,,,N,,12730,BAO_0000218,,1,,10116.0,,50597,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL627151,
Intermediate,,A,8594,,,1,,,N,,12731,BAO_0000218,,1,,10116.0,,50597,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,CHEMBL627152,
Intermediate,,A,8594,,,1,,,N,,12732,BAO_0000218,,1,,10116.0,,50597,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL627153,
Autocuration,,A,12904,,,1,,,U,,12733,BAO_0000019,,0,,,,22224,Rate of acetate production by the compound was determined,,CHEMBL627154,
Autocuration,,A,12904,,,1,,,U,,12734,BAO_0000019,,0,,,,22224,Rate of acetate production by the compound was determined; Not determined,,CHEMBL627155,
Autocuration,,A,3730,,,1,,,U,,12735,BAO_0000019,,0,,,,22224,Rate of hydrolysis of nitrocefin by compound was evaluated in water,,CHEMBL627156,
Autocuration,,A,3627,,,1,,,U,,12736,BAO_0000019,,0,,,,22224,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,,CHEMBL627157,
Intermediate,,A,13799,,,1,,,N,,12737,BAO_0000218,,1,,9986.0,,50592,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,Oryctolagus cuniculus,CHEMBL627158,
Intermediate,,A,13799,,,1,,,N,,12738,BAO_0000218,,1,,9986.0,1969.0,50592,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,Oryctolagus cuniculus,CHEMBL627159,Plasma
Intermediate,,A,13799,,,1,,,N,,12739,BAO_0000218,,1,,10090.0,,50594,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,Mus musculus,CHEMBL627160,
Intermediate,,A,13799,,,1,,,N,,12740,BAO_0000218,,1,,10116.0,,50597,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,Rattus norvegicus,CHEMBL628540,
Intermediate,,A,13799,,,1,,,N,,12741,BAO_0000218,,1,,10116.0,1969.0,50597,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,Rattus norvegicus,CHEMBL628541,Plasma
Intermediate,,A,13799,,,1,,,N,,12742,BAO_0000218,,1,,10116.0,1969.0,50597,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,Rattus norvegicus,CHEMBL628542,Plasma
Autocuration,,P,6629,,,1,,,U,,12743,BAO_0000100,,0,,,,22229,Solubility after at a pH 1.2,,CHEMBL628543,
Autocuration,,P,6629,,,1,,,U,,12744,BAO_0000100,,0,,,,22229,Solubility after at pH 1.2,,CHEMBL628544,
Autocuration,,P,6629,,,1,,,U,,12745,BAO_0000100,,0,,,,22229,Solubility after injection of water,,CHEMBL628545,
Autocuration,,A,14000,,,1,,,U,,12746,BAO_0000019,,0,,,,22224,Statistical significance of IC 50 values; Expressed as R value,,CHEMBL628546,
Autocuration,,A,8267,,,1,,,U,,12747,BAO_0000019,,0,,,,22224,Systemic availability with respect to methyldopa was determined,,CHEMBL874455,
Intermediate,,A,13799,,,1,,,N,,12748,BAO_0000218,,1,,10116.0,,50597,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,Rattus norvegicus,CHEMBL628547,
Intermediate,,A,13799,,,1,,,N,,12749,BAO_0000218,,1,,10116.0,1969.0,50597,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,Rattus norvegicus,CHEMBL628548,Plasma
Intermediate,,A,7132,,,1,,,N,,12750,BAO_0000218,,1,,9986.0,1988.0,50592,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",Oryctolagus cuniculus,CHEMBL628549,Feces
Intermediate,,A,7132,,,1,,,N,,12751,BAO_0000218,,1,,9986.0,1988.0,50592,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",Oryctolagus cuniculus,CHEMBL628550,Feces
Intermediate,,A,7132,,,1,,,N,,12752,BAO_0000218,,1,,9986.0,1988.0,50592,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",Oryctolagus cuniculus,CHEMBL628551,Feces
Intermediate,,A,7132,,,1,,,N,,12753,BAO_0000218,,1,,9986.0,1088.0,50592,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",Oryctolagus cuniculus,CHEMBL628552,Urine
Intermediate,,A,7132,,,1,,,N,,12754,BAO_0000218,,1,,9986.0,1088.0,50592,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",Oryctolagus cuniculus,CHEMBL628553,Urine
Intermediate,,A,7132,,,1,,,N,,12755,BAO_0000218,,1,,9986.0,1088.0,50592,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",Oryctolagus cuniculus,CHEMBL628554,Urine
Intermediate,,A,7132,,,1,,,N,,12756,BAO_0000218,,1,,9986.0,1088.0,50592,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",Oryctolagus cuniculus,CHEMBL628555,Urine
Intermediate,,A,7132,,,1,,,N,,12757,BAO_0000218,,1,,9986.0,1088.0,50592,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",Oryctolagus cuniculus,CHEMBL628556,Urine
Intermediate,,A,7132,,,1,,,N,,12758,BAO_0000218,,1,,9986.0,2113.0,50592,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",Oryctolagus cuniculus,CHEMBL628557,Kidney
Intermediate,,A,7132,,,1,,,N,,12759,BAO_0000218,,1,,9986.0,1988.0,50592,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",Oryctolagus cuniculus,CHEMBL628558,Feces
Intermediate,,A,7132,,,1,,,N,,12760,BAO_0000218,,1,,9986.0,1988.0,50592,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",Oryctolagus cuniculus,CHEMBL628559,Feces
Intermediate,,A,7132,,,1,,,N,,12761,BAO_0000218,,1,,9986.0,1988.0,50592,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",Oryctolagus cuniculus,CHEMBL628560,Feces
Intermediate,,A,7132,,,1,,,N,,12762,BAO_0000218,,1,,9986.0,1088.0,50592,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",Oryctolagus cuniculus,CHEMBL874456,Urine
Intermediate,,A,7132,,,1,,,N,,12763,BAO_0000218,,1,,9986.0,1988.0,50592,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",Oryctolagus cuniculus,CHEMBL628561,Feces
Intermediate,,A,7132,,,1,,,N,,12764,BAO_0000218,,1,,9986.0,1988.0,50592,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",Oryctolagus cuniculus,CHEMBL628562,Feces
Intermediate,,A,7132,,,1,,,N,,12765,BAO_0000218,,1,,9986.0,1088.0,50592,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",Oryctolagus cuniculus,CHEMBL628563,Urine
Intermediate,,A,7132,,,1,,,N,,12766,BAO_0000218,,1,,9986.0,1088.0,50592,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",Oryctolagus cuniculus,CHEMBL628564,Urine
Intermediate,,A,7132,,,1,,,N,,12767,BAO_0000218,,1,,9986.0,1088.0,50592,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",Oryctolagus cuniculus,CHEMBL628565,Urine
Intermediate,,A,7132,,,1,,,N,,12768,BAO_0000218,,1,,9986.0,1088.0,50592,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",Oryctolagus cuniculus,CHEMBL631248,Urine
Intermediate,,A,7132,,,1,,,N,,12769,BAO_0000218,,1,,9986.0,1088.0,50592,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",Oryctolagus cuniculus,CHEMBL631249,Urine
Intermediate,,A,7132,,,1,,,N,,12770,BAO_0000218,,1,,9986.0,2113.0,50592,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",Oryctolagus cuniculus,CHEMBL627214,Kidney
Intermediate,,A,7132,,,1,,,N,,12771,BAO_0000218,,1,,9986.0,1988.0,50592,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",Oryctolagus cuniculus,CHEMBL874591,Feces
Intermediate,,A,7132,,,1,,,N,,12772,BAO_0000218,,1,,9986.0,1988.0,50592,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",Oryctolagus cuniculus,CHEMBL627215,Feces
Intermediate,,A,7132,,,1,,,N,,12773,BAO_0000218,,1,,9986.0,1988.0,50592,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,Oryctolagus cuniculus,CHEMBL625471,Feces
Intermediate,,A,7132,,,1,,,N,,12774,BAO_0000218,,1,,9986.0,,50592,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,Oryctolagus cuniculus,CHEMBL625472,
Intermediate,,A,7132,,,1,,,N,,12775,BAO_0000218,,1,,9986.0,,50592,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,Oryctolagus cuniculus,CHEMBL625473,
Intermediate,,A,13317,In vivo,,1,,,N,,12776,BAO_0000218,,1,,9615.0,,50588,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,Canis lupus familiaris,CHEMBL625474,
Intermediate,,A,15341,In vivo,,1,,,N,,12777,BAO_0000218,,1,,9615.0,,50588,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,Canis lupus familiaris,CHEMBL625475,
Intermediate,,A,15341,In vivo,,1,,,N,,12778,BAO_0000218,,1,,10116.0,,50597,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,Rattus norvegicus,CHEMBL625476,
Intermediate,,A,15341,In vivo,,1,,,N,,12779,BAO_0000218,,1,,10116.0,,50597,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,Rattus norvegicus,CHEMBL625477,
Intermediate,,A,15341,In vivo,,1,,,N,,12780,BAO_0000218,,1,,10116.0,,50597,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,Rattus norvegicus,CHEMBL625478,
Intermediate,,A,12801,In vitro,,1,,,N,,12781,BAO_0000218,,1,,10116.0,,50597,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,Rattus norvegicus,CHEMBL625479,esophageal tunica muscularis mucosae
Intermediate,,A,12801,In vitro,,1,,,N,,12782,BAO_0000218,,1,,10116.0,,50597,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,Rattus norvegicus,CHEMBL625480,esophageal tunica muscularis mucosae
Intermediate,,A,14856,In vivo,,1,,,N,,12783,BAO_0000218,,1,,10116.0,1969.0,50597,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,Rattus norvegicus,CHEMBL625481,Plasma
Intermediate,,A,14062,In vivo,,1,,,N,,12784,BAO_0000218,,1,,10116.0,,50597,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,Rattus norvegicus,CHEMBL625482,
Intermediate,,A,14062,In vivo,,1,,,N,,12785,BAO_0000218,,1,,10116.0,,50597,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,Rattus norvegicus,CHEMBL625483,
Intermediate,,A,14062,In vivo,,1,,,N,,12786,BAO_0000218,,1,,10116.0,,50597,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,Rattus norvegicus,CHEMBL625484,
Intermediate,,A,14062,In vivo,,1,,,N,,12787,BAO_0000218,,1,,10116.0,,50597,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,Rattus norvegicus,CHEMBL625485,
Intermediate,,A,14346,In vivo,,1,,,N,,12788,BAO_0000218,,1,,9615.0,1969.0,50588,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,Canis lupus familiaris,CHEMBL625486,Plasma
Intermediate,,A,14346,In vivo,,1,,,N,,12789,BAO_0000218,,1,,10116.0,1969.0,50597,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,Rattus norvegicus,CHEMBL625487,Plasma
Intermediate,,A,14346,In vivo,,1,,,N,,12790,BAO_0000218,,1,,10116.0,1969.0,50597,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,Rattus norvegicus,CHEMBL625488,Plasma
Intermediate,,A,14346,In vivo,,1,,,N,,12791,BAO_0000218,,1,,10116.0,1969.0,50597,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,Rattus norvegicus,CHEMBL625489,Plasma
Intermediate,,A,14346,In vivo,,1,,,N,,12792,BAO_0000218,,1,,10116.0,1969.0,50597,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,Rattus norvegicus,CHEMBL625490,Plasma
Intermediate,,A,14346,In vivo,,1,,,N,,12793,BAO_0000218,,1,,9615.0,1969.0,50588,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,Canis lupus familiaris,CHEMBL625491,Plasma
Intermediate,,A,14346,In vivo,,1,,,N,,12794,BAO_0000218,,1,,10116.0,1969.0,50597,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,Rattus norvegicus,CHEMBL625492,Plasma
Intermediate,,A,15711,In vivo,,1,,,N,,12795,BAO_0000218,,1,,9606.0,1969.0,50587,plasma clearance in human,Homo sapiens,CHEMBL625493,Plasma
Intermediate,,A,14886,In vivo,,1,,,N,,12796,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,Rattus norvegicus,CHEMBL625494,
Intermediate,,A,14886,In vivo,,1,,,N,,12797,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,Rattus norvegicus,CHEMBL625495,
Intermediate,,A,14886,In vivo,,1,,,N,,12798,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,Rattus norvegicus,CHEMBL625496,
Autocuration,,P,4115,,,1,,,U,,12799,BAO_0000100,,0,,,,22229,1-Octanol/water partition coefficient measured at 7.4,,CHEMBL625497,
Autocuration,,P,13733,,,1,,,U,,12800,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625498,
Autocuration,,A,12102,,,1,,,U,,12801,BAO_0000019,,0,,,,22224,Partition coefficient (logP),,CHEMBL625499,
Autocuration,,P,12676,,,1,,,U,,12802,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625500,
Autocuration,,P,13733,,,1,,,U,,12803,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625501,
Autocuration,,P,13740,,,1,,,U,,12804,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625502,
Autocuration,,P,12766,,,1,,,U,,12805,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP) (relative to BAY K 8644),,CHEMBL625503,
Autocuration,,P,2764,,,1,,,U,,12806,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625504,
Autocuration,,P,12355,,,1,,,U,,12807,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625505,
Autocuration,,P,11314,,,1,,,U,,12808,BAO_0000100,,0,,,,22229,Calculated partition coefficient of the compound,,CHEMBL625506,
Autocuration,,A,12706,,,1,,,U,,12809,BAO_0000019,,0,,,,22224,Partition coefficient (logP),,CHEMBL625507,
Autocuration,,P,12645,,,1,,,U,,12810,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625508,
Autocuration,,P,13668,,,1,,,U,,12811,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625509,
Autocuration,,P,12819,,,1,,,U,,12812,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625510,
Autocuration,,P,13668,,,1,,,U,,12813,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL883125,
Autocuration,,P,13017,,,1,,,U,,12814,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625511,
Autocuration,,A,2448,,,1,,,U,,12815,BAO_0000019,,0,,,,22224,Partition coefficient of the compound,,CHEMBL874650,
Autocuration,,A,11526,,,1,,,U,,12816,BAO_0000019,,0,,,,22224,Partition coefficient of the compound,,CHEMBL625512,
Autocuration,,A,12426,,,1,,,U,,12817,BAO_0000019,,0,,,,22224,Partition coefficient of compound was determined,,CHEMBL625513,
Autocuration,,A,2448,,,1,,,U,,12818,BAO_0000019,,0,,,,22224,Partition coefficient was determined,,CHEMBL625514,
Autocuration,,P,12001,,,1,,,U,,12819,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625515,
Autocuration,,P,12426,,,1,,,U,,12820,BAO_0000100,,0,,,,22229,partition coefficient of compound was determined,,CHEMBL625516,
Intermediate,,A,13204,In vivo,,1,,,N,,12821,BAO_0000218,,1,,9615.0,,50588,The total body administered intravenously in dog,Canis lupus familiaris,CHEMBL625517,
Intermediate,,A,13204,In vivo,,1,,,N,,12822,BAO_0000218,,1,,10116.0,,50597,The total body administered intravenously in rats,Rattus norvegicus,CHEMBL625518,
Intermediate,,A,13889,,,1,,,N,,12823,BAO_0000218,,1,,10090.0,,50594,Time taken for the administration to female NIH mice weighing 25-30 g.,Mus musculus,CHEMBL625519,
Autocuration,,A,13889,,,1,,,U,,12824,BAO_0000019,,0,,,,22224,Time taken for the administration,,CHEMBL625520,
Intermediate,,A,17025,In vivo,,1,,,N,,12825,BAO_0000218,,1,,9615.0,,50588,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,Canis lupus familiaris,CHEMBL874651,
Autocuration,,A,17025,In vivo,,1,,,U,,12826,BAO_0000218,,0,,314293.0,,22224,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,Simiiformes,CHEMBL625521,
Intermediate,,A,17025,In vivo,,1,,,N,,12827,BAO_0000218,,1,,9986.0,,50592,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,Oryctolagus cuniculus,CHEMBL623171,
Intermediate,,A,17025,In vivo,,1,,,N,,12828,BAO_0000218,,1,,10116.0,,50597,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,Rattus norvegicus,CHEMBL623853,
Autocuration,,A,15067,,,1,,,U,,12829,BAO_0000019,,0,,,,22224,Plasma clearance for the compound was determined.,,CHEMBL623854,
Autocuration,,P,3091,,,1,,,U,,12830,BAO_0000100,,0,,,,22224,CLog P value of the compound,,CHEMBL874405,
Autocuration,,P,15592,,,1,,,U,,12831,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL623855,
Autocuration,,P,14738,,,1,,,U,,12832,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL623856,
Autocuration,,P,14738,,,1,,,U,,12833,BAO_0000100,,0,,,,22224,ClogP value of the compound; nd ='no data',,CHEMBL623857,
Autocuration,,P,14738,,,1,,,U,,12834,BAO_0000100,,0,,,,22224,ClogP value of the compound; nd ='not determined',,CHEMBL623858,
Autocuration,,P,6076,,,1,,,U,,12835,BAO_0000100,,0,,,,22224,CLog P was determined,,CHEMBL623859,
Autocuration,,P,17840,,,1,,,U,,12836,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL839829,
Autocuration,,A,13589,,,1,,,U,,12837,BAO_0000019,,0,,,,22224,CLogP was calculated,,CHEMBL623860,
Autocuration,,A,17655,,,1,,,U,,12838,BAO_0000019,,0,,,,22224,CLogP value was determined,,CHEMBL623861,
Autocuration,,A,5867,,,1,,,U,,12839,BAO_0000019,,0,,,,22224,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,,CHEMBL623862,
Autocuration,,P,5867,,,1,,,U,,12840,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL874406,
Autocuration,,P,10783,,,1,,,U,,12841,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL623863,
Autocuration,,P,14849,,,1,,,U,,12842,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL624021,
Intermediate,,A,8170,,,1,,,N,,12843,BAO_0000218,,1,,9615.0,1236.0,50588,Distribution in female dog adrenal medulla 24 hours after administration.,Canis lupus familiaris,CHEMBL624022,Adrenal medulla
Intermediate,,A,8170,,,1,,,N,,12844,BAO_0000218,,1,,9615.0,1236.0,50588,Distribution in female dog adrenal medulla 72 hours after administration.,Canis lupus familiaris,CHEMBL624023,Adrenal medulla
Intermediate,,A,8170,,,1,,,N,,12845,BAO_0000218,,1,,9615.0,,50588,Distribution in female dog bile 24 hours after administration.,Canis lupus familiaris,CHEMBL624024,
Intermediate,,A,8170,,,1,,,N,,12846,BAO_0000218,,1,,9615.0,,50588,Distribution in female dog bile 72 hr after administration.,Canis lupus familiaris,CHEMBL624025,
Intermediate,,A,8170,,,1,,,N,,12847,BAO_0000218,,1,,9615.0,,50588,Distribution in female dog blood 24 hours after administration.,Canis lupus familiaris,CHEMBL624026,
Intermediate,,A,8170,,,1,,,N,,12848,BAO_0000218,,1,,9615.0,,50588,Distribution in female dog blood 72 hours after administration.,Canis lupus familiaris,CHEMBL624027,
Intermediate,,A,8170,,,1,,,N,,12849,BAO_0000218,,1,,9615.0,,50588,Distribution in female dog heart 24 hours after administration.,Canis lupus familiaris,CHEMBL624028,
Intermediate,,A,8170,,,1,,,N,,12850,BAO_0000218,,1,,9615.0,,50588,Distribution in female dog heart 72 hours after administration.,Canis lupus familiaris,CHEMBL624029,
Intermediate,,A,8170,,,1,,,N,,12851,BAO_0000218,,1,,9615.0,,50588,Distribution in female dog kidney 24 hours after administration.,Canis lupus familiaris,CHEMBL624030,
Intermediate,,A,8170,,,1,,,N,,12852,BAO_0000218,,1,,9615.0,,50588,Distribution in female dog kidney 72 hours after administration.,Canis lupus familiaris,CHEMBL624031,
Intermediate,,A,8170,,,1,,,N,,12853,BAO_0000218,,1,,9615.0,160.0,50588,Distribution in female dog large intestine 24 hours after administration.,Canis lupus familiaris,CHEMBL624032,Intestine
Intermediate,,A,8170,,,1,,,N,,12854,BAO_0000218,,1,,9615.0,160.0,50588,Distribution in female dog large intestine 72 hours after administration.,Canis lupus familiaris,CHEMBL874407,Intestine
Intermediate,,A,8170,,,1,,,N,,12855,BAO_0000218,,1,,9615.0,,50588,Distribution in female dog liver 24 hours after administration.,Canis lupus familiaris,CHEMBL624033,
Intermediate,,A,8170,,,1,,,N,,12856,BAO_0000218,,1,,9615.0,,50588,Distribution in female dog liver 72 hours after administration.,Canis lupus familiaris,CHEMBL624034,
Intermediate,,A,8170,,,1,,,N,,12857,BAO_0000218,,1,,9615.0,,50588,Distribution in female dog lung 24 hours after administration.,Canis lupus familiaris,CHEMBL624035,
Intermediate,,A,8170,,,1,,,N,,12858,BAO_0000218,,1,,9615.0,,50588,Distribution in female dog lung 72 hours after administration.,Canis lupus familiaris,CHEMBL624036,
Intermediate,,A,8170,,,1,,,N,,12859,BAO_0000218,,1,,9615.0,2385.0,50588,Distribution in female dog muscle 24 hours after administration.,Canis lupus familiaris,CHEMBL624037,Muscle tissue
Intermediate,,A,8170,,,1,,,N,,12860,BAO_0000218,,1,,9615.0,2385.0,50588,Distribution in female dog muscle 72 hours after administration.,Canis lupus familiaris,CHEMBL624038,Muscle tissue
Intermediate,,A,8170,,,1,,,N,,12861,BAO_0000218,,1,,9615.0,,50588,Distribution in female dog pancreas 24 hours after administration.,Canis lupus familiaris,CHEMBL624039,
Intermediate,,A,8170,,,1,,,N,,12862,BAO_0000218,,1,,9615.0,,50588,Distribution in female dog pancreas 72 hours after administration.,Canis lupus familiaris,CHEMBL624040,
Intermediate,,A,8170,,,1,,,N,,12863,BAO_0000218,,1,,9615.0,160.0,50588,Distribution in female dog small intestine 24 hours after administration.,Canis lupus familiaris,CHEMBL624041,Intestine
Intermediate,,A,8170,,,1,,,N,,12864,BAO_0000218,,1,,9615.0,160.0,50588,Distribution in female dog small intestine 72 hours after administration.,Canis lupus familiaris,CHEMBL624042,Intestine
Intermediate,,A,8170,,,1,,,N,,12865,BAO_0000218,,1,,9615.0,2106.0,50588,Distribution in female dog spleen 24 hours after administration.,Canis lupus familiaris,CHEMBL624043,Spleen
Intermediate,,A,8170,,,1,,,N,,12866,BAO_0000218,,1,,9615.0,2106.0,50588,Distribution in female dog spleen 72 hours after administration.,Canis lupus familiaris,CHEMBL624044,Spleen
Intermediate,,A,8170,,,1,,,N,,12867,BAO_0000218,,1,,9615.0,945.0,50588,Distribution in female dog stomach 24 hours after administration.,Canis lupus familiaris,CHEMBL624045,Stomach
Intermediate,,A,8170,,,1,,,N,,12868,BAO_0000218,,1,,9615.0,945.0,50588,Distribution in female dog stomach 72 hours after administration.,Canis lupus familiaris,CHEMBL624046,Stomach
Intermediate,,A,8170,,,1,,,N,,12869,BAO_0000218,,1,,9615.0,2046.0,50588,Distribution in female dog thyroid 24 hours after administration.,Canis lupus familiaris,CHEMBL624047,Thyroid gland
Intermediate,,A,8170,,,1,,,N,,12870,BAO_0000218,,1,,9615.0,2046.0,50588,Distribution in female dog thyroid 72 hours after administration.,Canis lupus familiaris,CHEMBL624048,Thyroid gland
Intermediate,,A,8170,,,1,,,N,,12871,BAO_0000218,,1,,9615.0,1088.0,50588,Distribution in female dog urine 24 hours after administration.,Canis lupus familiaris,CHEMBL874408,Urine
Intermediate,,A,8170,,,1,,,N,,12872,BAO_0000218,,1,,9615.0,1088.0,50588,Distribution in female dog urine 72 hr after administration.,Canis lupus familiaris,CHEMBL624049,Urine
Autocuration,,A,14283,,,1,,,U,,12873,BAO_0000218,,0,,,1969.0,22224,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,,CHEMBL624050,Plasma
Autocuration,,A,5623,,,1,,,U,,12874,BAO_0000019,,0,,,,22224,Plasma concentration at 7 hr after intravenous dosing,,CHEMBL624051,
Intermediate,,A,13477,,,1,,,N,,12875,BAO_0000218,,1,,10116.0,,50597,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,Rattus norvegicus,CHEMBL623278,
Intermediate,,A,13477,,,1,,,N,,12876,BAO_0000218,,1,,10116.0,,50597,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,Rattus norvegicus,CHEMBL623279,
Intermediate,,A,13477,,,1,,,N,,12877,BAO_0000218,,1,,10116.0,,50597,Plasma concentration of 3 mg/kg iv after 1 hr in rats,Rattus norvegicus,CHEMBL623280,
Intermediate,,A,13477,,,1,,,N,,12878,BAO_0000218,,1,,10116.0,,50597,Plasma concentration of 3 mg/kg iv after 2 hr in rats,Rattus norvegicus,CHEMBL623963,
Intermediate,,A,13477,,,1,,,N,,12879,BAO_0000218,,1,,10116.0,,50597,Plasma concentration of 3 mg/kg iv after 4 hr in rats,Rattus norvegicus,CHEMBL623964,
Intermediate,,A,13477,,,1,,,N,,12880,BAO_0000218,,1,,10116.0,,50597,Plasma concentration of 3 mg/kg iv after 6 hr in rats,Rattus norvegicus,CHEMBL623965,
Intermediate,,A,13477,,,1,,,N,,12881,BAO_0000218,,1,,10116.0,,50597,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,Rattus norvegicus,CHEMBL623966,
Intermediate,,A,13477,,,1,,,N,,12882,BAO_0000218,,1,,10116.0,,50597,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,Rattus norvegicus,CHEMBL874415,
Intermediate,,A,13477,,,1,,,N,,12883,BAO_0000218,,1,,10116.0,,50597,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,Rattus norvegicus,CHEMBL623967,
Intermediate,,A,13477,,,1,,,N,,12884,BAO_0000218,,1,,10116.0,,50597,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,Rattus norvegicus,CHEMBL623968,
Intermediate,,A,13477,,,1,,,N,,12885,BAO_0000218,,1,,10116.0,,50597,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,Rattus norvegicus,CHEMBL623969,
Intermediate,,A,13477,,,1,,,N,,12886,BAO_0000218,,1,,10116.0,,50597,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,Rattus norvegicus,CHEMBL628409,
Intermediate,,A,13477,,,1,,,N,,12887,BAO_0000218,,1,,10116.0,,50597,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,Rattus norvegicus,CHEMBL628410,
Intermediate,,A,13477,,,1,,,N,,12888,BAO_0000218,,1,,10116.0,,50597,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,Rattus norvegicus,CHEMBL628411,
Intermediate,,A,13477,,,1,,,N,,12889,BAO_0000218,,1,,10116.0,,50597,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,Rattus norvegicus,CHEMBL628412,
Autocuration,,A,12553,,,1,,,U,,12890,BAO_0000019,,0,,,,22224,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,,CHEMBL628413,
Autocuration,,A,14548,,,1,,,U,,12891,BAO_0000019,,0,,,1969.0,22224,The concentration in plasmat; Not determined,,CHEMBL628414,Plasma
Intermediate,,A,14393,,,1,,,N,,12892,BAO_0000218,,1,,10116.0,,50597,Tissue level at 10 mg/kg/po in wistar rats in blood,Rattus norvegicus,CHEMBL628415,
Intermediate,,A,14393,,,1,,,N,,12893,BAO_0000218,,1,,10116.0,,50597,Tissue level at 10 mg/kg/po in wistar rats in brown fat,Rattus norvegicus,CHEMBL628416,
Intermediate,,A,14393,,,1,,,N,,12894,BAO_0000218,,1,,10116.0,,50597,Tissue level at 10 mg/kg/po in wistar rats in heart,Rattus norvegicus,CHEMBL628417,
Intermediate,,A,14393,,,1,,,N,,12895,BAO_0000218,,1,,10116.0,2107.0,50597,Tissue level at 10 mg/kg/po in wistar rats in liver,Rattus norvegicus,CHEMBL874908,Liver
Intermediate,,A,14393,,,1,,,N,,12896,BAO_0000218,,1,,10116.0,,50597,Tissue level at 10 mg/kg/po in wistar rats in plasma,Rattus norvegicus,CHEMBL628418,
Intermediate,,A,14393,,,1,,,N,,12897,BAO_0000218,,1,,10116.0,2385.0,50597,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,Rattus norvegicus,CHEMBL628419,Muscle tissue
Intermediate,,A,14393,,,1,,,N,,12898,BAO_0000218,,1,,10116.0,,50597,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,Rattus norvegicus,CHEMBL628420,
Autocuration,,A,1629,,,1,,,U,,12899,BAO_0000019,,0,,,,22224,Water solubility at 37 degree C.,,CHEMBL628421,
Autocuration,,P,8194,,,1,,,U,,12900,BAO_0000100,,0,,,,22229,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,CHEMBL626726,
Autocuration,,P,8194,,,1,,,U,,12901,BAO_0000100,,0,,,,22229,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,CHEMBL626727,
Intermediate,,A,8594,,,1,,,N,,12902,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL626728,Blood
Intermediate,,A,8594,,,1,,,N,,12903,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL626729,Blood
Intermediate,,A,8594,,,1,,,N,,12904,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL626730,Blood
Intermediate,,A,8594,,,1,,,N,,12905,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL626731,Blood
Intermediate,,A,8594,,,1,,,N,,12906,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL626732,Blood
Intermediate,,A,8594,,,1,,,N,,12907,BAO_0000218,,1,,10116.0,948.0,50597,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL626733,Heart
Intermediate,,A,8594,,,1,,,N,,12908,BAO_0000218,,1,,10116.0,948.0,50597,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL626734,Heart
Intermediate,,A,8594,,,1,,,N,,12909,BAO_0000218,,1,,10116.0,948.0,50597,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL626735,Heart
Intermediate,,A,8594,,,1,,,N,,12910,BAO_0000218,,1,,10116.0,948.0,50597,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL874909,Heart
Intermediate,,A,8594,,,1,,,N,,12911,BAO_0000218,,1,,10116.0,948.0,50597,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL626736,Heart
Intermediate,,A,8594,,,1,,,N,,12912,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL626737,Kidney
Intermediate,,A,8594,,,1,,,N,,12913,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL630999,Kidney
Intermediate,,A,8594,,,1,,,N,,12914,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL631000,Kidney
Intermediate,,A,8594,,,1,,,N,,12915,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL631001,Kidney
Intermediate,,A,8594,,,1,,,N,,12916,BAO_0000218,,1,,10116.0,2113.0,50597,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL631002,Kidney
Intermediate,,A,8594,,,1,,,N,,12917,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL631003,Liver
Intermediate,,A,8594,,,1,,,N,,12918,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL631004,Liver
Intermediate,,A,8594,,,1,,,N,,12919,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL631005,Liver
Intermediate,,A,8594,,,1,,,N,,12920,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL631006,Liver
Intermediate,,A,8594,,,1,,,N,,12921,BAO_0000218,,1,,10116.0,2107.0,50597,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL631007,Liver
Intermediate,,A,8594,,,1,,,N,,12922,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL631008,Lung
Intermediate,,A,8594,,,1,,,N,,12923,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL631009,Lung
Intermediate,,A,8594,,,1,,,N,,12924,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL631010,Lung
Intermediate,,A,8594,,,1,,,N,,12925,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL631011,Lung
Intermediate,,A,8594,,,1,,,N,,12926,BAO_0000218,,1,,10116.0,2048.0,50597,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL631012,Lung
Intermediate,,A,8594,,,1,,,N,,12927,BAO_0000218,,1,,10116.0,2046.0,50597,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL630271,Thyroid gland
Intermediate,,A,8594,,,1,,,N,,12928,BAO_0000218,,1,,10116.0,2046.0,50597,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL630272,Thyroid gland
Intermediate,,A,8594,,,1,,,N,,12929,BAO_0000218,,1,,10116.0,2046.0,50597,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL630273,Thyroid gland
Intermediate,,A,8594,,,1,,,N,,12930,BAO_0000218,,1,,10116.0,2046.0,50597,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL630274,Thyroid gland
Intermediate,,A,8594,,,1,,,N,,12931,BAO_0000218,,1,,10116.0,2046.0,50597,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL630275,Thyroid gland
Intermediate,,A,8594,,,1,,,N,,12932,BAO_0000218,,1,,10116.0,,50597,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL875782,
Intermediate,,A,8594,,,1,,,N,,12933,BAO_0000218,,1,,10116.0,,50597,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL630276,
Intermediate,,A,8594,,,1,,,N,,12934,BAO_0000218,,1,,10116.0,,50597,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL630277,
Intermediate,,A,8594,,,1,,,N,,12935,BAO_0000218,,1,,10116.0,,50597,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL630278,
Intermediate,,A,8594,,,1,,,N,,12936,BAO_0000218,,1,,10116.0,,50597,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,CHEMBL630279,
Autocuration,,A,8151,,,1,,,U,,12937,BAO_0000019,,0,,,,22224,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,,CHEMBL630280,
Autocuration,,A,8151,,,1,,,U,,12938,BAO_0000019,,0,,,,22224,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,CHEMBL630281,
Intermediate,,A,7132,,,1,,,N,,12939,BAO_0000218,,1,,9986.0,,50592,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,Oryctolagus cuniculus,CHEMBL630282,
Intermediate,,A,7132,,,1,,,N,,12940,BAO_0000218,,1,,9986.0,,50592,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,Oryctolagus cuniculus,CHEMBL630283,
Autocuration,,A,5797,,,1,,,U,,12941,BAO_0000019,,0,,,,22224,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),,CHEMBL630284,
Autocuration,,A,7849,,,1,,,U,,12942,BAO_0000019,,0,,,,22224,Alkylating activity was determined,,CHEMBL630285,
Autocuration,,A,14220,,,1,,Microsomes,U,,12943,BAO_0000251,,0,,,,22224,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),,CHEMBL630286,
Intermediate,,A,8650,,,1,,,N,,12944,BAO_0000218,,1,,9986.0,,50592,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",Oryctolagus cuniculus,CHEMBL630069,
Intermediate,,A,8650,,,1,,,N,,12945,BAO_0000218,,1,,9986.0,,50592,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",Oryctolagus cuniculus,CHEMBL630070,
Intermediate,,A,8650,,,1,,,N,,12946,BAO_0000218,,1,,9986.0,,50592,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",Oryctolagus cuniculus,CHEMBL630071,
Intermediate,,A,8650,,,1,,,N,,12947,BAO_0000218,,1,,9986.0,,50592,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",Oryctolagus cuniculus,CHEMBL630072,
Intermediate,,A,8650,,,1,,,N,,12948,BAO_0000218,,1,,9986.0,,50592,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",Oryctolagus cuniculus,CHEMBL875110,
Intermediate,,A,7116,,,1,,,N,,12949,BAO_0000218,,1,,10116.0,,50597,Compound was tested for antidiuretic activity in rats,Rattus norvegicus,CHEMBL630073,
Autocuration,,A,14131,,,1,,,U,,12950,BAO_0000019,,0,,,,22224,Compound was tested for inactivation kinetic values,,CHEMBL630074,
Autocuration,,A,7415,In vivo,,1,,,U,,12951,BAO_0000218,,0,,,,22224,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,,CHEMBL630075,
Autocuration,,A,13178,,,1,,,U,,12952,BAO_0000019,,0,,,,22224,Dissociation rate calculated from the first-order equation using the t1/2 value,,CHEMBL630076,
Autocuration,,P,8815,,,1,,,U,,12953,BAO_0000100,,0,,,,22229,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,,CHEMBL630077,
Autocuration,,P,1450,,,1,,,U,,12954,BAO_0000100,,0,,,,22229,Aqueous solubility was measured,,CHEMBL630078,
Autocuration,,P,1450,,,1,,,U,,12955,BAO_0000100,,0,,,,22229,Aqueous solubility was measured at a pH 4,,CHEMBL630079,
Autocuration,,P,1450,,,1,,,U,,12956,BAO_0000100,,0,,,,22229,Aqueous solubility (pH 7),,CHEMBL630080,
Autocuration,,P,1450,,,1,,,U,,12957,BAO_0000100,,0,,,,22229,Aqueous solubility was measured at a pH 9,,CHEMBL630081,
Autocuration,,A,12711,,,1,,,U,,12958,BAO_0000019,,0,,,,22224,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",,CHEMBL630082,
Autocuration,,A,12711,,,1,,,U,,12959,BAO_0000019,,0,,,,22224,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,CHEMBL630083,
Autocuration,,A,12711,,,1,,,U,,12960,BAO_0000019,,0,,,,22224,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,CHEMBL630084,
Autocuration,,P,15032,,,1,,,U,,12961,BAO_0000100,,0,,,,22229,Aqueous solubility of the compound,,CHEMBL629198,
Autocuration,,P,9964,,,1,,,U,,12962,BAO_0000100,,0,,,,22229,Aqueous solubility at 37 degree Celsius at pH 7.38,,CHEMBL629199,
Autocuration,,P,14962,,,1,,,U,,12963,BAO_0000100,,0,,,,22229,Aqueous solubility in pH 7.4 phosphate buffer,,CHEMBL629200,
Intermediate,,A,12487,,,1,,,N,,12964,BAO_0000218,,1,,9615.0,,50588,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,Canis lupus familiaris,CHEMBL629201,
Intermediate,,A,12487,,,1,,,N,,12965,BAO_0000218,,1,,9615.0,,50588,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,Canis lupus familiaris,CHEMBL629202,
Intermediate,,A,10026,,,1,,,N,,12966,BAO_0000218,,1,,9606.0,,50587,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,Homo sapiens,CHEMBL875111,
Intermediate,,A,10026,,,1,,,N,,12967,BAO_0000218,,1,,9606.0,,50587,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,Homo sapiens,CHEMBL629203,
Intermediate,,A,10026,,,1,,,N,,12968,BAO_0000218,,1,,9606.0,,50587,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,Homo sapiens,CHEMBL629204,
Intermediate,,A,10026,,,1,,,N,,12969,BAO_0000218,,1,,9606.0,,50587,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,Homo sapiens,CHEMBL629205,
Intermediate,,A,10026,,,1,,,N,,12970,BAO_0000218,,1,,9606.0,,50587,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,Homo sapiens,CHEMBL629206,
Autocuration,,A,10026,,,1,,,U,,12971,BAO_0000019,,0,,,,22224,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,,CHEMBL631185,
Intermediate,,A,7415,,,1,,,N,,12972,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for the average bile flow rat in rats,Rattus norvegicus,CHEMBL631186,
Intermediate,,A,17025,,,1,,,N,,12973,BAO_0000218,,1,,9986.0,,50592,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",Oryctolagus cuniculus,CHEMBL631187,
Intermediate,,A,17025,,,1,,,N,,12974,BAO_0000218,,1,,9986.0,,50592,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",Oryctolagus cuniculus,CHEMBL631188,
Autocuration,,A,10184,,,1,,,U,,12975,BAO_0000019,,0,,,,22224,Average half life period was determined,,CHEMBL876419,
Autocuration,,A,10184,,,1,,,U,,12976,BAO_0000019,,0,,,,22224,Average half life period was determined,,CHEMBL631189,
Intermediate,,A,8613,,,1,,,N,,12977,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,Human herpesvirus 1,CHEMBL631190,
Intermediate,,A,8613,,,1,,,N,,12978,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,Human herpesvirus 1,CHEMBL631191,
Intermediate,,A,8613,,,1,,,N,,12979,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,Human herpesvirus 1,CHEMBL631192,
Intermediate,,A,8613,,,1,,,N,,12980,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,Human herpesvirus 1,CHEMBL632400,
Intermediate,,A,8613,,,1,,,N,,12981,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,Human herpesvirus 1,CHEMBL630564,
Intermediate,,A,8613,,,1,,,N,,12982,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,Human herpesvirus 1,CHEMBL630565,
Intermediate,,A,8613,,,1,,,N,,12983,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,Human herpesvirus 1,CHEMBL630566,
Intermediate,,A,8613,,,1,,,N,,12984,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,Human herpesvirus 1,CHEMBL631229,
Intermediate,,A,8613,,,1,,,N,,12985,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,Human herpesvirus 1,CHEMBL631230,
Autocuration,,P,6030,,,1,,,U,,12986,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL876428,
Autocuration,,P,6147,,,1,,,U,,12987,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL631231,
Autocuration,,P,14556,,,1,,,U,,12988,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP) (MacLogP),,CHEMBL631232,
Autocuration,,A,768,,,1,,,U,,12989,BAO_0000019,,0,,,,22224,Hydrophilicity was determined,,CHEMBL631233,
Autocuration,,P,14452,,,1,,,U,,12990,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL631234,
Autocuration,,A,5237,,,1,,,U,,12991,BAO_0000019,,0,,,,22224,Increased absorption was determined,,CHEMBL883126,
Autocuration,,P,14378,,,1,,,U,,12992,BAO_0000100,,0,,,,22224,Lipophilicity value was evaluated,,CHEMBL631235,
Autocuration,,P,14418,,,1,,,U,,12993,BAO_0000100,,0,,,,22224,Log P value of the compound.,,CHEMBL631236,
Autocuration,,A,5249,,,1,,,U,,12994,BAO_0000019,,0,,,,22224,Partition coefficient of compound was determined,,CHEMBL631237,
Autocuration,,P,14621,,,1,,,U,,12995,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL631238,
Autocuration,,P,12542,,,1,,,U,,12996,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL876429,
Autocuration,,A,12542,,,1,,,U,,12997,BAO_0000019,,0,,,,22224,Partition coefficient was measured by medchem software; Not calculated,,CHEMBL631414,
Autocuration,,P,12542,,,1,,,U,,12998,BAO_0000100,,0,,,,22224,Partition coefficient was measured by octanol-water using standard shake-flask method,,CHEMBL631415,
Autocuration,,P,15462,,,1,,,U,,12999,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL631416,
Autocuration,,A,14884,,,1,,,U,,13000,BAO_0000019,,0,,,,22224,Partition coefficient (logP),,CHEMBL631417,
Autocuration,,P,16526,,,1,,,U,,13001,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL631418,
Autocuration,,P,13693,,,1,,,U,,13002,BAO_0000100,,0,,,,22229,The Octanol/Water partition coefficient CLogP,,CHEMBL631419,
Autocuration,,A,13693,,,1,,,U,,13003,BAO_0000019,,0,,,,22224,The pharmacokinetic parameter C Log p was reported,,CHEMBL631420,
Autocuration,,P,13779,,,1,,,U,,13004,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL631421,
Autocuration,,P,14772,,,1,,,U,,13005,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL631422,
Autocuration,,P,14393,,,1,,,U,,13006,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL631423,
Intermediate,,A,14793,In vivo,,1,,,N,,13007,BAO_0000218,,1,,10116.0,1969.0,50597,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Rattus norvegicus,CHEMBL876430,Plasma
Intermediate,,A,14793,In vivo,,1,,,N,,13008,BAO_0000218,,1,,10116.0,1969.0,50597,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,Rattus norvegicus,CHEMBL631424,Plasma
Intermediate,,A,13744,In vivo,,1,,,N,,13009,BAO_0000218,,1,,9615.0,1969.0,50588,Compound was administered intravenously in dog to evaluate plasma clearance values,Canis lupus familiaris,CHEMBL631425,Plasma
Autocuration,,A,13744,In vivo,,1,,,U,,13010,BAO_0000218,,0,,314293.0,1969.0,22224,Compound was administered intravenously in monkey to evaluate plasma clearance values,Simiiformes,CHEMBL631426,Plasma
Intermediate,,A,13744,In vivo,,1,,,N,,13011,BAO_0000218,,1,,10090.0,1969.0,50594,Compound was administered intravenously in mouse to evaluate plasma clearance values,Mus musculus,CHEMBL631427,Plasma
Intermediate,,A,13207,In vivo,,1,,,N,,13012,BAO_0000218,,1,,9615.0,1969.0,50588,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,Canis lupus familiaris,CHEMBL631428,Plasma
Intermediate,,A,5669,In vitro,,1,,Microsomes,N,,13013,BAO_0000218,,1,,9544.0,2107.0,50797,Intrinsic clearance in Rhesus liver microsome,Macaca mulatta,CHEMBL631429,Liver
Intermediate,,A,5669,In vitro,,1,,Microsomes,N,,13014,BAO_0000218,,1,,9615.0,2107.0,50588,Intrinsic clearance in dog liver microsome,Canis lupus familiaris,CHEMBL631430,Liver
Intermediate,,A,5669,In vitro,,1,,Microsomes,N,,13015,BAO_0000218,,1,,10116.0,2107.0,50597,Intrinsic clearance in rat liver microsome,Rattus norvegicus,CHEMBL631431,Liver
Intermediate,,A,4853,In vivo,,1,,,N,,13016,BAO_0000218,,1,,9544.0,1969.0,50797,Low plasma clearance was calculated in rhesus monkey,Macaca mulatta,CHEMBL631432,Plasma
Intermediate,,A,16452,In vivo,,1,,,N,,13017,BAO_0000218,,1,,9615.0,,50588,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,Canis lupus familiaris,CHEMBL631433,
Autocuration,,A,11954,In vivo,,1,,,U,,13018,BAO_0000218,,0,,,,22224,Plasma clearance after intravenous dose of 0.3 mg/kg,,CHEMBL631434,
Autocuration,,A,11954,In vivo,,1,,,U,,13019,BAO_0000218,,0,,,,22224,Plasma clearance after intravenous dose of 1 mg/kg,,CHEMBL631435,
Autocuration,,A,11954,In vivo,,1,,,U,,13020,BAO_0000218,,0,,,,22224,Plasma clearance after intravenous dose of 3 mg/kg,,CHEMBL631436,
Autocuration,,A,11954,In vivo,,1,,,U,,13021,BAO_0000218,,0,,,,22224,Plasma clearance after intravenous dose of 3.87 mg/kg,,CHEMBL631437,
Intermediate,,A,5669,In vivo,,1,,,N,,13022,BAO_0000218,,1,,10116.0,,50597,Plasma clearance after peroral administration at 10 mpk in Rat,Rattus norvegicus,CHEMBL631438,
Intermediate,,A,5669,In vivo,,1,,,N,,13023,BAO_0000218,,1,,9544.0,,50797,Plasma clearance after peroral administration at 10 mpk in Rhesus,Macaca mulatta,CHEMBL876431,
Intermediate,,A,5669,In vivo,,1,,,N,,13024,BAO_0000218,,1,,9615.0,,50588,Plasma clearance after peroral administration at 10 mpk in dog,Canis lupus familiaris,CHEMBL631439,
Intermediate,,A,13662,In vivo,,1,,,N,,13025,BAO_0000218,,1,,10116.0,,50597,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,Rattus norvegicus,CHEMBL631440,
Autocuration,,A,8272,,,1,,,U,,13026,BAO_0000019,,0,,,,22224,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),,CHEMBL631441,
Autocuration,,A,13410,,,1,,,U,,13027,BAO_0000019,,0,,,,22224,Critical Micellar concentration was determined,,CHEMBL631442,
Autocuration,,A,13410,,,1,,,U,,13028,BAO_0000019,,0,,,,22224,Critical Micellar concentration of the compound. was determined,,CHEMBL626525,
Autocuration,,A,12628,,,1,,,U,,13029,BAO_0000019,,0,,,,22224,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,,CHEMBL627168,
Autocuration,,A,9675,,,1,,,U,,13030,BAO_0000019,,0,,,,22224,Critical micellar concentration was measured in water by the dye solubilization method,,CHEMBL875618,
Autocuration,,B,12628,,,1,,,U,,13031,BAO_0000019,,0,,,,22224,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,,CHEMBL626612,
Autocuration,,A,12766,,,1,,,U,,13032,BAO_0000019,,0,,,,22224,CMR value (relative to BAY K 8644),,CHEMBL626613,
Autocuration,,A,7849,,,1,,,U,,13033,BAO_0000019,,0,,,,22224,Carbamoylating activity was determined,,CHEMBL626614,
Autocuration,,A,12187,,,1,,,U,,13034,BAO_0000218,,0,,314293.0,,22224,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,Simiiformes,CHEMBL626615,
Autocuration,,A,2040,,,1,,,U,,13035,BAO_0000019,,0,,,,22224,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,,CHEMBL626616,
Autocuration,,A,2040,,,1,,,U,,13036,BAO_0000019,,0,,,,22224,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,,CHEMBL626617,
Intermediate,,A,14180,In vivo,,1,,,N,,13037,BAO_0000218,,1,,9615.0,1969.0,50588,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,Canis lupus familiaris,CHEMBL626618,Plasma
Intermediate,,A,14180,In vivo,,1,,,N,,13038,BAO_0000218,,1,,10116.0,1969.0,50597,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,Rattus norvegicus,CHEMBL626619,Plasma
Intermediate,,A,14474,In vivo,,1,,,N,,13039,BAO_0000218,,1,,9615.0,,50588,"Clearance rate at 0.46 mg/kg, iv, in dogs",Canis lupus familiaris,CHEMBL626620,
Intermediate,,A,14474,In vivo,,1,,,N,,13040,BAO_0000218,,1,,10116.0,,50597,"Clearance rate at 5.5 mg/kg, iv, in rat",Rattus norvegicus,CHEMBL626621,
Intermediate,,A,14548,In vivo,,1,,,N,,13041,BAO_0000218,,1,,9541.0,,100710,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,Macaca fascicularis,CHEMBL626622,
Intermediate,,A,14548,In vivo,,1,,,N,,13042,BAO_0000218,,1,,9541.0,,100710,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,Macaca fascicularis,CHEMBL626623,
Intermediate,,A,14548,In vivo,,1,,,N,,13043,BAO_0000218,,1,,9615.0,,50588,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,Canis lupus familiaris,CHEMBL626624,
Intermediate,,A,14548,In vivo,,1,,,N,,13044,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,Rattus norvegicus,CHEMBL626625,
Intermediate,,A,6125,Ex vivo,,1,,,N,,13045,BAO_0000218,,1,,10116.0,2107.0,50597,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Rattus norvegicus,CHEMBL626626,Liver
Autocuration,,A,6874,In vivo,,1,,,U,,13046,BAO_0000218,,0,,,,22224,Tested for the total clearance of the compound,,CHEMBL626627,
Intermediate,,A,15343,In vivo,,1,,,N,,13047,BAO_0000218,,1,,9615.0,,50588,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,Canis lupus familiaris,CHEMBL626628,
Autocuration,,A,6236,In vivo,,1,,,U,,13048,BAO_0000218,,0,,,,22224,Total body clearance was determined,,CHEMBL626629,
Intermediate,,A,11510,,,1,,,N,,13049,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,Rattus norvegicus,CHEMBL626630,
Intermediate,,A,11510,,,1,,,N,,13050,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,Rattus norvegicus,CHEMBL626631,
Autocuration,,P,8194,,,1,,,U,,13051,BAO_0000100,,0,,,,22229,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,CHEMBL626632,
Autocuration,,P,8194,,,1,,,U,,13052,BAO_0000100,,0,,,,22229,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,CHEMBL626633,
Autocuration,,P,8194,,,1,,,U,,13053,BAO_0000100,,0,,,,22229,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,,CHEMBL626634,
Autocuration,,P,8194,,,1,,,U,,13054,BAO_0000100,,0,,,,22229,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,CHEMBL626635,
Autocuration,,P,8194,,,1,,,U,,13055,BAO_0000100,,0,,,,22229,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,CHEMBL626636,
Autocuration,,P,8194,,,1,,,U,,13056,BAO_0000100,,0,,,,22229,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,CHEMBL626637,
Intermediate,,A,13273,,,1,,,N,,13057,BAO_0000218,,1,,4754.0,,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),Pneumocystis carinii,CHEMBL626638,
Intermediate,,A,13273,,,1,,,N,,13058,BAO_0000218,,1,,4754.0,,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,Pneumocystis carinii,CHEMBL626639,
Intermediate,,A,13273,,,1,,,N,,13059,BAO_0000218,,1,,4754.0,,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,Pneumocystis carinii,CHEMBL626640,
Intermediate,,A,13273,,,1,,,N,,13060,BAO_0000218,,1,,4754.0,,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,Pneumocystis carinii,CHEMBL626641,
Intermediate,,A,13273,,,1,,,N,,13061,BAO_0000218,,1,,4754.0,,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,Pneumocystis carinii,CHEMBL627272,
Intermediate,,A,13273,,,1,,,N,,13062,BAO_0000218,,1,,4754.0,,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,Pneumocystis carinii,CHEMBL627273,
Intermediate,,A,13273,,,1,,,N,,13063,BAO_0000218,,1,,4754.0,,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),Pneumocystis carinii,CHEMBL627441,
Intermediate,,A,13273,,,1,,,N,,13064,BAO_0000218,,1,,4754.0,,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),Pneumocystis carinii,CHEMBL628355,
Intermediate,,A,13273,,,1,,,N,,13065,BAO_0000218,,1,,4754.0,,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),Pneumocystis carinii,CHEMBL628356,
Intermediate,,A,13273,,,1,,,N,,13066,BAO_0000218,,1,,4754.0,,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),Pneumocystis carinii,CHEMBL628357,
Intermediate,,A,13273,,,1,,,N,,13067,BAO_0000218,,1,,4754.0,,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),Pneumocystis carinii,CHEMBL628358,
Intermediate,,A,13273,,,1,,,N,,13068,BAO_0000218,,1,,4754.0,,50339,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),Pneumocystis carinii,CHEMBL622307,
Autocuration,,A,13118,,,1,,,U,,13069,BAO_0000019,,0,,,,22224,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,,CHEMBL622527,
Autocuration,,A,13118,,,1,,,U,,13070,BAO_0000019,,0,,,,22224,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,,CHEMBL622528,
Autocuration,,A,13118,,,1,,,U,,13071,BAO_0000019,,0,,,,22224,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,,CHEMBL622529,
Autocuration,,A,13118,,,1,,,U,,13072,BAO_0000019,,0,,,,22224,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,,CHEMBL622992,
Autocuration,,A,13118,,,1,,,U,,13073,BAO_0000019,,0,,,,22224,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,,CHEMBL622993,
Autocuration,,A,13118,,,1,,,U,,13074,BAO_0000019,,0,,,,22224,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,,CHEMBL622994,
Intermediate,,A,10633,,,1,,,N,,13075,BAO_0000218,,1,,10116.0,,50597,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",Rattus norvegicus,CHEMBL622995,
Intermediate,,A,10633,,,1,,,N,,13076,BAO_0000218,,1,,10116.0,,50597,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",Rattus norvegicus,CHEMBL622996,
Intermediate,,A,10633,,,1,,,N,,13077,BAO_0000218,,1,,10116.0,,50597,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",Rattus norvegicus,CHEMBL622997,
Intermediate,,A,10633,,,1,,,N,,13078,BAO_0000218,,1,,10116.0,,50597,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",Rattus norvegicus,CHEMBL622998,
Autocuration,,A,5767,,,1,,,U,,13079,BAO_0000218,,0,,,,22224,Cp max following ip administration at 1 mg/kg,,CHEMBL622999,
Autocuration,,A,3302,In vivo,,1,,,U,,13080,BAO_0000218,,0,,,1969.0,22224,Maximum concentration in plasma was reported at 0.5 hour,,CHEMBL623000,Plasma
Autocuration,,A,3302,In vivo,,1,,,U,,13081,BAO_0000218,,0,,,1969.0,22224,Maximum concentration in plasma was reported at 2 hour,,CHEMBL623001,Plasma
Intermediate,,A,12467,,,1,,,N,,13082,BAO_0000218,,1,,10090.0,,50594,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,Mus musculus,CHEMBL623002,
Autocuration,,P,11778,,,1,,,U,,13083,BAO_0000100,,0,,,,22229,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),,CHEMBL623003,
Autocuration,,A,4321,,,1,,,U,,13084,BAO_0000019,,0,,,,22224,Steady state concentration was evaluated,,CHEMBL623004,
Autocuration,,A,14884,,,1,,,U,,13085,BAO_0000019,,0,,,,22224,Partition coefficient (logP),,CHEMBL623005,
Autocuration,,A,15234,,,1,,,U,,13086,BAO_0000019,,0,,,,22224,Partition coefficient (logD7.4),,CHEMBL623006,
Intermediate,,A,14198,In vivo,,1,,,N,,13087,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,Rattus norvegicus,CHEMBL623007,Liver
Intermediate,,A,14198,In vivo,,1,,,N,,13088,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,Rattus norvegicus,CHEMBL623008,Bone
Intermediate,,A,14198,In vivo,,1,,,N,,13089,BAO_0000218,,1,,10116.0,2037.0,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,Rattus norvegicus,CHEMBL876654,Cerebellum
Intermediate,,A,14198,In vivo,,1,,,N,,13090,BAO_0000218,,1,,10116.0,,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,Rattus norvegicus,CHEMBL623009,
Intermediate,,A,14198,In vivo,,1,,,N,,13091,BAO_0000218,,1,,10116.0,,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,Rattus norvegicus,CHEMBL623010,
Intermediate,,A,14198,In vivo,,1,,,N,,13092,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,Rattus norvegicus,CHEMBL623011,Heart
Intermediate,,A,14198,In vivo,,1,,,N,,13093,BAO_0000218,,1,,10116.0,160.0,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,Rattus norvegicus,CHEMBL623012,Intestine
Autocuration,,A,8151,,,1,,,U,,13094,BAO_0000019,,0,,,,22224,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,CHEMBL623013,
Autocuration,,A,8151,,,1,,,U,,13095,BAO_0000019,,0,,,,22224,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,CHEMBL623014,
Autocuration,,A,8151,,,1,,,U,,13096,BAO_0000019,,0,,,1088.0,22224,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,,CHEMBL623015,Urine
Autocuration,,A,8151,,,1,,,U,,13097,BAO_0000019,,0,,,1088.0,22224,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,CHEMBL623016,Urine
Autocuration,,A,8151,,,1,,,U,,13098,BAO_0000019,,0,,,1088.0,22224,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,,CHEMBL624858,Urine
Intermediate,,A,8151,,,1,,,N,,13099,BAO_0000218,,1,,10116.0,,50597,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,Rattus norvegicus,CHEMBL624859,
Intermediate,,A,8151,,,1,,,N,,13100,BAO_0000218,,1,,10116.0,,50597,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Rattus norvegicus,CHEMBL624860,
Intermediate,,A,8151,,,1,,,N,,13101,BAO_0000218,,1,,10116.0,,50597,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,Rattus norvegicus,CHEMBL624861,
Intermediate,,A,8151,,,1,,,N,,13102,BAO_0000218,,1,,10116.0,,50597,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,Rattus norvegicus,CHEMBL624862,
Intermediate,,A,8151,,,1,,,N,,13103,BAO_0000218,,1,,10116.0,,50597,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,Rattus norvegicus,CHEMBL624863,
Intermediate,,A,8151,,,1,,,N,,13104,BAO_0000218,,1,,10116.0,,50597,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,Rattus norvegicus,CHEMBL876655,
Intermediate,,A,6996,,,1,,,N,,13105,BAO_0000218,,1,,9615.0,,50588,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,Canis lupus familiaris,CHEMBL624864,
Intermediate,,A,6996,,,1,,,N,,13106,BAO_0000218,,1,,9615.0,,50588,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,Canis lupus familiaris,CHEMBL624865,
Intermediate,,A,6996,,,1,,,N,,13107,BAO_0000218,,1,,9615.0,,50588,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,Canis lupus familiaris,CHEMBL624866,
Expert,,F,6996,,,1,,,N,,13108,BAO_0000218,,1,,9615.0,,50588,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,Canis lupus familiaris,CHEMBL624867,
Intermediate,,A,6996,,,1,,,N,,13109,BAO_0000218,,1,,9615.0,,50588,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,Canis lupus familiaris,CHEMBL624868,
Intermediate,,A,6996,,,1,,,N,,13110,BAO_0000218,,1,,9615.0,,50588,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,Canis lupus familiaris,CHEMBL628450,
Intermediate,,A,6996,,,1,,,N,,13111,BAO_0000218,,1,,9615.0,,50588,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,Canis lupus familiaris,CHEMBL628451,
Intermediate,,A,6996,,,1,,,N,,13112,BAO_0000218,,1,,9615.0,,50588,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,Canis lupus familiaris,CHEMBL628452,
Intermediate,,A,6996,,,1,,,N,,13113,BAO_0000218,,1,,9615.0,,50588,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,Canis lupus familiaris,CHEMBL628453,
Intermediate,,A,6996,,,1,,,N,,13114,BAO_0000218,,1,,9615.0,,50588,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,Canis lupus familiaris,CHEMBL628454,
Intermediate,,A,6996,,,1,,,N,,13115,BAO_0000218,,1,,9615.0,,50588,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,Canis lupus familiaris,CHEMBL628455,
Intermediate,,A,6996,,,1,,,N,,13116,BAO_0000218,,1,,9615.0,,50588,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,Canis lupus familiaris,CHEMBL628456,
Intermediate,,A,6996,,,1,,,N,,13117,BAO_0000218,,1,,9615.0,,50588,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,Canis lupus familiaris,CHEMBL628457,
Intermediate,,A,6996,,,1,,,N,,13118,BAO_0000218,,1,,9615.0,,50588,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,Canis lupus familiaris,CHEMBL877505,
Intermediate,,A,6996,,,1,,,N,,13119,BAO_0000218,,1,,9615.0,,50588,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,Canis lupus familiaris,CHEMBL628458,
Intermediate,,A,6996,,,1,,,N,,13120,BAO_0000218,,1,,9615.0,,50588,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,Canis lupus familiaris,CHEMBL628459,
Intermediate,,A,6996,,,1,,,N,,13121,BAO_0000218,,1,,9615.0,,50588,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,Canis lupus familiaris,CHEMBL628460,
Intermediate,,A,6996,,,1,,,N,,13122,BAO_0000218,,1,,9615.0,,50588,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,Canis lupus familiaris,CHEMBL628461,
Autocuration,,B,6996,,,1,,,U,,13123,BAO_0000218,,0,,,,22224,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",,CHEMBL628462,
Intermediate,,A,6996,,,1,,,N,,13124,BAO_0000218,,1,,9615.0,,50588,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Canis lupus familiaris,CHEMBL628463,
Expert,,F,6996,,,1,,,N,,13125,BAO_0000218,,1,,10116.0,,50597,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",Rattus norvegicus,CHEMBL625666,
Autocuration,,B,6996,,,1,,,U,,13126,BAO_0000218,,0,,,,22224,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,CHEMBL625667,
Expert,,A,6996,,,1,,,N,,13127,BAO_0000218,,1,,10116.0,,50597,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Rattus norvegicus,CHEMBL625668,
Intermediate,,A,6996,,,1,,,N,,13128,BAO_0000218,,1,,10116.0,,50597,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Rattus norvegicus,CHEMBL625669,
Autocuration,,A,7114,,,1,,,U,,13129,BAO_0000019,,0,,,,22224,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,,CHEMBL625670,
Intermediate,,A,7114,,,1,,,N,,13130,BAO_0000218,,1,,10116.0,,50597,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,Rattus norvegicus,CHEMBL625671,
Intermediate,,A,8613,,,1,,,N,,13131,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,Human herpesvirus 1,CHEMBL625672,
Intermediate,,A,8613,,,1,,,N,,13132,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,Human herpesvirus 1,CHEMBL625673,
Intermediate,,A,8613,,,1,,,N,,13133,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,Human herpesvirus 1,CHEMBL625674,
Intermediate,,A,8613,,,1,,,N,,13134,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,Human herpesvirus 1,CHEMBL625675,
Intermediate,,A,8613,,,1,,,N,,13135,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,Human herpesvirus 1,CHEMBL627637,
Intermediate,,A,8613,,,1,,,N,,13136,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,Human herpesvirus 1,CHEMBL627638,
Intermediate,,A,8613,,,1,,,N,,13137,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,Human herpesvirus 1,CHEMBL627639,
Intermediate,,A,8613,,,1,,,N,,13138,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,Human herpesvirus 1,CHEMBL627640,
Intermediate,,A,8613,,,1,,,N,,13139,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,Human herpesvirus 1,CHEMBL627641,
Intermediate,,A,8613,,,1,,,N,,13140,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,Human herpesvirus 1,CHEMBL627642,
Intermediate,,A,8613,,,1,,,N,,13141,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,Human herpesvirus 1,CHEMBL877506,
Intermediate,,A,8613,,,1,,,N,,13142,BAO_0000218,,1,,10090.0,,50594,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,Mus musculus,CHEMBL627275,
Intermediate,,A,11219,,,1,,,N,,13143,BAO_0000218,,1,,9669.0,,50506,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",Mustela putorius furo,CHEMBL627643,
Intermediate,,A,11219,,,1,,,N,,13144,BAO_0000218,,1,,9669.0,,50506,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",Mustela putorius furo,CHEMBL631246,
Intermediate,,A,11219,,,1,,,N,,13145,BAO_0000218,,1,,9669.0,,50506,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",Mustela putorius furo,CHEMBL631247,
Intermediate,,A,11219,,,1,,,N,,13146,BAO_0000218,,1,,9669.0,,50506,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,Mustela putorius furo,CHEMBL629532,
Intermediate,,A,11219,,,1,,,N,,13147,BAO_0000218,,1,,9669.0,,50506,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,Mustela putorius furo,CHEMBL629533,
Intermediate,,A,11219,,,1,,,N,,13148,BAO_0000218,,1,,9669.0,,50506,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,Mustela putorius furo,CHEMBL629534,
Intermediate,,A,11219,,,1,,,N,,13149,BAO_0000218,,1,,9669.0,,50506,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,Mustela putorius furo,CHEMBL629535,
Autocuration,,A,14837,,,1,,,U,,13150,BAO_0000019,,0,,,,22224,Pharmacokinetic parameter :drug bound to plasma was reported,,CHEMBL625932,
Autocuration,,A,14837,,,1,,,U,,13151,BAO_0000019,,0,,,,22224,compound was evaluated for drug bound in plasma,,CHEMBL625933,
Intermediate,,A,15343,,,1,,,N,,13152,BAO_0000218,,1,,10116.0,,50597,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,Rattus norvegicus,CHEMBL625934,
Autocuration,,A,13761,,,1,,,U,,13153,BAO_0000218,,0,,9347.0,,22224,Bioavailability,Eutheria,CHEMBL625935,
Intermediate,,A,14810,,,1,,,N,,13154,BAO_0000218,,1,,10116.0,,50597,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,Rattus norvegicus,CHEMBL625936,
Intermediate,,A,14810,,,1,,,N,,13155,BAO_0000218,,1,,10116.0,,50597,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,Rattus norvegicus,CHEMBL625937,
Intermediate,,A,13249,,,1,,,N,,13156,BAO_0000218,,1,,9615.0,,50588,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,Canis lupus familiaris,CHEMBL625938,
Intermediate,,A,9267,,,1,,,N,,13157,BAO_0000218,,1,,10116.0,1970.0,50597,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,Rattus norvegicus,CHEMBL625939,Bile
Intermediate,,A,9267,,,1,,,N,,13158,BAO_0000218,,1,,10116.0,1970.0,50597,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,Rattus norvegicus,CHEMBL625940,Bile
Intermediate,,A,9267,,,1,,,N,,13159,BAO_0000218,,1,,10116.0,1970.0,50597,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,Rattus norvegicus,CHEMBL874464,Bile
Intermediate,,A,9267,,,1,,,N,,13160,BAO_0000218,,1,,10116.0,1970.0,50597,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,Rattus norvegicus,CHEMBL625941,Bile
Intermediate,,A,9267,,,1,,,N,,13161,BAO_0000218,,1,,10116.0,1970.0,50597,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,Rattus norvegicus,CHEMBL625942,Bile
Intermediate,,A,9267,,,1,,,N,,13162,BAO_0000218,,1,,10116.0,1970.0,50597,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,Rattus norvegicus,CHEMBL625943,Bile
Intermediate,,A,15549,,,1,,,N,,13163,BAO_0000218,,1,,9606.0,1977.0,50587,In vitro protein binding in human serum at 5 ug/ml,Homo sapiens,CHEMBL625944,Serum
Autocuration,,A,10929,,,1,,,U,,13164,BAO_0000019,,0,,,,22224,Serum protein binding ability was measured,,CHEMBL625945,
Autocuration,,A,15444,,,1,,,U,,13165,BAO_0000019,,0,,,,22224,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),,CHEMBL625946,
Autocuration,,A,12860,In vivo,,1,,,U,,13166,BAO_0000218,,0,,9615.0,,22224,Oral bioavailability in dog,Canis lupus familiaris,CHEMBL625947,
Intermediate,,A,12170,In vivo,,1,,,N,,13167,BAO_0000218,,1,,10116.0,,50597,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,Rattus norvegicus,CHEMBL625948,
Autocuration,,A,15173,In vivo,,1,,,U,,13168,BAO_0000218,,0,,,,22224,Absolute oral bioavailability at an iv dose of 14 mg/kg,,CHEMBL625949,
Autocuration,,A,15173,In vivo,,1,,,U,,13169,BAO_0000218,,0,,,,22224,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,,CHEMBL625950,
Autocuration,,A,15173,In vivo,,1,,,U,,13170,BAO_0000218,,0,,9347.0,,22224,Oral bioavailability (dose 15 mg/kg i.v.),Eutheria,CHEMBL625951,
Autocuration,,A,15173,In vivo,,1,,,U,,13171,BAO_0000218,,0,,,,22224,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,,CHEMBL625952,
Autocuration,,A,15173,In vivo,,1,,,U,,13172,BAO_0000218,,0,,,,22224,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,,CHEMBL625953,
Autocuration,,A,15173,In vivo,,1,,,U,,13173,BAO_0000218,,0,,,,22224,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,,CHEMBL625954,
Autocuration,,A,15173,In vivo,,1,,,U,,13174,BAO_0000218,,0,,,,22224,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,,CHEMBL882959,
Intermediate,,A,11767,In vivo,,1,,,N,,13175,BAO_0000218,,1,,9615.0,,50588,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,Canis lupus familiaris,CHEMBL625955,
Autocuration,,A,11219,In vivo,,1,,,U,,13176,BAO_0000218,,0,,9669.0,,22224,Bioavailability in ferret,Mustela putorius furo,CHEMBL625956,
Intermediate,,A,12186,In vivo,,1,,,N,,13177,BAO_0000218,,1,,9541.0,,100710,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,Macaca fascicularis,CHEMBL625957,
Intermediate,,A,11510,,,1,,,N,,13178,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,Rattus norvegicus,CHEMBL625958,
Intermediate,,A,11510,,,1,,,N,,13179,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,Rattus norvegicus,CHEMBL625959,
Intermediate,,A,11510,,,1,,,N,,13180,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,Rattus norvegicus,CHEMBL626642,
Intermediate,,A,11510,,,1,,,N,,13181,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,Rattus norvegicus,CHEMBL631330,
Intermediate,,A,11510,,,1,,,N,,13182,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,Rattus norvegicus,CHEMBL631331,
Intermediate,,A,11510,,,1,,,N,,13183,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,Rattus norvegicus,CHEMBL631332,
Intermediate,,A,11510,,,1,,,N,,13184,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,Rattus norvegicus,CHEMBL631333,
Intermediate,,A,11510,,,1,,,N,,13185,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,Rattus norvegicus,CHEMBL632018,
Intermediate,,A,11510,,,1,,,N,,13186,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,Rattus norvegicus,CHEMBL632019,
Intermediate,,A,11510,,,1,,,N,,13187,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,Rattus norvegicus,CHEMBL632020,
Intermediate,,A,11510,,,1,,,N,,13188,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,Rattus norvegicus,CHEMBL632021,
Intermediate,,A,11510,,,1,,,N,,13189,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,Rattus norvegicus,CHEMBL632022,
Intermediate,,A,11510,,,1,,,N,,13190,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,Rattus norvegicus,CHEMBL632023,
Intermediate,,A,11510,,,1,,,N,,13191,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,Rattus norvegicus,CHEMBL632024,
Intermediate,,A,11510,,,1,,,N,,13192,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,Rattus norvegicus,CHEMBL874472,
Intermediate,,A,11510,,,1,,,N,,13193,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,Rattus norvegicus,CHEMBL632025,
Intermediate,,A,11510,,,1,,,N,,13194,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,Rattus norvegicus,CHEMBL632026,
Intermediate,,A,11510,,,1,,,N,,13195,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,Rattus norvegicus,CHEMBL632027,
Intermediate,,A,11510,,,1,,,N,,13196,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,Rattus norvegicus,CHEMBL632028,
Intermediate,,A,11510,,,1,,,N,,13197,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,Rattus norvegicus,CHEMBL626430,
Intermediate,,A,11510,,,1,,,N,,13198,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,Rattus norvegicus,CHEMBL626431,
Intermediate,,A,11510,,,1,,,N,,13199,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,Rattus norvegicus,CHEMBL626432,
Intermediate,,A,11510,,,1,,,N,,13200,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,Rattus norvegicus,CHEMBL626433,
Intermediate,,A,11510,,,1,,,N,,13201,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,Rattus norvegicus,CHEMBL626434,
Intermediate,,A,11510,,,1,,,N,,13202,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,Rattus norvegicus,CHEMBL627280,
Intermediate,,A,11510,,,1,,,N,,13203,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,Rattus norvegicus,CHEMBL627281,
Intermediate,,A,11510,,,1,,,N,,13204,BAO_0000218,,1,,10116.0,,50597,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,Rattus norvegicus,CHEMBL627282,
Autocuration,,A,7199,,,1,,,U,,13205,BAO_0000019,,0,,,,22224,Total body clearance was measured at given dose,,CHEMBL627283,
Autocuration,,A,7199,,,1,,,U,,13206,BAO_0000218,,0,,,,22224,Total body clearance was measured at given dose.,,CHEMBL627284,
Intermediate,,A,7095,,,1,,,N,,13207,BAO_0000218,,1,,10116.0,,50597,Metabolic clearance from the body in rat,Rattus norvegicus,CHEMBL627285,
Autocuration,,A,7095,In vivo,,1,,,U,,13208,BAO_0000218,,0,,,,22224,Renal clearance from the body,,CHEMBL627286,
Intermediate,,A,7095,In vivo,,1,,,N,,13209,BAO_0000218,,1,,10116.0,,50597,Renal clearance from the body in rat,Rattus norvegicus,CHEMBL875477,
Intermediate,,A,12528,In vivo,,1,,,N,,13210,BAO_0000218,,1,,10116.0,,50597,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,Rattus norvegicus,CHEMBL627287,
Intermediate,,A,12528,In vivo,,1,,,N,,13211,BAO_0000218,,1,,9615.0,,50588,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,Canis lupus familiaris,CHEMBL627288,
Intermediate,,A,7095,,,1,,,N,,13212,BAO_0000218,,1,,10116.0,,50597,Total clearance from the body in rat,Rattus norvegicus,CHEMBL627289,
Intermediate,,A,14223,In vivo,,1,,,N,,13213,BAO_0000218,,1,,10116.0,1969.0,50597,Clearance into cortex from rat plasma or PBS,Rattus norvegicus,CHEMBL627290,Plasma
Autocuration,,A,13569,In vivo,,1,,,U,,13214,BAO_0000218,,0,,,,22224,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,,CHEMBL627291,
Autocuration,,A,13569,In vivo,,1,,,U,,13215,BAO_0000218,,0,,,,22224,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,,CHEMBL627292,
Autocuration,,A,13569,In vivo,,1,,,U,,13216,BAO_0000218,,0,,,,22224,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,,CHEMBL627293,
Autocuration,,A,13569,In vivo,,1,,,U,,13217,BAO_0000218,,0,,,,22224,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,CHEMBL627294,
Autocuration,,A,13569,In vivo,,1,,,U,,13218,BAO_0000218,,0,,,,22224,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,,CHEMBL875478,
Autocuration,,A,13979,In vivo,,1,,,U,,13219,BAO_0000218,,0,,,,22224,Clearance was determined,,CHEMBL627295,
Intermediate,,A,14315,In vivo,,1,,,N,,13220,BAO_0000218,,1,,10090.0,,50594,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,Mus musculus,CHEMBL627296,
Intermediate,,A,14315,In vivo,,1,,,N,,13221,BAO_0000218,,1,,9986.0,,50592,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,Oryctolagus cuniculus,CHEMBL626119,
Intermediate,,A,14315,In vivo,,1,,,N,,13222,BAO_0000218,,1,,10116.0,,50597,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,Rattus norvegicus,CHEMBL626120,
Intermediate,,A,12174,In vivo,,1,,,N,,13223,BAO_0000218,,1,,10116.0,,50597,Clearance in rat after iv dose (100 ug/kg),Rattus norvegicus,CHEMBL626121,
Autocuration,,A,12797,In vivo,,1,,,U,,13224,BAO_0000218,,0,,10141.0,,22224,Clearance in guinea pig,Cavia porcellus,CHEMBL626122,
Intermediate,,A,12797,In vivo,,1,,,N,,13225,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for clearance in rat,Rattus norvegicus,CHEMBL626123,
Intermediate,,A,12797,In vivo,,1,,,N,,13226,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for the clearance in dog,Canis lupus familiaris,CHEMBL623456,
Intermediate,,A,12797,In vivo,,1,,,N,,13227,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for the clearance in rat,Rattus norvegicus,CHEMBL623457,
Intermediate,,A,11500,In vivo,,1,,,N,,13228,BAO_0000218,,1,,10116.0,,50597,Compound was tested in vivo for clearance after iv administration in the rat,Rattus norvegicus,CHEMBL623458,
Autocuration,,A,15173,In vivo,,1,,,U,,13229,BAO_0000218,,0,,,,22224,IV clearance determined at an iv dose of 14 mg/kg,,CHEMBL623459,
Autocuration,,A,15173,In vivo,,1,,,U,,13230,BAO_0000218,,0,,,,22224,IV clearance determined at an iv dose of 15.2 mg/kg,,CHEMBL875484,
Autocuration,,A,15173,In vivo,,1,,,U,,13231,BAO_0000218,,0,,,,22224,IV clearance determined at an iv dose of 15 mg/kg,,CHEMBL623460,
Autocuration,,A,15173,In vivo,,1,,,U,,13232,BAO_0000218,,0,,,,22224,IV clearance determined at an peroral dose of 30 mg/kg.,,CHEMBL623461,
Autocuration,,A,15173,In vivo,,1,,,U,,13233,BAO_0000218,,0,,,,22224,IV clearance determined at an peroral dose of 30.2 mg/kg.,,CHEMBL623462,
Autocuration,,A,15173,In vivo,,1,,,U,,13234,BAO_0000218,,0,,,,22224,IV clearance determined at an peroral dose of 30.3 mg/kg.,,CHEMBL627386,
Intermediate,,A,14198,In vivo,,1,,,N,,13235,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,Rattus norvegicus,CHEMBL627387,Kidney
Intermediate,,A,14198,In vivo,,1,,,N,,13236,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,Rattus norvegicus,CHEMBL627388,Liver
Intermediate,,A,14198,In vivo,,1,,,N,,13237,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,Rattus norvegicus,CHEMBL627389,Lung
Intermediate,,A,14198,In vivo,,1,,,N,,13238,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,Rattus norvegicus,CHEMBL627390,Muscle tissue
Intermediate,,A,14198,In vivo,,1,,,N,,13239,BAO_0000218,,1,,10116.0,1969.0,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,Rattus norvegicus,CHEMBL627391,Plasma
Intermediate,,A,14198,In vivo,,1,,,N,,13240,BAO_0000218,,1,,10116.0,,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,Rattus norvegicus,CHEMBL627392,
Intermediate,,A,14198,In vivo,,1,,,N,,13241,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,Rattus norvegicus,CHEMBL627393,Spleen
Intermediate,,A,14198,In vivo,,1,,,N,,13242,BAO_0000218,,1,,10116.0,3126.0,50597,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,Rattus norvegicus,CHEMBL627394,Trachea
Intermediate,,A,14198,In vivo,,1,,,N,,13243,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,Rattus norvegicus,CHEMBL627395,Bone
Intermediate,,A,14198,In vivo,,1,,,N,,13244,BAO_0000218,,1,,10116.0,2037.0,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,Rattus norvegicus,CHEMBL875485,Cerebellum
Intermediate,,A,14198,In vivo,,1,,,N,,13245,BAO_0000218,,1,,10116.0,,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,Rattus norvegicus,CHEMBL627396,
Intermediate,,A,14198,In vivo,,1,,,N,,13246,BAO_0000218,,1,,10116.0,,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,Rattus norvegicus,CHEMBL627397,
Intermediate,,A,14198,In vivo,,1,,,N,,13247,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,Rattus norvegicus,CHEMBL627398,Heart
Intermediate,,A,14198,In vivo,,1,,,N,,13248,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,Rattus norvegicus,CHEMBL627399,Bone
Intermediate,,A,14198,In vivo,,1,,,N,,13249,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,Rattus norvegicus,CHEMBL627400,Kidney
Intermediate,,A,14198,In vivo,,1,,,N,,13250,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,Rattus norvegicus,CHEMBL627401,Liver
Intermediate,,A,14198,In vivo,,1,,,N,,13251,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,Rattus norvegicus,CHEMBL627402,Lung
Intermediate,,A,14198,In vivo,,1,,,N,,13252,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,Rattus norvegicus,CHEMBL627403,Muscle tissue
Intermediate,,A,14198,In vivo,,1,,,N,,13253,BAO_0000218,,1,,10116.0,1969.0,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,Rattus norvegicus,CHEMBL627404,Plasma
Intermediate,,A,14198,In vivo,,1,,,N,,13254,BAO_0000218,,1,,10116.0,,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,Rattus norvegicus,CHEMBL623101,
Intermediate,,A,14198,In vivo,,1,,,N,,13255,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,Rattus norvegicus,CHEMBL877480,Spleen
Intermediate,,A,14198,In vivo,,1,,,N,,13256,BAO_0000218,,1,,10116.0,3126.0,50597,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,Rattus norvegicus,CHEMBL623102,Trachea
Intermediate,,A,14198,In vivo,,1,,,N,,13257,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,Rattus norvegicus,CHEMBL623103,Bone
Intermediate,,A,14198,In vivo,,1,,,N,,13258,BAO_0000218,,1,,10116.0,2037.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,Rattus norvegicus,CHEMBL623104,Cerebellum
Intermediate,,A,14198,In vivo,,1,,,N,,13259,BAO_0000218,,1,,10116.0,,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,Rattus norvegicus,CHEMBL623105,
Intermediate,,A,14198,In vivo,,1,,,N,,13260,BAO_0000218,,1,,10116.0,,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,Rattus norvegicus,CHEMBL623106,
Intermediate,,A,14198,In vivo,,1,,,N,,13261,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,Rattus norvegicus,CHEMBL623107,Heart
Intermediate,,A,14198,In vivo,,1,,,N,,13262,BAO_0000218,,1,,10116.0,160.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,Rattus norvegicus,CHEMBL623108,Intestine
Intermediate,,A,14198,In vivo,,1,,,N,,13263,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,Rattus norvegicus,CHEMBL623109,Kidney
Intermediate,,A,14198,In vivo,,1,,,N,,13264,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,Rattus norvegicus,CHEMBL623110,Liver
Intermediate,,A,14198,In vivo,,1,,,N,,13265,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,Rattus norvegicus,CHEMBL623111,Lung
Intermediate,,A,14198,In vivo,,1,,,N,,13266,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,Rattus norvegicus,CHEMBL625060,Muscle tissue
Intermediate,,A,14198,In vivo,,1,,,N,,13267,BAO_0000218,,1,,10116.0,1969.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,Rattus norvegicus,CHEMBL625061,Plasma
Intermediate,,A,14198,In vivo,,1,,,N,,13268,BAO_0000218,,1,,10116.0,,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,Rattus norvegicus,CHEMBL625062,
Intermediate,,A,14198,In vivo,,1,,,N,,13269,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,Rattus norvegicus,CHEMBL625063,Spleen
Intermediate,,A,14198,In vivo,,1,,,N,,13270,BAO_0000218,,1,,10116.0,3126.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,Rattus norvegicus,CHEMBL625064,Trachea
Intermediate,,A,14198,In vivo,,1,,,N,,13271,BAO_0000218,,1,,10116.0,10000001.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,Rattus norvegicus,CHEMBL625065,Bone
Intermediate,,A,14198,In vivo,,1,,,N,,13272,BAO_0000218,,1,,10116.0,2037.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,Rattus norvegicus,CHEMBL625066,Cerebellum
Intermediate,,A,14198,In vivo,,1,,,N,,13273,BAO_0000218,,1,,10116.0,,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,Rattus norvegicus,CHEMBL625067,
Intermediate,,A,14198,In vivo,,1,,,N,,13274,BAO_0000218,,1,,10116.0,,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,Rattus norvegicus,CHEMBL625068,
Intermediate,,A,14198,In vivo,,1,,,N,,13275,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,Rattus norvegicus,CHEMBL622159,Heart
Intermediate,,A,14198,In vivo,,1,,,N,,13276,BAO_0000218,,1,,10116.0,160.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,Rattus norvegicus,CHEMBL622160,Intestine
Intermediate,,A,14198,In vivo,,1,,,N,,13277,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,Rattus norvegicus,CHEMBL622161,Kidney
Intermediate,,A,14198,In vivo,,1,,,N,,13278,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,Rattus norvegicus,CHEMBL622162,Lung
Intermediate,,A,14198,In vivo,,1,,,N,,13279,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,Rattus norvegicus,CHEMBL622163,Muscle tissue
Intermediate,,A,14198,In vivo,,1,,,N,,13280,BAO_0000218,,1,,10116.0,1969.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,Rattus norvegicus,CHEMBL622313,Plasma
Intermediate,,A,14198,In vivo,,1,,,N,,13281,BAO_0000218,,1,,10116.0,,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,Rattus norvegicus,CHEMBL622314,
Intermediate,,A,14198,In vivo,,1,,,N,,13282,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,Rattus norvegicus,CHEMBL622315,Spleen
Intermediate,,A,14198,In vivo,,1,,,N,,13283,BAO_0000218,,1,,10116.0,3126.0,50597,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,Rattus norvegicus,CHEMBL622316,Trachea
Intermediate,,A,15599,,,1,,,N,,13284,BAO_0000218,,1,,562.0,,50212,Normal diffusion coefficient in water for Escherichia coli,Escherichia coli,CHEMBL877486,
Autocuration,,A,8204,,,1,,,U,,13285,BAO_0000019,,0,,,,22224,Average max percent decrease in RVR (renal vascular resistance) was determined,,CHEMBL622317,
Autocuration,,A,8204,,,1,,,U,,13286,BAO_0000019,,0,,,,22224,Average max percent decrease in RVR (renal vascular resistance) was determined.,,CHEMBL622318,
Autocuration,,A,6154,,,1,,,U,,13287,BAO_0000019,,0,,,,22224,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,,CHEMBL622319,
Autocuration,,A,6154,,,1,,,U,,13288,BAO_0000019,,0,,,,22224,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,,CHEMBL622320,
Autocuration,,A,6154,,,1,,,U,,13289,BAO_0000019,,0,,,,22224,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,,CHEMBL622321,
Autocuration,,A,6154,,,1,,,U,,13290,BAO_0000019,,0,,,,22224,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,,CHEMBL622322,
Autocuration,,A,7114,,,1,,,U,,13291,BAO_0000019,,0,,,,22224,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,,CHEMBL622323,
Intermediate,,A,7114,,,1,,,N,,13292,BAO_0000218,,1,,10116.0,,50597,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,Rattus norvegicus,CHEMBL622324,
Intermediate,,A,8133,,,1,,,N,,13293,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",Canis lupus familiaris,CHEMBL622325,Urine
Intermediate,,A,8133,,,1,,,N,,13294,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Canis lupus familiaris,CHEMBL622326,Urine
Intermediate,,A,8133,,,1,,,N,,13295,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",Canis lupus familiaris,CHEMBL877487,Urine
Intermediate,,A,8133,,,1,,,N,,13296,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",Canis lupus familiaris,CHEMBL622327,Urine
Intermediate,,A,8133,,,1,,,N,,13297,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",Canis lupus familiaris,CHEMBL622328,Urine
Intermediate,,A,8133,,,1,,,N,,13298,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",Canis lupus familiaris,CHEMBL622329,Urine
Intermediate,,A,8133,,,1,,,N,,13299,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Canis lupus familiaris,CHEMBL622330,Urine
Intermediate,,A,8133,,,1,,,N,,13300,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",Canis lupus familiaris,CHEMBL622331,Urine
Intermediate,,A,8133,,,1,,,N,,13301,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Canis lupus familiaris,CHEMBL622332,Urine
Intermediate,,A,8133,,,1,,,N,,13302,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",Canis lupus familiaris,CHEMBL622333,Urine
Autocuration,,A,8133,,,1,,,U,,13303,BAO_0000218,,0,,314293.0,1088.0,22224,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Simiiformes,CHEMBL627658,Urine
Autocuration,,A,8133,,,1,,,U,,13304,BAO_0000218,,0,,314293.0,1088.0,22224,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",Simiiformes,CHEMBL630428,Urine
Autocuration,,A,8133,,,1,,,U,,13305,BAO_0000218,,0,,314293.0,1088.0,22224,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Simiiformes,CHEMBL630429,Urine
Autocuration,,A,8133,,,1,,,U,,13306,BAO_0000218,,0,,314293.0,1088.0,22224,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",Simiiformes,CHEMBL630430,Urine
Autocuration,,A,8133,,,1,,,U,,13307,BAO_0000218,,0,,314293.0,1088.0,22224,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",Simiiformes,CHEMBL630431,Urine
Intermediate,,A,8133,,,1,,,N,,13308,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Rattus norvegicus,CHEMBL630432,Urine
Intermediate,,A,8133,,,1,,,N,,13309,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",Rattus norvegicus,CHEMBL630433,Urine
Intermediate,,A,8133,,,1,,,N,,13310,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",Rattus norvegicus,CHEMBL630434,Urine
Intermediate,,A,8133,,,1,,,N,,13311,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",Rattus norvegicus,CHEMBL629372,Urine
Intermediate,,A,8133,,,1,,,N,,13312,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",Rattus norvegicus,CHEMBL629553,Urine
Intermediate,,A,8133,,,1,,,N,,13313,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",Rattus norvegicus,CHEMBL629554,Urine
Intermediate,,A,8133,,,1,,,N,,13314,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",Rattus norvegicus,CHEMBL874447,Urine
Intermediate,,A,8133,,,1,,,N,,13315,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",Rattus norvegicus,CHEMBL629555,Urine
Intermediate,,A,8133,,,1,,,N,,13316,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",Rattus norvegicus,CHEMBL629556,Urine
Intermediate,,A,8133,,,1,,,N,,13317,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",Rattus norvegicus,CHEMBL629557,Urine
Intermediate,,A,8133,,,1,,,N,,13318,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",Rattus norvegicus,CHEMBL629558,Urine
Intermediate,,A,8133,,,1,,,N,,13319,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",Rattus norvegicus,CHEMBL629559,Urine
Intermediate,,A,8133,,,1,,,N,,13320,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",Rattus norvegicus,CHEMBL629560,Urine
Intermediate,,A,8133,,,1,,,N,,13321,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",Canis lupus familiaris,CHEMBL629561,Urine
Intermediate,,A,8133,,,1,,,N,,13322,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Canis lupus familiaris,CHEMBL629562,Urine
Intermediate,,A,8133,,,1,,,N,,13323,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",Canis lupus familiaris,CHEMBL629563,Urine
Intermediate,,A,8133,,,1,,,N,,13324,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Canis lupus familiaris,CHEMBL629564,Urine
Intermediate,,A,8133,,,1,,,N,,13325,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",Canis lupus familiaris,CHEMBL629565,Urine
Intermediate,,A,8133,,,1,,,N,,13326,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Canis lupus familiaris,CHEMBL629566,Urine
Intermediate,,A,8133,,,1,,,N,,13327,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",Canis lupus familiaris,CHEMBL629567,Urine
Intermediate,,A,8133,,,1,,,N,,13328,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",Canis lupus familiaris,CHEMBL629568,Urine
Intermediate,,A,8133,,,1,,,N,,13329,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",Canis lupus familiaris,CHEMBL629569,Urine
Intermediate,,A,8133,,,1,,,N,,13330,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",Canis lupus familiaris,CHEMBL629570,Urine
Autocuration,,A,8133,,,1,,,U,,13331,BAO_0000218,,0,,314293.0,1088.0,22224,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Simiiformes,CHEMBL629571,Urine
Autocuration,,A,12170,In vivo,,1,,,U,,13332,BAO_0000218,,0,,10116.0,,22224,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,Rattus norvegicus,CHEMBL629572,
Autocuration,,A,12170,In vivo,,1,,,U,,13333,BAO_0000218,,0,,10116.0,,22224,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,Rattus norvegicus,CHEMBL629573,
Autocuration,,A,4985,In vivo,,1,,,U,,13334,BAO_0000218,,0,,9347.0,,22224,Bioavailability (dose 20 mg/kg),Eutheria,CHEMBL629574,
Autocuration,,A,15145,In vivo,,1,,,U,,13335,BAO_0000218,,0,,9615.0,,22224,Bioavailability in dog,Canis lupus familiaris,CHEMBL629575,
Autocuration,,A,14080,In vivo,,1,,,U,,13336,BAO_0000218,,0,,10116.0,,22224,Bioavailability in rat (Sprague-Dawley) (male),Rattus norvegicus,CHEMBL874448,
Autocuration,,A,11219,In vivo,,1,,,U,,13337,BAO_0000218,,0,,9443.0,,22224,Bioavailability in monkey (dose 10 mg/kg i.d.),Primates,CHEMBL629576,
Autocuration,,A,15145,In vivo,,1,,,U,,13338,BAO_0000218,,0,,10116.0,,22224,Bioavailability in rat,Rattus norvegicus,CHEMBL629577,
Autocuration,,A,15145,In vivo,,1,,,U,,13339,BAO_0000218,,0,,10116.0,,22224,Bioavailability in rat,Rattus norvegicus,CHEMBL629578,
Autocuration,,A,1202,In vivo,,1,,,U,,13340,BAO_0000218,,0,,9615.0,,22224,Bioavailability in dog (dose 3.0 mg/kg p.o.),Canis lupus familiaris,CHEMBL629579,
Autocuration,,A,1202,In vivo,,1,,,U,,13341,BAO_0000218,,0,,9615.0,,22224,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,Canis lupus familiaris,CHEMBL882958,
Intermediate,,A,1202,In vivo,,1,,,N,,13342,BAO_0000218,,1,,9598.0,,50505,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,Pan troglodytes,CHEMBL629580,
Autocuration,,A,4026,In vivo,,1,,,U,,13343,BAO_0000218,,0,,9347.0,,22224,Bioavailability,Eutheria,CHEMBL629581,
Autocuration,,A,1492,In vivo,,1,,,U,,13344,BAO_0000218,,0,,9520.0,,22224,Bioavailability in squirrel monkey,Saimiri,CHEMBL629582,
Intermediate,,A,12793,In vivo,,1,,,N,,13345,BAO_0000218,,1,,9615.0,,50588,Bioavailability was evaluated in dog,Canis lupus familiaris,CHEMBL628522,
Intermediate,,A,12793,In vivo,,1,,,N,,13346,BAO_0000218,,1,,10026.0,,100712,Bioavailability was evaluated in hamster,Cricetinae,CHEMBL625432,
Autocuration,,A,12793,In vivo,,1,,,U,,13347,BAO_0000218,,0,,10116.0,,22224,Bioavailability in rat,Rattus norvegicus,CHEMBL625433,
Intermediate,,A,14793,In vivo,,1,,,N,,13348,BAO_0000218,,1,,10116.0,1969.0,50597,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Rattus norvegicus,CHEMBL625434,Plasma
Intermediate,,A,14793,In vivo,,1,,,N,,13349,BAO_0000218,,1,,10116.0,1969.0,50597,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,Rattus norvegicus,CHEMBL625435,Plasma
Autocuration,,A,14793,In vivo,,1,,,U,,13350,BAO_0000218,,0,,10116.0,,22224,Bioavailability in rat (dose 10 mg/kg p.o.),Rattus norvegicus,CHEMBL625436,
Intermediate,,A,14731,In vivo,,1,,,N,,13351,BAO_0000218,,1,,9541.0,,100710,Bioavailability was measured in cynomolgus monkeys.,Macaca fascicularis,CHEMBL874588,
Intermediate,,A,14731,In vivo,,1,,,N,,13352,BAO_0000218,,1,,10090.0,,50594,Bioavailability was measured in nude mice.,Mus musculus,CHEMBL625437,
Autocuration,,A,12187,In vivo,,1,,,U,,13353,BAO_0000218,,0,,9669.0,,22224,Bioavailability in ferret (dose 10 mg/kg i.d.),Mustela putorius furo,CHEMBL625438,
Autocuration,,A,12187,In vivo,,1,,,U,,13354,BAO_0000218,,0,,314293.0,,22224,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),Simiiformes,CHEMBL625439,
Autocuration,,A,12187,In vivo,,1,,,U,,13355,BAO_0000218,,0,,314293.0,,22224,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",Simiiformes,CHEMBL625440,
Autocuration,,A,12187,In vivo,,1,,,U,,13356,BAO_0000218,,0,,314293.0,,22224,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),Simiiformes,CHEMBL625441,
Autocuration,,A,12187,In vivo,,1,,,U,,13357,BAO_0000218,,0,,10116.0,,22224,Bioavailability in rat (dose 10 mg/kg i.d.),Rattus norvegicus,CHEMBL625442,
Intermediate,,A,12187,In vivo,,1,,,N,,13358,BAO_0000218,,1,,10116.0,,50597,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",Rattus norvegicus,CHEMBL625443,
Autocuration,,A,17431,In vivo,,1,,,U,,13359,BAO_0000218,,0,,,,22224,Bioavailability was determined; extremely poor,,CHEMBL625444,
Intermediate,,A,13318,In vivo,,1,,,N,,13360,BAO_0000218,,1,,10090.0,,50594,% bioavailability in mice after oral administration of prodrug,Mus musculus,CHEMBL625445,
Intermediate,,A,9025,In vivo,,1,,,N,,13361,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,Canis lupus familiaris,CHEMBL625446,
Intermediate,,A,9025,In vivo,,1,,,N,,13362,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,Canis lupus familiaris,CHEMBL882960,
Intermediate,,A,9025,In vivo,,1,,,N,,13363,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,Canis lupus familiaris,CHEMBL625447,
Intermediate,,A,9025,In vivo,,1,,,N,,13364,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,Canis lupus familiaris,CHEMBL625448,
Intermediate,,A,9025,In vivo,,1,,,N,,13365,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,Canis lupus familiaris,CHEMBL625449,
Intermediate,,A,9025,In vivo,,1,,,N,,13366,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),Canis lupus familiaris,CHEMBL874589,
Intermediate,,A,9025,In vivo,,1,,,N,,13367,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,Canis lupus familiaris,CHEMBL625450,
Intermediate,,A,9025,In vivo,,1,,,N,,13368,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,Canis lupus familiaris,CHEMBL625451,
Intermediate,,A,9025,In vivo,,1,,,N,,13369,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,Canis lupus familiaris,CHEMBL626584,
Intermediate,,A,9025,In vivo,,1,,,N,,13370,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,Canis lupus familiaris,CHEMBL626585,
Intermediate,,A,9025,In vivo,,1,,,N,,13371,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,Canis lupus familiaris,CHEMBL626586,
Intermediate,,A,9025,In vivo,,1,,,N,,13372,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,Canis lupus familiaris,CHEMBL626587,
Intermediate,,A,9025,In vivo,,1,,,N,,13373,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,Canis lupus familiaris,CHEMBL626588,
Intermediate,,A,9025,In vivo,,1,,,N,,13374,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,Canis lupus familiaris,CHEMBL626589,
Intermediate,,A,9025,In vivo,,1,,,N,,13375,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,Canis lupus familiaris,CHEMBL626590,
Intermediate,,A,9025,In vivo,,1,,,N,,13376,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,Canis lupus familiaris,CHEMBL626591,
Intermediate,,A,9025,In vivo,,1,,,N,,13377,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,Canis lupus familiaris,CHEMBL627181,
Intermediate,,A,9025,In vivo,,1,,,N,,13378,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,Canis lupus familiaris,CHEMBL628083,
Autocuration,,A,15173,In vivo,,1,,,U,,13379,BAO_0000218,,0,,,,22224,IV clearance determined at an peroral dose of 15 mg/kg.,,CHEMBL628084,
Expert,,F,7732,In vivo,,1,,,N,,13380,BAO_0000218,,1,,102285.0,,50064,Mouse oral clearance was measured against Hymenolepiasis nana.,Hymenolepis nana,CHEMBL628085,
Expert,,F,7732,In vivo,,1,,,N,,13381,BAO_0000218,,1,,6339.0,,50545,Mouse oral clearance was measured against Nematospiroides dubius,Heligmosomoides polygyrus,CHEMBL628086,
Autocuration,,F,7732,In vivo,,1,,,U,,13382,BAO_0000218,,0,,,,22224,Mouse oral clearance was measured against N. dubius; NT is Not Tested,,CHEMBL628087,
Intermediate,,A,7732,In vivo,,1,,,N,,13383,BAO_0000218,,1,,10090.0,,50594,Mouse oral clearance was measured against N. nana; NT is Not Tested,Mus musculus,CHEMBL628088,
Autocuration,,B,7732,In vivo,,1,,,U,,13384,BAO_0000218,,0,,,,22224,Mouse oral clearance was measured against N. nana; NT is Not Tested,,CHEMBL628089,
Autocuration,,A,8328,In vivo,,1,,,U,,13385,BAO_0000218,,0,,,,22224,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,,CHEMBL628090,
Autocuration,,A,8328,In vivo,,1,,,U,,13386,BAO_0000218,,0,,,,22224,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,,CHEMBL628091,
Autocuration,,A,8328,In vivo,,1,,,U,,13387,BAO_0000218,,0,,,,22224,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,,CHEMBL628092,
Autocuration,,A,8328,In vivo,,1,,,U,,13388,BAO_0000218,,0,,,,22224,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,,CHEMBL628093,
Autocuration,,A,8328,In vivo,,1,,,U,,13389,BAO_0000218,,0,,,,22224,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,,CHEMBL875607,
Autocuration,,A,8328,In vivo,,1,,,U,,13390,BAO_0000218,,0,,,,22224,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,,CHEMBL625710,
Autocuration,,A,8328,In vivo,,1,,,U,,13391,BAO_0000218,,0,,,,22224,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,,CHEMBL625711,
Autocuration,,A,8328,In vivo,,1,,,U,,13392,BAO_0000218,,0,,,,22224,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,,CHEMBL625712,
Autocuration,,A,8328,In vivo,,1,,,U,,13393,BAO_0000218,,0,,,,22224,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,,CHEMBL625713,
Intermediate,,A,13376,In vivo,,1,,,N,,13394,BAO_0000218,,1,,9615.0,,50588,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,Canis lupus familiaris,CHEMBL625714,
Intermediate,,A,13477,In vivo,,1,,,N,,13395,BAO_0000218,,1,,9544.0,,50797,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,Macaca mulatta,CHEMBL625715,
Intermediate,,A,13477,In vivo,,1,,,N,,13396,BAO_0000218,,1,,10116.0,,50597,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,Rattus norvegicus,CHEMBL625716,
Intermediate,,A,13477,In vivo,,1,,,N,,13397,BAO_0000218,,1,,10116.0,,50597,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,Rattus norvegicus,CHEMBL625717,
Intermediate,,A,13313,In vivo,,1,,,N,,13398,BAO_0000218,,1,,10116.0,,50597,Plasma clearance was determined for the compound in rats,Rattus norvegicus,CHEMBL625718,
Intermediate,,A,12504,In vivo,,1,,,N,,13399,BAO_0000218,,1,,10116.0,,50597,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,Rattus norvegicus,CHEMBL625719,
Intermediate,,A,12504,In vivo,,1,,,N,,13400,BAO_0000218,,1,,10116.0,,50597,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,Rattus norvegicus,CHEMBL625720,
Intermediate,,A,12504,In vivo,,1,,,N,,13401,BAO_0000218,,1,,10116.0,,50597,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,Rattus norvegicus,CHEMBL625721,
Intermediate,,A,12504,In vivo,,1,,,N,,13402,BAO_0000218,,1,,10116.0,,50597,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,Rattus norvegicus,CHEMBL625722,
Intermediate,,A,13129,In vivo,,1,,,N,,13403,BAO_0000218,,1,,10116.0,,50597,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,Rattus norvegicus,CHEMBL625723,
Intermediate,,A,7732,In vivo,,1,,,N,,13404,BAO_0000218,,1,,6339.0,,50545,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,Heligmosomoides polygyrus,CHEMBL625724,
Intermediate,,A,7732,In vivo,,1,,,N,,13405,BAO_0000218,,1,,6339.0,,50545,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,Heligmosomoides polygyrus,CHEMBL625725,
Intermediate,,A,7732,In vivo,,1,,,N,,13406,BAO_0000218,,1,,6339.0,,50545,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,Heligmosomoides polygyrus,CHEMBL625726,
Intermediate,,A,7732,In vivo,,1,,,N,,13407,BAO_0000218,,1,,6339.0,,50545,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,Heligmosomoides polygyrus,CHEMBL875608,
Intermediate,,A,7732,In vivo,,1,,,N,,13408,BAO_0000218,,1,,6339.0,,50545,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,Heligmosomoides polygyrus,CHEMBL625727,
Autocuration,,A,9278,In vivo,,1,,,U,,13409,BAO_0000218,,0,,10116.0,1088.0,22224,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,Rattus norvegicus,CHEMBL625728,Urine
Autocuration,,A,9278,In vivo,,1,,,U,,13410,BAO_0000218,,0,,10116.0,,22224,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,Rattus norvegicus,CHEMBL625729,
Autocuration,,A,9278,In vivo,,1,,,U,,13411,BAO_0000218,,0,,10116.0,,22224,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,Rattus norvegicus,CHEMBL625730,
Autocuration,,A,9278,In vivo,,1,,,U,,13412,BAO_0000218,,0,,10116.0,1088.0,22224,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,Rattus norvegicus,CHEMBL625731,Urine
Autocuration,,A,9278,In vivo,,1,,,U,,13413,BAO_0000218,,0,,10116.0,1088.0,22224,Urinary clearance was determined in rat at 25 mg/kg os dosage,Rattus norvegicus,CHEMBL626417,Urine
Intermediate,,A,9278,In vivo,,1,,,N,,13414,BAO_0000218,,1,,9606.0,1088.0,50587,Urinary clearance was determined at 100 mg/kg oral dosage in human,Homo sapiens,CHEMBL626418,Urine
Intermediate,,A,9278,In vivo,,1,,,N,,13415,BAO_0000218,,1,,9615.0,1088.0,50588,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,Canis lupus familiaris,CHEMBL626419,Urine
Intermediate,,A,5932,In vivo,,1,,,N,,13416,BAO_0000218,,1,,9615.0,1969.0,50588,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,Canis lupus familiaris,CHEMBL626592,Plasma
Intermediate,,A,5932,In vivo,,1,,,N,,13417,BAO_0000218,,1,,10116.0,1969.0,50597,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,Rattus norvegicus,CHEMBL626593,Plasma
Intermediate,,A,5182,In vivo,,1,,,N,,13418,BAO_0000218,,1,,10116.0,,50597,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,Rattus norvegicus,CHEMBL626594,
Intermediate,,A,10499,In vivo,,1,,,N,,13419,BAO_0000218,,1,,9615.0,,50588,Clearance rate in dogs,Canis lupus familiaris,CHEMBL625035,
Autocuration,,A,6051,In vitro,,1,,,U,,13420,BAO_0000019,,0,,,,22224,Compound was measured for intrinsic clearance,,CHEMBL625036,
Autocuration,,P,17508,,,1,,,U,,13421,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625037,
Autocuration,,P,6228,,,1,,,U,,13422,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625038,
Autocuration,,P,6231,,,1,,,U,,13423,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625039,
Autocuration,,P,17740,,,1,,,U,,13424,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625040,
Autocuration,,P,6495,,,1,,,U,,13425,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625041,
Autocuration,,P,2171,,,1,,,U,,13426,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625042,
Autocuration,,A,3255,,,1,,,U,,13427,BAO_0000019,,0,,,,22224,Partition coefficient of the compound,,CHEMBL874411,
Autocuration,,A,6821,,,1,,,U,,13428,BAO_0000019,,0,,,,22224,Permeability,,CHEMBL625043,
Autocuration,,P,2685,,,1,,,U,,13429,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625044,
Autocuration,,A,17584,,,1,,,U,,13430,BAO_0000019,,0,,,,22224,Partition coefficient (logD),,CHEMBL625045,
Autocuration,,P,13824,,,1,,,U,,13431,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,CHEMBL625046,
Autocuration,,P,13824,,,1,,,U,,13432,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,CHEMBL625047,
Autocuration,,P,16479,,,1,,,U,,13433,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625048,
Autocuration,,P,11997,,,1,,,U,,13434,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625049,
Autocuration,,P,2988,,,1,,,U,,13435,BAO_0000100,,0,,,,22229,Calculated logarithm of partition coefficient (P) was determined,,CHEMBL625050,
Autocuration,,P,931,,,1,,,U,,13436,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625051,
Autocuration,,P,4381,,,1,,,U,,13437,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL874412,
Autocuration,,P,4397,,,1,,,U,,13438,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625052,
Autocuration,,P,5889,,,1,,,U,,13439,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL625053,
Autocuration,,A,6154,,,1,,,U,,13440,BAO_0000019,,0,,,,22224,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,,CHEMBL623250,
Autocuration,,A,6154,,,1,,,U,,13441,BAO_0000019,,0,,,,22224,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,,CHEMBL623251,
Autocuration,,A,6154,,,1,,,U,,13442,BAO_0000019,,0,,,,22224,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,,CHEMBL623252,
Autocuration,,A,6154,,,1,,,U,,13443,BAO_0000019,,0,,,,22224,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,,CHEMBL623253,
Autocuration,,A,6154,,,1,,,U,,13444,BAO_0000019,,0,,,,22224,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,,CHEMBL623254,
Autocuration,,A,6154,,,1,,,U,,13445,BAO_0000019,,0,,,,22224,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,,CHEMBL623255,
Autocuration,,A,6887,,,1,,,U,,13446,BAO_0000019,,0,,,,22224,Percent degradation of compound at a pH of 1 over a 18 hr period,,CHEMBL626831,
Autocuration,,A,6887,,,1,,,U,,13447,BAO_0000019,,0,,,,22224,Percent degradation of compound at pH of 1 over an 18 hr period,,CHEMBL877494,
Autocuration,,A,14116,,,1,,,U,,13448,BAO_0000019,,0,,,,22224,Delta Logarithm of Partition Coefficient value was determined.,,CHEMBL626832,
Autocuration,,A,11137,,,1,,,U,,13449,BAO_0000019,,0,,,,22224,Delta logPoct-cyc,,CHEMBL626833,
Autocuration,,P,7230,,,1,,,U,,13450,BAO_0000100,,0,,,,22224,Lipophilicity estimated on reversed phase TLC,,CHEMBL626834,
Autocuration,,A,15741,,,1,,,U,,13451,BAO_0000019,,0,,,,22224,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,,CHEMBL626835,
Autocuration,,A,9663,,,1,,,U,,13452,BAO_0000019,,0,,,,22224,Delta logPoct-cyc,,CHEMBL626836,
Autocuration,,P,9663,,,1,,,U,,13453,BAO_0000100,,0,,,,22229,Change in logarithm of partition coefficient of the compound,,CHEMBL626837,
Autocuration,,A,13807,,,1,,,U,,13454,BAO_0000019,,0,,,,22224,Delta logD (pH 6.5),,CHEMBL626838,
Autocuration,,P,13807,,,1,,,U,,13455,BAO_0000100,,0,,,,22224,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",,CHEMBL626839,
Autocuration,,A,17425,,,1,,,U,,13456,BAO_0000019,,0,,,,22224,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,,CHEMBL626840,
Autocuration,,A,12143,,,1,,,U,,13457,BAO_0000019,,0,,,,22224,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),,CHEMBL626841,
Autocuration,,A,12608,,,1,,,U,,13458,BAO_0000219,,0,,,,22224,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,,CHEMBL626842,
Autocuration,,A,12608,,,1,,,U,,13459,BAO_0000219,,0,,,,22224,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,,CHEMBL626843,
Intermediate,,A,8649,,,1,,,N,,13460,BAO_0000218,,1,,10116.0,,50597,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,Rattus norvegicus,CHEMBL626844,
Intermediate,,A,8649,,,1,,,N,,13461,BAO_0000218,,1,,10116.0,,50597,Amount of deuterium retained was reported after normal workup in rats,Rattus norvegicus,CHEMBL877495,
Intermediate,,A,8649,,,1,,,N,,13462,BAO_0000218,,1,,10116.0,,50597,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,Rattus norvegicus,CHEMBL626845,
Intermediate,,A,8649,,,1,,,N,,13463,BAO_0000218,,1,,10116.0,,50597,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,Rattus norvegicus,CHEMBL626846,
Intermediate,,A,8649,,,1,,,N,,13464,BAO_0000218,,1,,10116.0,,50597,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,Rattus norvegicus,CHEMBL626847,
Intermediate,,A,8649,,,1,,,N,,13465,BAO_0000218,,1,,10116.0,,50597,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,Rattus norvegicus,CHEMBL628677,
Intermediate,,A,8649,,,1,,,N,,13466,BAO_0000218,,1,,10116.0,,50597,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,Rattus norvegicus,CHEMBL628678,
Autocuration,,A,9659,,,1,,,U,,13467,BAO_0000019,,0,,,,22224,Compound was subjected to electrochemical oxidation,,CHEMBL628679,
Autocuration,,A,9659,,,1,,,U,,13468,BAO_0000019,,0,,,,22224,Compound was subjected to photochemical oxidation,,CHEMBL628680,
Autocuration,,A,9659,,,1,,,U,,13469,BAO_0000019,,0,,,,22224,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,,CHEMBL628681,
Autocuration,,A,9659,,,1,,,U,,13470,BAO_0000019,,0,,,,22224,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,,CHEMBL628682,
Autocuration,,A,9659,,,1,,,U,,13471,BAO_0000019,,0,,,,22224,Oxidation of compound by methemoglobin in presence of hydroperoxide,,CHEMBL628683,
Intermediate,,A,9607,,,1,,,N,,13472,BAO_0000218,,1,,10116.0,,50597,Percent diffusion through fuzzy rat skin after 48 h of incubation,Rattus norvegicus,CHEMBL628684,
Autocuration,,P,7057,,,1,,,U,,13473,BAO_0000100,,0,,,,22229,Dissociation constant (pKa),,CHEMBL877501,
Autocuration,,P,7057,,,1,,,U,,13474,BAO_0000100,,0,,,,22224,Dissociation constant value of the compound; ND means not determined.,,CHEMBL628685,
Intermediate,,A,7911,,,1,,,N,,13475,BAO_0000218,,1,,10116.0,178.0,50597,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,Rattus norvegicus,CHEMBL628686,Blood
Intermediate,,A,7911,,,1,,,N,,13476,BAO_0000218,,1,,10116.0,178.0,50597,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Rattus norvegicus,CHEMBL628687,Blood
Intermediate,,A,7911,,,1,,,N,,13477,BAO_0000218,,1,,10116.0,,50597,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,Rattus norvegicus,CHEMBL628688,
Intermediate,,A,7911,,,1,,,N,,13478,BAO_0000218,,1,,10116.0,,50597,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Rattus norvegicus,CHEMBL628689,
Intermediate,,A,7911,,,1,,,N,,13479,BAO_0000218,,1,,10116.0,2107.0,50597,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,Rattus norvegicus,CHEMBL628690,Liver
Intermediate,,A,7911,,,1,,,N,,13480,BAO_0000218,,1,,10116.0,2107.0,50597,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,Rattus norvegicus,CHEMBL629363,Liver
Intermediate,,A,7911,,,1,,,N,,13481,BAO_0000218,,1,,10116.0,2106.0,50597,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,Rattus norvegicus,CHEMBL629364,Spleen
Intermediate,,A,7911,,,1,,,N,,13482,BAO_0000218,,1,,10116.0,2106.0,50597,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Rattus norvegicus,CHEMBL629365,Spleen
Intermediate,,A,7911,,,1,,,N,,13483,BAO_0000218,,1,,10116.0,,50597,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,Rattus norvegicus,CHEMBL629366,
Intermediate,,A,7911,,,1,,,N,,13484,BAO_0000218,,1,,10116.0,1088.0,50597,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,Rattus norvegicus,CHEMBL629367,Urine
Intermediate,,A,7911,,,1,,,N,,13485,BAO_0000218,,1,,10116.0,1988.0,50597,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Rattus norvegicus,CHEMBL629368,Feces
Intermediate,,A,7911,,,1,,,N,,13486,BAO_0000218,,1,,10116.0,1088.0,50597,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,Rattus norvegicus,CHEMBL877502,Urine
Intermediate,,A,13792,,,1,,,N,,13487,BAO_0000218,,1,,10090.0,2037.0,50594,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,Mus musculus,CHEMBL629369,Cerebellum
Intermediate,,A,13792,,,1,,,N,,13488,BAO_0000218,,1,,10090.0,955.0,50594,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,Mus musculus,CHEMBL629370,Brain
Autocuration,,A,8133,,,1,,,U,,13489,BAO_0000218,,0,,314293.0,1088.0,22224,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",Simiiformes,CHEMBL629371,Urine
Autocuration,,A,8133,,,1,,,U,,13490,BAO_0000218,,0,,314293.0,1088.0,22224,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Simiiformes,CHEMBL626276,Urine
Autocuration,,A,8133,,,1,,,U,,13491,BAO_0000218,,0,,314293.0,1088.0,22224,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",Simiiformes,CHEMBL626277,Urine
Autocuration,,A,8133,,,1,,,U,,13492,BAO_0000218,,0,,314293.0,1088.0,22224,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",Simiiformes,CHEMBL631250,Urine
Intermediate,,A,8133,,,1,,,N,,13493,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Rattus norvegicus,CHEMBL631251,Urine
Intermediate,,A,8133,,,1,,,N,,13494,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",Rattus norvegicus,CHEMBL631252,Urine
Intermediate,,A,8133,,,1,,,N,,13495,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",Rattus norvegicus,CHEMBL631253,Urine
Intermediate,,A,8133,,,1,,,N,,13496,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",Rattus norvegicus,CHEMBL631254,Urine
Intermediate,,A,8133,,,1,,,N,,13497,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",Rattus norvegicus,CHEMBL631255,Urine
Intermediate,,A,8133,,,1,,,N,,13498,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",Rattus norvegicus,CHEMBL631256,Urine
Intermediate,,A,8133,,,1,,,N,,13499,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",Rattus norvegicus,CHEMBL631257,Urine
Intermediate,,A,8133,,,1,,,N,,13500,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",Rattus norvegicus,CHEMBL628009,Urine
Intermediate,,A,8133,,,1,,,N,,13501,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",Rattus norvegicus,CHEMBL628010,Urine
Intermediate,,A,8133,,,1,,,N,,13502,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",Rattus norvegicus,CHEMBL628011,Urine
Intermediate,,A,8133,,,1,,,N,,13503,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",Rattus norvegicus,CHEMBL628012,Urine
Intermediate,,A,8133,,,1,,,N,,13504,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",Rattus norvegicus,CHEMBL628013,Urine
Intermediate,,A,8133,,,1,,,N,,13505,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",Rattus norvegicus,CHEMBL628014,Urine
Intermediate,,A,8133,,,1,,,N,,13506,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",Canis lupus familiaris,CHEMBL628015,Urine
Intermediate,,A,8133,,,1,,,N,,13507,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Canis lupus familiaris,CHEMBL628016,Urine
Intermediate,,A,8133,,,1,,,N,,13508,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",Canis lupus familiaris,CHEMBL874461,Urine
Intermediate,,A,8133,,,1,,,N,,13509,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Canis lupus familiaris,CHEMBL628017,Urine
Intermediate,,A,8133,,,1,,,N,,13510,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",Canis lupus familiaris,CHEMBL628018,Urine
Intermediate,,A,8133,,,1,,,N,,13511,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Canis lupus familiaris,CHEMBL628019,Urine
Intermediate,,A,8133,,,1,,,N,,13512,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",Canis lupus familiaris,CHEMBL628020,Urine
Intermediate,,A,8133,,,1,,,N,,13513,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",Canis lupus familiaris,CHEMBL628021,Urine
Intermediate,,A,8133,,,1,,,N,,13514,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",Canis lupus familiaris,CHEMBL628022,Urine
Intermediate,,A,8133,,,1,,,N,,13515,BAO_0000218,,1,,9615.0,1088.0,50588,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",Canis lupus familiaris,CHEMBL628023,Urine
Autocuration,,A,8133,,,1,,,U,,13516,BAO_0000218,,0,,314293.0,1088.0,22224,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Simiiformes,CHEMBL628024,Urine
Autocuration,,A,8133,,,1,,,U,,13517,BAO_0000218,,0,,314293.0,1088.0,22224,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",Simiiformes,CHEMBL628025,Urine
Autocuration,,A,8133,,,1,,,U,,13518,BAO_0000218,,0,,314293.0,1088.0,22224,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Simiiformes,CHEMBL628026,Urine
Autocuration,,A,8133,,,1,,,U,,13519,BAO_0000218,,0,,314293.0,1088.0,22224,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",Simiiformes,CHEMBL628027,Urine
Autocuration,,A,8133,,,1,,,U,,13520,BAO_0000218,,0,,314293.0,1088.0,22224,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",Simiiformes,CHEMBL628028,Urine
Intermediate,,A,8133,,,1,,,N,,13521,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Rattus norvegicus,CHEMBL628029,Urine
Intermediate,,A,8133,,,1,,,N,,13522,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",Rattus norvegicus,CHEMBL628030,Urine
Intermediate,,A,8133,,,1,,,N,,13523,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",Rattus norvegicus,CHEMBL628031,Urine
Intermediate,,A,8133,,,1,,,N,,13524,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",Rattus norvegicus,CHEMBL628032,Urine
Intermediate,,A,8133,,,1,,,N,,13525,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",Rattus norvegicus,CHEMBL628033,Urine
Intermediate,,A,8133,,,1,,,N,,13526,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",Rattus norvegicus,CHEMBL628034,Urine
Intermediate,,A,8133,,,1,,,N,,13527,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",Rattus norvegicus,CHEMBL628035,Urine
Intermediate,,A,8133,,,1,,,N,,13528,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",Rattus norvegicus,CHEMBL628036,Urine
Intermediate,,A,8133,,,1,,,N,,13529,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",Rattus norvegicus,CHEMBL874462,Urine
Intermediate,,A,9025,In vivo,,1,,,N,,13530,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,Canis lupus familiaris,CHEMBL628037,
Intermediate,,A,9025,In vivo,,1,,,N,,13531,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,Canis lupus familiaris,CHEMBL628123,
Intermediate,,A,9025,In vivo,,1,,,N,,13532,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,Canis lupus familiaris,CHEMBL628124,
Intermediate,,A,9025,In vivo,,1,,,N,,13533,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,Canis lupus familiaris,CHEMBL628125,
Intermediate,,A,9025,In vivo,,1,,,N,,13534,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,Canis lupus familiaris,CHEMBL628126,
Intermediate,,A,9025,In vivo,,1,,,N,,13535,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),Canis lupus familiaris,CHEMBL628127,
Intermediate,,A,9025,In vivo,,1,,,N,,13536,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,Canis lupus familiaris,CHEMBL628128,
Intermediate,,A,9025,In vivo,,1,,,N,,13537,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,Canis lupus familiaris,CHEMBL628129,
Intermediate,,A,9025,In vivo,,1,,,N,,13538,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,Canis lupus familiaris,CHEMBL628130,
Intermediate,,A,9025,In vivo,,1,,,N,,13539,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,Canis lupus familiaris,CHEMBL628131,
Intermediate,,A,9025,In vivo,,1,,,N,,13540,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,Canis lupus familiaris,CHEMBL628132,
Intermediate,,A,9025,In vivo,,1,,,N,,13541,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,Canis lupus familiaris,CHEMBL628133,
Intermediate,,A,9025,In vivo,,1,,,N,,13542,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,Canis lupus familiaris,CHEMBL628134,
Intermediate,,A,9025,In vivo,,1,,,N,,13543,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,Canis lupus familiaris,CHEMBL628135,
Intermediate,,A,9025,In vivo,,1,,,N,,13544,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,Canis lupus familiaris,CHEMBL628136,
Intermediate,,A,9025,In vivo,,1,,,N,,13545,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,Canis lupus familiaris,CHEMBL628137,
Intermediate,,A,9025,In vivo,,1,,,N,,13546,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,Canis lupus familiaris,CHEMBL628138,
Intermediate,,A,9025,In vivo,,1,,,N,,13547,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,Canis lupus familiaris,CHEMBL628139,
Intermediate,,A,9025,In vivo,,1,,,N,,13548,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,Canis lupus familiaris,CHEMBL628140,
Intermediate,,A,9025,In vivo,,1,,,N,,13549,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,Canis lupus familiaris,CHEMBL628141,
Intermediate,,A,9025,In vivo,,1,,,N,,13550,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,Canis lupus familiaris,CHEMBL628142,
Intermediate,,A,9025,In vivo,,1,,,N,,13551,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,Canis lupus familiaris,CHEMBL628143,
Intermediate,,A,9025,In vivo,,1,,,N,,13552,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,Canis lupus familiaris,CHEMBL628144,
Intermediate,,A,9025,In vivo,,1,,,N,,13553,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,Canis lupus familiaris,CHEMBL628145,
Intermediate,,A,9025,In vivo,,1,,,N,,13554,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,Canis lupus familiaris,CHEMBL628146,
Intermediate,,A,9025,In vivo,,1,,,N,,13555,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,Canis lupus familiaris,CHEMBL625355,
Intermediate,,A,9025,In vivo,,1,,,N,,13556,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,Canis lupus familiaris,CHEMBL625356,
Intermediate,,A,9025,In vivo,,1,,,N,,13557,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,Canis lupus familiaris,CHEMBL625357,
Intermediate,,A,9025,In vivo,,1,,,N,,13558,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,Canis lupus familiaris,CHEMBL625527,
Intermediate,,A,9025,In vivo,,1,,,N,,13559,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),Canis lupus familiaris,CHEMBL875473,
Intermediate,,A,9025,In vivo,,1,,,N,,13560,BAO_0000218,,1,,9615.0,,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,Canis lupus familiaris,CHEMBL625528,
Intermediate,,A,9025,In vivo,,1,,,N,,13561,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,Rattus norvegicus,CHEMBL626304,
Intermediate,,A,9025,In vivo,,1,,,N,,13562,BAO_0000218,,1,,9615.0,1637.0,50588,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,Canis lupus familiaris,CHEMBL624138,Artery
Autocuration,,P,6448,,,1,,,U,,13563,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL624139,
Autocuration,,P,17221,,,1,,,U,,13564,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL624140,
Autocuration,,P,6545,,,1,,,U,,13565,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL624141,
Autocuration,,P,577,,,1,,,U,,13566,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL624142,
Autocuration,,P,6285,,,1,,,U,,13567,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL624143,
Autocuration,,P,6500,,,1,,,U,,13568,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL624144,
Autocuration,,P,6716,,,1,,,U,,13569,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL624145,
Autocuration,,P,13658,,,1,,,U,,13570,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL624146,
Autocuration,,P,6549,,,1,,,U,,13571,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL624147,
Autocuration,,P,14685,,,1,,,U,,13572,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP) (MacLogP),,CHEMBL883123,
Autocuration,,A,6893,,,1,,,U,,13573,BAO_0000019,,0,,,,22224,Partition coefficient (logP),,CHEMBL624148,
Autocuration,,A,3687,,,1,,,U,,13574,BAO_0000019,,0,,,,22224,Kinetic parameter was determined,,CHEMBL874416,
Autocuration,,P,4207,,,1,,,U,,13575,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL624149,
Autocuration,,P,4626,,,1,,,U,,13576,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL624150,
Autocuration,,P,1021,,,1,,,U,,13577,BAO_0000100,,0,,,,22224,Lipophilicity was determined,,CHEMBL624151,
Autocuration,,P,3777,,,1,,,U,,13578,BAO_0000100,,0,,,,22224,Lipophilicity was determined,,CHEMBL624152,
Autocuration,,P,17533,,,1,,,U,,13579,BAO_0000100,,0,,,,22224,Lipophilicity was determined,,CHEMBL622139,
Autocuration,,P,6524,,,1,,,U,,13580,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL622140,
Autocuration,,P,17533,,,1,,,U,,13581,BAO_0000100,,0,,,,22224,Lipophilicity was determined,,CHEMBL622141,
Autocuration,,P,6480,,,1,,,U,,13582,BAO_0000100,,0,,,,22224,Lipophilicity in octanol-water,,CHEMBL622142,
Autocuration,,P,17606,,,1,,,U,,13583,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL622143,
Autocuration,,P,6863,,,1,,,U,,13584,BAO_0000100,,0,,,,22229,Octanol-water partition coefficient was determined,,CHEMBL622144,
Autocuration,,A,1356,,,1,,,U,,13585,BAO_0000019,,0,,,,22224,Partition coefficient (logP),,CHEMBL877473,
Autocuration,,P,3326,,,1,,,U,,13586,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL622145,
Autocuration,,A,1356,,,1,,,U,,13587,BAO_0000019,,0,,,,22224,Partition coefficient was determined; ND means not determined,,CHEMBL622146,
Autocuration,,P,12984,,,1,,,U,,13588,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP),,CHEMBL622147,
Autocuration,,A,17363,,,1,,,U,,13589,BAO_0000019,,0,,,,22224,Partition coefficient of the compound,,CHEMBL622148,
Autocuration,,A,6827,,,1,,,U,,13590,BAO_0000019,,0,,,,22224,Permeability was determined,,CHEMBL883124,
Autocuration,,P,261,,,1,,,U,,13591,BAO_0000100,,0,,,,22229,The compound was evaluated for the partition coefficient,,CHEMBL622149,
Autocuration,,A,2685,,,1,,,U,,13592,BAO_0000019,,0,,,,22224,Partition coefficient (logP),,CHEMBL622150,
Autocuration,,P,414,,,1,,,U,,13593,BAO_0000100,,0,,,,22224,The lipophilicity was reported,,CHEMBL622151,
Autocuration,,P,15769,,,1,,,U,,13594,BAO_0000100,,0,,,,22229,logarithm of the octanol-water partition coefficient for the compound,,CHEMBL622152,
Autocuration,,A,17248,,,1,,,U,,13595,BAO_0000019,,0,,,,22224,Clogp value was determined,,CHEMBL622153,
Autocuration,,A,16935,In vivo,,1,,,U,,13596,BAO_0000218,,0,,,,22224,Clp at a dose of 1.5 mg/kg,,CHEMBL877474,
Autocuration,,A,16935,In vivo,,1,,,U,,13597,BAO_0000218,,0,,,,22224,Clp at a dose of 2.0 mg/kg,,CHEMBL622154,
Autocuration,,A,14832,In vivo,,1,,,U,,13598,BAO_0000218,,0,,,1969.0,22224,"Clp, plasma clearance at a dose of 10 mg/kg",,CHEMBL622155,Plasma
Autocuration,,A,14832,In vivo,,1,,,U,,13599,BAO_0000218,,0,,,1969.0,22224,"Clp, plasma clearance at a dose of 50 mg/kg",,CHEMBL622156,Plasma
Intermediate,,A,2399,In vivo,,1,,,N,,13600,BAO_0000218,,1,,10116.0,1969.0,50597,Compound was tested for plasma clearance in rat,Rattus norvegicus,CHEMBL622157,Plasma
Intermediate,,A,2399,In vivo,,1,,,N,,13601,BAO_0000218,,1,,10116.0,1969.0,50597,Compound was tested for plasma clearance in rat; Not determined,Rattus norvegicus,CHEMBL622158,Plasma
Intermediate,,A,6227,In vivo,,1,,,N,,13602,BAO_0000218,,1,,10116.0,,50597,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,Rattus norvegicus,CHEMBL622807,
Intermediate,,A,6227,In vivo,,1,,,N,,13603,BAO_0000218,,1,,9544.0,,50797,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,Macaca mulatta,CHEMBL622808,
Autocuration,,A,5623,In vivo,,1,,,U,,13604,BAO_0000218,,0,,,,22224,Plasma clearance by iv administration at a dose 0.003 ug/mL,,CHEMBL622809,
Autocuration,,A,4854,In vivo,,1,,,U,,13605,BAO_0000218,,0,,,,22224,Plasma clearance determined,,CHEMBL622810,
Intermediate,,A,4493,In vivo,,1,,,N,,13606,BAO_0000218,,1,,10026.0,,100712,Plasma clearance after iv administration at 3 mg/kg in hamster,Cricetinae,CHEMBL876653,
Intermediate,,A,4493,In vivo,,1,,,N,,13607,BAO_0000218,,1,,10026.0,,100712,Plasma clearance after iv administration at 4 mg/kg in hamster,Cricetinae,CHEMBL622811,
Intermediate,,A,14956,In vivo,,1,,,N,,13608,BAO_0000218,,1,,10116.0,,50597,Rate of clearance in rat was determined,Rattus norvegicus,CHEMBL622986,
Intermediate,,A,15372,In vivo,,1,,,N,,13609,BAO_0000218,,1,,10116.0,1969.0,50597,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,Rattus norvegicus,CHEMBL622987,Plasma
Intermediate,,A,15372,In vivo,,1,,,N,,13610,BAO_0000218,,1,,10116.0,1969.0,50597,Total plasma clearance after iv dose of 5.10 mg/kg in rats,Rattus norvegicus,CHEMBL622988,Plasma
Intermediate,,A,15372,In vivo,,1,,,N,,13611,BAO_0000218,,1,,10116.0,1969.0,50597,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,Rattus norvegicus,CHEMBL622989,Plasma
Intermediate,,A,15372,In vivo,,1,,,N,,13612,BAO_0000218,,1,,10116.0,1969.0,50597,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,Rattus norvegicus,CHEMBL622990,Plasma
Autocuration,,A,15604,In vivo,,1,,,U,,13613,BAO_0000218,,0,,314293.0,1969.0,22224,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,Simiiformes,CHEMBL622991,Plasma
Intermediate,,A,15604,In vivo,,1,,,N,,13614,BAO_0000218,,1,,10116.0,1969.0,50597,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,Rattus norvegicus,CHEMBL622227,Plasma
Intermediate,,A,15604,In vivo,,1,,,N,,13615,BAO_0000218,,1,,9615.0,1969.0,50588,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,Canis lupus familiaris,CHEMBL622228,Plasma
Intermediate,,A,14964,In vivo,,1,,,N,,13616,BAO_0000218,,1,,10116.0,,50597,Clpl value in rat,Rattus norvegicus,CHEMBL622229,
Intermediate,,A,15240,In vivo,,1,,,N,,13617,BAO_0000218,,1,,10141.0,,50512,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,Cavia porcellus,CHEMBL622230,
Intermediate,,A,16449,In vivo,,1,,,N,,13618,BAO_0000218,,1,,10116.0,,50597,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,Rattus norvegicus,CHEMBL622231,
Intermediate,,A,16449,In vivo,,1,,,N,,13619,BAO_0000218,,1,,9541.0,,100710,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,Macaca fascicularis,CHEMBL622232,
Autocuration,,A,12902,In vivo,,1,,,U,,13620,BAO_0000218,,0,,,,22224,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,,CHEMBL622233,
Autocuration,,A,12902,In vivo,,1,,,U,,13621,BAO_0000218,,0,,,,22224,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,,CHEMBL622234,
Autocuration,,A,12902,In vivo,,1,,,U,,13622,BAO_0000218,,0,,,,22224,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,,CHEMBL622235,
Autocuration,,A,12902,In vivo,,1,,,U,,13623,BAO_0000218,,0,,,,22224,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,,CHEMBL622236,
Autocuration,,A,12902,In vivo,,1,,,U,,13624,BAO_0000218,,0,,,,22224,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,,CHEMBL622237,
Autocuration,,A,12902,In vivo,,1,,,U,,13625,BAO_0000218,,0,,,,22224,Cmax in minutes at a po dose of 10.0(pmol/g/h).,,CHEMBL877482,
Autocuration,,A,12902,In vivo,,1,,,U,,13626,BAO_0000218,,0,,,,22224,Cmax in minutes at a po dose of 20.0(pmol/g/h).,,CHEMBL622238,
Autocuration,,A,12902,In vivo,,1,,,U,,13627,BAO_0000218,,0,,,,22224,Cmax in minutes at a po dose of 40.0(pmol/g/h).,,CHEMBL622239,
Autocuration,,A,11149,In vivo,,1,,,U,,13628,BAO_0000218,,0,,,178.0,22224,Cmax was calculated as maximum concentration reached in the blood,,CHEMBL622240,Blood
Autocuration,,A,11149,In vivo,,1,,,U,,13629,BAO_0000218,,0,,,178.0,22224,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,,CHEMBL622241,Blood
Intermediate,,A,5669,In vivo,,1,,,N,,13630,BAO_0000218,,1,,10116.0,,50597,Cmax was determine after peroral administration at 10 mpk in Rat,Rattus norvegicus,CHEMBL631013,
Intermediate,,A,5669,In vivo,,1,,,N,,13631,BAO_0000218,,1,,9544.0,,50797,Cmax was determine after peroral administration at 10 mpk in Rhesus,Macaca mulatta,CHEMBL631014,
Intermediate,,A,5669,In vivo,,1,,,N,,13632,BAO_0000218,,1,,9615.0,,50588,Cmax was determine after peroral administration at 10 mpk in dog,Canis lupus familiaris,CHEMBL631015,
Intermediate,,A,5669,In vivo,,1,,,N,,13633,BAO_0000218,,1,,10116.0,,50597,Cmax was determine after peroral administration at 160 mpk in Rat,Rattus norvegicus,CHEMBL631016,
Intermediate,,A,5669,In vivo,,1,,,N,,13634,BAO_0000218,,1,,10116.0,,50597,Cmax was determine after peroral administration at 20 mpk in Rat,Rattus norvegicus,CHEMBL631017,
Intermediate,,A,5669,In vivo,,1,,,N,,13635,BAO_0000218,,1,,10116.0,,50597,Cmax was determine after peroral administration at 50 mpk in Rat,Rattus norvegicus,CHEMBL631018,
Autocuration,,A,4236,In vivo,,1,,,U,,13636,BAO_0000218,,0,,,,22224,Cmax was determined,,CHEMBL631019,
Intermediate,,A,13792,,,1,,,N,,13637,BAO_0000218,,1,,10090.0,955.0,50594,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,Mus musculus,CHEMBL875761,Brain
Intermediate,,A,13792,,,1,,,N,,13638,BAO_0000218,,1,,10090.0,955.0,50594,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,Mus musculus,CHEMBL631020,Brain
Intermediate,,A,13792,,,1,,,N,,13639,BAO_0000218,,1,,10090.0,955.0,50594,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,Mus musculus,CHEMBL631669,Brain
Intermediate,,A,13792,,,1,,,N,,13640,BAO_0000218,,1,,10090.0,955.0,50594,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,Mus musculus,CHEMBL631670,Brain
Intermediate,,A,13792,,,1,,,N,,13641,BAO_0000218,,1,,10090.0,2435.0,50594,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,Mus musculus,CHEMBL631671,Striatum
Intermediate,,A,8418,,,1,,,N,,13642,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,Rattus norvegicus,CHEMBL631672,Blood
Intermediate,,A,8418,,,1,,,N,,13643,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,Rattus norvegicus,CHEMBL631673,Blood
Intermediate,,A,8418,,,1,,,N,,13644,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,Rattus norvegicus,CHEMBL631856,Blood
Intermediate,,A,8418,,,1,,,N,,13645,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,Rattus norvegicus,CHEMBL631857,Blood
Intermediate,,A,8418,,,1,,,N,,13646,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,Rattus norvegicus,CHEMBL631858,Blood
Intermediate,,A,8418,,,1,,,N,,13647,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,Rattus norvegicus,CHEMBL631859,Blood
Intermediate,,A,8418,,,1,,,N,,13648,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,Rattus norvegicus,CHEMBL631860,Blood
Intermediate,,A,8418,,,1,,,N,,13649,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,Rattus norvegicus,CHEMBL631861,Blood
Intermediate,,A,8418,,,1,,,N,,13650,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,Rattus norvegicus,CHEMBL631862,Blood
Intermediate,,A,8418,,,1,,,N,,13651,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,Rattus norvegicus,CHEMBL631863,Blood
Intermediate,,A,8418,,,1,,,N,,13652,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,Rattus norvegicus,CHEMBL631864,Blood
Intermediate,,A,8418,,,1,,,N,,13653,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,Rattus norvegicus,CHEMBL631865,Blood
Intermediate,,A,8418,,,1,,,N,,13654,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,Rattus norvegicus,CHEMBL631866,Blood
Intermediate,,A,8418,,,1,,,N,,13655,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,Rattus norvegicus,CHEMBL629360,Blood
Intermediate,,A,8418,,,1,,,N,,13656,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,Rattus norvegicus,CHEMBL629361,Blood
Intermediate,,A,8418,,,1,,,N,,13657,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,Rattus norvegicus,CHEMBL629362,Blood
Intermediate,,A,8418,,,1,,,N,,13658,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,Rattus norvegicus,CHEMBL630740,Blood
Intermediate,,A,8418,,,1,,,N,,13659,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,Rattus norvegicus,CHEMBL630741,Blood
Intermediate,,A,8418,,,1,,,N,,13660,BAO_0000218,,1,,10116.0,178.0,50597,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,Rattus norvegicus,CHEMBL630742,Blood
Intermediate,,A,8418,,,1,,,N,,13661,BAO_0000218,,1,,10116.0,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,Rattus norvegicus,CHEMBL630743,
Intermediate,,A,8418,,,1,,,N,,13662,BAO_0000218,,1,,10116.0,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,Rattus norvegicus,CHEMBL630744,
Intermediate,,A,8418,,,1,,,N,,13663,BAO_0000218,,1,,10116.0,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,Rattus norvegicus,CHEMBL630745,
Intermediate,,A,8418,,,1,,,N,,13664,BAO_0000218,,1,,10116.0,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,Rattus norvegicus,CHEMBL630746,
Intermediate,,A,8418,,,1,,,N,,13665,BAO_0000218,,1,,10116.0,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,Rattus norvegicus,CHEMBL630747,
Intermediate,,A,8418,,,1,,,N,,13666,BAO_0000218,,1,,10116.0,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,Rattus norvegicus,CHEMBL630748,
Intermediate,,A,8418,,,1,,,N,,13667,BAO_0000218,,1,,10116.0,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,Rattus norvegicus,CHEMBL632056,
Intermediate,,A,8418,,,1,,,N,,13668,BAO_0000218,,1,,10116.0,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,Rattus norvegicus,CHEMBL632057,
Intermediate,,A,8418,,,1,,,N,,13669,BAO_0000218,,1,,10116.0,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,Rattus norvegicus,CHEMBL632058,
Intermediate,,A,8418,,,1,,,N,,13670,BAO_0000218,,1,,10116.0,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,Rattus norvegicus,CHEMBL632059,
Intermediate,,A,8418,,,1,,,N,,13671,BAO_0000218,,1,,10116.0,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,Rattus norvegicus,CHEMBL632060,
Intermediate,,A,8418,,,1,,,N,,13672,BAO_0000218,,1,,10116.0,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,Rattus norvegicus,CHEMBL632061,
Intermediate,,A,8418,,,1,,,N,,13673,BAO_0000218,,1,,10116.0,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,Rattus norvegicus,CHEMBL629207,
Intermediate,,A,8418,,,1,,,N,,13674,BAO_0000218,,1,,10116.0,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,Rattus norvegicus,CHEMBL629208,
Intermediate,,A,8418,,,1,,,N,,13675,BAO_0000218,,1,,10116.0,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,Rattus norvegicus,CHEMBL629209,
Intermediate,,A,8418,,,1,,,N,,13676,BAO_0000218,,1,,10116.0,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,Rattus norvegicus,CHEMBL629210,
Intermediate,,A,8418,,,1,,,N,,13677,BAO_0000218,,1,,10116.0,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,Rattus norvegicus,CHEMBL629211,
Intermediate,,A,8418,,,1,,,N,,13678,BAO_0000218,,1,,10116.0,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,Rattus norvegicus,CHEMBL629212,
Intermediate,,A,8418,,,1,,,N,,13679,BAO_0000218,,1,,10116.0,,50597,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,Rattus norvegicus,CHEMBL629213,
Intermediate,,A,8133,,,1,,,N,,13680,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",Rattus norvegicus,CHEMBL629214,Urine
Intermediate,,A,8133,,,1,,,N,,13681,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",Rattus norvegicus,CHEMBL629215,Urine
Intermediate,,A,8133,,,1,,,N,,13682,BAO_0000218,,1,,10116.0,1088.0,50597,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",Rattus norvegicus,CHEMBL635154,Urine
Intermediate,,A,6996,,,1,,,N,,13683,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Rattus norvegicus,CHEMBL629216,
Intermediate,,A,6996,,,1,,,N,,13684,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,Rattus norvegicus,CHEMBL629217,
Intermediate,,A,6996,,,1,,,N,,13685,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,CHEMBL629218,
Intermediate,,A,6996,,,1,,,N,,13686,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),Rattus norvegicus,CHEMBL629219,
Intermediate,,A,6996,,,1,,,N,,13687,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,CHEMBL629220,
Intermediate,,A,6996,,,1,,,N,,13688,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,CHEMBL629221,
Intermediate,,A,6996,,,1,,,N,,13689,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,CHEMBL631127,
Intermediate,,A,6996,,,1,,,N,,13690,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,Rattus norvegicus,CHEMBL631128,
Intermediate,,A,6996,,,1,,,N,,13691,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,CHEMBL631129,
Intermediate,,A,6996,,,1,,,N,,13692,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),Rattus norvegicus,CHEMBL631130,
Intermediate,,A,6996,,,1,,,N,,13693,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,CHEMBL631131,
Intermediate,,A,6996,,,1,,,N,,13694,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,CHEMBL631132,
Intermediate,,A,6996,,,1,,,N,,13695,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,CHEMBL631133,
Intermediate,,A,6996,,,1,,,N,,13696,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,Rattus norvegicus,CHEMBL631134,
Intermediate,,A,6996,,,1,,,N,,13697,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,CHEMBL875120,
Intermediate,,A,6996,,,1,,,N,,13698,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),Rattus norvegicus,CHEMBL631135,
Intermediate,,A,6996,,,1,,,N,,13699,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,CHEMBL631136,
Intermediate,,A,6996,,,1,,,N,,13700,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,CHEMBL631137,
Intermediate,,A,6996,,,1,,,N,,13701,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,CHEMBL631138,
Intermediate,,A,6996,,,1,,,N,,13702,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,Rattus norvegicus,CHEMBL631139,
Intermediate,,A,6996,,,1,,,N,,13703,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,CHEMBL631140,
Intermediate,,A,6996,,,1,,,N,,13704,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Rattus norvegicus,CHEMBL631141,
Intermediate,,A,6996,,,1,,,N,,13705,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,CHEMBL631142,
Intermediate,,A,6996,,,1,,,N,,13706,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,CHEMBL631143,
Intermediate,,A,6996,,,1,,,N,,13707,BAO_0000218,,1,,10116.0,,50597,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,CHEMBL631144,
Intermediate,,A,6996,,,1,,,N,,13708,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,Canis lupus familiaris,CHEMBL631145,
Intermediate,,A,6996,,,1,,,N,,13709,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,CHEMBL631146,
Intermediate,,A,6996,,,1,,,N,,13710,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,Canis lupus familiaris,CHEMBL631147,
Intermediate,,A,6996,,,1,,,N,,13711,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,CHEMBL631148,
Intermediate,,A,6996,,,1,,,N,,13712,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,CHEMBL631149,
Intermediate,,A,6996,,,1,,,N,,13713,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,CHEMBL631150,
Intermediate,,A,6996,,,1,,,N,,13714,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,CHEMBL631151,
Intermediate,,A,6996,,,1,,,N,,13715,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,CHEMBL631152,
Intermediate,,A,6996,,,1,,,N,,13716,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,CHEMBL631443,
Intermediate,,A,6996,,,1,,,N,,13717,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,CHEMBL631444,
Intermediate,,A,6996,,,1,,,N,,13718,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,CHEMBL631445,
Intermediate,,A,6996,,,1,,,N,,13719,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),Canis lupus familiaris,CHEMBL631446,
Intermediate,,A,6996,,,1,,,N,,13720,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),Canis lupus familiaris,CHEMBL631447,
Intermediate,,A,6996,,,1,,,N,,13721,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,CHEMBL631448,
Intermediate,,A,6996,,,1,,,N,,13722,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,Canis lupus familiaris,CHEMBL631449,
Intermediate,,A,6996,,,1,,,N,,13723,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,CHEMBL631450,
Intermediate,,A,6996,,,1,,,N,,13724,BAO_0000218,,1,,9615.0,,50588,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,CHEMBL629724,
Intermediate,,A,9716,In vivo,,1,,,N,,13725,BAO_0000218,,1,,10090.0,14.0,50594,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,CHEMBL629725,Zone of skin
Intermediate,,A,9716,In vivo,,1,,,N,,13726,BAO_0000218,,1,,10090.0,14.0,50594,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,CHEMBL629726,Zone of skin
Intermediate,,A,9716,In vivo,,1,,,N,,13727,BAO_0000218,,1,,10090.0,2106.0,50594,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,CHEMBL629727,Spleen
Intermediate,,A,9716,In vivo,,1,,,N,,13728,BAO_0000218,,1,,10090.0,2106.0,50594,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,CHEMBL630404,Spleen
Intermediate,,A,9716,In vivo,,1,,,N,,13729,BAO_0000218,,1,,10090.0,2106.0,50594,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,CHEMBL630405,Spleen
Intermediate,,A,9716,In vivo,,1,,,N,,13730,BAO_0000218,,1,,10090.0,2106.0,50594,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,CHEMBL630406,Spleen
Intermediate,,A,9716,In vivo,,1,,,N,,13731,BAO_0000218,,1,,10090.0,945.0,50594,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,CHEMBL630407,Stomach
Intermediate,,A,9716,In vivo,,1,,,N,,13732,BAO_0000218,,1,,10090.0,945.0,50594,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,CHEMBL630573,Stomach
Intermediate,,A,9716,In vivo,,1,,,N,,13733,BAO_0000218,,1,,10090.0,945.0,50594,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,CHEMBL630574,Stomach
Intermediate,,A,9716,In vivo,,1,,,N,,13734,BAO_0000218,,1,,10090.0,945.0,50594,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,CHEMBL630575,Stomach
Intermediate,,A,9716,In vivo,,1,,,N,,13735,BAO_0000218,,1,,10090.0,,50594,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,CHEMBL630576,
Intermediate,,A,9716,In vivo,,1,,,N,,13736,BAO_0000218,,1,,10090.0,,50594,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,CHEMBL630577,
Intermediate,,A,9716,In vivo,,1,,,N,,13737,BAO_0000218,,1,,10090.0,,50594,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,CHEMBL630578,
Intermediate,,A,9716,In vivo,,1,,,N,,13738,BAO_0000218,,1,,10090.0,,50594,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,CHEMBL630579,
Intermediate,,A,12192,,,1,,,N,,13739,BAO_0000218,,1,,10090.0,2113.0,50594,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),Mus musculus,CHEMBL630580,Kidney
Intermediate,,A,12192,,,1,,,N,,13740,BAO_0000218,,1,,10090.0,2113.0,50594,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,Mus musculus,CHEMBL630581,Kidney
Intermediate,,A,12192,,,1,,,N,,13741,BAO_0000218,,1,,10090.0,2113.0,50594,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),Mus musculus,CHEMBL630582,Kidney
Intermediate,,A,12192,,,1,,,N,,13742,BAO_0000218,,1,,10090.0,,50594,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,Mus musculus,CHEMBL630583,
Intermediate,,A,12192,,,1,,,N,,13743,BAO_0000218,,1,,10090.0,,50594,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),Mus musculus,CHEMBL630584,
Intermediate,,A,12192,,,1,,,N,,13744,BAO_0000218,,1,,10090.0,,50594,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,Mus musculus,CHEMBL630585,
Intermediate,,A,12192,,,1,,,N,,13745,BAO_0000218,,1,,10090.0,,50594,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),Mus musculus,CHEMBL630586,
Intermediate,,A,12192,,,1,,,N,,13746,BAO_0000218,,1,,10090.0,,50594,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,Mus musculus,CHEMBL630587,
Intermediate,,A,12192,,,1,,,N,,13747,BAO_0000218,,1,,10090.0,,50594,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),Mus musculus,CHEMBL630588,
Intermediate,,A,12192,,,1,,,N,,13748,BAO_0000218,,1,,10090.0,,50594,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,Mus musculus,CHEMBL630589,
Intermediate,,A,12192,,,1,,,N,,13749,BAO_0000218,,1,,10090.0,,50594,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),Mus musculus,CHEMBL630590,
Autocuration,,A,12192,,,1,,,U,,13750,BAO_0000019,,0,,,1988.0,22224,Removal of 238-Plutonium(IV) in feces at 24 h,,CHEMBL630591,Feces
Autocuration,,A,12192,,,1,,,U,,13751,BAO_0000019,,0,,,1988.0,22224,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),,CHEMBL630592,Feces
Autocuration,,A,12192,,,1,,,U,,13752,BAO_0000019,,0,,,,22224,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,,CHEMBL630593,
Autocuration,,A,12192,,,1,,,U,,13753,BAO_0000019,,0,,,,22224,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),,CHEMBL630594,
Autocuration,,A,12192,,,1,,,U,,13754,BAO_0000019,,0,,,1088.0,22224,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),,CHEMBL630595,Urine
Autocuration,,A,12192,,,1,,,U,,13755,BAO_0000019,,0,,,1088.0,22224,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),,CHEMBL630596,Urine
Autocuration,,A,12192,,,1,,,U,,13756,BAO_0000019,,0,,,1088.0,22224,Removal of 238-Plutonium(IV) in urine after 0-24 h,,CHEMBL630597,Urine
Autocuration,,A,12192,,,1,,,U,,13757,BAO_0000019,,0,,,1088.0,22224,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),,CHEMBL630598,Urine
Autocuration,,A,12192,,,1,,,U,,13758,BAO_0000019,,0,,,1088.0,22224,Removal of 238-Plutonium(IV) in urine after 0-4 h,,CHEMBL630599,Urine
Autocuration,,A,12192,,,1,,,U,,13759,BAO_0000019,,0,,,1088.0,22224,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),,CHEMBL630600,Urine
Autocuration,,A,12192,,,1,,,U,,13760,BAO_0000019,,0,,,1088.0,22224,Removal of 238-Plutonium(IV) in urine after 4-24 h,,CHEMBL630601,Urine
Autocuration,,A,12192,,,1,,,U,,13761,BAO_0000019,,0,,,1088.0,22224,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),,CHEMBL630602,Urine
Autocuration,,A,12192,,,1,,,U,,13762,BAO_0000019,,0,,,1088.0,22224,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),,CHEMBL630603,Urine
Autocuration,,A,12192,,,1,,,U,,13763,BAO_0000019,,0,,,1088.0,22224,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),,CHEMBL630604,Urine
Intermediate,,A,12017,In vivo,,1,,,N,,13764,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL624869,Blood
Intermediate,,A,12017,In vivo,,1,,,N,,13765,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL624870,Blood
Intermediate,,A,12017,In vivo,,1,,,N,,13766,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,CHEMBL623189,Blood
Intermediate,,A,12017,In vivo,,1,,,N,,13767,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL623190,Blood
Intermediate,,A,12017,In vivo,,1,,,N,,13768,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL623191,Blood
Intermediate,,A,12017,In vivo,,1,,,N,,13769,BAO_0000218,,1,,10116.0,,50597,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL623192,
Intermediate,,A,12017,In vivo,,1,,,N,,13770,BAO_0000218,,1,,10116.0,,50597,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL623193,
Intermediate,,A,12017,In vivo,,1,,,N,,13771,BAO_0000218,,1,,10116.0,,50597,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,CHEMBL623194,
Intermediate,,A,12017,In vivo,,1,,,N,,13772,BAO_0000218,,1,,10116.0,,50597,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL623195,
Intermediate,,A,12017,In vivo,,1,,,N,,13773,BAO_0000218,,1,,10116.0,,50597,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL623196,
Intermediate,,A,11836,,,1,,,N,,13774,BAO_0000218,,1,,10116.0,,50597,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,Rattus norvegicus,CHEMBL623197,
Intermediate,,A,11836,,,1,,,N,,13775,BAO_0000218,,1,,10116.0,,50597,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Rattus norvegicus,CHEMBL623198,
Intermediate,,A,11836,,,1,,,N,,13776,BAO_0000218,,1,,10116.0,,50597,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,Rattus norvegicus,CHEMBL623199,
Intermediate,,A,11836,,,1,,,N,,13777,BAO_0000218,,1,,10116.0,2385.0,50597,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,Rattus norvegicus,CHEMBL623200,Muscle tissue
Intermediate,,A,11836,,,1,,,N,,13778,BAO_0000218,,1,,10116.0,2385.0,50597,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,Rattus norvegicus,CHEMBL623201,Muscle tissue
Intermediate,,A,11836,,,1,,,N,,13779,BAO_0000218,,1,,10116.0,2385.0,50597,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,Rattus norvegicus,CHEMBL623202,Muscle tissue
Intermediate,,A,11836,,,1,,,N,,13780,BAO_0000218,,1,,10116.0,2385.0,50597,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,Rattus norvegicus,CHEMBL623203,Muscle tissue
Intermediate,,A,11836,,,1,,,N,,13781,BAO_0000218,,1,,10116.0,2385.0,50597,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,Rattus norvegicus,CHEMBL623204,Muscle tissue
Intermediate,,A,11836,,,1,,,N,,13782,BAO_0000218,,1,,10116.0,2385.0,50597,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,Rattus norvegicus,CHEMBL623205,Muscle tissue
Intermediate,,A,11836,,,1,,,N,,13783,BAO_0000218,,1,,10116.0,2385.0,50597,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,Rattus norvegicus,CHEMBL623206,Muscle tissue
Intermediate,,A,11836,,,1,,,N,,13784,BAO_0000218,,1,,10116.0,2385.0,50597,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,Rattus norvegicus,CHEMBL623207,Muscle tissue
Intermediate,,A,11836,,,1,,,N,,13785,BAO_0000218,,1,,10116.0,2385.0,50597,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,Rattus norvegicus,CHEMBL623208,Muscle tissue
Intermediate,,A,11836,,,1,,,N,,13786,BAO_0000218,,1,,10116.0,2385.0,50597,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Rattus norvegicus,CHEMBL623209,Muscle tissue
Intermediate,,A,11836,,,1,,,N,,13787,BAO_0000218,,1,,10116.0,2385.0,50597,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,Rattus norvegicus,CHEMBL623210,Muscle tissue
Intermediate,,A,11836,,,1,,,N,,13788,BAO_0000218,,1,,10116.0,,50597,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Rattus norvegicus,CHEMBL623211,
Intermediate,,A,11836,,,1,,,N,,13789,BAO_0000218,,1,,10116.0,995.0,50597,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,Rattus norvegicus,CHEMBL623212,Uterus
Autocuration,,A,12640,,,1,,,U,,13790,BAO_0000019,,0,,,,22224,Tested in vitro for intrinsic activity relative to quinpirole,,CHEMBL623213,
Autocuration,,A,14218,,,1,,,U,,13791,BAO_0000019,,0,,,,22224,"Relative ion enhancement, determined in pulsed ultrafiltration",,CHEMBL623214,
Autocuration,,A,11296,,,1,,,U,,13792,BAO_0000019,,0,,,,22224,% ionization at the pH 7.4 at 37 degree Centigrade,,CHEMBL623215,
Autocuration,,A,10929,,,1,,,U,,13793,BAO_0000019,,0,,,,22224,Percentage ionization was measured,,CHEMBL623216,
Intermediate,,A,13841,,,1,,,N,,13794,BAO_0000218,,1,,9913.0,,50591,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,Bos taurus,CHEMBL623217,
Autocuration,,A,10431,,,1,,,U,,13795,BAO_0000019,,0,,,,22224,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,,CHEMBL623218,
Autocuration,,A,10431,,,1,,,U,,13796,BAO_0000019,,0,,,,22224,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,,CHEMBL623913,
Autocuration,,A,10431,,,1,,,U,,13797,BAO_0000019,,0,,,,22224,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,,CHEMBL623914,
Autocuration,,P,8826,,,1,,,U,,13798,BAO_0000100,,0,,,,22229,Compound was evaluated for the partition coefficient in octanol/water,,CHEMBL623915,
Autocuration,,P,8826,,,1,,,U,,13799,BAO_0000100,,0,,,,22229,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),,CHEMBL624080,
Autocuration,,A,9884,,,1,,,U,,13800,BAO_0000019,,0,,,,22224,Equilibrium constant measured by the pulse radiolysis at pH 7,,CHEMBL624081,
Intermediate,,A,9827,,,1,,,N,,13801,BAO_0000218,,1,,9606.0,,50587,In vitro hydrolytic rate constant determined in human blood,Homo sapiens,CHEMBL624082,
Intermediate,,A,10009,,,1,,,N,,13802,BAO_0000218,,1,,9606.0,,50587,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,Homo sapiens,CHEMBL625054,
Autocuration,,A,10009,,,1,,,U,,13803,BAO_0000019,,0,,,,22224,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,,CHEMBL877485,
Intermediate,,A,10009,,,1,,,N,,13804,BAO_0000218,,1,,10090.0,,50594,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,Mus musculus,CHEMBL625055,
Intermediate,,A,10009,,,1,,,N,,13805,BAO_0000218,,1,,10090.0,,50594,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,Mus musculus,CHEMBL625056,
Intermediate,,A,10009,,,1,,,N,,13806,BAO_0000218,,1,,9606.0,,50587,In vitro oxidation of compound in presence of human plasma,Homo sapiens,CHEMBL625057,
Autocuration,,A,10009,,,1,,,U,,13807,BAO_0000019,,0,,,,22224,In vitro oxidation of compound in presence of hydrogen peroxide,,CHEMBL625058,
Intermediate,,A,10009,,,1,,,N,,13808,BAO_0000218,,1,,10090.0,,50594,In vitro oxidation of compound in presence of mouse brain homogenate,Mus musculus,CHEMBL625059,
Intermediate,,A,10009,,,1,,,N,,13809,BAO_0000218,,1,,10090.0,,50594,In vitro oxidation of compound in presence of mouse liver homogenate,Mus musculus,CHEMBL629536,
Intermediate,,A,11510,,,1,,,N,,13810,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,Rattus norvegicus,CHEMBL629537,
Intermediate,,A,11510,,,1,,,N,,13811,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,Rattus norvegicus,CHEMBL629538,
Intermediate,,A,11510,,,1,,,N,,13812,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,Rattus norvegicus,CHEMBL629539,
Intermediate,,A,11510,,,1,,,N,,13813,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,Rattus norvegicus,CHEMBL874445,
Intermediate,,A,11510,,,1,,,N,,13814,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,Rattus norvegicus,CHEMBL629540,
Intermediate,,A,11510,,,1,,,N,,13815,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,Rattus norvegicus,CHEMBL629541,
Intermediate,,A,11510,,,1,,,N,,13816,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,Rattus norvegicus,CHEMBL629542,
Intermediate,,A,11510,,,1,,,N,,13817,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,Rattus norvegicus,CHEMBL630243,
Intermediate,,A,11510,,,1,,,N,,13818,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,Rattus norvegicus,CHEMBL630244,
Intermediate,,A,11510,,,1,,,N,,13819,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,Rattus norvegicus,CHEMBL630245,
Intermediate,,A,11510,,,1,,,N,,13820,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,Rattus norvegicus,CHEMBL630246,
Intermediate,,A,11510,,,1,,,N,,13821,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,Rattus norvegicus,CHEMBL630247,
Intermediate,,A,11510,,,1,,,N,,13822,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,Rattus norvegicus,CHEMBL630248,
Intermediate,,A,13100,In vivo,,1,,,N,,13823,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood at 240 minutes after dose administration.,Rattus norvegicus,CHEMBL630249,Blood
Intermediate,,A,13100,In vivo,,1,,,N,,13824,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood at 30 minutes after dose administration.,Rattus norvegicus,CHEMBL630250,Blood
Intermediate,,A,13100,In vivo,,1,,,N,,13825,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood at 360 minutes after dose administration.,Rattus norvegicus,CHEMBL630251,Blood
Intermediate,,A,13100,In vivo,,1,,,N,,13826,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood at 3 hr after dose administration.,Rattus norvegicus,CHEMBL630252,Blood
Intermediate,,A,13100,In vivo,,1,,,N,,13827,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood at 60 minutes after dose administration.,Rattus norvegicus,CHEMBL630408,Blood
Intermediate,,A,13100,In vivo,,1,,,N,,13828,BAO_0000218,,1,,10116.0,2037.0,50597,Biodistribution in rat cerebellum at 120 minutes after dose administration.,Rattus norvegicus,CHEMBL630409,Cerebellum
Intermediate,,A,13100,In vivo,,1,,,N,,13829,BAO_0000218,,1,,10116.0,2037.0,50597,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,Rattus norvegicus,CHEMBL874446,Cerebellum
Intermediate,,A,13100,In vivo,,1,,,N,,13830,BAO_0000218,,1,,10116.0,2037.0,50597,Biodistribution in rat cerebellum at 15 minutes after dose administration.,Rattus norvegicus,CHEMBL630410,Cerebellum
Intermediate,,A,13100,In vivo,,1,,,N,,13831,BAO_0000218,,1,,10116.0,2037.0,50597,Biodistribution in rat cerebellum at 240 minutes after dose administration.,Rattus norvegicus,CHEMBL630411,Cerebellum
Intermediate,,A,13100,In vivo,,1,,,N,,13832,BAO_0000218,,1,,10116.0,2037.0,50597,Biodistribution in rat cerebellum at 30 minutes after dose administration.,Rattus norvegicus,CHEMBL630412,Cerebellum
Intermediate,,A,13100,In vivo,,1,,,N,,13833,BAO_0000218,,1,,10116.0,2037.0,50597,Biodistribution in rat cerebellum at 360 minutes after dose administration.,Rattus norvegicus,CHEMBL630413,Cerebellum
Intermediate,,A,13100,In vivo,,1,,,N,,13834,BAO_0000218,,1,,10116.0,2037.0,50597,Biodistribution in rat cerebellum at 3 hr after dose administration.,Rattus norvegicus,CHEMBL630414,Cerebellum
Intermediate,,A,13100,In vivo,,1,,,N,,13835,BAO_0000218,,1,,10116.0,2037.0,50597,Biodistribution in rat cerebellum at 60 minutes after dose administration.,Rattus norvegicus,CHEMBL630415,Cerebellum
Intermediate,,A,13100,In vivo,,1,,,N,,13836,BAO_0000218,,1,,10116.0,,50597,Biodistribution in rat cortex at 120 minutes after dose administration.,Rattus norvegicus,CHEMBL630416,
Intermediate,,A,13100,In vivo,,1,,,N,,13837,BAO_0000218,,1,,10116.0,,50597,Biodistribution in rat cortex at 1440 minutes after dose administration.,Rattus norvegicus,CHEMBL630417,
Intermediate,,A,13100,In vivo,,1,,,N,,13838,BAO_0000218,,1,,10116.0,,50597,Biodistribution in rat cortex at 15 minutes after dose administration.,Rattus norvegicus,CHEMBL630418,
Intermediate,,A,13100,In vivo,,1,,,N,,13839,BAO_0000218,,1,,10116.0,,50597,Biodistribution in rat cortex at 240 minutes after dose administration.,Rattus norvegicus,CHEMBL630419,
Intermediate,,A,13100,In vivo,,1,,,N,,13840,BAO_0000218,,1,,10116.0,,50597,Biodistribution in rat cortex at 30 minutes after dose administration.,Rattus norvegicus,CHEMBL630420,
Intermediate,,A,13100,In vivo,,1,,,N,,13841,BAO_0000218,,1,,10116.0,,50597,Biodistribution in rat cortex at 360 minutes after dose administration.,Rattus norvegicus,CHEMBL630421,
Intermediate,,A,13100,In vivo,,1,,,N,,13842,BAO_0000218,,1,,10116.0,,50597,Biodistribution in rat cortex at 3 hr after dose administration.,Rattus norvegicus,CHEMBL630422,
Intermediate,,A,13100,In vivo,,1,,,N,,13843,BAO_0000218,,1,,10116.0,,50597,Biodistribution in rat cortex at 60 minutes after dose administration.,Rattus norvegicus,CHEMBL630423,
Intermediate,,A,13100,In vivo,,1,,,N,,13844,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart at 120 minutes after dose administration.,Rattus norvegicus,CHEMBL630424,Heart
Intermediate,,A,13100,In vivo,,1,,,N,,13845,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart at 15 minutes after dose administration.,Rattus norvegicus,CHEMBL630425,Heart
Intermediate,,A,13100,In vivo,,1,,,N,,13846,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart at 240 minutes after dose administration.,Rattus norvegicus,CHEMBL629462,Heart
Intermediate,,A,13100,In vivo,,1,,,N,,13847,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart at 30 minutes after dose administration.,Rattus norvegicus,CHEMBL630426,Heart
Intermediate,,A,13100,In vivo,,1,,,N,,13848,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart at 360 minutes after dose administration.,Rattus norvegicus,CHEMBL630427,Heart
Intermediate,,A,13100,In vivo,,1,,,N,,13849,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart at 3 hr after dose administration.,Rattus norvegicus,CHEMBL625877,Heart
Intermediate,,A,13100,In vivo,,1,,,N,,13850,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart at 60 minutes after dose administration.,Rattus norvegicus,CHEMBL625878,Heart
Intermediate,,A,13100,In vivo,,1,,,N,,13851,BAO_0000218,,1,,10116.0,10000000.0,50597,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,Rattus norvegicus,CHEMBL625879,Hippocampus
Intermediate,,A,13100,In vivo,,1,,,N,,13852,BAO_0000218,,1,,10116.0,10000000.0,50597,Biodistribution in rat hippocampus at 240 minutes after dose administration.,Rattus norvegicus,CHEMBL625880,Hippocampus
Intermediate,,A,13100,In vivo,,1,,,N,,13853,BAO_0000218,,1,,10116.0,10000000.0,50597,Biodistribution in rat hippocampus at 30 minutes after dose administration.,Rattus norvegicus,CHEMBL625881,Hippocampus
Intermediate,,A,13100,In vivo,,1,,,N,,13854,BAO_0000218,,1,,10116.0,10000000.0,50597,Biodistribution in rat hippocampus at 360 minutes after dose administration.,Rattus norvegicus,CHEMBL625882,Hippocampus
Intermediate,,A,13100,In vivo,,1,,,N,,13855,BAO_0000218,,1,,10116.0,10000000.0,50597,Biodistribution in rat hippocampus at 15 minutes after dose administration.,Rattus norvegicus,CHEMBL625883,Hippocampus
Intermediate,,A,13100,In vivo,,1,,,N,,13856,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in rat kidney at 120 minutes after dose administration.,Rattus norvegicus,CHEMBL625884,Kidney
Intermediate,,A,13100,In vivo,,1,,,N,,13857,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in rat kidney at 1440 minutes after dose administration.,Rattus norvegicus,CHEMBL625885,Kidney
Intermediate,,A,13100,In vivo,,1,,,N,,13858,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in rat kidney at 15 minutes after dose administration.,Rattus norvegicus,CHEMBL628649,Kidney
Intermediate,,A,13100,In vivo,,1,,,N,,13859,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in rat kidney at 240 minutes after dose administration.,Rattus norvegicus,CHEMBL628650,Kidney
Intermediate,,A,13100,In vivo,,1,,,N,,13860,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in rat kidney at 30 minutes after dose administration.,Rattus norvegicus,CHEMBL628651,Kidney
Intermediate,,A,13100,In vivo,,1,,,N,,13861,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in rat kidney at 360 minutes after dose administration.,Rattus norvegicus,CHEMBL628652,Kidney
Intermediate,,A,13100,In vivo,,1,,,N,,13862,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in rat kidney at 60 minutes after dose administration.,Rattus norvegicus,CHEMBL628653,Kidney
Intermediate,,A,13100,In vivo,,1,,,N,,13863,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver at 120 minutes after dose administration.,Rattus norvegicus,CHEMBL628654,Liver
Intermediate,,A,13100,In vivo,,1,,,N,,13864,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver at 1440 minutes after dose administration.,Rattus norvegicus,CHEMBL628655,Liver
Intermediate,,A,13100,In vivo,,1,,,N,,13865,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver at 15 minutes after dose administration.,Rattus norvegicus,CHEMBL625238,Liver
Intermediate,,A,13100,In vivo,,1,,,N,,13866,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver at 240 minutes after dose administration.,Rattus norvegicus,CHEMBL625239,Liver
Intermediate,,A,13100,In vivo,,1,,,N,,13867,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver at 30 minutes after dose administration.,Rattus norvegicus,CHEMBL625240,Liver
Intermediate,,A,13100,In vivo,,1,,,N,,13868,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver at 360 minutes after dose administration.,Rattus norvegicus,CHEMBL625241,Liver
Intermediate,,A,13100,In vivo,,1,,,N,,13869,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver at 60 minutes after dose administration.,Rattus norvegicus,CHEMBL625242,Liver
Intermediate,,A,13100,In vivo,,1,,,N,,13870,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in rat lung at 120 minutes after dose administration.,Rattus norvegicus,CHEMBL874587,Lung
Intermediate,,A,13100,In vivo,,1,,,N,,13871,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in rat lung at 1440 minutes after dose administration.,Rattus norvegicus,CHEMBL625405,Lung
Intermediate,,A,13100,In vivo,,1,,,N,,13872,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in rat lung at 15 minutes after dose administration.,Rattus norvegicus,CHEMBL625406,Lung
Intermediate,,A,13100,In vivo,,1,,,N,,13873,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in rat lung at 240 minutes after dose administration.,Rattus norvegicus,CHEMBL625407,Lung
Intermediate,,A,13100,In vivo,,1,,,N,,13874,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in rat lung at 30 minutes after dose administration.,Rattus norvegicus,CHEMBL625408,Lung
Intermediate,,A,13100,In vivo,,1,,,N,,13875,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in rat lung at 360 minutes after dose administration.,Rattus norvegicus,CHEMBL625409,Lung
Intermediate,,A,12361,,,1,,,N,,13876,BAO_0000218,,1,,10116.0,1515.0,50597,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,Rattus norvegicus,CHEMBL625410,Thoracic aorta
Intermediate,,A,12361,,,1,,,N,,13877,BAO_0000218,,1,,10116.0,1515.0,50597,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,Rattus norvegicus,CHEMBL625411,Thoracic aorta
Intermediate,,A,12361,,,1,,,N,,13878,BAO_0000218,,1,,10116.0,1515.0,50597,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,Rattus norvegicus,CHEMBL625412,Thoracic aorta
Intermediate,,A,12361,,,1,,,N,,13879,BAO_0000218,,1,,10116.0,1515.0,50597,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,Rattus norvegicus,CHEMBL625413,Thoracic aorta
Intermediate,,A,12361,,,1,,,N,,13880,BAO_0000218,,1,,10116.0,1515.0,50597,Percent of maximal contractile response to compound in rat thoracic aorta strips v,Rattus norvegicus,CHEMBL625414,Thoracic aorta
Intermediate,,A,12361,,,1,,,N,,13881,BAO_0000218,,1,,10116.0,1515.0,50597,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,Rattus norvegicus,CHEMBL625415,Thoracic aorta
Intermediate,,A,12361,,,1,,,N,,13882,BAO_0000218,,1,,10116.0,1515.0,50597,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,Rattus norvegicus,CHEMBL625416,Thoracic aorta
Intermediate,,A,12712,,,1,,,N,,13883,BAO_0000218,,1,,10116.0,1088.0,50597,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,Rattus norvegicus,CHEMBL625417,Urine
Intermediate,,A,7415,,,1,,,N,,13884,BAO_0000218,,1,,10116.0,1988.0,50597,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,Rattus norvegicus,CHEMBL625418,Feces
Intermediate,,A,7415,,,1,,,N,,13885,BAO_0000218,,1,,10116.0,1088.0,50597,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,Rattus norvegicus,CHEMBL625419,Urine
Intermediate,,A,7415,,,1,,,N,,13886,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,Rattus norvegicus,CHEMBL625420,
Intermediate,,A,7415,,,1,,,N,,13887,BAO_0000218,,1,,10116.0,,50597,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,Rattus norvegicus,CHEMBL626996,
Intermediate,,A,7415,,,1,,,N,,13888,BAO_0000218,,1,,10116.0,1988.0,50597,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",Rattus norvegicus,CHEMBL626997,Feces
Intermediate,,A,7415,,,1,,,N,,13889,BAO_0000218,,1,,10116.0,1088.0,50597,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",Rattus norvegicus,CHEMBL626998,Urine
Intermediate,,A,7415,,,1,,,N,,13890,BAO_0000218,,1,,10116.0,,50597,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",Rattus norvegicus,CHEMBL626999,
Intermediate,,A,8050,,,1,,,N,,13891,BAO_0000218,,1,,10090.0,,50594,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,Mus musculus,CHEMBL627000,
Intermediate,,A,8050,,,1,,,N,,13892,BAO_0000218,,1,,10090.0,,50594,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,Mus musculus,CHEMBL627001,
Intermediate,,A,8050,,,1,,,N,,13893,BAO_0000218,,1,,10090.0,,50594,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,Mus musculus,CHEMBL627002,
Intermediate,,A,8050,,,1,,,N,,13894,BAO_0000218,,1,,10090.0,,50594,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,Mus musculus,CHEMBL627003,
Intermediate,,A,8050,,,1,,,N,,13895,BAO_0000218,,1,,10090.0,1088.0,50594,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,Mus musculus,CHEMBL627004,Urine
Intermediate,,A,8050,,,1,,,N,,13896,BAO_0000218,,1,,10090.0,1088.0,50594,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,Mus musculus,CHEMBL627005,Urine
Intermediate,,A,8050,,,1,,,N,,13897,BAO_0000218,,1,,10090.0,1088.0,50594,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,Mus musculus,CHEMBL874594,Urine
Intermediate,,A,8050,,,1,,,N,,13898,BAO_0000218,,1,,10090.0,1088.0,50594,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,Mus musculus,CHEMBL627006,Urine
Intermediate,,A,8050,,,1,,,N,,13899,BAO_0000218,,1,,10090.0,1088.0,50594,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,Mus musculus,CHEMBL627007,Urine
Intermediate,,A,8050,,,1,,,N,,13900,BAO_0000218,,1,,10090.0,1088.0,50594,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,Mus musculus,CHEMBL627884,Urine
Intermediate,,A,8050,,,1,,,N,,13901,BAO_0000218,,1,,10090.0,1088.0,50594,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,Mus musculus,CHEMBL627885,Urine
Intermediate,,A,8050,,,1,,,N,,13902,BAO_0000218,,1,,10090.0,1088.0,50594,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,Mus musculus,CHEMBL627886,Urine
Intermediate,,A,8050,,,1,,,N,,13903,BAO_0000218,,1,,10090.0,1088.0,50594,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,Mus musculus,CHEMBL627887,Urine
Intermediate,,A,8050,,,1,,,N,,13904,BAO_0000218,,1,,10090.0,1088.0,50594,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,Mus musculus,CHEMBL627888,Urine
Intermediate,,A,8050,,,1,,,N,,13905,BAO_0000218,,1,,10090.0,1088.0,50594,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,Mus musculus,CHEMBL628057,Urine
Intermediate,,A,8050,,,1,,,N,,13906,BAO_0000218,,1,,10090.0,1088.0,50594,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,Mus musculus,CHEMBL627405,Urine
Intermediate,,A,12582,,,1,,,N,,13907,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Canis lupus familiaris,CHEMBL627406,Urine
Intermediate,,A,12582,,,1,,,N,,13908,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Canis lupus familiaris,CHEMBL627407,Urine
Intermediate,,A,12582,,,1,,,N,,13909,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Canis lupus familiaris,CHEMBL627408,Urine
Intermediate,,A,12582,,,1,,,N,,13910,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Canis lupus familiaris,CHEMBL627409,Urine
Intermediate,,A,12582,,,1,,,N,,13911,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Canis lupus familiaris,CHEMBL875486,Urine
Intermediate,,A,12582,,,1,,,N,,13912,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Canis lupus familiaris,CHEMBL627410,Urine
Intermediate,,A,12582,,,1,,,N,,13913,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Canis lupus familiaris,CHEMBL627411,Urine
Intermediate,,A,12582,,,1,,,N,,13914,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Canis lupus familiaris,CHEMBL627412,Urine
Intermediate,,A,12582,,,1,,,N,,13915,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Canis lupus familiaris,CHEMBL627413,Urine
Intermediate,,A,12582,,,1,,,N,,13916,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Canis lupus familiaris,CHEMBL627414,Urine
Intermediate,,A,12582,,,1,,,N,,13917,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Canis lupus familiaris,CHEMBL627415,Urine
Intermediate,,A,12582,,,1,,,N,,13918,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,Canis lupus familiaris,CHEMBL627416,Urine
Intermediate,,A,12582,,,1,,,N,,13919,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Canis lupus familiaris,CHEMBL627417,Urine
Intermediate,,A,12582,,,1,,,N,,13920,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Canis lupus familiaris,CHEMBL627418,Urine
Intermediate,,A,12582,,,1,,,N,,13921,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,Canis lupus familiaris,CHEMBL627419,Urine
Intermediate,,A,12582,,,1,,,N,,13922,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,Canis lupus familiaris,CHEMBL627320,Urine
Intermediate,,A,12582,,,1,,,N,,13923,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,Canis lupus familiaris,CHEMBL627321,Urine
Intermediate,,A,12017,In vivo,,1,,,N,,13924,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL627322,Kidney
Intermediate,,A,12017,In vivo,,1,,,N,,13925,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL627323,Kidney
Intermediate,,A,12017,In vivo,,1,,,N,,13926,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,CHEMBL627491,Kidney
Intermediate,,A,12017,In vivo,,1,,,N,,13927,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL627492,Kidney
Intermediate,,A,12017,In vivo,,1,,,N,,13928,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL627493,Kidney
Intermediate,,A,12017,In vivo,,1,,,N,,13929,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL627494,Liver
Intermediate,,A,12017,In vivo,,1,,,N,,13930,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL627495,Liver
Intermediate,,A,12017,In vivo,,1,,,N,,13931,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,CHEMBL627496,Liver
Intermediate,,A,12017,In vivo,,1,,,N,,13932,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL627497,Liver
Intermediate,,A,12017,In vivo,,1,,,N,,13933,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL627498,Liver
Intermediate,,A,12017,In vivo,,1,,,N,,13934,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL627499,Lung
Intermediate,,A,12017,In vivo,,1,,,N,,13935,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL627500,Lung
Intermediate,,A,12017,In vivo,,1,,,N,,13936,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,CHEMBL627501,Lung
Intermediate,,A,12017,In vivo,,1,,,N,,13937,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL625616,Lung
Intermediate,,A,12017,In vivo,,1,,,N,,13938,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL625617,Lung
Intermediate,,A,12017,In vivo,,1,,,N,,13939,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL625618,Muscle tissue
Intermediate,,A,12017,In vivo,,1,,,N,,13940,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL625619,Muscle tissue
Intermediate,,A,12017,In vivo,,1,,,N,,13941,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,CHEMBL625620,Muscle tissue
Intermediate,,A,12017,In vivo,,1,,,N,,13942,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL625621,Muscle tissue
Intermediate,,A,12017,In vivo,,1,,,N,,13943,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL625622,Muscle tissue
Intermediate,,A,12017,In vivo,,1,,,N,,13944,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL625788,Spleen
Intermediate,,A,12017,In vivo,,1,,,N,,13945,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL625789,Spleen
Intermediate,,A,12017,In vivo,,1,,,N,,13946,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,CHEMBL625790,Spleen
Intermediate,,A,12017,In vivo,,1,,,N,,13947,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL625791,Spleen
Intermediate,,A,12017,In vivo,,1,,,N,,13948,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL622334,Spleen
Intermediate,,A,12017,In vivo,,1,,,N,,13949,BAO_0000218,,1,,10116.0,2046.0,50597,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL622335,Thyroid gland
Intermediate,,A,12017,In vivo,,1,,,N,,13950,BAO_0000218,,1,,10116.0,2046.0,50597,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL622336,Thyroid gland
Intermediate,,A,12017,In vivo,,1,,,N,,13951,BAO_0000218,,1,,10116.0,2046.0,50597,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,CHEMBL622337,Thyroid gland
Intermediate,,A,12017,In vivo,,1,,,N,,13952,BAO_0000218,,1,,10116.0,2046.0,50597,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL622338,Thyroid gland
Intermediate,,A,12017,In vivo,,1,,,N,,13953,BAO_0000218,,1,,10116.0,2046.0,50597,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL622339,Thyroid gland
Intermediate,,A,12017,In vivo,,1,,,N,,13954,BAO_0000218,,1,,10116.0,,50597,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL624153,
Intermediate,,A,12017,In vivo,,1,,,N,,13955,BAO_0000218,,1,,10116.0,,50597,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL628430,
Intermediate,,A,12017,In vivo,,1,,,N,,13956,BAO_0000218,,1,,10116.0,,50597,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,CHEMBL628431,
Intermediate,,A,12017,In vivo,,1,,,N,,13957,BAO_0000218,,1,,10116.0,,50597,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL628432,
Intermediate,,A,12017,In vivo,,1,,,N,,13958,BAO_0000218,,1,,10116.0,,50597,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL628433,
Intermediate,,A,12017,In vivo,,1,,,N,,13959,BAO_0000218,,1,,10116.0,2106.0,50597,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Rattus norvegicus,CHEMBL628434,Spleen
Intermediate,,A,12017,In vivo,,1,,,N,,13960,BAO_0000218,,1,,10116.0,2106.0,50597,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Rattus norvegicus,CHEMBL626789,Spleen
Intermediate,,A,12017,In vivo,,1,,,N,,13961,BAO_0000218,,1,,10116.0,2106.0,50597,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",Rattus norvegicus,CHEMBL626790,Spleen
Intermediate,,A,12017,In vivo,,1,,,N,,13962,BAO_0000218,,1,,10116.0,2106.0,50597,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Rattus norvegicus,CHEMBL626791,Spleen
Intermediate,,A,12017,In vivo,,1,,,N,,13963,BAO_0000218,,1,,10116.0,2106.0,50597,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Rattus norvegicus,CHEMBL626792,Spleen
Intermediate,,A,12017,In vivo,,1,,,N,,13964,BAO_0000218,,1,,10116.0,2106.0,50597,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Rattus norvegicus,CHEMBL626793,Spleen
Intermediate,,A,11510,,,1,,,N,,13965,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,Rattus norvegicus,CHEMBL627436,
Intermediate,,A,11510,,,1,,,N,,13966,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,Rattus norvegicus,CHEMBL627437,
Intermediate,,A,11510,,,1,,,N,,13967,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,Rattus norvegicus,CHEMBL627438,
Intermediate,,A,11510,,,1,,,N,,13968,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,Rattus norvegicus,CHEMBL627439,
Intermediate,,A,11510,,,1,,,N,,13969,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,Rattus norvegicus,CHEMBL627440,
Intermediate,,A,11510,,,1,,,N,,13970,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,Rattus norvegicus,CHEMBL627602,
Intermediate,,A,11510,,,1,,,N,,13971,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,Rattus norvegicus,CHEMBL627603,
Intermediate,,A,11510,,,1,,,N,,13972,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,Rattus norvegicus,CHEMBL627604,
Intermediate,,A,11510,,,1,,,N,,13973,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,Rattus norvegicus,CHEMBL627605,
Intermediate,,A,11510,,,1,,,N,,13974,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,Rattus norvegicus,CHEMBL627606,
Intermediate,,A,11510,,,1,,,N,,13975,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,Rattus norvegicus,CHEMBL627607,
Intermediate,,A,11510,,,1,,,N,,13976,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,Rattus norvegicus,CHEMBL627608,
Intermediate,,A,11510,,,1,,,N,,13977,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,Rattus norvegicus,CHEMBL627609,
Intermediate,,A,11510,,,1,,,N,,13978,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,Rattus norvegicus,CHEMBL627610,
Intermediate,,A,11510,,,1,,,N,,13979,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,Rattus norvegicus,CHEMBL627611,
Intermediate,,A,11510,,,1,,,N,,13980,BAO_0000218,,1,,10116.0,,50597,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,Rattus norvegicus,CHEMBL627612,
Autocuration,,P,8362,,,1,,,U,,13981,BAO_0000100,,0,,,,22229,Octanol:water partition coefficient is evaluated,,CHEMBL627613,
Autocuration,,P,8257,,,1,,,U,,13982,BAO_0000100,,0,,,,22224,Partition coefficient in 1-octanol/water system,,CHEMBL627614,
Autocuration,,P,8257,,,1,,,U,,13983,BAO_0000100,,0,,,,22224,Partition coefficient in 1-octanol/water system measured using radio active compounds,,CHEMBL627615,
Autocuration,,P,9468,,,1,,,U,,13984,BAO_0000100,,0,,,,22224,Partition coefficient in octanol/water system was determined,,CHEMBL627616,
Autocuration,,P,9468,,,1,,,U,,13985,BAO_0000100,,0,,,,22224,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,,CHEMBL627617,
Autocuration,,A,10568,,,1,,,U,,13986,BAO_0000019,,0,,,,22224,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,,CHEMBL627618,
Autocuration,,A,10568,,,1,,,U,,13987,BAO_0000019,,0,,,,22224,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",,CHEMBL627619,
Autocuration,,A,15359,,,1,,,U,,13988,BAO_0000019,,0,,,,22224,Pseudo-first-order rate constant of the compound,,CHEMBL627620,
Autocuration,,A,15359,,,1,,,U,,13989,BAO_0000019,,0,,,,22224,Pseudo-first-order rate constant with 1-min time point,,CHEMBL627621,
Autocuration,,A,15359,,,1,,,U,,13990,BAO_0000019,,0,,,,22224,Pseudo-first-order rate constant without 1-min time point,,CHEMBL627622,
Autocuration,,A,10431,,,1,,,U,,13991,BAO_0000019,,0,,,,22224,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,,CHEMBL627623,
Autocuration,,A,10431,,,1,,,U,,13992,BAO_0000019,,0,,,,22224,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,,CHEMBL627624,
Autocuration,,A,10431,,,1,,,U,,13993,BAO_0000019,,0,,,,22224,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,,CHEMBL627625,
Autocuration,,A,15704,,,1,,,U,,13994,BAO_0000019,,0,,,,22224,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,,CHEMBL628523,
Autocuration,,A,15287,,,1,,,U,,13995,BAO_0000019,,0,,,,22224,The alkaline hydrolysis second order rate constant(K OH) of the compound,,CHEMBL628524,
Autocuration,,A,7516,,,1,,,U,,13996,BAO_0000019,,0,,,,22224,The efflux rate constant of the compound,,CHEMBL628525,
Autocuration,,A,12973,,,1,,,U,,13997,BAO_0000019,,0,,,,22224,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,CHEMBL625732,
Autocuration,,A,12973,,,1,,,U,,13998,BAO_0000019,,0,,,,22224,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,CHEMBL625733,
Autocuration,,F,12973,,,1,,,U,,13999,BAO_0000019,,0,,,,22224,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,CHEMBL625734,
Autocuration,,A,12973,,,1,,,U,,14000,BAO_0000019,,0,,,,22224,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,,CHEMBL625913,
Autocuration,,A,8696,,,1,,,U,,14001,BAO_0000019,,0,,,,22224,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,,CHEMBL625914,
Autocuration,,A,15052,,,1,,,U,,14002,BAO_0000019,,0,,,,22224,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,,CHEMBL625915,
Autocuration,,A,15052,,,1,,,U,,14003,BAO_0000019,,0,,,,22224,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,,CHEMBL625916,
Autocuration,,A,10503,,,1,,,U,,14004,BAO_0000019,,0,,,,22224,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),,CHEMBL625917,
Autocuration,,A,8354,,,1,,,U,,14005,BAO_0000019,,0,,,,22224,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL625918,
Autocuration,,A,8354,,,1,,,U,,14006,BAO_0000019,,0,,,,22224,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL625919,
Autocuration,,A,8354,,,1,,,U,,14007,BAO_0000019,,0,,,,22224,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL625920,
Autocuration,,A,8354,,,1,,,U,,14008,BAO_0000019,,0,,,,22224,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL874453,
Autocuration,,A,8354,,,1,,,U,,14009,BAO_0000019,,0,,,,22224,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",,CHEMBL625921,
Autocuration,,A,10503,,,1,,,U,,14010,BAO_0000019,,0,,,,22224,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,,CHEMBL625922,
Autocuration,,A,8354,,,1,,,U,,14011,BAO_0000019,,0,,,,22224,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL625923,
Autocuration,,A,8354,,,1,,,U,,14012,BAO_0000019,,0,,,,22224,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL625924,
Autocuration,,A,8354,,,1,,,U,,14013,BAO_0000019,,0,,,,22224,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL625925,
Autocuration,,A,8354,,,1,,,U,,14014,BAO_0000019,,0,,,,22224,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL625926,
Intermediate,,A,13100,In vivo,,1,,,N,,14015,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in rat lung at 60 minutes after dose administration.,Rattus norvegicus,CHEMBL627704,Lung
Intermediate,,A,13100,In vivo,,1,,,N,,14016,BAO_0000218,,1,,10116.0,,50597,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,Rattus norvegicus,CHEMBL627705,
Intermediate,,A,13100,In vivo,,1,,,N,,14017,BAO_0000218,,1,,10116.0,,50597,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,Rattus norvegicus,CHEMBL627706,
Intermediate,,A,13100,In vivo,,1,,,N,,14018,BAO_0000218,,1,,10116.0,,50597,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,Rattus norvegicus,CHEMBL627707,
Intermediate,,A,13100,In vivo,,1,,,N,,14019,BAO_0000218,,1,,10116.0,,50597,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,Rattus norvegicus,CHEMBL627708,
Intermediate,,A,13100,In vivo,,1,,,N,,14020,BAO_0000218,,1,,10116.0,,50597,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,Rattus norvegicus,CHEMBL628361,
Intermediate,,A,13100,In vivo,,1,,,N,,14021,BAO_0000218,,1,,10116.0,,50597,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,Rattus norvegicus,CHEMBL628362,
Intermediate,,A,13100,In vivo,,1,,,N,,14022,BAO_0000218,,1,,10116.0,2435.0,50597,Biodistribution in rat striatum at 120 minutes after dose administration.,Rattus norvegicus,CHEMBL628363,Striatum
Intermediate,,A,13100,In vivo,,1,,,N,,14023,BAO_0000218,,1,,10116.0,2435.0,50597,Biodistribution in rat striatum at 1440 minutes after dose administration.,Rattus norvegicus,CHEMBL628364,Striatum
Intermediate,,A,13100,In vivo,,1,,,N,,14024,BAO_0000218,,1,,10116.0,2435.0,50597,Biodistribution in rat striatum at 15 minutes after dose administration.,Rattus norvegicus,CHEMBL628365,Striatum
Intermediate,,A,13100,In vivo,,1,,,N,,14025,BAO_0000218,,1,,10116.0,2435.0,50597,Biodistribution in rat striatum at 240 minutes after dose administration.,Rattus norvegicus,CHEMBL874454,Striatum
Intermediate,,A,13100,In vivo,,1,,,N,,14026,BAO_0000218,,1,,10116.0,2435.0,50597,Biodistribution in rat striatum at 30 minutes after dose administration.,Rattus norvegicus,CHEMBL628531,Striatum
Intermediate,,A,13100,In vivo,,1,,,N,,14027,BAO_0000218,,1,,10116.0,2435.0,50597,Biodistribution in rat striatum at 360 minutes after dose administration.,Rattus norvegicus,CHEMBL628532,Striatum
Intermediate,,A,13100,In vivo,,1,,,N,,14028,BAO_0000218,,1,,10116.0,2435.0,50597,Biodistribution in rat striatum at 3 hr after dose administration.,Rattus norvegicus,CHEMBL628533,Striatum
Intermediate,,A,13100,In vivo,,1,,,N,,14029,BAO_0000218,,1,,10116.0,2435.0,50597,Biodistribution in rat striatum at 60 minutes after dose administration.,Rattus norvegicus,CHEMBL628534,Striatum
Intermediate,,A,13100,In vivo,,1,,,N,,14030,BAO_0000218,,1,,10116.0,2046.0,50597,Biodistribution in rat thyroid at 120 minutes after dose administration.,Rattus norvegicus,CHEMBL628535,Thyroid gland
Intermediate,,A,13100,In vivo,,1,,,N,,14031,BAO_0000218,,1,,10116.0,2046.0,50597,Biodistribution in rat thyroid at 1440 minutes after dose administration.,Rattus norvegicus,CHEMBL628536,Thyroid gland
Intermediate,,A,13100,In vivo,,1,,,N,,14032,BAO_0000218,,1,,10116.0,2046.0,50597,Biodistribution in rat thyroid at 15 minutes after dose administration.,Rattus norvegicus,CHEMBL628537,Thyroid gland
Intermediate,,A,13100,In vivo,,1,,,N,,14033,BAO_0000218,,1,,10116.0,2046.0,50597,Biodistribution in rat thyroid at 240 minutes after dose administration.,Rattus norvegicus,CHEMBL628538,Thyroid gland
Intermediate,,A,13100,In vivo,,1,,,N,,14034,BAO_0000218,,1,,10116.0,2046.0,50597,Biodistribution in rat thyroid at 30 minutes after dose administration.,Rattus norvegicus,CHEMBL628539,Thyroid gland
Intermediate,,A,13100,In vivo,,1,,,N,,14035,BAO_0000218,,1,,10116.0,2046.0,50597,Biodistribution in rat thyroid at 360 minutes after dose administration.,Rattus norvegicus,CHEMBL630297,Thyroid gland
Intermediate,,A,13100,In vivo,,1,,,N,,14036,BAO_0000218,,1,,10116.0,2046.0,50597,Biodistribution in rat thyroid at 60 minutes after dose administration.,Rattus norvegicus,CHEMBL630298,Thyroid gland
Intermediate,,A,13100,In vivo,,1,,,N,,14037,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution in rest of brain of rat 120 minutes after dose administration.,Rattus norvegicus,CHEMBL630299,Brain
Intermediate,,A,13100,In vivo,,1,,,N,,14038,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,Rattus norvegicus,CHEMBL628094,Brain
Intermediate,,A,13100,In vivo,,1,,,N,,14039,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,Rattus norvegicus,CHEMBL628095,Brain
Intermediate,,A,13100,In vivo,,1,,,N,,14040,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,Rattus norvegicus,CHEMBL874648,Brain
Intermediate,,A,13100,In vivo,,1,,,N,,14041,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,Rattus norvegicus,CHEMBL628096,Brain
Intermediate,,A,13100,In vivo,,1,,,N,,14042,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,Rattus norvegicus,CHEMBL628097,Brain
Intermediate,,A,13100,In vivo,,1,,,N,,14043,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,Rattus norvegicus,CHEMBL628098,Brain
Autocuration,,A,13331,,,1,,,U,,14044,BAO_0000019,,0,,,,22224,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",,CHEMBL628099,
Autocuration,,A,13331,,,1,,,U,,14045,BAO_0000019,,0,,,,22224,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,CHEMBL628100,
Autocuration,,A,13331,,,1,,,U,,14046,BAO_0000019,,0,,,,22224,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),,CHEMBL628101,
Autocuration,,A,13331,,,1,,,U,,14047,BAO_0000019,,0,,,,22224,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",,CHEMBL628102,
Autocuration,,A,13331,,,1,,,U,,14048,BAO_0000019,,0,,,,22224,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",,CHEMBL628103,
Autocuration,,A,13331,,,1,,,U,,14049,BAO_0000019,,0,,,,22224,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,CHEMBL628104,
Autocuration,,A,13331,,,1,,,U,,14050,BAO_0000019,,0,,,,22224,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",,CHEMBL628105,
Autocuration,,A,13331,,,1,,,U,,14051,BAO_0000019,,0,,,,22224,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",,CHEMBL628106,
Intermediate,,A,10086,,,1,,,N,,14052,BAO_0000218,,1,,10116.0,1088.0,50597,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,Rattus norvegicus,CHEMBL628107,Urine
Autocuration,,F,10086,,,1,,,U,,14053,BAO_0000218,,0,,,1088.0,22224,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,CHEMBL628108,Urine
Intermediate,,A,10086,,,1,,,N,,14054,BAO_0000218,,1,,10116.0,1088.0,50597,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,Rattus norvegicus,CHEMBL628109,Urine
Autocuration,,F,10086,,,1,,,U,,14055,BAO_0000218,,0,,,1088.0,22224,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,CHEMBL625299,Urine
Intermediate,,A,10086,,,1,,,N,,14056,BAO_0000218,,1,,10116.0,1088.0,50597,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,Rattus norvegicus,CHEMBL625300,Urine
Intermediate,,A,10086,,,1,,,N,,14057,BAO_0000218,,1,,10116.0,1088.0,50597,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,Rattus norvegicus,CHEMBL625301,Urine
Intermediate,,A,10086,,,1,,,N,,14058,BAO_0000218,,1,,10116.0,1088.0,50597,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,Rattus norvegicus,CHEMBL625302,Urine
Intermediate,,A,10086,,,1,,,N,,14059,BAO_0000218,,1,,10116.0,1088.0,50597,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,Rattus norvegicus,CHEMBL874649,Urine
Intermediate,,A,13248,,,1,,,N,,14060,BAO_0000218,,1,,10116.0,,50597,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,Rattus norvegicus,CHEMBL625303,
Intermediate,,A,13248,,,1,,,N,,14061,BAO_0000218,,1,,10116.0,,50597,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,Rattus norvegicus,CHEMBL625463,
Intermediate,,A,14527,,,1,,,N,,14062,BAO_0000218,,1,,9606.0,2107.0,50587,In vitro metabolism in human liver microsomes,Homo sapiens,CHEMBL625464,Liver
Intermediate,,A,3008,,,1,,,N,,14063,BAO_0000218,,1,,9606.0,,50587,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,Homo sapiens,CHEMBL625465,
Intermediate,,A,12582,,,1,,,N,,14064,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,Canis lupus familiaris,CHEMBL625466,Urine
Intermediate,,A,12582,,,1,,,N,,14065,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Canis lupus familiaris,CHEMBL625467,Urine
Intermediate,,A,12582,,,1,,,N,,14066,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,Rattus norvegicus,CHEMBL625468,Urine
Intermediate,,A,12582,,,1,,,N,,14067,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,Rattus norvegicus,CHEMBL625469,Urine
Intermediate,,A,12582,,,1,,,N,,14068,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,Rattus norvegicus,CHEMBL625470,Urine
Intermediate,,A,12582,,,1,,,N,,14069,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,Rattus norvegicus,CHEMBL632418,Urine
Intermediate,,A,12582,,,1,,,N,,14070,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,Rattus norvegicus,CHEMBL627250,Urine
Intermediate,,A,12582,,,1,,,N,,14071,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,Rattus norvegicus,CHEMBL627251,Urine
Intermediate,,A,12582,,,1,,,N,,14072,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,Rattus norvegicus,CHEMBL627252,Urine
Intermediate,,A,12582,,,1,,,N,,14073,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,Rattus norvegicus,CHEMBL627253,Urine
Intermediate,,A,12582,,,1,,,N,,14074,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,Rattus norvegicus,CHEMBL627254,Urine
Intermediate,,A,12582,,,1,,,N,,14075,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,Rattus norvegicus,CHEMBL875471,Urine
Intermediate,,A,12582,,,1,,,N,,14076,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,Rattus norvegicus,CHEMBL627255,Urine
Intermediate,,A,12582,,,1,,,N,,14077,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,Rattus norvegicus,CHEMBL627256,Urine
Intermediate,,A,12582,,,1,,,N,,14078,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,Rattus norvegicus,CHEMBL627257,Urine
Intermediate,,A,12582,,,1,,,N,,14079,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,Rattus norvegicus,CHEMBL627258,Urine
Intermediate,,A,12582,,,1,,,N,,14080,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,Rattus norvegicus,CHEMBL627259,Urine
Intermediate,,A,12582,,,1,,,N,,14081,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,Rattus norvegicus,CHEMBL627260,Urine
Intermediate,,A,12582,,,1,,,N,,14082,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,Rattus norvegicus,CHEMBL623256,Urine
Intermediate,,A,12582,,,1,,,N,,14083,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,Rattus norvegicus,CHEMBL874413,Urine
Intermediate,,A,12582,,,1,,,N,,14084,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,Rattus norvegicus,CHEMBL623257,Urine
Intermediate,,A,12582,,,1,,,N,,14085,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,Rattus norvegicus,CHEMBL623258,Urine
Intermediate,,A,12582,,,1,,,N,,14086,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,Rattus norvegicus,CHEMBL623259,Urine
Intermediate,,A,12582,,,1,,,N,,14087,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,Rattus norvegicus,CHEMBL623260,Urine
Intermediate,,A,12582,,,1,,,N,,14088,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,Rattus norvegicus,CHEMBL623261,Urine
Intermediate,,A,12582,,,1,,,N,,14089,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,Rattus norvegicus,CHEMBL623262,Urine
Intermediate,,A,12582,,,1,,,N,,14090,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,Rattus norvegicus,CHEMBL623263,Urine
Intermediate,,A,12582,,,1,,,N,,14091,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,Rattus norvegicus,CHEMBL623264,Urine
Intermediate,,A,12582,,,1,,,N,,14092,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,Rattus norvegicus,CHEMBL623265,Urine
Intermediate,,A,12582,,,1,,,N,,14093,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,Rattus norvegicus,CHEMBL623266,Urine
Intermediate,,A,12582,,,1,,,N,,14094,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,Rattus norvegicus,CHEMBL623267,Urine
Intermediate,,A,12582,,,1,,,N,,14095,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,Rattus norvegicus,CHEMBL623268,Urine
Intermediate,,A,12582,,,1,,,N,,14096,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,Rattus norvegicus,CHEMBL623269,Urine
Intermediate,,A,12582,,,1,,,N,,14097,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,Rattus norvegicus,CHEMBL623270,Urine
Intermediate,,A,12582,,,1,,,N,,14098,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,Rattus norvegicus,CHEMBL623271,Urine
Intermediate,,A,12582,,,1,,,N,,14099,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,Rattus norvegicus,CHEMBL623272,Urine
Intermediate,,A,12582,,,1,,,N,,14100,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,Rattus norvegicus,CHEMBL623273,Urine
Intermediate,,A,12582,,,1,,,N,,14101,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,Rattus norvegicus,CHEMBL623274,Urine
Intermediate,,A,12582,,,1,,,N,,14102,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,Rattus norvegicus,CHEMBL874414,Urine
Intermediate,,A,12582,,,1,,,N,,14103,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,Rattus norvegicus,CHEMBL623275,Urine
Intermediate,,A,12582,,,1,,,N,,14104,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,Rattus norvegicus,CHEMBL629150,Urine
Intermediate,,A,12582,,,1,,,N,,14105,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,Rattus norvegicus,CHEMBL623276,Urine
Intermediate,,A,12582,,,1,,,N,,14106,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,Rattus norvegicus,CHEMBL623277,Urine
Intermediate,,A,12582,,,1,,,N,,14107,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,Rattus norvegicus,CHEMBL623112,Urine
Intermediate,,A,12582,,,1,,,N,,14108,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,Rattus norvegicus,CHEMBL623113,Urine
Intermediate,,A,12582,,,1,,,N,,14109,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,Rattus norvegicus,CHEMBL623800,Urine
Intermediate,,A,12582,,,1,,,N,,14110,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,Rattus norvegicus,CHEMBL623801,Urine
Intermediate,,A,12017,In vivo,,1,,,N,,14111,BAO_0000218,,1,,10116.0,2106.0,50597,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Rattus norvegicus,CHEMBL623802,Spleen
Intermediate,,A,12017,In vivo,,1,,,N,,14112,BAO_0000218,,1,,10116.0,995.0,50597,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL623803,Uterus
Intermediate,,A,12017,In vivo,,1,,,N,,14113,BAO_0000218,,1,,10116.0,995.0,50597,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL623970,Uterus
Intermediate,,A,12017,In vivo,,1,,,N,,14114,BAO_0000218,,1,,10116.0,995.0,50597,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL623971,Uterus
Intermediate,,A,14045,In vivo,,1,,,N,,14115,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),Rattus norvegicus,CHEMBL623972,Blood
Intermediate,,A,14045,In vivo,,1,,,N,,14116,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),Rattus norvegicus,CHEMBL623973,Blood
Intermediate,,A,14045,In vivo,,1,,,N,,14117,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),Rattus norvegicus,CHEMBL623974,Blood
Intermediate,,A,14045,In vivo,,1,,,N,,14118,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),Rattus norvegicus,CHEMBL623975,Blood
Intermediate,,A,14045,In vivo,,1,,,N,,14119,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),Rattus norvegicus,CHEMBL623976,Brain
Intermediate,,A,14045,In vivo,,1,,,N,,14120,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),Rattus norvegicus,CHEMBL623977,Brain
Intermediate,,A,14045,In vivo,,1,,,N,,14121,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),Rattus norvegicus,CHEMBL623978,Brain
Intermediate,,A,14045,In vivo,,1,,,N,,14122,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),Rattus norvegicus,CHEMBL623979,Brain
Intermediate,,A,14045,In vivo,,1,,,N,,14123,BAO_0000218,,1,,10116.0,,50597,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),Rattus norvegicus,CHEMBL623980,
Intermediate,,A,14045,In vivo,,1,,,N,,14124,BAO_0000218,,1,,10116.0,,50597,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),Rattus norvegicus,CHEMBL623981,
Intermediate,,A,14045,In vivo,,1,,,N,,14125,BAO_0000218,,1,,10116.0,,50597,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),Rattus norvegicus,CHEMBL626278,
Intermediate,,A,14045,In vivo,,1,,,N,,14126,BAO_0000218,,1,,10116.0,,50597,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),Rattus norvegicus,CHEMBL626279,
Intermediate,,A,14045,In vivo,,1,,,N,,14127,BAO_0000218,,1,,10090.0,,50594,Biodistribution in mice bladder plus excreted urine was determined,Mus musculus,CHEMBL626280,
Intermediate,,A,14045,,,1,,,N,,14128,BAO_0000218,,1,,10090.0,,50594,"Percentage biodistribution in mouse blood, 10 minutes post injection",Mus musculus,CHEMBL626281,
Intermediate,,A,14045,,,1,,,N,,14129,BAO_0000218,,1,,10090.0,,50594,"Percentage biodistribution in mouse blood, 30 minutes post injection",Mus musculus,CHEMBL626282,
Intermediate,,A,14045,,,1,,,N,,14130,BAO_0000218,,1,,10090.0,,50594,"Percentage biodistribution in mouse blood, 5 minutes post injection",Mus musculus,CHEMBL626283,
Intermediate,,A,14045,,,1,,,N,,14131,BAO_0000218,,1,,10090.0,,50594,"Percentage biodistribution in mouse blood, 60 minutes post injection",Mus musculus,CHEMBL626284,
Intermediate,,A,14045,,,1,,,N,,14132,BAO_0000218,,1,,10090.0,955.0,50594,"Percentage biodistribution in mouse brain, 10 minutes post injection",Mus musculus,CHEMBL626285,Brain
Intermediate,,A,14045,,,1,,,N,,14133,BAO_0000218,,1,,10090.0,955.0,50594,"Percentage biodistribution in mouse brain, 30 minutes post injection",Mus musculus,CHEMBL626286,Brain
Intermediate,,A,14045,,,1,,,N,,14134,BAO_0000218,,1,,10090.0,955.0,50594,"Percentage biodistribution in mouse brain, 5 minutes post injection",Mus musculus,CHEMBL626287,Brain
Intermediate,,A,14045,,,1,,,N,,14135,BAO_0000218,,1,,10090.0,955.0,50594,"Percentage biodistribution in mouse brain, 60 minutes post injection",Mus musculus,CHEMBL626288,Brain
Intermediate,,A,14045,,,1,,,N,,14136,BAO_0000218,,1,,10090.0,,50594,"Percentage biodistribution in mouse heart, 10 minutes post injection",Mus musculus,CHEMBL626289,
Intermediate,,A,14045,,,1,,,N,,14137,BAO_0000218,,1,,10090.0,,50594,"Percentage biodistribution in mouse heart, 30 minutes post injection",Mus musculus,CHEMBL626290,
Intermediate,,A,14045,,,1,,,N,,14138,BAO_0000218,,1,,10090.0,,50594,"Percentage biodistribution in mouse heart, 5 minutes post injection",Mus musculus,CHEMBL626291,
Intermediate,,A,14045,,,1,,,N,,14139,BAO_0000218,,1,,10090.0,,50594,"Percentage biodistribution in mouse heart, 60 minutes post injection",Mus musculus,CHEMBL839888,
Intermediate,,A,14045,,,1,,,N,,14140,BAO_0000218,,1,,10090.0,160.0,50594,"Percentage biodistribution in mouse intestine, 10 minutes post injection",Mus musculus,CHEMBL626292,Intestine
Intermediate,,A,14045,,,1,,,N,,14141,BAO_0000218,,1,,10090.0,160.0,50594,"Percentage biodistribution in mouse intestine, 30 minutes post injection",Mus musculus,CHEMBL626293,Intestine
Intermediate,,A,14045,,,1,,,N,,14142,BAO_0000218,,1,,10090.0,160.0,50594,"Percentage biodistribution in mouse intestine, 5 minutes post injection",Mus musculus,CHEMBL626294,Intestine
Intermediate,,A,14045,,,1,,,N,,14143,BAO_0000218,,1,,10090.0,160.0,50594,"Percentage biodistribution in mouse intestine, 60 minutes post injection",Mus musculus,CHEMBL626295,Intestine
Intermediate,,A,14045,,,1,,,N,,14144,BAO_0000218,,1,,10090.0,2107.0,50594,"Percentage biodistribution in mouse liver, 10 minutes post injection",Mus musculus,CHEMBL627659,Liver
Intermediate,,A,14045,,,1,,,N,,14145,BAO_0000218,,1,,10090.0,2107.0,50594,"Percentage biodistribution in mouse liver, 30 minutes of post injection",Mus musculus,CHEMBL627660,Liver
Intermediate,,A,14045,,,1,,,N,,14146,BAO_0000218,,1,,10090.0,2107.0,50594,"Percentage biodistribution in mouse liver, 5 minutes post injection",Mus musculus,CHEMBL627661,Liver
Intermediate,,A,14045,In vivo,,1,,,N,,14147,BAO_0000218,,1,,10090.0,2107.0,50594,Biodistribution in mice liver at 60 minutes of post injection,Mus musculus,CHEMBL627662,Liver
Intermediate,,A,14045,In vivo,,1,,,N,,14148,BAO_0000218,,1,,10090.0,2048.0,50594,Biodistribution in mice lungs at 10 min of post injection,Mus musculus,CHEMBL627663,Lung
Intermediate,,A,14045,,,1,,,N,,14149,BAO_0000218,,1,,10090.0,,50594,"Percentage biodistribution in mouse lung, 30 minutes post injection",Mus musculus,CHEMBL627664,
Intermediate,,A,14045,,,1,,,N,,14150,BAO_0000218,,1,,10090.0,,50594,"Percentage biodistribution in mousee lung, 5 minutes post injection",Mus musculus,CHEMBL627665,
Intermediate,,A,14045,In vivo,,1,,,N,,14151,BAO_0000218,,1,,10090.0,2048.0,50594,Biodistribution in mice lungs at 60 min of post injection,Mus musculus,CHEMBL627666,Lung
Intermediate,,A,14045,,,1,,,N,,14152,BAO_0000218,,1,,10090.0,2106.0,50594,Percentage biodistribution in mouse spleen,Mus musculus,CHEMBL627667,Spleen
Intermediate,,A,14045,,,1,,,N,,14153,BAO_0000218,,1,,10090.0,945.0,50594,Percentage biodistribution in mouse stomach,Mus musculus,CHEMBL627668,Stomach
Intermediate,,A,11745,,,1,,,N,,14154,BAO_0000218,,1,,10090.0,1088.0,50594,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,Mus musculus,CHEMBL627669,Urine
Autocuration,,A,13257,In vivo,,1,,,U,,14155,BAO_0000218,,0,,,1255.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,,CHEMBL627670,Urinary bladder
Autocuration,,A,13257,In vivo,,1,,,U,,14156,BAO_0000218,,0,,,178.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,,CHEMBL627671,Blood
Autocuration,,A,13257,In vivo,,1,,,U,,14157,BAO_0000218,,0,,,1474.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,,CHEMBL627672,Bone element
Autocuration,,A,13257,In vivo,,1,,,U,,14158,BAO_0000218,,0,,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,,CHEMBL627673,
Autocuration,,A,13257,In vivo,,1,,,U,,14159,BAO_0000218,,0,,,2113.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,,CHEMBL627674,Kidney
Autocuration,,A,13257,In vivo,,1,,,U,,14160,BAO_0000218,,0,,,2107.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,,CHEMBL627675,Liver
Autocuration,,A,13257,In vivo,,1,,,U,,14161,BAO_0000218,,0,,,2048.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,,CHEMBL627676,Lung
Autocuration,,A,13257,In vivo,,1,,,U,,14162,BAO_0000218,,0,,,2385.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,,CHEMBL627677,Muscle tissue
Autocuration,,A,8354,,,1,,,U,,14163,BAO_0000019,,0,,,,22224,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",,CHEMBL627678,
Intermediate,,A,7095,,,1,,,N,,14164,BAO_0000218,,1,,10116.0,1977.0,50597,Affinity for protein binding expressed as association constant in fresh rat serum,Rattus norvegicus,CHEMBL627679,Serum
Autocuration,,A,12185,,,1,,,U,,14165,BAO_0000019,,0,,,,22224,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,CHEMBL627680,
Autocuration,,A,12185,,,1,,,U,,14166,BAO_0000019,,0,,,,22224,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,CHEMBL627681,
Autocuration,,A,12185,,,1,,,U,,14167,BAO_0000019,,0,,,,22224,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,CHEMBL627682,
Autocuration,,A,12185,,,1,,,U,,14168,BAO_0000019,,0,,,,22224,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,CHEMBL627683,
Autocuration,,A,12686,,,1,,,U,,14169,BAO_0000019,,0,,,,22224,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,,CHEMBL627684,
Autocuration,,A,12686,,,1,,,U,,14170,BAO_0000019,,0,,,,22224,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,CHEMBL874441,
Autocuration,,A,12686,,,1,,,U,,14171,BAO_0000019,,0,,,,22224,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,,CHEMBL627685,
Autocuration,,A,12686,,,1,,,U,,14172,BAO_0000019,,0,,,,22224,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,CHEMBL627686,
Autocuration,,A,8057,,,1,,,U,,14173,BAO_0000019,,0,,,,22224,Apparent rate constant Koff for inactivation of dTMP synthase.,,CHEMBL627687,
Autocuration,,A,15778,,,1,,,U,,14174,BAO_0000019,,0,,,,22224,The irreversible inhibitor activity by second order rate equation.,,CHEMBL627688,
Intermediate,,A,12375,,,1,,,N,,14175,BAO_0000218,,1,,10116.0,,50597,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,Rattus norvegicus,CHEMBL628038,
Intermediate,,A,12375,,,1,,,N,,14176,BAO_0000218,,1,,10116.0,,50597,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,Rattus norvegicus,CHEMBL628039,
Intermediate,,A,12375,,,1,,,N,,14177,BAO_0000218,,1,,10116.0,,50597,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,Rattus norvegicus,CHEMBL628040,
Autocuration,,A,13588,,,1,,,U,,14178,BAO_0000019,,0,,,,22224,Dissociation rate calculated from the first-order equation using t1/2 value,,CHEMBL628041,
Autocuration,,A,15039,,,1,,,U,,14179,BAO_0000019,,0,,,,22224,The compound was tested for Binding constant against DNA,,CHEMBL630226,
Autocuration,,A,9500,,,1,,,U,,14180,BAO_0000019,,0,,,,22224,First order rate constant for cyclization of the compound,,CHEMBL628042,
Autocuration,,A,10014,,,1,,,U,,14181,BAO_0000019,,0,,,,22224,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,CHEMBL625232,
Autocuration,,A,10014,,,1,,,U,,14182,BAO_0000019,,0,,,,22224,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,CHEMBL625233,
Autocuration,,A,568,,,1,,,U,,14183,BAO_0000019,,0,,,,22224,Hydrolysis rate constant was determined,,CHEMBL625979,
Autocuration,,A,10026,,,1,,,U,,14184,BAO_0000019,,0,,,,22224,Observed first order rate constant,,CHEMBL625980,
Autocuration,,A,10281,,,1,,,U,,14185,BAO_0000019,,0,,,,22224,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,CHEMBL625981,
Autocuration,,A,10281,,,1,,,U,,14186,BAO_0000019,,0,,,,22224,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,CHEMBL625982,
Autocuration,,A,9680,,,1,,,U,,14187,BAO_0000019,,0,,,,22224,Second-order rate constant for attack on PNPA at 25 degree Centigrade,,CHEMBL625983,
Autocuration,,A,13028,,,1,,,U,,14188,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL625984,
Autocuration,,A,13028,,,1,,,U,,14189,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL625985,
Autocuration,,A,13028,,,1,,,U,,14190,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL625986,
Autocuration,,A,13028,,,1,,,U,,14191,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL625987,
Autocuration,,A,13028,,,1,,,U,,14192,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL625988,
Autocuration,,A,13028,,,1,,,U,,14193,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL625989,
Autocuration,,A,13028,,,1,,,U,,14194,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL625990,
Autocuration,,A,13028,,,1,,,U,,14195,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL625991,
Autocuration,,A,13028,,,1,,,U,,14196,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL625992,
Autocuration,,A,13028,,,1,,,U,,14197,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL625993,
Autocuration,,A,13028,,,1,,,U,,14198,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL631973,
Autocuration,,A,13028,,,1,,,U,,14199,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL632143,
Autocuration,,A,13028,,,1,,,U,,14200,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL632144,
Autocuration,,A,13028,,,1,,,U,,14201,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL632145,
Autocuration,,A,13028,,,1,,,U,,14202,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL632146,
Autocuration,,A,13028,,,1,,,U,,14203,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL632147,
Autocuration,,A,13028,,,1,,,U,,14204,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL632148,
Autocuration,,A,13028,,,1,,,U,,14205,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL632149,
Autocuration,,A,13028,,,1,,,U,,14206,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL632150,
Autocuration,,A,13028,,,1,,,U,,14207,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL632151,
Intermediate,,A,3008,,,1,,,N,,14208,BAO_0000218,,1,,9606.0,,50587,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,Homo sapiens,CHEMBL632152,
Intermediate,,A,4509,,,1,,,N,,14209,BAO_0000218,,1,,9606.0,,50587,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,Homo sapiens,CHEMBL632153,
Intermediate,,A,4509,,,1,,,N,,14210,BAO_0000218,,1,,9606.0,,50587,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,Homo sapiens,CHEMBL632154,
Intermediate,,A,8613,,,1,,,N,,14211,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,Human herpesvirus 1,CHEMBL632155,
Intermediate,,A,8613,,,1,,,N,,14212,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,Human herpesvirus 1,CHEMBL632156,
Intermediate,,A,8613,,,1,,,N,,14213,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,Human herpesvirus 1,CHEMBL632157,
Intermediate,,A,8613,,,1,,,N,,14214,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,Human herpesvirus 1,CHEMBL632158,
Intermediate,,A,8613,,,1,,,N,,14215,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,Human herpesvirus 1,CHEMBL632159,
Intermediate,,A,8613,,,1,,,N,,14216,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,Human herpesvirus 1,CHEMBL626305,
Intermediate,,A,8613,,,1,,,N,,14217,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,Human herpesvirus 1,CHEMBL626306,
Intermediate,,A,8613,,,1,,,N,,14218,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,Human herpesvirus 1,CHEMBL626307,
Intermediate,,A,8613,,,1,,,N,,14219,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,Human herpesvirus 1,CHEMBL626308,
Intermediate,,A,8613,,,1,,,N,,14220,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,Human herpesvirus 1,CHEMBL626479,
Intermediate,,A,8613,,,1,,,N,,14221,BAO_0000218,,1,,10298.0,,50602,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,Human herpesvirus 1,CHEMBL626480,
Autocuration,,P,6021,,,1,,,U,,14222,BAO_0000100,,0,,,,22229,Calculated partition coefficient (clogP) (MlogP),,CHEMBL626481,
Autocuration,,A,9348,,,1,,,U,,14223,BAO_0000019,,0,,,,22224,Equipotent potent ratio relative to carbachol (nicotinic activity),,CHEMBL626482,
Intermediate,,A,15592,,,1,,,N,,14224,BAO_0000218,,1,,9615.0,,50588,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",Canis lupus familiaris,CHEMBL626483,
Intermediate,,A,15592,,,1,,,N,,14225,BAO_0000218,,1,,9615.0,,50588,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",Canis lupus familiaris,CHEMBL626484,
Autocuration,,P,15592,,,1,,,U,,14226,BAO_0000100,,0,,,,22229,Solubility at pH 7.4 in micro g/mL;NA denotes available,,CHEMBL626485,
Autocuration,,P,15592,,,1,,,U,,14227,BAO_0000100,,0,,,,22229,Solubility at pH 7.4 in micro g/mL;NA denotes not available,,CHEMBL626486,
Autocuration,,P,15592,,,1,,,U,,14228,BAO_0000100,,0,,,,22229,Solubility at pH 7.4 in ug/mL;NA denotes not available,,CHEMBL626487,
Intermediate,,A,15592,In vivo,,1,,,N,,14229,BAO_0000218,,1,,9615.0,1969.0,50588,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Canis lupus familiaris,CHEMBL626488,Plasma
Intermediate,,A,7095,,,1,,,N,,14230,BAO_0000218,,1,,10116.0,1977.0,50597,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,Rattus norvegicus,CHEMBL626489,Serum
Autocuration,,A,16618,,,1,,,U,,14231,BAO_0000019,,0,,,,22224,Area under the MAP curve measured over 5 min; ND means Not determined,,CHEMBL626490,
Autocuration,,P,16835,,,1,,,U,,14232,BAO_0000100,,0,,,,22224,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,,CHEMBL626491,
Autocuration,,P,15284,,,1,,,U,,14233,BAO_0000100,,0,,,,22229,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,,CHEMBL626492,
Autocuration,,A,15750,,,1,,,U,,14234,BAO_0000019,,0,,,,22224,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,,CHEMBL626493,
Intermediate,,A,16618,In vivo,,1,,,N,,14235,BAO_0000218,,1,,10116.0,,50597,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,Rattus norvegicus,CHEMBL626494,
Autocuration,,A,16618,In vivo,,1,,,U,,14236,BAO_0000218,,0,,,,22224,Half life after oral tested,,CHEMBL626495,
Intermediate,,A,15812,,,1,,,N,,14237,BAO_0000218,,1,,10116.0,1969.0,50597,Half life was determined in plasma of rat; NT indicates not tested,Rattus norvegicus,CHEMBL626496,Plasma
Intermediate,,A,16618,In vivo,,1,,,N,,14238,BAO_0000218,,1,,10116.0,,50597,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,Rattus norvegicus,CHEMBL626497,
Autocuration,,A,16618,In vivo,,1,,,U,,14239,BAO_0000218,,0,,,,22224,Oral bioavailability after oral tested,,CHEMBL626498,
Intermediate,,A,13098,,,1,,,N,,14240,BAO_0000218,,1,,10116.0,,50597,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),Rattus norvegicus,CHEMBL626499,
Intermediate,,A,13098,,,1,,,N,,14241,BAO_0000218,,1,,10116.0,,50597,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),Rattus norvegicus,CHEMBL626500,
Intermediate,,A,15812,,,1,,,N,,14242,BAO_0000218,,1,,10116.0,1969.0,50597,half life was determined in plasma of rat; NT indicates not tested,Rattus norvegicus,CHEMBL626501,Plasma
Intermediate,,A,15812,,,1,,,N,,14243,BAO_0000218,,1,,10116.0,1969.0,50597,half life was determined in plasma of rat; NT means not tested,Rattus norvegicus,CHEMBL626502,Plasma
Intermediate,,A,11510,,,1,,,N,,14244,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,Rattus norvegicus,CHEMBL626503,
Intermediate,,A,11510,,,1,,,N,,14245,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats (Control/Drug treatment value); inactive,Rattus norvegicus,CHEMBL626504,
Intermediate,,A,11510,,,1,,,N,,14246,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,Rattus norvegicus,CHEMBL626505,
Intermediate,,A,11510,,,1,,,N,,14247,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,Rattus norvegicus,CHEMBL626506,
Intermediate,,A,11510,,,1,,,N,,14248,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,Rattus norvegicus,CHEMBL626507,
Intermediate,,A,11510,,,1,,,N,,14249,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,Rattus norvegicus,CHEMBL626508,
Intermediate,,A,11510,,,1,,,N,,14250,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,Rattus norvegicus,CHEMBL626509,
Intermediate,,A,11510,,,1,,,N,,14251,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,Rattus norvegicus,CHEMBL875480,
Intermediate,,A,11510,,,1,,,N,,14252,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,Rattus norvegicus,CHEMBL626510,
Intermediate,,A,11510,,,1,,,N,,14253,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,Rattus norvegicus,CHEMBL626511,
Intermediate,,A,11510,,,1,,,N,,14254,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,Rattus norvegicus,CHEMBL626512,
Intermediate,,A,11510,,,1,,,N,,14255,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,Rattus norvegicus,CHEMBL628208,
Intermediate,,A,11510,,,1,,,N,,14256,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,Rattus norvegicus,CHEMBL628209,
Intermediate,,A,11510,,,1,,,N,,14257,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,Rattus norvegicus,CHEMBL628210,
Intermediate,,A,11510,,,1,,,N,,14258,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,Rattus norvegicus,CHEMBL628211,
Intermediate,,A,11510,,,1,,,N,,14259,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,Rattus norvegicus,CHEMBL628212,
Intermediate,,A,11510,,,1,,,N,,14260,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,Rattus norvegicus,CHEMBL628213,
Intermediate,,A,12582,,,1,,,N,,14261,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,Rattus norvegicus,CHEMBL628214,Urine
Intermediate,,A,12582,,,1,,,N,,14262,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,Rattus norvegicus,CHEMBL628215,Urine
Intermediate,,A,12582,,,1,,,N,,14263,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,Rattus norvegicus,CHEMBL628216,Urine
Intermediate,,A,12582,,,1,,,N,,14264,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,Rattus norvegicus,CHEMBL626595,Urine
Intermediate,,A,12582,,,1,,,N,,14265,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,Rattus norvegicus,CHEMBL626596,Urine
Intermediate,,A,12582,,,1,,,N,,14266,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,Rattus norvegicus,CHEMBL626597,Urine
Intermediate,,A,12582,,,1,,,N,,14267,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,Rattus norvegicus,CHEMBL626598,Urine
Intermediate,,A,12582,,,1,,,N,,14268,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,Rattus norvegicus,CHEMBL622242,Urine
Intermediate,,A,12582,,,1,,,N,,14269,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,Rattus norvegicus,CHEMBL622243,Urine
Intermediate,,A,12582,,,1,,,N,,14270,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,Rattus norvegicus,CHEMBL622244,Urine
Intermediate,,A,12582,,,1,,,N,,14271,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,Rattus norvegicus,CHEMBL622245,Urine
Intermediate,,A,12582,,,1,,,N,,14272,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,Rattus norvegicus,CHEMBL622246,Urine
Intermediate,,A,12582,,,1,,,N,,14273,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,Rattus norvegicus,CHEMBL622247,Urine
Intermediate,,A,12582,,,1,,,N,,14274,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,Rattus norvegicus,CHEMBL622248,Urine
Intermediate,,A,12582,,,1,,,N,,14275,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,Rattus norvegicus,CHEMBL877483,Urine
Intermediate,,A,12582,,,1,,,N,,14276,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,Rattus norvegicus,CHEMBL622249,Urine
Intermediate,,A,12582,,,1,,,N,,14277,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Canis lupus familiaris,CHEMBL622250,Urine
Intermediate,,A,12582,,,1,,,N,,14278,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Canis lupus familiaris,CHEMBL622251,Urine
Intermediate,,A,12582,,,1,,,N,,14279,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Canis lupus familiaris,CHEMBL622252,Urine
Intermediate,,A,12582,,,1,,,N,,14280,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Canis lupus familiaris,CHEMBL622253,Urine
Intermediate,,A,12582,,,1,,,N,,14281,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Canis lupus familiaris,CHEMBL622254,Urine
Intermediate,,A,12582,,,1,,,N,,14282,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Canis lupus familiaris,CHEMBL622255,Urine
Intermediate,,A,12582,,,1,,,N,,14283,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Canis lupus familiaris,CHEMBL622256,Urine
Intermediate,,A,12582,,,1,,,N,,14284,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Canis lupus familiaris,CHEMBL622257,Urine
Intermediate,,A,12582,,,1,,,N,,14285,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Canis lupus familiaris,CHEMBL622258,Urine
Intermediate,,A,12582,,,1,,,N,,14286,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Canis lupus familiaris,CHEMBL622259,Urine
Intermediate,,A,12582,,,1,,,N,,14287,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Canis lupus familiaris,CHEMBL622927,Urine
Intermediate,,A,12582,,,1,,,N,,14288,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Canis lupus familiaris,CHEMBL622928,Urine
Intermediate,,A,12582,,,1,,,N,,14289,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Canis lupus familiaris,CHEMBL622929,Urine
Intermediate,,A,12582,,,1,,,N,,14290,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,Canis lupus familiaris,CHEMBL623182,Urine
Intermediate,,A,12582,,,1,,,N,,14291,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Canis lupus familiaris,CHEMBL623183,Urine
Intermediate,,A,12582,,,1,,,N,,14292,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,Rattus norvegicus,CHEMBL623184,Urine
Intermediate,,A,12582,,,1,,,N,,14293,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,Rattus norvegicus,CHEMBL623185,Urine
Intermediate,,A,12582,,,1,,,N,,14294,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,Rattus norvegicus,CHEMBL877484,Urine
Intermediate,,A,12582,,,1,,,N,,14295,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,Rattus norvegicus,CHEMBL627274,Urine
Intermediate,,A,12582,,,1,,,N,,14296,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,Rattus norvegicus,CHEMBL623186,Urine
Intermediate,,A,12582,,,1,,,N,,14297,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,Rattus norvegicus,CHEMBL623187,Urine
Intermediate,,A,12582,,,1,,,N,,14298,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,Rattus norvegicus,CHEMBL623188,Urine
Intermediate,,A,12582,,,1,,,N,,14299,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,Rattus norvegicus,CHEMBL628055,Urine
Intermediate,,A,12582,,,1,,,N,,14300,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,Rattus norvegicus,CHEMBL628056,Urine
Intermediate,,A,12582,,,1,,,N,,14301,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,Rattus norvegicus,CHEMBL628200,Urine
Intermediate,,A,12582,,,1,,,N,,14302,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,Rattus norvegicus,CHEMBL628201,Urine
Intermediate,,A,12582,,,1,,,N,,14303,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,Rattus norvegicus,CHEMBL628202,Urine
Intermediate,,A,12582,,,1,,,N,,14304,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,Rattus norvegicus,CHEMBL628203,Urine
Intermediate,,A,12582,,,1,,,N,,14305,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,Rattus norvegicus,CHEMBL628204,Urine
Intermediate,,A,12582,,,1,,,N,,14306,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,Rattus norvegicus,CHEMBL628205,Urine
Intermediate,,A,12582,,,1,,,N,,14307,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,Rattus norvegicus,CHEMBL628206,Urine
Autocuration,,A,13257,In vivo,,1,,,U,,14308,BAO_0000218,,0,,,2367.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),,CHEMBL628207,Prostate gland
Autocuration,,A,13257,In vivo,,1,,,U,,14309,BAO_0000218,,0,,,2367.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,,CHEMBL627220,Prostate gland
Autocuration,,A,13257,In vivo,,1,,,U,,14310,BAO_0000218,,0,,,2385.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,,CHEMBL627221,Muscle tissue
Autocuration,,A,13257,In vivo,,1,,,U,,14311,BAO_0000218,,0,,,2367.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),,CHEMBL627222,Prostate gland
Autocuration,,A,13257,In vivo,,1,,,U,,14312,BAO_0000218,,0,,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,,CHEMBL627223,
Autocuration,,A,13257,In vivo,,1,,,U,,14313,BAO_0000218,,0,,,2385.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,,CHEMBL632062,Muscle tissue
Autocuration,,A,13257,In vivo,,1,,,U,,14314,BAO_0000218,,0,,,2106.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,,CHEMBL632063,Spleen
Autocuration,,A,13257,In vivo,,1,,,U,,14315,BAO_0000218,,0,,,1255.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,,CHEMBL632064,Urinary bladder
Autocuration,,A,13257,In vivo,,1,,,U,,14316,BAO_0000218,,0,,,178.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,,CHEMBL632065,Blood
Autocuration,,A,13257,In vivo,,1,,,U,,14317,BAO_0000218,,0,,,1474.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,,CHEMBL632066,Bone element
Autocuration,,A,13257,In vivo,,1,,,U,,14318,BAO_0000218,,0,,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,,CHEMBL632067,
Autocuration,,A,13257,In vivo,,1,,,U,,14319,BAO_0000218,,0,,,2113.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,,CHEMBL629188,Kidney
Autocuration,,A,13257,In vivo,,1,,,U,,14320,BAO_0000218,,0,,,2107.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,,CHEMBL629189,Liver
Autocuration,,A,13257,In vivo,,1,,,U,,14321,BAO_0000218,,0,,,2048.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,,CHEMBL629190,Lung
Autocuration,,A,13257,In vivo,,1,,,U,,14322,BAO_0000218,,0,,,2385.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,,CHEMBL629191,Muscle tissue
Autocuration,,A,13257,In vivo,,1,,,U,,14323,BAO_0000218,,0,,,2367.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),,CHEMBL629192,Prostate gland
Autocuration,,A,13257,In vivo,,1,,,U,,14324,BAO_0000218,,0,,,2385.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,,CHEMBL629193,Muscle tissue
Autocuration,,A,13257,In vivo,,1,,,U,,14325,BAO_0000218,,0,,,2367.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),,CHEMBL629194,Prostate gland
Autocuration,,A,13257,In vivo,,1,,,U,,14326,BAO_0000218,,0,,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,,CHEMBL629195,
Autocuration,,A,13257,In vivo,,1,,,U,,14327,BAO_0000218,,0,,,2385.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,,CHEMBL629373,Muscle tissue
Autocuration,,A,13257,In vivo,,1,,,U,,14328,BAO_0000218,,0,,,2106.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,,CHEMBL629374,Spleen
Autocuration,,A,13257,In vivo,,1,,,U,,14329,BAO_0000218,,0,,,2367.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,,CHEMBL629375,Prostate gland
Autocuration,,A,13257,In vivo,,1,,,U,,14330,BAO_0000218,,0,,,1255.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,,CHEMBL629376,Urinary bladder
Autocuration,,A,13257,In vivo,,1,,,U,,14331,BAO_0000218,,0,,,178.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,,CHEMBL629377,Blood
Autocuration,,A,13257,In vivo,,1,,,U,,14332,BAO_0000218,,0,,,1474.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,,CHEMBL629378,Bone element
Autocuration,,A,13257,In vivo,,1,,,U,,14333,BAO_0000218,,0,,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,,CHEMBL629379,
Autocuration,,A,13257,In vivo,,1,,,U,,14334,BAO_0000218,,0,,,2113.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,,CHEMBL629151,Kidney
Autocuration,,A,13257,In vivo,,1,,,U,,14335,BAO_0000218,,0,,,2107.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,,CHEMBL629152,Liver
Autocuration,,A,13257,In vivo,,1,,,U,,14336,BAO_0000218,,0,,,2048.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,,CHEMBL629153,Lung
Autocuration,,A,13257,In vivo,,1,,,U,,14337,BAO_0000218,,0,,,2385.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,,CHEMBL629154,Muscle tissue
Autocuration,,A,13257,In vivo,,1,,,U,,14338,BAO_0000218,,0,,,2367.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),,CHEMBL629155,Prostate gland
Autocuration,,A,13257,In vivo,,1,,,U,,14339,BAO_0000218,,0,,,2367.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,,CHEMBL629156,Prostate gland
Autocuration,,A,13257,In vivo,,1,,,U,,14340,BAO_0000218,,0,,,2385.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,,CHEMBL629157,Muscle tissue
Autocuration,,A,13257,In vivo,,1,,,U,,14341,BAO_0000218,,0,,,2367.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),,CHEMBL629158,Prostate gland
Autocuration,,A,13257,In vivo,,1,,,U,,14342,BAO_0000218,,0,,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,,CHEMBL629159,
Autocuration,,A,13257,In vivo,,1,,,U,,14343,BAO_0000218,,0,,,2385.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,,CHEMBL629160,Muscle tissue
Autocuration,,A,13257,In vivo,,1,,,U,,14344,BAO_0000218,,0,,,2106.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,,CHEMBL629161,Spleen
Autocuration,,A,13257,In vivo,,1,,,U,,14345,BAO_0000218,,0,,,1255.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,,CHEMBL629162,Urinary bladder
Autocuration,,A,13257,In vivo,,1,,,U,,14346,BAO_0000218,,0,,,178.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,,CHEMBL629163,Blood
Autocuration,,A,13257,In vivo,,1,,,U,,14347,BAO_0000218,,0,,,1474.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,,CHEMBL629164,Bone element
Autocuration,,A,13257,In vivo,,1,,,U,,14348,BAO_0000218,,0,,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,,CHEMBL629165,
Autocuration,,A,13257,In vivo,,1,,,U,,14349,BAO_0000218,,0,,,2107.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,,CHEMBL629166,Liver
Autocuration,,A,13257,In vivo,,1,,,U,,14350,BAO_0000218,,0,,,2048.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,,CHEMBL629167,Lung
Autocuration,,A,13257,In vivo,,1,,,U,,14351,BAO_0000218,,0,,,2385.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,,CHEMBL629168,Muscle tissue
Autocuration,,A,2193,,,1,,,U,,14352,BAO_0000019,,0,,,,22224,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,,CHEMBL629169,
Autocuration,,A,2193,,,1,,,U,,14353,BAO_0000019,,0,,,,22224,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,,CHEMBL629170,
Autocuration,,A,2193,,,1,,,U,,14354,BAO_0000019,,0,,,,22224,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,,CHEMBL631153,
Autocuration,,A,2193,,,1,,,U,,14355,BAO_0000019,,0,,,,22224,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,,CHEMBL875121,
Autocuration,,A,2193,,,1,,,U,,14356,BAO_0000019,,0,,,,22224,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,,CHEMBL631154,
Autocuration,,A,2193,,,1,,,U,,14357,BAO_0000019,,0,,,,22224,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,,CHEMBL631155,
Autocuration,,A,568,,,1,,,U,,14358,BAO_0000019,,0,,,,22224,Hydrolysis rate constant was determined,,CHEMBL631156,
Autocuration,,A,9680,,,1,,,U,,14359,BAO_0000019,,0,,,,22224,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",,CHEMBL631157,
Autocuration,,A,9680,,,1,,,U,,14360,BAO_0000019,,0,,,,22224,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,CHEMBL631158,
Autocuration,,A,9680,,,1,,,U,,14361,BAO_0000019,,0,,,,22224,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,CHEMBL631159,
Autocuration,,A,10026,,,1,,,U,,14362,BAO_0000019,,0,,,,22224,Observed second order rate constant,,CHEMBL631160,
Autocuration,,A,10281,,,1,,,U,,14363,BAO_0000019,,0,,,,22224,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,CHEMBL631161,
Autocuration,,A,10014,,,1,,,U,,14364,BAO_0000019,,0,,,,22224,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,CHEMBL631162,
Autocuration,,A,10014,,,1,,,U,,14365,BAO_0000019,,0,,,,22224,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,CHEMBL630313,
Autocuration,,A,9680,,,1,,,U,,14366,BAO_0000019,,0,,,,22224,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,CHEMBL630314,
Autocuration,,A,9680,,,1,,,U,,14367,BAO_0000019,,0,,,,22224,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,CHEMBL630315,
Autocuration,,A,13028,,,1,,,U,,14368,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL630316,
Autocuration,,A,13028,,,1,,,U,,14369,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL630986,
Autocuration,,A,13028,,,1,,,U,,14370,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL630987,
Autocuration,,A,13028,,,1,,,U,,14371,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL630988,
Autocuration,,A,13028,,,1,,,U,,14372,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL630989,
Autocuration,,A,13028,,,1,,,U,,14373,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL630990,
Autocuration,,A,13028,,,1,,,U,,14374,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL630991,
Autocuration,,A,13028,,,1,,,U,,14375,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL630992,
Autocuration,,A,13028,,,1,,,U,,14376,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL630993,
Autocuration,,A,13028,,,1,,,U,,14377,BAO_0000019,,0,,,,22224,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,CHEMBL630994,
Intermediate,,A,10014,,,1,,,N,,14378,BAO_0000218,,1,,10116.0,,50597,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,Rattus norvegicus,CHEMBL630995,
Autocuration,,A,9962,,,1,,,U,,14379,BAO_0000019,,0,,,,22224,Association constant for compound at 31 degree C was determined,,CHEMBL629252,
Autocuration,,A,12029,,,1,,,U,,14380,BAO_0000019,,0,,,,22224,Calculated antagonist equilibrium dissociation constant of the compound,,CHEMBL629253,
Autocuration,,A,12029,,,1,,,U,,14381,BAO_0000019,,0,,,,22224,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,,CHEMBL629944,
Intermediate,,A,10583,,,1,,,N,,14382,BAO_0000218,,1,,10141.0,3126.0,50512,Dissociation constants vs LTE4 on guinea pig trachea,Cavia porcellus,CHEMBL629945,Trachea
Autocuration,,A,568,,,1,,,U,,14383,BAO_0000019,,0,,,,22224,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",,CHEMBL629946,
Autocuration,,A,568,,,1,,,U,,14384,BAO_0000019,,0,,,,22224,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",,CHEMBL629947,
Autocuration,,A,568,,,1,,,U,,14385,BAO_0000019,,0,,,,22224,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",,CHEMBL629948,
Autocuration,,A,568,,,1,,,U,,14386,BAO_0000019,,0,,,,22224,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",,CHEMBL856024,
Autocuration,,A,7493,,,1,,,U,,14387,BAO_0000019,,0,,,,22224,Affinity constant KD value was derived from TMP,,CHEMBL629949,
Autocuration,,A,8371,,,1,,,U,,14388,BAO_0000019,,0,,,,22224,Apparent dissociation (binding) rate constant was evaluated,,CHEMBL629950,
Autocuration,,P,13114,,,1,,,U,,14389,BAO_0000100,,0,,,,22224,Dissociation constant (KD) of the compound,,CHEMBL630127,
Autocuration,,P,15515,,,1,,,U,,14390,BAO_0000100,,0,,,,22224,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,,CHEMBL630128,
Autocuration,,P,522,,,1,,,U,,14391,BAO_0000100,,0,,,,22224,Dissociation constant from ESR titration experiments,,CHEMBL630129,
Autocuration,,,13888,,,1,,,U,,14392,BAO_0000019,,0,,,,22224,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,CHEMBL630130,
Autocuration,,P,2616,,,1,,,U,,14393,BAO_0000100,,0,,,,22224,Dissociation constant was evaluated.,,CHEMBL875234,
Autocuration,,P,3798,,,1,,,U,,14394,BAO_0000100,,0,,,,22224,Dissociation constant was reported,,CHEMBL630131,
Intermediate,,A,8731,,,1,,,N,,14395,BAO_0000218,,1,,10116.0,,50597,Dissociation constant was determined in rat pituitary cells.,Rattus norvegicus,CHEMBL630132,
Autocuration,,A,11892,,,1,,,U,,14396,BAO_0000019,,0,,,,22224,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,,CHEMBL630133,
Autocuration,,A,11892,,,1,,,U,,14397,BAO_0000019,,0,,,,22224,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,,CHEMBL630134,
Autocuration,,A,2582,,,1,,,U,,14398,BAO_0000019,,0,,,,22224,Equilibrium dissociation constant of the compound,,CHEMBL630135,
Autocuration,,A,11892,,,1,,,U,,14399,BAO_0000019,,0,,,,22224,Equilibrium dissociation constant was determined,,CHEMBL630136,
Autocuration,,A,13396,,,1,,,U,,14400,BAO_0000019,,0,,,,22224,Kinetic constant KD was evaluated,,CHEMBL630137,
Autocuration,,A,603,,,1,,,U,,14401,BAO_0000019,,0,,,,22224,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,,CHEMBL630138,
Autocuration,,A,15673,,,1,,,U,,14402,BAO_0000019,,0,,,,22224,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,,CHEMBL630139,
Autocuration,,A,10368,,,1,,,U,,14403,BAO_0000019,,0,,,,22224,Rate constant for hydrolysis in aqueous acetone.,,CHEMBL630140,
Autocuration,,A,14228,,,1,,,U,,14404,BAO_0000019,,0,,,,22224,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,,CHEMBL875235,
Intermediate,,A,11510,,,1,,,N,,14405,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,Rattus norvegicus,CHEMBL876439,
Intermediate,,A,11510,,,1,,,N,,14406,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,Rattus norvegicus,CHEMBL630605,
Intermediate,,A,11510,,,1,,,N,,14407,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,Rattus norvegicus,CHEMBL630606,
Intermediate,,A,11510,,,1,,,N,,14408,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,Rattus norvegicus,CHEMBL630607,
Intermediate,,A,11510,,,1,,,N,,14409,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,Rattus norvegicus,CHEMBL630608,
Intermediate,,A,11510,,,1,,,N,,14410,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,Rattus norvegicus,CHEMBL630609,
Intermediate,,A,11510,,,1,,,N,,14411,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,Rattus norvegicus,CHEMBL630610,
Intermediate,,A,11510,,,1,,,N,,14412,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,Rattus norvegicus,CHEMBL630611,
Intermediate,,A,11510,,,1,,,N,,14413,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,Rattus norvegicus,CHEMBL629552,
Intermediate,,A,11510,,,1,,,N,,14414,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,Rattus norvegicus,CHEMBL629733,
Intermediate,,A,11510,,,1,,,N,,14415,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,Rattus norvegicus,CHEMBL629734,
Intermediate,,A,11510,,,1,,,N,,14416,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,Rattus norvegicus,CHEMBL629735,
Intermediate,,A,11510,,,1,,,N,,14417,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,Rattus norvegicus,CHEMBL629736,
Intermediate,,A,11510,,,1,,,N,,14418,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,Rattus norvegicus,CHEMBL629737,
Intermediate,,A,11510,,,1,,,N,,14419,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,Rattus norvegicus,CHEMBL629738,
Intermediate,,A,11510,,,1,,,N,,14420,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,Rattus norvegicus,CHEMBL629739,
Intermediate,,A,11510,,,1,,,N,,14421,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,Rattus norvegicus,CHEMBL629740,
Intermediate,,A,11510,,,1,,,N,,14422,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,Rattus norvegicus,CHEMBL629741,
Intermediate,,A,11510,,,1,,,N,,14423,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,Rattus norvegicus,CHEMBL629742,
Intermediate,,A,11510,,,1,,,N,,14424,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,Rattus norvegicus,CHEMBL629743,
Intermediate,,A,11510,,,1,,,N,,14425,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,Rattus norvegicus,CHEMBL629744,
Intermediate,,A,11510,,,1,,,N,,14426,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,Rattus norvegicus,CHEMBL629745,
Intermediate,,A,11510,,,1,,,N,,14427,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,Rattus norvegicus,CHEMBL629746,
Intermediate,,A,11510,,,1,,,N,,14428,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,Rattus norvegicus,CHEMBL629747,
Intermediate,,A,11510,,,1,,,N,,14429,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,Rattus norvegicus,CHEMBL629748,
Intermediate,,A,11510,,,1,,,N,,14430,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,Rattus norvegicus,CHEMBL629749,
Intermediate,,A,11510,,,1,,,N,,14431,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,Rattus norvegicus,CHEMBL629750,
Intermediate,,A,11510,,,1,,,N,,14432,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,Rattus norvegicus,CHEMBL629751,
Intermediate,,A,11510,,,1,,,N,,14433,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,Rattus norvegicus,CHEMBL629752,
Intermediate,,A,11510,,,1,,,N,,14434,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,Rattus norvegicus,CHEMBL629753,
Intermediate,,A,11510,,,1,,,N,,14435,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,Rattus norvegicus,CHEMBL629754,
Intermediate,,A,11510,,,1,,,N,,14436,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,Rattus norvegicus,CHEMBL629755,
Intermediate,,A,11510,,,1,,,N,,14437,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,Rattus norvegicus,CHEMBL629756,
Intermediate,,A,11510,,,1,,,N,,14438,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,Rattus norvegicus,CHEMBL629757,
Intermediate,,A,11510,,,1,,,N,,14439,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,Rattus norvegicus,CHEMBL629758,
Intermediate,,A,11510,,,1,,,N,,14440,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,Rattus norvegicus,CHEMBL629759,
Intermediate,,A,11510,,,1,,,N,,14441,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,Rattus norvegicus,CHEMBL629760,
Intermediate,,A,11510,,,1,,,N,,14442,BAO_0000218,,1,,10116.0,,50597,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,Rattus norvegicus,CHEMBL876443,
Intermediate,,A,8310,,,1,,,N,,14443,BAO_0000218,,1,,9615.0,,50588,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,Canis lupus familiaris,CHEMBL629761,
Intermediate,,A,8310,,,1,,,N,,14444,BAO_0000218,,1,,9615.0,,50588,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,Canis lupus familiaris,CHEMBL629762,
Intermediate,,A,8310,,,1,,,N,,14445,BAO_0000218,,1,,10090.0,,50594,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Mus musculus,CHEMBL629763,
Intermediate,,A,8310,,,1,,,N,,14446,BAO_0000218,,1,,10090.0,,50594,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,Mus musculus,CHEMBL629764,
Intermediate,,A,8310,,,1,,,N,,14447,BAO_0000218,,1,,10090.0,,50594,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,Mus musculus,CHEMBL629765,
Intermediate,,A,8310,,,1,,,N,,14448,BAO_0000218,,1,,10090.0,,50594,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,Mus musculus,CHEMBL629766,
Intermediate,,A,8310,,,1,,,N,,14449,BAO_0000218,,1,,10090.0,,50594,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Mus musculus,CHEMBL629767,
Intermediate,,A,8310,,,1,,,N,,14450,BAO_0000218,,1,,9615.0,,50588,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,Canis lupus familiaris,CHEMBL629768,
Intermediate,,A,8310,,,1,,,N,,14451,BAO_0000218,,1,,10090.0,,50594,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,Mus musculus,CHEMBL629769,
Intermediate,,A,8310,,,1,,,N,,14452,BAO_0000218,,1,,9615.0,,50588,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,Canis lupus familiaris,CHEMBL629770,
Intermediate,,A,8310,,,1,,,N,,14453,BAO_0000218,,1,,9615.0,,50588,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,Canis lupus familiaris,CHEMBL629771,
Intermediate,,A,8310,,,1,,,N,,14454,BAO_0000218,,1,,10090.0,,50594,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Mus musculus,CHEMBL629772,
Intermediate,,A,8310,,,1,,,N,,14455,BAO_0000218,,1,,10090.0,,50594,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Mus musculus,CHEMBL629773,
Intermediate,,A,8310,,,1,,,N,,14456,BAO_0000218,,1,,10090.0,,50594,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,Mus musculus,CHEMBL625455,
Intermediate,,A,8310,,,1,,,N,,14457,BAO_0000218,,1,,10090.0,,50594,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,Mus musculus,CHEMBL625456,
Intermediate,,A,8310,,,1,,,N,,14458,BAO_0000218,,1,,10090.0,,50594,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,Mus musculus,CHEMBL625457,
Intermediate,,A,12582,,,1,,,N,,14459,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,Rattus norvegicus,CHEMBL625458,Urine
Intermediate,,A,12582,,,1,,,N,,14460,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,Rattus norvegicus,CHEMBL625459,Urine
Intermediate,,A,12582,,,1,,,N,,14461,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,Rattus norvegicus,CHEMBL875483,Urine
Intermediate,,A,12582,,,1,,,N,,14462,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,Rattus norvegicus,CHEMBL634779,Urine
Intermediate,,A,12582,,,1,,,N,,14463,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,Rattus norvegicus,CHEMBL625460,Urine
Intermediate,,A,12582,,,1,,,N,,14464,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,Rattus norvegicus,CHEMBL626117,Urine
Intermediate,,A,12582,,,1,,,N,,14465,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,Rattus norvegicus,CHEMBL626118,Urine
Intermediate,,A,12582,,,1,,,N,,14466,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,Rattus norvegicus,CHEMBL628342,Urine
Intermediate,,A,12582,,,1,,,N,,14467,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,Rattus norvegicus,CHEMBL628343,Urine
Intermediate,,A,12582,,,1,,,N,,14468,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,Rattus norvegicus,CHEMBL628344,Urine
Intermediate,,A,12582,,,1,,,N,,14469,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,Rattus norvegicus,CHEMBL628345,Urine
Intermediate,,A,12582,,,1,,,N,,14470,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,Rattus norvegicus,CHEMBL628346,Urine
Intermediate,,A,12582,,,1,,,N,,14471,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,Rattus norvegicus,CHEMBL628347,Urine
Intermediate,,A,12582,,,1,,,N,,14472,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,Rattus norvegicus,CHEMBL628348,Urine
Intermediate,,A,12582,,,1,,,N,,14473,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,Rattus norvegicus,CHEMBL628349,Urine
Intermediate,,A,12582,,,1,,,N,,14474,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,Rattus norvegicus,CHEMBL875611,Urine
Intermediate,,A,12582,,,1,,,N,,14475,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,Rattus norvegicus,CHEMBL628350,Urine
Intermediate,,A,12582,,,1,,,N,,14476,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,Rattus norvegicus,CHEMBL628351,Urine
Intermediate,,A,12582,,,1,,,N,,14477,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,Rattus norvegicus,CHEMBL628352,Urine
Intermediate,,A,12582,,,1,,,N,,14478,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,Rattus norvegicus,CHEMBL628353,Urine
Intermediate,,A,12582,,,1,,,N,,14479,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,Rattus norvegicus,CHEMBL628354,Urine
Intermediate,,A,12582,,,1,,,N,,14480,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,Rattus norvegicus,CHEMBL626667,Urine
Intermediate,,A,12582,,,1,,,N,,14481,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,Rattus norvegicus,CHEMBL626668,Urine
Intermediate,,A,12582,,,1,,,N,,14482,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,Rattus norvegicus,CHEMBL626669,Urine
Intermediate,,A,12582,,,1,,,N,,14483,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,Rattus norvegicus,CHEMBL626670,Urine
Intermediate,,A,12582,,,1,,,N,,14484,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,Rattus norvegicus,CHEMBL626671,Urine
Intermediate,,A,12582,,,1,,,N,,14485,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,Rattus norvegicus,CHEMBL626672,Urine
Intermediate,,A,12582,,,1,,,N,,14486,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,Rattus norvegicus,CHEMBL626673,Urine
Intermediate,,A,12582,,,1,,,N,,14487,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,Rattus norvegicus,CHEMBL626674,Urine
Intermediate,,A,12582,,,1,,,N,,14488,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,Rattus norvegicus,CHEMBL626675,Urine
Intermediate,,A,12582,,,1,,,N,,14489,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,Rattus norvegicus,CHEMBL626676,Urine
Intermediate,,A,12582,,,1,,,N,,14490,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,Rattus norvegicus,CHEMBL626677,Urine
Intermediate,,A,12582,,,1,,,N,,14491,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,Rattus norvegicus,CHEMBL626678,Urine
Intermediate,,A,12582,,,1,,,N,,14492,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,Rattus norvegicus,CHEMBL626679,Urine
Intermediate,,A,12582,,,1,,,N,,14493,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,Rattus norvegicus,CHEMBL875612,Urine
Intermediate,,A,12582,,,1,,,N,,14494,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,Rattus norvegicus,CHEMBL626680,Urine
Intermediate,,A,12582,,,1,,,N,,14495,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,Rattus norvegicus,CHEMBL626681,Urine
Intermediate,,A,12582,,,1,,,N,,14496,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,Rattus norvegicus,CHEMBL626682,Urine
Intermediate,,A,12582,,,1,,,N,,14497,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,Rattus norvegicus,CHEMBL626683,Urine
Intermediate,,A,12582,,,1,,,N,,14498,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,Rattus norvegicus,CHEMBL626684,Urine
Intermediate,,A,12582,,,1,,,N,,14499,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,Rattus norvegicus,CHEMBL626685,Urine
Intermediate,,A,12582,,,1,,,N,,14500,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,Rattus norvegicus,CHEMBL626686,Urine
Intermediate,,A,12582,,,1,,,N,,14501,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,Rattus norvegicus,CHEMBL626687,Urine
Intermediate,,A,12582,,,1,,,N,,14502,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,Rattus norvegicus,CHEMBL624978,Urine
Intermediate,,A,12582,,,1,,,N,,14503,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,Rattus norvegicus,CHEMBL624979,Urine
Intermediate,,A,12582,,,1,,,N,,14504,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,Rattus norvegicus,CHEMBL624980,Urine
Intermediate,,A,12582,,,1,,,N,,14505,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,Rattus norvegicus,CHEMBL624981,Urine
Intermediate,,A,12582,,,1,,,N,,14506,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Canis lupus familiaris,CHEMBL624982,Urine
Autocuration,,A,13257,In vivo,,1,,,U,,14507,BAO_0000218,,0,,,2367.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),,CHEMBL627564,Prostate gland
Autocuration,,A,13257,In vivo,,1,,,U,,14508,BAO_0000218,,0,,,2367.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),,CHEMBL627565,Prostate gland
Autocuration,,A,13257,In vivo,,1,,,U,,14509,BAO_0000218,,0,,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,,CHEMBL627566,
Autocuration,,A,13257,In vivo,,1,,,U,,14510,BAO_0000218,,0,,,2385.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,,CHEMBL627567,Muscle tissue
Autocuration,,A,13257,In vivo,,1,,,U,,14511,BAO_0000218,,0,,,2106.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,,CHEMBL627568,Spleen
Autocuration,,A,13257,In vivo,,1,,,U,,14512,BAO_0000218,,0,,,2113.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,,CHEMBL627569,Kidney
Autocuration,,A,13257,In vivo,,1,,,U,,14513,BAO_0000218,,0,,,1255.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,,CHEMBL627570,Urinary bladder
Autocuration,,A,13257,In vivo,,1,,,U,,14514,BAO_0000218,,0,,,178.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,,CHEMBL627571,Blood
Autocuration,,A,13257,In vivo,,1,,,U,,14515,BAO_0000218,,0,,,1474.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,,CHEMBL627572,Bone element
Autocuration,,A,13257,In vivo,,1,,,U,,14516,BAO_0000218,,0,,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,,CHEMBL627573,
Autocuration,,A,13257,In vivo,,1,,,U,,14517,BAO_0000218,,0,,,2113.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,,CHEMBL627574,Kidney
Autocuration,,A,13257,In vivo,,1,,,U,,14518,BAO_0000218,,0,,,2107.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,,CHEMBL627575,Liver
Autocuration,,A,13257,In vivo,,1,,,U,,14519,BAO_0000218,,0,,,2048.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,,CHEMBL627576,Lung
Autocuration,,A,13257,In vivo,,1,,,U,,14520,BAO_0000218,,0,,,2385.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,,CHEMBL627577,Muscle tissue
Autocuration,,A,13257,In vivo,,1,,,U,,14521,BAO_0000218,,0,,,2367.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),,CHEMBL627578,Prostate gland
Autocuration,,A,13257,In vivo,,1,,,U,,14522,BAO_0000218,,0,,,2367.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,,CHEMBL627579,Prostate gland
Autocuration,,A,13257,In vivo,,1,,,U,,14523,BAO_0000218,,0,,,2385.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,,CHEMBL627580,Muscle tissue
Autocuration,,A,13257,In vivo,,1,,,U,,14524,BAO_0000218,,0,,,2367.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),,CHEMBL627581,Prostate gland
Autocuration,,A,13257,In vivo,,1,,,U,,14525,BAO_0000218,,0,,,,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,,CHEMBL627582,
Autocuration,,A,13257,In vivo,,1,,,U,,14526,BAO_0000218,,0,,,2385.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,,CHEMBL627583,Muscle tissue
Autocuration,,A,13257,In vivo,,1,,,U,,14527,BAO_0000218,,0,,,2106.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,,CHEMBL627584,Spleen
Autocuration,,A,13257,In vivo,,1,,,U,,14528,BAO_0000218,,0,,,2367.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,,CHEMBL627585,Prostate gland
Autocuration,,A,13257,In vivo,,1,,,U,,14529,BAO_0000218,,0,,,2385.0,22224,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,,CHEMBL627586,Muscle tissue
Intermediate,,A,15413,In vivo,,1,,,N,,14530,BAO_0000218,,1,,10116.0,,50597,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,Rattus norvegicus,CHEMBL627587,
Intermediate,,A,15413,In vivo,,1,,,N,,14531,BAO_0000218,,1,,10116.0,,50597,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,CHEMBL627588,
Intermediate,,A,15413,In vivo,,1,,,N,,14532,BAO_0000218,,1,,10116.0,,50597,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,Rattus norvegicus,CHEMBL628250,
Intermediate,,A,15413,In vivo,,1,,,N,,14533,BAO_0000218,,1,,10116.0,,50597,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,CHEMBL628251,
Intermediate,,A,15413,In vivo,,1,,,N,,14534,BAO_0000218,,1,,10116.0,10000000.0,50597,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,Rattus norvegicus,CHEMBL628252,Hippocampus
Intermediate,,A,15413,In vivo,,1,,,N,,14535,BAO_0000218,,1,,10116.0,10000000.0,50597,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,CHEMBL628253,Hippocampus
Intermediate,,A,15413,In vivo,,1,,,N,,14536,BAO_0000218,,1,,10116.0,1898.0,50597,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,Rattus norvegicus,CHEMBL628254,Hypothalamus
Intermediate,,A,15413,In vivo,,1,,,N,,14537,BAO_0000218,,1,,10116.0,1898.0,50597,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,CHEMBL877493,Hypothalamus
Intermediate,,A,15413,In vivo,,1,,,N,,14538,BAO_0000218,,1,,10116.0,,50597,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,CHEMBL628255,
Intermediate,,A,15413,In vivo,,1,,,N,,14539,BAO_0000218,,1,,10116.0,,50597,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,CHEMBL628256,
Intermediate,,A,15413,In vivo,,1,,,N,,14540,BAO_0000218,,1,,10116.0,10000000.0,50597,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,CHEMBL628257,Hippocampus
Intermediate,,A,15413,In vivo,,1,,,N,,14541,BAO_0000218,,1,,10116.0,1898.0,50597,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,CHEMBL628258,Hypothalamus
Intermediate,,A,15413,In vivo,,1,,,N,,14542,BAO_0000218,,1,,10116.0,,50597,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,CHEMBL628259,
Intermediate,,A,15413,In vivo,,1,,,N,,14543,BAO_0000218,,1,,10116.0,,50597,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,CHEMBL628429,
Intermediate,,A,15413,In vivo,,1,,,N,,14544,BAO_0000218,,1,,10116.0,10000000.0,50597,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,CHEMBL626862,Hippocampus
Intermediate,,A,15413,In vivo,,1,,,N,,14545,BAO_0000218,,1,,10116.0,1898.0,50597,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,Rattus norvegicus,CHEMBL626863,Hypothalamus
Intermediate,,A,15413,In vivo,,1,,,N,,14546,BAO_0000218,,1,,10116.0,2037.0,50597,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,Rattus norvegicus,CHEMBL625886,Cerebellum
Intermediate,,A,15413,In vivo,,1,,,N,,14547,BAO_0000218,,1,,10116.0,2037.0,50597,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,Rattus norvegicus,CHEMBL625887,Cerebellum
Intermediate,,A,15413,In vivo,,1,,,N,,14548,BAO_0000218,,1,,10116.0,,50597,Biodistribution of the [11C]-radiolabeled compound in rat cortex,Rattus norvegicus,CHEMBL625888,
Intermediate,,A,15413,In vivo,,1,,,N,,14549,BAO_0000218,,1,,10116.0,,50597,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,Rattus norvegicus,CHEMBL625889,
Intermediate,,A,15413,In vivo,,1,,,N,,14550,BAO_0000218,,1,,10116.0,10000000.0,50597,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,Rattus norvegicus,CHEMBL625890,Hippocampus
Intermediate,,A,15413,In vivo,,1,,,N,,14551,BAO_0000218,,1,,10116.0,10000000.0,50597,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,Rattus norvegicus,CHEMBL625891,Hippocampus
Intermediate,,A,15413,In vivo,,1,,,N,,14552,BAO_0000218,,1,,10116.0,1898.0,50597,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,Rattus norvegicus,CHEMBL625892,Hypothalamus
Intermediate,,A,15413,In vivo,,1,,,N,,14553,BAO_0000218,,1,,10116.0,1898.0,50597,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,Rattus norvegicus,CHEMBL625893,Hypothalamus
Intermediate,,A,15413,In vivo,,1,,,N,,14554,BAO_0000218,,1,,10116.0,2037.0,50597,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,Rattus norvegicus,CHEMBL625894,Cerebellum
Intermediate,,A,15413,In vivo,,1,,,N,,14555,BAO_0000218,,1,,10116.0,,50597,Biodistribution of the [18F]-radiolabeled compound in rat cortex,Rattus norvegicus,CHEMBL625895,
Autocuration,,A,12404,,,1,,,U,,14556,BAO_0000019,,0,,,,22224,Reaction rate parameter value for phosphate with transfer with respect to ATP,,CHEMBL625896,
Autocuration,,A,568,,,1,,,U,,14557,BAO_0000019,,0,,,,22224,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",,CHEMBL625897,
Autocuration,,A,568,,,1,,,U,,14558,BAO_0000019,,0,,,,22224,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,CHEMBL625898,
Autocuration,,A,568,,,1,,,U,,14559,BAO_0000019,,0,,,,22224,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,CHEMBL625899,
Autocuration,,A,12404,,,1,,,U,,14560,BAO_0000019,,0,,,,22224,Reaction rate parameter value for phosphate with transfer with respect to ATP,,CHEMBL626124,
Intermediate,,A,7624,,,1,,,N,,14561,BAO_0000218,,1,,562.0,,50212,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,Escherichia coli,CHEMBL628500,
Intermediate,,A,7624,,,1,,,N,,14562,BAO_0000218,,1,,10116.0,,50597,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",Rattus norvegicus,CHEMBL857856,
Intermediate,,A,7624,,,1,,,N,,14563,BAO_0000218,,1,,10116.0,,50597,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",Rattus norvegicus,CHEMBL628501,
Autocuration,,A,4643,,,1,,,U,,14564,BAO_0000019,,0,,,,22224,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",,CHEMBL628502,
Autocuration,,A,11532,,,1,,,U,,14565,BAO_0000019,,0,,,,22224,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,,CHEMBL628503,
Autocuration,,A,11018,,,1,,,U,,14566,BAO_0000019,,0,,,,22224,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,,CHEMBL628504,
Autocuration,,A,2276,,,1,,,U,,14567,BAO_0000019,,0,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,CHEMBL628505,
Autocuration,,A,2276,,,1,,,U,,14568,BAO_0000019,,0,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",,CHEMBL874452,
Autocuration,,A,2276,,,1,,,U,,14569,BAO_0000019,,0,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",,CHEMBL628506,
Autocuration,,A,2276,,,1,,,U,,14570,BAO_0000019,,0,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,CHEMBL628507,
Autocuration,,A,2276,,,1,,,U,,14571,BAO_0000019,,0,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",,CHEMBL628508,
Autocuration,,A,8949,,,1,,,U,,14572,BAO_0000019,,0,,,,22224,Michaelis constant (KM) was evaluated,,CHEMBL628509,
Autocuration,,A,12404,,,1,,,U,,14573,BAO_0000019,,0,,,,22224,Reaction rate parameter value for phosphate with transfer with respect to ATP,,CHEMBL628510,
Autocuration,,B,7625,,,1,,,U,,14574,BAO_0000019,,0,,,,22224,Substrate concentration for half maximal velocity was reported for rat hexokinase I,,CHEMBL628511,
Autocuration,,B,7625,,,1,,,U,,14575,BAO_0000019,,0,,,,22224,Substrate concentration for half maximal velocity was reported for rat hexokinase II,,CHEMBL628512,
Autocuration,,B,7625,,,1,,,U,,14576,BAO_0000019,,0,,,,22224,Substrate concentration for half maximal velocity was reported for rat hexokinase III,,CHEMBL628513,
Autocuration,,B,7625,,,1,,,U,,14577,BAO_0000019,,0,,,,22224,Substrate concentration for half maximal velocity was reported for yeast hexokinase,,CHEMBL628514,
Autocuration,,A,12908,,,1,,,U,,14578,BAO_0000019,,0,,,,22224,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,,CHEMBL628515,
Autocuration,,A,10368,,,1,,,U,,14579,BAO_0000019,,0,,,,22224,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,,CHEMBL628516,
Autocuration,,A,13108,,,1,,,U,,14580,BAO_0000019,,0,,,,22224,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,CHEMBL628517,
Autocuration,,A,13108,,,1,,,U,,14581,BAO_0000019,,0,,,,22224,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,CHEMBL628518,
Autocuration,,A,15217,,,1,,,U,,14582,BAO_0000019,,0,,,,22224,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,,CHEMBL628519,
Autocuration,,A,15217,,,1,,,U,,14583,BAO_0000019,,0,,,,22224,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,,CHEMBL628520,
Autocuration,,A,10933,,,1,,,U,,14584,BAO_0000019,,0,,,,22224,Binding constant was determined,,CHEMBL628521,
Autocuration,,A,2363,,,1,,,U,,14585,BAO_0000019,,0,,,,22224,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,,CHEMBL630443,
Autocuration,,A,2363,,,1,,,U,,14586,BAO_0000019,,0,,,,22224,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,,CHEMBL630444,
Autocuration,,A,2276,,,1,,,U,,14587,BAO_0000019,,0,,,,22224,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,,CHEMBL857732,
Autocuration,,P,14915,,,1,,,U,,14588,BAO_0000100,,0,,,,22224,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,,CHEMBL630445,
Autocuration,,A,8847,,,1,,,U,,14589,BAO_0000019,,0,,,,22224,Catalytic rate constant of the compound,,CHEMBL630446,
Autocuration,,B,15357,,,1,,,U,,14590,BAO_0000019,,0,,,,22224,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,,CHEMBL630447,
Autocuration,,A,2869,,,1,,,U,,14591,BAO_0000019,,0,,,,22224,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),,CHEMBL630448,
Autocuration,,A,3484,,,1,,,U,,14592,BAO_0000019,,0,,,,22224,Catalytic rate constant against phospholipase A2 was determined,,CHEMBL630449,
Autocuration,,A,1373,,,1,,,U,,14593,BAO_0000019,,0,,,,22224,"Compound was evaluated for catalytic constant, Kcat",,CHEMBL630450,
Autocuration,,A,8142,,,1,,,U,,14594,BAO_0000019,,0,,,,22224,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,,CHEMBL630451,
Autocuration,,A,14131,,,1,,,U,,14595,BAO_0000019,,0,,,,22224,Kcat calculated from 0.693/T1/2,,CHEMBL630452,
Autocuration,,A,17269,,,1,,,U,,14596,BAO_0000019,,0,,,,22224,Kcat was determined,,CHEMBL630453,
Autocuration,,A,3485,,,1,,,U,,14597,BAO_0000019,,0,,,,22224,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,,CHEMBL630454,
Autocuration,,A,3485,,,1,,,U,,14598,BAO_0000019,,0,,,,22224,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,,CHEMBL630455,
Autocuration,,A,3485,,,1,,,U,,14599,BAO_0000019,,0,,,,22224,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,,CHEMBL631487,
Autocuration,,A,5962,,,1,,,U,,14600,BAO_0000019,,0,,,,22224,Kcat value was determined,,CHEMBL631488,
Autocuration,,A,3133,,,1,,,U,,14601,BAO_0000019,,0,,,,22224,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,,CHEMBL876440,
Autocuration,,A,3133,,,1,,,U,,14602,BAO_0000019,,0,,,,22224,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,,CHEMBL631489,
Autocuration,,A,2276,,,1,,,U,,14603,BAO_0000019,,0,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,CHEMBL857742,
Autocuration,,A,2276,,,1,,,U,,14604,BAO_0000019,,0,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",,CHEMBL631490,
Autocuration,,A,2276,,,1,,,U,,14605,BAO_0000019,,0,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",,CHEMBL631491,
Autocuration,,A,2276,,,1,,,U,,14606,BAO_0000019,,0,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,CHEMBL631492,
Autocuration,,A,2276,,,1,,,U,,14607,BAO_0000019,,0,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",,CHEMBL631493,
Autocuration,,A,4892,,,1,,,U,,14608,BAO_0000019,,0,,,,22224,Kinetic parameter for rate of conversion to PABA was determined,,CHEMBL631494,
Autocuration,,A,3133,,,1,,,U,,14609,BAO_0000019,,0,,,,22224,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,CHEMBL631495,
Intermediate,,A,11488,,,1,,,N,,14610,BAO_0000218,,1,,10116.0,1988.0,50597,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",Rattus norvegicus,CHEMBL631496,Feces
Intermediate,,A,11488,,,1,,,N,,14611,BAO_0000218,,1,,10116.0,1088.0,50597,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",Rattus norvegicus,CHEMBL631497,Urine
Intermediate,,A,11488,,,1,,,N,,14612,BAO_0000218,,1,,10116.0,1088.0,50597,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",Rattus norvegicus,CHEMBL631498,Urine
Intermediate,,A,11488,,,1,,,N,,14613,BAO_0000218,,1,,10116.0,1088.0,50597,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",Rattus norvegicus,CHEMBL629776,Urine
Intermediate,,A,11488,,,1,,,N,,14614,BAO_0000218,,1,,10116.0,1088.0,50597,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",Rattus norvegicus,CHEMBL629777,Urine
Intermediate,,A,11488,,,1,,,N,,14615,BAO_0000218,,1,,10116.0,1088.0,50597,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",Rattus norvegicus,CHEMBL629778,Urine
Intermediate,,A,11488,,,1,,,N,,14616,BAO_0000218,,1,,10116.0,,50597,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,Rattus norvegicus,CHEMBL630456,
Intermediate,,A,11488,,,1,,,N,,14617,BAO_0000218,,1,,10116.0,,50597,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,Rattus norvegicus,CHEMBL630457,
Intermediate,,A,11488,,,1,,,N,,14618,BAO_0000218,,1,,10116.0,,50597,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,Rattus norvegicus,CHEMBL630458,
Intermediate,,A,11488,,,1,,,N,,14619,BAO_0000218,,1,,10116.0,,50597,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,Rattus norvegicus,CHEMBL630459,
Intermediate,,A,11488,,,1,,,N,,14620,BAO_0000218,,1,,10116.0,,50597,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,Rattus norvegicus,CHEMBL630460,
Intermediate,,A,11488,,,1,,,N,,14621,BAO_0000218,,1,,10116.0,,50597,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,Rattus norvegicus,CHEMBL876550,
Intermediate,,A,11488,,,1,,,N,,14622,BAO_0000218,,1,,10116.0,,50597,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,Rattus norvegicus,CHEMBL630461,
Intermediate,,A,11488,,,1,,,N,,14623,BAO_0000218,,1,,10116.0,,50597,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,Rattus norvegicus,CHEMBL630462,
Intermediate,,A,11488,,,1,,,N,,14624,BAO_0000218,,1,,10116.0,,50597,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,Rattus norvegicus,CHEMBL630463,
Intermediate,,A,11488,,,1,,,N,,14625,BAO_0000218,,1,,10116.0,,50597,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,Rattus norvegicus,CHEMBL630464,
Intermediate,,A,11488,,,1,,,N,,14626,BAO_0000218,,1,,10116.0,,50597,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,Rattus norvegicus,CHEMBL630465,
Intermediate,,A,11488,,,1,,,N,,14627,BAO_0000218,,1,,10116.0,,50597,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,Rattus norvegicus,CHEMBL630466,
Intermediate,,A,11488,,,1,,,N,,14628,BAO_0000218,,1,,10116.0,,50597,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,Rattus norvegicus,CHEMBL630467,
Intermediate,,A,11488,,,1,,,N,,14629,BAO_0000218,,1,,10116.0,,50597,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,Rattus norvegicus,CHEMBL630633,
Intermediate,,A,11488,,,1,,,N,,14630,BAO_0000218,,1,,10116.0,,50597,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,Rattus norvegicus,CHEMBL630634,
Intermediate,,A,11488,,,1,,,N,,14631,BAO_0000218,,1,,10116.0,,50597,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,Rattus norvegicus,CHEMBL630635,
Intermediate,,A,11488,,,1,,,N,,14632,BAO_0000218,,1,,10116.0,,50597,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,Rattus norvegicus,CHEMBL630636,
Intermediate,,A,11488,,,1,,,N,,14633,BAO_0000218,,1,,10116.0,,50597,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,Rattus norvegicus,CHEMBL630637,
Intermediate,,A,7132,,,1,,,N,,14634,BAO_0000218,,1,,9986.0,1988.0,50592,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",Oryctolagus cuniculus,CHEMBL630638,Feces
Intermediate,,A,7132,,,1,,,N,,14635,BAO_0000218,,1,,9986.0,1988.0,50592,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",Oryctolagus cuniculus,CHEMBL630639,Feces
Intermediate,,A,7132,,,1,,,N,,14636,BAO_0000218,,1,,9986.0,1988.0,50592,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",Oryctolagus cuniculus,CHEMBL630640,Feces
Intermediate,,A,7132,,,1,,,N,,14637,BAO_0000218,,1,,9986.0,1988.0,50592,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",Oryctolagus cuniculus,CHEMBL876551,Feces
Intermediate,,A,7132,,,1,,,N,,14638,BAO_0000218,,1,,9986.0,1088.0,50592,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",Oryctolagus cuniculus,CHEMBL630641,Urine
Intermediate,,A,7132,,,1,,,N,,14639,BAO_0000218,,1,,9986.0,1088.0,50592,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",Oryctolagus cuniculus,CHEMBL630642,Urine
Intermediate,,A,7132,,,1,,,N,,14640,BAO_0000218,,1,,9986.0,1088.0,50592,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",Oryctolagus cuniculus,CHEMBL630643,Urine
Intermediate,,A,7132,,,1,,,N,,14641,BAO_0000218,,1,,9986.0,1088.0,50592,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",Oryctolagus cuniculus,CHEMBL630644,Urine
Intermediate,,A,7132,,,1,,,N,,14642,BAO_0000218,,1,,9986.0,1088.0,50592,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",Oryctolagus cuniculus,CHEMBL630645,Urine
Intermediate,,A,7132,,,1,,,N,,14643,BAO_0000218,,1,,9986.0,1988.0,50592,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",Oryctolagus cuniculus,CHEMBL625599,Feces
Intermediate,,A,7132,,,1,,,N,,14644,BAO_0000218,,1,,9986.0,1988.0,50592,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",Oryctolagus cuniculus,CHEMBL625600,Feces
Intermediate,,A,7132,,,1,,,N,,14645,BAO_0000218,,1,,9986.0,1988.0,50592,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",Oryctolagus cuniculus,CHEMBL625601,Feces
Intermediate,,A,7132,,,1,,,N,,14646,BAO_0000218,,1,,9986.0,1988.0,50592,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",Oryctolagus cuniculus,CHEMBL625602,Feces
Intermediate,,A,7132,,,1,,,N,,14647,BAO_0000218,,1,,9986.0,1088.0,50592,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",Oryctolagus cuniculus,CHEMBL627470,Urine
Intermediate,,A,7132,,,1,,,N,,14648,BAO_0000218,,1,,9986.0,1088.0,50592,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",Oryctolagus cuniculus,CHEMBL627471,Urine
Intermediate,,A,7132,,,1,,,N,,14649,BAO_0000218,,1,,9986.0,1088.0,50592,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",Oryctolagus cuniculus,CHEMBL627472,Urine
Intermediate,,A,7132,,,1,,,N,,14650,BAO_0000218,,1,,9986.0,1088.0,50592,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",Oryctolagus cuniculus,CHEMBL627473,Urine
Intermediate,,A,7132,,,1,,,N,,14651,BAO_0000218,,1,,9986.0,1088.0,50592,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",Oryctolagus cuniculus,CHEMBL627474,Urine
Intermediate,,A,13925,In vivo,,1,,,N,,14652,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,CHEMBL627475,Blood
Intermediate,,A,13925,In vivo,,1,,,N,,14653,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,CHEMBL627476,Blood
Intermediate,,A,12582,,,1,,,N,,14654,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Canis lupus familiaris,CHEMBL627477,Urine
Intermediate,,A,12582,,,1,,,N,,14655,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Canis lupus familiaris,CHEMBL627478,Urine
Intermediate,,A,12582,,,1,,,N,,14656,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Canis lupus familiaris,CHEMBL627479,Urine
Intermediate,,A,12582,,,1,,,N,,14657,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Canis lupus familiaris,CHEMBL627480,Urine
Intermediate,,A,12582,,,1,,,N,,14658,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Canis lupus familiaris,CHEMBL627481,Urine
Intermediate,,A,12582,,,1,,,N,,14659,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Canis lupus familiaris,CHEMBL627482,Urine
Intermediate,,A,12582,,,1,,,N,,14660,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Canis lupus familiaris,CHEMBL627483,Urine
Intermediate,,A,12582,,,1,,,N,,14661,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Canis lupus familiaris,CHEMBL875636,Urine
Intermediate,,A,12582,,,1,,,N,,14662,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Canis lupus familiaris,CHEMBL625764,Urine
Intermediate,,A,12582,,,1,,,N,,14663,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Canis lupus familiaris,CHEMBL625765,Urine
Intermediate,,A,12582,,,1,,,N,,14664,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,Canis lupus familiaris,CHEMBL625766,Urine
Intermediate,,A,12582,,,1,,,N,,14665,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Canis lupus familiaris,CHEMBL625767,Urine
Intermediate,,A,12582,,,1,,,N,,14666,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Canis lupus familiaris,CHEMBL625768,Urine
Intermediate,,A,12582,,,1,,,N,,14667,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,Canis lupus familiaris,CHEMBL625769,Urine
Intermediate,,A,12582,,,1,,,N,,14668,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,Canis lupus familiaris,CHEMBL625770,Urine
Intermediate,,A,12582,,,1,,,N,,14669,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,Canis lupus familiaris,CHEMBL625771,Urine
Intermediate,,A,12582,,,1,,,N,,14670,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,Canis lupus familiaris,CHEMBL625772,Urine
Intermediate,,A,12582,,,1,,,N,,14671,BAO_0000218,,1,,9615.0,1088.0,50588,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Canis lupus familiaris,CHEMBL625773,Urine
Intermediate,,A,12582,,,1,,,N,,14672,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,Rattus norvegicus,CHEMBL625774,Urine
Intermediate,,A,12582,,,1,,,N,,14673,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,Rattus norvegicus,CHEMBL625775,Urine
Intermediate,,A,12582,,,1,,,N,,14674,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,Rattus norvegicus,CHEMBL625776,Urine
Intermediate,,A,12582,,,1,,,N,,14675,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,Rattus norvegicus,CHEMBL625777,Urine
Intermediate,,A,12582,,,1,,,N,,14676,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,Rattus norvegicus,CHEMBL625778,Urine
Intermediate,,A,12582,,,1,,,N,,14677,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,Rattus norvegicus,CHEMBL625779,Urine
Intermediate,,A,12582,,,1,,,N,,14678,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,Rattus norvegicus,CHEMBL625780,Urine
Intermediate,,A,12582,,,1,,,N,,14679,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,Rattus norvegicus,CHEMBL625781,Urine
Intermediate,,A,12582,,,1,,,N,,14680,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,Rattus norvegicus,CHEMBL875637,Urine
Intermediate,,A,12582,,,1,,,N,,14681,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,Rattus norvegicus,CHEMBL626473,Urine
Intermediate,,A,12582,,,1,,,N,,14682,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,Rattus norvegicus,CHEMBL626474,Urine
Intermediate,,A,12582,,,1,,,N,,14683,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,Rattus norvegicus,CHEMBL626475,Urine
Intermediate,,A,12582,,,1,,,N,,14684,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,Rattus norvegicus,CHEMBL626476,Urine
Intermediate,,A,12582,,,1,,,N,,14685,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,Rattus norvegicus,CHEMBL634397,Urine
Intermediate,,A,12582,,,1,,,N,,14686,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,Rattus norvegicus,CHEMBL626477,Urine
Intermediate,,A,12582,,,1,,,N,,14687,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,Rattus norvegicus,CHEMBL631069,Urine
Intermediate,,A,12582,,,1,,,N,,14688,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,Rattus norvegicus,CHEMBL631070,Urine
Intermediate,,A,12582,,,1,,,N,,14689,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,Rattus norvegicus,CHEMBL631071,Urine
Intermediate,,A,12582,,,1,,,N,,14690,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,Rattus norvegicus,CHEMBL631072,Urine
Intermediate,,A,12582,,,1,,,N,,14691,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,Rattus norvegicus,CHEMBL631073,Urine
Intermediate,,A,12582,,,1,,,N,,14692,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,Rattus norvegicus,CHEMBL631074,Urine
Intermediate,,A,12582,,,1,,,N,,14693,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,Rattus norvegicus,CHEMBL631075,Urine
Intermediate,,A,12582,,,1,,,N,,14694,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,Rattus norvegicus,CHEMBL631725,Urine
Intermediate,,A,12582,,,1,,,N,,14695,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,Rattus norvegicus,CHEMBL631726,Urine
Intermediate,,A,12582,,,1,,,N,,14696,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,Rattus norvegicus,CHEMBL631727,Urine
Intermediate,,A,12582,,,1,,,N,,14697,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,Rattus norvegicus,CHEMBL631728,Urine
Intermediate,,A,12582,,,1,,,N,,14698,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,Rattus norvegicus,CHEMBL631729,Urine
Intermediate,,A,12582,,,1,,,N,,14699,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,Rattus norvegicus,CHEMBL631730,Urine
Intermediate,,A,12582,,,1,,,N,,14700,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,Rattus norvegicus,CHEMBL631731,Urine
Intermediate,,A,12582,,,1,,,N,,14701,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,Rattus norvegicus,CHEMBL631910,Urine
Intermediate,,A,15413,In vivo,,1,,,N,,14702,BAO_0000218,,1,,10116.0,10000000.0,50597,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,Rattus norvegicus,CHEMBL631911,Hippocampus
Intermediate,,A,15413,In vivo,,1,,,N,,14703,BAO_0000218,,1,,10116.0,1898.0,50597,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,Rattus norvegicus,CHEMBL631912,Hypothalamus
Intermediate,,A,15413,In vivo,,1,,,N,,14704,BAO_0000218,,1,,10116.0,1898.0,50597,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,Rattus norvegicus,CHEMBL631913,Hypothalamus
Intermediate,,A,12017,In vivo,,1,,,N,,14705,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL631914,Blood
Intermediate,,A,12017,In vivo,,1,,,N,,14706,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL631915,Blood
Intermediate,,A,12017,In vivo,,1,,,N,,14707,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,CHEMBL875778,Blood
Intermediate,,A,12017,In vivo,,1,,,N,,14708,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL631916,Blood
Intermediate,,A,12017,In vivo,,1,,,N,,14709,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL631917,Blood
Intermediate,,A,12017,In vivo,,1,,,N,,14710,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL631918,Blood
Intermediate,,A,12017,In vivo,,1,,,N,,14711,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL631919,Blood
Intermediate,,A,12017,In vivo,,1,,,N,,14712,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,CHEMBL631920,Blood
Intermediate,,A,12017,In vivo,,1,,,N,,14713,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL631921,Blood
Intermediate,,A,12017,In vivo,,1,,,N,,14714,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL631922,Blood
Intermediate,,A,12017,In vivo,,1,,,N,,14715,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,CHEMBL631923,Blood
Intermediate,,A,12017,In vivo,,1,,,N,,14716,BAO_0000218,,1,,10116.0,,50597,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL631924,
Intermediate,,A,12017,In vivo,,1,,,N,,14717,BAO_0000218,,1,,10116.0,,50597,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630234,
Intermediate,,A,12017,In vivo,,1,,,N,,14718,BAO_0000218,,1,,10116.0,,50597,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,CHEMBL630235,
Intermediate,,A,12017,In vivo,,1,,,N,,14719,BAO_0000218,,1,,10116.0,,50597,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630236,
Intermediate,,A,12017,In vivo,,1,,,N,,14720,BAO_0000218,,1,,10116.0,,50597,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630237,
Intermediate,,A,12017,In vivo,,1,,,N,,14721,BAO_0000218,,1,,10116.0,,50597,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630238,
Intermediate,,A,12017,In vivo,,1,,,N,,14722,BAO_0000218,,1,,10116.0,,50597,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630239,
Intermediate,,A,12017,In vivo,,1,,,N,,14723,BAO_0000218,,1,,10116.0,,50597,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,CHEMBL630303,
Intermediate,,A,12017,In vivo,,1,,,N,,14724,BAO_0000218,,1,,10116.0,,50597,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630304,
Intermediate,,A,12017,In vivo,,1,,,N,,14725,BAO_0000218,,1,,10116.0,,50597,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630305,
Intermediate,,A,12017,In vivo,,1,,,N,,14726,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630306,Kidney
Intermediate,,A,12017,In vivo,,1,,,N,,14727,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630307,Kidney
Intermediate,,A,12017,In vivo,,1,,,N,,14728,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,CHEMBL630308,Kidney
Intermediate,,A,12017,In vivo,,1,,,N,,14729,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630309,Kidney
Intermediate,,A,12017,In vivo,,1,,,N,,14730,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL629309,Kidney
Intermediate,,A,12017,In vivo,,1,,,N,,14731,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL629993,Kidney
Intermediate,,A,12017,In vivo,,1,,,N,,14732,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL629994,Kidney
Intermediate,,A,12017,In vivo,,1,,,N,,14733,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,CHEMBL629995,Kidney
Intermediate,,A,12017,In vivo,,1,,,N,,14734,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL631993,Kidney
Intermediate,,A,12017,In vivo,,1,,,N,,14735,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL631994,Kidney
Intermediate,,A,12017,In vivo,,1,,,N,,14736,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL631995,Kidney
Intermediate,,A,12017,In vivo,,1,,,N,,14737,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,CHEMBL631996,Liver
Intermediate,,A,12017,In vivo,,1,,,N,,14738,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL631997,Liver
Intermediate,,A,12017,In vivo,,1,,,N,,14739,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL631998,Liver
Intermediate,,A,12017,In vivo,,1,,,N,,14740,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL631999,Liver
Intermediate,,A,12017,In vivo,,1,,,N,,14741,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,CHEMBL632000,Liver
Intermediate,,A,12017,In vivo,,1,,,N,,14742,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL632001,Liver
Intermediate,,A,12017,In vivo,,1,,,N,,14743,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL874424,Liver
Intermediate,,A,12017,In vivo,,1,,,N,,14744,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL632002,Liver
Intermediate,,A,12017,In vivo,,1,,,N,,14745,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL632003,Liver
Autocuration,,A,3133,,,1,,,U,,14746,BAO_0000019,,0,,,,22224,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,CHEMBL632004,
Autocuration,,A,2742,,,1,,,U,,14747,BAO_0000019,,0,,,,22224,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,,CHEMBL632005,
Autocuration,,A,2742,,,1,,,U,,14748,BAO_0000019,,0,,,,22224,Compound was tested for amidase rate in the presence of N62C screen enzyme,,CHEMBL632006,
Autocuration,,A,2742,,,1,,,U,,14749,BAO_0000019,,0,,,,22224,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,,CHEMBL632007,
Autocuration,,A,2742,,,1,,,U,,14750,BAO_0000019,,0,,,,22224,Compound was tested for amidase rate in the presence of S166C screen enzyme,,CHEMBL632008,
Autocuration,,A,2742,,,1,,,U,,14751,BAO_0000019,,0,,,,22224,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,,CHEMBL632009,
Autocuration,,A,2742,,,1,,,U,,14752,BAO_0000019,,0,,,,22224,Compound was tested for esterase rate in the presence of N62C screen enzyme,,CHEMBL632010,
Autocuration,,A,2742,,,1,,,U,,14753,BAO_0000019,,0,,,,22224,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,,CHEMBL857750,
Autocuration,,A,2742,,,1,,,U,,14754,BAO_0000019,,0,,,,22224,Compound was tested for esterase rate in the presence of S166C screen enzyme,,CHEMBL632011,
Autocuration,,A,2276,,,1,,,U,,14755,BAO_0000019,,0,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,CHEMBL632012,
Autocuration,,A,2276,,,1,,,U,,14756,BAO_0000019,,0,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,CHEMBL632013,
Autocuration,,A,2276,,,1,,,U,,14757,BAO_0000019,,0,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",,CHEMBL632014,
Autocuration,,A,2276,,,1,,,U,,14758,BAO_0000019,,0,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,CHEMBL629622,
Autocuration,,A,2276,,,1,,,U,,14759,BAO_0000019,,0,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,CHEMBL629623,
Autocuration,,A,2276,,,1,,,U,,14760,BAO_0000019,,0,,,,22224,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",,CHEMBL629624,
Autocuration,,A,17269,,,1,,,U,,14761,BAO_0000019,,0,,,,22224,Ratio of Kcat to that of Km was determined,,CHEMBL629625,
Autocuration,,A,2276,,,1,,,U,,14762,BAO_0000019,,0,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,CHEMBL629626,
Autocuration,,A,2276,,,1,,,U,,14763,BAO_0000019,,0,,,,22224,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,CHEMBL629627,
Autocuration,,A,15917,,,1,,,U,,14764,BAO_0000019,,0,,,,22224,"Compound was evaluated for constant, Kd",,CHEMBL629628,
Autocuration,,A,10933,,,1,,,U,,14765,BAO_0000019,,0,,,,22224,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,,CHEMBL629629,
Autocuration,,A,10933,,,1,,,U,,14766,BAO_0000019,,0,,,,22224,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,,CHEMBL629630,
Autocuration,,A,14293,,,1,,,U,,14767,BAO_0000019,,0,,,,22224,Dissociation Constant of compound determined,,CHEMBL856030,
Autocuration,,B,6698,,,1,,,U,,14768,BAO_0000019,,0,,,,22224,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,,CHEMBL629631,
Autocuration,,B,6698,,,1,,,U,,14769,BAO_0000019,,0,,,,22224,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,,CHEMBL629632,
Autocuration,,P,4318,,,1,,,U,,14770,BAO_0000100,,0,,,,22224,Dissociation constant of compound with Fructose was determined,,CHEMBL629633,
Autocuration,,P,4318,,,1,,,U,,14771,BAO_0000100,,0,,,,22224,Dissociation constant of compound with Fructose was determined; Not determined,,CHEMBL629634,
Autocuration,,P,4318,,,1,,,U,,14772,BAO_0000100,,0,,,,22224,Dissociation constant of compound with Lactulose was determined,,CHEMBL629635,
Autocuration,,P,4318,,,1,,,U,,14773,BAO_0000100,,0,,,,22224,Dissociation constant of compound with Lactulose was determined; Not determined,,CHEMBL629636,
Autocuration,,P,14959,,,1,,,U,,14774,BAO_0000100,,0,,,,22224,Dissociation constant of the Compound,,CHEMBL629637,
Autocuration,,P,5913,,,1,,,U,,14775,BAO_0000100,,0,,,,22224,Dissociation constant by non-linear regression analysis,,CHEMBL629638,
Autocuration,,P,14218,,,1,,,U,,14776,BAO_0000100,,0,,,,22224,Dissociation constant was determined,,CHEMBL629639,
Autocuration,,P,10689,,,1,,,U,,14777,BAO_0000100,,0,,,,22224,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,,CHEMBL629640,
Autocuration,,P,13925,,,1,,,U,,14778,BAO_0000100,,0,,,,22224,Dissociation constant was determined,,CHEMBL629641,
Autocuration,,P,16359,,,1,,,U,,14779,BAO_0000100,,0,,,,22224,Dissociation constant was determined,,CHEMBL631344,
Intermediate,,A,10944,,,1,,,N,,14780,BAO_0000218,,1,,10116.0,2385.0,50597,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,Rattus norvegicus,CHEMBL631345,Muscle tissue
Autocuration,,A,11080,,,1,,,U,,14781,BAO_0000019,,0,,,,22224,The dissociation constant determined by fluorescence displacement assay,,CHEMBL631346,
Autocuration,,A,17805,,,1,,,U,,14782,BAO_0000019,,0,,,,22224,kd value surface plasmon resonance (SPR) method,,CHEMBL631524,
Intermediate,,A,10944,,,1,,,N,,14783,BAO_0000218,,1,,10116.0,2385.0,50597,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,Rattus norvegicus,CHEMBL631525,Muscle tissue
Autocuration,,F,16645,,,1,,,U,,14784,BAO_0000019,,0,,,,22224,First dissociation constant of the binding of compound to V30M TTR,,CHEMBL631526,
Autocuration,,F,16645,,,1,,,U,,14785,BAO_0000019,,0,,,,22224,Second dissociation constant of the binding of compound to V30M TTR,,CHEMBL631527,
Autocuration,,A,7793,,,1,,,U,,14786,BAO_0000019,,0,,,,22224,"Compound was evaluated for equilibrium constant, Ke",,CHEMBL631528,
Autocuration,,A,12199,,,1,,,U,,14787,BAO_0000019,,0,,,1898.0,22224,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,,CHEMBL631529,Hypothalamus
Autocuration,,A,12199,,,1,,,U,,14788,BAO_0000019,,0,,,1898.0,22224,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,,CHEMBL631530,Hypothalamus
Autocuration,,A,9680,,,1,,,U,,14789,BAO_0000019,,0,,,,22224,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,,CHEMBL631531,
Autocuration,,A,9680,,,1,,,U,,14790,BAO_0000019,,0,,,,22224,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,,CHEMBL631532,
Autocuration,,A,9680,,,1,,,U,,14791,BAO_0000019,,0,,,,22224,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,,CHEMBL631533,
Intermediate,,A,13758,,,1,,,N,,14792,BAO_0000218,,1,,10090.0,,50594,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Mus musculus,CHEMBL876552,
Intermediate,,A,13758,,,1,,,N,,14793,BAO_0000218,,1,,10090.0,,50594,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,Mus musculus,CHEMBL631534,
Intermediate,,A,13758,,,1,,,N,,14794,BAO_0000218,,1,,10090.0,,50594,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Mus musculus,CHEMBL631535,
Intermediate,,A,13758,,,1,,,N,,14795,BAO_0000218,,1,,10090.0,,50594,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Mus musculus,CHEMBL631536,
Intermediate,,A,13758,,,1,,,N,,14796,BAO_0000218,,1,,10090.0,,50594,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,Mus musculus,CHEMBL631537,
Intermediate,,A,13758,,,1,,,N,,14797,BAO_0000218,,1,,10090.0,,50594,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,Mus musculus,CHEMBL631538,
Intermediate,,A,13758,,,1,,,N,,14798,BAO_0000218,,1,,10090.0,,50594,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,Mus musculus,CHEMBL631539,
Intermediate,,A,13758,,,1,,,N,,14799,BAO_0000218,,1,,10090.0,,50594,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Mus musculus,CHEMBL631540,
Intermediate,,A,14393,,,1,,,N,,14800,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Rattus norvegicus,CHEMBL625637,
Intermediate,,A,14393,,,1,,,N,,14801,BAO_0000218,,1,,10116.0,,50597,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Rattus norvegicus,CHEMBL625638,
Intermediate,,A,15078,,,1,,,N,,14802,BAO_0000218,,1,,10116.0,,50597,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,CHEMBL625639,
Intermediate,,A,13925,In vivo,,1,,,N,,14803,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,CHEMBL625640,Brain
Intermediate,,A,13925,In vivo,,1,,,N,,14804,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,CHEMBL625641,Brain
Intermediate,,A,13925,In vivo,,1,,,N,,14805,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,CHEMBL625642,Heart
Intermediate,,A,13925,In vivo,,1,,,N,,14806,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,CHEMBL625643,Heart
Intermediate,,A,13925,In vivo,,1,,,N,,14807,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,CHEMBL625644,Kidney
Intermediate,,A,13925,In vivo,,1,,,N,,14808,BAO_0000218,,1,,10116.0,2113.0,50597,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,CHEMBL625645,Kidney
Intermediate,,A,13925,In vivo,,1,,,N,,14809,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,CHEMBL625646,Liver
Intermediate,,A,13925,In vivo,,1,,,N,,14810,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,CHEMBL625647,Liver
Intermediate,,A,13925,In vivo,,1,,,N,,14811,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,CHEMBL625648,Lung
Intermediate,,A,13925,In vivo,,1,,,N,,14812,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,CHEMBL625649,Lung
Intermediate,,A,13925,In vivo,,1,,,N,,14813,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,CHEMBL625650,Muscle tissue
Intermediate,,A,13925,In vivo,,1,,,N,,14814,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,CHEMBL625651,Muscle tissue
Intermediate,,A,13925,In vivo,,1,,,N,,14815,BAO_0000218,,1,,10116.0,14.0,50597,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,CHEMBL625652,Zone of skin
Intermediate,,A,13925,In vivo,,1,,,N,,14816,BAO_0000218,,1,,10116.0,14.0,50597,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,CHEMBL625653,Zone of skin
Intermediate,,A,13925,In vivo,,1,,,N,,14817,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,CHEMBL625654,Spleen
Intermediate,,A,13925,In vivo,,1,,,N,,14818,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,CHEMBL625655,Spleen
Intermediate,,A,9712,In vivo,,1,,,N,,14819,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution of Compound in rat blood after 15 minutes of administration,Rattus norvegicus,CHEMBL625656,Blood
Intermediate,,A,9712,In vivo,,1,,,N,,14820,BAO_0000218,,1,,10116.0,178.0,50597,Biodistribution of Compound in rat blood after 2 minutes of administration,Rattus norvegicus,CHEMBL625657,Blood
Intermediate,,A,9712,In vivo,,1,,,N,,14821,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution of Compound in rat brain after 15 minutes of administration,Rattus norvegicus,CHEMBL625658,Brain
Intermediate,,A,9712,In vivo,,1,,,N,,14822,BAO_0000218,,1,,10116.0,955.0,50597,Biodistribution of Compound in rat brain after 2 minutes of administration,Rattus norvegicus,CHEMBL625659,Brain
Intermediate,,A,9712,In vivo,,1,,,N,,14823,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution of Compound in rat heart after 15 minutes of administration,Rattus norvegicus,CHEMBL625660,Heart
Intermediate,,A,9712,In vivo,,1,,,N,,14824,BAO_0000218,,1,,10116.0,948.0,50597,Biodistribution of Compound in rat heart after 2 minutes of administration,Rattus norvegicus,CHEMBL625661,Heart
Intermediate,,A,9712,In vivo,,1,,,N,,14825,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution of Compound in rat liver after 15 minutes of administration,Rattus norvegicus,CHEMBL625662,Liver
Intermediate,,A,9712,In vivo,,1,,,N,,14826,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution of Compound in rat liver after 2 minutes of administration,Rattus norvegicus,CHEMBL625663,Liver
Intermediate,,A,9712,In vivo,,1,,,N,,14827,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution of Compound in rat lung after 15 minutes of administration,Rattus norvegicus,CHEMBL875621,Lung
Intermediate,,A,9712,In vivo,,1,,,N,,14828,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution of Compound in rat lung after 2 minutes of administration,Rattus norvegicus,CHEMBL628382,Lung
Intermediate,,A,9712,In vivo,,1,,,N,,14829,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution of Compound in rat muscle after 15 minutes of administration,Rattus norvegicus,CHEMBL628383,Muscle tissue
Intermediate,,A,9712,In vivo,,1,,,N,,14830,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution of Compound in rat muscle after 2 minutes of administration,Rattus norvegicus,CHEMBL628384,Muscle tissue
Intermediate,,A,13925,,,1,,,N,,14831,BAO_0000218,,1,,10116.0,,50597,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,Rattus norvegicus,CHEMBL628385,
Intermediate,,A,13925,,,1,,,N,,14832,BAO_0000218,,1,,10116.0,,50597,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,Rattus norvegicus,CHEMBL875753,
Intermediate,,A,13925,,,1,,,N,,14833,BAO_0000218,,1,,10116.0,,50597,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,Rattus norvegicus,CHEMBL628386,
Intermediate,,A,6941,,,1,,,N,,14834,BAO_0000218,,1,,10116.0,,50597,Organ distribution in rat blood 2 minutes after intravenous injection,Rattus norvegicus,CHEMBL628387,
Intermediate,,A,6941,,,1,,,N,,14835,BAO_0000218,,1,,10116.0,,50597,Organ distribution in rat blood 2 hr after intravenous injection,Rattus norvegicus,CHEMBL628388,
Intermediate,,A,6941,,,1,,,N,,14836,BAO_0000218,,1,,10116.0,,50597,Organ distribution in rat blood 30 minutes after intravenous injection,Rattus norvegicus,CHEMBL628389,
Intermediate,,A,6941,,,1,,,N,,14837,BAO_0000218,,1,,10116.0,,50597,Organ distribution in rat blood 30 min after intravenous injection,Rattus norvegicus,CHEMBL632756,
Intermediate,,A,6941,,,1,,,N,,14838,BAO_0000218,,1,,10116.0,,50597,Organ distribution in rat brain 2 minutes after intravenous injection,Rattus norvegicus,CHEMBL628390,
Intermediate,,A,6941,,,1,,,N,,14839,BAO_0000218,,1,,10116.0,,50597,Organ distribution in rat brain 2 hr after intravenous injection,Rattus norvegicus,CHEMBL631811,
Intermediate,,A,6941,,,1,,,N,,14840,BAO_0000218,,1,,10116.0,,50597,Organ distribution in rat brain 30 minutes after intravenous injection,Rattus norvegicus,CHEMBL631812,
Intermediate,,A,6941,,,1,,,N,,14841,BAO_0000218,,1,,10116.0,,50597,Organ distribution in rat heart 2 minutes after intravenous injection,Rattus norvegicus,CHEMBL631813,
Intermediate,,A,6941,,,1,,,N,,14842,BAO_0000218,,1,,10116.0,,50597,Organ distribution in rat heart 2 hr after intravenous injection,Rattus norvegicus,CHEMBL631814,
Intermediate,,A,6941,,,1,,,N,,14843,BAO_0000218,,1,,10116.0,,50597,Organ distribution in rat heart 30 minutes after intravenous injection,Rattus norvegicus,CHEMBL631815,
Intermediate,,A,6941,,,1,,,N,,14844,BAO_0000218,,1,,10116.0,,50597,Organ distribution in rat kidney 2 minutes after intravenous injection,Rattus norvegicus,CHEMBL631816,
Intermediate,,A,6941,,,1,,,N,,14845,BAO_0000218,,1,,10116.0,,50597,Organ distribution in rat kidney 2 hr after intravenous injection,Rattus norvegicus,CHEMBL875758,
Intermediate,,A,6941,,,1,,,N,,14846,BAO_0000218,,1,,10116.0,,50597,Organ distribution in rat kidney 30 minutes after intravenous injection,Rattus norvegicus,CHEMBL631817,
Intermediate,,A,6941,,,1,,,N,,14847,BAO_0000218,,1,,10116.0,2107.0,50597,Organ distribution in rat liver 2 minutes after intravenous injection,Rattus norvegicus,CHEMBL631818,Liver
Intermediate,,A,6941,,,1,,,N,,14848,BAO_0000218,,1,,10116.0,2107.0,50597,Organ distribution in rat liver 2 hr after intravenous injection,Rattus norvegicus,CHEMBL631819,Liver
Intermediate,,A,6941,,,1,,,N,,14849,BAO_0000218,,1,,10116.0,2107.0,50597,Organ distribution in rat liver 30 minutes after intravenous injection,Rattus norvegicus,CHEMBL631820,Liver
Intermediate,,A,6941,,,1,,,N,,14850,BAO_0000218,,1,,10116.0,,50597,Organ distribution in rat lung 2 minutes after intravenous injection,Rattus norvegicus,CHEMBL631821,
Intermediate,,A,6941,,,1,,,N,,14851,BAO_0000218,,1,,10116.0,,50597,Organ distribution in rat lung 2 hr after intravenous injection,Rattus norvegicus,CHEMBL631822,
Intermediate,,A,6941,,,1,,,N,,14852,BAO_0000218,,1,,10116.0,,50597,Organ distribution in rat lung 30 minutes after intravenous injection,Rattus norvegicus,CHEMBL631823,
Intermediate,,A,6941,,,1,,,N,,14853,BAO_0000218,,1,,10116.0,2385.0,50597,Organ distribution in rat muscle 2 minutes after intravenous injection,Rattus norvegicus,CHEMBL631824,Muscle tissue
Intermediate,,A,6941,,,1,,,N,,14854,BAO_0000218,,1,,10116.0,2385.0,50597,Organ distribution in rat muscle 2 hr after intravenous injection,Rattus norvegicus,CHEMBL631825,Muscle tissue
Intermediate,,A,6941,,,1,,,N,,14855,BAO_0000218,,1,,10116.0,2385.0,50597,Organ distribution in rat muscle 30 minutes after intravenous injection,Rattus norvegicus,CHEMBL631826,Muscle tissue
Intermediate,,A,14439,In vivo,,1,,,N,,14856,BAO_0000218,,1,,10090.0,,50594,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),Mus musculus,CHEMBL631827,
Intermediate,,A,14439,In vivo,,1,,,N,,14857,BAO_0000218,,1,,10090.0,,50594,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),Mus musculus,CHEMBL631828,
Intermediate,,A,14439,In vivo,,1,,,N,,14858,BAO_0000218,,1,,10090.0,,50594,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),Mus musculus,CHEMBL631829,
Intermediate,,A,12582,,,1,,,N,,14859,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,Rattus norvegicus,CHEMBL875759,Urine
Intermediate,,A,12582,,,1,,,N,,14860,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,Rattus norvegicus,CHEMBL631830,Urine
Intermediate,,A,12582,,,1,,,N,,14861,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,Rattus norvegicus,CHEMBL631831,Urine
Intermediate,,A,12582,,,1,,,N,,14862,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,Rattus norvegicus,CHEMBL631832,Urine
Intermediate,,A,12582,,,1,,,N,,14863,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,Rattus norvegicus,CHEMBL631833,Urine
Intermediate,,A,12582,,,1,,,N,,14864,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,Rattus norvegicus,CHEMBL631834,Urine
Intermediate,,A,12582,,,1,,,N,,14865,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,Rattus norvegicus,CHEMBL631835,Urine
Intermediate,,A,12582,,,1,,,N,,14866,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,Rattus norvegicus,CHEMBL631836,Urine
Intermediate,,A,12582,,,1,,,N,,14867,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,Rattus norvegicus,CHEMBL631837,Urine
Intermediate,,A,12582,,,1,,,N,,14868,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,Rattus norvegicus,CHEMBL631838,Urine
Intermediate,,A,12582,,,1,,,N,,14869,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,Rattus norvegicus,CHEMBL631839,Urine
Intermediate,,A,12582,,,1,,,N,,14870,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,Rattus norvegicus,CHEMBL631840,Urine
Intermediate,,A,12582,,,1,,,N,,14871,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,Rattus norvegicus,CHEMBL631841,Urine
Intermediate,,A,12582,,,1,,,N,,14872,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,Rattus norvegicus,CHEMBL631842,Urine
Intermediate,,A,12582,,,1,,,N,,14873,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,Rattus norvegicus,CHEMBL631843,Urine
Intermediate,,A,12582,,,1,,,N,,14874,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,Rattus norvegicus,CHEMBL631844,Urine
Intermediate,,A,12582,,,1,,,N,,14875,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,Rattus norvegicus,CHEMBL631845,Urine
Intermediate,,A,12582,,,1,,,N,,14876,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,Rattus norvegicus,CHEMBL631846,Urine
Intermediate,,A,12582,,,1,,,N,,14877,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,Rattus norvegicus,CHEMBL875760,Urine
Intermediate,,A,12582,,,1,,,N,,14878,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,Rattus norvegicus,CHEMBL632199,Urine
Intermediate,,A,12582,,,1,,,N,,14879,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,Rattus norvegicus,CHEMBL631847,Urine
Intermediate,,A,12582,,,1,,,N,,14880,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,Rattus norvegicus,CHEMBL631848,Urine
Intermediate,,A,12582,,,1,,,N,,14881,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,Rattus norvegicus,CHEMBL628707,Urine
Intermediate,,A,12582,,,1,,,N,,14882,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,Rattus norvegicus,CHEMBL628708,Urine
Intermediate,,A,12582,,,1,,,N,,14883,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,Rattus norvegicus,CHEMBL628709,Urine
Intermediate,,A,12582,,,1,,,N,,14884,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,Rattus norvegicus,CHEMBL628710,Urine
Intermediate,,A,12582,,,1,,,N,,14885,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,Rattus norvegicus,CHEMBL628711,Urine
Intermediate,,A,12582,,,1,,,N,,14886,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,Rattus norvegicus,CHEMBL628712,Urine
Intermediate,,A,12582,,,1,,,N,,14887,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,Rattus norvegicus,CHEMBL628713,Urine
Intermediate,,A,12582,,,1,,,N,,14888,BAO_0000218,,1,,10116.0,1088.0,50597,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,Rattus norvegicus,CHEMBL628714,Urine
Intermediate,,A,7415,,,1,,,N,,14889,BAO_0000218,,1,,10116.0,,50597,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",Rattus norvegicus,CHEMBL628715,
Autocuration,,A,7313,,,1,,,U,,14890,BAO_0000019,,0,,,,22224,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,,CHEMBL629179,
Autocuration,,A,7313,,,1,,,U,,14891,BAO_0000019,,0,,,,22224,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,,CHEMBL629180,
Autocuration,,A,7313,,,1,,,U,,14892,BAO_0000019,,0,,,,22224,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,,CHEMBL875108,
Autocuration,,A,7570,,,1,,,U,,14893,BAO_0000019,,0,,,1235.0,22224,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,CHEMBL629181,Adrenal cortex
Autocuration,,A,7570,,,1,,,U,,14894,BAO_0000019,,0,,,1235.0,22224,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,CHEMBL629182,Adrenal cortex
Autocuration,,A,7570,,,1,,,U,,14895,BAO_0000019,,0,,,,22224,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,,CHEMBL629183,
Autocuration,,A,7570,,,1,,,U,,14896,BAO_0000019,,0,,,,22224,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,,CHEMBL629184,
Autocuration,,A,7570,,,1,,,U,,14897,BAO_0000019,,0,,,1235.0,22224,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,CHEMBL629185,Adrenal cortex
Autocuration,,A,7570,,,1,,,U,,14898,BAO_0000019,,0,,,1235.0,22224,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,,CHEMBL629186,Adrenal cortex
Autocuration,,A,7570,,,1,,,U,,14899,BAO_0000019,,0,,,,22224,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,,CHEMBL629187,
Autocuration,,A,7570,,,1,,,U,,14900,BAO_0000019,,0,,,,22224,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,,CHEMBL629887,
Autocuration,,A,7570,,,1,,,U,,14901,BAO_0000019,,0,,,,22224,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,,CHEMBL629888,
Autocuration,,A,7570,,,1,,,U,,14902,BAO_0000019,,0,,,,22224,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,,CHEMBL629889,
Autocuration,,A,7570,,,1,,,U,,14903,BAO_0000019,,0,,,1235.0,22224,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,,CHEMBL629890,Adrenal cortex
Autocuration,,A,7570,,,1,,,U,,14904,BAO_0000019,,0,,,,22224,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,,CHEMBL629891,
Autocuration,,A,7570,,,1,,,U,,14905,BAO_0000019,,0,,,,22224,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,,CHEMBL629892,
Autocuration,,A,7570,,,1,,,U,,14906,BAO_0000019,,0,,,1235.0,22224,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,CHEMBL629893,Adrenal cortex
Autocuration,,A,7570,,,1,,,U,,14907,BAO_0000019,,0,,,,22224,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,,CHEMBL629894,
Autocuration,,A,7570,,,1,,,U,,14908,BAO_0000019,,0,,,,22224,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,,CHEMBL629895,
Autocuration,,A,14122,In vivo,,1,,,U,,14909,BAO_0000218,,0,,9615.0,,22224,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",Canis lupus familiaris,CHEMBL875109,
Autocuration,,A,16449,In vivo,,1,,,U,,14910,BAO_0000218,,0,,9541.0,,22224,Absolute bioavailability in male cynomolgus monkeys,Macaca fascicularis,CHEMBL629896,
Autocuration,,A,16449,In vivo,,1,,,U,,14911,BAO_0000218,,0,,10116.0,,22224,Absolute bioavailability in maleSprague-Dawley rats,Rattus norvegicus,CHEMBL629897,
Intermediate,,A,12017,In vivo,,1,,,N,,14912,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,CHEMBL629898,Liver
Intermediate,,A,12017,In vivo,,1,,,N,,14913,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630057,Liver
Intermediate,,A,12017,In vivo,,1,,,N,,14914,BAO_0000218,,1,,10116.0,2107.0,50597,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630058,Liver
Intermediate,,A,12017,In vivo,,1,,,N,,14915,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630059,Lung
Intermediate,,A,12017,In vivo,,1,,,N,,14916,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630060,Lung
Intermediate,,A,12017,In vivo,,1,,,N,,14917,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,CHEMBL630061,Lung
Intermediate,,A,12017,In vivo,,1,,,N,,14918,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630062,Lung
Intermediate,,A,12017,In vivo,,1,,,N,,14919,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630063,Lung
Intermediate,,A,12017,In vivo,,1,,,N,,14920,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630064,Lung
Intermediate,,A,12017,In vivo,,1,,,N,,14921,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630065,Lung
Intermediate,,A,12017,In vivo,,1,,,N,,14922,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,CHEMBL630066,Lung
Intermediate,,A,12017,In vivo,,1,,,N,,14923,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630067,Lung
Intermediate,,A,12017,In vivo,,1,,,N,,14924,BAO_0000218,,1,,10116.0,2048.0,50597,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630068,Lung
Intermediate,,A,12017,In vivo,,1,,,N,,14925,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL631113,Muscle tissue
Intermediate,,A,12017,In vivo,,1,,,N,,14926,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL631114,Muscle tissue
Intermediate,,A,12017,In vivo,,1,,,N,,14927,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,CHEMBL631115,Muscle tissue
Intermediate,,A,12017,In vivo,,1,,,N,,14928,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL631116,Muscle tissue
Intermediate,,A,12017,In vivo,,1,,,N,,14929,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630528,Muscle tissue
Intermediate,,A,12017,In vivo,,1,,,N,,14930,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630529,Muscle tissue
Intermediate,,A,12017,In vivo,,1,,,N,,14931,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630530,Muscle tissue
Intermediate,,A,12017,In vivo,,1,,,N,,14932,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,CHEMBL630531,Muscle tissue
Intermediate,,A,12017,In vivo,,1,,,N,,14933,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630532,Muscle tissue
Intermediate,,A,12017,In vivo,,1,,,N,,14934,BAO_0000218,,1,,10116.0,2385.0,50597,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630533,Muscle tissue
Intermediate,,A,15045,In vivo,,1,,,N,,14935,BAO_0000218,,1,,10090.0,178.0,50594,Biodistribution in normal mice blood after 120 hr,Mus musculus,CHEMBL630534,Blood
Intermediate,,A,15045,In vivo,,1,,,N,,14936,BAO_0000218,,1,,10090.0,178.0,50594,Biodistribution in normal mice blood after 24 hr,Mus musculus,CHEMBL630535,Blood
Intermediate,,A,15045,In vivo,,1,,,N,,14937,BAO_0000218,,1,,10090.0,178.0,50594,Biodistribution in normal mice blood after 4 hr,Mus musculus,CHEMBL630536,Blood
Intermediate,,A,15045,In vivo,,1,,,N,,14938,BAO_0000218,,1,,10090.0,10000001.0,50594,Biodistribution in normal mice bone after 120 hr,Mus musculus,CHEMBL630537,Bone
Intermediate,,A,15045,In vivo,,1,,,N,,14939,BAO_0000218,,1,,10090.0,10000001.0,50594,Biodistribution in normal mice bone after 24 hr,Mus musculus,CHEMBL630538,Bone
Intermediate,,A,15045,In vivo,,1,,,N,,14940,BAO_0000218,,1,,10090.0,10000001.0,50594,Biodistribution in normal mice bone after 4 hr,Mus musculus,CHEMBL630539,Bone
Intermediate,,A,15045,In vivo,,1,,,N,,14941,BAO_0000218,,1,,10090.0,948.0,50594,Biodistribution in normal mice heart after 120 hr,Mus musculus,CHEMBL630540,Heart
Intermediate,,A,15045,In vivo,,1,,,N,,14942,BAO_0000218,,1,,10090.0,948.0,50594,Biodistribution in normal mice heart after 24 hr,Mus musculus,CHEMBL630541,Heart
Intermediate,,A,15045,In vivo,,1,,,N,,14943,BAO_0000218,,1,,10090.0,948.0,50594,Biodistribution in normal mice heart after 4 hr,Mus musculus,CHEMBL630542,Heart
Intermediate,,A,15045,In vivo,,1,,,N,,14944,BAO_0000218,,1,,10090.0,2113.0,50594,Biodistribution in normal mice kidney after 120 hr,Mus musculus,CHEMBL630543,Kidney
Intermediate,,A,15045,In vivo,,1,,,N,,14945,BAO_0000218,,1,,10090.0,2113.0,50594,Biodistribution in normal mice kidney after 24 hr,Mus musculus,CHEMBL630544,Kidney
Intermediate,,A,15045,In vivo,,1,,,N,,14946,BAO_0000218,,1,,10090.0,2113.0,50594,Biodistribution in normal mice kidney after 4 hr,Mus musculus,CHEMBL630545,Kidney
Intermediate,,A,15045,In vivo,,1,,,N,,14947,BAO_0000218,,1,,10090.0,2107.0,50594,Biodistribution in normal mice liver after 120 hr,Mus musculus,CHEMBL630546,Liver
Intermediate,,A,15045,In vivo,,1,,,N,,14948,BAO_0000218,,1,,10090.0,2107.0,50594,Biodistribution in normal mice liver after 24 hr,Mus musculus,CHEMBL630547,Liver
Intermediate,,A,15045,In vivo,,1,,,N,,14949,BAO_0000218,,1,,10090.0,2107.0,50594,Biodistribution in normal mice liver after 4 hr,Mus musculus,CHEMBL630548,Liver
Intermediate,,A,15045,In vivo,,1,,,N,,14950,BAO_0000218,,1,,10090.0,2106.0,50594,Biodistribution in normal mice spleen after 120 hr,Mus musculus,CHEMBL630549,Spleen
Intermediate,,A,15045,In vivo,,1,,,N,,14951,BAO_0000218,,1,,10090.0,2106.0,50594,Biodistribution in normal mice spleen after 24 hr,Mus musculus,CHEMBL630550,Spleen
Intermediate,,A,15045,In vivo,,1,,,N,,14952,BAO_0000218,,1,,10090.0,2106.0,50594,Biodistribution in normal mice spleen after 4 hr,Mus musculus,CHEMBL876426,Spleen
Intermediate,,A,12017,In vivo,,1,,,N,,14953,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630551,Spleen
Intermediate,,A,12017,In vivo,,1,,,N,,14954,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630552,Spleen
Intermediate,,A,12017,In vivo,,1,,,N,,14955,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,CHEMBL630553,Spleen
Intermediate,,A,12017,In vivo,,1,,,N,,14956,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630554,Spleen
Intermediate,,A,12017,In vivo,,1,,,N,,14957,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630555,Spleen
Intermediate,,A,12017,In vivo,,1,,,N,,14958,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630556,Spleen
Intermediate,,A,12017,In vivo,,1,,,N,,14959,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630557,Spleen
Intermediate,,A,12017,In vivo,,1,,,N,,14960,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,CHEMBL630558,Spleen
Intermediate,,A,12017,In vivo,,1,,,N,,14961,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630559,Spleen
Intermediate,,A,12017,In vivo,,1,,,N,,14962,BAO_0000218,,1,,10116.0,2106.0,50597,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL630560,Spleen
Intermediate,,A,12017,In vivo,,1,,,N,,14963,BAO_0000218,,1,,10116.0,2046.0,50597,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,CHEMBL876427,Thyroid gland
Intermediate,,A,14941,,,1,,,N,,14964,BAO_0000218,,1,,10116.0,,50597,The Kel values in female wistar rats.,Rattus norvegicus,CHEMBL630561,
Autocuration,,A,4646,,,1,,,U,,14965,BAO_0000019,,0,,,,22224,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,,CHEMBL630562,
Autocuration,,A,8847,,,1,,,U,,14966,BAO_0000019,,0,,,,22224,Hydrolysis rate constant of the compound,,CHEMBL630563,
Autocuration,,P,11778,,,1,,,U,,14967,BAO_0000100,,0,,,,22229,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,,CHEMBL629673,
Autocuration,,A,2363,,,1,,,U,,14968,BAO_0000019,,0,,,,22224,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",,CHEMBL629674,
Autocuration,,A,2363,,,1,,,U,,14969,BAO_0000019,,0,,,,22224,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",,CHEMBL629675,
Autocuration,,A,2363,,,1,,,U,,14970,BAO_0000019,,0,,,,22224,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",,CHEMBL629676,
Autocuration,,A,2363,,,1,,,U,,14971,BAO_0000019,,0,,,,22224,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",,CHEMBL629677,
Autocuration,,A,8371,,,1,,,U,,14972,BAO_0000019,,0,,,,22224,Apparent inactivation rate constant was evaluated,,CHEMBL629678,
Autocuration,,A,14883,,,1,,,U,,14973,BAO_0000019,,0,,,,22224,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,,CHEMBL629679,
Autocuration,,A,14883,,,1,,,U,,14974,BAO_0000019,,0,,,,22224,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,,CHEMBL629680,
Autocuration,,A,4643,,,1,,,U,,14975,BAO_0000019,,0,,,,22224,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,,CHEMBL629681,
Autocuration,,A,3519,,,1,,,U,,14976,BAO_0000019,,0,,,,22224,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,,CHEMBL629682,
Autocuration,,A,10600,,,1,,,U,,14977,BAO_0000019,,0,,,,22224,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,,CHEMBL629683,
Autocuration,,F,8501,,,1,,,U,,14978,BAO_0000019,,0,,,,22224,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,,CHEMBL629684,
Autocuration,,P,8505,,,1,,,U,,14979,BAO_0000100,,0,,,,22224,Dissociation constant was determined,,CHEMBL629685,
Autocuration,,P,9778,,,1,,,U,,14980,BAO_0000100,,0,,,,22224,Dissociation constant was determined,,CHEMBL629686,
Autocuration,,P,9778,,,1,,,U,,14981,BAO_0000100,,0,,,,22224,Dissociation constant at pH 7.4,,CHEMBL872932,
Autocuration,,P,9778,,,1,,,U,,14982,BAO_0000100,,0,,,,22224,Dissociation constant in presence of 1 mM dithiothreitol,,CHEMBL629687,
Autocuration,,A,13007,,,1,,,U,,14983,BAO_0000019,,0,,,,22224,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,CHEMBL872931,
Autocuration,,A,13007,,,1,,,U,,14984,BAO_0000019,,0,,,,22224,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,CHEMBL628151,
Autocuration,,A,13007,,,1,,,U,,14985,BAO_0000019,,0,,,,22224,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,CHEMBL628152,
Autocuration,,A,13007,,,1,,,U,,14986,BAO_0000019,,0,,,,22224,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,CHEMBL628153,
Autocuration,,A,11482,,,1,,,U,,14987,BAO_0000019,,0,,,,22224,Kinetic constant for aromatization of androstenedione,,CHEMBL628154,
Autocuration,,A,11482,,,1,,,U,,14988,BAO_0000019,,0,,,,22224,Kinetic constant for aromatization of testosterone,,CHEMBL628155,
Autocuration,,A,2303,,,1,,,U,,14989,BAO_0000019,,0,,,,22224,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,,CHEMBL628156,
Autocuration,,A,11964,,,1,,,U,,14990,BAO_0000019,,0,,,,22224,Local inhibition constant was determined,,CHEMBL628157,
Intermediate,,A,3140,,,1,,,N,,14991,BAO_0000218,,1,,4932.0,,50347,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,Saccharomyces cerevisiae,CHEMBL857533,
Autocuration,,P,10650,,,1,,,U,,14992,BAO_0000100,,0,,,,22224,Dissociation constant value of the compound,,CHEMBL628158,
Autocuration,,A,4667,,,1,,,U,,14993,BAO_0000019,,0,,,964.0,22224,In vitro permeability through cornea without epithelium,,CHEMBL628159,Cornea
Autocuration,,A,4667,,,1,,,U,,14994,BAO_0000019,,0,,,964.0,22224,In vitro permeability through intact cornea,,CHEMBL875616,Cornea
Intermediate,,A,9199,,,1,,,N,,14995,BAO_0000218,,1,,9986.0,964.0,50592,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,Oryctolagus cuniculus,CHEMBL628160,Cornea
Autocuration,,A,11966,,,1,,,U,,14996,BAO_0000019,,0,,,,22224,Rate of enzyme inactivation for the compound was determined,,CHEMBL628161,
Autocuration,,A,4667,,,1,,,U,,14997,BAO_0000019,,0,,,964.0,22224,In vitro permeability through cornea without epithelium,,CHEMBL628162,Cornea
Autocuration,,A,4667,,,1,,,U,,14998,BAO_0000019,,0,,,964.0,22224,In vitro permeability through intact cornea,,CHEMBL628163,Cornea
Autocuration,,A,8354,,,1,,,U,,14999,BAO_0000019,,0,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL628164,
Autocuration,,A,8354,,,1,,,U,,15000,BAO_0000019,,0,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL628165,
Autocuration,,A,8354,,,1,,,U,,15001,BAO_0000019,,0,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL628166,
Autocuration,,A,8354,,,1,,,U,,15002,BAO_0000019,,0,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL628167,
Autocuration,,A,8354,,,1,,,U,,15003,BAO_0000019,,0,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL628168,
Autocuration,,A,8354,,,1,,,U,,15004,BAO_0000019,,0,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL628169,
Autocuration,,A,8354,,,1,,,U,,15005,BAO_0000019,,0,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL628170,
Autocuration,,A,8354,,,1,,,U,,15006,BAO_0000019,,0,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL628171,
Autocuration,,A,8354,,,1,,,U,,15007,BAO_0000019,,0,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL627434,
Autocuration,,A,8354,,,1,,,U,,15008,BAO_0000019,,0,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL627435,
Autocuration,,A,8354,,,1,,,U,,15009,BAO_0000019,,0,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL628110,
Autocuration,,A,8354,,,1,,,U,,15010,BAO_0000019,,0,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL628111,
Autocuration,,A,8354,,,1,,,U,,15011,BAO_0000019,,0,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL628112,
Autocuration,,A,8354,,,1,,,U,,15012,BAO_0000019,,0,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL628260,
Autocuration,,A,8354,,,1,,,U,,15013,BAO_0000019,,0,,,,22224,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,CHEMBL628261,
Intermediate,,A,14439,In vivo,,1,,,N,,15014,BAO_0000218,,1,,10090.0,,50594,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),Mus musculus,CHEMBL628262,
Intermediate,,A,14439,In vivo,,1,,,N,,15015,BAO_0000218,,1,,9606.0,,50587,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,Homo sapiens,CHEMBL628263,
Intermediate,,A,14439,In vivo,,1,,,N,,15016,BAO_0000218,,1,,10090.0,,50594,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),Mus musculus,CHEMBL628264,
Intermediate,,A,14439,In vivo,,1,,,N,,15017,BAO_0000218,,1,,10090.0,,50594,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),Mus musculus,CHEMBL628265,
Intermediate,,A,14439,In vivo,,1,,,N,,15018,BAO_0000218,,1,,10090.0,,50594,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),Mus musculus,CHEMBL628266,
Intermediate,,A,14439,In vivo,,1,,,N,,15019,BAO_0000218,,1,,10090.0,,50594,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),Mus musculus,CHEMBL628267,
Intermediate,,A,14439,In vivo,,1,,,N,,15020,BAO_0000218,,1,,10090.0,,50594,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,Mus musculus,CHEMBL628268,
Intermediate,,A,14439,In vivo,,1,,,N,,15021,BAO_0000218,,1,,10090.0,,50594,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),Mus musculus,CHEMBL628269,
Intermediate,,A,14439,In vivo,,1,,,N,,15022,BAO_0000218,,1,,10090.0,,50594,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),Mus musculus,CHEMBL628270,
Intermediate,,A,14439,In vivo,,1,,,N,,15023,BAO_0000218,,1,,10090.0,,50594,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),Mus musculus,CHEMBL628271,
Intermediate,,A,14439,In vivo,,1,,,N,,15024,BAO_0000218,,1,,10090.0,,50594,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),Mus musculus,CHEMBL628272,
